,id,cid,dsn,cmpdname,srccmpd,srccmpdname,srccmpdurl,srctarget,srctargetname,srctargeturl,protacxn,protname,geneid,genename,taxid,taxname,action,actname,actvalue,evids,evurls,pmids,dois,citations
0,516223,3758,Comparative Toxicogenomics Database (CTD),3-Isobutyl-1-methylxanthine,D015056,1-Methyl-3-isobutylxanthine,https://ctdbase.org/detail.go?type=chem&acc=D015056,196441,ZFC3H1,https://ctdbase.org/detail.go?type=gene&acc=196441,,,196441.0,ZFC3H1,9606.0,Homo sapiens (human),[INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of ZFC3H1 mrna|[ins protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bisphenol F] results in decreased expression of ZFC3H1 mrna|[ins protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bisphenol A] results in decreased expression of ZFC3H1 mRNA,,,PMID:28628672,https://www.ncbi.nlm.nih.gov/pubmed/28628672,28628672,,
1,516224,3758,Comparative Toxicogenomics Database (CTD),3-Isobutyl-1-methylxanthine,D015056,1-Methyl-3-isobutylxanthine,https://ctdbase.org/detail.go?type=chem&acc=D015056,79776,ZFHX4,https://ctdbase.org/detail.go?type=gene&acc=79776,,,79776.0,ZFHX4,9606.0,Homo sapiens (human),[INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of ZFHX4 mrna|[ins protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bisphenol F] results in decreased expression of ZFHX4 mrna|[ins protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bisphenol A] results in decreased expression of ZFHX4 mRNA,,,PMID:28628672,https://www.ncbi.nlm.nih.gov/pubmed/28628672,28628672,,
2,518417,3758,Comparative Toxicogenomics Database (CTD),3-Isobutyl-1-methylxanthine,D015056,1-Methyl-3-isobutylxanthine,https://ctdbase.org/detail.go?type=chem&acc=D015056,23528,ZNF281,https://ctdbase.org/detail.go?type=gene&acc=23528,,,23528.0,ZNF281,9606.0,Homo sapiens (human),[INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bisphenol F] results in decreased expression of ZNF281 mRNA,,,PMID:28628672,https://www.ncbi.nlm.nih.gov/pubmed/28628672,28628672,,
3,520055,3758,Comparative Toxicogenomics Database (CTD),3-Isobutyl-1-methylxanthine,D015056,1-Methyl-3-isobutylxanthine,https://ctdbase.org/detail.go?type=chem&acc=D015056,8871,SYNJ2,https://ctdbase.org/detail.go?type=gene&acc=8871,,,8871.0,SYNJ2,9606.0,Homo sapiens (human),[INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of SYNJ2 mrna|[ins protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin] results in decreased expression of SYNJ2 mrna|[ins protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bisphenol A] results in decreased expression of SYNJ2 mRNA,,,PMID:28628672,https://www.ncbi.nlm.nih.gov/pubmed/28628672,28628672,,
4,520056,3758,Comparative Toxicogenomics Database (CTD),3-Isobutyl-1-methylxanthine,D015056,1-Methyl-3-isobutylxanthine,https://ctdbase.org/detail.go?type=chem&acc=D015056,8871,SYNJ2,https://ctdbase.org/detail.go?type=gene&acc=8871,,,8871.0,SYNJ2,9940.0,Ovis aries (sheep),[[biotin co-treated with pantothenic acid co-treated with INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with rosiglitazone] results in increased susceptibility to bisphenol A] which results in decreased expression of SYNJ2 mRNA,,,PMID:35504463,https://www.ncbi.nlm.nih.gov/pubmed/35504463,35504463,,
5,520057,3758,Comparative Toxicogenomics Database (CTD),3-Isobutyl-1-methylxanthine,D015056,1-Methyl-3-isobutylxanthine,https://ctdbase.org/detail.go?type=chem&acc=D015056,23336,SYNM,https://ctdbase.org/detail.go?type=gene&acc=23336,,,23336.0,SYNM,9606.0,Homo sapiens (human),[INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of SYNM mRNA,,,PMID:28628672,https://www.ncbi.nlm.nih.gov/pubmed/28628672,28628672,,
6,520856,3758,Comparative Toxicogenomics Database (CTD),3-Isobutyl-1-methylxanthine,D015056,1-Methyl-3-isobutylxanthine,https://ctdbase.org/detail.go?type=chem&acc=D015056,23102,TBC1D2B,https://ctdbase.org/detail.go?type=gene&acc=23102,,,23102.0,TBC1D2B,9606.0,Homo sapiens (human),[INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bisphenol A] results in increased expression of TBC1D2B mRNA,,,PMID:28628672,https://www.ncbi.nlm.nih.gov/pubmed/28628672,28628672,,
7,520857,3758,Comparative Toxicogenomics Database (CTD),3-Isobutyl-1-methylxanthine,D015056,1-Methyl-3-isobutylxanthine,https://ctdbase.org/detail.go?type=chem&acc=D015056,9779,TBC1D5,https://ctdbase.org/detail.go?type=gene&acc=9779,,,9779.0,TBC1D5,9606.0,Homo sapiens (human),[INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bisphenol A] results in increased expression of TBC1D5 mRNA,,,PMID:28628672,https://www.ncbi.nlm.nih.gov/pubmed/28628672,28628672,,
8,520858,3758,Comparative Toxicogenomics Database (CTD),3-Isobutyl-1-methylxanthine,D015056,1-Methyl-3-isobutylxanthine,https://ctdbase.org/detail.go?type=chem&acc=D015056,23158,TBC1D9,https://ctdbase.org/detail.go?type=gene&acc=23158,,,23158.0,TBC1D9,9606.0,Homo sapiens (human),[INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bisphenol F] results in increased expression of TBC1D9 mrna|[ins protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of TBC1D9 mRNA,,,PMID:28628672,https://www.ncbi.nlm.nih.gov/pubmed/28628672,28628672,,
9,520859,3758,Comparative Toxicogenomics Database (CTD),3-Isobutyl-1-methylxanthine,D015056,1-Methyl-3-isobutylxanthine,https://ctdbase.org/detail.go?type=chem&acc=D015056,23061,TBC1D9B,https://ctdbase.org/detail.go?type=gene&acc=23061,,,23061.0,TBC1D9B,9606.0,Homo sapiens (human),[INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of TBC1D9B mRNA,,,PMID:28628672,https://www.ncbi.nlm.nih.gov/pubmed/28628672,28628672,,
10,520860,3758,Comparative Toxicogenomics Database (CTD),3-Isobutyl-1-methylxanthine,D015056,1-Methyl-3-isobutylxanthine,https://ctdbase.org/detail.go?type=chem&acc=D015056,6903,TBCC,https://ctdbase.org/detail.go?type=gene&acc=6903,,,6903.0,TBCC,9606.0,Homo sapiens (human),[INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bisphenol A] results in increased expression of TBCC mRNA,,,PMID:28628672,https://www.ncbi.nlm.nih.gov/pubmed/28628672,28628672,,
11,520861,3758,Comparative Toxicogenomics Database (CTD),3-Isobutyl-1-methylxanthine,D015056,1-Methyl-3-isobutylxanthine,https://ctdbase.org/detail.go?type=chem&acc=D015056,6904,TBCD,https://ctdbase.org/detail.go?type=gene&acc=6904,,,6904.0,TBCD,9606.0,Homo sapiens (human),[INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bisphenol F] results in decreased expression of TBCD mrna|[ins protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bisphenol A] results in decreased expression of TBCD mRNA,,,PMID:28628672,https://www.ncbi.nlm.nih.gov/pubmed/28628672,28628672,,
12,520862,3758,Comparative Toxicogenomics Database (CTD),3-Isobutyl-1-methylxanthine,D015056,1-Methyl-3-isobutylxanthine,https://ctdbase.org/detail.go?type=chem&acc=D015056,219899,TBCEL,https://ctdbase.org/detail.go?type=gene&acc=219899,,,219899.0,TBCEL,9606.0,Homo sapiens (human),[INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bisphenol F] results in increased expression of TBCEL mRNA,,,PMID:28628672,https://www.ncbi.nlm.nih.gov/pubmed/28628672,28628672,,
13,520863,3758,Comparative Toxicogenomics Database (CTD),3-Isobutyl-1-methylxanthine,D015056,1-Methyl-3-isobutylxanthine,https://ctdbase.org/detail.go?type=chem&acc=D015056,90665,TBL1Y,https://ctdbase.org/detail.go?type=gene&acc=90665,,,90665.0,TBL1Y,9606.0,Homo sapiens (human),[INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bisphenol A] results in decreased expression of TBL1Y mRNA,,,PMID:28628672,https://www.ncbi.nlm.nih.gov/pubmed/28628672,28628672,,
14,525045,3758,Comparative Toxicogenomics Database (CTD),3-Isobutyl-1-methylxanthine,D015056,1-Methyl-3-isobutylxanthine,https://ctdbase.org/detail.go?type=chem&acc=D015056,23673,STX12,https://ctdbase.org/detail.go?type=gene&acc=23673,,,23673.0,STX12,9606.0,Homo sapiens (human),[INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bisphenol A] results in increased expression of STX12 mRNA,,,PMID:28628672,https://www.ncbi.nlm.nih.gov/pubmed/28628672,28628672,,
15,526988,3758,Comparative Toxicogenomics Database (CTD),3-Isobutyl-1-methylxanthine,D015056,1-Methyl-3-isobutylxanthine,https://ctdbase.org/detail.go?type=chem&acc=D015056,84790,TUBA1C,https://ctdbase.org/detail.go?type=gene&acc=84790,,,84790.0,TUBA1C,9606.0,Homo sapiens (human),[INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bisphenol F] results in decreased expression of TUBA1C mrna|[ins protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bisphenol A] results in decreased expression of TUBA1C mRNA,,,PMID:28628672,https://www.ncbi.nlm.nih.gov/pubmed/28628672,28628672,,
16,516571,3973,Comparative Toxicogenomics Database (CTD),2-(4-Morpholinyl)-8-phenyl-4H-1-benzopyran-4-one,C085911,2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one,https://ctdbase.org/detail.go?type=chem&acc=C085911,3606,IL18,https://ctdbase.org/detail.go?type=gene&acc=3606,,,3606.0,IL18,10116.0,Rattus norvegicus (Norway rat),2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [sodium bisulfide inhibits the reaction [uranyl acetate results in increased secretion of IL18 protein]],,,PMID:36094782,https://www.ncbi.nlm.nih.gov/pubmed/36094782,36094782,,
17,516572,3973,Comparative Toxicogenomics Database (CTD),2-(4-Morpholinyl)-8-phenyl-4H-1-benzopyran-4-one,C085911,2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one,https://ctdbase.org/detail.go?type=chem&acc=C085911,3552,IL1A,https://ctdbase.org/detail.go?type=gene&acc=3552,,,3552.0,IL1A,9606.0,Homo sapiens (human),2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [IL1A protein results in increased expression of BDKRB1 protein],,,PMID:29775649,https://www.ncbi.nlm.nih.gov/pubmed/29775649,29775649,,
18,516573,3973,Comparative Toxicogenomics Database (CTD),2-(4-Morpholinyl)-8-phenyl-4H-1-benzopyran-4-one,C085911,2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one,https://ctdbase.org/detail.go?type=chem&acc=C085911,3553,IL1B,https://ctdbase.org/detail.go?type=gene&acc=3553,,,3553.0,IL1B,9606.0,Homo sapiens (human),2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [digitoxin inhibits the reaction [IL1B protein results in increased expression of CCL2 protein]]|2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [digitoxin inhibits the reaction [IL1B protein results in increased activity of NFKB1 protein]],,,PMID:19446813,https://www.ncbi.nlm.nih.gov/pubmed/19446813,19446813,,
19,516574,3973,Comparative Toxicogenomics Database (CTD),2-(4-Morpholinyl)-8-phenyl-4H-1-benzopyran-4-one,C085911,2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one,https://ctdbase.org/detail.go?type=chem&acc=C085911,3553,IL1B,https://ctdbase.org/detail.go?type=gene&acc=3553,,,3553.0,IL1B,9606.0,Homo sapiens (human),2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [IL1B protein results in increased expression of MMP12 mrna]|2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [IL1B protein results in increased activity of MMP12 protein],,,PMID:16359550,https://www.ncbi.nlm.nih.gov/pubmed/16359550,16359550,,
20,518261,3973,Comparative Toxicogenomics Database (CTD),2-(4-Morpholinyl)-8-phenyl-4H-1-benzopyran-4-one,C085911,2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one,https://ctdbase.org/detail.go?type=chem&acc=C085911,5595,MAPK3,https://ctdbase.org/detail.go?type=gene&acc=5595,,,5595.0,MAPK3,9606.0,Homo sapiens (human),Tamibarotene promotes the reaction [2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in decreased phosphorylation of and results in decreased activity of MAPK3 protein]|2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in decreased phosphorylation of and results in decreased activity of MAPK3 protein,,,PMID:15020266,https://www.ncbi.nlm.nih.gov/pubmed/15020266,15020266,,
21,518262,3973,Comparative Toxicogenomics Database (CTD),2-(4-Morpholinyl)-8-phenyl-4H-1-benzopyran-4-one,C085911,2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one,https://ctdbase.org/detail.go?type=chem&acc=C085911,5595,MAPK3,https://ctdbase.org/detail.go?type=gene&acc=5595,,,5595.0,MAPK3,9606.0,Homo sapiens (human),2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in decreased phosphorylation of MAPK3 protein,,,PMID:14757120|PMID:24568969|PMID:27032576,https://www.ncbi.nlm.nih.gov/pubmed/14757120|https://www.ncbi.nlm.nih.gov/pubmed/24568969|https://www.ncbi.nlm.nih.gov/pubmed/27032576,14757120|24568969|27032576,,
22,518263,3973,Comparative Toxicogenomics Database (CTD),2-(4-Morpholinyl)-8-phenyl-4H-1-benzopyran-4-one,C085911,2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one,https://ctdbase.org/detail.go?type=chem&acc=C085911,5595,MAPK3,https://ctdbase.org/detail.go?type=gene&acc=5595,,,5595.0,MAPK3,9606.0,Homo sapiens (human),2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in increased phosphorylation of MAPK3 protein,,,PMID:19139269,https://www.ncbi.nlm.nih.gov/pubmed/19139269,19139269,,
23,518264,3973,Comparative Toxicogenomics Database (CTD),2-(4-Morpholinyl)-8-phenyl-4H-1-benzopyran-4-one,C085911,2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one,https://ctdbase.org/detail.go?type=chem&acc=C085911,5595,MAPK3,https://ctdbase.org/detail.go?type=gene&acc=5595,,,5595.0,MAPK3,10090.0,Mus musculus (house mouse),2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [etoxazole results in increased phosphorylation of MAPK3 protein],,,PMID:33618463,https://www.ncbi.nlm.nih.gov/pubmed/33618463,33618463,,
24,518265,3973,Comparative Toxicogenomics Database (CTD),2-(4-Morpholinyl)-8-phenyl-4H-1-benzopyran-4-one,C085911,2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one,https://ctdbase.org/detail.go?type=chem&acc=C085911,5595,MAPK3,https://ctdbase.org/detail.go?type=gene&acc=5595,,,5595.0,MAPK3,10090.0,Mus musculus (house mouse),2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [flufenoxuron results in increased phosphorylation of MAPK3 protein],,,PMID:33771252,https://www.ncbi.nlm.nih.gov/pubmed/33771252,33771252,,
25,519744,3973,Comparative Toxicogenomics Database (CTD),2-(4-Morpholinyl)-8-phenyl-4H-1-benzopyran-4-one,C085911,2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one,https://ctdbase.org/detail.go?type=chem&acc=C085911,4323,MMP14,https://ctdbase.org/detail.go?type=gene&acc=4323,,,4323.0,MMP14,10090.0,Mus musculus (house mouse),2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in decreased activity of MMP14 protein,,,PMID:22326785,https://www.ncbi.nlm.nih.gov/pubmed/22326785,22326785,,
26,519745,3973,Comparative Toxicogenomics Database (CTD),2-(4-Morpholinyl)-8-phenyl-4H-1-benzopyran-4-one,C085911,2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one,https://ctdbase.org/detail.go?type=chem&acc=C085911,4323,MMP14,https://ctdbase.org/detail.go?type=gene&acc=4323,,,4323.0,MMP14,10090.0,Mus musculus (house mouse),2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in decreased expression of MMP14 mRNA,,,PMID:19393235|PMID:22326785,https://www.ncbi.nlm.nih.gov/pubmed/19393235|https://www.ncbi.nlm.nih.gov/pubmed/22326785,19393235|22326785,,
27,519746,3973,Comparative Toxicogenomics Database (CTD),2-(4-Morpholinyl)-8-phenyl-4H-1-benzopyran-4-one,C085911,2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one,https://ctdbase.org/detail.go?type=chem&acc=C085911,4323,MMP14,https://ctdbase.org/detail.go?type=gene&acc=4323,,,4323.0,MMP14,10090.0,Mus musculus (house mouse),2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in decreased expression of MMP14 protein,,,PMID:19393235,https://www.ncbi.nlm.nih.gov/pubmed/19393235,19393235,,
28,519747,3973,Comparative Toxicogenomics Database (CTD),2-(4-Morpholinyl)-8-phenyl-4H-1-benzopyran-4-one,C085911,2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one,https://ctdbase.org/detail.go?type=chem&acc=C085911,4313,MMP2,https://ctdbase.org/detail.go?type=gene&acc=4313,,,4313.0,MMP2,9606.0,Homo sapiens (human),2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [bisphenol A results in increased expression of and results in increased activity of MMP2 protein],,,PMID:24997338,https://www.ncbi.nlm.nih.gov/pubmed/24997338,24997338,,
29,519748,3973,Comparative Toxicogenomics Database (CTD),2-(4-Morpholinyl)-8-phenyl-4H-1-benzopyran-4-one,C085911,2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one,https://ctdbase.org/detail.go?type=chem&acc=C085911,4313,MMP2,https://ctdbase.org/detail.go?type=gene&acc=4313,,,4313.0,MMP2,9606.0,Homo sapiens (human),2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [bisphenol A results in increased expression of MMP2 protein]|2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [estradiol results in decreased expression of MMP2 mrna]|2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [estradiol results in decreased expression of MMP2 protein]|2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [diethylhexyl phthalate results in increased expression of MMP2 protein]|2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [diethylhexyl phthalate results in increased expression of MMP2 mrna]|2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [bisphenol A results in increased expression of MMP2 mrna],,,PMID:19956873,https://www.ncbi.nlm.nih.gov/pubmed/19956873,19956873,,
30,531163,4002,Drug Gene Interaction database (DGIdb),Makaluvamine A,,MAKALUVAMINE A,https://www.dgidb.org/drugs/chembl:CHEMBL449905,,TOP2A,https://www.dgidb.org/genes/hgnc:11989,,,7153.0,TOP2A,9606.0,Homo sapiens (human),,,,,,,,
31,531164,4004,Drug Gene Interaction database (DGIdb),Malathion,,MALATHION,https://www.dgidb.org/drugs/rxcui:6606,,ACHE,https://www.dgidb.org/genes/hgnc:108,,,43.0,ACHE,9606.0,Homo sapiens (human),,,,,,,,
32,520216,4011,Toxin and Toxin Target Database (T3DB),Maprotiline,T3D2934,Maprotiline,http://www.t3db.ca/toxins/T3D2934,BE0000442,Histamine H1 receptor,http://www.t3db.ca/biodb/bio_entities/BE0000442,P35367,Histamine H1 receptor,3269.0,HRH1,9606.0,Homo sapiens (human),"Maprotiline exerts its antidepressant action by inhibition of presynaptic uptake of catecholamines, thereby increasing their concentration at the synaptic clefts of the brain. in single doses, the effect of maprotiline on the EEG revealed a rise in the alpha-wave density, a reduction of the alpha-wave frequency and an increase in the alpha-wave amplitude. however, as with other tricyclic antidepressants, maprotiline lowers the convulsive threshold. maprotiline acts as an antagonist at central presynaptic α2 adrenergic inhibitory autoreceptors and hetero-receptors, an action that is postulated to result in an increase in central noradrenergic and serotonergic activity. maprotiline is also a moderate peripheral α1 adrenergic antagonist, which may explain the occasional orthostatic hypotension reported in association with its use. maprotiline also inhibits the amine transporter, delaying the reuptake of noradrenaline and norepinephrine. lastly, maprotiline is a strong inhibitor of the histamine H1 receptor, which explains its sedative actions.",,,PMID:1353628|PMID:19091563|PMID:6146381,https://www.ncbi.nlm.nih.gov/pubmed/1353628|https://www.ncbi.nlm.nih.gov/pubmed/19091563|https://www.ncbi.nlm.nih.gov/pubmed/6146381,1353628|19091563|6146381,,
33,531165,4021,Comparative Toxicogenomics Database (CTD),Edaravone,D000077553,Edaravone,https://ctdbase.org/detail.go?type=chem&acc=D000077553,6383,SDC2,https://ctdbase.org/detail.go?type=gene&acc=6383,,,6383.0,SDC2,10116.0,Rattus norvegicus (Norway rat),Edaravone inhibits the reaction [SDC2 protein results in increased expression of and results in increased secretion of TNF protein]|edaravone inhibits the reaction [SDC2 protein results in increased expression of and results in increased secretion of IL1B protein]|edaravone inhibits the reaction [SDC2 protein results in increased expression of and results in increased secretion of CXCL12 protein]|edaravone inhibits the reaction [SDC2 protein results in increased expression of and results in increased secretion of CCL2 protein]|edaravone inhibits the reaction [SDC2 protein promotes the reaction [oxygen deficiency results in increased abundance of reactive oxygen species]],,,PMID:18803305,https://www.ncbi.nlm.nih.gov/pubmed/18803305,18803305,,
34,531166,4021,Comparative Toxicogenomics Database (CTD),Edaravone,D000077553,Edaravone,https://ctdbase.org/detail.go?type=chem&acc=D000077553,6401,SELE,https://ctdbase.org/detail.go?type=gene&acc=6401,,,6401.0,SELE,10116.0,Rattus norvegicus (Norway rat),Edaravone results in decreased expression of SELE protein|edaravone results in decreased expression of SELE mRNA,,,PMID:17064733,https://www.ncbi.nlm.nih.gov/pubmed/17064733,17064733,,
35,531167,4021,Comparative Toxicogenomics Database (CTD),Edaravone,D000077553,Edaravone,https://ctdbase.org/detail.go?type=chem&acc=D000077553,6403,SELP,https://ctdbase.org/detail.go?type=gene&acc=6403,,,6403.0,SELP,9615.0,Canis lupus familiaris (dog),Edaravone results in decreased expression of SELP protein,,,PMID:16041266,https://www.ncbi.nlm.nih.gov/pubmed/16041266,16041266,,
36,531168,4021,Comparative Toxicogenomics Database (CTD),Edaravone,D000077553,Edaravone,https://ctdbase.org/detail.go?type=chem&acc=D000077553,55117,SLC6A15,https://ctdbase.org/detail.go?type=gene&acc=55117,,,55117.0,SLC6A15,10090.0,Mus musculus (house mouse),Edaravone inhibits the reaction [corticosterone results in decreased expression of SLC6A15 mrna],,,PMID:31344373,https://www.ncbi.nlm.nih.gov/pubmed/31344373,31344373,,
37,522999,4116,Toxin and Toxin Target Database (T3DB),Methoxyflurane,T3D2962,Methoxyflurane,http://www.t3db.ca/toxins/T3D2962,BE0000218,Calcium-transporting ATPase type 2C member 1,http://www.t3db.ca/biodb/bio_entities/BE0000218,P98194,Calcium-transporting ATPase type 2C member 1,27032.0,ATP2C1,9606.0,Homo sapiens (human),"Methoxyflurane induces a reduction in junctional conductance by decreasing gap junction channel opening times and increasing gap junction channel closing times. methoxyflurane also activates calcium dependent atpase in the sarcoplasmic reticulum by increasing the fluidity of the lipid membrane. it also appears to bind the D subunit of ATP synthase and NADH dehydogenase. methoxyflurane also binds to the GABA receptor, the large conductance ca<sup>2+</sup> activated potassium channel, the glutamate receptor and the glycine receptor.",,,PMID:17139284|PMID:17016423,https://www.ncbi.nlm.nih.gov/pubmed/17139284|https://www.ncbi.nlm.nih.gov/pubmed/17016423,17139284|17016423,,
38,523000,4116,Toxin and Toxin Target Database (T3DB),Methoxyflurane,T3D2962,Methoxyflurane,http://www.t3db.ca/toxins/T3D2962,BE0000795,Gamma-aminobutyric acid receptor subunit alpha-1,http://www.t3db.ca/biodb/bio_entities/BE0000795,P14867,Gamma-aminobutyric acid receptor subunit alpha-1,2554.0,GABRA1,9606.0,Homo sapiens (human),"Methoxyflurane induces a reduction in junctional conductance by decreasing gap junction channel opening times and increasing gap junction channel closing times. methoxyflurane also activates calcium dependent atpase in the sarcoplasmic reticulum by increasing the fluidity of the lipid membrane. it also appears to bind the D subunit of ATP synthase and NADH dehydogenase. methoxyflurane also binds to the GABA receptor, the large conductance ca<sup>2+</sup> activated potassium channel, the glutamate receptor and the glycine receptor.",,,PMID:17139284|PMID:17016423,https://www.ncbi.nlm.nih.gov/pubmed/17139284|https://www.ncbi.nlm.nih.gov/pubmed/17016423,17139284|17016423,,
39,523001,4116,Toxin and Toxin Target Database (T3DB),Methoxyflurane,T3D2962,Methoxyflurane,http://www.t3db.ca/toxins/T3D2962,BE0000640,Glutamate receptor 1,http://www.t3db.ca/biodb/bio_entities/BE0000640,P42261,Glutamate receptor 1,2890.0,GRIA1,9606.0,Homo sapiens (human),"Methoxyflurane induces a reduction in junctional conductance by decreasing gap junction channel opening times and increasing gap junction channel closing times. methoxyflurane also activates calcium dependent atpase in the sarcoplasmic reticulum by increasing the fluidity of the lipid membrane. it also appears to bind the D subunit of ATP synthase and NADH dehydogenase. methoxyflurane also binds to the GABA receptor, the large conductance ca<sup>2+</sup> activated potassium channel, the glutamate receptor and the glycine receptor.",,,PMID:17139284|PMID:17016423,https://www.ncbi.nlm.nih.gov/pubmed/17139284|https://www.ncbi.nlm.nih.gov/pubmed/17016423,17139284|17016423,,
40,523002,4116,Toxin and Toxin Target Database (T3DB),Methoxyflurane,T3D2962,Methoxyflurane,http://www.t3db.ca/toxins/T3D2962,BE0000433,Glycine receptor subunit alpha-1,http://www.t3db.ca/biodb/bio_entities/BE0000433,P23415,Glycine receptor subunit alpha-1,2741.0,GLRA1,9606.0,Homo sapiens (human),"Methoxyflurane induces a reduction in junctional conductance by decreasing gap junction channel opening times and increasing gap junction channel closing times. methoxyflurane also activates calcium dependent atpase in the sarcoplasmic reticulum by increasing the fluidity of the lipid membrane. it also appears to bind the D subunit of ATP synthase and NADH dehydogenase. methoxyflurane also binds to the GABA receptor, the large conductance ca<sup>2+</sup> activated potassium channel, the glutamate receptor and the glycine receptor.",,,PMID:17139284|PMID:17016423,https://www.ncbi.nlm.nih.gov/pubmed/17139284|https://www.ncbi.nlm.nih.gov/pubmed/17016423,17139284|17016423,,
41,523003,4116,Toxin and Toxin Target Database (T3DB),Methoxyflurane,T3D2962,Methoxyflurane,http://www.t3db.ca/toxins/T3D2962,BE0000503,NADH-ubiquinone oxidoreductase chain 1,http://www.t3db.ca/biodb/bio_entities/BE0000503,P03886,NADH-ubiquinone oxidoreductase chain 1,4535.0,ND1,9606.0,Homo sapiens (human),"Methoxyflurane induces a reduction in junctional conductance by decreasing gap junction channel opening times and increasing gap junction channel closing times. methoxyflurane also activates calcium dependent atpase in the sarcoplasmic reticulum by increasing the fluidity of the lipid membrane. it also appears to bind the D subunit of ATP synthase and NADH dehydogenase. methoxyflurane also binds to the GABA receptor, the large conductance ca<sup>2+</sup> activated potassium channel, the glutamate receptor and the glycine receptor.",,,PMID:17139284|PMID:17016423,https://www.ncbi.nlm.nih.gov/pubmed/17139284|https://www.ncbi.nlm.nih.gov/pubmed/17016423,17139284|17016423,,
42,523004,4116,Toxin and Toxin Target Database (T3DB),Methoxyflurane,T3D2962,Methoxyflurane,http://www.t3db.ca/toxins/T3D2962,BE0000781,Potassium voltage-gated channel subfamily A member 1,http://www.t3db.ca/biodb/bio_entities/BE0000781,Q09470,Potassium voltage-gated channel subfamily A member 1,3736.0,KCNA1,9606.0,Homo sapiens (human),"Methoxyflurane induces a reduction in junctional conductance by decreasing gap junction channel opening times and increasing gap junction channel closing times. methoxyflurane also activates calcium dependent atpase in the sarcoplasmic reticulum by increasing the fluidity of the lipid membrane. it also appears to bind the D subunit of ATP synthase and NADH dehydogenase. methoxyflurane also binds to the GABA receptor, the large conductance ca<sup>2+</sup> activated potassium channel, the glutamate receptor and the glycine receptor.",,,PMID:17139284|PMID:17016423,https://www.ncbi.nlm.nih.gov/pubmed/17139284|https://www.ncbi.nlm.nih.gov/pubmed/17016423,17139284|17016423,,
43,518095,4156,Comparative Toxicogenomics Database (CTD),Methyl methanesulfonate,D008741,Methyl Methanesulfonate,https://ctdbase.org/detail.go?type=chem&acc=D008741,335894,DNAJA3A,https://ctdbase.org/detail.go?type=gene&acc=335894,,,335894.0,dnaja3a,7955.0,Danio rerio (zebrafish),Methyl methanesulfonate results in increased expression of DNAJA3A mRNA,,,PMID:26011545,https://www.ncbi.nlm.nih.gov/pubmed/26011545,26011545,,
44,518096,4156,Comparative Toxicogenomics Database (CTD),Methyl methanesulfonate,D008741,Methyl Methanesulfonate,https://ctdbase.org/detail.go?type=chem&acc=D008741,3337,DNAJB1,https://ctdbase.org/detail.go?type=gene&acc=3337,,,3337.0,DNAJB1,9606.0,Homo sapiens (human),Methyl methanesulfonate results in increased expression of DNAJB1 mRNA,,,PMID:23649840,https://www.ncbi.nlm.nih.gov/pubmed/23649840,23649840,,
45,519238,4156,Comparative Toxicogenomics Database (CTD),Methyl methanesulfonate,D008741,Methyl Methanesulfonate,https://ctdbase.org/detail.go?type=chem&acc=D008741,100151488,DOCK9B,https://ctdbase.org/detail.go?type=gene&acc=100151488,,,100151488.0,dock9b,7955.0,Danio rerio (zebrafish),Methyl methanesulfonate results in decreased expression of DOCK9B mRNA,,,PMID:26011545,https://www.ncbi.nlm.nih.gov/pubmed/26011545,26011545,,
46,519239,4156,Comparative Toxicogenomics Database (CTD),Methyl methanesulfonate,D008741,Methyl Methanesulfonate,https://ctdbase.org/detail.go?type=chem&acc=D008741,83475,DOHH,https://ctdbase.org/detail.go?type=gene&acc=83475,,,83475.0,DOHH,7955.0,Danio rerio (zebrafish),Methyl methanesulfonate results in increased expression of DOHH mRNA,,,PMID:26011545,https://www.ncbi.nlm.nih.gov/pubmed/26011545,26011545,,
47,519240,4156,Comparative Toxicogenomics Database (CTD),Methyl methanesulfonate,D008741,Methyl Methanesulfonate,https://ctdbase.org/detail.go?type=chem&acc=D008741,55715,DOK4,https://ctdbase.org/detail.go?type=gene&acc=55715,,,55715.0,DOK4,7955.0,Danio rerio (zebrafish),Methyl methanesulfonate results in decreased expression of DOK4 mRNA,,,PMID:26011545,https://www.ncbi.nlm.nih.gov/pubmed/26011545,26011545,,
48,519241,4156,Comparative Toxicogenomics Database (CTD),Methyl methanesulfonate,D008741,Methyl Methanesulfonate,https://ctdbase.org/detail.go?type=chem&acc=D008741,220164,DOK6,https://ctdbase.org/detail.go?type=gene&acc=220164,,,220164.0,DOK6,7955.0,Danio rerio (zebrafish),Methyl methanesulfonate results in decreased expression of DOK6 mRNA,,,PMID:26011545,https://www.ncbi.nlm.nih.gov/pubmed/26011545,26011545,,
49,519242,4156,Comparative Toxicogenomics Database (CTD),Methyl methanesulfonate,D008741,Methyl Methanesulfonate,https://ctdbase.org/detail.go?type=chem&acc=D008741,57171,DOLPP1,https://ctdbase.org/detail.go?type=gene&acc=57171,,,57171.0,DOLPP1,7955.0,Danio rerio (zebrafish),Methyl methanesulfonate results in decreased expression of DOLPP1 mRNA,,,PMID:26011545,https://www.ncbi.nlm.nih.gov/pubmed/26011545,26011545,,
50,519243,4156,Comparative Toxicogenomics Database (CTD),Methyl methanesulfonate,D008741,Methyl Methanesulfonate,https://ctdbase.org/detail.go?type=chem&acc=D008741,29980,DONSON,https://ctdbase.org/detail.go?type=gene&acc=29980,,,29980.0,DONSON,9606.0,Homo sapiens (human),Methyl methanesulfonate results in increased expression of DONSON mRNA,,,PMID:23649840,https://www.ncbi.nlm.nih.gov/pubmed/23649840,23649840,,
51,519244,4156,Comparative Toxicogenomics Database (CTD),Methyl methanesulfonate,D008741,Methyl Methanesulfonate,https://ctdbase.org/detail.go?type=chem&acc=D008741,23033,DOP1A,https://ctdbase.org/detail.go?type=gene&acc=23033,,,23033.0,DOP1A,9606.0,Homo sapiens (human),Methyl methanesulfonate results in increased expression of DOP1A mRNA,,,PMID:23649840,https://www.ncbi.nlm.nih.gov/pubmed/23649840,23649840,,
52,519245,4156,Comparative Toxicogenomics Database (CTD),Methyl methanesulfonate,D008741,Methyl Methanesulfonate,https://ctdbase.org/detail.go?type=chem&acc=D008741,9980,DOP1B,https://ctdbase.org/detail.go?type=gene&acc=9980,,,9980.0,DOP1B,9606.0,Homo sapiens (human),Methyl methanesulfonate results in increased expression of DOP1B mRNA,,,PMID:23649840,https://www.ncbi.nlm.nih.gov/pubmed/23649840,23649840,,
53,521012,4156,Comparative Toxicogenomics Database (CTD),Methyl methanesulfonate,D008741,Methyl Methanesulfonate,https://ctdbase.org/detail.go?type=chem&acc=D008741,144455,E2F7,https://ctdbase.org/detail.go?type=gene&acc=144455,,,144455.0,E2F7,9606.0,Homo sapiens (human),Methyl methanesulfonate results in increased expression of E2F7 mRNA,,,PMID:23649840,https://www.ncbi.nlm.nih.gov/pubmed/23649840,23649840,,
54,521013,4156,Comparative Toxicogenomics Database (CTD),Methyl methanesulfonate,D008741,Methyl Methanesulfonate,https://ctdbase.org/detail.go?type=chem&acc=D008741,79733,E2F8,https://ctdbase.org/detail.go?type=gene&acc=79733,,,79733.0,E2F8,7955.0,Danio rerio (zebrafish),Methyl methanesulfonate results in decreased expression of E2F8 mRNA,,,PMID:26011545,https://www.ncbi.nlm.nih.gov/pubmed/26011545,26011545,,
55,523005,4156,Comparative Toxicogenomics Database (CTD),Methyl methanesulfonate,D008741,Methyl Methanesulfonate,https://ctdbase.org/detail.go?type=chem&acc=D008741,8665,EIF3F,https://ctdbase.org/detail.go?type=gene&acc=8665,,,8665.0,EIF3F,7955.0,Danio rerio (zebrafish),Methyl methanesulfonate results in increased expression of EIF3F mRNA,,,PMID:26011545,https://www.ncbi.nlm.nih.gov/pubmed/26011545,26011545,,
56,524867,4156,Comparative Toxicogenomics Database (CTD),Methyl methanesulfonate,D008741,Methyl Methanesulfonate,https://ctdbase.org/detail.go?type=chem&acc=D008741,91966,EOLA1,https://ctdbase.org/detail.go?type=gene&acc=91966,,,91966.0,EOLA1,9606.0,Homo sapiens (human),Methyl methanesulfonate results in increased expression of EOLA1 mRNA,,,PMID:23649840,https://www.ncbi.nlm.nih.gov/pubmed/23649840,23649840,,
57,525704,4156,Comparative Toxicogenomics Database (CTD),Methyl methanesulfonate,D008741,Methyl Methanesulfonate,https://ctdbase.org/detail.go?type=chem&acc=D008741,1161,ERCC8,https://ctdbase.org/detail.go?type=gene&acc=1161,,,1161.0,ERCC8,7955.0,Danio rerio (zebrafish),Methyl methanesulfonate results in increased expression of ERCC8 mRNA,,,PMID:26011545,https://www.ncbi.nlm.nih.gov/pubmed/26011545,26011545,,
58,525705,4156,Comparative Toxicogenomics Database (CTD),Methyl methanesulfonate,D008741,Methyl Methanesulfonate,https://ctdbase.org/detail.go?type=chem&acc=D008741,1161,ERCC8,https://ctdbase.org/detail.go?type=gene&acc=1161,,,1161.0,ERCC8,9606.0,Homo sapiens (human),Methyl methanesulfonate results in increased expression of ERCC8 mRNA,,,PMID:23649840,https://www.ncbi.nlm.nih.gov/pubmed/23649840,23649840,,
59,525706,4156,Comparative Toxicogenomics Database (CTD),Methyl methanesulfonate,D008741,Methyl Methanesulfonate,https://ctdbase.org/detail.go?type=chem&acc=D008741,558126,ERFL1,https://ctdbase.org/detail.go?type=gene&acc=558126,,,558126.0,erfl1,7955.0,Danio rerio (zebrafish),Methyl methanesulfonate results in increased expression of ERFL1 mRNA,,,PMID:26011545,https://www.ncbi.nlm.nih.gov/pubmed/26011545,26011545,,
60,526347,4156,Comparative Toxicogenomics Database (CTD),Methyl methanesulfonate,D008741,Methyl Methanesulfonate,https://ctdbase.org/detail.go?type=chem&acc=D008741,84141,EVA1A,https://ctdbase.org/detail.go?type=gene&acc=84141,,,84141.0,EVA1A,7955.0,Danio rerio (zebrafish),Methyl methanesulfonate results in decreased expression of EVA1A mRNA,,,PMID:26011545,https://www.ncbi.nlm.nih.gov/pubmed/26011545,26011545,,
61,526832,4156,Comparative Toxicogenomics Database (CTD),Methyl methanesulfonate,D008741,Methyl Methanesulfonate,https://ctdbase.org/detail.go?type=chem&acc=D008741,56915,EXOSC5,https://ctdbase.org/detail.go?type=gene&acc=56915,,,56915.0,EXOSC5,9606.0,Homo sapiens (human),Methyl methanesulfonate results in decreased expression of EXOSC5 mRNA,,,PMID:23649840,https://www.ncbi.nlm.nih.gov/pubmed/23649840,23649840,,
62,526833,4156,Comparative Toxicogenomics Database (CTD),Methyl methanesulfonate,D008741,Methyl Methanesulfonate,https://ctdbase.org/detail.go?type=chem&acc=D008741,118460,EXOSC6,https://ctdbase.org/detail.go?type=gene&acc=118460,,,118460.0,EXOSC6,7955.0,Danio rerio (zebrafish),Methyl methanesulfonate results in increased expression of EXOSC6 mRNA,,,PMID:26011545,https://www.ncbi.nlm.nih.gov/pubmed/26011545,26011545,,
63,526834,4156,Comparative Toxicogenomics Database (CTD),Methyl methanesulfonate,D008741,Methyl Methanesulfonate,https://ctdbase.org/detail.go?type=chem&acc=D008741,23016,EXOSC7,https://ctdbase.org/detail.go?type=gene&acc=23016,,,23016.0,EXOSC7,9606.0,Homo sapiens (human),Methyl methanesulfonate results in decreased expression of EXOSC7 mRNA,,,PMID:23649840,https://www.ncbi.nlm.nih.gov/pubmed/23649840,23649840,,
64,526835,4156,Comparative Toxicogenomics Database (CTD),Methyl methanesulfonate,D008741,Methyl Methanesulfonate,https://ctdbase.org/detail.go?type=chem&acc=D008741,11340,EXOSC8,https://ctdbase.org/detail.go?type=gene&acc=11340,,,11340.0,EXOSC8,7955.0,Danio rerio (zebrafish),Methyl methanesulfonate results in increased expression of EXOSC8 mRNA,,,PMID:26011545,https://www.ncbi.nlm.nih.gov/pubmed/26011545,26011545,,
65,527458,4156,Comparative Toxicogenomics Database (CTD),Methyl methanesulfonate,D008741,Methyl Methanesulfonate,https://ctdbase.org/detail.go?type=chem&acc=D008741,83641,FAM107B,https://ctdbase.org/detail.go?type=gene&acc=83641,,,83641.0,FAM107B,7955.0,Danio rerio (zebrafish),Methyl methanesulfonate results in decreased expression of FAM107B mRNA,,,PMID:26011545,https://www.ncbi.nlm.nih.gov/pubmed/26011545,26011545,,
66,527459,4156,Comparative Toxicogenomics Database (CTD),Methyl methanesulfonate,D008741,Methyl Methanesulfonate,https://ctdbase.org/detail.go?type=chem&acc=D008741,83541,FAM110A,https://ctdbase.org/detail.go?type=gene&acc=83541,,,83541.0,FAM110A,9606.0,Homo sapiens (human),Methyl methanesulfonate results in increased expression of FAM110A mRNA,,,PMID:23649840,https://www.ncbi.nlm.nih.gov/pubmed/23649840,23649840,,
67,527460,4156,Comparative Toxicogenomics Database (CTD),Methyl methanesulfonate,D008741,Methyl Methanesulfonate,https://ctdbase.org/detail.go?type=chem&acc=D008741,90362,FAM110B,https://ctdbase.org/detail.go?type=gene&acc=90362,,,90362.0,FAM110B,7955.0,Danio rerio (zebrafish),Methyl methanesulfonate results in decreased expression of FAM110B mRNA,,,PMID:26011545,https://www.ncbi.nlm.nih.gov/pubmed/26011545,26011545,,
68,527461,4156,Comparative Toxicogenomics Database (CTD),Methyl methanesulfonate,D008741,Methyl Methanesulfonate,https://ctdbase.org/detail.go?type=chem&acc=D008741,63901,FAM111A,https://ctdbase.org/detail.go?type=gene&acc=63901,,,63901.0,FAM111A,9606.0,Homo sapiens (human),Methyl methanesulfonate results in increased expression of FAM111A mRNA,,,PMID:23649840,https://www.ncbi.nlm.nih.gov/pubmed/23649840,23649840,,
69,527462,4156,Comparative Toxicogenomics Database (CTD),Methyl methanesulfonate,D008741,Methyl Methanesulfonate,https://ctdbase.org/detail.go?type=chem&acc=D008741,374393,FAM111B,https://ctdbase.org/detail.go?type=gene&acc=374393,,,374393.0,FAM111B,9606.0,Homo sapiens (human),Methyl methanesulfonate results in increased expression of FAM111B mRNA,,,PMID:23649840,https://www.ncbi.nlm.nih.gov/pubmed/23649840,23649840,,
70,530043,4156,Comparative Toxicogenomics Database (CTD),Methyl methanesulfonate,D008741,Methyl Methanesulfonate,https://ctdbase.org/detail.go?type=chem&acc=D008741,26263,FBXO22,https://ctdbase.org/detail.go?type=gene&acc=26263,,,26263.0,FBXO22,9606.0,Homo sapiens (human),Methyl methanesulfonate results in increased expression of FBXO22 mRNA,,,PMID:23649840,https://www.ncbi.nlm.nih.gov/pubmed/23649840,23649840,,
71,530044,4156,Comparative Toxicogenomics Database (CTD),Methyl methanesulfonate,D008741,Methyl Methanesulfonate,https://ctdbase.org/detail.go?type=chem&acc=D008741,23219,FBXO28,https://ctdbase.org/detail.go?type=gene&acc=23219,,,23219.0,FBXO28,7955.0,Danio rerio (zebrafish),Methyl methanesulfonate results in increased expression of FBXO28 mRNA,,,PMID:26011545,https://www.ncbi.nlm.nih.gov/pubmed/26011545,26011545,,
72,530045,4156,Comparative Toxicogenomics Database (CTD),Methyl methanesulfonate,D008741,Methyl Methanesulfonate,https://ctdbase.org/detail.go?type=chem&acc=D008741,100001417,FBXO30A,https://ctdbase.org/detail.go?type=gene&acc=100001417,,,100001417.0,fbxo30a,7955.0,Danio rerio (zebrafish),Methyl methanesulfonate results in increased expression of FBXO30A mRNA,,,PMID:26011545,https://www.ncbi.nlm.nih.gov/pubmed/26011545,26011545,,
73,523600,4184,IUPHAR/BPS Guide to PHARMACOLOGY,Mianserin,135,mianserin,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=135,11,5-HT6 receptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=11,,,64354.0,Htr6,10116.0,Rattus norvegicus (Norway rat),Antagonist,pKi,6.9 - 7.4,PMID:7680751|PMID:9225298|PMID:9730917,https://www.ncbi.nlm.nih.gov/pubmed/7680751|https://www.ncbi.nlm.nih.gov/pubmed/9225298|https://www.ncbi.nlm.nih.gov/pubmed/9730917,7680751|9225298|9730917,,
74,523601,4184,IUPHAR/BPS Guide to PHARMACOLOGY,Mianserin,135,mianserin,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=135,11,5-HT6 receptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=11,P50406,5-hydroxytryptamine receptor 6,3362.0,HTR6,9606.0,Homo sapiens (human),Antagonist,pKi,6.9 - 7.3,PMID:8522988|PMID:9730917|PMID:9284367,https://www.ncbi.nlm.nih.gov/pubmed/8522988|https://www.ncbi.nlm.nih.gov/pubmed/9730917|https://www.ncbi.nlm.nih.gov/pubmed/9284367,8522988|9730917|9284367,,
75,523602,4184,IUPHAR/BPS Guide to PHARMACOLOGY,Mianserin,135,mianserin,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=135,12,5-HT7 receptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=12,P34969,5-hydroxytryptamine receptor 7,3363.0,HTR7,9606.0,Homo sapiens (human),Antagonist,pKi,7.3 - 7.6,PMID:9298538,https://www.ncbi.nlm.nih.gov/pubmed/9298538,9298538,,
76,523603,4184,IUPHAR/BPS Guide to PHARMACOLOGY,Mianserin,135,mianserin,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=135,12,5-HT7 receptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=12,P32304,5-hydroxytryptamine receptor 7 ,15566.0,Htr7,10090.0,Mus musculus (house mouse),Antagonist,pKi,7,PMID:8394987,https://www.ncbi.nlm.nih.gov/pubmed/8394987,8394987,,
77,523604,4184,IUPHAR/BPS Guide to PHARMACOLOGY,Mianserin,135,mianserin,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=135,12,5-HT7 receptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=12,P32305,5-hydroxytryptamine receptor 7 ,65032.0,Htr7,10116.0,Rattus norvegicus (Norway rat),Antagonist,pKi,7 - 7.4,PMID:8394362|PMID:8397408,https://www.ncbi.nlm.nih.gov/pubmed/8394362|https://www.ncbi.nlm.nih.gov/pubmed/8397408,8394362|8397408,,
78,516714,4449,Comparative Toxicogenomics Database (CTD),Nefazodone,C051752,nefazodone,https://ctdbase.org/detail.go?type=chem&acc=C051752,6569,SLC34A1,https://ctdbase.org/detail.go?type=gene&acc=6569,,,6569.0,SLC34A1,10116.0,Rattus norvegicus (Norway rat),Nefazodone results in increased expression of SLC34A1 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
79,516715,4449,Comparative Toxicogenomics Database (CTD),Nefazodone,C051752,nefazodone,https://ctdbase.org/detail.go?type=chem&acc=C051752,10568,SLC34A2,https://ctdbase.org/detail.go?type=gene&acc=10568,,,10568.0,SLC34A2,10116.0,Rattus norvegicus (Norway rat),Nefazodone results in decreased expression of SLC34A2 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
80,516716,4449,Comparative Toxicogenomics Database (CTD),Nefazodone,C051752,nefazodone,https://ctdbase.org/detail.go?type=chem&acc=C051752,10237,SLC35B1,https://ctdbase.org/detail.go?type=gene&acc=10237,,,10237.0,SLC35B1,9606.0,Homo sapiens (human),[glycochenodeoxycholic acid co-treated with deoxycholic acid co-treated with chenodeoxycholic acid co-treated with glycodeoxycholic acid co-treated with glycocholic acid co-treated with nefazodone] results in increased expression of SLC35B1 mRNA,,,PMID:33819548,https://www.ncbi.nlm.nih.gov/pubmed/33819548,33819548,,
81,516717,4449,Comparative Toxicogenomics Database (CTD),Nefazodone,C051752,nefazodone,https://ctdbase.org/detail.go?type=chem&acc=C051752,55508,SLC35E3,https://ctdbase.org/detail.go?type=gene&acc=55508,,,55508.0,SLC35E3,10116.0,Rattus norvegicus (Norway rat),Nefazodone results in increased expression of SLC35E3 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
82,516718,4449,Comparative Toxicogenomics Database (CTD),Nefazodone,C051752,nefazodone,https://ctdbase.org/detail.go?type=chem&acc=C051752,64116,SLC39A8,https://ctdbase.org/detail.go?type=gene&acc=64116,,,64116.0,SLC39A8,10116.0,Rattus norvegicus (Norway rat),Nefazodone results in decreased expression of SLC39A8 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
83,516719,4449,Comparative Toxicogenomics Database (CTD),Nefazodone,C051752,nefazodone,https://ctdbase.org/detail.go?type=chem&acc=C051752,6520,SLC3A2,https://ctdbase.org/detail.go?type=gene&acc=6520,,,6520.0,SLC3A2,10116.0,Rattus norvegicus (Norway rat),Nefazodone results in increased expression of SLC3A2 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
84,516720,4449,Comparative Toxicogenomics Database (CTD),Nefazodone,C051752,nefazodone,https://ctdbase.org/detail.go?type=chem&acc=C051752,30061,SLC40A1,https://ctdbase.org/detail.go?type=gene&acc=30061,,,30061.0,SLC40A1,10116.0,Rattus norvegicus (Norway rat),Nefazodone results in increased expression of SLC40A1 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
85,519389,4449,Comparative Toxicogenomics Database (CTD),Nefazodone,C051752,nefazodone,https://ctdbase.org/detail.go?type=chem&acc=C051752,10959,TMED2,https://ctdbase.org/detail.go?type=gene&acc=10959,,,10959.0,TMED2,10116.0,Rattus norvegicus (Norway rat),Nefazodone results in increased expression of TMED2 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
86,519390,4449,Comparative Toxicogenomics Database (CTD),Nefazodone,C051752,nefazodone,https://ctdbase.org/detail.go?type=chem&acc=C051752,54732,TMED9,https://ctdbase.org/detail.go?type=gene&acc=54732,,,54732.0,TMED9,10116.0,Rattus norvegicus (Norway rat),Nefazodone results in increased expression of TMED9 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
87,519391,4449,Comparative Toxicogenomics Database (CTD),Nefazodone,C051752,nefazodone,https://ctdbase.org/detail.go?type=chem&acc=C051752,54664,TMEM106B,https://ctdbase.org/detail.go?type=gene&acc=54664,,,54664.0,TMEM106B,10116.0,Rattus norvegicus (Norway rat),Nefazodone results in increased expression of TMEM106B mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
88,519392,4449,Comparative Toxicogenomics Database (CTD),Nefazodone,C051752,nefazodone,https://ctdbase.org/detail.go?type=chem&acc=C051752,8834,TMEM11,https://ctdbase.org/detail.go?type=gene&acc=8834,,,8834.0,TMEM11,10116.0,Rattus norvegicus (Norway rat),Nefazodone results in increased expression of TMEM11 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
89,519393,4449,Comparative Toxicogenomics Database (CTD),Nefazodone,C051752,nefazodone,https://ctdbase.org/detail.go?type=chem&acc=C051752,84233,TMEM126A,https://ctdbase.org/detail.go?type=gene&acc=84233,,,84233.0,TMEM126A,10116.0,Rattus norvegicus (Norway rat),Nefazodone results in increased expression of TMEM126A mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
90,519394,4449,Comparative Toxicogenomics Database (CTD),Nefazodone,C051752,nefazodone,https://ctdbase.org/detail.go?type=chem&acc=C051752,80194,TMEM134,https://ctdbase.org/detail.go?type=gene&acc=80194,,,80194.0,TMEM134,10116.0,Rattus norvegicus (Norway rat),Nefazodone results in increased expression of TMEM134 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
91,522531,4463,Comparative Toxicogenomics Database (CTD),Nevirapine,D019829,Nevirapine,https://ctdbase.org/detail.go?type=chem&acc=D019829,213,ALB,https://ctdbase.org/detail.go?type=gene&acc=213,,,213.0,ALB,9913.0,Bos taurus (cattle),Nevirapine binds to ALB protein,,,PMID:27417440,https://www.ncbi.nlm.nih.gov/pubmed/27417440,27417440,,
92,524367,4463,Comparative Toxicogenomics Database (CTD),Nevirapine,D019829,Nevirapine,https://ctdbase.org/detail.go?type=chem&acc=D019829,9970,NR1I3,https://ctdbase.org/detail.go?type=gene&acc=9970,,,9970.0,NR1I3,9606.0,Homo sapiens (human),[nevirapine results in increased activity of NR1I3 protein] which results in increased expression of CYP2B6 mrna|[nevirapine results in increased activity of NR1I3 protein alternative form] which results in increased expression of CYP2B6 mRNA,,,PMID:17041008,https://www.ncbi.nlm.nih.gov/pubmed/17041008,17041008,,
93,524368,4463,Comparative Toxicogenomics Database (CTD),Nevirapine,D019829,Nevirapine,https://ctdbase.org/detail.go?type=chem&acc=D019829,9315,NREP,https://ctdbase.org/detail.go?type=gene&acc=9315,,,9315.0,NREP,10116.0,Rattus norvegicus (Norway rat),Nevirapine results in decreased expression of NREP mrna|nevirapine metabolite results in decreased expression of NREP mRNA,,,PMID:23947594,https://www.ncbi.nlm.nih.gov/pubmed/23947594,23947594,,
94,524369,4463,Comparative Toxicogenomics Database (CTD),Nevirapine,D019829,Nevirapine,https://ctdbase.org/detail.go?type=chem&acc=D019829,5027,P2RX7,https://ctdbase.org/detail.go?type=gene&acc=5027,,,5027.0,P2RX7,10116.0,Rattus norvegicus (Norway rat),Nevirapine results in decreased expression of P2RX7 mRNA,,,PMID:23947594,https://www.ncbi.nlm.nih.gov/pubmed/23947594,23947594,,
95,524370,4463,Comparative Toxicogenomics Database (CTD),Nevirapine,D019829,Nevirapine,https://ctdbase.org/detail.go?type=chem&acc=D019829,654790,PCP4L1,https://ctdbase.org/detail.go?type=gene&acc=654790,,,654790.0,PCP4L1,10116.0,Rattus norvegicus (Norway rat),Nevirapine results in decreased expression of PCP4L1 mRNA,,,PMID:23947594,https://www.ncbi.nlm.nih.gov/pubmed/23947594,23947594,,
96,524371,4463,Comparative Toxicogenomics Database (CTD),Nevirapine,D019829,Nevirapine,https://ctdbase.org/detail.go?type=chem&acc=D019829,5166,PDK4,https://ctdbase.org/detail.go?type=gene&acc=5166,,,5166.0,PDK4,10116.0,Rattus norvegicus (Norway rat),Nevirapine metabolite results in increased expression of PDK4 mRNA,,,PMID:23947594,https://www.ncbi.nlm.nih.gov/pubmed/23947594,23947594,,
97,524868,4485,Comparative Toxicogenomics Database (CTD),Nifedipine,D009543,Nifedipine,https://ctdbase.org/detail.go?type=chem&acc=D009543,775,CACNA1C,https://ctdbase.org/detail.go?type=gene&acc=775,,,775.0,CACNA1C,10090.0,Mus musculus (house mouse),Nifedipine binds to and results in decreased activity of CACNA1C protein|cacna1c protein affects the susceptibility to nifedipine,,,PMID:18441296,https://www.ncbi.nlm.nih.gov/pubmed/18441296,18441296,,
98,524869,4485,Comparative Toxicogenomics Database (CTD),Nifedipine,D009543,Nifedipine,https://ctdbase.org/detail.go?type=chem&acc=D009543,775,CACNA1C,https://ctdbase.org/detail.go?type=gene&acc=775,,,775.0,CACNA1C,9606.0,Homo sapiens (human),Nifedipine results in decreased activity of CACNA1C protein,,,PMID:23261645,https://www.ncbi.nlm.nih.gov/pubmed/23261645,23261645,,
99,524870,4485,Comparative Toxicogenomics Database (CTD),Nifedipine,D009543,Nifedipine,https://ctdbase.org/detail.go?type=chem&acc=D009543,776,CACNA1D,https://ctdbase.org/detail.go?type=gene&acc=776,,,776.0,CACNA1D,9606.0,Homo sapiens (human),Nifedipine binds to and results in decreased activity of CACNA1D protein,,,PMID:18441296,https://www.ncbi.nlm.nih.gov/pubmed/18441296,18441296,,
100,524871,4485,Comparative Toxicogenomics Database (CTD),Nifedipine,D009543,Nifedipine,https://ctdbase.org/detail.go?type=chem&acc=D009543,815,CAMK2A,https://ctdbase.org/detail.go?type=gene&acc=815,,,815.0,CAMK2A,10090.0,Mus musculus (house mouse),Nifedipine inhibits the reaction [cocaine results in increased expression of and results in increased phosphorylation of CAMK2A protein],,,PMID:28194001,https://www.ncbi.nlm.nih.gov/pubmed/28194001,28194001,,
101,524872,4485,Comparative Toxicogenomics Database (CTD),Nifedipine,D009543,Nifedipine,https://ctdbase.org/detail.go?type=chem&acc=D009543,815,CAMK2A,https://ctdbase.org/detail.go?type=gene&acc=815,,,815.0,CAMK2A,10116.0,Rattus norvegicus (Norway rat),Nifedipine inhibits the reaction [FPL 64176 promotes the reaction [CAMK2A protein binds to DRD3 protein]],,,PMID:19217379,https://www.ncbi.nlm.nih.gov/pubmed/19217379,19217379,,
102,524873,4485,Comparative Toxicogenomics Database (CTD),Nifedipine,D009543,Nifedipine,https://ctdbase.org/detail.go?type=chem&acc=D009543,824,CAPN2,https://ctdbase.org/detail.go?type=gene&acc=824,,,824.0,CAPN2,59899.0,Clarias batrachus (walking catfish),Nifedipine inhibits the reaction [arsenic results in increased expression of CAPN2 protein],,,PMID:21798276,https://www.ncbi.nlm.nih.gov/pubmed/21798276,21798276,,
103,524874,4485,Comparative Toxicogenomics Database (CTD),Nifedipine,D009543,Nifedipine,https://ctdbase.org/detail.go?type=chem&acc=D009543,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,9606.0,Homo sapiens (human),Nifedipine inhibits the reaction [iohexol results in increased cleavage of CASP3 protein],,,PMID:36207783,https://www.ncbi.nlm.nih.gov/pubmed/36207783,36207783,,
104,525707,4485,Comparative Toxicogenomics Database (CTD),Nifedipine,D009543,Nifedipine,https://ctdbase.org/detail.go?type=chem&acc=D009543,25642,CYP3A23-3A1,https://ctdbase.org/detail.go?type=gene&acc=25642,,,25642.0,Cyp3a23-3a1,10116.0,Rattus norvegicus (Norway rat),Nifedipine results in increased expression of CYP3A23-3A1 mRNA,,,PMID:16125621,https://www.ncbi.nlm.nih.gov/pubmed/16125621,16125621,,
105,525708,4485,Comparative Toxicogenomics Database (CTD),Nifedipine,D009543,Nifedipine,https://ctdbase.org/detail.go?type=chem&acc=D009543,403324,CYP3A29,https://ctdbase.org/detail.go?type=gene&acc=403324,,,403324.0,CYP3A29,9823.0,Sus scrofa (pig),Troleandomycin inhibits the reaction [CYP3A29 protein results in increased oxidation of nifedipine]|ketoconazole inhibits the reaction [CYP3A29 protein results in increased oxidation of nifedipine]|cyp3a29 protein results in increased oxidation of nifedipine,,,PMID:20863320,https://www.ncbi.nlm.nih.gov/pubmed/20863320,20863320,,
106,525709,4485,Comparative Toxicogenomics Database (CTD),Nifedipine,D009543,Nifedipine,https://ctdbase.org/detail.go?type=chem&acc=D009543,678669,CYP3A37,https://ctdbase.org/detail.go?type=gene&acc=678669,,,678669.0,,9103.0,Meleagris gallopavo (turkey),CYP3A37 protein results in increased oxidation of nifedipine|ethinyl estradiol inhibits the reaction [CYP3A37 protein results in increased oxidation of nifedipine],,,PMID:20707407,https://www.ncbi.nlm.nih.gov/pubmed/20707407,20707407,,
107,525710,4485,Comparative Toxicogenomics Database (CTD),Nifedipine,D009543,Nifedipine,https://ctdbase.org/detail.go?type=chem&acc=D009543,1576,CYP3A4,https://ctdbase.org/detail.go?type=gene&acc=1576,,,1576.0,CYP3A4,9606.0,Homo sapiens (human),"6',7'-dihydroxybergamottin inhibits the reaction [CYP3A4 protein results in increased oxidation of nifedipine]",,,PMID:23146034,https://www.ncbi.nlm.nih.gov/pubmed/23146034,23146034,,
108,525711,4485,Comparative Toxicogenomics Database (CTD),Nifedipine,D009543,Nifedipine,https://ctdbase.org/detail.go?type=chem&acc=D009543,1576,CYP3A4,https://ctdbase.org/detail.go?type=gene&acc=1576,,,1576.0,CYP3A4,9606.0,Homo sapiens (human),Allyl isothiocyanate inhibits the reaction [NR1I2 protein promotes the reaction [nifedipine results in increased expression of CYP3A4 mrna]]|nr1i2 protein promotes the reaction [nifedipine results in increased expression of CYP3A4 mrna],,,PMID:25069801,https://www.ncbi.nlm.nih.gov/pubmed/25069801,25069801,,
109,526836,4485,Comparative Toxicogenomics Database (CTD),Nifedipine,D009543,Nifedipine,https://ctdbase.org/detail.go?type=chem&acc=D009543,3479,IGF1,https://ctdbase.org/detail.go?type=gene&acc=3479,,,3479.0,IGF1,9606.0,Homo sapiens (human),Nifedipine results in decreased susceptibility to IGF1 protein,,,PMID:16485066,https://www.ncbi.nlm.nih.gov/pubmed/16485066,16485066,,
110,526837,4485,Comparative Toxicogenomics Database (CTD),Nifedipine,D009543,Nifedipine,https://ctdbase.org/detail.go?type=chem&acc=D009543,3481,IGF2,https://ctdbase.org/detail.go?type=gene&acc=3481,,,3481.0,IGF2,9606.0,Homo sapiens (human),Nifedipine results in decreased susceptibility to IGF2 protein,,,PMID:16485066,https://www.ncbi.nlm.nih.gov/pubmed/16485066,16485066,,
111,526838,4485,Comparative Toxicogenomics Database (CTD),Nifedipine,D009543,Nifedipine,https://ctdbase.org/detail.go?type=chem&acc=D009543,3553,IL1B,https://ctdbase.org/detail.go?type=gene&acc=3553,,,3553.0,IL1B,9606.0,Homo sapiens (human),Nifedipine results in increased expression of IL1B mRNA,,,PMID:28138970,https://www.ncbi.nlm.nih.gov/pubmed/28138970,28138970,,
112,526839,4485,Comparative Toxicogenomics Database (CTD),Nifedipine,D009543,Nifedipine,https://ctdbase.org/detail.go?type=chem&acc=D009543,16333,INS1,https://ctdbase.org/detail.go?type=gene&acc=16333,,,16333.0,Ins1,10116.0,Rattus norvegicus (Norway rat),Nifedipine inhibits the reaction [quercetin results in increased secretion of INS1 protein],,,PMID:23530660,https://www.ncbi.nlm.nih.gov/pubmed/23530660,23530660,,
113,529900,4488,Comparative Toxicogenomics Database (CTD),Niflumic acid,D009544,Niflumic Acid,https://ctdbase.org/detail.go?type=chem&acc=D009544,6517,SLC2A4,https://ctdbase.org/detail.go?type=gene&acc=6517,,,6517.0,SLC2A4,10090.0,Mus musculus (house mouse),Niflumic acid results in increased expression of SLC2A4 protein|niflumic acid results in increased expression of SLC2A4 mrna|[niflumic acid results in increased expression of SLC2A4 protein] which results in increased uptake of hexoses,,,PMID:16447059,https://www.ncbi.nlm.nih.gov/pubmed/16447059,16447059,,
114,529901,4488,Comparative Toxicogenomics Database (CTD),Niflumic acid,D009544,Niflumic Acid,https://ctdbase.org/detail.go?type=chem&acc=D009544,6521,SLC4A1,https://ctdbase.org/detail.go?type=gene&acc=6521,,,6521.0,SLC4A1,9606.0,Homo sapiens (human),Niflumic acid inhibits the reaction [SLC4A1 protein results in increased transport of chlorides],,,PMID:2511191,https://www.ncbi.nlm.nih.gov/pubmed/2511191,2511191,,
115,529902,4488,Comparative Toxicogenomics Database (CTD),Niflumic acid,D009544,Niflumic Acid,https://ctdbase.org/detail.go?type=chem&acc=D009544,6529,SLC6A1,https://ctdbase.org/detail.go?type=gene&acc=6529,,,6529.0,SLC6A1,9606.0,Homo sapiens (human),Niflumic acid inhibits the reaction [SLC6A1 protein results in increased uptake of gamma-aminobutyric acid],,,PMID:15981712,https://www.ncbi.nlm.nih.gov/pubmed/15981712,15981712,,
116,529903,4488,Comparative Toxicogenomics Database (CTD),Niflumic acid,D009544,Niflumic Acid,https://ctdbase.org/detail.go?type=chem&acc=D009544,6538,SLC6A11,https://ctdbase.org/detail.go?type=gene&acc=6538,,,6538.0,SLC6A11,10090.0,Mus musculus (house mouse),Niflumic acid inhibits the reaction [SLC6A11 protein results in increased uptake of gamma-aminobutyric acid],,,PMID:15981712,https://www.ncbi.nlm.nih.gov/pubmed/15981712,15981712,,
117,529904,4488,Comparative Toxicogenomics Database (CTD),Niflumic acid,D009544,Niflumic Acid,https://ctdbase.org/detail.go?type=chem&acc=D009544,54658,UGT1A1,https://ctdbase.org/detail.go?type=gene&acc=54658,,,54658.0,UGT1A1,9606.0,Homo sapiens (human),Niflumic acid results in decreased activity of UGT1A1 protein,,,PMID:15593333,https://www.ncbi.nlm.nih.gov/pubmed/15593333,15593333,,
118,529905,4488,Comparative Toxicogenomics Database (CTD),Niflumic acid,D009544,Niflumic Acid,https://ctdbase.org/detail.go?type=chem&acc=D009544,54600,UGT1A9,https://ctdbase.org/detail.go?type=gene&acc=54600,,,54600.0,UGT1A9,9606.0,Homo sapiens (human),Niflumic acid results in decreased activity of UGT1A9 protein|niflumic acid inhibits the reaction [UGT1A9 protein results in increased glucuronidation of 4-cresol],,,PMID:32421801,https://www.ncbi.nlm.nih.gov/pubmed/32421801,32421801,,
119,529906,4493,Comparative Toxicogenomics Database (CTD),Nilutamide,C021277,nilutamide,https://ctdbase.org/detail.go?type=chem&acc=C021277,207,AKT1,https://ctdbase.org/detail.go?type=gene&acc=207,,,207.0,AKT1,10141.0,Cavia porcellus (domestic guinea pig),Nilutamide inhibits the reaction [ginsenoside re results in increased phosphorylation of AKT1 protein],,,PMID:16985185,https://www.ncbi.nlm.nih.gov/pubmed/16985185,16985185,,
120,529907,4493,Comparative Toxicogenomics Database (CTD),Nilutamide,C021277,nilutamide,https://ctdbase.org/detail.go?type=chem&acc=C021277,207,AKT1,https://ctdbase.org/detail.go?type=gene&acc=207,,,207.0,AKT1,10090.0,Mus musculus (house mouse),Nilutamide results in increased expression of AKT1 protein,,,PMID:16616092,https://www.ncbi.nlm.nih.gov/pubmed/16616092,16616092,,
121,526348,4549,Therapeutic Target Database (TTD),5-Nitro-2-(3-phenylpropylamino)benzoic acid,D08DQL,NPPB,https://idrblab.net/ttd/data/drug/details/D08DQL,T84040,Transformation-sensitive protein p120 (TRPA1),https://idrblab.net/ttd/data/target/details/T84040,O75762,Transient receptor potential cation channel subfamily A member 1,8989.0,TRPA1,9606.0,Homo sapiens (human),Activator,,,,,,,
122,526349,4549,Therapeutic Target Database (TTD),5-Nitro-2-(3-phenylpropylamino)benzoic acid,D08DQL,NPPB,https://idrblab.net/ttd/data/drug/details/D08DQL,T05089,Calcium-dependent chloride channel anoctamin (ANO),https://idrblab.net/ttd/data/target/details/T05089,Q5XXA6,Anoctamin-1,55107.0,ANO1,9606.0,Homo sapiens (human),Blocker (channel blocker),,,,,,,
123,526350,4549,IUPHAR/BPS Guide to PHARMACOLOGY,5-Nitro-2-(3-phenylpropylamino)benzoic acid,4270,NPPB,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4270,708,CaCC,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=708,Q5XXA6,Anoctamin-1,55107.0,ANO1,9606.0,Homo sapiens (human),,,6.6,,,,,
124,526351,4549,IUPHAR/BPS Guide to PHARMACOLOGY,5-Nitro-2-(3-phenylpropylamino)benzoic acid,4270,NPPB,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4270,706,ClC-7,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=706,P51798,H(+)/Cl(-) exchange transporter 7,1186.0,CLCN7,9606.0,Homo sapiens (human),,pIC50,3.8,PMID:20830208,https://www.ncbi.nlm.nih.gov/pubmed/20830208,20830208,,
125,526352,4549,IUPHAR/BPS Guide to PHARMACOLOGY,5-Nitro-2-(3-phenylpropylamino)benzoic acid,4270,NPPB,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4270,699,ClC-2,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=699,P51788,Chloride channel protein 2,1181.0,CLCN2,9606.0,Homo sapiens (human),,,10.8,,,,,
126,526353,4551,Therapeutic Target Database (TTD),"8-Bromo-4h-[1,2,4]oxadiazolo[3,4-c][1,4]benzoxazin-1-one",D0U3YQ,NS 2028,https://idrblab.net/ttd/data/drug/details/D0U3YQ,T19693,Soluble guanylyl cyclase (GUCY2D),https://idrblab.net/ttd/data/target/details/T19693,Q02846,Retinal guanylyl cyclase 1,3000.0,GUCY2D,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
127,526354,4567,DrugBank,Nylidrin,DB06152,Nylidrin,https://www.drugbank.ca/drugs/DB06152,BE0000385,Interferon alpha/beta receptor 2,https://www.drugbank.ca/bio_entities/BE0000385,P48551,Interferon alpha/beta receptor 2,3455.0,IFNAR2,9606.0,Homo sapiens (human),Agonist,,,,,,,
128,529437,4794,Comparative Toxicogenomics Database (CTD),Glufosinate,C003121,phosphinothricin,https://ctdbase.org/detail.go?type=chem&acc=C003121,561050,ACKR3B,https://ctdbase.org/detail.go?type=gene&acc=561050,,,561050.0,ackr3b,7955.0,Danio rerio (zebrafish),Phosphinothricin results in decreased expression of ACKR3B mRNA,,,PMID:31545209,https://www.ncbi.nlm.nih.gov/pubmed/31545209,31545209,,
129,529438,4794,Comparative Toxicogenomics Database (CTD),Glufosinate,C003121,phosphinothricin,https://ctdbase.org/detail.go?type=chem&acc=C003121,50,ACO2,https://ctdbase.org/detail.go?type=gene&acc=50,,,50.0,ACO2,7955.0,Danio rerio (zebrafish),Phosphinothricin results in decreased expression of ACO2 mRNA,,,PMID:31545209,https://www.ncbi.nlm.nih.gov/pubmed/31545209,31545209,,
130,529439,4794,Comparative Toxicogenomics Database (CTD),Glufosinate,C003121,phosphinothricin,https://ctdbase.org/detail.go?type=chem&acc=C003121,402867,ACOT16,https://ctdbase.org/detail.go?type=gene&acc=402867,,,402867.0,acot16,7955.0,Danio rerio (zebrafish),Phosphinothricin results in increased expression of ACOT16 mRNA,,,PMID:31545209,https://www.ncbi.nlm.nih.gov/pubmed/31545209,31545209,,
131,530038,4794,Comparative Toxicogenomics Database (CTD),Glufosinate,C003121,phosphinothricin,https://ctdbase.org/detail.go?type=chem&acc=C003121,568926,ANK2A,https://ctdbase.org/detail.go?type=gene&acc=568926,,,568926.0,ank2a,7955.0,Danio rerio (zebrafish),Phosphinothricin results in decreased expression of ANK2A mRNA,,,PMID:31545209,https://www.ncbi.nlm.nih.gov/pubmed/31545209,31545209,,
132,530039,4794,Comparative Toxicogenomics Database (CTD),Glufosinate,C003121,phosphinothricin,https://ctdbase.org/detail.go?type=chem&acc=C003121,57763,ANKRA2,https://ctdbase.org/detail.go?type=gene&acc=57763,,,57763.0,ANKRA2,7955.0,Danio rerio (zebrafish),Phosphinothricin results in increased expression of ANKRA2 mRNA,,,PMID:31545209,https://www.ncbi.nlm.nih.gov/pubmed/31545209,31545209,,
133,530040,4794,Comparative Toxicogenomics Database (CTD),Glufosinate,C003121,phosphinothricin,https://ctdbase.org/detail.go?type=chem&acc=C003121,322533,ANPEPB.1,https://ctdbase.org/detail.go?type=gene&acc=322533,,,322533.0,anpepb.1,7955.0,Danio rerio (zebrafish),Phosphinothricin results in increased expression of ANPEPB.1 mRNA,,,PMID:31545209,https://www.ncbi.nlm.nih.gov/pubmed/31545209,31545209,,
134,530041,4794,Comparative Toxicogenomics Database (CTD),Glufosinate,C003121,phosphinothricin,https://ctdbase.org/detail.go?type=chem&acc=C003121,26,AOC1,https://ctdbase.org/detail.go?type=gene&acc=26,,,26.0,AOC1,7955.0,Danio rerio (zebrafish),Phosphinothricin results in increased expression of AOC1 mRNA,,,PMID:31545209,https://www.ncbi.nlm.nih.gov/pubmed/31545209,31545209,,
135,530042,4794,Comparative Toxicogenomics Database (CTD),Glufosinate,C003121,phosphinothricin,https://ctdbase.org/detail.go?type=chem&acc=C003121,8906,AP1G2,https://ctdbase.org/detail.go?type=gene&acc=8906,,,8906.0,AP1G2,7955.0,Danio rerio (zebrafish),Phosphinothricin results in increased expression of AP1G2 mRNA,,,PMID:31545209,https://www.ncbi.nlm.nih.gov/pubmed/31545209,31545209,,
136,530385,4794,Comparative Toxicogenomics Database (CTD),Glufosinate,C003121,phosphinothricin,https://ctdbase.org/detail.go?type=chem&acc=C003121,567649,ARHGEF10LB,https://ctdbase.org/detail.go?type=gene&acc=567649,,,567649.0,arhgef10lb,7955.0,Danio rerio (zebrafish),Phosphinothricin results in decreased expression of ARHGEF10LB mRNA,,,PMID:31545209,https://www.ncbi.nlm.nih.gov/pubmed/31545209,31545209,,
137,530536,4794,Comparative Toxicogenomics Database (CTD),Glufosinate,C003121,phosphinothricin,https://ctdbase.org/detail.go?type=chem&acc=C003121,100535284,ASB14B,https://ctdbase.org/detail.go?type=gene&acc=100535284,,,100535284.0,asb14b,7955.0,Danio rerio (zebrafish),Phosphinothricin results in increased expression of ASB14B mRNA,,,PMID:31545209,https://www.ncbi.nlm.nih.gov/pubmed/31545209,31545209,,
138,530537,4794,Comparative Toxicogenomics Database (CTD),Glufosinate,C003121,phosphinothricin,https://ctdbase.org/detail.go?type=chem&acc=C003121,101882127,ASGR1A,https://ctdbase.org/detail.go?type=gene&acc=101882127,,,101882127.0,asgr1a,7955.0,Danio rerio (zebrafish),Phosphinothricin results in increased expression of ASGR1A mRNA,,,PMID:31545209,https://www.ncbi.nlm.nih.gov/pubmed/31545209,31545209,,
139,530538,4794,Comparative Toxicogenomics Database (CTD),Glufosinate,C003121,phosphinothricin,https://ctdbase.org/detail.go?type=chem&acc=C003121,438,ASMT,https://ctdbase.org/detail.go?type=gene&acc=438,,,438.0,ASMT,7955.0,Danio rerio (zebrafish),Phosphinothricin results in decreased expression of ASMT mRNA,,,PMID:31545209,https://www.ncbi.nlm.nih.gov/pubmed/31545209,31545209,,
140,530539,4794,Comparative Toxicogenomics Database (CTD),Glufosinate,C003121,phosphinothricin,https://ctdbase.org/detail.go?type=chem&acc=C003121,79969,ATAT1,https://ctdbase.org/detail.go?type=gene&acc=79969,,,79969.0,ATAT1,7955.0,Danio rerio (zebrafish),Phosphinothricin results in decreased expression of ATAT1 mRNA,,,PMID:31545209,https://www.ncbi.nlm.nih.gov/pubmed/31545209,31545209,,
141,530540,4794,Comparative Toxicogenomics Database (CTD),Glufosinate,C003121,phosphinothricin,https://ctdbase.org/detail.go?type=chem&acc=C003121,11101,ATE1,https://ctdbase.org/detail.go?type=gene&acc=11101,,,11101.0,ATE1,7955.0,Danio rerio (zebrafish),Phosphinothricin results in decreased expression of ATE1 mRNA,,,PMID:31545209,https://www.ncbi.nlm.nih.gov/pubmed/31545209,31545209,,
142,530541,4794,Comparative Toxicogenomics Database (CTD),Glufosinate,C003121,phosphinothricin,https://ctdbase.org/detail.go?type=chem&acc=C003121,1822,ATN1,https://ctdbase.org/detail.go?type=gene&acc=1822,,,1822.0,ATN1,7955.0,Danio rerio (zebrafish),Phosphinothricin results in increased expression of ATN1 mRNA,,,PMID:31545209,https://www.ncbi.nlm.nih.gov/pubmed/31545209,31545209,,
143,530542,4794,Comparative Toxicogenomics Database (CTD),Glufosinate,C003121,phosphinothricin,https://ctdbase.org/detail.go?type=chem&acc=C003121,23250,ATP11A,https://ctdbase.org/detail.go?type=gene&acc=23250,,,23250.0,ATP11A,7955.0,Danio rerio (zebrafish),Phosphinothricin results in decreased expression of ATP11A mRNA,,,PMID:31545209,https://www.ncbi.nlm.nih.gov/pubmed/31545209,31545209,,
144,530543,4794,Comparative Toxicogenomics Database (CTD),Glufosinate,C003121,phosphinothricin,https://ctdbase.org/detail.go?type=chem&acc=C003121,64614,ATP1A1A.3,https://ctdbase.org/detail.go?type=gene&acc=64614,,,64614.0,atp1a1a.3,7955.0,Danio rerio (zebrafish),Phosphinothricin results in increased expression of ATP1A1A.3 mRNA,,,PMID:31545209,https://www.ncbi.nlm.nih.gov/pubmed/31545209,31545209,,
145,516721,5042,Comparative Toxicogenomics Database (CTD),Rebamipide,C052785,rebamipide,https://ctdbase.org/detail.go?type=chem&acc=C052785,4609,MYC,https://ctdbase.org/detail.go?type=gene&acc=4609,,,4609.0,MYC,10116.0,Rattus norvegicus (Norway rat),Rebamipide results in increased expression of MYC mRNA,,,PMID:15104358,https://www.ncbi.nlm.nih.gov/pubmed/15104358,15104358,,
146,517790,5090,Comparative Toxicogenomics Database (CTD),Rofecoxib,C116926,rofecoxib,https://ctdbase.org/detail.go?type=chem&acc=C116926,56519,DEFB4,https://ctdbase.org/detail.go?type=gene&acc=56519,,,56519.0,Defb4,9606.0,Homo sapiens (human),Rofecoxib results in increased expression of DEFB4 mRNA,,,PMID:17070997,https://www.ncbi.nlm.nih.gov/pubmed/17070997,17070997,,
147,520058,5090,Therapeutic Target Database (TTD),Rofecoxib,D05VLS,Rofecoxib,https://idrblab.net/ttd/data/drug/details/D05VLS,T66665,Prostaglandin G/H synthase 2 (COX-2),https://idrblab.net/ttd/data/target/details/T66665,P35354,Prostaglandin G/H synthase 2,5743.0,PTGS2,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
148,520059,5092,Drug Gene Interaction database (DGIdb),Rolipram,,ROLIPRAM,https://www.dgidb.org/drugs/ncit:C72842,,PDE4A,https://www.dgidb.org/genes/hgnc:8780,,,5141.0,PDE4A,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
149,520060,5092,Drug Gene Interaction database (DGIdb),Rolipram,,ROLIPRAM,https://www.dgidb.org/drugs/ncit:C72842,,PDE4B,https://www.dgidb.org/genes/hgnc:8781,,,5142.0,PDE4B,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
150,520061,5092,Comparative Toxicogenomics Database (CTD),Rolipram,D020889,Rolipram,https://ctdbase.org/detail.go?type=chem&acc=D020889,116,ADCYAP1,https://ctdbase.org/detail.go?type=gene&acc=116,,,116.0,ADCYAP1,10090.0,Mus musculus (house mouse),Rolipram promotes the reaction [ADCYAP1 protein affects the secretion of acids],,,PMID:20388963,https://www.ncbi.nlm.nih.gov/pubmed/20388963,20388963,,
151,520062,5092,Comparative Toxicogenomics Database (CTD),Rolipram,D020889,Rolipram,https://ctdbase.org/detail.go?type=chem&acc=D020889,116,ADCYAP1,https://ctdbase.org/detail.go?type=gene&acc=116,,,116.0,ADCYAP1,9823.0,Sus scrofa (pig),Rolipram results in decreased activity of ADCYAP1 protein alternative form,,,PMID:16847435,https://www.ncbi.nlm.nih.gov/pubmed/16847435,16847435,,
152,520209,5092,Comparative Toxicogenomics Database (CTD),Rolipram,D020889,Rolipram,https://ctdbase.org/detail.go?type=chem&acc=D020889,6348,CCL3,https://ctdbase.org/detail.go?type=gene&acc=6348,,,6348.0,CCL3,10090.0,Mus musculus (house mouse),Rolipram inhibits the reaction [lipopolysaccharides results in increased expression of CCL3 mrna]|rolipram inhibits the reaction [lipopolysaccharides results in increased secretion of CCL3 protein],,,PMID:9863660,https://www.ncbi.nlm.nih.gov/pubmed/9863660,9863660,,
153,520210,5092,Comparative Toxicogenomics Database (CTD),Rolipram,D020889,Rolipram,https://ctdbase.org/detail.go?type=chem&acc=D020889,999,CDH1,https://ctdbase.org/detail.go?type=gene&acc=999,,,999.0,CDH1,9606.0,Homo sapiens (human),Rolipram results in increased expression of CDH1 mrna|rolipram results in increased expression of CDH1 protein|pde4d protein inhibits the reaction [rolipram results in increased expression of CDH1 protein],,,PMID:37020384,https://www.ncbi.nlm.nih.gov/pubmed/37020384,37020384,,
154,520211,5092,Comparative Toxicogenomics Database (CTD),Rolipram,D020889,Rolipram,https://ctdbase.org/detail.go?type=chem&acc=D020889,1051,CEBPB,https://ctdbase.org/detail.go?type=gene&acc=1051,,,1051.0,CEBPB,10116.0,Rattus norvegicus (Norway rat),Rolipram promotes the reaction [FSHB protein results in increased expression of CEBPB protein],,,PMID:25253736,https://www.ncbi.nlm.nih.gov/pubmed/25253736,25253736,,
155,520212,5092,Comparative Toxicogenomics Database (CTD),Rolipram,D020889,Rolipram,https://ctdbase.org/detail.go?type=chem&acc=D020889,1080,CFTR,https://ctdbase.org/detail.go?type=gene&acc=1080,,,1080.0,CFTR,9606.0,Homo sapiens (human),Rolipram results in increased activity of CFTR protein|rolipram promotes the reaction [CFTR protein affects the secretion of chlorides],,,PMID:12714375,https://www.ncbi.nlm.nih.gov/pubmed/12714375,12714375,,
156,520213,5092,Comparative Toxicogenomics Database (CTD),Rolipram,D020889,Rolipram,https://ctdbase.org/detail.go?type=chem&acc=D020889,1080,CFTR,https://ctdbase.org/detail.go?type=gene&acc=1080,,,1080.0,CFTR,9606.0,Homo sapiens (human),Rolipram results in decreased activity of CFTR protein,,,PMID:15611099,https://www.ncbi.nlm.nih.gov/pubmed/15611099,15611099,,
157,520214,5092,Comparative Toxicogenomics Database (CTD),Rolipram,D020889,Rolipram,https://ctdbase.org/detail.go?type=chem&acc=D020889,1385,CREB1,https://ctdbase.org/detail.go?type=gene&acc=1385,,,1385.0,CREB1,10116.0,Rattus norvegicus (Norway rat),2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [rolipram promotes the reaction [nitroprusside results in increased phosphorylation of CREB1 protein]]|rolipram promotes the reaction [nitroprusside results in increased phosphorylation of CREB1 protein],,,PMID:18276108,https://www.ncbi.nlm.nih.gov/pubmed/18276108,18276108,,
158,520215,5092,Comparative Toxicogenomics Database (CTD),Rolipram,D020889,Rolipram,https://ctdbase.org/detail.go?type=chem&acc=D020889,1385,CREB1,https://ctdbase.org/detail.go?type=gene&acc=1385,,,1385.0,CREB1,10116.0,Rattus norvegicus (Norway rat),Rolipram inhibits the reaction [manganese results in decreased phosphorylation of CREB1 protein],,,PMID:31161640,https://www.ncbi.nlm.nih.gov/pubmed/31161640,31161640,,
159,518097,5311,BindingDB,Vorinostat,19149,CHEMBL98,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19149,50003563,Histone deacetylase 1/11/4/6/8,https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=50003563,Q13547,Histone deacetylase 1,3065.0,HDAC1,9606.0,Homo sapiens (human),,IC50 (nM),110,PMID:25019596|DOI:10.3109/14756366.2013.827675,https://www.ncbi.nlm.nih.gov/pubmed/25019596|https://doi.org/10.3109/14756366.2013.827675,25019596,10.3109/14756366.2013.827675,
160,518098,5311,BindingDB,Vorinostat,19149,CHEMBL98,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19149,1996,Histone deacetylase 8,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1996,Q9BY41,Histone deacetylase 8,55869.0,HDAC8,9606.0,Homo sapiens (human),,IC50 (nM),1406,PMID:24059701|DOI:10.3109/14756366.2013.827678,https://www.ncbi.nlm.nih.gov/pubmed/24059701|https://doi.org/10.3109/14756366.2013.827678,24059701,10.3109/14756366.2013.827678,
161,519387,5311,Comparative Toxicogenomics Database (CTD),Vorinostat,D000077337,Vorinostat,https://ctdbase.org/detail.go?type=chem&acc=D000077337,5308,PITX2,https://ctdbase.org/detail.go?type=gene&acc=5308,,,5308.0,PITX2,9606.0,Homo sapiens (human),"[NOG protein co-treated with vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PITX2 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
162,519388,5311,Comparative Toxicogenomics Database (CTD),Vorinostat,D000077337,Vorinostat,https://ctdbase.org/detail.go?type=chem&acc=D000077337,5308,PITX2,https://ctdbase.org/detail.go?type=gene&acc=5308,,,5308.0,PITX2,9606.0,Homo sapiens (human),Vorinostat results in increased expression of PITX2 mRNA,,,PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/26272509,26272509,,
163,520692,5311,Comparative Toxicogenomics Database (CTD),Vorinostat,D000077337,Vorinostat,https://ctdbase.org/detail.go?type=chem&acc=D000077337,25957,PNISR,https://ctdbase.org/detail.go?type=gene&acc=25957,,,25957.0,PNISR,9606.0,Homo sapiens (human),Vorinostat results in decreased expression of PNISR mRNA,,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
164,521190,5311,Comparative Toxicogenomics Database (CTD),Vorinostat,D000077337,Vorinostat,https://ctdbase.org/detail.go?type=chem&acc=D000077337,8497,PPFIA4,https://ctdbase.org/detail.go?type=gene&acc=8497,,,8497.0,PPFIA4,9606.0,Homo sapiens (human),Vorinostat results in decreased expression of PPFIA4 mRNA,,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
165,522686,5311,Comparative Toxicogenomics Database (CTD),Vorinostat,D000077337,Vorinostat,https://ctdbase.org/detail.go?type=chem&acc=D000077337,5690,PSMB2,https://ctdbase.org/detail.go?type=gene&acc=5690,,,5690.0,PSMB2,9606.0,Homo sapiens (human),Vorinostat results in decreased expression of PSMB2 protein,,,PMID:17593366|PMID:20543569,https://www.ncbi.nlm.nih.gov/pubmed/17593366|https://www.ncbi.nlm.nih.gov/pubmed/20543569,17593366|20543569,,
166,522687,5311,Comparative Toxicogenomics Database (CTD),Vorinostat,D000077337,Vorinostat,https://ctdbase.org/detail.go?type=chem&acc=D000077337,5692,PSMB4,https://ctdbase.org/detail.go?type=gene&acc=5692,,,5692.0,PSMB4,9606.0,Homo sapiens (human),Vorinostat results in decreased expression of PSMB4 protein,,,PMID:17593366,https://www.ncbi.nlm.nih.gov/pubmed/17593366,17593366,,
167,522688,5311,Comparative Toxicogenomics Database (CTD),Vorinostat,D000077337,Vorinostat,https://ctdbase.org/detail.go?type=chem&acc=D000077337,9861,PSMD6,https://ctdbase.org/detail.go?type=gene&acc=9861,,,9861.0,PSMD6,9606.0,Homo sapiens (human),Vorinostat results in decreased expression of PSMD6 mRNA,,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
168,522689,5311,Comparative Toxicogenomics Database (CTD),Vorinostat,D000077337,Vorinostat,https://ctdbase.org/detail.go?type=chem&acc=D000077337,23198,PSME4,https://ctdbase.org/detail.go?type=gene&acc=23198,,,23198.0,PSME4,9606.0,Homo sapiens (human),Vorinostat results in decreased expression of PSME4 mRNA,,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
169,522690,5311,Comparative Toxicogenomics Database (CTD),Vorinostat,D000077337,Vorinostat,https://ctdbase.org/detail.go?type=chem&acc=D000077337,9991,PTBP3,https://ctdbase.org/detail.go?type=gene&acc=9991,,,9991.0,PTBP3,9606.0,Homo sapiens (human),Vorinostat results in decreased expression of PTBP3 mRNA,,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
170,522691,5311,Comparative Toxicogenomics Database (CTD),Vorinostat,D000077337,Vorinostat,https://ctdbase.org/detail.go?type=chem&acc=D000077337,79810,PTCD2,https://ctdbase.org/detail.go?type=gene&acc=79810,,,79810.0,PTCD2,9606.0,Homo sapiens (human),Vorinostat results in increased expression of PTCD2 mRNA,,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
171,522692,5311,Comparative Toxicogenomics Database (CTD),Vorinostat,D000077337,Vorinostat,https://ctdbase.org/detail.go?type=chem&acc=D000077337,5727,PTCH1,https://ctdbase.org/detail.go?type=gene&acc=5727,,,5727.0,PTCH1,9606.0,Homo sapiens (human),"[NOG protein co-treated with vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PTCH1 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
172,522693,5311,Comparative Toxicogenomics Database (CTD),Vorinostat,D000077337,Vorinostat,https://ctdbase.org/detail.go?type=chem&acc=D000077337,5727,PTCH1,https://ctdbase.org/detail.go?type=gene&acc=5727,,,5727.0,PTCH1,9606.0,Homo sapiens (human),Vorinostat results in decreased expression of PTCH1 mRNA,,,PMID:19421011|PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/19421011|https://www.ncbi.nlm.nih.gov/pubmed/26272509,19421011|26272509,,
173,527588,5311,Comparative Toxicogenomics Database (CTD),Vorinostat,D000077337,Vorinostat,https://ctdbase.org/detail.go?type=chem&acc=D000077337,6263,RYR3,https://ctdbase.org/detail.go?type=gene&acc=6263,,,6263.0,RYR3,9606.0,Homo sapiens (human),Vorinostat results in decreased expression of RYR3 mRNA,,,PMID:26272509|PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/26272509|https://www.ncbi.nlm.nih.gov/pubmed/27188386,26272509|27188386,,
174,527589,5311,Comparative Toxicogenomics Database (CTD),Vorinostat,D000077337,Vorinostat,https://ctdbase.org/detail.go?type=chem&acc=D000077337,6281,S100A10,https://ctdbase.org/detail.go?type=gene&acc=6281,,,6281.0,S100A10,9606.0,Homo sapiens (human),[decitabine co-treated with vorinostat] affects the expression of S100A10 mRNA,,,PMID:17330099,https://www.ncbi.nlm.nih.gov/pubmed/17330099,17330099,,
175,527590,5311,Comparative Toxicogenomics Database (CTD),Vorinostat,D000077337,Vorinostat,https://ctdbase.org/detail.go?type=chem&acc=D000077337,6281,S100A10,https://ctdbase.org/detail.go?type=gene&acc=6281,,,6281.0,S100A10,9606.0,Homo sapiens (human),"[NOG protein co-treated with vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of S100A10 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
176,529153,5311,Comparative Toxicogenomics Database (CTD),Vorinostat,D000077337,Vorinostat,https://ctdbase.org/detail.go?type=chem&acc=D000077337,51091,SEPSECS,https://ctdbase.org/detail.go?type=gene&acc=51091,,,51091.0,SEPSECS,9606.0,Homo sapiens (human),Vorinostat results in increased expression of SEPSECS mRNA,,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
177,529154,5311,Comparative Toxicogenomics Database (CTD),Vorinostat,D000077337,Vorinostat,https://ctdbase.org/detail.go?type=chem&acc=D000077337,55964,SEPTIN3,https://ctdbase.org/detail.go?type=gene&acc=55964,,,55964.0,SEPTIN3,9606.0,Homo sapiens (human),Vorinostat results in decreased expression of SEPTIN3 mRNA,,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
178,529155,5311,Comparative Toxicogenomics Database (CTD),Vorinostat,D000077337,Vorinostat,https://ctdbase.org/detail.go?type=chem&acc=D000077337,23157,SEPTIN6,https://ctdbase.org/detail.go?type=gene&acc=23157,,,23157.0,SEPTIN6,9606.0,Homo sapiens (human),Vorinostat results in increased expression of SEPTIN6 mRNA,,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
179,529156,5311,Comparative Toxicogenomics Database (CTD),Vorinostat,D000077337,Vorinostat,https://ctdbase.org/detail.go?type=chem&acc=D000077337,23176,SEPTIN8,https://ctdbase.org/detail.go?type=gene&acc=23176,,,23176.0,SEPTIN8,9606.0,Homo sapiens (human),Vorinostat results in decreased expression of SEPTIN8 mRNA,,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
180,529157,5311,Comparative Toxicogenomics Database (CTD),Vorinostat,D000077337,Vorinostat,https://ctdbase.org/detail.go?type=chem&acc=D000077337,27230,SERP1,https://ctdbase.org/detail.go?type=gene&acc=27230,,,27230.0,SERP1,9606.0,Homo sapiens (human),Vorinostat results in increased expression of SERP1 mRNA,,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
181,529158,5311,Comparative Toxicogenomics Database (CTD),Vorinostat,D000077337,Vorinostat,https://ctdbase.org/detail.go?type=chem&acc=D000077337,5104,SERPINA5,https://ctdbase.org/detail.go?type=gene&acc=5104,,,5104.0,SERPINA5,9606.0,Homo sapiens (human),Vorinostat results in increased expression of SERPINA5 mRNA,,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
182,518099,5312,Comparative Toxicogenomics Database (CTD),"4,6-Dioxoheptanoic acid",C020804,succinylacetone,https://ctdbase.org/detail.go?type=chem&acc=C020804,179898,AIP-1,https://ctdbase.org/detail.go?type=gene&acc=179898,,,179898.0,aip-1,6239.0,Caenorhabditis elegans,Succinylacetone results in increased expression of AIP-1 mRNA,,,PMID:20351174,https://www.ncbi.nlm.nih.gov/pubmed/20351174,20351174,,
183,518100,5312,Comparative Toxicogenomics Database (CTD),"4,6-Dioxoheptanoic acid",C020804,succinylacetone,https://ctdbase.org/detail.go?type=chem&acc=C020804,210,ALAD,https://ctdbase.org/detail.go?type=gene&acc=210,,,210.0,ALAD,9606.0,Homo sapiens (human),[succinylacetone results in decreased activity of ALAD protein] which affects the abundance of heme|succinylacetone results in decreased activity of ALAD protein,,,PMID:22859313,https://www.ncbi.nlm.nih.gov/pubmed/22859313,22859313,,
184,518101,5312,Comparative Toxicogenomics Database (CTD),"4,6-Dioxoheptanoic acid",C020804,succinylacetone,https://ctdbase.org/detail.go?type=chem&acc=C020804,211,ALAS1,https://ctdbase.org/detail.go?type=gene&acc=211,,,211.0,ALAS1,9606.0,Homo sapiens (human),Succinylacetone inhibits the reaction [heme results in decreased expression of ALAS1 protein],,,PMID:21659532,https://www.ncbi.nlm.nih.gov/pubmed/21659532,21659532,,
185,518102,5312,Comparative Toxicogenomics Database (CTD),"4,6-Dioxoheptanoic acid",C020804,succinylacetone,https://ctdbase.org/detail.go?type=chem&acc=C020804,211,ALAS1,https://ctdbase.org/detail.go?type=gene&acc=211,,,211.0,ALAS1,10090.0,Mus musculus (house mouse),NFE2L2 gene mutant form inhibits the reaction [succinylacetone results in increased expression of ALAS1 mrna]|succinylacetone results in increased expression of ALAS1 mRNA,,,PMID:22859313,https://www.ncbi.nlm.nih.gov/pubmed/22859313,22859313,,
186,526025,5386,DrugBank,Tegafur,DB09256,Tegafur,https://www.drugbank.ca/drugs/DB09256,BE0002433,Cytochrome P450 1A2,https://www.drugbank.ca/bio_entities/BE0002433,P05177,Cytochrome P450 1A2,1544.0,CYP1A2,9606.0,Homo sapiens (human),Substrate,,,PMID:11095583|PMID:11353746,https://www.ncbi.nlm.nih.gov/pubmed/11095583|https://www.ncbi.nlm.nih.gov/pubmed/11353746,11095583|11353746,,
187,516567,5394,Comparative Toxicogenomics Database (CTD),Temozolomide,D000077204,Temozolomide,https://ctdbase.org/detail.go?type=chem&acc=D000077204,9638,FEZ1,https://ctdbase.org/detail.go?type=gene&acc=9638,,,9638.0,FEZ1,9606.0,Homo sapiens (human),Temozolomide results in increased expression of FEZ1 mRNA,,,PMID:31758290,https://www.ncbi.nlm.nih.gov/pubmed/31758290,31758290,,
188,516568,5394,Comparative Toxicogenomics Database (CTD),Temozolomide,D000077204,Temozolomide,https://ctdbase.org/detail.go?type=chem&acc=D000077204,89846,FGD3,https://ctdbase.org/detail.go?type=gene&acc=89846,,,89846.0,FGD3,9606.0,Homo sapiens (human),Temozolomide results in decreased expression of FGD3 mRNA,,,PMID:31758290,https://www.ncbi.nlm.nih.gov/pubmed/31758290,31758290,,
189,516569,5394,Comparative Toxicogenomics Database (CTD),Temozolomide,D000077204,Temozolomide,https://ctdbase.org/detail.go?type=chem&acc=D000077204,283481,FGF14-AS2,https://ctdbase.org/detail.go?type=gene&acc=283481,,,283481.0,FGF14-AS2,9606.0,Homo sapiens (human),Temozolomide results in decreased expression of FGF14-AS2 mRNA,,,PMID:31758290,https://www.ncbi.nlm.nih.gov/pubmed/31758290,31758290,,
190,516570,5394,Comparative Toxicogenomics Database (CTD),Temozolomide,D000077204,Temozolomide,https://ctdbase.org/detail.go?type=chem&acc=D000077204,2247,FGF2,https://ctdbase.org/detail.go?type=gene&acc=2247,,,2247.0,FGF2,9606.0,Homo sapiens (human),Temozolomide results in increased expression of FGF2 mRNA,,,PMID:31758290,https://www.ncbi.nlm.nih.gov/pubmed/31758290,31758290,,
191,517791,5394,Comparative Toxicogenomics Database (CTD),Temozolomide,D000077204,Temozolomide,https://ctdbase.org/detail.go?type=chem&acc=D000077204,79068,FTO,https://ctdbase.org/detail.go?type=gene&acc=79068,,,79068.0,FTO,9606.0,Homo sapiens (human),Temozolomide results in decreased expression of FTO mRNA,,,PMID:31758290,https://www.ncbi.nlm.nih.gov/pubmed/31758290,31758290,,
192,517792,5394,Comparative Toxicogenomics Database (CTD),Temozolomide,D000077204,Temozolomide,https://ctdbase.org/detail.go?type=chem&acc=D000077204,2517,FUCA1,https://ctdbase.org/detail.go?type=gene&acc=2517,,,2517.0,FUCA1,9606.0,Homo sapiens (human),Temozolomide results in increased expression of FUCA1 mRNA,,,PMID:31758290,https://www.ncbi.nlm.nih.gov/pubmed/31758290,31758290,,
193,517793,5394,Comparative Toxicogenomics Database (CTD),Temozolomide,D000077204,Temozolomide,https://ctdbase.org/detail.go?type=chem&acc=D000077204,139341,FUNDC1,https://ctdbase.org/detail.go?type=gene&acc=139341,,,139341.0,FUNDC1,9606.0,Homo sapiens (human),Temozolomide results in increased expression of FUNDC1 mRNA,,,PMID:31758290,https://www.ncbi.nlm.nih.gov/pubmed/31758290,31758290,,
194,517794,5394,Comparative Toxicogenomics Database (CTD),Temozolomide,D000077204,Temozolomide,https://ctdbase.org/detail.go?type=chem&acc=D000077204,2530,FUT8,https://ctdbase.org/detail.go?type=gene&acc=2530,,,2530.0,FUT8,9606.0,Homo sapiens (human),FUT8 mRNA affects the susceptibility to temozolomide,,,PMID:16365179,https://www.ncbi.nlm.nih.gov/pubmed/16365179,16365179,,
195,517795,5394,Comparative Toxicogenomics Database (CTD),Temozolomide,D000077204,Temozolomide,https://ctdbase.org/detail.go?type=chem&acc=D000077204,84248,FYTTD1,https://ctdbase.org/detail.go?type=gene&acc=84248,,,84248.0,FYTTD1,9606.0,Homo sapiens (human),Temozolomide results in increased expression of FYTTD1 mRNA,,,PMID:31758290,https://www.ncbi.nlm.nih.gov/pubmed/31758290,31758290,,
196,517796,5394,Comparative Toxicogenomics Database (CTD),Temozolomide,D000077204,Temozolomide,https://ctdbase.org/detail.go?type=chem&acc=D000077204,2535,FZD2,https://ctdbase.org/detail.go?type=gene&acc=2535,,,2535.0,FZD2,9606.0,Homo sapiens (human),Temozolomide results in increased expression of FZD2 mRNA,,,PMID:31758290,https://www.ncbi.nlm.nih.gov/pubmed/31758290,31758290,,
197,517797,5394,Comparative Toxicogenomics Database (CTD),Temozolomide,D000077204,Temozolomide,https://ctdbase.org/detail.go?type=chem&acc=D000077204,7976,FZD3,https://ctdbase.org/detail.go?type=gene&acc=7976,,,7976.0,FZD3,9606.0,Homo sapiens (human),Temozolomide results in increased expression of FZD3 mRNA,,,PMID:31758290,https://www.ncbi.nlm.nih.gov/pubmed/31758290,31758290,,
198,518723,5394,Comparative Toxicogenomics Database (CTD),Temozolomide,D000077204,Temozolomide,https://ctdbase.org/detail.go?type=chem&acc=D000077204,2745,GLRX,https://ctdbase.org/detail.go?type=gene&acc=2745,,,2745.0,GLRX,9606.0,Homo sapiens (human),Temozolomide results in decreased expression of GLRX mRNA,,,PMID:31758290,https://www.ncbi.nlm.nih.gov/pubmed/31758290,31758290,,
199,518724,5394,Comparative Toxicogenomics Database (CTD),Temozolomide,D000077204,Temozolomide,https://ctdbase.org/detail.go?type=chem&acc=D000077204,10539,GLRX3,https://ctdbase.org/detail.go?type=gene&acc=10539,,,10539.0,GLRX3,9606.0,Homo sapiens (human),Temozolomide results in decreased expression of GLRX3 mRNA,,,PMID:31758290,https://www.ncbi.nlm.nih.gov/pubmed/31758290,31758290,,
200,518725,5394,Comparative Toxicogenomics Database (CTD),Temozolomide,D000077204,Temozolomide,https://ctdbase.org/detail.go?type=chem&acc=D000077204,2744,GLS,https://ctdbase.org/detail.go?type=gene&acc=2744,,,2744.0,GLS,9606.0,Homo sapiens (human),Temozolomide results in decreased expression of GLS mRNA,,,PMID:31758290,https://www.ncbi.nlm.nih.gov/pubmed/31758290,31758290,,
201,520360,5394,Comparative Toxicogenomics Database (CTD),Temozolomide,D000077204,Temozolomide,https://ctdbase.org/detail.go?type=chem&acc=D000077204,5423,POLB,https://ctdbase.org/detail.go?type=gene&acc=5423,,,5423.0,POLB,9606.0,Homo sapiens (human),POLB protein inhibits the reaction [MPG protein promotes the reaction [methoxyamine results in increased susceptibility to temozolomide]],,,PMID:21377995,https://www.ncbi.nlm.nih.gov/pubmed/21377995,21377995,,
202,520361,5394,Comparative Toxicogenomics Database (CTD),Temozolomide,D000077204,Temozolomide,https://ctdbase.org/detail.go?type=chem&acc=D000077204,5423,POLB,https://ctdbase.org/detail.go?type=gene&acc=5423,,,5423.0,POLB,9606.0,Homo sapiens (human),POLB protein results in decreased susceptibility to temozolomide,,,PMID:16024643,https://www.ncbi.nlm.nih.gov/pubmed/16024643,16024643,,
203,520362,5394,Comparative Toxicogenomics Database (CTD),Temozolomide,D000077204,Temozolomide,https://ctdbase.org/detail.go?type=chem&acc=D000077204,57804,POLD4,https://ctdbase.org/detail.go?type=gene&acc=57804,,,57804.0,POLD4,9606.0,Homo sapiens (human),Temozolomide results in decreased expression of POLD4 mRNA,,,PMID:31758290,https://www.ncbi.nlm.nih.gov/pubmed/31758290,31758290,,
204,520363,5394,Comparative Toxicogenomics Database (CTD),Temozolomide,D000077204,Temozolomide,https://ctdbase.org/detail.go?type=chem&acc=D000077204,11232,POLG2,https://ctdbase.org/detail.go?type=gene&acc=11232,,,11232.0,POLG2,9606.0,Homo sapiens (human),POLG2 mRNA affects the susceptibility to temozolomide,,,PMID:16365179,https://www.ncbi.nlm.nih.gov/pubmed/16365179,16365179,,
205,520364,5394,Comparative Toxicogenomics Database (CTD),Temozolomide,D000077204,Temozolomide,https://ctdbase.org/detail.go?type=chem&acc=D000077204,11232,POLG2,https://ctdbase.org/detail.go?type=gene&acc=11232,,,11232.0,POLG2,9606.0,Homo sapiens (human),Temozolomide results in increased expression of POLG2 mRNA,,,PMID:31758290,https://www.ncbi.nlm.nih.gov/pubmed/31758290,31758290,,
206,520365,5394,Comparative Toxicogenomics Database (CTD),Temozolomide,D000077204,Temozolomide,https://ctdbase.org/detail.go?type=chem&acc=D000077204,9533,POLR1C,https://ctdbase.org/detail.go?type=gene&acc=9533,,,9533.0,POLR1C,9606.0,Homo sapiens (human),Temozolomide results in increased expression of POLR1C mRNA,,,PMID:31758290,https://www.ncbi.nlm.nih.gov/pubmed/31758290,31758290,,
207,520366,5394,Comparative Toxicogenomics Database (CTD),Temozolomide,D000077204,Temozolomide,https://ctdbase.org/detail.go?type=chem&acc=D000077204,51082,POLR1D,https://ctdbase.org/detail.go?type=gene&acc=51082,,,51082.0,POLR1D,9606.0,Homo sapiens (human),Temozolomide results in increased expression of POLR1D mRNA,,,PMID:31758290,https://www.ncbi.nlm.nih.gov/pubmed/31758290,31758290,,
208,520367,5394,Comparative Toxicogenomics Database (CTD),Temozolomide,D000077204,Temozolomide,https://ctdbase.org/detail.go?type=chem&acc=D000077204,64425,POLR1E,https://ctdbase.org/detail.go?type=gene&acc=64425,,,64425.0,POLR1E,9606.0,Homo sapiens (human),Temozolomide results in increased expression of POLR1E mRNA,,,PMID:31758290,https://www.ncbi.nlm.nih.gov/pubmed/31758290,31758290,,
209,520535,5394,Comparative Toxicogenomics Database (CTD),Temozolomide,D000077204,Temozolomide,https://ctdbase.org/detail.go?type=chem&acc=D000077204,3122,HLA-DRA,https://ctdbase.org/detail.go?type=gene&acc=3122,,,3122.0,HLA-DRA,9606.0,Homo sapiens (human),Temozolomide results in decreased expression of HLA-DRA mRNA,,,PMID:31758290,https://www.ncbi.nlm.nih.gov/pubmed/31758290,31758290,,
210,520536,5394,Comparative Toxicogenomics Database (CTD),Temozolomide,D000077204,Temozolomide,https://ctdbase.org/detail.go?type=chem&acc=D000077204,3123,HLA-DRB1,https://ctdbase.org/detail.go?type=gene&acc=3123,,,3123.0,HLA-DRB1,9606.0,Homo sapiens (human),Temozolomide results in decreased expression of HLA-DRB1 mRNA,,,PMID:31758290,https://www.ncbi.nlm.nih.gov/pubmed/31758290,31758290,,
211,520537,5394,Comparative Toxicogenomics Database (CTD),Temozolomide,D000077204,Temozolomide,https://ctdbase.org/detail.go?type=chem&acc=D000077204,3126,HLA-DRB4,https://ctdbase.org/detail.go?type=gene&acc=3126,,,3126.0,HLA-DRB4,9606.0,Homo sapiens (human),Temozolomide results in decreased expression of HLA-DRB4 mRNA,,,PMID:31758290,https://www.ncbi.nlm.nih.gov/pubmed/31758290,31758290,,
212,520538,5394,Comparative Toxicogenomics Database (CTD),Temozolomide,D000077204,Temozolomide,https://ctdbase.org/detail.go?type=chem&acc=D000077204,3127,HLA-DRB5,https://ctdbase.org/detail.go?type=gene&acc=3127,,,3127.0,HLA-DRB5,9606.0,Homo sapiens (human),Temozolomide results in decreased expression of HLA-DRB5 mRNA,,,PMID:31758290,https://www.ncbi.nlm.nih.gov/pubmed/31758290,31758290,,
213,521655,5394,Comparative Toxicogenomics Database (CTD),Temozolomide,D000077204,Temozolomide,https://ctdbase.org/detail.go?type=chem&acc=D000077204,5683,PSMA2,https://ctdbase.org/detail.go?type=gene&acc=5683,,,5683.0,PSMA2,9606.0,Homo sapiens (human),Temozolomide results in decreased expression of PSMA2 mRNA,,,PMID:31758290,https://www.ncbi.nlm.nih.gov/pubmed/31758290,31758290,,
214,521656,5394,Comparative Toxicogenomics Database (CTD),Temozolomide,D000077204,Temozolomide,https://ctdbase.org/detail.go?type=chem&acc=D000077204,5699,PSMB10,https://ctdbase.org/detail.go?type=gene&acc=5699,,,5699.0,PSMB10,9606.0,Homo sapiens (human),Temozolomide results in increased expression of PSMB10 mRNA,,,PMID:31758290,https://www.ncbi.nlm.nih.gov/pubmed/31758290,31758290,,
215,521842,5394,Comparative Toxicogenomics Database (CTD),Temozolomide,D000077204,Temozolomide,https://ctdbase.org/detail.go?type=chem&acc=D000077204,375743,PTAR1,https://ctdbase.org/detail.go?type=gene&acc=375743,,,375743.0,PTAR1,9606.0,Homo sapiens (human),Temozolomide results in decreased expression of PTAR1 mRNA,,,PMID:31758290,https://www.ncbi.nlm.nih.gov/pubmed/31758290,31758290,,
216,521843,5394,Comparative Toxicogenomics Database (CTD),Temozolomide,D000077204,Temozolomide,https://ctdbase.org/detail.go?type=chem&acc=D000077204,58155,PTBP2,https://ctdbase.org/detail.go?type=gene&acc=58155,,,58155.0,PTBP2,9606.0,Homo sapiens (human),Temozolomide results in increased expression of PTBP2 mRNA,,,PMID:31758290,https://www.ncbi.nlm.nih.gov/pubmed/31758290,31758290,,
217,521844,5394,Comparative Toxicogenomics Database (CTD),Temozolomide,D000077204,Temozolomide,https://ctdbase.org/detail.go?type=chem&acc=D000077204,5732,PTGER2,https://ctdbase.org/detail.go?type=gene&acc=5732,,,5732.0,PTGER2,9606.0,Homo sapiens (human),Temozolomide results in decreased expression of PTGER2 mRNA,,,PMID:31758290,https://www.ncbi.nlm.nih.gov/pubmed/31758290,31758290,,
218,522021,5394,Comparative Toxicogenomics Database (CTD),Temozolomide,D000077204,Temozolomide,https://ctdbase.org/detail.go?type=chem&acc=D000077204,442727,PTMAP10,https://ctdbase.org/detail.go?type=gene&acc=442727,,,442727.0,PTMAP10,9606.0,Homo sapiens (human),Temozolomide results in increased expression of PTMAP10 mRNA,,,PMID:31758290,https://www.ncbi.nlm.nih.gov/pubmed/31758290,31758290,,
219,522022,5394,Comparative Toxicogenomics Database (CTD),Temozolomide,D000077204,Temozolomide,https://ctdbase.org/detail.go?type=chem&acc=D000077204,728873,PTMAP8,https://ctdbase.org/detail.go?type=gene&acc=728873,,,728873.0,PTMAP8,9606.0,Homo sapiens (human),Temozolomide results in increased expression of PTMAP8 mRNA,,,PMID:31758290,https://www.ncbi.nlm.nih.gov/pubmed/31758290,31758290,,
220,522023,5394,Comparative Toxicogenomics Database (CTD),Temozolomide,D000077204,Temozolomide,https://ctdbase.org/detail.go?type=chem&acc=D000077204,5763,PTMS,https://ctdbase.org/detail.go?type=gene&acc=5763,,,5763.0,PTMS,9606.0,Homo sapiens (human),Temozolomide results in decreased expression of PTMS mRNA,,,PMID:31758290,https://www.ncbi.nlm.nih.gov/pubmed/31758290,31758290,,
221,522024,5394,Comparative Toxicogenomics Database (CTD),Temozolomide,D000077204,Temozolomide,https://ctdbase.org/detail.go?type=chem&acc=D000077204,53635,PTOV1,https://ctdbase.org/detail.go?type=gene&acc=53635,,,53635.0,PTOV1,9606.0,Homo sapiens (human),Temozolomide results in decreased expression of PTOV1 mRNA,,,PMID:31758290,https://www.ncbi.nlm.nih.gov/pubmed/31758290,31758290,,
222,522193,5394,Comparative Toxicogenomics Database (CTD),Temozolomide,D000077204,Temozolomide,https://ctdbase.org/detail.go?type=chem&acc=D000077204,5789,PTPRD,https://ctdbase.org/detail.go?type=gene&acc=5789,,,5789.0,PTPRD,9606.0,Homo sapiens (human),Temozolomide results in decreased expression of PTPRD mRNA,,,PMID:31758290,https://www.ncbi.nlm.nih.gov/pubmed/31758290,31758290,,
223,522194,5394,Comparative Toxicogenomics Database (CTD),Temozolomide,D000077204,Temozolomide,https://ctdbase.org/detail.go?type=chem&acc=D000077204,5791,PTPRE,https://ctdbase.org/detail.go?type=gene&acc=5791,,,5791.0,PTPRE,9606.0,Homo sapiens (human),Temozolomide results in decreased expression of PTPRE mRNA,,,PMID:31758290,https://www.ncbi.nlm.nih.gov/pubmed/31758290,31758290,,
224,522195,5394,Comparative Toxicogenomics Database (CTD),Temozolomide,D000077204,Temozolomide,https://ctdbase.org/detail.go?type=chem&acc=D000077204,5792,PTPRF,https://ctdbase.org/detail.go?type=gene&acc=5792,,,5792.0,PTPRF,9606.0,Homo sapiens (human),Temozolomide results in increased expression of PTPRF mRNA,,,PMID:31758290,https://www.ncbi.nlm.nih.gov/pubmed/31758290,31758290,,
225,522196,5394,Comparative Toxicogenomics Database (CTD),Temozolomide,D000077204,Temozolomide,https://ctdbase.org/detail.go?type=chem&acc=D000077204,5796,PTPRK,https://ctdbase.org/detail.go?type=gene&acc=5796,,,5796.0,PTPRK,9606.0,Homo sapiens (human),Temozolomide results in decreased expression of PTPRK mRNA,,,PMID:31758290,https://www.ncbi.nlm.nih.gov/pubmed/31758290,31758290,,
226,522197,5394,Comparative Toxicogenomics Database (CTD),Temozolomide,D000077204,Temozolomide,https://ctdbase.org/detail.go?type=chem&acc=D000077204,5797,PTPRM,https://ctdbase.org/detail.go?type=gene&acc=5797,,,5797.0,PTPRM,9606.0,Homo sapiens (human),Temozolomide results in decreased expression of PTPRM mRNA,,,PMID:31758290,https://www.ncbi.nlm.nih.gov/pubmed/31758290,31758290,,
227,522198,5394,Comparative Toxicogenomics Database (CTD),Temozolomide,D000077204,Temozolomide,https://ctdbase.org/detail.go?type=chem&acc=D000077204,5799,PTPRN2,https://ctdbase.org/detail.go?type=gene&acc=5799,,,5799.0,PTPRN2,9606.0,Homo sapiens (human),Temozolomide results in decreased expression of PTPRN2 mRNA,,,PMID:31758290,https://www.ncbi.nlm.nih.gov/pubmed/31758290,31758290,,
228,522199,5394,Comparative Toxicogenomics Database (CTD),Temozolomide,D000077204,Temozolomide,https://ctdbase.org/detail.go?type=chem&acc=D000077204,5801,PTPRR,https://ctdbase.org/detail.go?type=gene&acc=5801,,,5801.0,PTPRR,9606.0,Homo sapiens (human),Temozolomide results in decreased expression of PTPRR mRNA,,,PMID:31758290,https://www.ncbi.nlm.nih.gov/pubmed/31758290,31758290,,
229,522364,5394,Comparative Toxicogenomics Database (CTD),Temozolomide,D000077204,Temozolomide,https://ctdbase.org/detail.go?type=chem&acc=D000077204,5820,PVT1,https://ctdbase.org/detail.go?type=gene&acc=5820,,,5820.0,PVT1,9606.0,Homo sapiens (human),Temozolomide results in increased expression of PVT1 mRNA,,,PMID:31758290,https://www.ncbi.nlm.nih.gov/pubmed/31758290,31758290,,
230,522365,5394,Comparative Toxicogenomics Database (CTD),Temozolomide,D000077204,Temozolomide,https://ctdbase.org/detail.go?type=chem&acc=D000077204,11137,PWP1,https://ctdbase.org/detail.go?type=gene&acc=11137,,,11137.0,PWP1,9606.0,Homo sapiens (human),Temozolomide results in increased expression of PWP1 mRNA,,,PMID:31758290,https://www.ncbi.nlm.nih.gov/pubmed/31758290,31758290,,
231,522366,5394,Comparative Toxicogenomics Database (CTD),Temozolomide,D000077204,Temozolomide,https://ctdbase.org/detail.go?type=chem&acc=D000077204,84939,PWWP3A,https://ctdbase.org/detail.go?type=gene&acc=84939,,,84939.0,PWWP3A,9606.0,Homo sapiens (human),Temozolomide results in decreased expression of PWWP3A mRNA,,,PMID:31758290,https://www.ncbi.nlm.nih.gov/pubmed/31758290,31758290,,
232,522367,5394,Comparative Toxicogenomics Database (CTD),Temozolomide,D000077204,Temozolomide,https://ctdbase.org/detail.go?type=chem&acc=D000077204,7837,PXDN,https://ctdbase.org/detail.go?type=gene&acc=7837,,,7837.0,PXDN,9606.0,Homo sapiens (human),Temozolomide results in increased expression of PXDN mRNA,,,PMID:31758290,https://www.ncbi.nlm.nih.gov/pubmed/31758290,31758290,,
233,522368,5394,Comparative Toxicogenomics Database (CTD),Temozolomide,D000077204,Temozolomide,https://ctdbase.org/detail.go?type=chem&acc=D000077204,5827,PXMP2,https://ctdbase.org/detail.go?type=gene&acc=5827,,,5827.0,PXMP2,9606.0,Homo sapiens (human),Temozolomide results in increased expression of PXMP2 mRNA,,,PMID:31758290,https://www.ncbi.nlm.nih.gov/pubmed/31758290,31758290,,
234,522369,5394,Comparative Toxicogenomics Database (CTD),Temozolomide,D000077204,Temozolomide,https://ctdbase.org/detail.go?type=chem&acc=D000077204,5831,PYCR1,https://ctdbase.org/detail.go?type=gene&acc=5831,,,5831.0,PYCR1,9606.0,Homo sapiens (human),Temozolomide results in increased expression of PYCR1 mRNA,,,PMID:31758290,https://www.ncbi.nlm.nih.gov/pubmed/31758290,31758290,,
235,522370,5394,Comparative Toxicogenomics Database (CTD),Temozolomide,D000077204,Temozolomide,https://ctdbase.org/detail.go?type=chem&acc=D000077204,5834,PYGB,https://ctdbase.org/detail.go?type=gene&acc=5834,,,5834.0,PYGB,9606.0,Homo sapiens (human),Temozolomide results in increased expression of PYGB mRNA,,,PMID:31758290,https://www.ncbi.nlm.nih.gov/pubmed/31758290,31758290,,
236,523145,5394,Comparative Toxicogenomics Database (CTD),Temozolomide,D000077204,Temozolomide,https://ctdbase.org/detail.go?type=chem&acc=D000077204,51528,JKAMP,https://ctdbase.org/detail.go?type=gene&acc=51528,,,51528.0,JKAMP,9606.0,Homo sapiens (human),Temozolomide results in decreased expression of JKAMP mRNA,,,PMID:31758290,https://www.ncbi.nlm.nih.gov/pubmed/31758290,31758290,,
237,523146,5394,Comparative Toxicogenomics Database (CTD),Temozolomide,D000077204,Temozolomide,https://ctdbase.org/detail.go?type=chem&acc=D000077204,339123,JMJD8,https://ctdbase.org/detail.go?type=gene&acc=339123,,,339123.0,JMJD8,9606.0,Homo sapiens (human),Temozolomide results in increased expression of JMJD8 mRNA,,,PMID:31758290,https://www.ncbi.nlm.nih.gov/pubmed/31758290,31758290,,
238,523147,5394,Comparative Toxicogenomics Database (CTD),Temozolomide,D000077204,Temozolomide,https://ctdbase.org/detail.go?type=chem&acc=D000077204,51155,JPT1,https://ctdbase.org/detail.go?type=gene&acc=51155,,,51155.0,JPT1,9606.0,Homo sapiens (human),Temozolomide results in increased expression of JPT1 mRNA,,,PMID:31758290,https://www.ncbi.nlm.nih.gov/pubmed/31758290,31758290,,
239,523148,5394,Comparative Toxicogenomics Database (CTD),Temozolomide,D000077204,Temozolomide,https://ctdbase.org/detail.go?type=chem&acc=D000077204,100130171,JPT1P1,https://ctdbase.org/detail.go?type=gene&acc=100130171,,,100130171.0,JPT1P1,9606.0,Homo sapiens (human),Temozolomide results in increased expression of JPT1P1 mRNA,,,PMID:31758290,https://www.ncbi.nlm.nih.gov/pubmed/31758290,31758290,,
240,523149,5394,Comparative Toxicogenomics Database (CTD),Temozolomide,D000077204,Temozolomide,https://ctdbase.org/detail.go?type=chem&acc=D000077204,23189,KANK1,https://ctdbase.org/detail.go?type=gene&acc=23189,,,23189.0,KANK1,9606.0,Homo sapiens (human),Temozolomide results in increased expression of KANK1 mRNA,,,PMID:31758290,https://www.ncbi.nlm.nih.gov/pubmed/31758290,31758290,,
241,523150,5394,Comparative Toxicogenomics Database (CTD),Temozolomide,D000077204,Temozolomide,https://ctdbase.org/detail.go?type=chem&acc=D000077204,25959,KANK2,https://ctdbase.org/detail.go?type=gene&acc=25959,,,25959.0,KANK2,9606.0,Homo sapiens (human),Temozolomide results in decreased expression of KANK2 mRNA,,,PMID:31758290,https://www.ncbi.nlm.nih.gov/pubmed/31758290,31758290,,
242,523151,5394,Comparative Toxicogenomics Database (CTD),Temozolomide,D000077204,Temozolomide,https://ctdbase.org/detail.go?type=chem&acc=D000077204,57325,KAT14,https://ctdbase.org/detail.go?type=gene&acc=57325,,,57325.0,KAT14,9606.0,Homo sapiens (human),Temozolomide results in increased expression of KAT14 mRNA,,,PMID:31758290,https://www.ncbi.nlm.nih.gov/pubmed/31758290,31758290,,
243,525186,5394,Comparative Toxicogenomics Database (CTD),Temozolomide,D000077204,Temozolomide,https://ctdbase.org/detail.go?type=chem&acc=D000077204,728658,RPL13AP5,https://ctdbase.org/detail.go?type=gene&acc=728658,,,728658.0,RPL13AP5,9606.0,Homo sapiens (human),Temozolomide results in increased expression of RPL13AP5 mRNA,,,PMID:31758290,https://www.ncbi.nlm.nih.gov/pubmed/31758290,31758290,,
244,525187,5394,Comparative Toxicogenomics Database (CTD),Temozolomide,D000077204,Temozolomide,https://ctdbase.org/detail.go?type=chem&acc=D000077204,644511,RPL13AP6,https://ctdbase.org/detail.go?type=gene&acc=644511,,,644511.0,RPL13AP6,9606.0,Homo sapiens (human),Temozolomide results in increased expression of RPL13AP6 mRNA,,,PMID:31758290,https://www.ncbi.nlm.nih.gov/pubmed/31758290,31758290,,
245,525188,5394,Comparative Toxicogenomics Database (CTD),Temozolomide,D000077204,Temozolomide,https://ctdbase.org/detail.go?type=chem&acc=D000077204,284821,RPL13AP7,https://ctdbase.org/detail.go?type=gene&acc=284821,,,284821.0,RPL13AP7,9606.0,Homo sapiens (human),Temozolomide results in increased expression of RPL13AP7 mRNA,,,PMID:31758290,https://www.ncbi.nlm.nih.gov/pubmed/31758290,31758290,,
246,525189,5394,Comparative Toxicogenomics Database (CTD),Temozolomide,D000077204,Temozolomide,https://ctdbase.org/detail.go?type=chem&acc=D000077204,402694,RPL15P11,https://ctdbase.org/detail.go?type=gene&acc=402694,,,402694.0,RPL15P11,9606.0,Homo sapiens (human),Temozolomide results in increased expression of RPL15P11 mRNA,,,PMID:31758290,https://www.ncbi.nlm.nih.gov/pubmed/31758290,31758290,,
247,525190,5394,Comparative Toxicogenomics Database (CTD),Temozolomide,D000077204,Temozolomide,https://ctdbase.org/detail.go?type=chem&acc=D000077204,646672,RPL15P20,https://ctdbase.org/detail.go?type=gene&acc=646672,,,646672.0,RPL15P20,9606.0,Homo sapiens (human),Temozolomide results in increased expression of RPL15P20 mRNA,,,PMID:31758290,https://www.ncbi.nlm.nih.gov/pubmed/31758290,31758290,,
248,525191,5394,Comparative Toxicogenomics Database (CTD),Temozolomide,D000077204,Temozolomide,https://ctdbase.org/detail.go?type=chem&acc=D000077204,100127993,RPL15P5,https://ctdbase.org/detail.go?type=gene&acc=100127993,,,100127993.0,RPL15P5,9606.0,Homo sapiens (human),Temozolomide results in increased expression of RPL15P5 mRNA,,,PMID:31758290,https://www.ncbi.nlm.nih.gov/pubmed/31758290,31758290,,
249,525192,5394,Comparative Toxicogenomics Database (CTD),Temozolomide,D000077204,Temozolomide,https://ctdbase.org/detail.go?type=chem&acc=D000077204,347544,RPL18AP16,https://ctdbase.org/detail.go?type=gene&acc=347544,,,347544.0,RPL18AP16,9606.0,Homo sapiens (human),Temozolomide results in increased expression of RPL18AP16 mRNA,,,PMID:31758290,https://www.ncbi.nlm.nih.gov/pubmed/31758290,31758290,,
250,525193,5394,Comparative Toxicogenomics Database (CTD),Temozolomide,D000077204,Temozolomide,https://ctdbase.org/detail.go?type=chem&acc=D000077204,390354,RPL18AP3,https://ctdbase.org/detail.go?type=gene&acc=390354,,,390354.0,RPL18AP3,9606.0,Homo sapiens (human),Temozolomide results in increased expression of RPL18AP3 mRNA,,,PMID:31758290,https://www.ncbi.nlm.nih.gov/pubmed/31758290,31758290,,
251,525388,5394,Comparative Toxicogenomics Database (CTD),Temozolomide,D000077204,Temozolomide,https://ctdbase.org/detail.go?type=chem&acc=D000077204,441775,RPL18P13,https://ctdbase.org/detail.go?type=gene&acc=441775,,,441775.0,RPL18P13,9606.0,Homo sapiens (human),Temozolomide results in increased expression of RPL18P13 mRNA,,,PMID:31758290,https://www.ncbi.nlm.nih.gov/pubmed/31758290,31758290,,
252,525389,5394,Comparative Toxicogenomics Database (CTD),Temozolomide,D000077204,Temozolomide,https://ctdbase.org/detail.go?type=chem&acc=D000077204,645157,RPL21P61,https://ctdbase.org/detail.go?type=gene&acc=645157,,,645157.0,RPL21P61,9606.0,Homo sapiens (human),Temozolomide results in increased expression of RPL21P61 mRNA,,,PMID:31758290,https://www.ncbi.nlm.nih.gov/pubmed/31758290,31758290,,
253,525390,5394,Comparative Toxicogenomics Database (CTD),Temozolomide,D000077204,Temozolomide,https://ctdbase.org/detail.go?type=chem&acc=D000077204,645452,RPL21P68,https://ctdbase.org/detail.go?type=gene&acc=645452,,,645452.0,RPL21P68,9606.0,Homo sapiens (human),Temozolomide results in decreased expression of RPL21P68 mRNA,,,PMID:31758290,https://www.ncbi.nlm.nih.gov/pubmed/31758290,31758290,,
254,525391,5394,Comparative Toxicogenomics Database (CTD),Temozolomide,D000077204,Temozolomide,https://ctdbase.org/detail.go?type=chem&acc=D000077204,729764,RPL23AP45,https://ctdbase.org/detail.go?type=gene&acc=729764,,,729764.0,RPL23AP45,9606.0,Homo sapiens (human),Temozolomide results in decreased expression of RPL23AP45 mRNA,,,PMID:31758290,https://www.ncbi.nlm.nih.gov/pubmed/31758290,31758290,,
255,525392,5394,Comparative Toxicogenomics Database (CTD),Temozolomide,D000077204,Temozolomide,https://ctdbase.org/detail.go?type=chem&acc=D000077204,6154,RPL26,https://ctdbase.org/detail.go?type=gene&acc=6154,,,6154.0,RPL26,9606.0,Homo sapiens (human),Temozolomide results in increased expression of RPL26 mRNA,,,PMID:31758290,https://www.ncbi.nlm.nih.gov/pubmed/31758290,31758290,,
256,525393,5394,Comparative Toxicogenomics Database (CTD),Temozolomide,D000077204,Temozolomide,https://ctdbase.org/detail.go?type=chem&acc=D000077204,51121,RPL26L1,https://ctdbase.org/detail.go?type=gene&acc=51121,,,51121.0,RPL26L1,9606.0,Homo sapiens (human),Temozolomide results in decreased expression of RPL26L1 mRNA,,,PMID:31758290,https://www.ncbi.nlm.nih.gov/pubmed/31758290,31758290,,
257,525394,5394,Comparative Toxicogenomics Database (CTD),Temozolomide,D000077204,Temozolomide,https://ctdbase.org/detail.go?type=chem&acc=D000077204,653147,RPL26P30,https://ctdbase.org/detail.go?type=gene&acc=653147,,,653147.0,RPL26P30,9606.0,Homo sapiens (human),Temozolomide results in decreased expression of RPL26P30 mRNA,,,PMID:31758290,https://www.ncbi.nlm.nih.gov/pubmed/31758290,31758290,,
258,525395,5394,Comparative Toxicogenomics Database (CTD),Temozolomide,D000077204,Temozolomide,https://ctdbase.org/detail.go?type=chem&acc=D000077204,100132547,RPL26P33,https://ctdbase.org/detail.go?type=gene&acc=100132547,,,100132547.0,RPL26P33,9606.0,Homo sapiens (human),Temozolomide results in increased expression of RPL26P33 mRNA,,,PMID:31758290,https://www.ncbi.nlm.nih.gov/pubmed/31758290,31758290,,
259,526189,5394,Comparative Toxicogenomics Database (CTD),Temozolomide,D000077204,Temozolomide,https://ctdbase.org/detail.go?type=chem&acc=D000077204,6192,RPS4Y1,https://ctdbase.org/detail.go?type=gene&acc=6192,,,6192.0,RPS4Y1,9606.0,Homo sapiens (human),Temozolomide results in increased expression of RPS4Y1 mRNA,,,PMID:31758290,https://www.ncbi.nlm.nih.gov/pubmed/31758290,31758290,,
260,526190,5394,Comparative Toxicogenomics Database (CTD),Temozolomide,D000077204,Temozolomide,https://ctdbase.org/detail.go?type=chem&acc=D000077204,140032,RPS4Y2,https://ctdbase.org/detail.go?type=gene&acc=140032,,,140032.0,RPS4Y2,9606.0,Homo sapiens (human),Temozolomide results in increased expression of RPS4Y2 mRNA,,,PMID:31758290,https://www.ncbi.nlm.nih.gov/pubmed/31758290,31758290,,
261,526191,5394,Comparative Toxicogenomics Database (CTD),Temozolomide,D000077204,Temozolomide,https://ctdbase.org/detail.go?type=chem&acc=D000077204,6195,RPS6KA1,https://ctdbase.org/detail.go?type=gene&acc=6195,,,6195.0,RPS6KA1,9606.0,Homo sapiens (human),Temozolomide results in increased expression of RPS6KA1 mRNA,,,PMID:31758290,https://www.ncbi.nlm.nih.gov/pubmed/31758290,31758290,,
262,526192,5394,Comparative Toxicogenomics Database (CTD),Temozolomide,D000077204,Temozolomide,https://ctdbase.org/detail.go?type=chem&acc=D000077204,8986,RPS6KA4,https://ctdbase.org/detail.go?type=gene&acc=8986,,,8986.0,RPS6KA4,9606.0,Homo sapiens (human),Temozolomide results in decreased expression of RPS6KA4 mRNA,,,PMID:31758290,https://www.ncbi.nlm.nih.gov/pubmed/31758290,31758290,,
263,527315,5394,Comparative Toxicogenomics Database (CTD),Temozolomide,D000077204,Temozolomide,https://ctdbase.org/detail.go?type=chem&acc=D000077204,6383,SDC2,https://ctdbase.org/detail.go?type=gene&acc=6383,,,6383.0,SDC2,9606.0,Homo sapiens (human),Temozolomide results in increased expression of SDC2 mRNA,,,PMID:31758290,https://www.ncbi.nlm.nih.gov/pubmed/31758290,31758290,,
264,527888,5394,Comparative Toxicogenomics Database (CTD),Temozolomide,D000077204,Temozolomide,https://ctdbase.org/detail.go?type=chem&acc=D000077204,10992,SF3B2,https://ctdbase.org/detail.go?type=gene&acc=10992,,,10992.0,SF3B2,9606.0,Homo sapiens (human),Temozolomide results in decreased expression of SF3B2 mRNA,,,PMID:31758290,https://www.ncbi.nlm.nih.gov/pubmed/31758290,31758290,,
265,527889,5394,Comparative Toxicogenomics Database (CTD),Temozolomide,D000077204,Temozolomide,https://ctdbase.org/detail.go?type=chem&acc=D000077204,57713,SFMBT2,https://ctdbase.org/detail.go?type=gene&acc=57713,,,57713.0,SFMBT2,9606.0,Homo sapiens (human),Temozolomide results in increased expression of SFMBT2 mRNA,,,PMID:31758290,https://www.ncbi.nlm.nih.gov/pubmed/31758290,31758290,,
266,527890,5394,Comparative Toxicogenomics Database (CTD),Temozolomide,D000077204,Temozolomide,https://ctdbase.org/detail.go?type=chem&acc=D000077204,6422,SFRP1,https://ctdbase.org/detail.go?type=gene&acc=6422,,,6422.0,SFRP1,9606.0,Homo sapiens (human),Temozolomide results in increased expression of SFRP1 mRNA,,,PMID:31758290,https://www.ncbi.nlm.nih.gov/pubmed/31758290,31758290,,
267,527891,5394,Comparative Toxicogenomics Database (CTD),Temozolomide,D000077204,Temozolomide,https://ctdbase.org/detail.go?type=chem&acc=D000077204,207107,SFTA1P,https://ctdbase.org/detail.go?type=gene&acc=207107,,,207107.0,SFTA1P,9606.0,Homo sapiens (human),Temozolomide results in increased expression of SFTA1P mRNA,,,PMID:31758290,https://www.ncbi.nlm.nih.gov/pubmed/31758290,31758290,,
268,527892,5394,Comparative Toxicogenomics Database (CTD),Temozolomide,D000077204,Temozolomide,https://ctdbase.org/detail.go?type=chem&acc=D000077204,81855,SFXN3,https://ctdbase.org/detail.go?type=gene&acc=81855,,,81855.0,SFXN3,9606.0,Homo sapiens (human),Temozolomide results in decreased expression of SFXN3 mRNA,,,PMID:31758290,https://www.ncbi.nlm.nih.gov/pubmed/31758290,31758290,,
269,527893,5394,Comparative Toxicogenomics Database (CTD),Temozolomide,D000077204,Temozolomide,https://ctdbase.org/detail.go?type=chem&acc=D000077204,94097,SFXN5,https://ctdbase.org/detail.go?type=gene&acc=94097,,,94097.0,SFXN5,9606.0,Homo sapiens (human),Temozolomide results in increased expression of SFXN5 mRNA,,,PMID:31758290,https://www.ncbi.nlm.nih.gov/pubmed/31758290,31758290,,
270,527894,5394,Comparative Toxicogenomics Database (CTD),Temozolomide,D000077204,Temozolomide,https://ctdbase.org/detail.go?type=chem&acc=D000077204,6445,SGCG,https://ctdbase.org/detail.go?type=gene&acc=6445,,,6445.0,SGCG,9606.0,Homo sapiens (human),Temozolomide results in decreased expression of SGCG mRNA,,,PMID:31758290,https://www.ncbi.nlm.nih.gov/pubmed/31758290,31758290,,
271,527895,5394,Comparative Toxicogenomics Database (CTD),Temozolomide,D000077204,Temozolomide,https://ctdbase.org/detail.go?type=chem&acc=D000077204,112869,SGF29,https://ctdbase.org/detail.go?type=gene&acc=112869,,,112869.0,SGF29,9606.0,Homo sapiens (human),Temozolomide results in increased expression of SGF29 mRNA,,,PMID:31758290,https://www.ncbi.nlm.nih.gov/pubmed/31758290,31758290,,
272,528054,5394,Comparative Toxicogenomics Database (CTD),Temozolomide,D000077204,Temozolomide,https://ctdbase.org/detail.go?type=chem&acc=D000077204,23616,SH3BP1,https://ctdbase.org/detail.go?type=gene&acc=23616,,,23616.0,SH3BP1,9606.0,Homo sapiens (human),Temozolomide results in increased expression of SH3BP1 mRNA,,,PMID:31758290,https://www.ncbi.nlm.nih.gov/pubmed/31758290,31758290,,
273,528055,5394,Comparative Toxicogenomics Database (CTD),Temozolomide,D000077204,Temozolomide,https://ctdbase.org/detail.go?type=chem&acc=D000077204,23677,SH3BP4,https://ctdbase.org/detail.go?type=gene&acc=23677,,,23677.0,SH3BP4,9606.0,Homo sapiens (human),Temozolomide results in increased expression of SH3BP4 mRNA,,,PMID:31758290,https://www.ncbi.nlm.nih.gov/pubmed/31758290,31758290,,
274,528056,5394,Comparative Toxicogenomics Database (CTD),Temozolomide,D000077204,Temozolomide,https://ctdbase.org/detail.go?type=chem&acc=D000077204,152503,SH3D19,https://ctdbase.org/detail.go?type=gene&acc=152503,,,152503.0,SH3D19,9606.0,Homo sapiens (human),Temozolomide results in decreased expression of SH3D19 mRNA,,,PMID:31758290,https://www.ncbi.nlm.nih.gov/pubmed/31758290,31758290,,
275,528057,5394,Comparative Toxicogenomics Database (CTD),Temozolomide,D000077204,Temozolomide,https://ctdbase.org/detail.go?type=chem&acc=D000077204,6457,SH3GL3,https://ctdbase.org/detail.go?type=gene&acc=6457,,,6457.0,SH3GL3,9606.0,Homo sapiens (human),Temozolomide results in increased expression of SH3GL3 mRNA,,,PMID:31758290,https://www.ncbi.nlm.nih.gov/pubmed/31758290,31758290,,
276,528058,5394,Comparative Toxicogenomics Database (CTD),Temozolomide,D000077204,Temozolomide,https://ctdbase.org/detail.go?type=chem&acc=D000077204,9644,SH3PXD2A,https://ctdbase.org/detail.go?type=gene&acc=9644,,,9644.0,SH3PXD2A,9606.0,Homo sapiens (human),Temozolomide results in decreased expression of SH3PXD2A mRNA,,,PMID:31758290,https://www.ncbi.nlm.nih.gov/pubmed/31758290,31758290,,
277,528059,5394,Comparative Toxicogenomics Database (CTD),Temozolomide,D000077204,Temozolomide,https://ctdbase.org/detail.go?type=chem&acc=D000077204,153769,SH3RF2,https://ctdbase.org/detail.go?type=gene&acc=153769,,,153769.0,SH3RF2,9606.0,Homo sapiens (human),Temozolomide results in decreased expression of SH3RF2 mRNA,,,PMID:31758290,https://www.ncbi.nlm.nih.gov/pubmed/31758290,31758290,,
278,528060,5394,Comparative Toxicogenomics Database (CTD),Temozolomide,D000077204,Temozolomide,https://ctdbase.org/detail.go?type=chem&acc=D000077204,26751,SH3YL1,https://ctdbase.org/detail.go?type=gene&acc=26751,,,26751.0,SH3YL1,9606.0,Homo sapiens (human),Temozolomide results in decreased expression of SH3YL1 mRNA,,,PMID:31758290,https://www.ncbi.nlm.nih.gov/pubmed/31758290,31758290,,
279,528207,5394,Comparative Toxicogenomics Database (CTD),Temozolomide,D000077204,Temozolomide,https://ctdbase.org/detail.go?type=chem&acc=D000077204,55337,SHFL,https://ctdbase.org/detail.go?type=gene&acc=55337,,,55337.0,SHFL,9606.0,Homo sapiens (human),Temozolomide results in increased expression of SHFL mRNA,,,PMID:31758290,https://www.ncbi.nlm.nih.gov/pubmed/31758290,31758290,,
280,528208,5394,Comparative Toxicogenomics Database (CTD),Temozolomide,D000077204,Temozolomide,https://ctdbase.org/detail.go?type=chem&acc=D000077204,387914,SHISA2,https://ctdbase.org/detail.go?type=gene&acc=387914,,,387914.0,SHISA2,9606.0,Homo sapiens (human),Temozolomide results in increased expression of SHISA2 mRNA,,,PMID:31758290,https://www.ncbi.nlm.nih.gov/pubmed/31758290,31758290,,
281,528209,5394,Comparative Toxicogenomics Database (CTD),Temozolomide,D000077204,Temozolomide,https://ctdbase.org/detail.go?type=chem&acc=D000077204,51246,SHISA5,https://ctdbase.org/detail.go?type=gene&acc=51246,,,51246.0,SHISA5,9606.0,Homo sapiens (human),Temozolomide results in increased expression of SHISA5 mRNA,,,PMID:31758290,https://www.ncbi.nlm.nih.gov/pubmed/31758290,31758290,,
282,528210,5394,Comparative Toxicogenomics Database (CTD),Temozolomide,D000077204,Temozolomide,https://ctdbase.org/detail.go?type=chem&acc=D000077204,85352,SHISAL1,https://ctdbase.org/detail.go?type=gene&acc=85352,,,85352.0,SHISAL1,9606.0,Homo sapiens (human),Temozolomide results in decreased expression of SHISAL1 mRNA,,,PMID:31758290,https://www.ncbi.nlm.nih.gov/pubmed/31758290,31758290,,
283,528211,5394,Comparative Toxicogenomics Database (CTD),Temozolomide,D000077204,Temozolomide,https://ctdbase.org/detail.go?type=chem&acc=D000077204,92799,SHKBP1,https://ctdbase.org/detail.go?type=gene&acc=92799,,,92799.0,SHKBP1,9606.0,Homo sapiens (human),Temozolomide results in decreased expression of SHKBP1 mRNA,,,PMID:31758290,https://www.ncbi.nlm.nih.gov/pubmed/31758290,31758290,,
284,528212,5394,Comparative Toxicogenomics Database (CTD),Temozolomide,D000077204,Temozolomide,https://ctdbase.org/detail.go?type=chem&acc=D000077204,149840,SHLD1,https://ctdbase.org/detail.go?type=gene&acc=149840,,,149840.0,SHLD1,9606.0,Homo sapiens (human),Temozolomide results in increased expression of SHLD1 mRNA,,,PMID:31758290,https://www.ncbi.nlm.nih.gov/pubmed/31758290,31758290,,
285,528213,5394,Comparative Toxicogenomics Database (CTD),Temozolomide,D000077204,Temozolomide,https://ctdbase.org/detail.go?type=chem&acc=D000077204,57619,SHROOM3,https://ctdbase.org/detail.go?type=gene&acc=57619,,,57619.0,SHROOM3,9606.0,Homo sapiens (human),Temozolomide results in increased expression of SHROOM3 mRNA,,,PMID:31758290,https://www.ncbi.nlm.nih.gov/pubmed/31758290,31758290,,
286,528214,5394,Comparative Toxicogenomics Database (CTD),Temozolomide,D000077204,Temozolomide,https://ctdbase.org/detail.go?type=chem&acc=D000077204,57477,SHROOM4,https://ctdbase.org/detail.go?type=gene&acc=57477,,,57477.0,SHROOM4,9606.0,Homo sapiens (human),Temozolomide results in decreased expression of SHROOM4 mRNA,,,PMID:31758290,https://www.ncbi.nlm.nih.gov/pubmed/31758290,31758290,,
287,529440,5394,Comparative Toxicogenomics Database (CTD),Temozolomide,D000077204,Temozolomide,https://ctdbase.org/detail.go?type=chem&acc=D000077204,28234,SLCO1B3,https://ctdbase.org/detail.go?type=gene&acc=28234,,,28234.0,SLCO1B3,9606.0,Homo sapiens (human),Temozolomide results in increased expression of SLCO1B3 mRNA,,,PMID:31758290,https://www.ncbi.nlm.nih.gov/pubmed/31758290,31758290,,
288,529441,5394,Comparative Toxicogenomics Database (CTD),Temozolomide,D000077204,Temozolomide,https://ctdbase.org/detail.go?type=chem&acc=D000077204,81796,SLCO5A1,https://ctdbase.org/detail.go?type=gene&acc=81796,,,81796.0,SLCO5A1,9606.0,Homo sapiens (human),Temozolomide results in increased expression of SLCO5A1 mRNA,,,PMID:31758290,https://www.ncbi.nlm.nih.gov/pubmed/31758290,31758290,,
289,529442,5394,Comparative Toxicogenomics Database (CTD),Temozolomide,D000077204,Temozolomide,https://ctdbase.org/detail.go?type=chem&acc=D000077204,84250,SLF1,https://ctdbase.org/detail.go?type=gene&acc=84250,,,84250.0,SLF1,9606.0,Homo sapiens (human),Temozolomide results in increased expression of SLF1 mRNA,,,PMID:31758290,https://www.ncbi.nlm.nih.gov/pubmed/31758290,31758290,,
290,529443,5394,Comparative Toxicogenomics Database (CTD),Temozolomide,D000077204,Temozolomide,https://ctdbase.org/detail.go?type=chem&acc=D000077204,91607,SLFN11,https://ctdbase.org/detail.go?type=gene&acc=91607,,,91607.0,SLFN11,9606.0,Homo sapiens (human),Temozolomide results in increased expression of SLFN11 mRNA,,,PMID:31758290,https://www.ncbi.nlm.nih.gov/pubmed/31758290,31758290,,
291,529444,5394,Comparative Toxicogenomics Database (CTD),Temozolomide,D000077204,Temozolomide,https://ctdbase.org/detail.go?type=chem&acc=D000077204,9353,SLIT2,https://ctdbase.org/detail.go?type=gene&acc=9353,,,9353.0,SLIT2,9606.0,Homo sapiens (human),Temozolomide results in increased expression of SLIT2 mRNA,,,PMID:31758290,https://www.ncbi.nlm.nih.gov/pubmed/31758290,31758290,,
292,524066,5413,Therapeutic Target Database (TTD),Tetraethylammonium,D06PZZ,[14C]TEA,https://idrblab.net/ttd/data/drug/details/D06PZZ,T76914,Voltage-gated potassium channel Kv1.3 (KCNA3),https://idrblab.net/ttd/data/target/details/T76914,P22001,Potassium voltage-gated channel subfamily A member 3,3738.0,KCNA3,9606.0,Homo sapiens (human),Blocker (channel blocker),,,,,,,
293,524067,5413,Therapeutic Target Database (TTD),Tetraethylammonium,D06PZZ,[14C]TEA,https://idrblab.net/ttd/data/drug/details/D06PZZ,T11911,Calcium-activated potassium channel KCa2.1 (KCNN1),https://idrblab.net/ttd/data/target/details/T11911,Q92952,Small conductance calcium-activated potassium channel protein 1,3780.0,KCNN1,9606.0,Homo sapiens (human),Blocker (channel blocker),,,,,,,
294,524068,5413,Therapeutic Target Database (TTD),Tetraethylammonium,D06PZZ,[14C]TEA,https://idrblab.net/ttd/data/drug/details/D06PZZ,T78318,Calcium-activated potassium channel KCa4.2 (KCNT2),https://idrblab.net/ttd/data/target/details/T78318,Q6UVM3,Potassium channel subfamily T member 2,343450.0,KCNT2,9606.0,Homo sapiens (human),Blocker (channel blocker),,,,,,,
295,524069,5413,Therapeutic Target Database (TTD),Tetraethylammonium,D06PZZ,[14C]TEA,https://idrblab.net/ttd/data/drug/details/D06PZZ,T55068,Voltage-gated potassium channel Kv7.5 (KCNQ5),https://idrblab.net/ttd/data/target/details/T55068,Q9NR82,Potassium voltage-gated channel subfamily KQT member 5,56479.0,KCNQ5,9606.0,Homo sapiens (human),Blocker (channel blocker),,,,,,,
296,524070,5413,Therapeutic Target Database (TTD),Tetraethylammonium,D06PZZ,[14C]TEA,https://idrblab.net/ttd/data/drug/details/D06PZZ,T55916,Voltage-gated potassium channel Kv7.4 (KCNQ4),https://idrblab.net/ttd/data/target/details/T55916,P56696,Potassium voltage-gated channel subfamily KQT member 4,9132.0,KCNQ4,9606.0,Homo sapiens (human),Blocker (channel blocker),,,,,,,
297,524071,5413,Therapeutic Target Database (TTD),Tetraethylammonium,D06PZZ,[14C]TEA,https://idrblab.net/ttd/data/drug/details/D06PZZ,T49080,Voltage-gated potassium channel Kv3.1 (KCNC1),https://idrblab.net/ttd/data/target/details/T49080,P48547,Potassium voltage-gated channel subfamily C member 1,3746.0,KCNC1,9606.0,Homo sapiens (human),Blocker (channel blocker),,,,,,,
298,524072,5413,Therapeutic Target Database (TTD),Tetraethylammonium,D06PZZ,[14C]TEA,https://idrblab.net/ttd/data/drug/details/D06PZZ,T54132,Voltage-gated potassium channel Kv7.3 (KCNQ3),https://idrblab.net/ttd/data/target/details/T54132,O43525,Potassium voltage-gated channel subfamily KQT member 3,3786.0,KCNQ3,9606.0,Homo sapiens (human),Blocker (channel blocker),,,,,,,
299,530848,5426,Comparative Toxicogenomics Database (CTD),Thalidomide,D013792,Thalidomide,https://ctdbase.org/detail.go?type=chem&acc=D013792,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,9606.0,Homo sapiens (human),CAT protein inhibits the reaction [thalidomide results in decreased activity of MYB protein],,,PMID:16616857,https://www.ncbi.nlm.nih.gov/pubmed/16616857,16616857,,
300,531019,5426,Comparative Toxicogenomics Database (CTD),Thalidomide,D013792,Thalidomide,https://ctdbase.org/detail.go?type=chem&acc=D013792,10344,CCL26,https://ctdbase.org/detail.go?type=gene&acc=10344,,,10344.0,CCL26,9031.0,Gallus gallus (chicken),Thalidomide results in decreased expression of CCL26 mRNA,,,PMID:28892372,https://www.ncbi.nlm.nih.gov/pubmed/28892372,28892372,,
301,531020,5426,Comparative Toxicogenomics Database (CTD),Thalidomide,D013792,Thalidomide,https://ctdbase.org/detail.go?type=chem&acc=D013792,6348,CCL3,https://ctdbase.org/detail.go?type=gene&acc=6348,,,6348.0,CCL3,10116.0,Rattus norvegicus (Norway rat),Thalidomide results in increased expression of CCL3 mRNA,,,PMID:16549389,https://www.ncbi.nlm.nih.gov/pubmed/16549389,16549389,,
302,531021,5426,Comparative Toxicogenomics Database (CTD),Thalidomide,D013792,Thalidomide,https://ctdbase.org/detail.go?type=chem&acc=D013792,890,CCNA2,https://ctdbase.org/detail.go?type=gene&acc=890,,,890.0,CCNA2,9606.0,Homo sapiens (human),[azacitidine co-treated with thalidomide] affects the expression of CCNA2 mRNA,,,PMID:18720364,https://www.ncbi.nlm.nih.gov/pubmed/18720364,18720364,,
303,531022,5426,Comparative Toxicogenomics Database (CTD),Thalidomide,D013792,Thalidomide,https://ctdbase.org/detail.go?type=chem&acc=D013792,891,CCNB1,https://ctdbase.org/detail.go?type=gene&acc=891,,,891.0,CCNB1,9606.0,Homo sapiens (human),[azacitidine co-treated with thalidomide] affects the expression of CCNB1 mRNA,,,PMID:18720364,https://www.ncbi.nlm.nih.gov/pubmed/18720364,18720364,,
304,531023,5426,Comparative Toxicogenomics Database (CTD),Thalidomide,D013792,Thalidomide,https://ctdbase.org/detail.go?type=chem&acc=D013792,595,CCND1,https://ctdbase.org/detail.go?type=gene&acc=595,,,595.0,CCND1,9606.0,Homo sapiens (human),Thalidomide analog results in decreased expression of CCND1 mRNA,,,PMID:20525221,https://www.ncbi.nlm.nih.gov/pubmed/20525221,20525221,,
305,531024,5426,Comparative Toxicogenomics Database (CTD),Thalidomide,D013792,Thalidomide,https://ctdbase.org/detail.go?type=chem&acc=D013792,10309,CCNO,https://ctdbase.org/detail.go?type=gene&acc=10309,,,10309.0,CCNO,10090.0,Mus musculus (house mouse),Thalidomide results in increased expression of CCNO mRNA,,,PMID:26217789,https://www.ncbi.nlm.nih.gov/pubmed/26217789,26217789,,
306,531025,5426,Comparative Toxicogenomics Database (CTD),Thalidomide,D013792,Thalidomide,https://ctdbase.org/detail.go?type=chem&acc=D013792,12484,CD24A,https://ctdbase.org/detail.go?type=gene&acc=12484,,,12484.0,Cd24a,10090.0,Mus musculus (house mouse),Thalidomide affects the expression of CD24A mRNA,,,PMID:26006729,https://www.ncbi.nlm.nih.gov/pubmed/26006729,26006729,,
307,522998,5455,Comparative Toxicogenomics Database (CTD),Thiram,D013893,Thiram,https://ctdbase.org/detail.go?type=chem&acc=D013893,221184,CPNE2,https://ctdbase.org/detail.go?type=gene&acc=221184,,,221184.0,CPNE2,7955.0,Danio rerio (zebrafish),Thiram results in increased expression of CPNE2 mRNA,,,PMID:20530235,https://www.ncbi.nlm.nih.gov/pubmed/20530235,20530235,,
308,523919,5455,Comparative Toxicogenomics Database (CTD),Thiram,D013893,Thiram,https://ctdbase.org/detail.go?type=chem&acc=D013893,11269,DDX19B,https://ctdbase.org/detail.go?type=gene&acc=11269,,,11269.0,DDX19B,7955.0,Danio rerio (zebrafish),Thiram results in decreased expression of DDX19B mRNA,,,PMID:20530235,https://www.ncbi.nlm.nih.gov/pubmed/20530235,20530235,,
309,523920,5455,Comparative Toxicogenomics Database (CTD),Thiram,D013893,Thiram,https://ctdbase.org/detail.go?type=chem&acc=D013893,1655,DDX5,https://ctdbase.org/detail.go?type=gene&acc=1655,,,1655.0,DDX5,7955.0,Danio rerio (zebrafish),Thiram results in decreased expression of DDX5 mRNA,,,PMID:20530235,https://www.ncbi.nlm.nih.gov/pubmed/20530235,20530235,,
310,523921,5455,Comparative Toxicogenomics Database (CTD),Thiram,D013893,Thiram,https://ctdbase.org/detail.go?type=chem&acc=D013893,79039,DDX54,https://ctdbase.org/detail.go?type=gene&acc=79039,,,79039.0,DDX54,7955.0,Danio rerio (zebrafish),Thiram results in decreased expression of DDX54 mRNA,,,PMID:20530235,https://www.ncbi.nlm.nih.gov/pubmed/20530235,20530235,,
311,523922,5455,Comparative Toxicogenomics Database (CTD),Thiram,D013893,Thiram,https://ctdbase.org/detail.go?type=chem&acc=D013893,26063,DECR2,https://ctdbase.org/detail.go?type=gene&acc=26063,,,26063.0,DECR2,7955.0,Danio rerio (zebrafish),Thiram results in increased expression of DECR2 mRNA,,,PMID:20530235,https://www.ncbi.nlm.nih.gov/pubmed/20530235,20530235,,
312,523923,5455,Comparative Toxicogenomics Database (CTD),Thiram,D013893,Thiram,https://ctdbase.org/detail.go?type=chem&acc=D013893,79139,DERL1,https://ctdbase.org/detail.go?type=gene&acc=79139,,,79139.0,DERL1,7955.0,Danio rerio (zebrafish),Thiram results in increased expression of DERL1 mRNA,,,PMID:20530235,https://www.ncbi.nlm.nih.gov/pubmed/20530235,20530235,,
313,523924,5455,Comparative Toxicogenomics Database (CTD),Thiram,D013893,Thiram,https://ctdbase.org/detail.go?type=chem&acc=D013893,1676,DFFA,https://ctdbase.org/detail.go?type=gene&acc=1676,,,1676.0,DFFA,7955.0,Danio rerio (zebrafish),Thiram results in increased expression of DFFA mRNA,,,PMID:20530235,https://www.ncbi.nlm.nih.gov/pubmed/20530235,20530235,,
314,523925,5455,Comparative Toxicogenomics Database (CTD),Thiram,D013893,Thiram,https://ctdbase.org/detail.go?type=chem&acc=D013893,1725,DHPS,https://ctdbase.org/detail.go?type=gene&acc=1725,,,1725.0,DHPS,7955.0,Danio rerio (zebrafish),Thiram results in increased expression of DHPS mRNA,,,PMID:20530235,https://www.ncbi.nlm.nih.gov/pubmed/20530235,20530235,,
315,523926,5455,Comparative Toxicogenomics Database (CTD),Thiram,D013893,Thiram,https://ctdbase.org/detail.go?type=chem&acc=D013893,147015,DHRS13,https://ctdbase.org/detail.go?type=gene&acc=147015,,,147015.0,DHRS13,7955.0,Danio rerio (zebrafish),Thiram results in decreased expression of DHRS13 mRNA,,,PMID:20530235,https://www.ncbi.nlm.nih.gov/pubmed/20530235,20530235,,
316,524517,5455,Comparative Toxicogenomics Database (CTD),Thiram,D013893,Thiram,https://ctdbase.org/detail.go?type=chem&acc=D013893,51386,EIF3L,https://ctdbase.org/detail.go?type=gene&acc=51386,,,51386.0,EIF3L,7955.0,Danio rerio (zebrafish),Thiram results in decreased expression of EIF3L mRNA,,,PMID:20530235,https://www.ncbi.nlm.nih.gov/pubmed/20530235,20530235,,
317,524518,5455,Comparative Toxicogenomics Database (CTD),Thiram,D013893,Thiram,https://ctdbase.org/detail.go?type=chem&acc=D013893,1984,EIF5A,https://ctdbase.org/detail.go?type=gene&acc=1984,,,1984.0,EIF5A,7955.0,Danio rerio (zebrafish),Thiram results in decreased expression of EIF5A mRNA,,,PMID:20530235,https://www.ncbi.nlm.nih.gov/pubmed/20530235,20530235,,
318,524519,5455,Comparative Toxicogenomics Database (CTD),Thiram,D013893,Thiram,https://ctdbase.org/detail.go?type=chem&acc=D013893,7260,EIPR1,https://ctdbase.org/detail.go?type=gene&acc=7260,,,7260.0,EIPR1,7955.0,Danio rerio (zebrafish),Thiram results in decreased expression of EIPR1 mRNA,,,PMID:20530235,https://www.ncbi.nlm.nih.gov/pubmed/20530235,20530235,,
319,524520,5455,Comparative Toxicogenomics Database (CTD),Thiram,D013893,Thiram,https://ctdbase.org/detail.go?type=chem&acc=D013893,1998,ELF2,https://ctdbase.org/detail.go?type=gene&acc=1998,,,1998.0,ELF2,7955.0,Danio rerio (zebrafish),Thiram results in decreased expression of ELF2 mRNA,,,PMID:20530235,https://www.ncbi.nlm.nih.gov/pubmed/20530235,20530235,,
320,524521,5455,Comparative Toxicogenomics Database (CTD),Thiram,D013893,Thiram,https://ctdbase.org/detail.go?type=chem&acc=D013893,9844,ELMO1,https://ctdbase.org/detail.go?type=gene&acc=9844,,,9844.0,ELMO1,7955.0,Danio rerio (zebrafish),Thiram results in decreased expression of ELMO1 mRNA,,,PMID:20530235,https://www.ncbi.nlm.nih.gov/pubmed/20530235,20530235,,
321,524522,5455,Comparative Toxicogenomics Database (CTD),Thiram,D013893,Thiram,https://ctdbase.org/detail.go?type=chem&acc=D013893,60481,ELOVL5,https://ctdbase.org/detail.go?type=gene&acc=60481,,,60481.0,ELOVL5,7955.0,Danio rerio (zebrafish),Thiram results in decreased expression of ELOVL5 mRNA,,,PMID:20530235,https://www.ncbi.nlm.nih.gov/pubmed/20530235,20530235,,
322,529159,5455,Comparative Toxicogenomics Database (CTD),Thiram,D013893,Thiram,https://ctdbase.org/detail.go?type=chem&acc=D013893,55154,MSTO1,https://ctdbase.org/detail.go?type=gene&acc=55154,,,55154.0,MSTO1,7955.0,Danio rerio (zebrafish),Thiram results in increased expression of MSTO1 mRNA,,,PMID:20530235,https://www.ncbi.nlm.nih.gov/pubmed/20530235,20530235,,
323,529160,5455,Comparative Toxicogenomics Database (CTD),Thiram,D013893,Thiram,https://ctdbase.org/detail.go?type=chem&acc=D013893,4495,MT1G,https://ctdbase.org/detail.go?type=gene&acc=4495,,,4495.0,MT1G,9606.0,Homo sapiens (human),Thiram results in increased expression of MT1G mRNA,,,PMID:32870474,https://www.ncbi.nlm.nih.gov/pubmed/32870474,32870474,,
324,527140,5467,Therapeutic Target Database (TTD),Tiapride,D02LCR,Tiapride,https://idrblab.net/ttd/data/drug/details/D02LCR,T67162,Dopamine D2 receptor (D2R),https://idrblab.net/ttd/data/target/details/T67162,P14416,D(2) dopamine receptor,1813.0,DRD2,9606.0,Homo sapiens (human),Antagonist,,,,,,,
325,527141,5468,Therapeutic Target Database (TTD),Tiaprofenic acid,D0S7VO,Tiaprofenic acid,https://idrblab.net/ttd/data/drug/details/D0S7VO,T66665,Prostaglandin G/H synthase 2 (COX-2),https://idrblab.net/ttd/data/target/details/T66665,P35354,Prostaglandin G/H synthase 2,5743.0,PTGS2,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
326,527142,5472,Therapeutic Target Database (TTD),Ticlopidine,D05LBU,Ticlopidine,https://idrblab.net/ttd/data/drug/details/D05LBU,T87023,Platelet-activating factor receptor (PTAFR),https://idrblab.net/ttd/data/target/details/T87023,P25105,Platelet-activating factor receptor,5724.0,PTAFR,9606.0,Homo sapiens (human),Modulator,,,,,,,
327,527143,5475,BindingDB,Tilorone,50364890,Amixin IC,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50364890,6126,DNA primase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=6126,,,,,,,,IC50 (nM),7.1e+3,PMID:24004110|DOI:10.1021/bi4011286,https://www.ncbi.nlm.nih.gov/pubmed/24004110|https://doi.org/10.1021/bi4011286,24004110,10.1021/bi4011286,
328,527144,5475,BindingDB,Tilorone,50364890,Amixin IC,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50364890,6127,DNA primase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=6127,P9WNW0,DNA primase,,,83331.0,Mycobacterium tuberculosis CDC1551,,IC50 (nM),6.9e+4,PMID:24004110|DOI:10.1021/bi4011286,https://www.ncbi.nlm.nih.gov/pubmed/24004110|https://doi.org/10.1021/bi4011286,24004110,10.1021/bi4011286,
329,527145,5482,Therapeutic Target Database (TTD),Tioconazole,D0CA6J,Tioconazole,https://idrblab.net/ttd/data/drug/details/D0CA6J,T73726,Candida Cytochrome P450 51 (Candi ERG11),https://idrblab.net/ttd/data/target/details/T73726,P10613,Lanosterol 14-alpha demethylase,3641571.0,ERG11,237561.0,Candida albicans SC5314,Inhibitor,,,,,,,
330,517078,5487,DrugBank,Tizanidine,DB00697,Tizanidine,https://www.drugbank.ca/drugs/DB00697,BE0003580,Nischarin,https://www.drugbank.ca/bio_entities/BE0003580,Q9Y2I1,Nischarin,11188.0,NISCH,9606.0,Homo sapiens (human),Agonist,,,PMID:18602099|PMID:26962521,https://www.ncbi.nlm.nih.gov/pubmed/18602099|https://www.ncbi.nlm.nih.gov/pubmed/26962521,18602099|26962521,,
331,517079,5487,DrugBank,Tizanidine,DB00697,Tizanidine,https://www.drugbank.ca/drugs/DB00697,BE0004863,Alpha-1A adrenergic receptor,https://www.drugbank.ca/bio_entities/BE0004863,P35348,Alpha-1A adrenergic receptor,148.0,ADRA1A,9606.0,Homo sapiens (human),Agonist,,,PMID:6329897|PMID:1666331,https://www.ncbi.nlm.nih.gov/pubmed/6329897|https://www.ncbi.nlm.nih.gov/pubmed/1666331,6329897|1666331,,
332,517080,5487,DrugBank,Tizanidine,DB00697,Tizanidine,https://www.drugbank.ca/drugs/DB00697,BE0004863,Alpha-1B adrenergic receptor,https://www.drugbank.ca/bio_entities/BE0004863,P35368,Alpha-1B adrenergic receptor,147.0,ADRA1B,9606.0,Homo sapiens (human),Agonist,,,PMID:6329897|PMID:1666331,https://www.ncbi.nlm.nih.gov/pubmed/6329897|https://www.ncbi.nlm.nih.gov/pubmed/1666331,6329897|1666331,,
333,517081,5487,DrugBank,Tizanidine,DB00697,Tizanidine,https://www.drugbank.ca/drugs/DB00697,BE0004863,Alpha-1D adrenergic receptor,https://www.drugbank.ca/bio_entities/BE0004863,P25100,Alpha-1D adrenergic receptor,146.0,ADRA1D,9606.0,Homo sapiens (human),Agonist,,,PMID:6329897|PMID:1666331,https://www.ncbi.nlm.nih.gov/pubmed/6329897|https://www.ncbi.nlm.nih.gov/pubmed/1666331,6329897|1666331,,
334,517082,5487,DrugBank,Tizanidine,DB00697,Tizanidine,https://www.drugbank.ca/drugs/DB00697,BE0004864,Alpha-2A adrenergic receptor,https://www.drugbank.ca/bio_entities/BE0004864,P08913,Alpha-2A adrenergic receptor,150.0,ADRA2A,9606.0,Homo sapiens (human),Agonist,,,PMID:8930173|PMID:25849473|PMID:15481719|PMID:19393691,https://www.ncbi.nlm.nih.gov/pubmed/8930173|https://www.ncbi.nlm.nih.gov/pubmed/25849473|https://www.ncbi.nlm.nih.gov/pubmed/15481719|https://www.ncbi.nlm.nih.gov/pubmed/19393691,8930173|25849473|15481719|19393691,,
335,517083,5487,DrugBank,Tizanidine,DB00697,Tizanidine,https://www.drugbank.ca/drugs/DB00697,BE0004864,Alpha-2B adrenergic receptor,https://www.drugbank.ca/bio_entities/BE0004864,P18089,Alpha-2B adrenergic receptor,151.0,ADRA2B,9606.0,Homo sapiens (human),Agonist,,,PMID:8930173|PMID:25849473|PMID:15481719|PMID:19393691,https://www.ncbi.nlm.nih.gov/pubmed/8930173|https://www.ncbi.nlm.nih.gov/pubmed/25849473|https://www.ncbi.nlm.nih.gov/pubmed/15481719|https://www.ncbi.nlm.nih.gov/pubmed/19393691,8930173|25849473|15481719|19393691,,
336,517084,5487,DrugBank,Tizanidine,DB00697,Tizanidine,https://www.drugbank.ca/drugs/DB00697,BE0004864,Alpha-2C adrenergic receptor,https://www.drugbank.ca/bio_entities/BE0004864,P18825,Alpha-2C adrenergic receptor,152.0,ADRA2C,9606.0,Homo sapiens (human),Agonist,,,PMID:8930173|PMID:25849473|PMID:15481719|PMID:19393691,https://www.ncbi.nlm.nih.gov/pubmed/8930173|https://www.ncbi.nlm.nih.gov/pubmed/25849473|https://www.ncbi.nlm.nih.gov/pubmed/15481719|https://www.ncbi.nlm.nih.gov/pubmed/19393691,8930173|25849473|15481719|19393691,,
337,517085,5487,DrugBank,Tizanidine,DB00697,Tizanidine,https://www.drugbank.ca/drugs/DB00697,BE0002433,Cytochrome P450 1A2,https://www.drugbank.ca/bio_entities/BE0002433,P05177,Cytochrome P450 1A2,1544.0,CYP1A2,9606.0,Homo sapiens (human),Substrate,,,PMID:19754423|PMID:9929503|PMID:16985100,https://www.ncbi.nlm.nih.gov/pubmed/19754423|https://www.ncbi.nlm.nih.gov/pubmed/9929503|https://www.ncbi.nlm.nih.gov/pubmed/16985100,19754423|9929503|16985100,,
338,516883,5560,BindingDB,Trichlormethiazide,26998,"6-chloro-3-(dichloromethyl)-1,1-dioxo-3,4-dihydro-2H-1,2,4-benzothiadiazine-7-sulfonamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=26998,1233,Carbonic anhydrase 9,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1233,Q16790,Carbonic anhydrase 9,768.0,CA9,9606.0,Homo sapiens (human),,Ki (nM),87,PMID:19119014|DOI:10.1016/j.bmc.2008.12.023,https://www.ncbi.nlm.nih.gov/pubmed/19119014|https://doi.org/10.1016/j.bmc.2008.12.023,19119014,10.1016/j.bmc.2008.12.023,
339,516884,5560,BindingDB,Trichlormethiazide,26998,"6-chloro-3-(dichloromethyl)-1,1-dioxo-3,4-dihydro-2H-1,2,4-benzothiadiazine-7-sulfonamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=26998,1363,Carbonic anhydrase 12,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1363,O43570,Carbonic anhydrase 12,771.0,CA12,9606.0,Homo sapiens (human),,Ki (nM),312,PMID:19119014|DOI:10.1016/j.bmc.2008.12.023,https://www.ncbi.nlm.nih.gov/pubmed/19119014|https://doi.org/10.1016/j.bmc.2008.12.023,19119014,10.1016/j.bmc.2008.12.023,
340,516885,5560,BindingDB,Trichlormethiazide,26998,"6-chloro-3-(dichloromethyl)-1,1-dioxo-3,4-dihydro-2H-1,2,4-benzothiadiazine-7-sulfonamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=26998,1364,Carbonic anhydrase 13,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1364,Q9D6N1,Carbonic anhydrase 13,71934.0,Car13,10090.0,Mus musculus (house mouse),,Ki (nM),645,PMID:19119014|DOI:10.1016/j.bmc.2008.12.023,https://www.ncbi.nlm.nih.gov/pubmed/19119014|https://doi.org/10.1016/j.bmc.2008.12.023,19119014,10.1016/j.bmc.2008.12.023,
341,516886,5560,BindingDB,Trichlormethiazide,26998,"6-chloro-3-(dichloromethyl)-1,1-dioxo-3,4-dihydro-2H-1,2,4-benzothiadiazine-7-sulfonamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=26998,1365,Carbonic anhydrase 14,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1365,Q9ULX7,Carbonic anhydrase 14,23632.0,CA14,9606.0,Homo sapiens (human),,Ki (nM),3450,PMID:19119014|DOI:10.1016/j.bmc.2008.12.023,https://www.ncbi.nlm.nih.gov/pubmed/19119014|https://doi.org/10.1016/j.bmc.2008.12.023,19119014,10.1016/j.bmc.2008.12.023,
342,517267,5564,Comparative Toxicogenomics Database (CTD),Triclosan,D014260,Triclosan,https://ctdbase.org/detail.go?type=chem&acc=D014260,340348,TSPAN33,https://ctdbase.org/detail.go?type=gene&acc=340348,,,340348.0,TSPAN33,9606.0,Homo sapiens (human),Triclosan results in decreased expression of TSPAN33 mRNA,,,PMID:30510588,https://www.ncbi.nlm.nih.gov/pubmed/30510588,30510588,,
343,517268,5564,Comparative Toxicogenomics Database (CTD),Triclosan,D014260,Triclosan,https://ctdbase.org/detail.go?type=chem&acc=D014260,10098,TSPAN5,https://ctdbase.org/detail.go?type=gene&acc=10098,,,10098.0,TSPAN5,9606.0,Homo sapiens (human),Triclosan results in increased expression of TSPAN5 mRNA,,,PMID:30510588,https://www.ncbi.nlm.nih.gov/pubmed/30510588,30510588,,
344,517269,5564,Comparative Toxicogenomics Database (CTD),Triclosan,D014260,Triclosan,https://ctdbase.org/detail.go?type=chem&acc=D014260,7102,TSPAN7,https://ctdbase.org/detail.go?type=gene&acc=7102,,,7102.0,TSPAN7,9606.0,Homo sapiens (human),Triclosan results in decreased expression of TSPAN7 mRNA,,,PMID:30510588,https://www.ncbi.nlm.nih.gov/pubmed/30510588,30510588,,
345,517270,5564,Comparative Toxicogenomics Database (CTD),Triclosan,D014260,Triclosan,https://ctdbase.org/detail.go?type=chem&acc=D014260,706,TSPO,https://ctdbase.org/detail.go?type=gene&acc=706,,,706.0,TSPO,9606.0,Homo sapiens (human),Triclosan results in increased expression of TSPO mRNA,,,PMID:30510588,https://www.ncbi.nlm.nih.gov/pubmed/30510588,30510588,,
346,517271,5564,Comparative Toxicogenomics Database (CTD),Triclosan,D014260,Triclosan,https://ctdbase.org/detail.go?type=chem&acc=D014260,7263,TST,https://ctdbase.org/detail.go?type=gene&acc=7263,,,7263.0,TST,9031.0,Gallus gallus (chicken),Triclosan results in decreased expression of TST protein|triclosan results in increased expression of TST protein,,,PMID:30219713,https://www.ncbi.nlm.nih.gov/pubmed/30219713,30219713,,
347,517272,5564,Comparative Toxicogenomics Database (CTD),Triclosan,D014260,Triclosan,https://ctdbase.org/detail.go?type=chem&acc=D014260,84630,TTBK1,https://ctdbase.org/detail.go?type=gene&acc=84630,,,84630.0,TTBK1,9606.0,Homo sapiens (human),Triclosan results in decreased expression of TTBK1 mRNA,,,PMID:30510588,https://www.ncbi.nlm.nih.gov/pubmed/30510588,30510588,,
348,529595,5564,Comparative Toxicogenomics Database (CTD),Triclosan,D014260,Triclosan,https://ctdbase.org/detail.go?type=chem&acc=D014260,7424,VEGFC,https://ctdbase.org/detail.go?type=gene&acc=7424,,,7424.0,VEGFC,9606.0,Homo sapiens (human),Triclosan results in decreased expression of VEGFC mRNA,,,PMID:30510588,https://www.ncbi.nlm.nih.gov/pubmed/30510588,30510588,,
349,530700,5564,Comparative Toxicogenomics Database (CTD),Triclosan,D014260,Triclosan,https://ctdbase.org/detail.go?type=chem&acc=D014260,254887,ZDHHC23,https://ctdbase.org/detail.go?type=gene&acc=254887,,,254887.0,ZDHHC23,9606.0,Homo sapiens (human),Triclosan results in decreased expression of ZDHHC23 mRNA,,,PMID:30510588,https://www.ncbi.nlm.nih.gov/pubmed/30510588,30510588,,
350,530701,5564,Comparative Toxicogenomics Database (CTD),Triclosan,D014260,Triclosan,https://ctdbase.org/detail.go?type=chem&acc=D014260,150244,ZDHHC8BP,https://ctdbase.org/detail.go?type=gene&acc=150244,,,150244.0,ZDHHC8BP,9606.0,Homo sapiens (human),Triclosan results in decreased expression of ZDHHC8BP mRNA,,,PMID:30510588,https://www.ncbi.nlm.nih.gov/pubmed/30510588,30510588,,
351,530702,5564,Comparative Toxicogenomics Database (CTD),Triclosan,D014260,Triclosan,https://ctdbase.org/detail.go?type=chem&acc=D014260,6935,ZEB1,https://ctdbase.org/detail.go?type=gene&acc=6935,,,6935.0,ZEB1,9606.0,Homo sapiens (human),Triclosan results in decreased expression of ZEB1 mRNA,,,PMID:30510588,https://www.ncbi.nlm.nih.gov/pubmed/30510588,30510588,,
352,530703,5564,Comparative Toxicogenomics Database (CTD),Triclosan,D014260,Triclosan,https://ctdbase.org/detail.go?type=chem&acc=D014260,90637,ZFAND2A,https://ctdbase.org/detail.go?type=gene&acc=90637,,,90637.0,ZFAND2A,9031.0,Gallus gallus (chicken),Triclosan results in decreased expression of ZFAND2A mRNA,,,PMID:29596926,https://www.ncbi.nlm.nih.gov/pubmed/29596926,29596926,,
353,530704,5564,Comparative Toxicogenomics Database (CTD),Triclosan,D014260,Triclosan,https://ctdbase.org/detail.go?type=chem&acc=D014260,93550,ZFAND4,https://ctdbase.org/detail.go?type=gene&acc=93550,,,93550.0,ZFAND4,9031.0,Gallus gallus (chicken),Triclosan results in decreased expression of ZFAND4 mRNA,,,PMID:29596926,https://www.ncbi.nlm.nih.gov/pubmed/29596926,29596926,,
354,516887,5566,Drug Gene Interaction database (DGIdb),Trifluoperazine,,TRIFLUOPERAZINE,https://www.dgidb.org/drugs/rxcui:10800,,CALY,https://www.dgidb.org/genes/hgnc:17938,,,50632.0,CALY,9606.0,Homo sapiens (human),,,,,,,,
355,516888,5584,Drug Gene Interaction database (DGIdb),Trimipramine,,TRIMIPRAMINE,https://www.dgidb.org/drugs/rxcui:10834,,SLC6A4,https://www.dgidb.org/genes/hgnc:11050,,,6532.0,SLC6A4,9606.0,Homo sapiens (human),,,,,,,,
356,516889,5584,Drug Gene Interaction database (DGIdb),Trimipramine,,TRIMIPRAMINE,https://www.dgidb.org/drugs/rxcui:10834,,SLC6A2,https://www.dgidb.org/genes/hgnc:11048,,,6530.0,SLC6A2,9606.0,Homo sapiens (human),,,,,,,,
357,516890,5584,Drug Gene Interaction database (DGIdb),Trimipramine,,TRIMIPRAMINE,https://www.dgidb.org/drugs/rxcui:10834,,CBX1,https://www.dgidb.org/genes/hgnc:1551,,,10951.0,CBX1,9606.0,Homo sapiens (human),,,,,,,,
358,517616,5591,Comparative Toxicogenomics Database (CTD),Troglitazone,D000077288,Troglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077288,8647,ABCB11,https://ctdbase.org/detail.go?type=gene&acc=8647,,,8647.0,ABCB11,10116.0,Rattus norvegicus (Norway rat),[troglitazone results in decreased activity of ABCB11 protein] which results in decreased secretion of rosuvastatin calcium,,,PMID:19853032,https://www.ncbi.nlm.nih.gov/pubmed/19853032,19853032,,
359,517617,5591,Comparative Toxicogenomics Database (CTD),Troglitazone,D000077288,Troglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077288,8647,ABCB11,https://ctdbase.org/detail.go?type=gene&acc=8647,,,8647.0,ABCB11,10116.0,Rattus norvegicus (Norway rat),Troglitazone results in decreased expression of ABCB11 mRNA,,,PMID:27765674,https://www.ncbi.nlm.nih.gov/pubmed/27765674,27765674,,
360,517930,5591,Comparative Toxicogenomics Database (CTD),Troglitazone,D000077288,Troglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077288,10397,NDRG1,https://ctdbase.org/detail.go?type=gene&acc=10397,,,10397.0,NDRG1,9606.0,Homo sapiens (human),[troglitazone co-treated with tert-butylhydroperoxide] results in increased expression of NDRG1 mrna|troglitazone inhibits the reaction [tert-butylhydroperoxide results in increased expression of NDRG1 mrna],,,PMID:20847119,https://www.ncbi.nlm.nih.gov/pubmed/20847119,20847119,,
361,517931,5591,Comparative Toxicogenomics Database (CTD),Troglitazone,D000077288,Troglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077288,10397,NDRG1,https://ctdbase.org/detail.go?type=gene&acc=10397,,,10397.0,NDRG1,9606.0,Homo sapiens (human),Troglitazone results in increased expression of NDRG1 mRNA,,,PMID:19140230,https://www.ncbi.nlm.nih.gov/pubmed/19140230,19140230,,
362,517932,5591,Comparative Toxicogenomics Database (CTD),Troglitazone,D000077288,Troglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077288,10397,NDRG1,https://ctdbase.org/detail.go?type=gene&acc=10397,,,10397.0,NDRG1,10090.0,Mus musculus (house mouse),Troglitazone results in decreased expression of NDRG1 mRNA,,,PMID:28973697,https://www.ncbi.nlm.nih.gov/pubmed/28973697,28973697,,
363,517933,5591,Comparative Toxicogenomics Database (CTD),Troglitazone,D000077288,Troglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077288,57446,NDRG3,https://ctdbase.org/detail.go?type=gene&acc=57446,,,57446.0,NDRG3,10090.0,Mus musculus (house mouse),Troglitazone results in decreased expression of NDRG3 mRNA,,,PMID:28973697,https://www.ncbi.nlm.nih.gov/pubmed/28973697,28973697,,
364,517934,5591,Comparative Toxicogenomics Database (CTD),Troglitazone,D000077288,Troglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077288,65009,NDRG4,https://ctdbase.org/detail.go?type=gene&acc=65009,,,65009.0,NDRG4,10090.0,Mus musculus (house mouse),Troglitazone results in increased expression of NDRG4 mRNA,,,PMID:17569031,https://www.ncbi.nlm.nih.gov/pubmed/17569031,17569031,,
365,517935,5591,Comparative Toxicogenomics Database (CTD),Troglitazone,D000077288,Troglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077288,3340,NDST1,https://ctdbase.org/detail.go?type=gene&acc=3340,,,3340.0,NDST1,10090.0,Mus musculus (house mouse),Troglitazone results in decreased expression of NDST1 mRNA,,,PMID:28973697,https://www.ncbi.nlm.nih.gov/pubmed/28973697,28973697,,
366,517936,5591,Comparative Toxicogenomics Database (CTD),Troglitazone,D000077288,Troglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077288,8509,NDST2,https://ctdbase.org/detail.go?type=gene&acc=8509,,,8509.0,NDST2,10090.0,Mus musculus (house mouse),Troglitazone results in decreased expression of NDST2 mRNA,,,PMID:28973697,https://www.ncbi.nlm.nih.gov/pubmed/28973697,28973697,,
367,517937,5591,Comparative Toxicogenomics Database (CTD),Troglitazone,D000077288,Troglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077288,5818,NECTIN1,https://ctdbase.org/detail.go?type=gene&acc=5818,,,5818.0,NECTIN1,10090.0,Mus musculus (house mouse),Troglitazone results in decreased expression of NECTIN1 mRNA,,,PMID:28973697,https://www.ncbi.nlm.nih.gov/pubmed/28973697,28973697,,
368,518266,5591,Comparative Toxicogenomics Database (CTD),Troglitazone,D000077288,Troglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077288,113868,ACAA1A,https://ctdbase.org/detail.go?type=gene&acc=113868,,,113868.0,Acaa1a,10090.0,Mus musculus (house mouse),Troglitazone results in decreased expression of ACAA1A protein,,,PMID:18495193,https://www.ncbi.nlm.nih.gov/pubmed/18495193,18495193,,
369,518267,5591,Comparative Toxicogenomics Database (CTD),Troglitazone,D000077288,Troglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077288,235674,ACAA1B,https://ctdbase.org/detail.go?type=gene&acc=235674,,,235674.0,Acaa1b,10090.0,Mus musculus (house mouse),Troglitazone results in increased expression of ACAA1B mRNA,,,PMID:28973697,https://www.ncbi.nlm.nih.gov/pubmed/28973697,28973697,,
370,518268,5591,Comparative Toxicogenomics Database (CTD),Troglitazone,D000077288,Troglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077288,10449,ACAA2,https://ctdbase.org/detail.go?type=gene&acc=10449,,,10449.0,ACAA2,10116.0,Rattus norvegicus (Norway rat),Troglitazone results in increased expression of ACAA2 mRNA,,,PMID:21515302,https://www.ncbi.nlm.nih.gov/pubmed/21515302,21515302,,
371,518418,5591,Comparative Toxicogenomics Database (CTD),Troglitazone,D000077288,Troglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077288,4780,NFE2L2,https://ctdbase.org/detail.go?type=gene&acc=4780,,,4780.0,NFE2L2,10116.0,Rattus norvegicus (Norway rat),Troglitazone results in decreased expression of NFE2L2 mRNA,,,PMID:25596134,https://www.ncbi.nlm.nih.gov/pubmed/25596134,25596134,,
372,518419,5591,Comparative Toxicogenomics Database (CTD),Troglitazone,D000077288,Troglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077288,4774,NFIA,https://ctdbase.org/detail.go?type=gene&acc=4774,,,4774.0,NFIA,10090.0,Mus musculus (house mouse),Troglitazone results in decreased expression of NFIA mRNA,,,PMID:28973697,https://www.ncbi.nlm.nih.gov/pubmed/28973697,28973697,,
373,518420,5591,Comparative Toxicogenomics Database (CTD),Troglitazone,D000077288,Troglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077288,4781,NFIB,https://ctdbase.org/detail.go?type=gene&acc=4781,,,4781.0,NFIB,10090.0,Mus musculus (house mouse),Troglitazone results in decreased expression of NFIB mRNA,,,PMID:28973697,https://www.ncbi.nlm.nih.gov/pubmed/28973697,28973697,,
374,518421,5591,Comparative Toxicogenomics Database (CTD),Troglitazone,D000077288,Troglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077288,4783,NFIL3,https://ctdbase.org/detail.go?type=gene&acc=4783,,,4783.0,NFIL3,9606.0,Homo sapiens (human),Troglitazone results in increased expression of NFIL3 mRNA,,,PMID:19140230,https://www.ncbi.nlm.nih.gov/pubmed/19140230,19140230,,
375,518422,5591,Comparative Toxicogenomics Database (CTD),Troglitazone,D000077288,Troglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077288,4784,NFIX,https://ctdbase.org/detail.go?type=gene&acc=4784,,,4784.0,NFIX,10090.0,Mus musculus (house mouse),Troglitazone results in decreased expression of NFIX mRNA,,,PMID:28973697,https://www.ncbi.nlm.nih.gov/pubmed/28973697,28973697,,
376,518423,5591,Comparative Toxicogenomics Database (CTD),Troglitazone,D000077288,Troglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077288,4790,NFKB1,https://ctdbase.org/detail.go?type=gene&acc=4790,,,4790.0,NFKB1,9606.0,Homo sapiens (human),Troglitazone affects the localization of NFKB1 protein,,,PMID:20540935,https://www.ncbi.nlm.nih.gov/pubmed/20540935,20540935,,
377,519567,5591,Comparative Toxicogenomics Database (CTD),Troglitazone,D000077288,Troglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077288,55811,ADCY10,https://ctdbase.org/detail.go?type=gene&acc=55811,,,55811.0,ADCY10,10116.0,Rattus norvegicus (Norway rat),Troglitazone results in increased expression of ADCY10 mRNA,,,PMID:21515302,https://www.ncbi.nlm.nih.gov/pubmed/21515302,21515302,,
378,520685,5591,Comparative Toxicogenomics Database (CTD),Troglitazone,D000077288,Troglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077288,6718,AKR1D1,https://ctdbase.org/detail.go?type=gene&acc=6718,,,6718.0,AKR1D1,10116.0,Rattus norvegicus (Norway rat),Troglitazone results in increased expression of AKR1D1 protein,,,PMID:21315101,https://www.ncbi.nlm.nih.gov/pubmed/21315101,21315101,,
379,520686,5591,Comparative Toxicogenomics Database (CTD),Troglitazone,D000077288,Troglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077288,207,AKT1,https://ctdbase.org/detail.go?type=gene&acc=207,,,207.0,AKT1,9913.0,Bos taurus (cattle),"2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [troglitazone results in increased phosphorylation of AKT1 protein]|troglitazone results in increased phosphorylation of AKT1 protein",,,PMID:14593122,https://www.ncbi.nlm.nih.gov/pubmed/14593122,14593122,,
380,520687,5591,Comparative Toxicogenomics Database (CTD),Troglitazone,D000077288,Troglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077288,207,AKT1,https://ctdbase.org/detail.go?type=gene&acc=207,,,207.0,AKT1,9606.0,Homo sapiens (human),[troglitazone co-treated with aspirin] results in decreased expression of AKT1 protein modified form|[troglitazone co-treated with aspirin] results in decreased expression of AKT1 protein,,,PMID:19908241,https://www.ncbi.nlm.nih.gov/pubmed/19908241,19908241,,
381,520688,5591,Comparative Toxicogenomics Database (CTD),Troglitazone,D000077288,Troglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077288,210,ALAD,https://ctdbase.org/detail.go?type=gene&acc=210,,,210.0,ALAD,10090.0,Mus musculus (house mouse),Troglitazone results in increased expression of ALAD mRNA,,,PMID:28973697,https://www.ncbi.nlm.nih.gov/pubmed/28973697,28973697,,
382,520689,5591,Comparative Toxicogenomics Database (CTD),Troglitazone,D000077288,Troglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077288,210,ALAD,https://ctdbase.org/detail.go?type=gene&acc=210,,,210.0,ALAD,9606.0,Homo sapiens (human),[troglitazone co-treated with TNF protein] results in decreased expression of ALAD mRNA,,,PMID:12732648,https://www.ncbi.nlm.nih.gov/pubmed/12732648,12732648,,
383,520690,5591,Comparative Toxicogenomics Database (CTD),Troglitazone,D000077288,Troglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077288,213,ALB,https://ctdbase.org/detail.go?type=gene&acc=213,,,213.0,ALB,9606.0,Homo sapiens (human),Troglitazone results in decreased expression of ALB protein,,,PMID:25934330,https://www.ncbi.nlm.nih.gov/pubmed/25934330,25934330,,
384,520691,5591,Comparative Toxicogenomics Database (CTD),Troglitazone,D000077288,Troglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077288,214,ALCAM,https://ctdbase.org/detail.go?type=gene&acc=214,,,214.0,ALCAM,10090.0,Mus musculus (house mouse),Troglitazone results in decreased expression of ALCAM mRNA,,,PMID:28973697,https://www.ncbi.nlm.nih.gov/pubmed/28973697,28973697,,
385,521183,5591,Comparative Toxicogenomics Database (CTD),Troglitazone,D000077288,Troglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077288,248,ALPI,https://ctdbase.org/detail.go?type=gene&acc=248,,,248.0,ALPI,10116.0,Rattus norvegicus (Norway rat),Troglitazone results in decreased expression of ALPI mRNA,,,PMID:21515302,https://www.ncbi.nlm.nih.gov/pubmed/21515302,21515302,,
386,521184,5591,Comparative Toxicogenomics Database (CTD),Troglitazone,D000077288,Troglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077288,249,ALPL,https://ctdbase.org/detail.go?type=gene&acc=249,,,249.0,ALPL,9606.0,Homo sapiens (human),Troglitazone inhibits the reaction [BMP2 protein results in increased expression of ALPL mrna],,,PMID:19122273,https://www.ncbi.nlm.nih.gov/pubmed/19122273,19122273,,
387,521185,5591,Comparative Toxicogenomics Database (CTD),Troglitazone,D000077288,Troglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077288,10189,ALYREF,https://ctdbase.org/detail.go?type=gene&acc=10189,,,10189.0,ALYREF,9606.0,Homo sapiens (human),Troglitazone results in decreased expression of ALYREF mRNA,,,PMID:19140230,https://www.ncbi.nlm.nih.gov/pubmed/19140230,19140230,,
388,521186,5591,Comparative Toxicogenomics Database (CTD),Troglitazone,D000077288,Troglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077288,144193,AMDHD1,https://ctdbase.org/detail.go?type=gene&acc=144193,,,144193.0,AMDHD1,10090.0,Mus musculus (house mouse),Troglitazone results in decreased expression of AMDHD1 mRNA,,,PMID:28973697,https://www.ncbi.nlm.nih.gov/pubmed/28973697,28973697,,
389,521187,5591,Comparative Toxicogenomics Database (CTD),Troglitazone,D000077288,Troglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077288,144193,AMDHD1,https://ctdbase.org/detail.go?type=gene&acc=144193,,,144193.0,AMDHD1,10116.0,Rattus norvegicus (Norway rat),Troglitazone results in increased expression of AMDHD1 protein,,,PMID:21315101,https://www.ncbi.nlm.nih.gov/pubmed/21315101,21315101,,
390,521188,5591,Comparative Toxicogenomics Database (CTD),Troglitazone,D000077288,Troglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077288,269,AMHR2,https://ctdbase.org/detail.go?type=gene&acc=269,,,269.0,AMHR2,10116.0,Rattus norvegicus (Norway rat),Troglitazone results in increased expression of AMHR2 mRNA,,,PMID:21515302,https://www.ncbi.nlm.nih.gov/pubmed/21515302,21515302,,
391,521189,5591,Comparative Toxicogenomics Database (CTD),Troglitazone,D000077288,Troglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077288,83607,AMMECR1L,https://ctdbase.org/detail.go?type=gene&acc=83607,,,83607.0,AMMECR1L,10090.0,Mus musculus (house mouse),Troglitazone results in decreased expression of AMMECR1L mRNA,,,PMID:28973697,https://www.ncbi.nlm.nih.gov/pubmed/28973697,28973697,,
392,521501,5591,Comparative Toxicogenomics Database (CTD),Troglitazone,D000077288,Troglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077288,54625,PARP14,https://ctdbase.org/detail.go?type=gene&acc=54625,,,54625.0,PARP14,10090.0,Mus musculus (house mouse),Troglitazone results in decreased expression of PARP14 mRNA,,,PMID:28973697,https://www.ncbi.nlm.nih.gov/pubmed/28973697,28973697,,
393,521502,5591,Comparative Toxicogenomics Database (CTD),Troglitazone,D000077288,Troglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077288,79668,PARP8,https://ctdbase.org/detail.go?type=gene&acc=79668,,,79668.0,PARP8,10116.0,Rattus norvegicus (Norway rat),Troglitazone results in decreased expression of PARP8 mRNA,,,PMID:21515302,https://www.ncbi.nlm.nih.gov/pubmed/21515302,21515302,,
394,521503,5591,Comparative Toxicogenomics Database (CTD),Troglitazone,D000077288,Troglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077288,100630918,PARTICL,https://ctdbase.org/detail.go?type=gene&acc=100630918,,,100630918.0,PARTICL,10090.0,Mus musculus (house mouse),Troglitazone results in decreased expression of PARTICL mRNA,,,PMID:28973697,https://www.ncbi.nlm.nih.gov/pubmed/28973697,28973697,,
395,521504,5591,Comparative Toxicogenomics Database (CTD),Troglitazone,D000077288,Troglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077288,55742,PARVA,https://ctdbase.org/detail.go?type=gene&acc=55742,,,55742.0,PARVA,10090.0,Mus musculus (house mouse),Troglitazone results in decreased expression of PARVA mRNA,,,PMID:28973697,https://www.ncbi.nlm.nih.gov/pubmed/28973697,28973697,,
396,522850,5591,Comparative Toxicogenomics Database (CTD),Troglitazone,D000077288,Troglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077288,10158,PDZK1IP1,https://ctdbase.org/detail.go?type=gene&acc=10158,,,10158.0,PDZK1IP1,10090.0,Mus musculus (house mouse),Troglitazone results in increased expression of PDZK1IP1 mRNA,,,PMID:28973697,https://www.ncbi.nlm.nih.gov/pubmed/28973697,28973697,,
397,522851,5591,Comparative Toxicogenomics Database (CTD),Troglitazone,D000077288,Troglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077288,8682,PEA15,https://ctdbase.org/detail.go?type=gene&acc=8682,,,8682.0,PEA15,10116.0,Rattus norvegicus (Norway rat),Troglitazone results in decreased expression of PEA15 mRNA,,,PMID:21515302,https://www.ncbi.nlm.nih.gov/pubmed/21515302,21515302,,
398,522852,5591,Comparative Toxicogenomics Database (CTD),Troglitazone,D000077288,Troglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077288,23089,PEG10,https://ctdbase.org/detail.go?type=gene&acc=23089,,,23089.0,PEG10,9606.0,Homo sapiens (human),Troglitazone results in decreased expression of PEG10 mRNA,,,PMID:25572481,https://www.ncbi.nlm.nih.gov/pubmed/25572481,25572481,,
399,522853,5591,Comparative Toxicogenomics Database (CTD),Troglitazone,D000077288,Troglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077288,10400,PEMT,https://ctdbase.org/detail.go?type=gene&acc=10400,,,10400.0,PEMT,9606.0,Homo sapiens (human),Troglitazone results in increased expression of PEMT mRNA,,,PMID:25572481,https://www.ncbi.nlm.nih.gov/pubmed/25572481,25572481,,
400,522854,5591,Comparative Toxicogenomics Database (CTD),Troglitazone,D000077288,Troglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077288,10400,PEMT,https://ctdbase.org/detail.go?type=gene&acc=10400,,,10400.0,PEMT,10090.0,Mus musculus (house mouse),[troglitazone co-treated with TNF protein] results in decreased expression of PEMT mrna|troglitazone results in decreased expression of PEMT mRNA,,,PMID:12732648,https://www.ncbi.nlm.nih.gov/pubmed/12732648,12732648,,
401,522855,5591,Comparative Toxicogenomics Database (CTD),Troglitazone,D000077288,Troglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077288,5184,PEPD,https://ctdbase.org/detail.go?type=gene&acc=5184,,,5184.0,PEPD,10090.0,Mus musculus (house mouse),Troglitazone results in increased expression of PEPD mRNA,,,PMID:28973697,https://www.ncbi.nlm.nih.gov/pubmed/28973697,28973697,,
402,522856,5591,Comparative Toxicogenomics Database (CTD),Troglitazone,D000077288,Troglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077288,8863,PER3,https://ctdbase.org/detail.go?type=gene&acc=8863,,,8863.0,PER3,10090.0,Mus musculus (house mouse),Troglitazone results in decreased expression of PER3 mRNA,,,PMID:28973697,https://www.ncbi.nlm.nih.gov/pubmed/28973697,28973697,,
403,522857,5591,Comparative Toxicogenomics Database (CTD),Troglitazone,D000077288,Troglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077288,8800,PEX11A,https://ctdbase.org/detail.go?type=gene&acc=8800,,,8800.0,PEX11A,10116.0,Rattus norvegicus (Norway rat),Troglitazone results in increased expression of PEX11A mRNA,,,PMID:21515302,https://www.ncbi.nlm.nih.gov/pubmed/21515302,21515302,,
404,523294,5591,Comparative Toxicogenomics Database (CTD),Troglitazone,D000077288,Troglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077288,5257,PHKB,https://ctdbase.org/detail.go?type=gene&acc=5257,,,5257.0,PHKB,10090.0,Mus musculus (house mouse),Troglitazone results in decreased expression of PHKB mRNA,,,PMID:28973697,https://www.ncbi.nlm.nih.gov/pubmed/28973697,28973697,,
405,523295,5591,Comparative Toxicogenomics Database (CTD),Troglitazone,D000077288,Troglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077288,7262,PHLDA2,https://ctdbase.org/detail.go?type=gene&acc=7262,,,7262.0,PHLDA2,9606.0,Homo sapiens (human),Troglitazone results in increased expression of PHLDA2 mRNA,,,PMID:19140230,https://www.ncbi.nlm.nih.gov/pubmed/19140230,19140230,,
406,523296,5591,Comparative Toxicogenomics Database (CTD),Troglitazone,D000077288,Troglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077288,23187,PHLDB1,https://ctdbase.org/detail.go?type=gene&acc=23187,,,23187.0,PHLDB1,10116.0,Rattus norvegicus (Norway rat),Troglitazone results in decreased expression of PHLDB1 mRNA,,,PMID:21515302,https://www.ncbi.nlm.nih.gov/pubmed/21515302,21515302,,
407,523765,5591,Comparative Toxicogenomics Database (CTD),Troglitazone,D000077288,Troglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077288,51227,PIGP,https://ctdbase.org/detail.go?type=gene&acc=51227,,,51227.0,PIGP,10090.0,Mus musculus (house mouse),Troglitazone results in increased expression of PIGP mRNA,,,PMID:28973697,https://www.ncbi.nlm.nih.gov/pubmed/28973697,28973697,,
408,524073,5591,Comparative Toxicogenomics Database (CTD),Troglitazone,D000077288,Troglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077288,506,ATP5F1B,https://ctdbase.org/detail.go?type=gene&acc=506,,,506.0,ATP5F1B,9606.0,Homo sapiens (human),Benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [troglitazone results in decreased expression of ATP5F1B mrna]|troglitazone results in decreased expression of ATP5F1B mrna|ppargc1a protein inhibits the reaction [troglitazone results in decreased expression of ATP5F1B mrna],,,PMID:20860658,https://www.ncbi.nlm.nih.gov/pubmed/20860658,20860658,,
409,524687,5591,Comparative Toxicogenomics Database (CTD),Troglitazone,D000077288,Troglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077288,5362,PLXNA2,https://ctdbase.org/detail.go?type=gene&acc=5362,,,5362.0,PLXNA2,10090.0,Mus musculus (house mouse),Troglitazone results in decreased expression of PLXNA2 mRNA,,,PMID:28973697,https://www.ncbi.nlm.nih.gov/pubmed/28973697,28973697,,
410,524688,5591,Comparative Toxicogenomics Database (CTD),Troglitazone,D000077288,Troglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077288,10154,PLXNC1,https://ctdbase.org/detail.go?type=gene&acc=10154,,,10154.0,PLXNC1,10090.0,Mus musculus (house mouse),Troglitazone results in decreased expression of PLXNC1 mRNA,,,PMID:17569031,https://www.ncbi.nlm.nih.gov/pubmed/17569031,17569031,,
411,524689,5591,Comparative Toxicogenomics Database (CTD),Troglitazone,D000077288,Troglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077288,23129,PLXND1,https://ctdbase.org/detail.go?type=gene&acc=23129,,,23129.0,PLXND1,10090.0,Mus musculus (house mouse),Troglitazone results in decreased expression of PLXND1 mRNA,,,PMID:28973697,https://www.ncbi.nlm.nih.gov/pubmed/28973697,28973697,,
412,524690,5591,Comparative Toxicogenomics Database (CTD),Troglitazone,D000077288,Troglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077288,5366,PMAIP1,https://ctdbase.org/detail.go?type=gene&acc=5366,,,5366.0,PMAIP1,9606.0,Homo sapiens (human),Troglitazone results in decreased expression of PMAIP1 mRNA,,,PMID:28934090,https://www.ncbi.nlm.nih.gov/pubmed/28934090,28934090,,
413,525542,5591,Comparative Toxicogenomics Database (CTD),Troglitazone,D000077288,Troglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077288,259282,BOD1L1,https://ctdbase.org/detail.go?type=gene&acc=259282,,,259282.0,BOD1L1,10090.0,Mus musculus (house mouse),Troglitazone results in decreased expression of BOD1L1 mRNA,,,PMID:28973697,https://www.ncbi.nlm.nih.gov/pubmed/28973697,28973697,,
414,526666,5591,Comparative Toxicogenomics Database (CTD),Troglitazone,D000077288,Troglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077288,8573,CASK,https://ctdbase.org/detail.go?type=gene&acc=8573,,,8573.0,CASK,10090.0,Mus musculus (house mouse),Troglitazone results in decreased expression of CASK mRNA,,,PMID:28973697,https://www.ncbi.nlm.nih.gov/pubmed/28973697,28973697,,
415,526667,5591,Comparative Toxicogenomics Database (CTD),Troglitazone,D000077288,Troglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077288,843,CASP10,https://ctdbase.org/detail.go?type=gene&acc=843,,,843.0,CASP10,9606.0,Homo sapiens (human),Troglitazone results in increased expression of CASP10 mRNA,,,PMID:19631733,https://www.ncbi.nlm.nih.gov/pubmed/19631733,19631733,,
416,526668,5591,Comparative Toxicogenomics Database (CTD),Troglitazone,D000077288,Troglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077288,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,9606.0,Homo sapiens (human),"[N-(4-methoxybenzyl)-N'-(5-nitro-1,3-thiazol-2-yl)urea results in decreased activity of GSK3B protein] results in increased susceptibility to [troglitazone results in increased expression of CASP3 protein]|troglitazone results in increased expression of CASP3 protein|gsk3b protein affects the susceptibility to [troglitazone results in increased expression of CASP3 protein]",,,PMID:20540935,https://www.ncbi.nlm.nih.gov/pubmed/20540935,20540935,,
417,526669,5591,Comparative Toxicogenomics Database (CTD),Troglitazone,D000077288,Troglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077288,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,9606.0,Homo sapiens (human),Palmitic acid promotes the reaction [troglitazone results in increased activity of CASP3 protein],,,PMID:22700542,https://www.ncbi.nlm.nih.gov/pubmed/22700542,22700542,,
418,526670,5591,Comparative Toxicogenomics Database (CTD),Troglitazone,D000077288,Troglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077288,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,9606.0,Homo sapiens (human),[troglitazone co-treated with aspirin] results in increased cleavage of and results in increased activity of CASP3 protein,,,PMID:19908241,https://www.ncbi.nlm.nih.gov/pubmed/19908241,19908241,,
419,526671,5591,Comparative Toxicogenomics Database (CTD),Troglitazone,D000077288,Troglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077288,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,9606.0,Homo sapiens (human),Troglitazone results in increased activity of CASP3 protein,,,PMID:18407589|PMID:22700542,https://www.ncbi.nlm.nih.gov/pubmed/18407589|https://www.ncbi.nlm.nih.gov/pubmed/22700542,18407589|22700542,,
420,526672,5591,Comparative Toxicogenomics Database (CTD),Troglitazone,D000077288,Troglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077288,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,9606.0,Homo sapiens (human),Troglitazone results in increased cleavage of CASP3 protein,,,PMID:19632256,https://www.ncbi.nlm.nih.gov/pubmed/19632256,19632256,,
421,526989,5591,Comparative Toxicogenomics Database (CTD),Troglitazone,D000077288,Troglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077288,5468,PPARG,https://ctdbase.org/detail.go?type=gene&acc=5468,,,5468.0,PPARG,9823.0,Sus scrofa (pig),Troglitazone inhibits the reaction [pioglitazone results in increased activity of PPARG protein],,,PMID:17065204,https://www.ncbi.nlm.nih.gov/pubmed/17065204,17065204,,
422,526990,5591,Comparative Toxicogenomics Database (CTD),Troglitazone,D000077288,Troglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077288,5468,PPARG,https://ctdbase.org/detail.go?type=gene&acc=5468,,,5468.0,PPARG,9823.0,Sus scrofa (pig),Troglitazone promotes the reaction [[beta-glycerophosphoric acid co-treated with ascorbic acid co-treated with dexamethasone] results in increased expression of PPARG mrna],,,PMID:30481989,https://www.ncbi.nlm.nih.gov/pubmed/30481989,30481989,,
423,526991,5591,Comparative Toxicogenomics Database (CTD),Troglitazone,D000077288,Troglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077288,5468,PPARG,https://ctdbase.org/detail.go?type=gene&acc=5468,,,5468.0,PPARG,9606.0,Homo sapiens (human),PPARG protein affects the reaction [troglitazone inhibits the reaction [[PDGFB protein binds to PDGFB protein] which results in increased expression of FOS mrna]],,,PMID:10678274,https://www.ncbi.nlm.nih.gov/pubmed/10678274,10678274,,
424,526992,5591,Comparative Toxicogenomics Database (CTD),Troglitazone,D000077288,Troglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077288,5468,PPARG,https://ctdbase.org/detail.go?type=gene&acc=5468,,,5468.0,PPARG,9606.0,Homo sapiens (human),PPARG protein affects the reaction [troglitazone results in decreased activity of TGFB1 protein],,,PMID:19120328,https://www.ncbi.nlm.nih.gov/pubmed/19120328,19120328,,
425,526993,5591,Comparative Toxicogenomics Database (CTD),Troglitazone,D000077288,Troglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077288,5468,PPARG,https://ctdbase.org/detail.go?type=gene&acc=5468,,,5468.0,PPARG,9606.0,Homo sapiens (human),Troglitazone binds to and results in increased activity of PPARG protein,,,PMID:10385688|PMID:11172467|PMID:11341955|PMID:11687581|PMID:11918743|PMID:12044893|PMID:12644321|PMID:15785241|PMID:16023420|PMID:16037295|PMID:16249460|PMID:16374840|PMID:16499875|PMID:16616945|PMID:16946405|PMID:16981146|PMID:17425601|PMID:17940898|PMID:18308446|PMID:18599600|PMID:18827362|PMID:19120328|PMID:19140230|PMID:19429239|PMID:19631733|PMID:19908241|PMID:20540935|PMID:21515302|PMID:21617575|PMID:23108036,https://www.ncbi.nlm.nih.gov/pubmed/10385688|https://www.ncbi.nlm.nih.gov/pubmed/11172467|https://www.ncbi.nlm.nih.gov/pubmed/11341955|https://www.ncbi.nlm.nih.gov/pubmed/11687581|https://www.ncbi.nlm.nih.gov/pubmed/11918743|https://www.ncbi.nlm.nih.gov/pubmed/12044893|https://www.ncbi.nlm.nih.gov/pubmed/12644321|https://www.ncbi.nlm.nih.gov/pubmed/15785241|https://www.ncbi.nlm.nih.gov/pubmed/16023420|https://www.ncbi.nlm.nih.gov/pubmed/16037295|https://www.ncbi.nlm.nih.gov/pubmed/16249460|https://www.ncbi.nlm.nih.gov/pubmed/16374840|https://www.ncbi.nlm.nih.gov/pubmed/16499875|https://www.ncbi.nlm.nih.gov/pubmed/16616945|https://www.ncbi.nlm.nih.gov/pubmed/16946405|https://www.ncbi.nlm.nih.gov/pubmed/16981146|https://www.ncbi.nlm.nih.gov/pubmed/17425601|https://www.ncbi.nlm.nih.gov/pubmed/17940898|https://www.ncbi.nlm.nih.gov/pubmed/18308446|https://www.ncbi.nlm.nih.gov/pubmed/18599600|https://www.ncbi.nlm.nih.gov/pubmed/18827362|https://www.ncbi.nlm.nih.gov/pubmed/19120328|https://www.ncbi.nlm.nih.gov/pubmed/19140230|https://www.ncbi.nlm.nih.gov/pubmed/19429239|https://www.ncbi.nlm.nih.gov/pubmed/19631733|https://www.ncbi.nlm.nih.gov/pubmed/19908241|https://www.ncbi.nlm.nih.gov/pubmed/20540935|https://www.ncbi.nlm.nih.gov/pubmed/21515302|https://www.ncbi.nlm.nih.gov/pubmed/21617575|https://www.ncbi.nlm.nih.gov/pubmed/23108036,10385688|11172467|11341955|11687581|11918743|12044893|12644321|15785241|16023420|16037295|16249460|16374840|16499875|16616945|16946405|16981146|17425601|17940898|18308446|18599600|18827362|19120328|19140230|19429239|19631733|19908241|20540935|21515302|21617575|23108036,,
426,526994,5591,Comparative Toxicogenomics Database (CTD),Troglitazone,D000077288,Troglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077288,5468,PPARG,https://ctdbase.org/detail.go?type=gene&acc=5468,,,5468.0,PPARG,9606.0,Homo sapiens (human),[troglitazone binds to and results in increased activity of PPARG protein] which results in decreased secretion of LEP protein,,,PMID:16037295,https://www.ncbi.nlm.nih.gov/pubmed/16037295,16037295,,
427,526995,5591,Comparative Toxicogenomics Database (CTD),Troglitazone,D000077288,Troglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077288,5468,PPARG,https://ctdbase.org/detail.go?type=gene&acc=5468,,,5468.0,PPARG,9606.0,Homo sapiens (human),Troglitazone binds to PPARG protein,,,PMID:10753628|PMID:10813377|PMID:10814527|PMID:14508522|PMID:16303758|PMID:18274627|PMID:19632256|PMID:19854250|PMID:20860658|PMID:21525782,https://www.ncbi.nlm.nih.gov/pubmed/10753628|https://www.ncbi.nlm.nih.gov/pubmed/10813377|https://www.ncbi.nlm.nih.gov/pubmed/10814527|https://www.ncbi.nlm.nih.gov/pubmed/14508522|https://www.ncbi.nlm.nih.gov/pubmed/16303758|https://www.ncbi.nlm.nih.gov/pubmed/18274627|https://www.ncbi.nlm.nih.gov/pubmed/19632256|https://www.ncbi.nlm.nih.gov/pubmed/19854250|https://www.ncbi.nlm.nih.gov/pubmed/20860658|https://www.ncbi.nlm.nih.gov/pubmed/21525782,10753628|10813377|10814527|14508522|16303758|18274627|19632256|19854250|20860658|21525782,,
428,527583,5591,Comparative Toxicogenomics Database (CTD),Troglitazone,D000077288,Troglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077288,6347,CCL2,https://ctdbase.org/detail.go?type=gene&acc=6347,,,6347.0,CCL2,10090.0,Mus musculus (house mouse),[troglitazone co-treated with buthionine sulfoximine] results in increased expression of CCL2 mRNA,,,PMID:31294483,https://www.ncbi.nlm.nih.gov/pubmed/31294483,31294483,,
429,527584,5591,Comparative Toxicogenomics Database (CTD),Troglitazone,D000077288,Troglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077288,6347,CCL2,https://ctdbase.org/detail.go?type=gene&acc=6347,,,6347.0,CCL2,10090.0,Mus musculus (house mouse),Troglitazone promotes the reaction [capsaicin results in decreased secretion of CCL2 protein],,,PMID:17719033,https://www.ncbi.nlm.nih.gov/pubmed/17719033,17719033,,
430,527585,5591,Comparative Toxicogenomics Database (CTD),Troglitazone,D000077288,Troglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077288,6347,CCL2,https://ctdbase.org/detail.go?type=gene&acc=6347,,,6347.0,CCL2,10090.0,Mus musculus (house mouse),Troglitazone results in decreased expression of CCL2 mRNA,,,PMID:12468449,https://www.ncbi.nlm.nih.gov/pubmed/12468449,12468449,,
431,527586,5591,Comparative Toxicogenomics Database (CTD),Troglitazone,D000077288,Troglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077288,6347,CCL2,https://ctdbase.org/detail.go?type=gene&acc=6347,,,6347.0,CCL2,10116.0,Rattus norvegicus (Norway rat),Troglitazone results in decreased expression of CCL2 mRNA,,,PMID:21515302,https://www.ncbi.nlm.nih.gov/pubmed/21515302,21515302,,
432,527587,5591,Comparative Toxicogenomics Database (CTD),Troglitazone,D000077288,Troglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077288,1490,CCN2,https://ctdbase.org/detail.go?type=gene&acc=1490,,,1490.0,CCN2,9606.0,Homo sapiens (human),Troglitazone results in increased expression of CCN2 mRNA,,,PMID:19140230,https://www.ncbi.nlm.nih.gov/pubmed/19140230,19140230,,
433,528357,5591,Comparative Toxicogenomics Database (CTD),Troglitazone,D000077288,Troglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077288,5630,PRPH,https://ctdbase.org/detail.go?type=gene&acc=5630,,,5630.0,PRPH,10090.0,Mus musculus (house mouse),Troglitazone results in increased expression of PRPH mRNA,,,PMID:28973697,https://www.ncbi.nlm.nih.gov/pubmed/28973697,28973697,,
434,528358,5591,Comparative Toxicogenomics Database (CTD),Troglitazone,D000077288,Troglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077288,328099,PRPS1L3,https://ctdbase.org/detail.go?type=gene&acc=328099,,,328099.0,Prps1l3,10090.0,Mus musculus (house mouse),Troglitazone results in decreased expression of PRPS1L3 mRNA,,,PMID:28973697,https://www.ncbi.nlm.nih.gov/pubmed/28973697,28973697,,
435,528359,5591,Comparative Toxicogenomics Database (CTD),Troglitazone,D000077288,Troglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077288,7916,PRRC2A,https://ctdbase.org/detail.go?type=gene&acc=7916,,,7916.0,PRRC2A,10090.0,Mus musculus (house mouse),Troglitazone results in decreased expression of PRRC2A mRNA,,,PMID:28973697,https://www.ncbi.nlm.nih.gov/pubmed/28973697,28973697,,
436,528360,5591,Comparative Toxicogenomics Database (CTD),Troglitazone,D000077288,Troglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077288,84726,PRRC2B,https://ctdbase.org/detail.go?type=gene&acc=84726,,,84726.0,PRRC2B,10090.0,Mus musculus (house mouse),Troglitazone results in decreased expression of PRRC2B mRNA,,,PMID:28973697,https://www.ncbi.nlm.nih.gov/pubmed/28973697,28973697,,
437,528361,5591,Comparative Toxicogenomics Database (CTD),Troglitazone,D000077288,Troglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077288,23215,PRRC2C,https://ctdbase.org/detail.go?type=gene&acc=23215,,,23215.0,PRRC2C,10090.0,Mus musculus (house mouse),Troglitazone results in decreased expression of PRRC2C mRNA,,,PMID:28973697,https://www.ncbi.nlm.nih.gov/pubmed/28973697,28973697,,
438,528362,5591,Comparative Toxicogenomics Database (CTD),Troglitazone,D000077288,Troglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077288,235628,PRSS42,https://ctdbase.org/detail.go?type=gene&acc=235628,,,235628.0,Prss42,10090.0,Mus musculus (house mouse),Troglitazone results in increased expression of PRSS42 mRNA,,,PMID:28973697,https://www.ncbi.nlm.nih.gov/pubmed/28973697,28973697,,
439,528363,5591,Comparative Toxicogenomics Database (CTD),Troglitazone,D000077288,Troglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077288,5662,PSD,https://ctdbase.org/detail.go?type=gene&acc=5662,,,5662.0,PSD,10090.0,Mus musculus (house mouse),Troglitazone results in decreased expression of PSD mRNA,,,PMID:17569031,https://www.ncbi.nlm.nih.gov/pubmed/17569031,17569031,,
440,528364,5591,Comparative Toxicogenomics Database (CTD),Troglitazone,D000077288,Troglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077288,5662,PSD,https://ctdbase.org/detail.go?type=gene&acc=5662,,,5662.0,PSD,10116.0,Rattus norvegicus (Norway rat),Troglitazone results in decreased expression of PSD mRNA,,,PMID:21515302,https://www.ncbi.nlm.nih.gov/pubmed/21515302,21515302,,
441,528507,5591,Comparative Toxicogenomics Database (CTD),Troglitazone,D000077288,Troglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077288,65109,UPF3B,https://ctdbase.org/detail.go?type=gene&acc=65109,,,65109.0,UPF3B,10090.0,Mus musculus (house mouse),Troglitazone results in decreased expression of UPF3B mRNA,,,PMID:28973697,https://www.ncbi.nlm.nih.gov/pubmed/28973697,28973697,,
442,528508,5591,Comparative Toxicogenomics Database (CTD),Troglitazone,D000077288,Troglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077288,7384,UQCRC1,https://ctdbase.org/detail.go?type=gene&acc=7384,,,7384.0,UQCRC1,10090.0,Mus musculus (house mouse),Troglitazone results in increased expression of UQCRC1 protein,,,PMID:18495193,https://www.ncbi.nlm.nih.gov/pubmed/18495193,18495193,,
443,528509,5591,Comparative Toxicogenomics Database (CTD),Troglitazone,D000077288,Troglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077288,10083,USH1C,https://ctdbase.org/detail.go?type=gene&acc=10083,,,10083.0,USH1C,10116.0,Rattus norvegicus (Norway rat),Troglitazone results in decreased expression of USH1C mRNA,,,PMID:21515302,https://www.ncbi.nlm.nih.gov/pubmed/21515302,21515302,,
444,528510,5591,Comparative Toxicogenomics Database (CTD),Troglitazone,D000077288,Troglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077288,9099,USP2,https://ctdbase.org/detail.go?type=gene&acc=9099,,,9099.0,USP2,10116.0,Rattus norvegicus (Norway rat),Troglitazone results in increased expression of USP2 mRNA,,,PMID:21515302,https://www.ncbi.nlm.nih.gov/pubmed/21515302,21515302,,
445,528511,5591,Comparative Toxicogenomics Database (CTD),Troglitazone,D000077288,Troglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077288,23358,USP24,https://ctdbase.org/detail.go?type=gene&acc=23358,,,23358.0,USP24,10090.0,Mus musculus (house mouse),Troglitazone results in decreased expression of USP24 mRNA,,,PMID:28973697,https://www.ncbi.nlm.nih.gov/pubmed/28973697,28973697,,
446,528512,5591,Comparative Toxicogenomics Database (CTD),Troglitazone,D000077288,Troglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077288,9712,USP6NL,https://ctdbase.org/detail.go?type=gene&acc=9712,,,9712.0,USP6NL,10090.0,Mus musculus (house mouse),Troglitazone results in decreased expression of USP6NL mRNA,,,PMID:28973697,https://www.ncbi.nlm.nih.gov/pubmed/28973697,28973697,,
447,528513,5591,Comparative Toxicogenomics Database (CTD),Troglitazone,D000077288,Troglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077288,7874,USP7,https://ctdbase.org/detail.go?type=gene&acc=7874,,,7874.0,USP7,10090.0,Mus musculus (house mouse),Troglitazone results in decreased expression of USP7 mRNA,,,PMID:28973697,https://www.ncbi.nlm.nih.gov/pubmed/28973697,28973697,,
448,528514,5591,Comparative Toxicogenomics Database (CTD),Troglitazone,D000077288,Troglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077288,171397,UST4R,https://ctdbase.org/detail.go?type=gene&acc=171397,,,171397.0,UST4r,10116.0,Rattus norvegicus (Norway rat),Troglitazone results in decreased expression of UST4R mRNA,,,PMID:21515302,https://www.ncbi.nlm.nih.gov/pubmed/21515302,21515302,,
449,528973,5591,Comparative Toxicogenomics Database (CTD),Troglitazone,D000077288,Troglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077288,114825,PWWP2A,https://ctdbase.org/detail.go?type=gene&acc=114825,,,114825.0,PWWP2A,10090.0,Mus musculus (house mouse),Troglitazone results in decreased expression of PWWP2A mRNA,,,PMID:28973697,https://www.ncbi.nlm.nih.gov/pubmed/28973697,28973697,,
450,528974,5591,Comparative Toxicogenomics Database (CTD),Troglitazone,D000077288,Troglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077288,84939,PWWP3A,https://ctdbase.org/detail.go?type=gene&acc=84939,,,84939.0,PWWP3A,10090.0,Mus musculus (house mouse),Troglitazone results in decreased expression of PWWP3A mRNA,,,PMID:28973697,https://www.ncbi.nlm.nih.gov/pubmed/28973697,28973697,,
451,528975,5591,Comparative Toxicogenomics Database (CTD),Troglitazone,D000077288,Troglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077288,7837,PXDN,https://ctdbase.org/detail.go?type=gene&acc=7837,,,7837.0,PXDN,10090.0,Mus musculus (house mouse),Troglitazone results in decreased expression of PXDN mRNA,,,PMID:28973697,https://www.ncbi.nlm.nih.gov/pubmed/28973697,28973697,,
452,528976,5591,Comparative Toxicogenomics Database (CTD),Troglitazone,D000077288,Troglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077288,5827,PXMP2,https://ctdbase.org/detail.go?type=gene&acc=5827,,,5827.0,PXMP2,9606.0,Homo sapiens (human),[troglitazone co-treated with TNF protein] results in decreased expression of PXMP2 mRNA,,,PMID:12732648,https://www.ncbi.nlm.nih.gov/pubmed/12732648,12732648,,
453,528977,5591,Comparative Toxicogenomics Database (CTD),Troglitazone,D000077288,Troglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077288,5829,PXN,https://ctdbase.org/detail.go?type=gene&acc=5829,,,5829.0,PXN,10090.0,Mus musculus (house mouse),Troglitazone results in decreased expression of PXN mRNA,,,PMID:28973697,https://www.ncbi.nlm.nih.gov/pubmed/28973697,28973697,,
454,528978,5591,Comparative Toxicogenomics Database (CTD),Troglitazone,D000077288,Troglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077288,5836,PYGL,https://ctdbase.org/detail.go?type=gene&acc=5836,,,5836.0,PYGL,10116.0,Rattus norvegicus (Norway rat),Troglitazone results in decreased expression of PYGL mRNA,,,PMID:21515302,https://www.ncbi.nlm.nih.gov/pubmed/21515302,21515302,,
455,528979,5591,Comparative Toxicogenomics Database (CTD),Troglitazone,D000077288,Troglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077288,5836,PYGL,https://ctdbase.org/detail.go?type=gene&acc=5836,,,5836.0,PYGL,10116.0,Rattus norvegicus (Norway rat),Troglitazone results in decreased expression of PYGL protein,,,PMID:21315101,https://www.ncbi.nlm.nih.gov/pubmed/21315101,21315101,,
456,530237,5591,Comparative Toxicogenomics Database (CTD),Troglitazone,D000077288,Troglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077288,1019,CDK4,https://ctdbase.org/detail.go?type=gene&acc=1019,,,1019.0,CDK4,9606.0,Homo sapiens (human),"Troglitazone results in decreased expression of CDK4 protein|gsk3b protein affects the susceptibility to [troglitazone results in decreased expression of CDK4 protein]|[n-(4-methoxybenzyl)-N'-(5-nitro-1,3-thiazol-2-yl)urea results in decreased activity of GSK3B protein] results in increased susceptibility to [troglitazone results in decreased expression of CDK4 protein]",,,PMID:20540935,https://www.ncbi.nlm.nih.gov/pubmed/20540935,20540935,,
457,530238,5591,Comparative Toxicogenomics Database (CTD),Troglitazone,D000077288,Troglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077288,1019,CDK4,https://ctdbase.org/detail.go?type=gene&acc=1019,,,1019.0,CDK4,9606.0,Homo sapiens (human),Troglitazone results in decreased expression of CDK4 mRNA,,,PMID:19140230,https://www.ncbi.nlm.nih.gov/pubmed/19140230,19140230,,
458,530239,5591,Comparative Toxicogenomics Database (CTD),Troglitazone,D000077288,Troglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077288,1019,CDK4,https://ctdbase.org/detail.go?type=gene&acc=1019,,,1019.0,CDK4,10090.0,Mus musculus (house mouse),Troglitazone results in decreased expression of CDK4 protein,,,PMID:15610522,https://www.ncbi.nlm.nih.gov/pubmed/15610522,15610522,,
459,530240,5591,Comparative Toxicogenomics Database (CTD),Troglitazone,D000077288,Troglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077288,153241,CEP120,https://ctdbase.org/detail.go?type=gene&acc=153241,,,153241.0,CEP120,10090.0,Mus musculus (house mouse),Troglitazone results in decreased expression of CEP120 mRNA,,,PMID:28973697,https://www.ncbi.nlm.nih.gov/pubmed/28973697,28973697,,
460,530241,5591,Comparative Toxicogenomics Database (CTD),Troglitazone,D000077288,Troglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077288,1020,CDK5,https://ctdbase.org/detail.go?type=gene&acc=1020,,,1020.0,CDK5,10116.0,Rattus norvegicus (Norway rat),Troglitazone promotes the reaction [CDK5 protein results in increased phosphorylation of PPARG protein]|2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [troglitazone results in increased phosphorylation of CDK5 protein]|troglitazone results in increased phosphorylation of and results in increased activity of CDK5 protein|pyrazolanthrone inhibits the reaction [troglitazone results in increased phosphorylation of CDK5 protein],,,PMID:24481447,https://www.ncbi.nlm.nih.gov/pubmed/24481447,24481447,,
461,530242,5591,Comparative Toxicogenomics Database (CTD),Troglitazone,D000077288,Troglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077288,80279,CDK5RAP3,https://ctdbase.org/detail.go?type=gene&acc=80279,,,80279.0,CDK5RAP3,9606.0,Homo sapiens (human),Troglitazone results in decreased expression of CDK5RAP3 mRNA,,,PMID:19140230,https://www.ncbi.nlm.nih.gov/pubmed/19140230,19140230,,
462,530243,5591,Comparative Toxicogenomics Database (CTD),Troglitazone,D000077288,Troglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077288,1021,CDK6,https://ctdbase.org/detail.go?type=gene&acc=1021,,,1021.0,CDK6,9606.0,Homo sapiens (human),Troglitazone results in decreased expression of CDK6 mRNA,,,PMID:19140230,https://www.ncbi.nlm.nih.gov/pubmed/19140230,19140230,,
463,530244,5591,Comparative Toxicogenomics Database (CTD),Troglitazone,D000077288,Troglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077288,1026,CDKN1A,https://ctdbase.org/detail.go?type=gene&acc=1026,,,1026.0,CDKN1A,9606.0,Homo sapiens (human),Troglitazone affects the localization of and results in increased expression of CDKN1A protein|2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [troglitazone affects the localization of and results in increased expression of CDKN1A protein]|troglitazone results in increased metabolism of CDKN1A protein,,,PMID:11888673,https://www.ncbi.nlm.nih.gov/pubmed/11888673,11888673,,
464,531330,5591,Comparative Toxicogenomics Database (CTD),Troglitazone,D000077288,Troglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077288,5997,RGS2,https://ctdbase.org/detail.go?type=gene&acc=5997,,,5997.0,RGS2,10090.0,Mus musculus (house mouse),Troglitazone results in decreased expression of RGS2 mrna|[troglitazone co-treated with TNF protein] results in decreased expression of RGS2 mRNA,,,PMID:12732648,https://www.ncbi.nlm.nih.gov/pubmed/12732648,12732648,,
465,531331,5591,Comparative Toxicogenomics Database (CTD),Troglitazone,D000077288,Troglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077288,5997,RGS2,https://ctdbase.org/detail.go?type=gene&acc=5997,,,5997.0,RGS2,10116.0,Rattus norvegicus (Norway rat),Troglitazone results in decreased expression of RGS2 mRNA,,,PMID:21515302,https://www.ncbi.nlm.nih.gov/pubmed/21515302,21515302,,
466,531332,5591,Comparative Toxicogenomics Database (CTD),Troglitazone,D000077288,Troglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077288,5999,RGS4,https://ctdbase.org/detail.go?type=gene&acc=5999,,,5999.0,RGS4,9606.0,Homo sapiens (human),Troglitazone results in decreased expression of RGS4 mRNA,,,PMID:19140230,https://www.ncbi.nlm.nih.gov/pubmed/19140230,19140230,,
467,531333,5591,Comparative Toxicogenomics Database (CTD),Troglitazone,D000077288,Troglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077288,5999,RGS4,https://ctdbase.org/detail.go?type=gene&acc=5999,,,5999.0,RGS4,10090.0,Mus musculus (house mouse),Troglitazone results in decreased expression of RGS4 mRNA,,,PMID:28973697,https://www.ncbi.nlm.nih.gov/pubmed/28973697,28973697,,
468,531334,5591,Comparative Toxicogenomics Database (CTD),Troglitazone,D000077288,Troglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077288,5999,RGS4,https://ctdbase.org/detail.go?type=gene&acc=5999,,,5999.0,RGS4,10116.0,Rattus norvegicus (Norway rat),Troglitazone results in increased expression of RGS4 mRNA,,,PMID:21515302,https://www.ncbi.nlm.nih.gov/pubmed/21515302,21515302,,
469,531335,5591,Comparative Toxicogenomics Database (CTD),Troglitazone,D000077288,Troglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077288,388,RHOB,https://ctdbase.org/detail.go?type=gene&acc=388,,,388.0,RHOB,9606.0,Homo sapiens (human),Troglitazone results in increased expression of RHOB mRNA,,,PMID:19140230,https://www.ncbi.nlm.nih.gov/pubmed/19140230,19140230,,
470,531336,5591,Comparative Toxicogenomics Database (CTD),Troglitazone,D000077288,Troglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077288,388,RHOB,https://ctdbase.org/detail.go?type=gene&acc=388,,,388.0,RHOB,10090.0,Mus musculus (house mouse),Troglitazone results in decreased expression of RHOB mRNA,,,PMID:28973697,https://www.ncbi.nlm.nih.gov/pubmed/28973697,28973697,,
471,531337,5591,Comparative Toxicogenomics Database (CTD),Troglitazone,D000077288,Troglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077288,54509,RHOF,https://ctdbase.org/detail.go?type=gene&acc=54509,,,54509.0,RHOF,9606.0,Homo sapiens (human),Troglitazone results in increased expression of RHOF mRNA,,,PMID:19140230,https://www.ncbi.nlm.nih.gov/pubmed/19140230,19140230,,
472,516225,5641,Comparative Toxicogenomics Database (CTD),Urethane,D014520,Urethane,https://ctdbase.org/detail.go?type=chem&acc=D014520,2491,CENPI,https://ctdbase.org/detail.go?type=gene&acc=2491,,,2491.0,CENPI,9606.0,Homo sapiens (human),Urethane results in decreased expression of CENPI mRNA,,,PMID:28818685,https://www.ncbi.nlm.nih.gov/pubmed/28818685,28818685,,
473,516226,5641,Comparative Toxicogenomics Database (CTD),Urethane,D014520,Urethane,https://ctdbase.org/detail.go?type=chem&acc=D014520,64105,CENPK,https://ctdbase.org/detail.go?type=gene&acc=64105,,,64105.0,CENPK,9606.0,Homo sapiens (human),Urethane results in decreased expression of CENPK mRNA,,,PMID:28818685,https://www.ncbi.nlm.nih.gov/pubmed/28818685,28818685,,
474,517458,5641,Comparative Toxicogenomics Database (CTD),Urethane,D014520,Urethane,https://ctdbase.org/detail.go?type=chem&acc=D014520,81027,TUBB1,https://ctdbase.org/detail.go?type=gene&acc=81027,,,81027.0,TUBB1,9606.0,Homo sapiens (human),Urethane results in decreased expression of TUBB1 mRNA,,,PMID:28818685,https://www.ncbi.nlm.nih.gov/pubmed/28818685,28818685,,
475,517459,5641,Comparative Toxicogenomics Database (CTD),Urethane,D014520,Urethane,https://ctdbase.org/detail.go?type=chem&acc=D014520,10381,TUBB3,https://ctdbase.org/detail.go?type=gene&acc=10381,,,10381.0,TUBB3,9606.0,Homo sapiens (human),Urethane results in increased expression of TUBB3 mRNA,,,PMID:28818685,https://www.ncbi.nlm.nih.gov/pubmed/28818685,28818685,,
476,517460,5641,Comparative Toxicogenomics Database (CTD),Urethane,D014520,Urethane,https://ctdbase.org/detail.go?type=chem&acc=D014520,10383,TUBB4B,https://ctdbase.org/detail.go?type=gene&acc=10383,,,10383.0,TUBB4B,9606.0,Homo sapiens (human),Urethane results in increased expression of TUBB4B mRNA,,,PMID:28818685,https://www.ncbi.nlm.nih.gov/pubmed/28818685,28818685,,
477,519560,5641,Comparative Toxicogenomics Database (CTD),Urethane,D014520,Urethane,https://ctdbase.org/detail.go?type=chem&acc=D014520,1437,CSF2,https://ctdbase.org/detail.go?type=gene&acc=1437,,,1437.0,CSF2,10090.0,Mus musculus (house mouse),Freund's adjuvant inhibits the reaction [urethane results in decreased expression of CSF2 mrna]|ifng protein inhibits the reaction [urethane results in decreased expression of CSF2 mrna],,,PMID:12810352,https://www.ncbi.nlm.nih.gov/pubmed/12810352,12810352,,
478,519561,5641,Comparative Toxicogenomics Database (CTD),Urethane,D014520,Urethane,https://ctdbase.org/detail.go?type=chem&acc=D014520,1437,CSF2,https://ctdbase.org/detail.go?type=gene&acc=1437,,,1437.0,CSF2,10090.0,Mus musculus (house mouse),[urethane co-treated with freund's adjuvant] results in increased expression of CSF2 mRNA,,,PMID:12400877,https://www.ncbi.nlm.nih.gov/pubmed/12400877,12400877,,
479,519562,5641,Comparative Toxicogenomics Database (CTD),Urethane,D014520,Urethane,https://ctdbase.org/detail.go?type=chem&acc=D014520,55454,CSGALNACT2,https://ctdbase.org/detail.go?type=gene&acc=55454,,,55454.0,CSGALNACT2,9606.0,Homo sapiens (human),Urethane results in increased expression of CSGALNACT2 mRNA,,,PMID:28818685,https://www.ncbi.nlm.nih.gov/pubmed/28818685,28818685,,
480,519563,5641,Comparative Toxicogenomics Database (CTD),Urethane,D014520,Urethane,https://ctdbase.org/detail.go?type=chem&acc=D014520,1452,CSNK1A1,https://ctdbase.org/detail.go?type=gene&acc=1452,,,1452.0,CSNK1A1,9606.0,Homo sapiens (human),Urethane results in increased expression of CSNK1A1 mRNA,,,PMID:28818685,https://www.ncbi.nlm.nih.gov/pubmed/28818685,28818685,,
481,519564,5641,Comparative Toxicogenomics Database (CTD),Urethane,D014520,Urethane,https://ctdbase.org/detail.go?type=chem&acc=D014520,122011,CSNK1A1L,https://ctdbase.org/detail.go?type=gene&acc=122011,,,122011.0,CSNK1A1L,9606.0,Homo sapiens (human),Urethane results in increased expression of CSNK1A1L mRNA,,,PMID:28818685,https://www.ncbi.nlm.nih.gov/pubmed/28818685,28818685,,
482,519565,5641,Comparative Toxicogenomics Database (CTD),Urethane,D014520,Urethane,https://ctdbase.org/detail.go?type=chem&acc=D014520,1453,CSNK1D,https://ctdbase.org/detail.go?type=gene&acc=1453,,,1453.0,CSNK1D,9606.0,Homo sapiens (human),Urethane results in increased expression of CSNK1D mRNA,,,PMID:28818685,https://www.ncbi.nlm.nih.gov/pubmed/28818685,28818685,,
483,519566,5641,Comparative Toxicogenomics Database (CTD),Urethane,D014520,Urethane,https://ctdbase.org/detail.go?type=chem&acc=D014520,1454,CSNK1E,https://ctdbase.org/detail.go?type=gene&acc=1454,,,1454.0,CSNK1E,9606.0,Homo sapiens (human),Urethane results in increased expression of CSNK1E mRNA,,,PMID:28818685,https://www.ncbi.nlm.nih.gov/pubmed/28818685,28818685,,
484,519915,5641,Comparative Toxicogenomics Database (CTD),Urethane,D014520,Urethane,https://ctdbase.org/detail.go?type=chem&acc=D014520,7453,WARS1,https://ctdbase.org/detail.go?type=gene&acc=7453,,,7453.0,WARS1,9606.0,Homo sapiens (human),Urethane results in decreased expression of WARS1 mRNA,,,PMID:28818685,https://www.ncbi.nlm.nih.gov/pubmed/28818685,28818685,,
485,519916,5641,Comparative Toxicogenomics Database (CTD),Urethane,D014520,Urethane,https://ctdbase.org/detail.go?type=chem&acc=D014520,8976,WASL,https://ctdbase.org/detail.go?type=gene&acc=8976,,,8976.0,WASL,9606.0,Homo sapiens (human),Urethane results in increased expression of WASL mRNA,,,PMID:28818685,https://www.ncbi.nlm.nih.gov/pubmed/28818685,28818685,,
486,521014,5641,Comparative Toxicogenomics Database (CTD),Urethane,D014520,Urethane,https://ctdbase.org/detail.go?type=chem&acc=D014520,4904,YBX1,https://ctdbase.org/detail.go?type=gene&acc=4904,,,4904.0,YBX1,9606.0,Homo sapiens (human),Urethane results in increased expression of YBX1 mRNA,,,PMID:28818685,https://www.ncbi.nlm.nih.gov/pubmed/28818685,28818685,,
487,521015,5641,Comparative Toxicogenomics Database (CTD),Urethane,D014520,Urethane,https://ctdbase.org/detail.go?type=chem&acc=D014520,8531,YBX3,https://ctdbase.org/detail.go?type=gene&acc=8531,,,8531.0,YBX3,9606.0,Homo sapiens (human),Urethane results in increased expression of YBX3 mRNA,,,PMID:28818685,https://www.ncbi.nlm.nih.gov/pubmed/28818685,28818685,,
488,521016,5641,Comparative Toxicogenomics Database (CTD),Urethane,D014520,Urethane,https://ctdbase.org/detail.go?type=chem&acc=D014520,150223,YDJC,https://ctdbase.org/detail.go?type=gene&acc=150223,,,150223.0,YDJC,9606.0,Homo sapiens (human),Urethane results in decreased expression of YDJC mRNA,,,PMID:28818685,https://www.ncbi.nlm.nih.gov/pubmed/28818685,28818685,,
489,521017,5641,Comparative Toxicogenomics Database (CTD),Urethane,D014520,Urethane,https://ctdbase.org/detail.go?type=chem&acc=D014520,10897,YIF1A,https://ctdbase.org/detail.go?type=gene&acc=10897,,,10897.0,YIF1A,9606.0,Homo sapiens (human),Urethane results in decreased expression of YIF1A mRNA,,,PMID:28818685,https://www.ncbi.nlm.nih.gov/pubmed/28818685,28818685,,
490,521018,5641,Comparative Toxicogenomics Database (CTD),Urethane,D014520,Urethane,https://ctdbase.org/detail.go?type=chem&acc=D014520,81576,YJU2B,https://ctdbase.org/detail.go?type=gene&acc=81576,,,81576.0,YJU2B,9606.0,Homo sapiens (human),Urethane results in increased expression of YJU2B mRNA,,,PMID:28818685,https://www.ncbi.nlm.nih.gov/pubmed/28818685,28818685,,
491,521019,5641,Comparative Toxicogenomics Database (CTD),Urethane,D014520,Urethane,https://ctdbase.org/detail.go?type=chem&acc=D014520,56252,YLPM1,https://ctdbase.org/detail.go?type=gene&acc=56252,,,56252.0,YLPM1,9606.0,Homo sapiens (human),Urethane results in increased expression of YLPM1 mRNA,,,PMID:28818685,https://www.ncbi.nlm.nih.gov/pubmed/28818685,28818685,,
492,525038,5641,Comparative Toxicogenomics Database (CTD),Urethane,D014520,Urethane,https://ctdbase.org/detail.go?type=chem&acc=D014520,79177,ZNF576,https://ctdbase.org/detail.go?type=gene&acc=79177,,,79177.0,ZNF576,9606.0,Homo sapiens (human),Urethane results in decreased expression of ZNF576 mRNA,,,PMID:28818685,https://www.ncbi.nlm.nih.gov/pubmed/28818685,28818685,,
493,525039,5641,Comparative Toxicogenomics Database (CTD),Urethane,D014520,Urethane,https://ctdbase.org/detail.go?type=chem&acc=D014520,163033,ZNF579,https://ctdbase.org/detail.go?type=gene&acc=163033,,,163033.0,ZNF579,9606.0,Homo sapiens (human),Urethane results in decreased expression of ZNF579 mRNA,,,PMID:28818685,https://www.ncbi.nlm.nih.gov/pubmed/28818685,28818685,,
494,525040,5641,Comparative Toxicogenomics Database (CTD),Urethane,D014520,Urethane,https://ctdbase.org/detail.go?type=chem&acc=D014520,51545,ZNF581,https://ctdbase.org/detail.go?type=gene&acc=51545,,,51545.0,ZNF581,9606.0,Homo sapiens (human),Urethane results in increased expression of ZNF581 mRNA,,,PMID:28818685,https://www.ncbi.nlm.nih.gov/pubmed/28818685,28818685,,
495,525041,5641,Comparative Toxicogenomics Database (CTD),Urethane,D014520,Urethane,https://ctdbase.org/detail.go?type=chem&acc=D014520,147949,ZNF583,https://ctdbase.org/detail.go?type=gene&acc=147949,,,147949.0,ZNF583,9606.0,Homo sapiens (human),Urethane results in decreased expression of ZNF583 mRNA,,,PMID:28818685,https://www.ncbi.nlm.nih.gov/pubmed/28818685,28818685,,
496,525042,5641,Comparative Toxicogenomics Database (CTD),Urethane,D014520,Urethane,https://ctdbase.org/detail.go?type=chem&acc=D014520,201514,ZNF584,https://ctdbase.org/detail.go?type=gene&acc=201514,,,201514.0,ZNF584,9606.0,Homo sapiens (human),Urethane results in decreased expression of ZNF584 mRNA,,,PMID:28818685,https://www.ncbi.nlm.nih.gov/pubmed/28818685,28818685,,
497,525043,5641,Comparative Toxicogenomics Database (CTD),Urethane,D014520,Urethane,https://ctdbase.org/detail.go?type=chem&acc=D014520,199704,ZNF585A,https://ctdbase.org/detail.go?type=gene&acc=199704,,,199704.0,ZNF585A,9606.0,Homo sapiens (human),Urethane results in increased expression of ZNF585A mRNA,,,PMID:28818685,https://www.ncbi.nlm.nih.gov/pubmed/28818685,28818685,,
498,525044,5641,Comparative Toxicogenomics Database (CTD),Urethane,D014520,Urethane,https://ctdbase.org/detail.go?type=chem&acc=D014520,84914,ZNF587,https://ctdbase.org/detail.go?type=gene&acc=84914,,,84914.0,ZNF587,9606.0,Homo sapiens (human),Urethane results in decreased expression of ZNF587 mRNA,,,PMID:28818685,https://www.ncbi.nlm.nih.gov/pubmed/28818685,28818685,,
499,525885,5641,Comparative Toxicogenomics Database (CTD),Urethane,D014520,Urethane,https://ctdbase.org/detail.go?type=chem&acc=D014520,92595,ZNF764,https://ctdbase.org/detail.go?type=gene&acc=92595,,,92595.0,ZNF764,9606.0,Homo sapiens (human),Urethane results in decreased expression of ZNF764 mRNA,,,PMID:28818685,https://www.ncbi.nlm.nih.gov/pubmed/28818685,28818685,,
500,525886,5641,Comparative Toxicogenomics Database (CTD),Urethane,D014520,Urethane,https://ctdbase.org/detail.go?type=chem&acc=D014520,79724,ZNF768,https://ctdbase.org/detail.go?type=gene&acc=79724,,,79724.0,ZNF768,9606.0,Homo sapiens (human),Urethane results in decreased expression of ZNF768 mRNA,,,PMID:28818685,https://www.ncbi.nlm.nih.gov/pubmed/28818685,28818685,,
501,525887,5641,Comparative Toxicogenomics Database (CTD),Urethane,D014520,Urethane,https://ctdbase.org/detail.go?type=chem&acc=D014520,54989,ZNF770,https://ctdbase.org/detail.go?type=gene&acc=54989,,,54989.0,ZNF770,9606.0,Homo sapiens (human),Urethane results in decreased expression of ZNF770 mRNA,,,PMID:28818685,https://www.ncbi.nlm.nih.gov/pubmed/28818685,28818685,,
502,525888,5641,Comparative Toxicogenomics Database (CTD),Urethane,D014520,Urethane,https://ctdbase.org/detail.go?type=chem&acc=D014520,400720,ZNF772,https://ctdbase.org/detail.go?type=gene&acc=400720,,,400720.0,ZNF772,9606.0,Homo sapiens (human),Urethane results in decreased expression of ZNF772 mRNA,,,PMID:28818685,https://www.ncbi.nlm.nih.gov/pubmed/28818685,28818685,,
503,525889,5641,Comparative Toxicogenomics Database (CTD),Urethane,D014520,Urethane,https://ctdbase.org/detail.go?type=chem&acc=D014520,285971,ZNF775,https://ctdbase.org/detail.go?type=gene&acc=285971,,,285971.0,ZNF775,9606.0,Homo sapiens (human),Urethane results in increased expression of ZNF775 mRNA,,,PMID:28818685,https://www.ncbi.nlm.nih.gov/pubmed/28818685,28818685,,
504,523597,5694,Comparative Toxicogenomics Database (CTD),Pirinixic acid,C006253,pirinixic acid,https://ctdbase.org/detail.go?type=chem&acc=C006253,3010,H1-6,https://ctdbase.org/detail.go?type=gene&acc=3010,,,3010.0,H1-6,9606.0,Homo sapiens (human),[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of H1-6 mRNA,,,PMID:19710929,https://www.ncbi.nlm.nih.gov/pubmed/19710929,19710929,,
505,523598,5694,Comparative Toxicogenomics Database (CTD),Pirinixic acid,C006253,pirinixic acid,https://ctdbase.org/detail.go?type=chem&acc=C006253,283120,H19,https://ctdbase.org/detail.go?type=gene&acc=283120,,,283120.0,H19,10090.0,Mus musculus (house mouse),Pirinixic acid results in increased expression of H19 mRNA,,,PMID:23811191,https://www.ncbi.nlm.nih.gov/pubmed/23811191,23811191,,
506,523599,5694,Comparative Toxicogenomics Database (CTD),Pirinixic acid,C006253,pirinixic acid,https://ctdbase.org/detail.go?type=chem&acc=C006253,14958,H1F0,https://ctdbase.org/detail.go?type=gene&acc=14958,,,14958.0,H1f0,10090.0,Mus musculus (house mouse),Pirinixic acid results in increased expression of H1F0 mRNA,,,PMID:18445702,https://www.ncbi.nlm.nih.gov/pubmed/18445702,18445702,,
507,524523,5694,Comparative Toxicogenomics Database (CTD),Pirinixic acid,C006253,pirinixic acid,https://ctdbase.org/detail.go?type=chem&acc=C006253,15000,H2-DMB2,https://ctdbase.org/detail.go?type=gene&acc=15000,,,15000.0,H2-DMb2,10090.0,Mus musculus (house mouse),Pirinixic acid results in decreased expression of H2-DMB2 mRNA,,,PMID:17426115,https://www.ncbi.nlm.nih.gov/pubmed/17426115,17426115,,
508,524524,5694,Comparative Toxicogenomics Database (CTD),Pirinixic acid,C006253,pirinixic acid,https://ctdbase.org/detail.go?type=chem&acc=C006253,100504404,H2-EA,https://ctdbase.org/detail.go?type=gene&acc=100504404,,,100504404.0,H2-Ea,10090.0,Mus musculus (house mouse),Pirinixic acid results in decreased expression of H2-EA mRNA,,,PMID:17426115,https://www.ncbi.nlm.nih.gov/pubmed/17426115,17426115,,
509,524691,5694,Comparative Toxicogenomics Database (CTD),Pirinixic acid,C006253,pirinixic acid,https://ctdbase.org/detail.go?type=chem&acc=C006253,55829,SELENOS,https://ctdbase.org/detail.go?type=gene&acc=55829,,,55829.0,SELENOS,10090.0,Mus musculus (house mouse),[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of SELENOS mRNA,,,PMID:19710929,https://www.ncbi.nlm.nih.gov/pubmed/19710929,19710929,,
510,524692,5694,Comparative Toxicogenomics Database (CTD),Pirinixic acid,C006253,pirinixic acid,https://ctdbase.org/detail.go?type=chem&acc=C006253,6415,SELENOW,https://ctdbase.org/detail.go?type=gene&acc=6415,,,6415.0,SELENOW,10116.0,Rattus norvegicus (Norway rat),Pirinixic acid results in decreased expression of SELENOW mRNA,,,PMID:15890375|PMID:19162173,https://www.ncbi.nlm.nih.gov/pubmed/15890375|https://www.ncbi.nlm.nih.gov/pubmed/19162173,15890375|19162173,,
511,524693,5694,Comparative Toxicogenomics Database (CTD),Pirinixic acid,C006253,pirinixic acid,https://ctdbase.org/detail.go?type=chem&acc=C006253,6402,SELL,https://ctdbase.org/detail.go?type=gene&acc=6402,,,6402.0,SELL,10090.0,Mus musculus (house mouse),Pirinixic acid results in decreased expression of SELL mRNA,,,PMID:20813756,https://www.ncbi.nlm.nih.gov/pubmed/20813756,20813756,,
512,524694,5694,Comparative Toxicogenomics Database (CTD),Pirinixic acid,C006253,pirinixic acid,https://ctdbase.org/detail.go?type=chem&acc=C006253,6403,SELP,https://ctdbase.org/detail.go?type=gene&acc=6403,,,6403.0,SELP,10090.0,Mus musculus (house mouse),Pirinixic acid results in decreased expression of SELP mrna|ppara protein promotes the reaction [pirinixic acid results in decreased expression of SELP mrna],,,PMID:20059764,https://www.ncbi.nlm.nih.gov/pubmed/20059764,20059764,,
513,525535,5694,Comparative Toxicogenomics Database (CTD),Pirinixic acid,C006253,pirinixic acid,https://ctdbase.org/detail.go?type=chem&acc=C006253,20700,SERPINA1A,https://ctdbase.org/detail.go?type=gene&acc=20700,,,20700.0,Serpina1a,10090.0,Mus musculus (house mouse),PPARA protein promotes the reaction [pirinixic acid results in decreased expression of SERPINA1A mrna],,,PMID:17950772,https://www.ncbi.nlm.nih.gov/pubmed/17950772,17950772,,
514,525536,5694,Comparative Toxicogenomics Database (CTD),Pirinixic acid,C006253,pirinixic acid,https://ctdbase.org/detail.go?type=chem&acc=C006253,20701,SERPINA1B,https://ctdbase.org/detail.go?type=gene&acc=20701,,,20701.0,Serpina1b,10090.0,Mus musculus (house mouse),[pirinixic acid co-treated with PPARA] results in decreased expression of SERPINA1B mRNA,,,PMID:20813756,https://www.ncbi.nlm.nih.gov/pubmed/20813756,20813756,,
515,525537,5694,Comparative Toxicogenomics Database (CTD),Pirinixic acid,C006253,pirinixic acid,https://ctdbase.org/detail.go?type=chem&acc=C006253,20701,SERPINA1B,https://ctdbase.org/detail.go?type=gene&acc=20701,,,20701.0,Serpina1b,10090.0,Mus musculus (house mouse),Pirinixic acid results in decreased expression of SERPINA1B mRNA,,,PMID:16221962|PMID:20813756|PMID:20936131,https://www.ncbi.nlm.nih.gov/pubmed/16221962|https://www.ncbi.nlm.nih.gov/pubmed/20813756|https://www.ncbi.nlm.nih.gov/pubmed/20936131,16221962|20813756|20936131,,
516,525538,5694,Comparative Toxicogenomics Database (CTD),Pirinixic acid,C006253,pirinixic acid,https://ctdbase.org/detail.go?type=chem&acc=C006253,20702,SERPINA1C,https://ctdbase.org/detail.go?type=gene&acc=20702,,,20702.0,Serpina1c,10090.0,Mus musculus (house mouse),Pirinixic acid results in decreased expression of SERPINA1C mRNA,,,PMID:16221962,https://www.ncbi.nlm.nih.gov/pubmed/16221962,16221962,,
517,525539,5694,Comparative Toxicogenomics Database (CTD),Pirinixic acid,C006253,pirinixic acid,https://ctdbase.org/detail.go?type=chem&acc=C006253,20703,SERPINA1D,https://ctdbase.org/detail.go?type=gene&acc=20703,,,20703.0,Serpina1d,10090.0,Mus musculus (house mouse),[pirinixic acid co-treated with PPARA] results in decreased expression of SERPINA1D mrna|pirinixic acid results in decreased expression of SERPINA1D mRNA,,,PMID:20813756,https://www.ncbi.nlm.nih.gov/pubmed/20813756,20813756,,
518,525540,5694,Comparative Toxicogenomics Database (CTD),Pirinixic acid,C006253,pirinixic acid,https://ctdbase.org/detail.go?type=chem&acc=C006253,20704,SERPINA1E,https://ctdbase.org/detail.go?type=gene&acc=20704,,,20704.0,Serpina1e,10090.0,Mus musculus (house mouse),Pirinixic acid results in decreased expression of SERPINA1E mRNA,,,PMID:16221962|PMID:20813756|PMID:23811191,https://www.ncbi.nlm.nih.gov/pubmed/16221962|https://www.ncbi.nlm.nih.gov/pubmed/20813756|https://www.ncbi.nlm.nih.gov/pubmed/23811191,16221962|20813756|23811191,,
519,525541,5694,Comparative Toxicogenomics Database (CTD),Pirinixic acid,C006253,pirinixic acid,https://ctdbase.org/detail.go?type=chem&acc=C006253,74069,SERPINA3A,https://ctdbase.org/detail.go?type=gene&acc=74069,,,74069.0,Serpina3a,10090.0,Mus musculus (house mouse),Pirinixic acid results in increased expression of SERPINA3A mRNA,,,PMID:18445702,https://www.ncbi.nlm.nih.gov/pubmed/18445702,18445702,,
520,526026,5694,Comparative Toxicogenomics Database (CTD),Pirinixic acid,C006253,pirinixic acid,https://ctdbase.org/detail.go?type=chem&acc=C006253,628916,SERPINA3L-PS,https://ctdbase.org/detail.go?type=gene&acc=628916,,,628916.0,Serpina3l-ps,10090.0,Mus musculus (house mouse),Pirinixic acid results in decreased expression of SERPINA3L-PS mRNA,,,PMID:23811191,https://www.ncbi.nlm.nih.gov/pubmed/23811191,23811191,,
521,526027,5694,Comparative Toxicogenomics Database (CTD),Pirinixic acid,C006253,pirinixic acid,https://ctdbase.org/detail.go?type=chem&acc=C006253,20717,SERPINA3M,https://ctdbase.org/detail.go?type=gene&acc=20717,,,20717.0,Serpina3m,10090.0,Mus musculus (house mouse),[pirinixic acid co-treated with PPARA] results in decreased expression of SERPINA3M mRNA,,,PMID:20813756,https://www.ncbi.nlm.nih.gov/pubmed/20813756,20813756,,
522,526028,5694,Comparative Toxicogenomics Database (CTD),Pirinixic acid,C006253,pirinixic acid,https://ctdbase.org/detail.go?type=chem&acc=C006253,20717,SERPINA3M,https://ctdbase.org/detail.go?type=gene&acc=20717,,,20717.0,Serpina3m,10090.0,Mus musculus (house mouse),Pirinixic acid results in decreased expression of SERPINA3M mRNA,,,PMID:16221962|PMID:20059764|PMID:20813756|PMID:25270620,https://www.ncbi.nlm.nih.gov/pubmed/16221962|https://www.ncbi.nlm.nih.gov/pubmed/20059764|https://www.ncbi.nlm.nih.gov/pubmed/20813756|https://www.ncbi.nlm.nih.gov/pubmed/25270620,16221962|20059764|20813756|25270620,,
523,526029,5694,Comparative Toxicogenomics Database (CTD),Pirinixic acid,C006253,pirinixic acid,https://ctdbase.org/detail.go?type=chem&acc=C006253,20717,SERPINA3M,https://ctdbase.org/detail.go?type=gene&acc=20717,,,20717.0,Serpina3m,10090.0,Mus musculus (house mouse),Pirinixic acid results in increased expression of SERPINA3M mRNA,,,PMID:18445702,https://www.ncbi.nlm.nih.gov/pubmed/18445702,18445702,,
524,526030,5694,Comparative Toxicogenomics Database (CTD),Pirinixic acid,C006253,pirinixic acid,https://ctdbase.org/detail.go?type=chem&acc=C006253,20717,SERPINA3M,https://ctdbase.org/detail.go?type=gene&acc=20717,,,20717.0,Serpina3m,10090.0,Mus musculus (house mouse),PPARA protein promotes the reaction [pirinixic acid results in decreased expression of SERPINA3M mrna],,,PMID:20059764,https://www.ncbi.nlm.nih.gov/pubmed/20059764,20059764,,
525,526031,5694,Comparative Toxicogenomics Database (CTD),Pirinixic acid,C006253,pirinixic acid,https://ctdbase.org/detail.go?type=chem&acc=C006253,20717,SERPINA3M,https://ctdbase.org/detail.go?type=gene&acc=20717,,,20717.0,Serpina3m,10116.0,Rattus norvegicus (Norway rat),Pirinixic acid results in decreased expression of SERPINA3M mRNA,,,PMID:19162173,https://www.ncbi.nlm.nih.gov/pubmed/19162173,19162173,,
526,526032,5694,Comparative Toxicogenomics Database (CTD),Pirinixic acid,C006253,pirinixic acid,https://ctdbase.org/detail.go?type=chem&acc=C006253,5272,SERPINB9,https://ctdbase.org/detail.go?type=gene&acc=5272,,,5272.0,SERPINB9,10090.0,Mus musculus (house mouse),Pirinixic acid results in decreased expression of SERPINB9 mRNA,,,PMID:20813756,https://www.ncbi.nlm.nih.gov/pubmed/20813756,20813756,,
527,526665,5694,Comparative Toxicogenomics Database (CTD),Pirinixic acid,C006253,pirinixic acid,https://ctdbase.org/detail.go?type=chem&acc=C006253,710,SERPING1,https://ctdbase.org/detail.go?type=gene&acc=710,,,710.0,SERPING1,10090.0,Mus musculus (house mouse),Pirinixic acid results in decreased expression of SERPING1 mRNA,,,PMID:16221962|PMID:20813756|PMID:23811191,https://www.ncbi.nlm.nih.gov/pubmed/16221962|https://www.ncbi.nlm.nih.gov/pubmed/20813756|https://www.ncbi.nlm.nih.gov/pubmed/23811191,16221962|20813756|23811191,,
528,528061,5694,Comparative Toxicogenomics Database (CTD),Pirinixic acid,C006253,pirinixic acid,https://ctdbase.org/detail.go?type=chem&acc=C006253,26275,HIBCH,https://ctdbase.org/detail.go?type=gene&acc=26275,,,26275.0,HIBCH,10116.0,Rattus norvegicus (Norway rat),Pirinixic acid results in increased expression of HIBCH mRNA,,,PMID:22484513,https://www.ncbi.nlm.nih.gov/pubmed/22484513,22484513,,
529,528972,5694,Comparative Toxicogenomics Database (CTD),Pirinixic acid,C006253,pirinixic acid,https://ctdbase.org/detail.go?type=chem&acc=C006253,3155,HMGCL,https://ctdbase.org/detail.go?type=gene&acc=3155,,,3155.0,HMGCL,10116.0,Rattus norvegicus (Norway rat),Pirinixic acid results in increased expression of HMGCL mRNA,,,PMID:17164430|PMID:19162173|PMID:22484513,https://www.ncbi.nlm.nih.gov/pubmed/17164430|https://www.ncbi.nlm.nih.gov/pubmed/19162173|https://www.ncbi.nlm.nih.gov/pubmed/22484513,17164430|19162173|22484513,,
530,530378,5694,Comparative Toxicogenomics Database (CTD),Pirinixic acid,C006253,pirinixic acid,https://ctdbase.org/detail.go?type=chem&acc=C006253,84525,HOPX,https://ctdbase.org/detail.go?type=gene&acc=84525,,,84525.0,HOPX,10090.0,Mus musculus (house mouse),Pirinixic acid results in decreased expression of HOPX mRNA,,,PMID:17426115|PMID:23811191,https://www.ncbi.nlm.nih.gov/pubmed/17426115|https://www.ncbi.nlm.nih.gov/pubmed/23811191,17426115|23811191,,
531,530379,5694,Comparative Toxicogenomics Database (CTD),Pirinixic acid,C006253,pirinixic acid,https://ctdbase.org/detail.go?type=chem&acc=C006253,84525,HOPX,https://ctdbase.org/detail.go?type=gene&acc=84525,,,84525.0,HOPX,10090.0,Mus musculus (house mouse),Pirinixic acid results in increased expression of HOPX mRNA,,,PMID:18301758,https://www.ncbi.nlm.nih.gov/pubmed/18301758,18301758,,
532,530380,5694,Comparative Toxicogenomics Database (CTD),Pirinixic acid,C006253,pirinixic acid,https://ctdbase.org/detail.go?type=chem&acc=C006253,3198,HOXA1,https://ctdbase.org/detail.go?type=gene&acc=3198,,,3198.0,HOXA1,10090.0,Mus musculus (house mouse),[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of HOXA1 mRNA,,,PMID:19710929,https://www.ncbi.nlm.nih.gov/pubmed/19710929,19710929,,
533,530381,5694,Comparative Toxicogenomics Database (CTD),Pirinixic acid,C006253,pirinixic acid,https://ctdbase.org/detail.go?type=chem&acc=C006253,3207,HOXA11,https://ctdbase.org/detail.go?type=gene&acc=3207,,,3207.0,HOXA11,10090.0,Mus musculus (house mouse),Pirinixic acid results in increased expression of HOXA11 mRNA,,,PMID:20813756,https://www.ncbi.nlm.nih.gov/pubmed/20813756,20813756,,
534,530382,5694,Comparative Toxicogenomics Database (CTD),Pirinixic acid,C006253,pirinixic acid,https://ctdbase.org/detail.go?type=chem&acc=C006253,3201,HOXA4,https://ctdbase.org/detail.go?type=gene&acc=3201,,,3201.0,HOXA4,10116.0,Rattus norvegicus (Norway rat),Pirinixic acid results in decreased expression of HOXA4 mRNA,,,PMID:19162173,https://www.ncbi.nlm.nih.gov/pubmed/19162173,19162173,,
535,530383,5694,Comparative Toxicogenomics Database (CTD),Pirinixic acid,C006253,pirinixic acid,https://ctdbase.org/detail.go?type=chem&acc=C006253,3202,HOXA5,https://ctdbase.org/detail.go?type=gene&acc=3202,,,3202.0,HOXA5,10090.0,Mus musculus (house mouse),[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of HOXA5 mRNA,,,PMID:19710929,https://www.ncbi.nlm.nih.gov/pubmed/19710929,19710929,,
536,530384,5694,Comparative Toxicogenomics Database (CTD),Pirinixic acid,C006253,pirinixic acid,https://ctdbase.org/detail.go?type=chem&acc=C006253,10481,HOXB13,https://ctdbase.org/detail.go?type=gene&acc=10481,,,10481.0,HOXB13,10090.0,Mus musculus (house mouse),[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of HOXB13 mRNA,,,PMID:19710929,https://www.ncbi.nlm.nih.gov/pubmed/19710929,19710929,,
537,527455,5708,Comparative Toxicogenomics Database (CTD),"1,4-Phenylenebis(methylene)selenocyanate",C074153,"1,4-phenylenebis(methylene)selenocyanate",https://ctdbase.org/detail.go?type=chem&acc=C074153,5743,PTGS2,https://ctdbase.org/detail.go?type=gene&acc=5743,,,5743.0,PTGS2,9606.0,Homo sapiens (human),"1,4-phenylenebis(methylene)selenocyanate results in decreased expression of PTGS2 mrna|1,4-phenylenebis(methylene)selenocyanate results in decreased expression of PTGS2 protein",,,PMID:16399772,https://www.ncbi.nlm.nih.gov/pubmed/16399772,16399772,,
538,527456,5708,Comparative Toxicogenomics Database (CTD),"1,4-Phenylenebis(methylene)selenocyanate",C074153,"1,4-phenylenebis(methylene)selenocyanate",https://ctdbase.org/detail.go?type=chem&acc=C074153,5743,PTGS2,https://ctdbase.org/detail.go?type=gene&acc=5743,,,5743.0,PTGS2,10090.0,Mus musculus (house mouse),"1,4-phenylenebis(methylene)selenocyanate results in decreased activity of PTGS2 protein",,,PMID:10753194,https://www.ncbi.nlm.nih.gov/pubmed/10753194,10753194,,
539,527457,5708,Comparative Toxicogenomics Database (CTD),"1,4-Phenylenebis(methylene)selenocyanate",C074153,"1,4-phenylenebis(methylene)selenocyanate",https://ctdbase.org/detail.go?type=chem&acc=C074153,6742,SSBP1,https://ctdbase.org/detail.go?type=gene&acc=6742,,,6742.0,SSBP1,9606.0,Homo sapiens (human),"1,4-phenylenebis(methylene)selenocyanate affects the expression of SSBP1 protein",,,PMID:18444160,https://www.ncbi.nlm.nih.gov/pubmed/18444160,18444160,,
540,528808,5741,Comparative Toxicogenomics Database (CTD),Donepezil Hydrochloride,D000077265,Donepezil,https://ctdbase.org/detail.go?type=chem&acc=D000077265,43,ACHE,https://ctdbase.org/detail.go?type=gene&acc=43,,,43.0,ACHE,10116.0,Rattus norvegicus (Norway rat),Donepezil inhibits the reaction [streptozocin results in increased activity of ACHE protein],,,PMID:19705549,https://www.ncbi.nlm.nih.gov/pubmed/19705549,19705549,,
541,528809,5741,Comparative Toxicogenomics Database (CTD),Donepezil Hydrochloride,D000077265,Donepezil,https://ctdbase.org/detail.go?type=chem&acc=D000077265,43,ACHE,https://ctdbase.org/detail.go?type=gene&acc=43,,,43.0,ACHE,10116.0,Rattus norvegicus (Norway rat),Donepezil results in decreased activity of ACHE protein,,,PMID:12589378|PMID:15135892|PMID:18571635|PMID:19345205,https://www.ncbi.nlm.nih.gov/pubmed/12589378|https://www.ncbi.nlm.nih.gov/pubmed/15135892|https://www.ncbi.nlm.nih.gov/pubmed/18571635|https://www.ncbi.nlm.nih.gov/pubmed/19345205,12589378|15135892|18571635|19345205,,
542,529294,5741,Comparative Toxicogenomics Database (CTD),Donepezil Hydrochloride,D000077265,Donepezil,https://ctdbase.org/detail.go?type=chem&acc=D000077265,581,BAX,https://ctdbase.org/detail.go?type=gene&acc=581,,,581.0,BAX,10090.0,Mus musculus (house mouse),Donepezil inhibits the reaction [scopolamine results in increased expression of BAX protein],,,PMID:34371027,https://www.ncbi.nlm.nih.gov/pubmed/34371027,34371027,,
543,529295,5741,Comparative Toxicogenomics Database (CTD),Donepezil Hydrochloride,D000077265,Donepezil,https://ctdbase.org/detail.go?type=chem&acc=D000077265,590,BCHE,https://ctdbase.org/detail.go?type=gene&acc=590,,,590.0,BCHE,9606.0,Homo sapiens (human),Donepezil results in decreased activity of BCHE protein,,,PMID:16036213|PMID:18656440,https://www.ncbi.nlm.nih.gov/pubmed/16036213|https://www.ncbi.nlm.nih.gov/pubmed/18656440,16036213|18656440,,
544,529296,5741,Comparative Toxicogenomics Database (CTD),Donepezil Hydrochloride,D000077265,Donepezil,https://ctdbase.org/detail.go?type=chem&acc=D000077265,590,BCHE,https://ctdbase.org/detail.go?type=gene&acc=590,,,590.0,BCHE,10090.0,Mus musculus (house mouse),Donepezil results in decreased activity of BCHE protein,,,PMID:18656440,https://www.ncbi.nlm.nih.gov/pubmed/18656440,18656440,,
545,529297,5741,Comparative Toxicogenomics Database (CTD),Donepezil Hydrochloride,D000077265,Donepezil,https://ctdbase.org/detail.go?type=chem&acc=D000077265,590,BCHE,https://ctdbase.org/detail.go?type=gene&acc=590,,,590.0,BCHE,10116.0,Rattus norvegicus (Norway rat),Donepezil results in decreased activity of BCHE protein,,,PMID:19345205,https://www.ncbi.nlm.nih.gov/pubmed/19345205,19345205,,
546,529298,5741,Comparative Toxicogenomics Database (CTD),Donepezil Hydrochloride,D000077265,Donepezil,https://ctdbase.org/detail.go?type=chem&acc=D000077265,596,BCL2,https://ctdbase.org/detail.go?type=gene&acc=596,,,596.0,BCL2,10090.0,Mus musculus (house mouse),Donepezil inhibits the reaction [scopolamine results in decreased expression of BCL2 protein],,,PMID:34371027,https://www.ncbi.nlm.nih.gov/pubmed/34371027,34371027,,
547,531161,5743,Comparative Toxicogenomics Database (CTD),Dexamethasone,D003907,Dexamethasone,https://ctdbase.org/detail.go?type=chem&acc=D003907,4060,LUM,https://ctdbase.org/detail.go?type=gene&acc=4060,,,4060.0,LUM,9606.0,Homo sapiens (human),Dexamethasone results in decreased expression of LUM mRNA,,,PMID:25047013,https://www.ncbi.nlm.nih.gov/pubmed/25047013,25047013,,
548,531162,5743,Comparative Toxicogenomics Database (CTD),Dexamethasone,D003907,Dexamethasone,https://ctdbase.org/detail.go?type=chem&acc=D003907,4060,LUM,https://ctdbase.org/detail.go?type=gene&acc=4060,,,4060.0,LUM,9606.0,Homo sapiens (human),[INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of LUM mrna|[ins protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bisphenol A] results in increased expression of LUM mrna|[ins protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bisphenol F] results in increased expression of LUM mRNA,,,PMID:28628672,https://www.ncbi.nlm.nih.gov/pubmed/28628672,28628672,,
549,519741,5746,Comparative Toxicogenomics Database (CTD),Mitomycin,D016685,Mitomycin,https://ctdbase.org/detail.go?type=chem&acc=D016685,5569,PKIA,https://ctdbase.org/detail.go?type=gene&acc=5569,,,5569.0,PKIA,9606.0,Homo sapiens (human),PKIA protein affects the susceptibility to mitomycin,,,PMID:16217747,https://www.ncbi.nlm.nih.gov/pubmed/16217747,16217747,,
550,519742,5746,Comparative Toxicogenomics Database (CTD),Mitomycin,D016685,Mitomycin,https://ctdbase.org/detail.go?type=chem&acc=D016685,5328,PLAU,https://ctdbase.org/detail.go?type=gene&acc=5328,,,5328.0,PLAU,9606.0,Homo sapiens (human),PLAU protein affects the susceptibility to mitomycin,,,PMID:16217747,https://www.ncbi.nlm.nih.gov/pubmed/16217747,16217747,,
551,519743,5746,Comparative Toxicogenomics Database (CTD),Mitomycin,D016685,Mitomycin,https://ctdbase.org/detail.go?type=chem&acc=D016685,5347,PLK1,https://ctdbase.org/detail.go?type=gene&acc=5347,,,5347.0,PLK1,10090.0,Mus musculus (house mouse),Mitomycin results in decreased expression of PLK1 mRNA,,,PMID:25270620,https://www.ncbi.nlm.nih.gov/pubmed/25270620,25270620,,
552,521343,5746,Comparative Toxicogenomics Database (CTD),Mitomycin,D016685,Mitomycin,https://ctdbase.org/detail.go?type=chem&acc=D016685,6648,SOD2,https://ctdbase.org/detail.go?type=gene&acc=6648,,,6648.0,SOD2,9606.0,Homo sapiens (human),SOD2 protein affects the susceptibility to mitomycin,,,PMID:16217747,https://www.ncbi.nlm.nih.gov/pubmed/16217747,16217747,,
553,521344,5746,Comparative Toxicogenomics Database (CTD),Mitomycin,D016685,Mitomycin,https://ctdbase.org/detail.go?type=chem&acc=D016685,10580,SORBS1,https://ctdbase.org/detail.go?type=gene&acc=10580,,,10580.0,SORBS1,9606.0,Homo sapiens (human),SORBS1 protein affects the susceptibility to mitomycin,,,PMID:16217747,https://www.ncbi.nlm.nih.gov/pubmed/16217747,16217747,,
554,521345,5746,Comparative Toxicogenomics Database (CTD),Mitomycin,D016685,Mitomycin,https://ctdbase.org/detail.go?type=chem&acc=D016685,6272,SORT1,https://ctdbase.org/detail.go?type=gene&acc=6272,,,6272.0,SORT1,9606.0,Homo sapiens (human),SORT1 protein affects the susceptibility to mitomycin,,,PMID:16217747,https://www.ncbi.nlm.nih.gov/pubmed/16217747,16217747,,
555,521346,5746,Comparative Toxicogenomics Database (CTD),Mitomycin,D016685,Mitomycin,https://ctdbase.org/detail.go?type=chem&acc=D016685,57405,SPC25,https://ctdbase.org/detail.go?type=gene&acc=57405,,,57405.0,SPC25,10090.0,Mus musculus (house mouse),Mitomycin results in increased expression of SPC25 mRNA,,,PMID:25270620,https://www.ncbi.nlm.nih.gov/pubmed/25270620,25270620,,
556,521347,5746,Comparative Toxicogenomics Database (CTD),Mitomycin,D016685,Mitomycin,https://ctdbase.org/detail.go?type=chem&acc=D016685,5552,SRGN,https://ctdbase.org/detail.go?type=gene&acc=5552,,,5552.0,SRGN,9606.0,Homo sapiens (human),SRGN protein affects the susceptibility to mitomycin,,,PMID:16217747,https://www.ncbi.nlm.nih.gov/pubmed/16217747,16217747,,
557,521348,5746,Comparative Toxicogenomics Database (CTD),Mitomycin,D016685,Mitomycin,https://ctdbase.org/detail.go?type=chem&acc=D016685,6426,SRSF1,https://ctdbase.org/detail.go?type=gene&acc=6426,,,6426.0,SRSF1,9606.0,Homo sapiens (human),SRSF1 protein affects the susceptibility to mitomycin,,,PMID:16217747,https://www.ncbi.nlm.nih.gov/pubmed/16217747,16217747,,
558,521349,5746,Comparative Toxicogenomics Database (CTD),Mitomycin,D016685,Mitomycin,https://ctdbase.org/detail.go?type=chem&acc=D016685,140809,SRXN1,https://ctdbase.org/detail.go?type=gene&acc=140809,,,140809.0,SRXN1,10090.0,Mus musculus (house mouse),Mitomycin results in increased expression of SRXN1 mRNA,,,PMID:22003191,https://www.ncbi.nlm.nih.gov/pubmed/22003191,22003191,,
559,521350,5746,Comparative Toxicogenomics Database (CTD),Mitomycin,D016685,Mitomycin,https://ctdbase.org/detail.go?type=chem&acc=D016685,6768,ST14,https://ctdbase.org/detail.go?type=gene&acc=6768,,,6768.0,ST14,10090.0,Mus musculus (house mouse),Mitomycin results in increased expression of ST14 mRNA,,,PMID:25270620,https://www.ncbi.nlm.nih.gov/pubmed/25270620,25270620,,
560,517610,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,1643,DDB2,https://ctdbase.org/detail.go?type=gene&acc=1643,,,1643.0,DDB2,9606.0,Homo sapiens (human),Estradiol results in decreased expression of DDB2 mRNA,,,PMID:31614463,https://www.ncbi.nlm.nih.gov/pubmed/31614463,31614463,,
561,517611,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,1643,DDB2,https://ctdbase.org/detail.go?type=gene&acc=1643,,,1643.0,DDB2,9606.0,Homo sapiens (human),Estradiol results in increased expression of DDB2 mRNA,,,PMID:19167446,https://www.ncbi.nlm.nih.gov/pubmed/19167446,19167446,,
562,517612,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,1644,DDC,https://ctdbase.org/detail.go?type=gene&acc=1644,,,1644.0,DDC,8090.0,Oryzias latipes (Japanese medaka),Estradiol results in decreased expression of DDC mRNA,,,PMID:32622090,https://www.ncbi.nlm.nih.gov/pubmed/32622090,32622090,,
563,517613,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,1644,DDC,https://ctdbase.org/detail.go?type=gene&acc=1644,,,1644.0,DDC,10116.0,Rattus norvegicus (Norway rat),Estradiol results in increased expression of DDC mRNA,,,PMID:20068009|PMID:32145629,https://www.ncbi.nlm.nih.gov/pubmed/20068009|https://www.ncbi.nlm.nih.gov/pubmed/32145629,20068009|32145629,,
564,517614,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,80821,DDHD1,https://ctdbase.org/detail.go?type=gene&acc=80821,,,80821.0,DDHD1,9606.0,Homo sapiens (human),Estradiol results in increased expression of DDHD1 mRNA,,,PMID:31614463,https://www.ncbi.nlm.nih.gov/pubmed/31614463,31614463,,
565,517615,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,80821,DDHD1,https://ctdbase.org/detail.go?type=gene&acc=80821,,,80821.0,DDHD1,10116.0,Rattus norvegicus (Norway rat),Estradiol results in decreased expression of DDHD1 mRNA,,,PMID:32145629|PMID:35192832,https://www.ncbi.nlm.nih.gov/pubmed/32145629|https://www.ncbi.nlm.nih.gov/pubmed/35192832,32145629|35192832,,
566,518718,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,2554,GABRA1,https://ctdbase.org/detail.go?type=gene&acc=2554,,,2554.0,GABRA1,9544.0,Macaca mulatta (Rhesus monkey),[estradiol co-treated with progesterone] affects the expression of GABRA1 mrna|estradiol results in decreased expression of GABRA1 mRNA,,,PMID:19833106,https://www.ncbi.nlm.nih.gov/pubmed/19833106,19833106,,
567,518719,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,2554,GABRA1,https://ctdbase.org/detail.go?type=gene&acc=2554,,,2554.0,GABRA1,10116.0,Rattus norvegicus (Norway rat),[bisphenol A co-treated with estradiol] results in increased expression of GABRA1 mRNA,,,PMID:26496021,https://www.ncbi.nlm.nih.gov/pubmed/26496021,26496021,,
568,518720,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,2554,GABRA1,https://ctdbase.org/detail.go?type=gene&acc=2554,,,2554.0,GABRA1,10116.0,Rattus norvegicus (Norway rat),[estradiol 3-benzoate co-treated with [testosterone co-treated with estradiol]] results in increased expression of GABRA1 mRNA,,,PMID:32741896,https://www.ncbi.nlm.nih.gov/pubmed/32741896,32741896,,
569,518721,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,2555,GABRA2,https://ctdbase.org/detail.go?type=gene&acc=2555,,,2555.0,GABRA2,7955.0,Danio rerio (zebrafish),Estradiol results in increased expression of GABRA2 mRNA,,,PMID:34808222,https://www.ncbi.nlm.nih.gov/pubmed/34808222,34808222,,
570,518722,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,2556,GABRA3,https://ctdbase.org/detail.go?type=gene&acc=2556,,,2556.0,GABRA3,9606.0,Homo sapiens (human),Estradiol results in increased expression of GABRA3 mRNA,,,PMID:16000229,https://www.ncbi.nlm.nih.gov/pubmed/16000229,16000229,,
571,519070,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,2564,GABRE,https://ctdbase.org/detail.go?type=gene&acc=2564,,,2564.0,GABRE,9606.0,Homo sapiens (human),Estradiol results in increased expression of GABRE mRNA,,,PMID:16000229,https://www.ncbi.nlm.nih.gov/pubmed/16000229,16000229,,
572,519071,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,2566,GABRG2,https://ctdbase.org/detail.go?type=gene&acc=2566,,,2566.0,GABRG2,9544.0,Macaca mulatta (Rhesus monkey),[estradiol co-treated with progesterone] results in decreased expression of GABRG2 mRNA,,,PMID:19833106,https://www.ncbi.nlm.nih.gov/pubmed/19833106,19833106,,
573,519072,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,2568,GABRP,https://ctdbase.org/detail.go?type=gene&acc=2568,,,2568.0,GABRP,9606.0,Homo sapiens (human),Estradiol affects the expression of GABRP mRNA,,,PMID:16000229,https://www.ncbi.nlm.nih.gov/pubmed/16000229,16000229,,
574,520531,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,2617,GARS1,https://ctdbase.org/detail.go?type=gene&acc=2617,,,2617.0,GARS1,9606.0,Homo sapiens (human),[estradiol co-treated with bucladesine co-treated with medroxyprogesterone acetate] results in decreased expression of GARS1 mRNA,,,PMID:20823114,https://www.ncbi.nlm.nih.gov/pubmed/20823114,20823114,,
575,520532,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,2617,GARS1,https://ctdbase.org/detail.go?type=gene&acc=2617,,,2617.0,GARS1,9606.0,Homo sapiens (human),Estradiol results in increased expression of GARS1 mRNA,,,PMID:20106945|PMID:36581016,https://www.ncbi.nlm.nih.gov/pubmed/20106945|https://www.ncbi.nlm.nih.gov/pubmed/36581016,20106945|36581016,,
576,520533,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,2619,GAS1,https://ctdbase.org/detail.go?type=gene&acc=2619,,,2619.0,GAS1,9606.0,Homo sapiens (human),Estradiol affects the expression of GAS1 mRNA,,,PMID:14699072,https://www.ncbi.nlm.nih.gov/pubmed/14699072,14699072,,
577,520534,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,2619,GAS1,https://ctdbase.org/detail.go?type=gene&acc=2619,,,2619.0,GAS1,9606.0,Homo sapiens (human),[estradiol co-treated with TGFB1 protein] results in decreased expression of GAS1 mRNA,,,PMID:30165855,https://www.ncbi.nlm.nih.gov/pubmed/30165855,30165855,,
578,522532,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,1755,DMBT1,https://ctdbase.org/detail.go?type=gene&acc=1755,,,1755.0,DMBT1,10116.0,Rattus norvegicus (Norway rat),[estradiol co-treated with plant preparations] results in increased expression of DMBT1 mRNA,,,PMID:26945725,https://www.ncbi.nlm.nih.gov/pubmed/26945725,26945725,,
579,522533,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,1755,DMBT1,https://ctdbase.org/detail.go?type=gene&acc=1755,,,1755.0,DMBT1,10116.0,Rattus norvegicus (Norway rat),Estradiol results in increased expression of DMBT1 mRNA,,,PMID:15564322|PMID:32145629,https://www.ncbi.nlm.nih.gov/pubmed/15564322|https://www.ncbi.nlm.nih.gov/pubmed/32145629,15564322|32145629,,
580,522534,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,127343,DMBX1,https://ctdbase.org/detail.go?type=gene&acc=127343,,,127343.0,DMBX1,27706.0,Micropterus salmoides (largemouth bass),[dieldrin co-treated with estradiol] results in increased expression of DMBX1 mRNA,,,PMID:23041725,https://www.ncbi.nlm.nih.gov/pubmed/23041725,23041725,,
581,522535,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,11144,DMC1,https://ctdbase.org/detail.go?type=gene&acc=11144,,,11144.0,DMC1,8090.0,Oryzias latipes (Japanese medaka),Estradiol results in decreased expression of DMC1 mRNA,,,PMID:32622090,https://www.ncbi.nlm.nih.gov/pubmed/32622090,32622090,,
582,522536,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,1756,DMD,https://ctdbase.org/detail.go?type=gene&acc=1756,,,1756.0,DMD,9606.0,Homo sapiens (human),[estradiol co-treated with progesterone] results in decreased expression of DMD mRNA,,,PMID:20660070,https://www.ncbi.nlm.nih.gov/pubmed/20660070,20660070,,
583,522537,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,1756,DMD,https://ctdbase.org/detail.go?type=gene&acc=1756,,,1756.0,DMD,10116.0,Rattus norvegicus (Norway rat),Estradiol results in decreased expression of DMD mRNA,,,PMID:32145629,https://www.ncbi.nlm.nih.gov/pubmed/32145629,32145629,,
584,522538,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,29958,DMGDH,https://ctdbase.org/detail.go?type=gene&acc=29958,,,29958.0,DMGDH,7955.0,Danio rerio (zebrafish),Estradiol affects the expression of DMGDH mRNA,,,PMID:23557687,https://www.ncbi.nlm.nih.gov/pubmed/23557687,23557687,,
585,523297,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,3300,DNAJB2,https://ctdbase.org/detail.go?type=gene&acc=3300,,,3300.0,DNAJB2,9606.0,Homo sapiens (human),Estradiol results in increased expression of DNAJB2 mRNA,,,PMID:20106945,https://www.ncbi.nlm.nih.gov/pubmed/20106945,20106945,,
586,523298,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,11080,DNAJB4,https://ctdbase.org/detail.go?type=gene&acc=11080,,,11080.0,DNAJB4,9606.0,Homo sapiens (human),Estradiol results in increased expression of DNAJB4 mRNA,,,PMID:20106945,https://www.ncbi.nlm.nih.gov/pubmed/20106945,20106945,,
587,523299,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,25822,DNAJB5,https://ctdbase.org/detail.go?type=gene&acc=25822,,,25822.0,DNAJB5,9606.0,Homo sapiens (human),[estradiol co-treated with TGFB1 protein] results in increased expression of DNAJB5 mRNA,,,PMID:30165855,https://www.ncbi.nlm.nih.gov/pubmed/30165855,30165855,,
588,523300,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,10049,DNAJB6,https://ctdbase.org/detail.go?type=gene&acc=10049,,,10049.0,DNAJB6,9606.0,Homo sapiens (human),Estradiol results in increased expression of DNAJB6 mRNA,,,PMID:20106945,https://www.ncbi.nlm.nih.gov/pubmed/20106945,20106945,,
589,523301,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,393275,DNAJB6B,https://ctdbase.org/detail.go?type=gene&acc=393275,,,393275.0,dnajb6b,8090.0,Oryzias latipes (Japanese medaka),Estradiol results in decreased expression of DNAJB6B mRNA,,,PMID:32622090,https://www.ncbi.nlm.nih.gov/pubmed/32622090,32622090,,
590,523456,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,124975,GGT6,https://ctdbase.org/detail.go?type=gene&acc=124975,,,124975.0,GGT6,9606.0,Homo sapiens (human),[estradiol co-treated with TGFB1 protein] results in decreased expression of GGT6 mRNA,,,PMID:30165855,https://www.ncbi.nlm.nih.gov/pubmed/30165855,30165855,,
591,523457,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,124975,GGT6,https://ctdbase.org/detail.go?type=gene&acc=124975,,,124975.0,GGT6,9606.0,Homo sapiens (human),Estradiol results in increased expression of GGT6 mRNA,,,PMID:21185374,https://www.ncbi.nlm.nih.gov/pubmed/21185374,21185374,,
592,523458,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,2681,GGTA1,https://ctdbase.org/detail.go?type=gene&acc=2681,,,2681.0,GGTA1,9606.0,Homo sapiens (human),[estradiol co-treated with progesterone] results in increased expression of GGTA1 mRNA,,,PMID:20660070,https://www.ncbi.nlm.nih.gov/pubmed/20660070,20660070,,
593,525890,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,7447,VSNL1,https://ctdbase.org/detail.go?type=gene&acc=7447,,,7447.0,VSNL1,10116.0,Rattus norvegicus (Norway rat),[estradiol 3-benzoate co-treated with [testosterone co-treated with estradiol]] results in increased expression of VSNL1 mRNA,,,PMID:32741896,https://www.ncbi.nlm.nih.gov/pubmed/32741896,32741896,,
594,525891,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,222008,VSTM2A,https://ctdbase.org/detail.go?type=gene&acc=222008,,,222008.0,VSTM2A,10116.0,Rattus norvegicus (Norway rat),[testosterone co-treated with estradiol] results in increased expression of VSTM2A mRNA,,,PMID:32741896,https://www.ncbi.nlm.nih.gov/pubmed/32741896,32741896,,
595,525892,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,128434,VSTM2L,https://ctdbase.org/detail.go?type=gene&acc=128434,,,128434.0,VSTM2L,9606.0,Homo sapiens (human),[estradiol co-treated with TGFB1 protein] results in increased expression of VSTM2L mRNA,,,PMID:30165855,https://www.ncbi.nlm.nih.gov/pubmed/30165855,30165855,,
596,526185,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,51053,GMNN,https://ctdbase.org/detail.go?type=gene&acc=51053,,,51053.0,GMNN,10090.0,Mus musculus (house mouse),ESR1 protein promotes the reaction [estradiol results in increased expression of GMNN mrna]|estradiol results in increased expression of GMNN mRNA,,,PMID:25210133,https://www.ncbi.nlm.nih.gov/pubmed/25210133,25210133,,
597,526186,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,51053,GMNN,https://ctdbase.org/detail.go?type=gene&acc=51053,,,51053.0,GMNN,10090.0,Mus musculus (house mouse),Estradiol affects the expression of GMNN mRNA,,,PMID:15598610,https://www.ncbi.nlm.nih.gov/pubmed/15598610,15598610,,
598,526187,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,51053,GMNN,https://ctdbase.org/detail.go?type=gene&acc=51053,,,51053.0,GMNN,8090.0,Oryzias latipes (Japanese medaka),Estradiol results in decreased expression of GMNN mRNA,,,PMID:32622090,https://www.ncbi.nlm.nih.gov/pubmed/32622090,32622090,,
599,526188,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,51053,GMNN,https://ctdbase.org/detail.go?type=gene&acc=51053,,,51053.0,GMNN,10116.0,Rattus norvegicus (Norway rat),Estradiol results in increased expression of GMNN mRNA,,,PMID:32145629,https://www.ncbi.nlm.nih.gov/pubmed/32145629,32145629,,
600,526516,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,559931,VTG2,https://ctdbase.org/detail.go?type=gene&acc=559931,,,559931.0,vtg2,9031.0,Gallus gallus (chicken),Sodium arsenite inhibits the reaction [estradiol results in increased expression of VTG2 mrna],,,PMID:17283378,https://www.ncbi.nlm.nih.gov/pubmed/17283378,17283378,,
601,526517,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,559931,VTG2,https://ctdbase.org/detail.go?type=gene&acc=559931,,,559931.0,vtg2,8090.0,Oryzias latipes (Japanese medaka),Estradiol results in increased expression of VTG2 mRNA,,,PMID:21216354,https://www.ncbi.nlm.nih.gov/pubmed/21216354,21216354,,
602,526518,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,30518,VTG3,https://ctdbase.org/detail.go?type=gene&acc=30518,,,30518.0,vtg3,7962.0,Cyprinus carpio (common carp),Estradiol results in increased expression of VTG3 mRNA,,,PMID:17912697,https://www.ncbi.nlm.nih.gov/pubmed/17912697,17912697,,
603,526519,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,30518,VTG3,https://ctdbase.org/detail.go?type=gene&acc=30518,,,30518.0,vtg3,7955.0,Danio rerio (zebrafish),Estradiol affects the expression of VTG3 mRNA,,,PMID:18214933,https://www.ncbi.nlm.nih.gov/pubmed/18214933,18214933,,
604,526520,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,30518,VTG3,https://ctdbase.org/detail.go?type=gene&acc=30518,,,30518.0,vtg3,7955.0,Danio rerio (zebrafish),Estradiol results in increased expression of VTG3 mRNA,,,PMID:24223173,https://www.ncbi.nlm.nih.gov/pubmed/24223173,24223173,,
605,526521,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,678536,VTG4,https://ctdbase.org/detail.go?type=gene&acc=678536,,,678536.0,vtg4,7955.0,Danio rerio (zebrafish),Estradiol results in increased expression of VTG4 mRNA,,,PMID:23306105,https://www.ncbi.nlm.nih.gov/pubmed/23306105,23306105,,
606,526522,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,64260,VTG5,https://ctdbase.org/detail.go?type=gene&acc=64260,,,64260.0,vtg5,7955.0,Danio rerio (zebrafish),Estradiol affects the expression of VTG5 mRNA,,,PMID:18214933,https://www.ncbi.nlm.nih.gov/pubmed/18214933,18214933,,
607,526523,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,64260,VTG5,https://ctdbase.org/detail.go?type=gene&acc=64260,,,64260.0,vtg5,7955.0,Danio rerio (zebrafish),Estradiol results in increased expression of VTG5 mRNA,,,PMID:23306105|PMID:24223173,https://www.ncbi.nlm.nih.gov/pubmed/23306105|https://www.ncbi.nlm.nih.gov/pubmed/24223173,23306105|24223173,,
608,527138,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,27232,GNMT,https://ctdbase.org/detail.go?type=gene&acc=27232,,,27232.0,GNMT,10116.0,Rattus norvegicus (Norway rat),Estradiol results in decreased expression of GNMT mrna|estradiol results in increased expression of GNMT protein,,,PMID:32145629,https://www.ncbi.nlm.nih.gov/pubmed/32145629,32145629,,
609,527139,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,27232,GNMT,https://ctdbase.org/detail.go?type=gene&acc=27232,,,27232.0,GNMT,10116.0,Rattus norvegicus (Norway rat),Estradiol results in increased expression of GNMT mRNA,,,PMID:35192832,https://www.ncbi.nlm.nih.gov/pubmed/35192832,35192832,,
610,527308,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,2796,GNRH1,https://ctdbase.org/detail.go?type=gene&acc=2796,,,2796.0,GNRH1,9606.0,Homo sapiens (human),Tamoxifen inhibits the reaction [[progesterone co-treated with estradiol] results in increased secretion of GNRH1 protein]|[progesterone co-treated with estradiol] results in increased secretion of GNRH1 protein,,,PMID:10566683,https://www.ncbi.nlm.nih.gov/pubmed/10566683,10566683,,
611,527309,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,2796,GNRH1,https://ctdbase.org/detail.go?type=gene&acc=2796,,,2796.0,GNRH1,9544.0,Macaca mulatta (Rhesus monkey),Estradiol results in decreased expression of GNRH1 mRNA,,,PMID:9588692,https://www.ncbi.nlm.nih.gov/pubmed/9588692,9588692,,
612,527310,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,2796,GNRH1,https://ctdbase.org/detail.go?type=gene&acc=2796,,,2796.0,GNRH1,10090.0,Mus musculus (house mouse),Estradiol inhibits the reaction [ESR2 protein alternative form results in increased expression of GNRH1 mrna],,,PMID:16439454,https://www.ncbi.nlm.nih.gov/pubmed/16439454,16439454,,
613,527311,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,2796,GNRH1,https://ctdbase.org/detail.go?type=gene&acc=2796,,,2796.0,GNRH1,10090.0,Mus musculus (house mouse),Estradiol results in decreased expression of GNRH1 mrna|fulvestrant inhibits the reaction [estradiol results in decreased expression of GNRH1 mrna],,,PMID:10537130,https://www.ncbi.nlm.nih.gov/pubmed/10537130,10537130,,
614,527312,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,2796,GNRH1,https://ctdbase.org/detail.go?type=gene&acc=2796,,,2796.0,GNRH1,8022.0,Oncorhynchus mykiss (rainbow trout),Estradiol results in increased expression of GNRH1 protein,,,PMID:8812359,https://www.ncbi.nlm.nih.gov/pubmed/8812359,8812359,,
615,527313,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,2796,GNRH1,https://ctdbase.org/detail.go?type=gene&acc=2796,,,2796.0,GNRH1,8090.0,Oryzias latipes (Japanese medaka),Estradiol affects the expression of GNRH1 mRNA,,,PMID:32940650,https://www.ncbi.nlm.nih.gov/pubmed/32940650,32940650,,
616,527314,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,2796,GNRH1,https://ctdbase.org/detail.go?type=gene&acc=2796,,,2796.0,GNRH1,8090.0,Oryzias latipes (Japanese medaka),Estradiol results in decreased expression of GNRH1 mRNA,,,PMID:22497783,https://www.ncbi.nlm.nih.gov/pubmed/22497783,22497783,,
617,529291,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,54361,WNT4,https://ctdbase.org/detail.go?type=gene&acc=54361,,,54361.0,WNT4,8090.0,Oryzias latipes (Japanese medaka),Estradiol results in increased expression of WNT4 mRNA,,,PMID:32622090,https://www.ncbi.nlm.nih.gov/pubmed/32622090,32622090,,
618,529292,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,54361,WNT4,https://ctdbase.org/detail.go?type=gene&acc=54361,,,54361.0,WNT4,10116.0,Rattus norvegicus (Norway rat),Estradiol results in decreased expression of WNT4 mRNA,,,PMID:32145629,https://www.ncbi.nlm.nih.gov/pubmed/32145629,32145629,,
619,529293,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,54361,WNT4,https://ctdbase.org/detail.go?type=gene&acc=54361,,,54361.0,WNT4,10116.0,Rattus norvegicus (Norway rat),Estradiol results in increased expression of WNT4 mRNA,,,PMID:31119341,https://www.ncbi.nlm.nih.gov/pubmed/31119341,31119341,,
620,530849,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,65983,GRAMD2B,https://ctdbase.org/detail.go?type=gene&acc=65983,,,65983.0,GRAMD2B,9606.0,Homo sapiens (human),Estradiol results in decreased expression of GRAMD2B mRNA,,,PMID:20106945,https://www.ncbi.nlm.nih.gov/pubmed/20106945,20106945,,
621,530850,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,426813,GRAMD3,https://ctdbase.org/detail.go?type=gene&acc=426813,,,426813.0,GRAMD3,10116.0,Rattus norvegicus (Norway rat),Estradiol results in increased expression of GRAMD3 mRNA,,,PMID:32145629,https://www.ncbi.nlm.nih.gov/pubmed/32145629,32145629,,
622,530851,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,10750,GRAP,https://ctdbase.org/detail.go?type=gene&acc=10750,,,10750.0,GRAP,9606.0,Homo sapiens (human),Estradiol results in decreased expression of GRAP mRNA,,,PMID:31614463,https://www.ncbi.nlm.nih.gov/pubmed/31614463,31614463,,
623,530852,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,10750,GRAP,https://ctdbase.org/detail.go?type=gene&acc=10750,,,10750.0,GRAP,10116.0,Rattus norvegicus (Norway rat),[estradiol 3-benzoate co-treated with [testosterone co-treated with estradiol]] results in increased expression of GRAP mRNA,,,PMID:32741896,https://www.ncbi.nlm.nih.gov/pubmed/32741896,32741896,,
624,530853,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,9402,GRAP2,https://ctdbase.org/detail.go?type=gene&acc=9402,,,9402.0,GRAP2,9606.0,Homo sapiens (human),[estradiol co-treated with TGFB1 protein] results in increased expression of GRAP2 mRNA,,,PMID:30165855,https://www.ncbi.nlm.nih.gov/pubmed/30165855,30165855,,
625,530854,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,2887,GRB10,https://ctdbase.org/detail.go?type=gene&acc=2887,,,2887.0,GRB10,9606.0,Homo sapiens (human),Estradiol affects the expression of GRB10 mRNA,,,PMID:14699072,https://www.ncbi.nlm.nih.gov/pubmed/14699072,14699072,,
626,530855,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,2887,GRB10,https://ctdbase.org/detail.go?type=gene&acc=2887,,,2887.0,GRB10,9606.0,Homo sapiens (human),[estradiol co-treated with TGFB1 protein] results in increased expression of GRB10 mRNA,,,PMID:30165855,https://www.ncbi.nlm.nih.gov/pubmed/30165855,30165855,,
627,531026,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,2885,GRB2,https://ctdbase.org/detail.go?type=gene&acc=2885,,,2885.0,GRB2,9606.0,Homo sapiens (human),IGF1R mutant form inhibits the reaction [estradiol results in increased expression of GRB2 mrna]|estradiol results in increased expression of GRB2 mRNA,,,PMID:23094148,https://www.ncbi.nlm.nih.gov/pubmed/23094148,23094148,,
628,531477,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,26154,ABCA12,https://ctdbase.org/detail.go?type=gene&acc=26154,,,26154.0,ABCA12,9606.0,Homo sapiens (human),[estradiol co-treated with TGFB1 protein] results in decreased expression of ABCA12 mRNA,,,PMID:30165855,https://www.ncbi.nlm.nih.gov/pubmed/30165855,30165855,,
629,531478,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,26154,ABCA12,https://ctdbase.org/detail.go?type=gene&acc=26154,,,26154.0,ABCA12,9606.0,Homo sapiens (human),Estradiol results in decreased expression of ABCA12 mRNA,,,PMID:19619570|PMID:21185374,https://www.ncbi.nlm.nih.gov/pubmed/19619570|https://www.ncbi.nlm.nih.gov/pubmed/21185374,19619570|21185374,,
630,531479,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,9687,GREB1,https://ctdbase.org/detail.go?type=gene&acc=9687,,,9687.0,GREB1,9606.0,Homo sapiens (human),Raloxifene hydrochloride inhibits the reaction [estradiol results in increased expression of GREB1 mrna],,,PMID:21185374,https://www.ncbi.nlm.nih.gov/pubmed/21185374,21185374,,
631,531480,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,9687,GREB1,https://ctdbase.org/detail.go?type=gene&acc=9687,,,9687.0,GREB1,9606.0,Homo sapiens (human),Sodium arsenite inhibits the reaction [estradiol results in increased expression of GREB1 mrna],,,PMID:17283378,https://www.ncbi.nlm.nih.gov/pubmed/17283378,17283378,,
632,531481,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,9687,GREB1,https://ctdbase.org/detail.go?type=gene&acc=9687,,,9687.0,GREB1,9606.0,Homo sapiens (human),TBX21 protein inhibits the reaction [estradiol results in increased expression of GREB1 mrna]|tbx21 protein inhibits the reaction [estradiol promotes the reaction [ESR1 protein binds to GREB1 enhancer]],,,PMID:20068169,https://www.ncbi.nlm.nih.gov/pubmed/20068169,20068169,,
633,531482,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,9687,GREB1,https://ctdbase.org/detail.go?type=gene&acc=9687,,,9687.0,GREB1,10090.0,Mus musculus (house mouse),Afimoxifene inhibits the reaction [estradiol results in increased expression of GREB1 mrna]|desmethylarzoxifene inhibits the reaction [estradiol results in increased expression of GREB1 mrna]|raloxifene hydrochloride inhibits the reaction [estradiol results in increased expression of GREB1 mrna],,,PMID:26879975,https://www.ncbi.nlm.nih.gov/pubmed/26879975,26879975,,
634,702425,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,5272,SERPINB9,https://ctdbase.org/detail.go?type=gene&acc=5272,,,5272.0,SERPINB9,9606.0,Homo sapiens (human),Estradiol promotes the reaction [ESR1 protein binds to SERPINB9 protein],,,PMID:14617632,https://www.ncbi.nlm.nih.gov/pubmed/14617632,14617632,,
635,702426,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,5272,SERPINB9,https://ctdbase.org/detail.go?type=gene&acc=5272,,,5272.0,SERPINB9,9606.0,Homo sapiens (human),Estradiol results in increased expression of SERPINB9 mRNA,,,PMID:10681578|PMID:17237823,https://www.ncbi.nlm.nih.gov/pubmed/10681578|https://www.ncbi.nlm.nih.gov/pubmed/17237823,10681578|17237823,,
636,702427,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,20706,SERPINB9B,https://ctdbase.org/detail.go?type=gene&acc=20706,,,20706.0,Serpinb9b,10116.0,Rattus norvegicus (Norway rat),Estradiol results in increased expression of SERPINB9B mRNA,,,PMID:32145629,https://www.ncbi.nlm.nih.gov/pubmed/32145629,32145629,,
637,702428,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,462,SERPINC1,https://ctdbase.org/detail.go?type=gene&acc=462,,,462.0,SERPINC1,7955.0,Danio rerio (zebrafish),Estradiol results in increased expression of SERPINC1 mRNA,,,PMID:23557687,https://www.ncbi.nlm.nih.gov/pubmed/23557687,23557687,,
638,702429,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,462,SERPINC1,https://ctdbase.org/detail.go?type=gene&acc=462,,,462.0,SERPINC1,9606.0,Homo sapiens (human),[estradiol co-treated with norethindrone acetate] results in decreased expression of SERPINC1 protein,,,PMID:17393018,https://www.ncbi.nlm.nih.gov/pubmed/17393018,17393018,,
639,702430,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,462,SERPINC1,https://ctdbase.org/detail.go?type=gene&acc=462,,,462.0,SERPINC1,8090.0,Oryzias latipes (Japanese medaka),Estradiol results in decreased expression of SERPINC1 mRNA,,,PMID:32622090,https://www.ncbi.nlm.nih.gov/pubmed/32622090,32622090,,
640,702431,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,3053,SERPIND1,https://ctdbase.org/detail.go?type=gene&acc=3053,,,3053.0,SERPIND1,9606.0,Homo sapiens (human),Estradiol results in decreased expression of SERPIND1 mRNA,,,PMID:20106945,https://www.ncbi.nlm.nih.gov/pubmed/20106945,20106945,,
641,703072,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,5274,SERPINI1,https://ctdbase.org/detail.go?type=gene&acc=5274,,,5274.0,SERPINI1,9606.0,Homo sapiens (human),Estradiol results in decreased expression of SERPINI1 mRNA,,,PMID:31614463,https://www.ncbi.nlm.nih.gov/pubmed/31614463,31614463,,
642,703073,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,29950,SERTAD1,https://ctdbase.org/detail.go?type=gene&acc=29950,,,29950.0,SERTAD1,10090.0,Mus musculus (house mouse),Estradiol results in increased expression of SERTAD1 mRNA,,,PMID:25210133,https://www.ncbi.nlm.nih.gov/pubmed/25210133,25210133,,
643,703074,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,29950,SERTAD1,https://ctdbase.org/detail.go?type=gene&acc=29950,,,29950.0,SERTAD1,10116.0,Rattus norvegicus (Norway rat),Estradiol results in increased expression of SERTAD1 mRNA,,,PMID:32145629,https://www.ncbi.nlm.nih.gov/pubmed/32145629,32145629,,
644,703075,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,9792,SERTAD2,https://ctdbase.org/detail.go?type=gene&acc=9792,,,9792.0,SERTAD2,9606.0,Homo sapiens (human),[estradiol co-treated with TGFB1 protein] results in decreased expression of SERTAD2 mRNA,,,PMID:30165855,https://www.ncbi.nlm.nih.gov/pubmed/30165855,30165855,,
645,703076,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,9792,SERTAD2,https://ctdbase.org/detail.go?type=gene&acc=9792,,,9792.0,SERTAD2,9606.0,Homo sapiens (human),Estradiol results in increased expression of SERTAD2 mRNA,,,PMID:31614463,https://www.ncbi.nlm.nih.gov/pubmed/31614463,31614463,,
646,703077,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,56256,SERTAD4,https://ctdbase.org/detail.go?type=gene&acc=56256,,,56256.0,SERTAD4,9606.0,Homo sapiens (human),Estradiol promotes the reaction [ESR2 protein results in decreased expression of SERTAD4 mrna],,,PMID:20404318,https://www.ncbi.nlm.nih.gov/pubmed/20404318,20404318,,
647,703078,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,574036,SERTAD4-AS1,https://ctdbase.org/detail.go?type=gene&acc=574036,,,574036.0,SERTAD4-AS1,9606.0,Homo sapiens (human),Estradiol results in decreased expression of SERTAD4-AS1 mRNA,,,PMID:31614463,https://www.ncbi.nlm.nih.gov/pubmed/31614463,31614463,,
648,706219,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,6461,SHB,https://ctdbase.org/detail.go?type=gene&acc=6461,,,6461.0,SHB,9606.0,Homo sapiens (human),Estradiol results in increased expression of SHB mRNA,,,PMID:12154049|PMID:31614463,https://www.ncbi.nlm.nih.gov/pubmed/12154049|https://www.ncbi.nlm.nih.gov/pubmed/31614463,12154049|31614463,,
649,706220,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,6462,SHBG,https://ctdbase.org/detail.go?type=gene&acc=6462,,,6462.0,SHBG,39030.0,Apodemus agrarius (Eurasian field mouse),Estradiol results in increased expression of SHBG mRNA,,,PMID:33822518,https://www.ncbi.nlm.nih.gov/pubmed/33822518,33822518,,
650,706221,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,6462,SHBG,https://ctdbase.org/detail.go?type=gene&acc=6462,,,6462.0,SHBG,9606.0,Homo sapiens (human),Estradiol promotes the reaction [copper affects the expression of SHBG mrna]|copper promotes the reaction [estradiol results in increased expression of SHBG mrna],,,PMID:19685012,https://www.ncbi.nlm.nih.gov/pubmed/19685012,19685012,,
651,706222,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,6462,SHBG,https://ctdbase.org/detail.go?type=gene&acc=6462,,,6462.0,SHBG,9606.0,Homo sapiens (human),ESR1 protein promotes the reaction [estradiol results in increased expression of SHBG protein],,,PMID:16551731,https://www.ncbi.nlm.nih.gov/pubmed/16551731,16551731,,
652,706223,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,6462,SHBG,https://ctdbase.org/detail.go?type=gene&acc=6462,,,6462.0,SHBG,9606.0,Homo sapiens (human),Estradiol binds to SHBG protein,,,PMID:25349334,https://www.ncbi.nlm.nih.gov/pubmed/25349334,25349334,,
653,706224,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,6462,SHBG,https://ctdbase.org/detail.go?type=gene&acc=6462,,,6462.0,SHBG,9606.0,Homo sapiens (human),Estradiol results in increased expression of SHBG mRNA,,,PMID:19685012|PMID:21632903,https://www.ncbi.nlm.nih.gov/pubmed/19685012|https://www.ncbi.nlm.nih.gov/pubmed/21632903,19685012|21632903,,
654,706225,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,6462,SHBG,https://ctdbase.org/detail.go?type=gene&acc=6462,,,6462.0,SHBG,9606.0,Homo sapiens (human),Estradiol results in increased expression of SHBG protein,,,PMID:16551731|PMID:17484513,https://www.ncbi.nlm.nih.gov/pubmed/16551731|https://www.ncbi.nlm.nih.gov/pubmed/17484513,16551731|17484513,,
655,706226,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,6462,SHBG,https://ctdbase.org/detail.go?type=gene&acc=6462,,,6462.0,SHBG,7998.0,Ictalurus punctatus (channel catfish),Estradiol binds to SHBG protein,,,PMID:15081833,https://www.ncbi.nlm.nih.gov/pubmed/15081833,15081833,,
656,707711,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,23309,SIN3B,https://ctdbase.org/detail.go?type=gene&acc=23309,,,23309.0,SIN3B,10090.0,Mus musculus (house mouse),Estradiol results in decreased expression of SIN3B mRNA,,,PMID:19484750,https://www.ncbi.nlm.nih.gov/pubmed/19484750,19484750,,
657,707712,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,58516,SINHCAF,https://ctdbase.org/detail.go?type=gene&acc=58516,,,58516.0,SINHCAF,9606.0,Homo sapiens (human),Estradiol results in increased expression of SINHCAF mRNA,,,PMID:31614463,https://www.ncbi.nlm.nih.gov/pubmed/31614463,31614463,,
658,707713,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,26037,SIPA1L1,https://ctdbase.org/detail.go?type=gene&acc=26037,,,26037.0,SIPA1L1,9606.0,Homo sapiens (human),[estradiol co-treated with TGFB1 protein] results in increased expression of SIPA1L1 mRNA,,,PMID:30165855,https://www.ncbi.nlm.nih.gov/pubmed/30165855,30165855,,
659,707714,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,57568,SIPA1L2,https://ctdbase.org/detail.go?type=gene&acc=57568,,,57568.0,SIPA1L2,9606.0,Homo sapiens (human),[estradiol co-treated with norethindrone acetate] results in increased expression of SIPA1L2 mRNA,,,PMID:22217510,https://www.ncbi.nlm.nih.gov/pubmed/22217510,22217510,,
660,707715,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,57568,SIPA1L2,https://ctdbase.org/detail.go?type=gene&acc=57568,,,57568.0,SIPA1L2,9606.0,Homo sapiens (human),Estradiol results in increased expression of SIPA1L2 mrna|progesterone inhibits the reaction [estradiol results in increased expression of SIPA1L2 mrna],,,PMID:21795739,https://www.ncbi.nlm.nih.gov/pubmed/21795739,21795739,,
661,707716,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,57568,SIPA1L2,https://ctdbase.org/detail.go?type=gene&acc=57568,,,57568.0,SIPA1L2,8090.0,Oryzias latipes (Japanese medaka),Estradiol results in increased expression of SIPA1L2 mRNA,,,PMID:32622090,https://www.ncbi.nlm.nih.gov/pubmed/32622090,32622090,,
662,707717,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,23094,SIPA1L3,https://ctdbase.org/detail.go?type=gene&acc=23094,,,23094.0,SIPA1L3,9606.0,Homo sapiens (human),Estradiol results in increased expression of SIPA1L3 mRNA,,,PMID:23019147|PMID:31614463,https://www.ncbi.nlm.nih.gov/pubmed/23019147|https://www.ncbi.nlm.nih.gov/pubmed/31614463,23019147|31614463,,
663,528618,5833,Comparative Toxicogenomics Database (CTD),Spironolactone,D013148,Spironolactone,https://ctdbase.org/detail.go?type=chem&acc=D013148,8647,ABCB11,https://ctdbase.org/detail.go?type=gene&acc=8647,,,8647.0,ABCB11,9606.0,Homo sapiens (human),Spironolactone inhibits the reaction [ABCB11 protein results in increased transport of taurocholic acid]|spironolactone results in decreased activity of ABCB11 protein,,,PMID:24014644,https://www.ncbi.nlm.nih.gov/pubmed/24014644,24014644,,
664,528619,5833,Comparative Toxicogenomics Database (CTD),Spironolactone,D013148,Spironolactone,https://ctdbase.org/detail.go?type=chem&acc=D013148,1244,ABCC2,https://ctdbase.org/detail.go?type=gene&acc=1244,,,1244.0,ABCC2,10116.0,Rattus norvegicus (Norway rat),[ethinyl estradiol co-treated with spironolactone] results in increased expression of ABCC2 protein,,,PMID:17686906,https://www.ncbi.nlm.nih.gov/pubmed/17686906,17686906,,
665,528620,5833,Comparative Toxicogenomics Database (CTD),Spironolactone,D013148,Spironolactone,https://ctdbase.org/detail.go?type=chem&acc=D013148,1244,ABCC2,https://ctdbase.org/detail.go?type=gene&acc=1244,,,1244.0,ABCC2,10116.0,Rattus norvegicus (Norway rat),"Ketoconazole inhibits the reaction [spironolactone results in increased expression of ABCC2 mrna]|[spironolactone results in increased expression of ABCC2 protein] which results in increased transport of S-(2,4-dinitrophenyl)glutathione",,,PMID:19766108,https://www.ncbi.nlm.nih.gov/pubmed/19766108,19766108,,
666,528621,5833,Comparative Toxicogenomics Database (CTD),Spironolactone,D013148,Spironolactone,https://ctdbase.org/detail.go?type=chem&acc=D013148,1244,ABCC2,https://ctdbase.org/detail.go?type=gene&acc=1244,,,1244.0,ABCC2,10116.0,Rattus norvegicus (Norway rat),Spironolactone results in increased expression of ABCC2 mRNA,,,PMID:17686906|PMID:19766108,https://www.ncbi.nlm.nih.gov/pubmed/17686906|https://www.ncbi.nlm.nih.gov/pubmed/19766108,17686906|19766108,,
667,528622,5833,Comparative Toxicogenomics Database (CTD),Spironolactone,D013148,Spironolactone,https://ctdbase.org/detail.go?type=chem&acc=D013148,1244,ABCC2,https://ctdbase.org/detail.go?type=gene&acc=1244,,,1244.0,ABCC2,10116.0,Rattus norvegicus (Norway rat),Spironolactone results in increased expression of ABCC2 protein,,,PMID:15652244|PMID:17686906|PMID:19766108,https://www.ncbi.nlm.nih.gov/pubmed/15652244|https://www.ncbi.nlm.nih.gov/pubmed/17686906|https://www.ncbi.nlm.nih.gov/pubmed/19766108,15652244|17686906|19766108,,
668,528623,5833,Comparative Toxicogenomics Database (CTD),Spironolactone,D013148,Spironolactone,https://ctdbase.org/detail.go?type=chem&acc=D013148,8714,ABCC3,https://ctdbase.org/detail.go?type=gene&acc=8714,,,8714.0,ABCC3,10090.0,Mus musculus (house mouse),[spironolactone binds to NR1I2 protein] which results in increased expression of ABCC3 mrna|spironolactone results in increased expression of ABCC3 mRNA,,,PMID:15833929,https://www.ncbi.nlm.nih.gov/pubmed/15833929,15833929,,
669,528624,5833,Comparative Toxicogenomics Database (CTD),Spironolactone,D013148,Spironolactone,https://ctdbase.org/detail.go?type=chem&acc=D013148,8714,ABCC3,https://ctdbase.org/detail.go?type=gene&acc=8714,,,8714.0,ABCC3,10116.0,Rattus norvegicus (Norway rat),[ethinyl estradiol co-treated with spironolactone] results in increased expression of ABCC3 protein,,,PMID:17686906,https://www.ncbi.nlm.nih.gov/pubmed/17686906,17686906,,
670,528625,5833,Comparative Toxicogenomics Database (CTD),Spironolactone,D013148,Spironolactone,https://ctdbase.org/detail.go?type=chem&acc=D013148,64240,ABCG5,https://ctdbase.org/detail.go?type=gene&acc=64240,,,64240.0,ABCG5,10116.0,Rattus norvegicus (Norway rat),Spironolactone results in decreased expression of ABCG5 mRNA,,,PMID:15683829,https://www.ncbi.nlm.nih.gov/pubmed/15683829,15683829,,
671,528810,5833,Comparative Toxicogenomics Database (CTD),Spironolactone,D013148,Spironolactone,https://ctdbase.org/detail.go?type=chem&acc=D013148,64241,ABCG8,https://ctdbase.org/detail.go?type=gene&acc=64241,,,64241.0,ABCG8,10116.0,Rattus norvegicus (Norway rat),Spironolactone results in decreased expression of ABCG8 mRNA,,,PMID:15683829,https://www.ncbi.nlm.nih.gov/pubmed/15683829,15683829,,
672,528811,5833,Comparative Toxicogenomics Database (CTD),Spironolactone,D013148,Spironolactone,https://ctdbase.org/detail.go?type=chem&acc=D013148,1636,ACE,https://ctdbase.org/detail.go?type=gene&acc=1636,,,1636.0,ACE,10116.0,Rattus norvegicus (Norway rat),Spironolactone affects the expression of ACE protein,,,PMID:30734886,https://www.ncbi.nlm.nih.gov/pubmed/30734886,30734886,,
673,528812,5833,Comparative Toxicogenomics Database (CTD),Spironolactone,D013148,Spironolactone,https://ctdbase.org/detail.go?type=chem&acc=D013148,1636,ACE,https://ctdbase.org/detail.go?type=gene&acc=1636,,,1636.0,ACE,10116.0,Rattus norvegicus (Norway rat),Spironolactone inhibits the reaction [aldosterone results in increased activity of ACE protein]|spironolactone inhibits the reaction [aldosterone results in increased expression of ACE mrna],,,PMID:15932931,https://www.ncbi.nlm.nih.gov/pubmed/15932931,15932931,,
674,528813,5833,Comparative Toxicogenomics Database (CTD),Spironolactone,D013148,Spironolactone,https://ctdbase.org/detail.go?type=chem&acc=D013148,1636,ACE,https://ctdbase.org/detail.go?type=gene&acc=1636,,,1636.0,ACE,10116.0,Rattus norvegicus (Norway rat),Spironolactone results in decreased expression of ACE protein,,,PMID:18586661,https://www.ncbi.nlm.nih.gov/pubmed/18586661,18586661,,
675,528814,5833,Comparative Toxicogenomics Database (CTD),Spironolactone,D013148,Spironolactone,https://ctdbase.org/detail.go?type=chem&acc=D013148,59272,ACE2,https://ctdbase.org/detail.go?type=gene&acc=59272,,,59272.0,ACE2,10116.0,Rattus norvegicus (Norway rat),Spironolactone affects the expression of ACE2 protein,,,PMID:30734886,https://www.ncbi.nlm.nih.gov/pubmed/30734886,30734886,,
676,528815,5833,Comparative Toxicogenomics Database (CTD),Spironolactone,D013148,Spironolactone,https://ctdbase.org/detail.go?type=chem&acc=D013148,59272,ACE2,https://ctdbase.org/detail.go?type=gene&acc=59272,,,59272.0,ACE2,10116.0,Rattus norvegicus (Norway rat),Spironolactone results in increased expression of ACE2 protein,,,PMID:18586661,https://www.ncbi.nlm.nih.gov/pubmed/18586661,18586661,,
677,530697,5833,Comparative Toxicogenomics Database (CTD),Spironolactone,D013148,Spironolactone,https://ctdbase.org/detail.go?type=chem&acc=D013148,4520,MTF1,https://ctdbase.org/detail.go?type=gene&acc=4520,,,4520.0,MTF1,10116.0,Rattus norvegicus (Norway rat),Spironolactone inhibits the reaction [aldosterone results in increased expression of MTF1 protein]|spironolactone inhibits the reaction [aldosterone results in increased expression of MTF1 mrna],,,PMID:19333130,https://www.ncbi.nlm.nih.gov/pubmed/19333130,19333130,,
678,530698,5833,Comparative Toxicogenomics Database (CTD),Spironolactone,D013148,Spironolactone,https://ctdbase.org/detail.go?type=chem&acc=D013148,2475,MTOR,https://ctdbase.org/detail.go?type=gene&acc=2475,,,2475.0,MTOR,9606.0,Homo sapiens (human),Spironolactone results in increased phosphorylation of MTOR protein,,,PMID:33562002,https://www.ncbi.nlm.nih.gov/pubmed/33562002,33562002,,
679,530699,5833,Comparative Toxicogenomics Database (CTD),Spironolactone,D013148,Spironolactone,https://ctdbase.org/detail.go?type=chem&acc=D013148,4603,MYBL1,https://ctdbase.org/detail.go?type=gene&acc=4603,,,4603.0,MYBL1,9606.0,Homo sapiens (human),Fulvestrant inhibits the reaction [spironolactone results in increased expression of MYBL1 mrna]|spironolactone results in increased expression of MYBL1 mRNA,,,PMID:33405908,https://www.ncbi.nlm.nih.gov/pubmed/33405908,33405908,,
680,700789,5991,Comparative Toxicogenomics Database (CTD),Ethinyl Estradiol,D004997,Ethinyl Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004997,29099,COMMD9,https://ctdbase.org/detail.go?type=gene&acc=29099,,,29099.0,COMMD9,10090.0,Mus musculus (house mouse),[tetrachlorodibenzodioxin co-treated with ethinyl estradiol] results in increased expression of COMMD9 mRNA,,,PMID:17942748,https://www.ncbi.nlm.nih.gov/pubmed/17942748,17942748,,
681,700790,5991,Comparative Toxicogenomics Database (CTD),Ethinyl Estradiol,D004997,Ethinyl Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004997,29099,COMMD9,https://ctdbase.org/detail.go?type=gene&acc=29099,,,29099.0,COMMD9,8364.0,Xenopus tropicalis (tropical clawed frog),Ethinyl estradiol results in increased expression of COMMD9 mRNA,,,PMID:23129252,https://www.ncbi.nlm.nih.gov/pubmed/23129252,23129252,,
682,702585,5991,Comparative Toxicogenomics Database (CTD),Ethinyl Estradiol,D004997,Ethinyl Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004997,1350,COX7C,https://ctdbase.org/detail.go?type=gene&acc=1350,,,1350.0,COX7C,10090.0,Mus musculus (house mouse),Ethinyl estradiol results in increased expression of COX7C mrna|[tetrachlorodibenzodioxin co-treated with ethinyl estradiol] results in increased expression of COX7C mRNA,,,PMID:17942748,https://www.ncbi.nlm.nih.gov/pubmed/17942748,17942748,,
683,702586,5991,Comparative Toxicogenomics Database (CTD),Ethinyl Estradiol,D004997,Ethinyl Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004997,1350,COX7C,https://ctdbase.org/detail.go?type=gene&acc=1350,,,1350.0,COX7C,8364.0,Xenopus tropicalis (tropical clawed frog),Ethinyl estradiol results in increased expression of COX7C mRNA,,,PMID:23129252,https://www.ncbi.nlm.nih.gov/pubmed/23129252,23129252,,
684,702587,5991,Comparative Toxicogenomics Database (CTD),Ethinyl Estradiol,D004997,Ethinyl Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004997,1351,COX8A,https://ctdbase.org/detail.go?type=gene&acc=1351,,,1351.0,COX8A,10090.0,Mus musculus (house mouse),Ethinyl estradiol affects the expression of COX8A mRNA,,,PMID:17555576,https://www.ncbi.nlm.nih.gov/pubmed/17555576,17555576,,
685,702588,5991,Comparative Toxicogenomics Database (CTD),Ethinyl Estradiol,D004997,Ethinyl Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004997,1356,CP,https://ctdbase.org/detail.go?type=gene&acc=1356,,,1356.0,CP,7957.0,Carassius auratus (goldfish),Ethinyl estradiol results in decreased expression of CP mRNA,,,PMID:16954407,https://www.ncbi.nlm.nih.gov/pubmed/16954407,16954407,,
686,702910,5991,Comparative Toxicogenomics Database (CTD),Ethinyl Estradiol,D004997,Ethinyl Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004997,51490,SPOUT1,https://ctdbase.org/detail.go?type=gene&acc=51490,,,51490.0,SPOUT1,44932.0,Boreogadus saida,Ethinyl estradiol results in increased expression of SPOUT1 mRNA,,,PMID:34015484,https://www.ncbi.nlm.nih.gov/pubmed/34015484,34015484,,
687,704397,5991,Comparative Toxicogenomics Database (CTD),Ethinyl Estradiol,D004997,Ethinyl Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004997,57585,CRAMP1,https://ctdbase.org/detail.go?type=gene&acc=57585,,,57585.0,CRAMP1,10090.0,Mus musculus (house mouse),[tetrachlorodibenzodioxin co-treated with ethinyl estradiol] results in increased expression of CRAMP1 mrna|ethinyl estradiol results in increased expression of CRAMP1 mRNA,,,PMID:17942748,https://www.ncbi.nlm.nih.gov/pubmed/17942748,17942748,,
688,704398,5991,Comparative Toxicogenomics Database (CTD),Ethinyl Estradiol,D004997,Ethinyl Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004997,1384,CRAT,https://ctdbase.org/detail.go?type=gene&acc=1384,,,1384.0,CRAT,44932.0,Boreogadus saida,[benzo(a)pyrene co-treated with ethinyl estradiol] results in decreased expression of CRAT mRNA,,,PMID:34015484,https://www.ncbi.nlm.nih.gov/pubmed/34015484,34015484,,
689,704399,5991,Comparative Toxicogenomics Database (CTD),Ethinyl Estradiol,D004997,Ethinyl Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004997,1384,CRAT,https://ctdbase.org/detail.go?type=gene&acc=1384,,,1384.0,CRAT,10090.0,Mus musculus (house mouse),[tetrachlorodibenzodioxin co-treated with ethinyl estradiol] results in increased expression of CRAT mRNA,,,PMID:17942748,https://www.ncbi.nlm.nih.gov/pubmed/17942748,17942748,,
690,704400,5991,Comparative Toxicogenomics Database (CTD),Ethinyl Estradiol,D004997,Ethinyl Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004997,449545,CRATA,https://ctdbase.org/detail.go?type=gene&acc=449545,,,449545.0,crata,8364.0,Xenopus tropicalis (tropical clawed frog),Ethinyl estradiol results in decreased expression of CRATA mRNA,,,PMID:23129252,https://www.ncbi.nlm.nih.gov/pubmed/23129252,23129252,,
691,704401,5991,Comparative Toxicogenomics Database (CTD),Ethinyl Estradiol,D004997,Ethinyl Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004997,286204,CRB2,https://ctdbase.org/detail.go?type=gene&acc=286204,,,286204.0,CRB2,8364.0,Xenopus tropicalis (tropical clawed frog),Ethinyl estradiol results in decreased expression of CRB2 mRNA,,,PMID:23129252,https://www.ncbi.nlm.nih.gov/pubmed/23129252,23129252,,
692,705009,5991,Comparative Toxicogenomics Database (CTD),Ethinyl Estradiol,D004997,Ethinyl Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004997,1396,CRIP1,https://ctdbase.org/detail.go?type=gene&acc=1396,,,1396.0,CRIP1,8364.0,Xenopus tropicalis (tropical clawed frog),Ethinyl estradiol results in decreased expression of CRIP1 mRNA,,,PMID:23129252,https://www.ncbi.nlm.nih.gov/pubmed/23129252,23129252,,
693,705010,5991,Comparative Toxicogenomics Database (CTD),Ethinyl Estradiol,D004997,Ethinyl Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004997,1397,CRIP2,https://ctdbase.org/detail.go?type=gene&acc=1397,,,1397.0,CRIP2,10116.0,Rattus norvegicus (Norway rat),Ethinyl estradiol results in decreased expression of CRIP2 mRNA,,,PMID:17108234,https://www.ncbi.nlm.nih.gov/pubmed/17108234,17108234,,
694,705011,5991,Comparative Toxicogenomics Database (CTD),Ethinyl Estradiol,D004997,Ethinyl Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004997,1397,CRIP2,https://ctdbase.org/detail.go?type=gene&acc=1397,,,1397.0,CRIP2,8364.0,Xenopus tropicalis (tropical clawed frog),Ethinyl estradiol results in decreased expression of CRIP2 mRNA,,,PMID:23129252,https://www.ncbi.nlm.nih.gov/pubmed/23129252,23129252,,
695,705012,5991,Comparative Toxicogenomics Database (CTD),Ethinyl Estradiol,D004997,Ethinyl Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004997,401262,CRIP3,https://ctdbase.org/detail.go?type=gene&acc=401262,,,401262.0,CRIP3,10090.0,Mus musculus (house mouse),Ethinyl estradiol affects the expression of CRIP3 mRNA,,,PMID:17555576,https://www.ncbi.nlm.nih.gov/pubmed/17555576,17555576,,
696,705013,5991,Comparative Toxicogenomics Database (CTD),Ethinyl Estradiol,D004997,Ethinyl Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004997,9419,CRIPT,https://ctdbase.org/detail.go?type=gene&acc=9419,,,9419.0,CRIPT,8364.0,Xenopus tropicalis (tropical clawed frog),Ethinyl estradiol results in increased expression of CRIPT mRNA,,,PMID:23129252,https://www.ncbi.nlm.nih.gov/pubmed/23129252,23129252,,
697,705014,5991,Comparative Toxicogenomics Database (CTD),Ethinyl Estradiol,D004997,Ethinyl Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004997,779849,CRIPTO.3,https://ctdbase.org/detail.go?type=gene&acc=779849,,,779849.0,cripto.3,8364.0,Xenopus tropicalis (tropical clawed frog),Ethinyl estradiol results in increased expression of CRIPTO.3 mRNA,,,PMID:23129252,https://www.ncbi.nlm.nih.gov/pubmed/23129252,23129252,,
698,705015,5991,Comparative Toxicogenomics Database (CTD),Ethinyl Estradiol,D004997,Ethinyl Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004997,7180,CRISP2,https://ctdbase.org/detail.go?type=gene&acc=7180,,,7180.0,CRISP2,8364.0,Xenopus tropicalis (tropical clawed frog),Ethinyl estradiol results in decreased expression of CRISP2 mRNA,,,PMID:23129252,https://www.ncbi.nlm.nih.gov/pubmed/23129252,23129252,,
699,705016,5991,Comparative Toxicogenomics Database (CTD),Ethinyl Estradiol,D004997,Ethinyl Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004997,10321,CRISP3,https://ctdbase.org/detail.go?type=gene&acc=10321,,,10321.0,CRISP3,8364.0,Xenopus tropicalis (tropical clawed frog),Ethinyl estradiol results in decreased expression of CRISP3 mRNA,,,PMID:23129252,https://www.ncbi.nlm.nih.gov/pubmed/23129252,23129252,,
700,705773,5991,Comparative Toxicogenomics Database (CTD),Ethinyl Estradiol,D004997,Ethinyl Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004997,6746,SSR2,https://ctdbase.org/detail.go?type=gene&acc=6746,,,6746.0,SSR2,8364.0,Xenopus tropicalis (tropical clawed frog),Ethinyl estradiol results in increased expression of SSR2 mRNA,,,PMID:23129252,https://www.ncbi.nlm.nih.gov/pubmed/23129252,23129252,,
701,705774,5991,Comparative Toxicogenomics Database (CTD),Ethinyl Estradiol,D004997,Ethinyl Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004997,6747,SSR3,https://ctdbase.org/detail.go?type=gene&acc=6747,,,6747.0,SSR3,8364.0,Xenopus tropicalis (tropical clawed frog),Ethinyl estradiol results in increased expression of SSR3 mRNA,,,PMID:23129252,https://www.ncbi.nlm.nih.gov/pubmed/23129252,23129252,,
702,705775,5991,Comparative Toxicogenomics Database (CTD),Ethinyl Estradiol,D004997,Ethinyl Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004997,6748,SSR4,https://ctdbase.org/detail.go?type=gene&acc=6748,,,6748.0,SSR4,7955.0,Danio rerio (zebrafish),Ethinyl estradiol results in increased expression of SSR4 protein,,,PMID:20227414,https://www.ncbi.nlm.nih.gov/pubmed/20227414,20227414,,
703,705776,5991,Comparative Toxicogenomics Database (CTD),Ethinyl Estradiol,D004997,Ethinyl Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004997,6748,SSR4,https://ctdbase.org/detail.go?type=gene&acc=6748,,,6748.0,SSR4,10090.0,Mus musculus (house mouse),Ethinyl estradiol results in increased expression of SSR4 mRNA,,,PMID:16174780|PMID:17555576|PMID:17942748,https://www.ncbi.nlm.nih.gov/pubmed/16174780|https://www.ncbi.nlm.nih.gov/pubmed/17555576|https://www.ncbi.nlm.nih.gov/pubmed/17942748,16174780|17555576|17942748,,
704,705777,5991,Comparative Toxicogenomics Database (CTD),Ethinyl Estradiol,D004997,Ethinyl Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004997,6748,SSR4,https://ctdbase.org/detail.go?type=gene&acc=6748,,,6748.0,SSR4,10090.0,Mus musculus (house mouse),[tetrachlorodibenzodioxin co-treated with ethinyl estradiol] results in increased expression of SSR4 mRNA,,,PMID:17942748,https://www.ncbi.nlm.nih.gov/pubmed/17942748,17942748,,
705,705778,5991,Comparative Toxicogenomics Database (CTD),Ethinyl Estradiol,D004997,Ethinyl Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004997,6748,SSR4,https://ctdbase.org/detail.go?type=gene&acc=6748,,,6748.0,SSR4,10116.0,Rattus norvegicus (Norway rat),Ethinyl estradiol results in increased expression of SSR4 mRNA,,,PMID:16174780,https://www.ncbi.nlm.nih.gov/pubmed/16174780,16174780,,
706,705779,5991,Comparative Toxicogenomics Database (CTD),Ethinyl Estradiol,D004997,Ethinyl Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004997,6749,SSRP1,https://ctdbase.org/detail.go?type=gene&acc=6749,,,6749.0,SSRP1,10090.0,Mus musculus (house mouse),[tetrachlorodibenzodioxin co-treated with ethinyl estradiol] results in increased expression of SSRP1 mrna|ethinyl estradiol results in increased expression of SSRP1 mRNA,,,PMID:17942748,https://www.ncbi.nlm.nih.gov/pubmed/17942748,17942748,,
707,705780,5991,Comparative Toxicogenomics Database (CTD),Ethinyl Estradiol,D004997,Ethinyl Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004997,6750,SST,https://ctdbase.org/detail.go?type=gene&acc=6750,,,6750.0,SST,10090.0,Mus musculus (house mouse),[tetrachlorodibenzodioxin co-treated with ethinyl estradiol] results in increased expression of SST mRNA,,,PMID:17942748,https://www.ncbi.nlm.nih.gov/pubmed/17942748,17942748,,
708,707532,5991,Comparative Toxicogenomics Database (CTD),Ethinyl Estradiol,D004997,Ethinyl Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004997,6776,STAT5A,https://ctdbase.org/detail.go?type=gene&acc=6776,,,6776.0,STAT5A,10090.0,Mus musculus (house mouse),Ethinyl estradiol results in increased expression of STAT5A mRNA,,,PMID:12072388|PMID:16467188,https://www.ncbi.nlm.nih.gov/pubmed/12072388|https://www.ncbi.nlm.nih.gov/pubmed/16467188,12072388|16467188,,
709,707533,5991,Comparative Toxicogenomics Database (CTD),Ethinyl Estradiol,D004997,Ethinyl Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004997,6777,STAT5B,https://ctdbase.org/detail.go?type=gene&acc=6777,,,6777.0,STAT5B,10090.0,Mus musculus (house mouse),Ethinyl estradiol results in decreased activity of STAT5B protein,,,PMID:30114225,https://www.ncbi.nlm.nih.gov/pubmed/30114225,30114225,,
710,707534,5991,Comparative Toxicogenomics Database (CTD),Ethinyl Estradiol,D004997,Ethinyl Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004997,6781,STC1,https://ctdbase.org/detail.go?type=gene&acc=6781,,,6781.0,STC1,10116.0,Rattus norvegicus (Norway rat),Ethinyl estradiol affects the expression of STC1 mRNA,,,PMID:20170705|PMID:26865667,https://www.ncbi.nlm.nih.gov/pubmed/20170705|https://www.ncbi.nlm.nih.gov/pubmed/26865667,20170705|26865667,,
711,707535,5991,Comparative Toxicogenomics Database (CTD),Ethinyl Estradiol,D004997,Ethinyl Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004997,6781,STC1,https://ctdbase.org/detail.go?type=gene&acc=6781,,,6781.0,STC1,8355.0,Xenopus laevis (African clawed frog),Ethinyl estradiol results in decreased expression of STC1 mRNA,,,PMID:23550701,https://www.ncbi.nlm.nih.gov/pubmed/23550701,23550701,,
712,707536,5991,Comparative Toxicogenomics Database (CTD),Ethinyl Estradiol,D004997,Ethinyl Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004997,393511,STC1L,https://ctdbase.org/detail.go?type=gene&acc=393511,,,393511.0,stc1l,7955.0,Danio rerio (zebrafish),Ethinyl estradiol affects the expression of STC1L mRNA,,,PMID:25064622,https://www.ncbi.nlm.nih.gov/pubmed/25064622,25064622,,
713,707537,5991,Comparative Toxicogenomics Database (CTD),Ethinyl Estradiol,D004997,Ethinyl Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004997,8614,STC2,https://ctdbase.org/detail.go?type=gene&acc=8614,,,8614.0,STC2,10090.0,Mus musculus (house mouse),[tetrachlorodibenzodioxin co-treated with ethinyl estradiol] results in increased expression of STC2 mrna|ethinyl estradiol results in increased expression of STC2 mRNA,,,PMID:17942748,https://www.ncbi.nlm.nih.gov/pubmed/17942748,17942748,,
714,707538,5991,Comparative Toxicogenomics Database (CTD),Ethinyl Estradiol,D004997,Ethinyl Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004997,79689,STEAP4,https://ctdbase.org/detail.go?type=gene&acc=79689,,,79689.0,STEAP4,8364.0,Xenopus tropicalis (tropical clawed frog),Ethinyl estradiol results in decreased expression of STEAP4 mRNA,,,PMID:23129252,https://www.ncbi.nlm.nih.gov/pubmed/23129252,23129252,,
715,706360,5993,Comparative Toxicogenomics Database (CTD),Chlordane,D002706,Chlordan,https://ctdbase.org/detail.go?type=chem&acc=D002706,6558,SLC12A2,https://ctdbase.org/detail.go?type=gene&acc=6558,,,6558.0,SLC12A2,10116.0,Rattus norvegicus (Norway rat),Chlordan results in decreased expression of SLC12A2 protein,,,PMID:35137321,https://www.ncbi.nlm.nih.gov/pubmed/35137321,35137321,,
716,706361,5993,Comparative Toxicogenomics Database (CTD),Chlordane,D002706,Chlordan,https://ctdbase.org/detail.go?type=chem&acc=D002706,6559,SLC12A3,https://ctdbase.org/detail.go?type=gene&acc=6559,,,6559.0,SLC12A3,8049.0,Gadus morhua (Atlantic cod),"[aroclors co-treated with hydrocarbons, chlorinated co-treated with hexachlorocyclohexane co-treated with toxaphene co-treated with chlordan] results in decreased expression of SLC12A3 mRNA",,,PMID:37528559,https://www.ncbi.nlm.nih.gov/pubmed/37528559,37528559,,
717,706362,5993,Comparative Toxicogenomics Database (CTD),Chlordane,D002706,Chlordan,https://ctdbase.org/detail.go?type=chem&acc=D002706,6505,SLC1A1,https://ctdbase.org/detail.go?type=gene&acc=6505,,,6505.0,SLC1A1,8049.0,Gadus morhua (Atlantic cod),"[aroclors co-treated with hydrocarbons, chlorinated co-treated with hexachlorocyclohexane co-treated with toxaphene co-treated with chlordan] results in decreased expression of SLC1A1 mRNA",,,PMID:37528559,https://www.ncbi.nlm.nih.gov/pubmed/37528559,37528559,,
718,706363,5993,Comparative Toxicogenomics Database (CTD),Chlordane,D002706,Chlordan,https://ctdbase.org/detail.go?type=chem&acc=D002706,6506,SLC1A2,https://ctdbase.org/detail.go?type=gene&acc=6506,,,6506.0,SLC1A2,10116.0,Rattus norvegicus (Norway rat),Chlordan results in decreased expression of SLC1A2 protein,,,PMID:35137321,https://www.ncbi.nlm.nih.gov/pubmed/35137321,35137321,,
719,706364,5993,Comparative Toxicogenomics Database (CTD),Chlordane,D002706,Chlordan,https://ctdbase.org/detail.go?type=chem&acc=D002706,6580,SLC22A1,https://ctdbase.org/detail.go?type=gene&acc=6580,,,6580.0,SLC22A1,9606.0,Homo sapiens (human),Chlordan results in decreased activity of SLC22A1 protein,,,PMID:24464585,https://www.ncbi.nlm.nih.gov/pubmed/24464585,24464585,,
720,706365,5993,Comparative Toxicogenomics Database (CTD),Chlordane,D002706,Chlordan,https://ctdbase.org/detail.go?type=chem&acc=D002706,564849,SLC2A11L,https://ctdbase.org/detail.go?type=gene&acc=564849,,,564849.0,slc2a11l,8049.0,Gadus morhua (Atlantic cod),"[aroclors co-treated with hydrocarbons, chlorinated co-treated with hexachlorocyclohexane co-treated with toxaphene co-treated with chlordan] results in decreased expression of SLC2A11L mRNA",,,PMID:37528559,https://www.ncbi.nlm.nih.gov/pubmed/37528559,37528559,,
721,706366,5993,Comparative Toxicogenomics Database (CTD),Chlordane,D002706,Chlordan,https://ctdbase.org/detail.go?type=chem&acc=D002706,6515,SLC2A3,https://ctdbase.org/detail.go?type=gene&acc=6515,,,6515.0,SLC2A3,10116.0,Rattus norvegicus (Norway rat),Chlordan results in increased expression of SLC2A3 mRNA,,,PMID:31704469,https://www.ncbi.nlm.nih.gov/pubmed/31704469,31704469,,
722,700783,5994,Comparative Toxicogenomics Database (CTD),Progesterone,D011374,Progesterone,https://ctdbase.org/detail.go?type=chem&acc=D011374,182297,NHR-150,https://ctdbase.org/detail.go?type=gene&acc=182297,,,182297.0,nhr-150,6239.0,Caenorhabditis elegans,Progesterone results in decreased expression of NHR-150 mRNA,,,PMID:21676746,https://www.ncbi.nlm.nih.gov/pubmed/21676746,21676746,,
723,700784,5994,Comparative Toxicogenomics Database (CTD),Progesterone,D011374,Progesterone,https://ctdbase.org/detail.go?type=chem&acc=D011374,185999,NHR-190,https://ctdbase.org/detail.go?type=gene&acc=185999,,,185999.0,nhr-190,6239.0,Caenorhabditis elegans,Progesterone results in decreased expression of NHR-190 mRNA,,,PMID:21676746,https://www.ncbi.nlm.nih.gov/pubmed/21676746,21676746,,
724,700785,5994,Comparative Toxicogenomics Database (CTD),Progesterone,D011374,Progesterone,https://ctdbase.org/detail.go?type=chem&acc=D011374,187663,NHR-209,https://ctdbase.org/detail.go?type=gene&acc=187663,,,187663.0,nhr-209,6239.0,Caenorhabditis elegans,Progesterone results in decreased expression of NHR-209 mRNA,,,PMID:21676746,https://www.ncbi.nlm.nih.gov/pubmed/21676746,21676746,,
725,700786,5994,Comparative Toxicogenomics Database (CTD),Progesterone,D011374,Progesterone,https://ctdbase.org/detail.go?type=chem&acc=D011374,180725,NHR-35,https://ctdbase.org/detail.go?type=gene&acc=180725,,,180725.0,nhr-35,6239.0,Caenorhabditis elegans,Progesterone results in increased expression of NHR-35 mRNA,,,PMID:21676746,https://www.ncbi.nlm.nih.gov/pubmed/21676746,21676746,,
726,700787,5994,Comparative Toxicogenomics Database (CTD),Progesterone,D011374,Progesterone,https://ctdbase.org/detail.go?type=chem&acc=D011374,180068,NHR-63,https://ctdbase.org/detail.go?type=gene&acc=180068,,,180068.0,nhr-63,6239.0,Caenorhabditis elegans,Progesterone results in decreased expression of NHR-63 mRNA,,,PMID:21676746,https://www.ncbi.nlm.nih.gov/pubmed/21676746,21676746,,
727,700788,5994,Comparative Toxicogenomics Database (CTD),Progesterone,D011374,Progesterone,https://ctdbase.org/detail.go?type=chem&acc=D011374,172840,NHR-69,https://ctdbase.org/detail.go?type=gene&acc=172840,,,172840.0,nhr-69,6239.0,Caenorhabditis elegans,Progesterone results in increased expression of NHR-69 mRNA,,,PMID:21676746,https://www.ncbi.nlm.nih.gov/pubmed/21676746,21676746,,
728,704096,5994,Comparative Toxicogenomics Database (CTD),Progesterone,D011374,Progesterone,https://ctdbase.org/detail.go?type=chem&acc=D011374,256281,NUDT14,https://ctdbase.org/detail.go?type=gene&acc=256281,,,256281.0,NUDT14,9913.0,Bos taurus (cattle),Progesterone results in decreased expression of NUDT14 mRNA,,,PMID:23018184,https://www.ncbi.nlm.nih.gov/pubmed/23018184,23018184,,
729,704097,5994,Comparative Toxicogenomics Database (CTD),Progesterone,D011374,Progesterone,https://ctdbase.org/detail.go?type=chem&acc=D011374,131870,NUDT16,https://ctdbase.org/detail.go?type=gene&acc=131870,,,131870.0,NUDT16,9940.0,Ovis aries (sheep),Progesterone results in decreased expression of NUDT16 mRNA,,,PMID:19690047,https://www.ncbi.nlm.nih.gov/pubmed/19690047,19690047,,
730,707852,5994,Comparative Toxicogenomics Database (CTD),Progesterone,D011374,Progesterone,https://ctdbase.org/detail.go?type=chem&acc=D011374,22990,PCNX1,https://ctdbase.org/detail.go?type=gene&acc=22990,,,22990.0,PCNX1,9940.0,Ovis aries (sheep),Progesterone results in decreased expression of PCNX1 mRNA,,,PMID:19690047,https://www.ncbi.nlm.nih.gov/pubmed/19690047,19690047,,
731,707853,5994,Comparative Toxicogenomics Database (CTD),Progesterone,D011374,Progesterone,https://ctdbase.org/detail.go?type=chem&acc=D011374,5118,PCOLCE,https://ctdbase.org/detail.go?type=gene&acc=5118,,,5118.0,PCOLCE,9913.0,Bos taurus (cattle),Progesterone results in decreased expression of PCOLCE mRNA,,,PMID:23018184,https://www.ncbi.nlm.nih.gov/pubmed/23018184,23018184,,
732,707854,5994,Comparative Toxicogenomics Database (CTD),Progesterone,D011374,Progesterone,https://ctdbase.org/detail.go?type=chem&acc=D011374,5125,PCSK5,https://ctdbase.org/detail.go?type=gene&acc=5125,,,5125.0,PCSK5,9606.0,Homo sapiens (human),[estradiol co-treated with progesterone] results in increased expression of PCSK5 mRNA,,,PMID:20660070,https://www.ncbi.nlm.nih.gov/pubmed/20660070,20660070,,
733,707855,5994,Comparative Toxicogenomics Database (CTD),Progesterone,D011374,Progesterone,https://ctdbase.org/detail.go?type=chem&acc=D011374,5046,PCSK6,https://ctdbase.org/detail.go?type=gene&acc=5046,,,5046.0,PCSK6,9606.0,Homo sapiens (human),[estradiol co-treated with progesterone] results in increased expression of PCSK6 mRNA,,,PMID:20660070,https://www.ncbi.nlm.nih.gov/pubmed/20660070,20660070,,
734,707856,5994,Comparative Toxicogenomics Database (CTD),Progesterone,D011374,Progesterone,https://ctdbase.org/detail.go?type=chem&acc=D011374,5046,PCSK6,https://ctdbase.org/detail.go?type=gene&acc=5046,,,5046.0,PCSK6,9606.0,Homo sapiens (human),[progesterone co-treated with estradiol] results in increased expression of PCSK6 mRNA,,,PMID:17404688,https://www.ncbi.nlm.nih.gov/pubmed/17404688,17404688,,
735,707857,5994,Comparative Toxicogenomics Database (CTD),Progesterone,D011374,Progesterone,https://ctdbase.org/detail.go?type=chem&acc=D011374,5046,PCSK6,https://ctdbase.org/detail.go?type=gene&acc=5046,,,5046.0,PCSK6,9606.0,Homo sapiens (human),Progesterone results in increased expression of PCSK6 mRNA,,,PMID:17404688|PMID:18070364,https://www.ncbi.nlm.nih.gov/pubmed/17404688|https://www.ncbi.nlm.nih.gov/pubmed/18070364,17404688|18070364,,
736,707858,5994,Comparative Toxicogenomics Database (CTD),Progesterone,D011374,Progesterone,https://ctdbase.org/detail.go?type=chem&acc=D011374,58488,PCTP,https://ctdbase.org/detail.go?type=gene&acc=58488,,,58488.0,PCTP,9913.0,Bos taurus (cattle),Progesterone results in decreased expression of PCTP mRNA,,,PMID:23012394,https://www.ncbi.nlm.nih.gov/pubmed/23012394,23012394,,
737,707859,5994,Comparative Toxicogenomics Database (CTD),Progesterone,D011374,Progesterone,https://ctdbase.org/detail.go?type=chem&acc=D011374,11333,PDAP1,https://ctdbase.org/detail.go?type=gene&acc=11333,,,11333.0,PDAP1,9606.0,Homo sapiens (human),Progesterone results in increased expression of PDAP1 mRNA,,,PMID:16888808,https://www.ncbi.nlm.nih.gov/pubmed/16888808,16888808,,
738,699481,6000,DrugBank,Tubocurarine,DB01199,Tubocurarine,https://www.drugbank.ca/drugs/DB01199,BE0000426,Acetylcholinesterase,https://www.drugbank.ca/bio_entities/BE0000426,P22303,Acetylcholinesterase,43.0,ACHE,9606.0,Homo sapiens (human),Inhibitor,,,PMID:10421444|PMID:11823003|PMID:11920914|PMID:1475066|PMID:15878275,https://www.ncbi.nlm.nih.gov/pubmed/10421444|https://www.ncbi.nlm.nih.gov/pubmed/11823003|https://www.ncbi.nlm.nih.gov/pubmed/11920914|https://www.ncbi.nlm.nih.gov/pubmed/1475066|https://www.ncbi.nlm.nih.gov/pubmed/15878275,10421444|11823003|11920914|1475066|15878275,,
739,699482,6000,DrugBank,Tubocurarine,DB01199,Tubocurarine,https://www.drugbank.ca/drugs/DB01199,BE0002341,Neuronal acetylcholine receptor subunit alpha-7,https://www.drugbank.ca/bio_entities/BE0002341,P36544,Neuronal acetylcholine receptor subunit alpha-7,89832.0,CHRFAM7A,9606.0,Homo sapiens (human),,,,PMID:10082212,https://www.ncbi.nlm.nih.gov/pubmed/10082212,10082212,,
740,699483,6000,DrugBank,Tubocurarine,DB01199,Tubocurarine,https://www.drugbank.ca/drugs/DB01199,BE0002180,Cholinesterase,https://www.drugbank.ca/bio_entities/BE0002180,P06276,Cholinesterase,590.0,BCHE,9606.0,Homo sapiens (human),Substrate,,,,,,,
741,699484,6000,DrugBank,Tubocurarine,DB01199,Tubocurarine,https://www.drugbank.ca/drugs/DB01199,BE0003648,Solute carrier family 22 member 1,https://www.drugbank.ca/bio_entities/BE0003648,O15245,Solute carrier family 22 member 1 ,6580.0,SLC22A1,9606.0,Homo sapiens (human),Substrate,,,PMID:8955087|PMID:23984399,https://www.ncbi.nlm.nih.gov/pubmed/8955087|https://www.ncbi.nlm.nih.gov/pubmed/23984399,8955087|23984399,,
742,699485,6000,DrugBank,Tubocurarine,DB01199,Tubocurarine,https://www.drugbank.ca/drugs/DB01199,BE0003647,Solute carrier family 22 member 2,https://www.drugbank.ca/bio_entities/BE0003647,O15244,Solute carrier family 22 member 2,6582.0,SLC22A2,9606.0,Homo sapiens (human),,,,PMID:9260930,https://www.ncbi.nlm.nih.gov/pubmed/9260930,9260930,,
743,699486,6005,Drug Gene Interaction database (DGIdb),Apomorphine,,WIN55212-2,https://www.dgidb.org/drugs/iuphar.ligand:733,,GLRA2,https://www.dgidb.org/genes/hgnc:4327,,,2742.0,GLRA2,9606.0,Homo sapiens (human),,,,,,,,
744,699487,6005,Drug Gene Interaction database (DGIdb),Apomorphine,,WIN55212-2,https://www.dgidb.org/drugs/iuphar.ligand:733,,MTOR,https://www.dgidb.org/genes/hgnc:3942,,,2475.0,MTOR,9606.0,Homo sapiens (human),,,,,,,,
745,699488,6005,Drug Gene Interaction database (DGIdb),Apomorphine,,WIN55212-2,https://www.dgidb.org/drugs/iuphar.ligand:733,,CBX1,https://www.dgidb.org/genes/hgnc:1551,,,10951.0,CBX1,9606.0,Homo sapiens (human),,,,,,,,
746,701943,6010,Comparative Toxicogenomics Database (CTD),Methyltestosterone,D008777,Methyltestosterone,https://ctdbase.org/detail.go?type=chem&acc=D008777,80000,GREB1L,https://ctdbase.org/detail.go?type=gene&acc=80000,,,80000.0,GREB1L,9031.0,Gallus gallus (chicken),Methyltestosterone results in decreased expression of GREB1L mRNA,,,PMID:29191790,https://www.ncbi.nlm.nih.gov/pubmed/29191790,29191790,,
747,701944,6010,Comparative Toxicogenomics Database (CTD),Methyltestosterone,D008777,Methyltestosterone,https://ctdbase.org/detail.go?type=chem&acc=D008777,9380,GRHPR,https://ctdbase.org/detail.go?type=gene&acc=9380,,,9380.0,GRHPR,9031.0,Gallus gallus (chicken),Methyltestosterone results in decreased expression of GRHPR mRNA,,,PMID:29191790,https://www.ncbi.nlm.nih.gov/pubmed/29191790,29191790,,
748,701945,6010,Comparative Toxicogenomics Database (CTD),Methyltestosterone,D008777,Methyltestosterone,https://ctdbase.org/detail.go?type=chem&acc=D008777,798689,GRIA1A,https://ctdbase.org/detail.go?type=gene&acc=798689,,,798689.0,gria1a,7955.0,Danio rerio (zebrafish),Methyltestosterone results in decreased expression of GRIA1A mRNA,,,PMID:29458080,https://www.ncbi.nlm.nih.gov/pubmed/29458080,29458080,,
749,701946,6010,Comparative Toxicogenomics Database (CTD),Methyltestosterone,D008777,Methyltestosterone,https://ctdbase.org/detail.go?type=chem&acc=D008777,170451,GRIA2B,https://ctdbase.org/detail.go?type=gene&acc=170451,,,170451.0,gria2b,7955.0,Danio rerio (zebrafish),Methyltestosterone results in decreased expression of GRIA2B mRNA,,,PMID:29458080,https://www.ncbi.nlm.nih.gov/pubmed/29458080,29458080,,
750,701947,6010,Comparative Toxicogenomics Database (CTD),Methyltestosterone,D008777,Methyltestosterone,https://ctdbase.org/detail.go?type=chem&acc=D008777,557511,GRID1B,https://ctdbase.org/detail.go?type=gene&acc=557511,,,557511.0,grid1b,7955.0,Danio rerio (zebrafish),Methyltestosterone results in decreased expression of GRID1B mRNA,,,PMID:29458080,https://www.ncbi.nlm.nih.gov/pubmed/29458080,29458080,,
751,701948,6010,Comparative Toxicogenomics Database (CTD),Methyltestosterone,D008777,Methyltestosterone,https://ctdbase.org/detail.go?type=chem&acc=D008777,798001,GRIK1A,https://ctdbase.org/detail.go?type=gene&acc=798001,,,798001.0,grik1a,7955.0,Danio rerio (zebrafish),Methyltestosterone results in decreased expression of GRIK1A mRNA,,,PMID:29458080,https://www.ncbi.nlm.nih.gov/pubmed/29458080,29458080,,
752,701949,6010,Comparative Toxicogenomics Database (CTD),Methyltestosterone,D008777,Methyltestosterone,https://ctdbase.org/detail.go?type=chem&acc=D008777,100005675,GRIN1B,https://ctdbase.org/detail.go?type=gene&acc=100005675,,,100005675.0,grin1b,7955.0,Danio rerio (zebrafish),Methyltestosterone results in decreased expression of GRIN1B mRNA,,,PMID:29458080,https://www.ncbi.nlm.nih.gov/pubmed/29458080,29458080,,
753,701950,6010,Comparative Toxicogenomics Database (CTD),Methyltestosterone,D008777,Methyltestosterone,https://ctdbase.org/detail.go?type=chem&acc=D008777,2914,GRM4,https://ctdbase.org/detail.go?type=gene&acc=2914,,,2914.0,GRM4,7955.0,Danio rerio (zebrafish),Methyltestosterone results in decreased expression of GRM4 mRNA,,,PMID:29458080,https://www.ncbi.nlm.nih.gov/pubmed/29458080,29458080,,
754,703922,6010,Comparative Toxicogenomics Database (CTD),Methyltestosterone,D008777,Methyltestosterone,https://ctdbase.org/detail.go?type=chem&acc=D008777,388135,INSYN1,https://ctdbase.org/detail.go?type=gene&acc=388135,,,388135.0,INSYN1,7955.0,Danio rerio (zebrafish),Methyltestosterone results in decreased expression of INSYN1 mRNA,,,PMID:29458080,https://www.ncbi.nlm.nih.gov/pubmed/29458080,29458080,,
755,703923,6010,Comparative Toxicogenomics Database (CTD),Methyltestosterone,D008777,Methyltestosterone,https://ctdbase.org/detail.go?type=chem&acc=D008777,25896,INTS7,https://ctdbase.org/detail.go?type=gene&acc=25896,,,25896.0,INTS7,9031.0,Gallus gallus (chicken),Methyltestosterone results in decreased expression of INTS7 mRNA,,,PMID:29191790,https://www.ncbi.nlm.nih.gov/pubmed/29191790,29191790,,
756,705917,6010,Comparative Toxicogenomics Database (CTD),Methyltestosterone,D008777,Methyltestosterone,https://ctdbase.org/detail.go?type=chem&acc=D008777,84695,LOXL3,https://ctdbase.org/detail.go?type=gene&acc=84695,,,84695.0,LOXL3,9031.0,Gallus gallus (chicken),Methyltestosterone results in decreased expression of LOXL3 mRNA,,,PMID:29191790,https://www.ncbi.nlm.nih.gov/pubmed/29191790,29191790,,
757,705918,6010,Comparative Toxicogenomics Database (CTD),Methyltestosterone,D008777,Methyltestosterone,https://ctdbase.org/detail.go?type=chem&acc=D008777,23175,LPIN1,https://ctdbase.org/detail.go?type=gene&acc=23175,,,23175.0,LPIN1,7955.0,Danio rerio (zebrafish),Methyltestosterone results in decreased expression of LPIN1 mRNA,,,PMID:29458080,https://www.ncbi.nlm.nih.gov/pubmed/29458080,29458080,,
758,705919,6010,Comparative Toxicogenomics Database (CTD),Methyltestosterone,D008777,Methyltestosterone,https://ctdbase.org/detail.go?type=chem&acc=D008777,556575,LRATB.2,https://ctdbase.org/detail.go?type=gene&acc=556575,,,556575.0,lratb.2,7955.0,Danio rerio (zebrafish),Methyltestosterone results in decreased expression of LRATB.2 mRNA,,,PMID:29458080,https://www.ncbi.nlm.nih.gov/pubmed/29458080,29458080,,
759,705920,6010,Comparative Toxicogenomics Database (CTD),Methyltestosterone,D008777,Methyltestosterone,https://ctdbase.org/detail.go?type=chem&acc=D008777,57631,LRCH2,https://ctdbase.org/detail.go?type=gene&acc=57631,,,57631.0,LRCH2,9031.0,Gallus gallus (chicken),Methyltestosterone results in decreased expression of LRCH2 mRNA,,,PMID:29191790,https://www.ncbi.nlm.nih.gov/pubmed/29191790,29191790,,
760,706367,6010,Comparative Toxicogenomics Database (CTD),Methyltestosterone,D008777,Methyltestosterone,https://ctdbase.org/detail.go?type=chem&acc=D008777,4047,LSS,https://ctdbase.org/detail.go?type=gene&acc=4047,,,4047.0,LSS,9606.0,Homo sapiens (human),[methyltestosterone co-treated with cholic acids] affects the expression of LSS mRNA,,,PMID:27344345,https://www.ncbi.nlm.nih.gov/pubmed/27344345,27344345,,
761,699622,6013,Comparative Toxicogenomics Database (CTD),Testosterone,D013739,Testosterone,https://ctdbase.org/detail.go?type=chem&acc=D013739,100415799,UGT5B2,https://ctdbase.org/detail.go?type=gene&acc=100415799,,,100415799.0,ugt5b2,7955.0,Danio rerio (zebrafish),UGT5B2 protein results in increased glucuronidation of testosterone,,,PMID:24728488,https://www.ncbi.nlm.nih.gov/pubmed/24728488,24728488,,
762,699623,6013,Comparative Toxicogenomics Database (CTD),Testosterone,D013739,Testosterone,https://ctdbase.org/detail.go?type=chem&acc=D013739,100002993,UGT5E1,https://ctdbase.org/detail.go?type=gene&acc=100002993,,,100002993.0,ugt5e1,7955.0,Danio rerio (zebrafish),UGT5E1 protein results in increased glucuronidation of testosterone,,,PMID:24728488,https://www.ncbi.nlm.nih.gov/pubmed/24728488,24728488,,
763,699624,6013,Comparative Toxicogenomics Database (CTD),Testosterone,D013739,Testosterone,https://ctdbase.org/detail.go?type=chem&acc=D013739,29128,UHRF1,https://ctdbase.org/detail.go?type=gene&acc=29128,,,29128.0,UHRF1,9606.0,Homo sapiens (human),Testosterone results in decreased expression of UHRF1 mrna|[testosterone co-treated with calcitriol] results in decreased expression of UHRF1 mRNA,,,PMID:21592394,https://www.ncbi.nlm.nih.gov/pubmed/21592394,21592394,,
764,699625,6013,Comparative Toxicogenomics Database (CTD),Testosterone,D013739,Testosterone,https://ctdbase.org/detail.go?type=chem&acc=D013739,115426,UHRF2,https://ctdbase.org/detail.go?type=gene&acc=115426,,,115426.0,UHRF2,10090.0,Mus musculus (house mouse),"1,2-dibromo-4-(1,2-dibromoethyl)cyclohexane inhibits the reaction [testosterone deficiency results in increased expression of UHRF2 mrna]|testosterone deficiency results in increased expression of UHRF2 mRNA",,,PMID:33848595,https://www.ncbi.nlm.nih.gov/pubmed/33848595,33848595,,
765,700966,6013,Comparative Toxicogenomics Database (CTD),Testosterone,D013739,Testosterone,https://ctdbase.org/detail.go?type=chem&acc=D013739,26464,VNN3,https://ctdbase.org/detail.go?type=gene&acc=26464,,,26464.0,Vnn3,10090.0,Mus musculus (house mouse),"Testosterone deficiency results in increased expression of VNN3 mrna|1,2-dibromo-4-(1,2-dibromoethyl)cyclohexane inhibits the reaction [testosterone deficiency results in increased expression of VNN3 mrna]",,,PMID:33848595,https://www.ncbi.nlm.nih.gov/pubmed/33848595,33848595,,
766,700967,6013,Comparative Toxicogenomics Database (CTD),Testosterone,D013739,Testosterone,https://ctdbase.org/detail.go?type=chem&acc=D013739,259227,VOF16,https://ctdbase.org/detail.go?type=gene&acc=259227,,,259227.0,Vof16,10116.0,Rattus norvegicus (Norway rat),[estradiol 3-benzoate co-treated with [testosterone co-treated with estradiol]] results in increased expression of VOF16 mRNA,,,PMID:32741896,https://www.ncbi.nlm.nih.gov/pubmed/32741896,32741896,,
767,700968,6013,Comparative Toxicogenomics Database (CTD),Testosterone,D013739,Testosterone,https://ctdbase.org/detail.go?type=chem&acc=D013739,689670,VOM2R73,https://ctdbase.org/detail.go?type=gene&acc=689670,,,689670.0,Vom2r73,10116.0,Rattus norvegicus (Norway rat),[testosterone co-treated with estradiol] results in increased expression of VOM2R73 mRNA,,,PMID:32741896,https://www.ncbi.nlm.nih.gov/pubmed/32741896,32741896,,
768,700969,6013,Comparative Toxicogenomics Database (CTD),Testosterone,D013739,Testosterone,https://ctdbase.org/detail.go?type=chem&acc=D013739,502285,VOM2R80,https://ctdbase.org/detail.go?type=gene&acc=502285,,,502285.0,Vom2r80,10116.0,Rattus norvegicus (Norway rat),[bisphenol A co-treated with testosterone] results in increased expression of VOM2R80 mRNA,,,PMID:26496021,https://www.ncbi.nlm.nih.gov/pubmed/26496021,26496021,,
769,700970,6013,Comparative Toxicogenomics Database (CTD),Testosterone,D013739,Testosterone,https://ctdbase.org/detail.go?type=chem&acc=D013739,23230,VPS13A,https://ctdbase.org/detail.go?type=gene&acc=23230,,,23230.0,VPS13A,9606.0,Homo sapiens (human),[testosterone co-treated with calcitriol] results in decreased expression of VPS13A mrna|testosterone results in decreased expression of VPS13A mRNA,,,PMID:21592394,https://www.ncbi.nlm.nih.gov/pubmed/21592394,21592394,,
770,700971,6013,Comparative Toxicogenomics Database (CTD),Testosterone,D013739,Testosterone,https://ctdbase.org/detail.go?type=chem&acc=D013739,9559,VPS26A,https://ctdbase.org/detail.go?type=gene&acc=9559,,,9559.0,VPS26A,9606.0,Homo sapiens (human),Testosterone results in decreased expression of VPS26A mRNA,,,PMID:33359661,https://www.ncbi.nlm.nih.gov/pubmed/33359661,33359661,,
771,706066,6041,Comparative Toxicogenomics Database (CTD),Phenylephrine,D010656,Phenylephrine,https://ctdbase.org/detail.go?type=chem&acc=D010656,148,ADRA1A,https://ctdbase.org/detail.go?type=gene&acc=148,,,148.0,ADRA1A,10116.0,Rattus norvegicus (Norway rat),Calcium affects the reaction [[phenylephrine results in increased activity of ADRA1A protein] which results in increased phosphorylation of RPS6KB1 protein]|calcium affects the reaction [[phenylephrine results in increased activity of ADRA1A protein] which results in increased phosphorylation of EIF4EBP1 protein]|ethanol inhibits the reaction [[phenylephrine results in increased activity of ADRA1A protein] which results in increased phosphorylation of MTOR protein]|[phenylephrine results in increased activity of ADRA1A protein] which results in increased phosphorylation of MTOR protein|[phenylephrine results in increased activity of ADRA1A protein] which results in increased phosphorylation of EIF4EBP1 protein|ethanol inhibits the reaction [[phenylephrine results in increased activity of ADRA1A protein] which results in increased phosphorylation of EIF4EBP1 protein]|ethanol inhibits the reaction [[phenylephrine results in increased activity of ADRA1A protein] which results in increased phosphorylation of RPS6KB1 protein]|[phenylephrine results in increased activity of ADRA1A protein] which results in increased phosphorylation of RPS6KB1 protein|calcium affects the reaction [[phenylephrine results in increased activity of ADRA1A protein] which results in increased phosphorylation of MTOR protein],,,PMID:12935885,https://www.ncbi.nlm.nih.gov/pubmed/12935885,12935885,,
772,706067,6041,Comparative Toxicogenomics Database (CTD),Phenylephrine,D010656,Phenylephrine,https://ctdbase.org/detail.go?type=chem&acc=D010656,148,ADRA1A,https://ctdbase.org/detail.go?type=gene&acc=148,,,148.0,ADRA1A,10116.0,Rattus norvegicus (Norway rat),Phenylephrine affects the activity of ADRA1A protein|[phenylephrine affects the activity of ADRA1A protein] which affects the transport of potassium,,,PMID:19133277,https://www.ncbi.nlm.nih.gov/pubmed/19133277,19133277,,
773,706068,6041,Comparative Toxicogenomics Database (CTD),Phenylephrine,D010656,Phenylephrine,https://ctdbase.org/detail.go?type=chem&acc=D010656,148,ADRA1A,https://ctdbase.org/detail.go?type=gene&acc=148,,,148.0,ADRA1A,10116.0,Rattus norvegicus (Norway rat),Phenylephrine binds to and results in increased activity of ADRA1A protein,,,PMID:15550506|PMID:15672411|PMID:16545797,https://www.ncbi.nlm.nih.gov/pubmed/15550506|https://www.ncbi.nlm.nih.gov/pubmed/15672411|https://www.ncbi.nlm.nih.gov/pubmed/16545797,15550506|15672411|16545797,,
774,706518,6041,Comparative Toxicogenomics Database (CTD),Phenylephrine,D010656,Phenylephrine,https://ctdbase.org/detail.go?type=chem&acc=D010656,147,ADRA1B,https://ctdbase.org/detail.go?type=gene&acc=147,,,147.0,ADRA1B,10116.0,Rattus norvegicus (Norway rat),ADRA1B protein affects the reaction [phenylephrine results in decreased activity of TGM2 protein],,,PMID:10801782,https://www.ncbi.nlm.nih.gov/pubmed/10801782,10801782,,
775,706519,6041,Comparative Toxicogenomics Database (CTD),Phenylephrine,D010656,Phenylephrine,https://ctdbase.org/detail.go?type=chem&acc=D010656,147,ADRA1B,https://ctdbase.org/detail.go?type=gene&acc=147,,,147.0,ADRA1B,10116.0,Rattus norvegicus (Norway rat),Phenylephrine results in decreased expression of ADRA1B protein|phenylephrine results in decreased expression of ADRA1B mRNA,,,PMID:11693201,https://www.ncbi.nlm.nih.gov/pubmed/11693201,11693201,,
776,706520,6041,Comparative Toxicogenomics Database (CTD),Phenylephrine,D010656,Phenylephrine,https://ctdbase.org/detail.go?type=chem&acc=D010656,147,ADRA1B,https://ctdbase.org/detail.go?type=gene&acc=147,,,147.0,ADRA1B,9823.0,Sus scrofa (pig),Phenylephrine results in increased activity of ADRA1B protein,,,PMID:19376108,https://www.ncbi.nlm.nih.gov/pubmed/19376108,19376108,,
777,706521,6041,Comparative Toxicogenomics Database (CTD),Phenylephrine,D010656,Phenylephrine,https://ctdbase.org/detail.go?type=chem&acc=D010656,146,ADRA1D,https://ctdbase.org/detail.go?type=gene&acc=146,,,146.0,ADRA1D,9615.0,Canis lupus familiaris (dog),BMY 7378 inhibits the reaction [phenylephrine binds to and results in increased activity of ADRA1D protein]|naftopidil inhibits the reaction [phenylephrine binds to and results in increased activity of ADRA1D protein]|phenylephrine binds to and results in increased activity of ADRA1D protein,,,PMID:19371927,https://www.ncbi.nlm.nih.gov/pubmed/19371927,19371927,,
778,706522,6041,Comparative Toxicogenomics Database (CTD),Phenylephrine,D010656,Phenylephrine,https://ctdbase.org/detail.go?type=chem&acc=D010656,146,ADRA1D,https://ctdbase.org/detail.go?type=gene&acc=146,,,146.0,ADRA1D,9606.0,Homo sapiens (human),Carvedilol inhibits the reaction [[phenylephrine results in increased activity of ADRA1D protein] which results in increased abundance of calcium]|phentolamine inhibits the reaction [[phenylephrine results in increased activity of ADRA1D protein] which results in increased abundance of calcium]|phentolamine inhibits the reaction [[phenylephrine co-treated with ADRA1D protein] results in increased phosphorylation of MAPK3 protein]|[phenylephrine co-treated with ADRA1D protein] results in increased phosphorylation of MAPK3 protein|phenylephrine results in increased activity of ADRA1D protein|carvedilol inhibits the reaction [[phenylephrine co-treated with ADRA1D protein] results in increased phosphorylation of MAPK3 protein]|carvedilol inhibits the reaction [[phenylephrine co-treated with ADRA1D protein] results in increased phosphorylation of MAPK1 protein]|[phenylephrine results in increased activity of ADRA1D protein] which results in increased abundance of calcium|[phenylephrine co-treated with ADRA1D protein] results in increased phosphorylation of MAPK1 protein|phentolamine inhibits the reaction [[phenylephrine co-treated with ADRA1D protein] results in increased phosphorylation of MAPK1 protein],,,PMID:15306222,https://www.ncbi.nlm.nih.gov/pubmed/15306222,15306222,,
779,707718,6041,Comparative Toxicogenomics Database (CTD),Phenylephrine,D010656,Phenylephrine,https://ctdbase.org/detail.go?type=chem&acc=D010656,551,AVP,https://ctdbase.org/detail.go?type=gene&acc=551,,,551.0,AVP,10116.0,Rattus norvegicus (Norway rat),Dexamethasone inhibits the reaction [phenylephrine results in increased secretion of AVP protein],,,PMID:2271928,https://www.ncbi.nlm.nih.gov/pubmed/2271928,2271928,,
780,516376,6124,Comparative Toxicogenomics Database (CTD),N-Nitrosodimethylamine,D004128,Dimethylnitrosamine,https://ctdbase.org/detail.go?type=chem&acc=D004128,7171,TPM4,https://ctdbase.org/detail.go?type=gene&acc=7171,,,7171.0,TPM4,10116.0,Rattus norvegicus (Norway rat),Dimethylnitrosamine results in increased expression of TPM4 mRNA,,,PMID:25380136,https://www.ncbi.nlm.nih.gov/pubmed/25380136,25380136,,
781,516377,6124,Comparative Toxicogenomics Database (CTD),N-Nitrosodimethylamine,D004128,Dimethylnitrosamine,https://ctdbase.org/detail.go?type=chem&acc=D004128,29896,TRA2A,https://ctdbase.org/detail.go?type=gene&acc=29896,,,29896.0,TRA2A,9606.0,Homo sapiens (human),Dimethylnitrosamine results in decreased expression of TRA2A mRNA,,,PMID:17547211,https://www.ncbi.nlm.nih.gov/pubmed/17547211,17547211,,
782,516378,6124,Comparative Toxicogenomics Database (CTD),N-Nitrosodimethylamine,D004128,Dimethylnitrosamine,https://ctdbase.org/detail.go?type=chem&acc=D004128,66008,TRAK2,https://ctdbase.org/detail.go?type=gene&acc=66008,,,66008.0,TRAK2,10116.0,Rattus norvegicus (Norway rat),Dimethylnitrosamine results in increased expression of TRAK2 mRNA,,,PMID:25380136,https://www.ncbi.nlm.nih.gov/pubmed/25380136,25380136,,
783,516379,6124,Comparative Toxicogenomics Database (CTD),N-Nitrosodimethylamine,D004128,Dimethylnitrosamine,https://ctdbase.org/detail.go?type=chem&acc=D004128,10221,TRIB1,https://ctdbase.org/detail.go?type=gene&acc=10221,,,10221.0,TRIB1,9606.0,Homo sapiens (human),Dimethylnitrosamine results in increased expression of TRIB1 mRNA,,,PMID:17547211,https://www.ncbi.nlm.nih.gov/pubmed/17547211,17547211,,
784,516380,6124,Comparative Toxicogenomics Database (CTD),N-Nitrosodimethylamine,D004128,Dimethylnitrosamine,https://ctdbase.org/detail.go?type=chem&acc=D004128,57761,TRIB3,https://ctdbase.org/detail.go?type=gene&acc=57761,,,57761.0,TRIB3,10116.0,Rattus norvegicus (Norway rat),Dimethylnitrosamine results in increased expression of TRIB3 mRNA,,,PMID:25380136,https://www.ncbi.nlm.nih.gov/pubmed/25380136,25380136,,
785,516381,6124,Comparative Toxicogenomics Database (CTD),N-Nitrosodimethylamine,D004128,Dimethylnitrosamine,https://ctdbase.org/detail.go?type=chem&acc=D004128,286827,TRIM59,https://ctdbase.org/detail.go?type=gene&acc=286827,,,286827.0,TRIM59,10116.0,Rattus norvegicus (Norway rat),Dimethylnitrosamine results in decreased expression of TRIM59 mRNA,,,PMID:25380136,https://www.ncbi.nlm.nih.gov/pubmed/25380136,25380136,,
786,516382,6124,Comparative Toxicogenomics Database (CTD),N-Nitrosodimethylamine,D004128,Dimethylnitrosamine,https://ctdbase.org/detail.go?type=chem&acc=D004128,8848,TSC22D1,https://ctdbase.org/detail.go?type=gene&acc=8848,,,8848.0,TSC22D1,10116.0,Rattus norvegicus (Norway rat),Dimethylnitrosamine results in decreased expression of TSC22D1 mRNA,,,PMID:15890375,https://www.ncbi.nlm.nih.gov/pubmed/15890375,15890375,,
787,516383,6124,Comparative Toxicogenomics Database (CTD),N-Nitrosodimethylamine,D004128,Dimethylnitrosamine,https://ctdbase.org/detail.go?type=chem&acc=D004128,7253,TSHR,https://ctdbase.org/detail.go?type=gene&acc=7253,,,7253.0,TSHR,10116.0,Rattus norvegicus (Norway rat),Dimethylnitrosamine results in decreased expression of TSHR mRNA,,,PMID:15976192,https://www.ncbi.nlm.nih.gov/pubmed/15976192,15976192,,
788,518896,6172,Comparative Toxicogenomics Database (CTD),Gallamine Triethiodide,D005703,Gallamine Triethiodide,https://ctdbase.org/detail.go?type=chem&acc=D005703,1133,CHRM5,https://ctdbase.org/detail.go?type=gene&acc=1133,,,1133.0,CHRM5,9606.0,Homo sapiens (human),CHRM5 protein binds to gallamine triethiodide|[chrm5 protein binds to gallamine triethiodide] affects the reaction [CHRM5 protein binds to N-methylscopolamine],,,PMID:16641315,https://www.ncbi.nlm.nih.gov/pubmed/16641315,16641315,,
789,518897,6172,Comparative Toxicogenomics Database (CTD),Gallamine Triethiodide,D005703,Gallamine Triethiodide,https://ctdbase.org/detail.go?type=chem&acc=D005703,1133,CHRM5,https://ctdbase.org/detail.go?type=gene&acc=1133,,,1133.0,CHRM5,9606.0,Homo sapiens (human),[CHRM5 protein binds to gallamine triethiodide] promotes the reaction [CHRM5 protein binds to N-methylscopolamine],,,PMID:15937215,https://www.ncbi.nlm.nih.gov/pubmed/15937215,15937215,,
790,518898,6172,Comparative Toxicogenomics Database (CTD),Gallamine Triethiodide,D005703,Gallamine Triethiodide,https://ctdbase.org/detail.go?type=chem&acc=D005703,1133,CHRM5,https://ctdbase.org/detail.go?type=gene&acc=1133,,,1133.0,CHRM5,9606.0,Homo sapiens (human),Gallamine triethiodide inhibits the reaction [N-methylscopolamine binds to CHRM5 protein],,,PMID:9846649,https://www.ncbi.nlm.nih.gov/pubmed/9846649,9846649,,
791,518899,6179,Drug Gene Interaction database (DGIdb),Mebanazine,,MEBANAZINE,https://www.dgidb.org/drugs/ncit:C80969,,MAOA,https://www.dgidb.org/genes/hgnc:6833,,,4128.0,MAOA,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
792,518900,6197,ChEMBL,Cycloheximide,CHEMBL123292,CYCLOHEXIMIDE,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL123292/,CHEMBL3987582,80S Ribosome,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL3987582/,P05386,60S acidic ribosomal protein P1,6176.0,RPLP1,9606.0,Homo sapiens (human),80S ribosome inhibitor,,,PMID:20118940|PMID:27665925,https://www.ncbi.nlm.nih.gov/pubmed/20118940|https://www.ncbi.nlm.nih.gov/pubmed/27665925,20118940|27665925,,
793,518901,6197,ChEMBL,Cycloheximide,CHEMBL123292,CYCLOHEXIMIDE,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL123292/,CHEMBL3987582,80S Ribosome,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL3987582/,P05388,60S acidic ribosomal protein P0,6175.0,RPLP0,9606.0,Homo sapiens (human),80S ribosome inhibitor,,,PMID:20118940|PMID:27665925,https://www.ncbi.nlm.nih.gov/pubmed/20118940|https://www.ncbi.nlm.nih.gov/pubmed/27665925,20118940|27665925,,
794,518902,6197,ChEMBL,Cycloheximide,CHEMBL123292,CYCLOHEXIMIDE,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL123292/,CHEMBL3987582,80S Ribosome,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL3987582/,P08708,40S ribosomal protein S17,6218.0,RPS17,9606.0,Homo sapiens (human),80S ribosome inhibitor,,,PMID:20118940|PMID:27665925,https://www.ncbi.nlm.nih.gov/pubmed/20118940|https://www.ncbi.nlm.nih.gov/pubmed/27665925,20118940|27665925,,
795,518903,6197,ChEMBL,Cycloheximide,CHEMBL123292,CYCLOHEXIMIDE,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL123292/,CHEMBL3987582,80S Ribosome,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL3987582/,P08865,40S ribosomal protein SA,3921.0,RPSA,9606.0,Homo sapiens (human),80S ribosome inhibitor,,,PMID:20118940|PMID:27665925,https://www.ncbi.nlm.nih.gov/pubmed/20118940|https://www.ncbi.nlm.nih.gov/pubmed/27665925,20118940|27665925,,
796,519065,6197,ChEMBL,Cycloheximide,CHEMBL123292,CYCLOHEXIMIDE,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL123292/,CHEMBL3987582,80S Ribosome,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL3987582/,P22090,"40S ribosomal protein S4, Y isoform 1",6192.0,RPS4Y1,9606.0,Homo sapiens (human),80S ribosome inhibitor,,,PMID:20118940|PMID:27665925,https://www.ncbi.nlm.nih.gov/pubmed/20118940|https://www.ncbi.nlm.nih.gov/pubmed/27665925,20118940|27665925,,
797,519066,6197,ChEMBL,Cycloheximide,CHEMBL123292,CYCLOHEXIMIDE,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL123292/,CHEMBL3987582,80S Ribosome,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL3987582/,P23396,40S ribosomal protein S3,6188.0,RPS3,9606.0,Homo sapiens (human),80S ribosome inhibitor,,,PMID:20118940|PMID:27665925,https://www.ncbi.nlm.nih.gov/pubmed/20118940|https://www.ncbi.nlm.nih.gov/pubmed/27665925,20118940|27665925,,
798,519067,6197,ChEMBL,Cycloheximide,CHEMBL123292,CYCLOHEXIMIDE,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL123292/,CHEMBL3987582,80S Ribosome,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL3987582/,P25398,40S ribosomal protein S12,6206.0,RPS12,9606.0,Homo sapiens (human),80S ribosome inhibitor,,,PMID:20118940|PMID:27665925,https://www.ncbi.nlm.nih.gov/pubmed/20118940|https://www.ncbi.nlm.nih.gov/pubmed/27665925,20118940|27665925,,
799,519068,6197,ChEMBL,Cycloheximide,CHEMBL123292,CYCLOHEXIMIDE,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL123292/,CHEMBL3987582,80S Ribosome,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL3987582/,P26373,60S ribosomal protein L13,6137.0,RPL13,9606.0,Homo sapiens (human),80S ribosome inhibitor,,,PMID:20118940|PMID:27665925,https://www.ncbi.nlm.nih.gov/pubmed/20118940|https://www.ncbi.nlm.nih.gov/pubmed/27665925,20118940|27665925,,
800,519069,6197,ChEMBL,Cycloheximide,CHEMBL123292,CYCLOHEXIMIDE,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL123292/,CHEMBL3987582,80S Ribosome,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL3987582/,P27635,60S ribosomal protein L10,6134.0,RPL10,9606.0,Homo sapiens (human),80S ribosome inhibitor,,,PMID:20118940|PMID:27665925,https://www.ncbi.nlm.nih.gov/pubmed/20118940|https://www.ncbi.nlm.nih.gov/pubmed/27665925,20118940|27665925,,
801,519917,6197,Comparative Toxicogenomics Database (CTD),Cycloheximide,D003513,Cycloheximide,https://ctdbase.org/detail.go?type=chem&acc=D003513,1435,CSF1,https://ctdbase.org/detail.go?type=gene&acc=1435,,,1435.0,CSF1,10090.0,Mus musculus (house mouse),Cycloheximide inhibits the reaction [genistein promotes the reaction [[zinc sulfate co-treated with CSF1 protein co-treated with TNFSF11 protein] results in increased expression of CASP3 mrna]],,,PMID:17295206,https://www.ncbi.nlm.nih.gov/pubmed/17295206,17295206,,
802,519918,6197,Comparative Toxicogenomics Database (CTD),Cycloheximide,D003513,Cycloheximide,https://ctdbase.org/detail.go?type=chem&acc=D003513,1435,CSF1,https://ctdbase.org/detail.go?type=gene&acc=1435,,,1435.0,CSF1,10090.0,Mus musculus (house mouse),Cycloheximide inhibits the reaction [zinc results in increased expression of CSF1 mrna],,,PMID:12112025,https://www.ncbi.nlm.nih.gov/pubmed/12112025,12112025,,
803,519919,6197,Comparative Toxicogenomics Database (CTD),Cycloheximide,D003513,Cycloheximide,https://ctdbase.org/detail.go?type=chem&acc=D003513,1437,CSF2,https://ctdbase.org/detail.go?type=gene&acc=1437,,,1437.0,CSF2,9606.0,Homo sapiens (human),Cycloheximide inhibits the reaction [IL1B results in increased secretion of CSF2 protein],,,PMID:9606035,https://www.ncbi.nlm.nih.gov/pubmed/9606035,9606035,,
804,519920,6197,Comparative Toxicogenomics Database (CTD),Cycloheximide,D003513,Cycloheximide,https://ctdbase.org/detail.go?type=chem&acc=D003513,1437,CSF2,https://ctdbase.org/detail.go?type=gene&acc=1437,,,1437.0,CSF2,9606.0,Homo sapiens (human),Cycloheximide inhibits the reaction [particulate matter results in increased secretion of CSF2 protein]|cycloheximide inhibits the reaction [vehicle emissions results in increased secretion of CSF2 protein],,,PMID:10645887,https://www.ncbi.nlm.nih.gov/pubmed/10645887,10645887,,
805,519921,6197,Comparative Toxicogenomics Database (CTD),Cycloheximide,D003513,Cycloheximide,https://ctdbase.org/detail.go?type=chem&acc=D003513,1453,CSNK1D,https://ctdbase.org/detail.go?type=gene&acc=1453,,,1453.0,CSNK1D,9606.0,Homo sapiens (human),Cycloheximide promotes the reaction [tetrachlorodibenzodioxin results in decreased expression of CSNK1D mrna],,,PMID:11007951,https://www.ncbi.nlm.nih.gov/pubmed/11007951,11007951,,
806,519922,6197,Comparative Toxicogenomics Database (CTD),Cycloheximide,D003513,Cycloheximide,https://ctdbase.org/detail.go?type=chem&acc=D003513,1460,CSNK2B,https://ctdbase.org/detail.go?type=gene&acc=1460,,,1460.0,CSNK2B,10090.0,Mus musculus (house mouse),Cycloheximide results in decreased degradation of CSNK2B protein|tnfaip1 protein inhibits the reaction [cycloheximide results in decreased degradation of CSNK2B protein]|diethylhexyl phthalate inhibits the reaction [cycloheximide results in decreased degradation of CSNK2B protein],,,PMID:37302538,https://www.ncbi.nlm.nih.gov/pubmed/37302538,37302538,,
807,521497,6197,Comparative Toxicogenomics Database (CTD),Cycloheximide,D003513,Cycloheximide,https://ctdbase.org/detail.go?type=chem&acc=D003513,1734,DIO2,https://ctdbase.org/detail.go?type=gene&acc=1734,,,1734.0,DIO2,9606.0,Homo sapiens (human),"[cycloheximide co-treated with benzyloxycarbonylleucyl-leucyl-leucine aldehyde] results in decreased activity of DIO2 protein|cycloheximide promotes the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [triiodothyronine, reverse results in decreased activity of DIO2 protein]]|[cycloheximide co-treated with benzyloxycarbonylleucyl-leucyl-leucine aldehyde] inhibits the reaction [2,2',4,4',5-brominated diphenyl ether metabolite results in decreased activity of DIO2 protein]|cycloheximide promotes the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [2,2',4,4',5-brominated diphenyl ether results in decreased activity of DIO2 protein]]",,,PMID:26004626,https://www.ncbi.nlm.nih.gov/pubmed/26004626,26004626,,
808,521498,6197,Comparative Toxicogenomics Database (CTD),Cycloheximide,D003513,Cycloheximide,https://ctdbase.org/detail.go?type=chem&acc=D003513,1735,DIO3,https://ctdbase.org/detail.go?type=gene&acc=1735,,,1735.0,DIO3,10116.0,Rattus norvegicus (Norway rat),Cycloheximide inhibits the reaction [hydrogen peroxide results in increased activity of DIO3 protein],,,PMID:18420745,https://www.ncbi.nlm.nih.gov/pubmed/18420745,18420745,,
809,521499,6197,Comparative Toxicogenomics Database (CTD),Cycloheximide,D003513,Cycloheximide,https://ctdbase.org/detail.go?type=chem&acc=D003513,8847,DLEU2,https://ctdbase.org/detail.go?type=gene&acc=8847,,,8847.0,DLEU2,9606.0,Homo sapiens (human),[cycloheximide co-treated with estradiol] results in increased expression of DLEU2 mrna|cycloheximide results in increased expression of DLEU2 mRNA,,,PMID:15072547,https://www.ncbi.nlm.nih.gov/pubmed/15072547,15072547,,
810,521500,6197,Comparative Toxicogenomics Database (CTD),Cycloheximide,D003513,Cycloheximide,https://ctdbase.org/detail.go?type=chem&acc=D003513,25822,DNAJB5,https://ctdbase.org/detail.go?type=gene&acc=25822,,,25822.0,DNAJB5,9606.0,Homo sapiens (human),Cycloheximide inhibits the reaction [tetrachlorodibenzodioxin results in decreased expression of DNAJB5 mrna],,,PMID:11007951,https://www.ncbi.nlm.nih.gov/pubmed/11007951,11007951,,
811,523758,6197,Comparative Toxicogenomics Database (CTD),Cycloheximide,D003513,Cycloheximide,https://ctdbase.org/detail.go?type=chem&acc=D003513,2619,GAS1,https://ctdbase.org/detail.go?type=gene&acc=2619,,,2619.0,GAS1,9606.0,Homo sapiens (human),Cycloheximide inhibits the reaction [tetrachlorodibenzodioxin results in decreased expression of GAS1 mrna],,,PMID:11007951,https://www.ncbi.nlm.nih.gov/pubmed/11007951,11007951,,
812,523759,6197,Comparative Toxicogenomics Database (CTD),Cycloheximide,D003513,Cycloheximide,https://ctdbase.org/detail.go?type=chem&acc=D003513,2729,GCLC,https://ctdbase.org/detail.go?type=gene&acc=2729,,,2729.0,GCLC,9913.0,Bos taurus (cattle),"Cycloheximide inhibits the reaction [2,3-dimethoxy-1,4-naphthoquinone results in increased expression of GCLC mrna]",,,PMID:7943345,https://www.ncbi.nlm.nih.gov/pubmed/7943345,7943345,,
813,523760,6197,Comparative Toxicogenomics Database (CTD),Cycloheximide,D003513,Cycloheximide,https://ctdbase.org/detail.go?type=chem&acc=D003513,2729,GCLC,https://ctdbase.org/detail.go?type=gene&acc=2729,,,2729.0,GCLC,10090.0,Mus musculus (house mouse),Cycloheximide inhibits the reaction [arsenite results in increased expression of [GCLC protein binds to GCLM protein]]|cycloheximide inhibits the reaction [arsenite results in increased expression of GCLC mrna]|cycloheximide inhibits the reaction [arsenite results in increased activity of [GCLC protein binds to GCLM protein]],,,PMID:19328227,https://www.ncbi.nlm.nih.gov/pubmed/19328227,19328227,,
814,523761,6197,Comparative Toxicogenomics Database (CTD),Cycloheximide,D003513,Cycloheximide,https://ctdbase.org/detail.go?type=chem&acc=D003513,2729,GCLC,https://ctdbase.org/detail.go?type=gene&acc=2729,,,2729.0,GCLC,10090.0,Mus musculus (house mouse),Cycloheximide inhibits the reaction [diphenylarsinic acid results in increased expression of GCLC protein],,,PMID:17628625,https://www.ncbi.nlm.nih.gov/pubmed/17628625,17628625,,
815,523762,6197,Comparative Toxicogenomics Database (CTD),Cycloheximide,D003513,Cycloheximide,https://ctdbase.org/detail.go?type=chem&acc=D003513,2729,GCLC,https://ctdbase.org/detail.go?type=gene&acc=2729,,,2729.0,GCLC,10116.0,Rattus norvegicus (Norway rat),Cycloheximide inhibits the reaction [notoginsenoside R1 results in increased expression of GCLC protein],,,PMID:24437944,https://www.ncbi.nlm.nih.gov/pubmed/24437944,24437944,,
816,523763,6197,Comparative Toxicogenomics Database (CTD),Cycloheximide,D003513,Cycloheximide,https://ctdbase.org/detail.go?type=chem&acc=D003513,2730,GCLM,https://ctdbase.org/detail.go?type=gene&acc=2730,,,2730.0,GCLM,10090.0,Mus musculus (house mouse),Cycloheximide inhibits the reaction [arsenite results in increased expression of [GCLC protein binds to GCLM protein]]|cycloheximide inhibits the reaction [arsenite results in increased expression of GCLM mrna]|cycloheximide inhibits the reaction [arsenite results in increased activity of [GCLC protein binds to GCLM protein]],,,PMID:19328227,https://www.ncbi.nlm.nih.gov/pubmed/19328227,19328227,,
817,523764,6197,Comparative Toxicogenomics Database (CTD),Cycloheximide,D003513,Cycloheximide,https://ctdbase.org/detail.go?type=chem&acc=D003513,9518,GDF15,https://ctdbase.org/detail.go?type=gene&acc=9518,,,9518.0,GDF15,9606.0,Homo sapiens (human),Cycloheximide inhibits the reaction [trichostatin A affects the expression of GDF15 mrna]|cycloheximide inhibits the reaction [trichostatin A affects the expression of GDF15 protein],,,PMID:18801729,https://www.ncbi.nlm.nih.gov/pubmed/18801729,18801729,,
818,524214,6197,Comparative Toxicogenomics Database (CTD),Cycloheximide,D003513,Cycloheximide,https://ctdbase.org/detail.go?type=chem&acc=D003513,3091,HIF1A,https://ctdbase.org/detail.go?type=gene&acc=3091,,,3091.0,HIF1A,9606.0,Homo sapiens (human),Cycloheximide inhibits the reaction [bruceine D inhibits the reaction [oxygen deficiency results in increased expression of HIF1A protein]],,,PMID:34900531,https://www.ncbi.nlm.nih.gov/pubmed/34900531,34900531,,
819,524215,6197,Comparative Toxicogenomics Database (CTD),Cycloheximide,D003513,Cycloheximide,https://ctdbase.org/detail.go?type=chem&acc=D003513,3091,HIF1A,https://ctdbase.org/detail.go?type=gene&acc=3091,,,3091.0,HIF1A,9606.0,Homo sapiens (human),Cycloheximide inhibits the reaction [[cobaltous chloride co-treated with glucose] results in increased expression of HIF1A protein]|scutellarin inhibits the reaction [[cobaltous chloride co-treated with glucose co-treated with cycloheximide] results in decreased expression of HIF1A protein]|scutellarin promotes the reaction [cycloheximide inhibits the reaction [[cobaltous chloride co-treated with glucose] results in increased expression of HIF1A protein]],,,PMID:25192544,https://www.ncbi.nlm.nih.gov/pubmed/25192544,25192544,,
820,699934,6197,Comparative Toxicogenomics Database (CTD),Cycloheximide,D003513,Cycloheximide,https://ctdbase.org/detail.go?type=chem&acc=D003513,5244,ABCB4,https://ctdbase.org/detail.go?type=gene&acc=5244,,,5244.0,ABCB4,9606.0,Homo sapiens (human),Cycloheximide inhibits the reaction [tetradecanoylphorbol acetate results in decreased expression of ABCB4 mrna],,,PMID:11331069,https://www.ncbi.nlm.nih.gov/pubmed/11331069,11331069,,
821,699935,6197,Comparative Toxicogenomics Database (CTD),Cycloheximide,D003513,Cycloheximide,https://ctdbase.org/detail.go?type=chem&acc=D003513,8714,ABCC3,https://ctdbase.org/detail.go?type=gene&acc=8714,,,8714.0,ABCC3,9606.0,Homo sapiens (human),[cycloheximide co-treated with estradiol] results in increased expression of ABCC3 mrna|cycloheximide results in increased expression of ABCC3 mRNA,,,PMID:15072547,https://www.ncbi.nlm.nih.gov/pubmed/15072547,15072547,,
822,699936,6197,Comparative Toxicogenomics Database (CTD),Cycloheximide,D003513,Cycloheximide,https://ctdbase.org/detail.go?type=chem&acc=D003513,10057,ABCC5,https://ctdbase.org/detail.go?type=gene&acc=10057,,,10057.0,ABCC5,9606.0,Homo sapiens (human),[cycloheximide co-treated with estradiol] results in decreased expression of ABCC5 mrna|cycloheximide results in decreased expression of ABCC5 mRNA,,,PMID:15072547,https://www.ncbi.nlm.nih.gov/pubmed/15072547,15072547,,
823,699937,6197,Comparative Toxicogenomics Database (CTD),Cycloheximide,D003513,Cycloheximide,https://ctdbase.org/detail.go?type=chem&acc=D003513,2181,ACSL3,https://ctdbase.org/detail.go?type=gene&acc=2181,,,2181.0,ACSL3,9606.0,Homo sapiens (human),[tetrachlorodibenzodioxin co-treated with cycloheximide] affects the expression of ACSL3 mRNA,,,PMID:19684285,https://www.ncbi.nlm.nih.gov/pubmed/19684285,19684285,,
824,699938,6197,Comparative Toxicogenomics Database (CTD),Cycloheximide,D003513,Cycloheximide,https://ctdbase.org/detail.go?type=chem&acc=D003513,23305,ACSL6,https://ctdbase.org/detail.go?type=gene&acc=23305,,,23305.0,ACSL6,10116.0,Rattus norvegicus (Norway rat),Cycloheximide inhibits the reaction [4-(3-(2-propyl-3-hydroxy-4-acetyl)phenoxy)propyloxyphenoxy acetic acid results in increased expression of ACSL6 mrna],,,PMID:10585473,https://www.ncbi.nlm.nih.gov/pubmed/10585473,10585473,,
825,699939,6197,Comparative Toxicogenomics Database (CTD),Cycloheximide,D003513,Cycloheximide,https://ctdbase.org/detail.go?type=chem&acc=D003513,6868,ADAM17,https://ctdbase.org/detail.go?type=gene&acc=6868,,,6868.0,ADAM17,9606.0,Homo sapiens (human),"N(6),N(6)-dimethyladenosine inhibits the reaction [cycloheximide results in decreased stability of ADAM17 protein]|cycloheximide results in decreased stability of ADAM17 protein|cordycepin inhibits the reaction [cycloheximide results in decreased stability of ADAM17 protein]",,,PMID:36558177,https://www.ncbi.nlm.nih.gov/pubmed/36558177,36558177,,
826,699940,6197,Comparative Toxicogenomics Database (CTD),Cycloheximide,D003513,Cycloheximide,https://ctdbase.org/detail.go?type=chem&acc=D003513,8754,ADAM9,https://ctdbase.org/detail.go?type=gene&acc=8754,,,8754.0,ADAM9,9606.0,Homo sapiens (human),Cycloheximide inhibits the reaction [hydrogen peroxide results in increased expression of ADAM9 protein],,,PMID:17018608,https://www.ncbi.nlm.nih.gov/pubmed/17018608,17018608,,
827,700112,6197,Comparative Toxicogenomics Database (CTD),Cycloheximide,D003513,Cycloheximide,https://ctdbase.org/detail.go?type=chem&acc=D003513,154,ADRB2,https://ctdbase.org/detail.go?type=gene&acc=154,,,154.0,ADRB2,9606.0,Homo sapiens (human),Cycloheximide results in increased expression of ADRB2 mrna|cycloheximide inhibits the reaction [olodaterol affects the expression of ADRB2 mrna]|dactinomycin inhibits the reaction [cycloheximide results in increased expression of ADRB2 protein]|formoterol fumarate promotes the reaction [cycloheximide results in increased expression of ADRB2 mrna]|cycloheximide results in increased expression of ADRB2 protein|n(6)-benzoyl-cyclic AMP promotes the reaction [cycloheximide results in increased expression of ADRB2 mrna],,,PMID:24705868,https://www.ncbi.nlm.nih.gov/pubmed/24705868,24705868,,
828,700113,6197,Comparative Toxicogenomics Database (CTD),Cycloheximide,D003513,Cycloheximide,https://ctdbase.org/detail.go?type=chem&acc=D003513,192669,AGO3,https://ctdbase.org/detail.go?type=gene&acc=192669,,,192669.0,AGO3,10090.0,Mus musculus (house mouse),Cycloheximide inhibits the reaction [thapsigargin affects the localization of AGO3 mrna],,,PMID:29576526,https://www.ncbi.nlm.nih.gov/pubmed/29576526,29576526,,
829,700114,6197,Comparative Toxicogenomics Database (CTD),Cycloheximide,D003513,Cycloheximide,https://ctdbase.org/detail.go?type=chem&acc=D003513,196,AHR,https://ctdbase.org/detail.go?type=gene&acc=196,,,196.0,AHR,9606.0,Homo sapiens (human),Cycloheximide promotes the reaction [tetrachlorodibenzodioxin results in increased degradation of and results in decreased expression of AHR protein]|benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [cycloheximide results in decreased expression of AHR protein]|cycloheximide results in decreased expression of AHR protein,,,PMID:15385644,https://www.ncbi.nlm.nih.gov/pubmed/15385644,15385644,,
830,700115,6197,Comparative Toxicogenomics Database (CTD),Cycloheximide,D003513,Cycloheximide,https://ctdbase.org/detail.go?type=chem&acc=D003513,196,AHR,https://ctdbase.org/detail.go?type=gene&acc=196,,,196.0,AHR,9606.0,Homo sapiens (human),Cycloheximide inhibits the reaction [TGFB1 protein results in decreased expression of AHR mrna],,,PMID:9145908,https://www.ncbi.nlm.nih.gov/pubmed/9145908,9145908,,
831,700116,6197,Comparative Toxicogenomics Database (CTD),Cycloheximide,D003513,Cycloheximide,https://ctdbase.org/detail.go?type=chem&acc=D003513,196,AHR,https://ctdbase.org/detail.go?type=gene&acc=196,,,196.0,AHR,10090.0,Mus musculus (house mouse),AHR protein promotes the reaction [cycloheximide results in increased expression of TIPARP mrna],,,PMID:12147270,https://www.ncbi.nlm.nih.gov/pubmed/12147270,12147270,,
832,700117,6197,Comparative Toxicogenomics Database (CTD),Cycloheximide,D003513,Cycloheximide,https://ctdbase.org/detail.go?type=chem&acc=D003513,196,AHR,https://ctdbase.org/detail.go?type=gene&acc=196,,,196.0,AHR,10090.0,Mus musculus (house mouse),Cycloheximide inhibits the reaction [tetrachlorodibenzodioxin results in increased degradation of AHR protein],,,PMID:10777561|PMID:12002481|PMID:16226227,https://www.ncbi.nlm.nih.gov/pubmed/10777561|https://www.ncbi.nlm.nih.gov/pubmed/12002481|https://www.ncbi.nlm.nih.gov/pubmed/16226227,10777561|12002481|16226227,,
833,700313,6197,Comparative Toxicogenomics Database (CTD),Cycloheximide,D003513,Cycloheximide,https://ctdbase.org/detail.go?type=chem&acc=D003513,196,AHR,https://ctdbase.org/detail.go?type=gene&acc=196,,,196.0,AHR,10090.0,Mus musculus (house mouse),Cycloheximide promotes the reaction [methylcholanthrene promotes the reaction [AHR protein binds to CYP1A1 enhancer]],,,PMID:20570689,https://www.ncbi.nlm.nih.gov/pubmed/20570689,20570689,,
834,700314,6197,Comparative Toxicogenomics Database (CTD),Cycloheximide,D003513,Cycloheximide,https://ctdbase.org/detail.go?type=chem&acc=D003513,196,AHR,https://ctdbase.org/detail.go?type=gene&acc=196,,,196.0,AHR,10090.0,Mus musculus (house mouse),Cycloheximide promotes the reaction [tetrachlorodibenzodioxin affects the localization of AHR protein],,,PMID:10777561,https://www.ncbi.nlm.nih.gov/pubmed/10777561,10777561,,
835,700315,6197,Comparative Toxicogenomics Database (CTD),Cycloheximide,D003513,Cycloheximide,https://ctdbase.org/detail.go?type=chem&acc=D003513,196,AHR,https://ctdbase.org/detail.go?type=gene&acc=196,,,196.0,AHR,10090.0,Mus musculus (house mouse),Cycloheximide results in increased localization of AHR protein|[cycloheximide results in increased activity of [AHR protein binds to ARNT protein]] which results in increased expression of CYP1A1 mrna|cycloheximide results in increased activity of [AHR protein binds to ARNT protein],,,PMID:12002481,https://www.ncbi.nlm.nih.gov/pubmed/12002481,12002481,,
836,700316,6197,Comparative Toxicogenomics Database (CTD),Cycloheximide,D003513,Cycloheximide,https://ctdbase.org/detail.go?type=chem&acc=D003513,196,AHR,https://ctdbase.org/detail.go?type=gene&acc=196,,,196.0,AHR,10090.0,Mus musculus (house mouse),[tretinoin co-treated with cycloheximide] results in increased expression of AHR mRNA,,,PMID:21807577,https://www.ncbi.nlm.nih.gov/pubmed/21807577,21807577,,
837,700317,6197,Comparative Toxicogenomics Database (CTD),Cycloheximide,D003513,Cycloheximide,https://ctdbase.org/detail.go?type=chem&acc=D003513,9495,AKAP5,https://ctdbase.org/detail.go?type=gene&acc=9495,,,9495.0,AKAP5,9606.0,Homo sapiens (human),Cycloheximide inhibits the reaction [tetrachlorodibenzodioxin results in decreased expression of AKAP5 mrna],,,PMID:11007951,https://www.ncbi.nlm.nih.gov/pubmed/11007951,11007951,,
838,700318,6197,Comparative Toxicogenomics Database (CTD),Cycloheximide,D003513,Cycloheximide,https://ctdbase.org/detail.go?type=chem&acc=D003513,9472,AKAP6,https://ctdbase.org/detail.go?type=gene&acc=9472,,,9472.0,AKAP6,9606.0,Homo sapiens (human),Cycloheximide inhibits the reaction [tetrachlorodibenzodioxin results in decreased expression of AKAP6 mrna],,,PMID:11007951,https://www.ncbi.nlm.nih.gov/pubmed/11007951,11007951,,
839,700319,6197,Comparative Toxicogenomics Database (CTD),Cycloheximide,D003513,Cycloheximide,https://ctdbase.org/detail.go?type=chem&acc=D003513,8644,AKR1C3,https://ctdbase.org/detail.go?type=gene&acc=8644,,,8644.0,AKR1C3,9606.0,Homo sapiens (human),Cycloheximide inhibits the reaction [cadmium acetate results in increased expression of AKR1C3 protein],,,PMID:21787718,https://www.ncbi.nlm.nih.gov/pubmed/21787718,21787718,,
840,701452,6241,Drug Gene Interaction database (DGIdb),Caffeine Citrate,,CAFFEINE CITRATE,https://www.dgidb.org/drugs/rxcui:20033,,ADORA1,https://www.dgidb.org/genes/hgnc:262,,,134.0,ADORA1,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
841,701453,6241,Drug Gene Interaction database (DGIdb),Caffeine Citrate,,CAFFEINE CITRATE,https://www.dgidb.org/drugs/rxcui:20033,,ADORA2B,https://www.dgidb.org/genes/hgnc:264,,,136.0,ADORA2B,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
842,701454,6251,Therapeutic Target Database (TTD),Mannitol,D0P7EK,Mannitol,https://idrblab.net/ttd/data/drug/details/D0P7EK,T08735,Aspergillus Mannitol 2-dehydrogenase (Asperg M2DH),https://idrblab.net/ttd/data/target/details/T08735,Q4WQY4,Mannitol 2-dehydrogenase,3509495.0,AFUA_4G14450,330879.0,Aspergillus fumigatus Af293,Activator,,,,,,,
843,701455,6251,Therapeutic Target Database (TTD),Mannitol,D0P7EK,Mannitol,https://idrblab.net/ttd/data/drug/details/D0P7EK,T93955,Aspergillus Mannitol-1-phosphate 5-dehydrogenase (Asperg mpdA),https://idrblab.net/ttd/data/target/details/T93955,Q4X1A4,Mannitol-1-phosphate 5-dehydrogenase,3513687.0,AFUA_2G10660,330879.0,Aspergillus fumigatus Af293,Activator,,,,,,,
844,699291,6294,Toxin and Toxin Target Database (T3DB),"p,p'-DDD",T3D0025,"P,P'-DDD",http://www.t3db.ca/toxins/T3D0025,BE0005003,Plasma membrane calcium-transporting ATPase 2,http://www.t3db.ca/biodb/bio_entities/BE0005003,Q01814,Plasma membrane calcium-transporting ATPase 2,491.0,ATP2B2,9606.0,Homo sapiens (human),"This organochloride inhibits na+/k+ atpase and ca2+ and mg2+ atpase, which are essential for the transport of calcium across membranes. this results in the accumulation of intracellular free calcium ions, which promotes release of neurotransmitters from storage vesicles, the subsequent depolarization of adjacent neurons, and the propagation of stimuli throughout the central nervous system. (T10)",,,,,,,
845,699292,6294,Toxin and Toxin Target Database (T3DB),"p,p'-DDD",T3D0025,"P,P'-DDD",http://www.t3db.ca/toxins/T3D0025,BE0004991,Plasma membrane calcium-transporting ATPase 3,http://www.t3db.ca/biodb/bio_entities/BE0004991,Q16720,Plasma membrane calcium-transporting ATPase 3,492.0,ATP2B3,9606.0,Homo sapiens (human),"This organochloride inhibits na+/k+ atpase and ca2+ and mg2+ atpase, which are essential for the transport of calcium across membranes. this results in the accumulation of intracellular free calcium ions, which promotes release of neurotransmitters from storage vesicles, the subsequent depolarization of adjacent neurons, and the propagation of stimuli throughout the central nervous system. (T10)",,,,,,,
846,699626,6294,Toxin and Toxin Target Database (T3DB),"p,p'-DDD",T3D0025,"P,P'-DDD",http://www.t3db.ca/toxins/T3D0025,BE0002082,Sodium channel protein type 3 subunit alpha,http://www.t3db.ca/biodb/bio_entities/BE0002082,Q9NY46,Sodium channel protein type 3 subunit alpha,6328.0,SCN3A,9606.0,Homo sapiens (human),"DDD inhibits the inactivation of voltaged-gated sodium channels. the channels activate (open) normally but are inactivated (closed) slowly, thus interfering with the active transport of sodium out of the nerve axon during repolarization and resulting in a state of hyperexcitability. (A99)",,,PMID:17487686,https://www.ncbi.nlm.nih.gov/pubmed/17487686,17487686,,
847,699627,6294,Toxin and Toxin Target Database (T3DB),"p,p'-DDD",T3D0025,"P,P'-DDD",http://www.t3db.ca/toxins/T3D0025,BE0002083,Sodium channel protein type 4 subunit alpha,http://www.t3db.ca/biodb/bio_entities/BE0002083,P35499,Sodium channel protein type 4 subunit alpha,6329.0,SCN4A,9606.0,Homo sapiens (human),"DDD inhibits the inactivation of voltaged-gated sodium channels. the channels activate (open) normally but are inactivated (closed) slowly, thus interfering with the active transport of sodium out of the nerve axon during repolarization and resulting in a state of hyperexcitability. (A99)",,,PMID:17487686,https://www.ncbi.nlm.nih.gov/pubmed/17487686,17487686,,
848,699628,6294,Toxin and Toxin Target Database (T3DB),"p,p'-DDD",T3D0025,"P,P'-DDD",http://www.t3db.ca/toxins/T3D0025,BE0000197,Sodium channel protein type 5 subunit alpha,http://www.t3db.ca/biodb/bio_entities/BE0000197,Q14524,Sodium channel protein type 5 subunit alpha,6331.0,SCN5A,9606.0,Homo sapiens (human),"DDD inhibits the inactivation of voltaged-gated sodium channels. the channels activate (open) normally but are inactivated (closed) slowly, thus interfering with the active transport of sodium out of the nerve axon during repolarization and resulting in a state of hyperexcitability. (A99)",,,PMID:17487686,https://www.ncbi.nlm.nih.gov/pubmed/17487686,17487686,,
849,699629,6294,Toxin and Toxin Target Database (T3DB),"p,p'-DDD",T3D0025,"P,P'-DDD",http://www.t3db.ca/toxins/T3D0025,BE0004900,Sodium channel protein type 7 subunit alpha,http://www.t3db.ca/biodb/bio_entities/BE0004900,Q01118,Sodium channel protein type 7 subunit alpha,6332.0,SCN7A,9606.0,Homo sapiens (human),"DDD inhibits the inactivation of voltaged-gated sodium channels. the channels activate (open) normally but are inactivated (closed) slowly, thus interfering with the active transport of sodium out of the nerve axon during repolarization and resulting in a state of hyperexcitability. (A99)",,,PMID:17487686,https://www.ncbi.nlm.nih.gov/pubmed/17487686,17487686,,
850,703263,6294,Comparative Toxicogenomics Database (CTD),"p,p'-DDD",D003632,Dichlorodiphenyldichloroethane,https://ctdbase.org/detail.go?type=chem&acc=D003632,100174814,ESR2.L,https://ctdbase.org/detail.go?type=gene&acc=100174814,,,100174814.0,esr2.L,8355.0,Xenopus laevis (African clawed frog),Dichlorodiphenyldichloroethane binds to and results in increased activity of ESR2.L protein,,,PMID:33049310,https://www.ncbi.nlm.nih.gov/pubmed/33049310,33049310,,
851,703264,6294,Comparative Toxicogenomics Database (CTD),"p,p'-DDD",D003632,Dichlorodiphenyldichloroethane,https://ctdbase.org/detail.go?type=chem&acc=D003632,2674,GFRA1,https://ctdbase.org/detail.go?type=gene&acc=2674,,,2674.0,GFRA1,9606.0,Homo sapiens (human),[hexachlorocyclohexane co-treated with aldrin co-treated with dieldrin co-treated with endrin co-treated with dichlorodiphenyl dichloroethylene co-treated with dichlorodiphenyldichloroethane co-treated with DDT co-treated with simvastatin] results in decreased expression of GFRA1 mRNA,,,PMID:28263720,https://www.ncbi.nlm.nih.gov/pubmed/28263720,28263720,,
852,703265,6294,Comparative Toxicogenomics Database (CTD),"p,p'-DDD",D003632,Dichlorodiphenyldichloroethane,https://ctdbase.org/detail.go?type=chem&acc=D003632,3815,KIT,https://ctdbase.org/detail.go?type=gene&acc=3815,,,3815.0,KIT,9606.0,Homo sapiens (human),"[dichlorodiphenyldichloroethane co-treated with dichlorodiphenyl dichloroethylene co-treated with 2,2-(2-chlorophenyl-4'-chlorophenyl)-1,1-dichloroethene co-treated with aldrin co-treated with dieldrin] results in increased expression of KIT mRNA",,,PMID:19422813,https://www.ncbi.nlm.nih.gov/pubmed/19422813,19422813,,
853,701124,6303,Comparative Toxicogenomics Database (CTD),Cordycepin,C058120,cordycepin,https://ctdbase.org/detail.go?type=chem&acc=C058120,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,9606.0,Homo sapiens (human),Cordycepin inhibits the reaction [hydrogen peroxide results in increased expression of CASP3 mrna],,,PMID:32714076,https://www.ncbi.nlm.nih.gov/pubmed/32714076,32714076,,
854,701125,6303,Comparative Toxicogenomics Database (CTD),Cordycepin,C058120,cordycepin,https://ctdbase.org/detail.go?type=chem&acc=C058120,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,9606.0,Homo sapiens (human),Cordycepin results in increased activity of CASP3 protein,,,PMID:21310227|PMID:21933677,https://www.ncbi.nlm.nih.gov/pubmed/21310227|https://www.ncbi.nlm.nih.gov/pubmed/21933677,21310227|21933677,,
855,701126,6303,Comparative Toxicogenomics Database (CTD),Cordycepin,C058120,cordycepin,https://ctdbase.org/detail.go?type=chem&acc=C058120,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,9606.0,Homo sapiens (human),Cordycepin results in increased cleavage of CASP3 protein,,,PMID:35732609|PMID:36299321,https://www.ncbi.nlm.nih.gov/pubmed/35732609|https://www.ncbi.nlm.nih.gov/pubmed/36299321,35732609|36299321,,
856,701127,6303,Comparative Toxicogenomics Database (CTD),Cordycepin,C058120,cordycepin,https://ctdbase.org/detail.go?type=chem&acc=C058120,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,9606.0,Homo sapiens (human),Cordycepin results in increased expression of CASP3 mRNA,,,PMID:28987792,https://www.ncbi.nlm.nih.gov/pubmed/28987792,28987792,,
857,701128,6303,Comparative Toxicogenomics Database (CTD),Cordycepin,C058120,cordycepin,https://ctdbase.org/detail.go?type=chem&acc=C058120,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,9606.0,Homo sapiens (human),[doxorubicin co-treated with cordycepin] results in increased cleavage of CASP3 protein,,,PMID:35186504,https://www.ncbi.nlm.nih.gov/pubmed/35186504,35186504,,
858,701129,6303,Comparative Toxicogenomics Database (CTD),Cordycepin,C058120,cordycepin,https://ctdbase.org/detail.go?type=chem&acc=C058120,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,10090.0,Mus musculus (house mouse),Cordycepin inhibits the reaction [FGF9 protein results in decreased cleavage of CASP3 protein],,,PMID:33172093,https://www.ncbi.nlm.nih.gov/pubmed/33172093,33172093,,
859,702432,6303,Comparative Toxicogenomics Database (CTD),Cordycepin,C058120,cordycepin,https://ctdbase.org/detail.go?type=chem&acc=C058120,1277,COL1A1,https://ctdbase.org/detail.go?type=gene&acc=1277,,,1277.0,COL1A1,9606.0,Homo sapiens (human),Cordycepin inhibits the reaction [pyrrolidine dithiocarbamic acid inhibits the reaction [[dexamethasone co-treated with ascorbate-2-phosphate co-treated with beta-glycerophosphoric acid] results in increased expression of COL1A1 mrna]],,,PMID:34575692,https://www.ncbi.nlm.nih.gov/pubmed/34575692,34575692,,
860,705358,6303,Comparative Toxicogenomics Database (CTD),Cordycepin,C058120,cordycepin,https://ctdbase.org/detail.go?type=chem&acc=C058120,4609,MYC,https://ctdbase.org/detail.go?type=gene&acc=4609,,,4609.0,MYC,9606.0,Homo sapiens (human),Cordycepin results in increased expression of MYC mRNA,,,PMID:34070360,https://www.ncbi.nlm.nih.gov/pubmed/34070360,34070360,,
861,705359,6303,Comparative Toxicogenomics Database (CTD),Cordycepin,C058120,cordycepin,https://ctdbase.org/detail.go?type=chem&acc=C058120,4609,MYC,https://ctdbase.org/detail.go?type=gene&acc=4609,,,4609.0,MYC,9606.0,Homo sapiens (human),[doxorubicin co-treated with cordycepin] results in decreased expression of MYC protein,,,PMID:35186504,https://www.ncbi.nlm.nih.gov/pubmed/35186504,35186504,,
862,705360,6303,Comparative Toxicogenomics Database (CTD),Cordycepin,C058120,cordycepin,https://ctdbase.org/detail.go?type=chem&acc=C058120,4615,MYD88,https://ctdbase.org/detail.go?type=gene&acc=4615,,,4615.0,MYD88,10090.0,Mus musculus (house mouse),Cordycepin inhibits the reaction [lipopolysaccharides results in increased expression of MYD88 protein],,,PMID:25342887,https://www.ncbi.nlm.nih.gov/pubmed/25342887,25342887,,
863,705361,6303,Comparative Toxicogenomics Database (CTD),Cordycepin,C058120,cordycepin,https://ctdbase.org/detail.go?type=chem&acc=C058120,79923,NANOG,https://ctdbase.org/detail.go?type=gene&acc=79923,,,79923.0,NANOG,9606.0,Homo sapiens (human),Sirtinol inhibits the reaction [cordycepin results in increased expression of NANOG mrna]|cordycepin affects the expression of NANOG mRNA,,,PMID:36881089,https://www.ncbi.nlm.nih.gov/pubmed/36881089,36881089,,
864,705362,6303,Comparative Toxicogenomics Database (CTD),Cordycepin,C058120,cordycepin,https://ctdbase.org/detail.go?type=chem&acc=C058120,79923,NANOG,https://ctdbase.org/detail.go?type=gene&acc=79923,,,79923.0,NANOG,10090.0,Mus musculus (house mouse),"Alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide inhibits the reaction [cordycepin results in increased expression of NANOG protein]|cordycepin results in increased expression of NANOG protein",,,PMID:32042022,https://www.ncbi.nlm.nih.gov/pubmed/32042022,32042022,,
865,705363,6303,Comparative Toxicogenomics Database (CTD),Cordycepin,C058120,cordycepin,https://ctdbase.org/detail.go?type=chem&acc=C058120,4790,NFKB1,https://ctdbase.org/detail.go?type=gene&acc=4790,,,4790.0,NFKB1,9606.0,Homo sapiens (human),Cordycepin results in decreased expression of NFKB1 mRNA,,,PMID:36881089,https://www.ncbi.nlm.nih.gov/pubmed/36881089,36881089,,
866,705364,6303,Comparative Toxicogenomics Database (CTD),Cordycepin,C058120,cordycepin,https://ctdbase.org/detail.go?type=chem&acc=C058120,4790,NFKB1,https://ctdbase.org/detail.go?type=gene&acc=4790,,,4790.0,NFKB1,9606.0,Homo sapiens (human),[doxorubicin co-treated with cordycepin] results in decreased expression of NFKB1 protein,,,PMID:35186504,https://www.ncbi.nlm.nih.gov/pubmed/35186504,35186504,,
867,705365,6303,Comparative Toxicogenomics Database (CTD),Cordycepin,C058120,cordycepin,https://ctdbase.org/detail.go?type=chem&acc=C058120,4792,NFKBIA,https://ctdbase.org/detail.go?type=gene&acc=4792,,,4792.0,NFKBIA,9606.0,Homo sapiens (human),Cordycepin inhibits the reaction [IL1B protein results in increased phosphorylation of and results in increased degradation of NFKBIA protein],,,PMID:24346509,https://www.ncbi.nlm.nih.gov/pubmed/24346509,24346509,,
868,523451,6344,Comparative Toxicogenomics Database (CTD),Methylene Chloride,D008752,Methylene Chloride,https://ctdbase.org/detail.go?type=chem&acc=D008752,10135,NAMPT,https://ctdbase.org/detail.go?type=gene&acc=10135,,,10135.0,NAMPT,10090.0,Mus musculus (house mouse),Methylene chloride results in decreased expression of NAMPT mRNA,,,PMID:28392392,https://www.ncbi.nlm.nih.gov/pubmed/28392392,28392392,,
869,523452,6344,Comparative Toxicogenomics Database (CTD),Methylene Chloride,D008752,Methylene Chloride,https://ctdbase.org/detail.go?type=chem&acc=D008752,4684,NCAM1,https://ctdbase.org/detail.go?type=gene&acc=4684,,,4684.0,NCAM1,10116.0,Rattus norvegicus (Norway rat),Methylene chloride results in decreased expression of NCAM1 mRNA,,,PMID:20955722,https://www.ncbi.nlm.nih.gov/pubmed/20955722,20955722,,
870,523453,6344,Comparative Toxicogenomics Database (CTD),Methylene Chloride,D008752,Methylene Chloride,https://ctdbase.org/detail.go?type=chem&acc=D008752,4688,NCF2,https://ctdbase.org/detail.go?type=gene&acc=4688,,,4688.0,NCF2,9606.0,Homo sapiens (human),Methylene chloride results in increased expression of NCF2 mRNA,,,PMID:20359517,https://www.ncbi.nlm.nih.gov/pubmed/20359517,20359517,,
871,523454,6344,Comparative Toxicogenomics Database (CTD),Methylene Chloride,D008752,Methylene Chloride,https://ctdbase.org/detail.go?type=chem&acc=D008752,9611,NCOR1,https://ctdbase.org/detail.go?type=gene&acc=9611,,,9611.0,NCOR1,10090.0,Mus musculus (house mouse),Methylene chloride results in decreased expression of NCOR1 mRNA,,,PMID:28392392,https://www.ncbi.nlm.nih.gov/pubmed/28392392,28392392,,
872,523455,6344,Comparative Toxicogenomics Database (CTD),Methylene Chloride,D008752,Methylene Chloride,https://ctdbase.org/detail.go?type=chem&acc=D008752,4714,NDUFB8,https://ctdbase.org/detail.go?type=gene&acc=4714,,,4714.0,NDUFB8,10090.0,Mus musculus (house mouse),Methylene chloride results in increased expression of NDUFB8 protein,,,PMID:30240022,https://www.ncbi.nlm.nih.gov/pubmed/30240022,30240022,,
873,524372,6344,Comparative Toxicogenomics Database (CTD),Methylene Chloride,D008752,Methylene Chloride,https://ctdbase.org/detail.go?type=chem&acc=D008752,6299,SALL1,https://ctdbase.org/detail.go?type=gene&acc=6299,,,6299.0,SALL1,10090.0,Mus musculus (house mouse),Methylene chloride results in decreased expression of SALL1 mRNA,,,PMID:28392392,https://www.ncbi.nlm.nih.gov/pubmed/28392392,28392392,,
874,524373,6344,Comparative Toxicogenomics Database (CTD),Methylene Chloride,D008752,Methylene Chloride,https://ctdbase.org/detail.go?type=chem&acc=D008752,6390,SDHB,https://ctdbase.org/detail.go?type=gene&acc=6390,,,6390.0,SDHB,10090.0,Mus musculus (house mouse),[propylene dichloride co-treated with methylene chloride] affects the expression of SDHB protein|methylene chloride affects the expression of SDHB protein,,,PMID:30240022,https://www.ncbi.nlm.nih.gov/pubmed/30240022,30240022,,
875,524374,6344,Comparative Toxicogenomics Database (CTD),Methylene Chloride,D008752,Methylene Chloride,https://ctdbase.org/detail.go?type=chem&acc=D008752,6391,SDHC,https://ctdbase.org/detail.go?type=gene&acc=6391,,,6391.0,SDHC,10090.0,Mus musculus (house mouse),[propylene dichloride co-treated with methylene chloride] affects the expression of SDHC protein|methylene chloride results in increased expression of SDHC protein,,,PMID:30240022,https://www.ncbi.nlm.nih.gov/pubmed/30240022,30240022,,
876,704683,6410,Comparative Toxicogenomics Database (CTD),tert-Butyl Hydroperoxide,D020122,tert-Butylhydroperoxide,https://ctdbase.org/detail.go?type=chem&acc=D020122,635,BHMT,https://ctdbase.org/detail.go?type=gene&acc=635,,,635.0,BHMT,9606.0,Homo sapiens (human),Tert-butylhydroperoxide results in decreased expression of BHMT mrna|tert-butylhydroperoxide results in increased methylation of BHMT gene,,,PMID:27509014,https://www.ncbi.nlm.nih.gov/pubmed/27509014,27509014,,
877,704684,6410,Comparative Toxicogenomics Database (CTD),tert-Butyl Hydroperoxide,D020122,tert-Butylhydroperoxide,https://ctdbase.org/detail.go?type=chem&acc=D020122,635,BHMT,https://ctdbase.org/detail.go?type=gene&acc=635,,,635.0,BHMT,8260.0,Platichthys flesus (European flounder),Tert-butylhydroperoxide results in increased expression of BHMT mRNA,,,PMID:18804290,https://www.ncbi.nlm.nih.gov/pubmed/18804290,18804290,,
878,704685,6410,Comparative Toxicogenomics Database (CTD),tert-Butyl Hydroperoxide,D020122,tert-Butylhydroperoxide,https://ctdbase.org/detail.go?type=chem&acc=D020122,636,BICD1,https://ctdbase.org/detail.go?type=gene&acc=636,,,636.0,BICD1,9606.0,Homo sapiens (human),Tert-butylhydroperoxide results in decreased expression of BICD1 mRNA,,,PMID:15336504,https://www.ncbi.nlm.nih.gov/pubmed/15336504,15336504,,
879,704686,6410,Comparative Toxicogenomics Database (CTD),tert-Butyl Hydroperoxide,D020122,tert-Butylhydroperoxide,https://ctdbase.org/detail.go?type=chem&acc=D020122,638,BIK,https://ctdbase.org/detail.go?type=gene&acc=638,,,638.0,BIK,9606.0,Homo sapiens (human),Tert-butylhydroperoxide results in increased expression of BIK mRNA,,,PMID:23410634,https://www.ncbi.nlm.nih.gov/pubmed/23410634,23410634,,
880,704687,6410,Comparative Toxicogenomics Database (CTD),tert-Butyl Hydroperoxide,D020122,tert-Butylhydroperoxide,https://ctdbase.org/detail.go?type=chem&acc=D020122,332,BIRC5,https://ctdbase.org/detail.go?type=gene&acc=332,,,332.0,BIRC5,10090.0,Mus musculus (house mouse),Tert-butylhydroperoxide results in increased expression of BIRC5 mRNA,,,PMID:15003993,https://www.ncbi.nlm.nih.gov/pubmed/15003993,15003993,,
881,704688,6410,Comparative Toxicogenomics Database (CTD),tert-Butyl Hydroperoxide,D020122,tert-Butylhydroperoxide,https://ctdbase.org/detail.go?type=chem&acc=D020122,29760,BLNK,https://ctdbase.org/detail.go?type=gene&acc=29760,,,29760.0,BLNK,10090.0,Mus musculus (house mouse),Tert-butylhydroperoxide results in increased expression of BLNK mRNA,,,PMID:14729362,https://www.ncbi.nlm.nih.gov/pubmed/14729362,14729362,,
882,704689,6410,Comparative Toxicogenomics Database (CTD),tert-Butyl Hydroperoxide,D020122,tert-Butylhydroperoxide,https://ctdbase.org/detail.go?type=chem&acc=D020122,29760,BLNK,https://ctdbase.org/detail.go?type=gene&acc=29760,,,29760.0,BLNK,8260.0,Platichthys flesus (European flounder),Tert-butylhydroperoxide results in decreased expression of BLNK mRNA,,,PMID:18804290,https://www.ncbi.nlm.nih.gov/pubmed/18804290,18804290,,
883,704690,6410,Comparative Toxicogenomics Database (CTD),tert-Butyl Hydroperoxide,D020122,tert-Butylhydroperoxide,https://ctdbase.org/detail.go?type=chem&acc=D020122,56938,BMAL2,https://ctdbase.org/detail.go?type=gene&acc=56938,,,56938.0,BMAL2,9606.0,Homo sapiens (human),Tert-butylhydroperoxide results in decreased expression of BMAL2 mRNA,,,PMID:15336504,https://www.ncbi.nlm.nih.gov/pubmed/15336504,15336504,,
884,700118,6579,Comparative Toxicogenomics Database (CTD),Acrylamide,D020106,Acrylamide,https://ctdbase.org/detail.go?type=chem&acc=D020106,9955,HS3ST3A1,https://ctdbase.org/detail.go?type=gene&acc=9955,,,9955.0,HS3ST3A1,10116.0,Rattus norvegicus (Norway rat),Acrylamide results in increased expression of HS3ST3A1 mRNA,,,PMID:28959563,https://www.ncbi.nlm.nih.gov/pubmed/28959563,28959563,,
885,700119,6579,Comparative Toxicogenomics Database (CTD),Acrylamide,D020106,Acrylamide,https://ctdbase.org/detail.go?type=chem&acc=D020106,90161,HS6ST2,https://ctdbase.org/detail.go?type=gene&acc=90161,,,90161.0,HS6ST2,10116.0,Rattus norvegicus (Norway rat),Acrylamide results in increased expression of HS6ST2 mRNA,,,PMID:28959563,https://www.ncbi.nlm.nih.gov/pubmed/28959563,28959563,,
886,700312,6579,Comparative Toxicogenomics Database (CTD),Acrylamide,D020106,Acrylamide,https://ctdbase.org/detail.go?type=chem&acc=D020106,6782,HSPA13,https://ctdbase.org/detail.go?type=gene&acc=6782,,,6782.0,HSPA13,10116.0,Rattus norvegicus (Norway rat),Acrylamide results in increased expression of HSPA13 mRNA,,,PMID:28959563,https://www.ncbi.nlm.nih.gov/pubmed/28959563,28959563,,
887,700666,6579,Comparative Toxicogenomics Database (CTD),Acrylamide,D020106,Acrylamide,https://ctdbase.org/detail.go?type=chem&acc=D020106,3309,HSPA5,https://ctdbase.org/detail.go?type=gene&acc=3309,,,3309.0,HSPA5,10116.0,Rattus norvegicus (Norway rat),Acrylamide results in increased expression of HSPA5 protein,,,PMID:33421551|PMID:37353096,https://www.ncbi.nlm.nih.gov/pubmed/33421551|https://www.ncbi.nlm.nih.gov/pubmed/37353096,33421551|37353096,,
888,700667,6579,Comparative Toxicogenomics Database (CTD),Acrylamide,D020106,Acrylamide,https://ctdbase.org/detail.go?type=chem&acc=D020106,3310,HSPA6,https://ctdbase.org/detail.go?type=gene&acc=3310,,,3310.0,HSPA6,9606.0,Homo sapiens (human),Acrylamide results in increased expression of HSPA6 mRNA,,,PMID:32763439,https://www.ncbi.nlm.nih.gov/pubmed/32763439,32763439,,
889,700668,6579,Comparative Toxicogenomics Database (CTD),Acrylamide,D020106,Acrylamide,https://ctdbase.org/detail.go?type=chem&acc=D020106,3312,HSPA8,https://ctdbase.org/detail.go?type=gene&acc=3312,,,3312.0,HSPA8,9606.0,Homo sapiens (human),Acrylamide results in increased expression of HSPA8 mRNA,,,PMID:32763439,https://www.ncbi.nlm.nih.gov/pubmed/32763439,32763439,,
890,700669,6579,Comparative Toxicogenomics Database (CTD),Acrylamide,D020106,Acrylamide,https://ctdbase.org/detail.go?type=chem&acc=D020106,3312,HSPA8,https://ctdbase.org/detail.go?type=gene&acc=3312,,,3312.0,HSPA8,10116.0,Rattus norvegicus (Norway rat),Tacrolimus inhibits the reaction [acrylamide results in decreased expression of HSPA8 protein]|acrylamide results in decreased expression of HSPA8 protein,,,PMID:15081597,https://www.ncbi.nlm.nih.gov/pubmed/15081597,15081597,,
891,700670,6579,Comparative Toxicogenomics Database (CTD),Acrylamide,D020106,Acrylamide,https://ctdbase.org/detail.go?type=chem&acc=D020106,3312,HSPA8,https://ctdbase.org/detail.go?type=gene&acc=3312,,,3312.0,HSPA8,10116.0,Rattus norvegicus (Norway rat),Acrylamide results in increased expression of HSPA8 mRNA,,,PMID:28959563,https://www.ncbi.nlm.nih.gov/pubmed/28959563,28959563,,
892,700671,6579,Comparative Toxicogenomics Database (CTD),Acrylamide,D020106,Acrylamide,https://ctdbase.org/detail.go?type=chem&acc=D020106,3313,HSPA9,https://ctdbase.org/detail.go?type=gene&acc=3313,,,3313.0,HSPA9,9606.0,Homo sapiens (human),Acrylamide results in increased expression of HSPA9 mRNA,,,PMID:32763439,https://www.ncbi.nlm.nih.gov/pubmed/32763439,32763439,,
893,700672,6579,Comparative Toxicogenomics Database (CTD),Acrylamide,D020106,Acrylamide,https://ctdbase.org/detail.go?type=chem&acc=D020106,3313,HSPA9,https://ctdbase.org/detail.go?type=gene&acc=3313,,,3313.0,HSPA9,10090.0,Mus musculus (house mouse),Acrylamide results in decreased expression of HSPA9 protein|benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [acrylamide results in decreased expression of HSPA9 protein]|acetylleucyl-leucyl-norleucinal inhibits the reaction [acrylamide results in decreased expression of HSPA9 protein],,,PMID:37353096,https://www.ncbi.nlm.nih.gov/pubmed/37353096,37353096,,
894,702112,6579,Comparative Toxicogenomics Database (CTD),Acrylamide,D020106,Acrylamide,https://ctdbase.org/detail.go?type=chem&acc=D020106,93185,IGSF8,https://ctdbase.org/detail.go?type=gene&acc=93185,,,93185.0,IGSF8,10090.0,Mus musculus (house mouse),Acrylamide affects the methylation of IGSF8 gene,,,PMID:35032568,https://www.ncbi.nlm.nih.gov/pubmed/35032568,35032568,,
895,702113,6579,Comparative Toxicogenomics Database (CTD),Acrylamide,D020106,Acrylamide,https://ctdbase.org/detail.go?type=chem&acc=D020106,57549,IGSF9,https://ctdbase.org/detail.go?type=gene&acc=57549,,,57549.0,IGSF9,9606.0,Homo sapiens (human),Acrylamide results in decreased expression of IGSF9 mRNA,,,PMID:32763439,https://www.ncbi.nlm.nih.gov/pubmed/32763439,32763439,,
896,702114,6579,Comparative Toxicogenomics Database (CTD),Acrylamide,D020106,Acrylamide,https://ctdbase.org/detail.go?type=chem&acc=D020106,3549,IHH,https://ctdbase.org/detail.go?type=gene&acc=3549,,,3549.0,IHH,10090.0,Mus musculus (house mouse),Acrylamide results in increased expression of IHH mRNA,,,PMID:30807115,https://www.ncbi.nlm.nih.gov/pubmed/30807115,30807115,,
897,702115,6579,Comparative Toxicogenomics Database (CTD),Acrylamide,D020106,Acrylamide,https://ctdbase.org/detail.go?type=chem&acc=D020106,3549,IHH,https://ctdbase.org/detail.go?type=gene&acc=3549,,,3549.0,IHH,10116.0,Rattus norvegicus (Norway rat),Acrylamide results in increased expression of IHH mRNA,,,PMID:28959563,https://www.ncbi.nlm.nih.gov/pubmed/28959563,28959563,,
898,702116,6579,Comparative Toxicogenomics Database (CTD),Acrylamide,D020106,Acrylamide,https://ctdbase.org/detail.go?type=chem&acc=D020106,8517,IKBKG,https://ctdbase.org/detail.go?type=gene&acc=8517,,,8517.0,IKBKG,9606.0,Homo sapiens (human),Acrylamide results in decreased expression of IKBKG mRNA,,,PMID:32763439,https://www.ncbi.nlm.nih.gov/pubmed/32763439,32763439,,
899,702117,6579,Comparative Toxicogenomics Database (CTD),Acrylamide,D020106,Acrylamide,https://ctdbase.org/detail.go?type=chem&acc=D020106,10320,IKZF1,https://ctdbase.org/detail.go?type=gene&acc=10320,,,10320.0,IKZF1,9606.0,Homo sapiens (human),"Acrylamide results in decreased activity of IKZF1 protein|4,5,6,7-tetrabromobenzotriazole inhibits the reaction [acrylamide results in decreased activity of IKZF1 protein]|acrylamide results in decreased expression of IKZF1 protein",,,PMID:20708675,https://www.ncbi.nlm.nih.gov/pubmed/20708675,20708675,,
900,702118,6579,Comparative Toxicogenomics Database (CTD),Acrylamide,D020106,Acrylamide,https://ctdbase.org/detail.go?type=chem&acc=D020106,3589,IL11,https://ctdbase.org/detail.go?type=gene&acc=3589,,,3589.0,IL11,9606.0,Homo sapiens (human),Acrylamide results in increased expression of IL11 mRNA,,,PMID:32763439,https://www.ncbi.nlm.nih.gov/pubmed/32763439,32763439,,
901,702119,6579,Comparative Toxicogenomics Database (CTD),Acrylamide,D020106,Acrylamide,https://ctdbase.org/detail.go?type=chem&acc=D020106,3590,IL11RA,https://ctdbase.org/detail.go?type=gene&acc=3590,,,3590.0,IL11RA,9606.0,Homo sapiens (human),Acrylamide results in decreased expression of IL11RA mRNA,,,PMID:32763439,https://www.ncbi.nlm.nih.gov/pubmed/32763439,32763439,,
902,702731,6579,Comparative Toxicogenomics Database (CTD),Acrylamide,D020106,Acrylamide,https://ctdbase.org/detail.go?type=chem&acc=D020106,146433,IL34,https://ctdbase.org/detail.go?type=gene&acc=146433,,,146433.0,IL34,10116.0,Rattus norvegicus (Norway rat),Acrylamide results in decreased expression of IL34 mRNA,,,PMID:28959563,https://www.ncbi.nlm.nih.gov/pubmed/28959563,28959563,,
903,702732,6579,Comparative Toxicogenomics Database (CTD),Acrylamide,D020106,Acrylamide,https://ctdbase.org/detail.go?type=chem&acc=D020106,26525,IL36RN,https://ctdbase.org/detail.go?type=gene&acc=26525,,,26525.0,IL36RN,10116.0,Rattus norvegicus (Norway rat),Acrylamide results in increased expression of IL36RN mRNA,,,PMID:28959563,https://www.ncbi.nlm.nih.gov/pubmed/28959563,28959563,,
904,702733,6579,Comparative Toxicogenomics Database (CTD),Acrylamide,D020106,Acrylamide,https://ctdbase.org/detail.go?type=chem&acc=D020106,3566,IL4R,https://ctdbase.org/detail.go?type=gene&acc=3566,,,3566.0,IL4R,10090.0,Mus musculus (house mouse),Acrylamide results in increased expression of IL4R mrna|nfe2l2 protein affects the reaction [acrylamide results in increased expression of IL4R mrna],,,PMID:33872730,https://www.ncbi.nlm.nih.gov/pubmed/33872730,33872730,,
905,702734,6579,Comparative Toxicogenomics Database (CTD),Acrylamide,D020106,Acrylamide,https://ctdbase.org/detail.go?type=chem&acc=D020106,3569,IL6,https://ctdbase.org/detail.go?type=gene&acc=3569,,,3569.0,IL6,10090.0,Mus musculus (house mouse),Acrylamide inhibits the reaction [streptozocin results in increased expression of IL6 mrna],,,PMID:34896238,https://www.ncbi.nlm.nih.gov/pubmed/34896238,34896238,,
906,702735,6579,Comparative Toxicogenomics Database (CTD),Acrylamide,D020106,Acrylamide,https://ctdbase.org/detail.go?type=chem&acc=D020106,3569,IL6,https://ctdbase.org/detail.go?type=gene&acc=3569,,,3569.0,IL6,10090.0,Mus musculus (house mouse),Acrylamide results in increased expression of IL6 mRNA,,,PMID:27836571|PMID:28526328|PMID:34896238|PMID:37037409,https://www.ncbi.nlm.nih.gov/pubmed/27836571|https://www.ncbi.nlm.nih.gov/pubmed/28526328|https://www.ncbi.nlm.nih.gov/pubmed/34896238|https://www.ncbi.nlm.nih.gov/pubmed/37037409,27836571|28526328|34896238|37037409,,
907,703596,6579,Comparative Toxicogenomics Database (CTD),Acrylamide,D020106,Acrylamide,https://ctdbase.org/detail.go?type=chem&acc=D020106,388135,INSYN1,https://ctdbase.org/detail.go?type=gene&acc=388135,,,388135.0,INSYN1,10116.0,Rattus norvegicus (Norway rat),Acrylamide affects the expression of INSYN1 mRNA,,,PMID:28959563,https://www.ncbi.nlm.nih.gov/pubmed/28959563,28959563,,
908,703597,6579,Comparative Toxicogenomics Database (CTD),Acrylamide,D020106,Acrylamide,https://ctdbase.org/detail.go?type=chem&acc=D020106,642938,INSYN2A,https://ctdbase.org/detail.go?type=gene&acc=642938,,,642938.0,INSYN2A,9606.0,Homo sapiens (human),Acrylamide results in increased expression of INSYN2A mRNA,,,PMID:32763439,https://www.ncbi.nlm.nih.gov/pubmed/32763439,32763439,,
909,703598,6579,Comparative Toxicogenomics Database (CTD),Acrylamide,D020106,Acrylamide,https://ctdbase.org/detail.go?type=chem&acc=D020106,26173,INTS1,https://ctdbase.org/detail.go?type=gene&acc=26173,,,26173.0,INTS1,9606.0,Homo sapiens (human),Acrylamide results in decreased expression of INTS1 mRNA,,,PMID:32763439,https://www.ncbi.nlm.nih.gov/pubmed/32763439,32763439,,
910,703599,6579,Comparative Toxicogenomics Database (CTD),Acrylamide,D020106,Acrylamide,https://ctdbase.org/detail.go?type=chem&acc=D020106,55174,INTS10,https://ctdbase.org/detail.go?type=gene&acc=55174,,,55174.0,INTS10,10116.0,Rattus norvegicus (Norway rat),Acrylamide results in increased expression of INTS10 mRNA,,,PMID:28959563,https://www.ncbi.nlm.nih.gov/pubmed/28959563,28959563,,
911,703600,6579,Comparative Toxicogenomics Database (CTD),Acrylamide,D020106,Acrylamide,https://ctdbase.org/detail.go?type=chem&acc=D020106,57508,INTS2,https://ctdbase.org/detail.go?type=gene&acc=57508,,,57508.0,INTS2,9606.0,Homo sapiens (human),Acrylamide results in increased expression of INTS2 mRNA,,,PMID:32763439,https://www.ncbi.nlm.nih.gov/pubmed/32763439,32763439,,
912,703601,6579,Comparative Toxicogenomics Database (CTD),Acrylamide,D020106,Acrylamide,https://ctdbase.org/detail.go?type=chem&acc=D020106,57508,INTS2,https://ctdbase.org/detail.go?type=gene&acc=57508,,,57508.0,INTS2,10116.0,Rattus norvegicus (Norway rat),Acrylamide results in increased expression of INTS2 mRNA,,,PMID:28959563,https://www.ncbi.nlm.nih.gov/pubmed/28959563,28959563,,
913,703602,6579,Comparative Toxicogenomics Database (CTD),Acrylamide,D020106,Acrylamide,https://ctdbase.org/detail.go?type=chem&acc=D020106,65123,INTS3,https://ctdbase.org/detail.go?type=gene&acc=65123,,,65123.0,INTS3,9606.0,Homo sapiens (human),Acrylamide results in decreased expression of INTS3 mRNA,,,PMID:32763439,https://www.ncbi.nlm.nih.gov/pubmed/32763439,32763439,,
914,707009,6579,Comparative Toxicogenomics Database (CTD),Acrylamide,D020106,Acrylamide,https://ctdbase.org/detail.go?type=chem&acc=D020106,7071,KLF10,https://ctdbase.org/detail.go?type=gene&acc=7071,,,7071.0,KLF10,9606.0,Homo sapiens (human),Acrylamide results in increased expression of KLF10 mRNA,,,PMID:32763439,https://www.ncbi.nlm.nih.gov/pubmed/32763439,32763439,,
915,707010,6579,Comparative Toxicogenomics Database (CTD),Acrylamide,D020106,Acrylamide,https://ctdbase.org/detail.go?type=chem&acc=D020106,7071,KLF10,https://ctdbase.org/detail.go?type=gene&acc=7071,,,7071.0,KLF10,10090.0,Mus musculus (house mouse),Acrylamide results in increased expression of KLF10 mRNA,,,PMID:30807115,https://www.ncbi.nlm.nih.gov/pubmed/30807115,30807115,,
916,707011,6579,Comparative Toxicogenomics Database (CTD),Acrylamide,D020106,Acrylamide,https://ctdbase.org/detail.go?type=chem&acc=D020106,8462,KLF11,https://ctdbase.org/detail.go?type=gene&acc=8462,,,8462.0,KLF11,10116.0,Rattus norvegicus (Norway rat),Acrylamide results in decreased expression of KLF11 mRNA,,,PMID:28959563,https://www.ncbi.nlm.nih.gov/pubmed/28959563,28959563,,
917,707012,6579,Comparative Toxicogenomics Database (CTD),Acrylamide,D020106,Acrylamide,https://ctdbase.org/detail.go?type=chem&acc=D020106,11278,KLF12,https://ctdbase.org/detail.go?type=gene&acc=11278,,,11278.0,KLF12,10090.0,Mus musculus (house mouse),Acrylamide results in decreased expression of KLF12 mRNA,,,PMID:30807115,https://www.ncbi.nlm.nih.gov/pubmed/30807115,30807115,,
918,707013,6579,Comparative Toxicogenomics Database (CTD),Acrylamide,D020106,Acrylamide,https://ctdbase.org/detail.go?type=chem&acc=D020106,136259,KLF14,https://ctdbase.org/detail.go?type=gene&acc=136259,,,136259.0,KLF14,10116.0,Rattus norvegicus (Norway rat),Acrylamide results in decreased expression of KLF14 mRNA,,,PMID:28959563,https://www.ncbi.nlm.nih.gov/pubmed/28959563,28959563,,
919,707014,6579,Comparative Toxicogenomics Database (CTD),Acrylamide,D020106,Acrylamide,https://ctdbase.org/detail.go?type=chem&acc=D020106,28999,KLF15,https://ctdbase.org/detail.go?type=gene&acc=28999,,,28999.0,KLF15,10116.0,Rattus norvegicus (Norway rat),Acrylamide results in increased expression of KLF15 mRNA,,,PMID:28959563,https://www.ncbi.nlm.nih.gov/pubmed/28959563,28959563,,
920,707015,6579,Comparative Toxicogenomics Database (CTD),Acrylamide,D020106,Acrylamide,https://ctdbase.org/detail.go?type=chem&acc=D020106,83855,KLF16,https://ctdbase.org/detail.go?type=gene&acc=83855,,,83855.0,KLF16,9606.0,Homo sapiens (human),Acrylamide results in increased expression of KLF16 mRNA,,,PMID:32763439,https://www.ncbi.nlm.nih.gov/pubmed/32763439,32763439,,
921,707016,6579,Comparative Toxicogenomics Database (CTD),Acrylamide,D020106,Acrylamide,https://ctdbase.org/detail.go?type=chem&acc=D020106,9314,KLF4,https://ctdbase.org/detail.go?type=gene&acc=9314,,,9314.0,KLF4,9606.0,Homo sapiens (human),Acrylamide results in increased expression of KLF4 mRNA,,,PMID:32763439,https://www.ncbi.nlm.nih.gov/pubmed/32763439,32763439,,
922,707377,6579,Comparative Toxicogenomics Database (CTD),Acrylamide,D020106,Acrylamide,https://ctdbase.org/detail.go?type=chem&acc=D020106,64410,KLHL25,https://ctdbase.org/detail.go?type=gene&acc=64410,,,64410.0,KLHL25,9606.0,Homo sapiens (human),Acrylamide results in increased expression of KLHL25 mRNA,,,PMID:32763439,https://www.ncbi.nlm.nih.gov/pubmed/32763439,32763439,,
923,707378,6579,Comparative Toxicogenomics Database (CTD),Acrylamide,D020106,Acrylamide,https://ctdbase.org/detail.go?type=chem&acc=D020106,64410,KLHL25,https://ctdbase.org/detail.go?type=gene&acc=64410,,,64410.0,KLHL25,10116.0,Rattus norvegicus (Norway rat),Acrylamide results in increased expression of KLHL25 mRNA,,,PMID:28959563,https://www.ncbi.nlm.nih.gov/pubmed/28959563,28959563,,
924,707379,6579,Comparative Toxicogenomics Database (CTD),Acrylamide,D020106,Acrylamide,https://ctdbase.org/detail.go?type=chem&acc=D020106,55295,KLHL26,https://ctdbase.org/detail.go?type=gene&acc=55295,,,55295.0,KLHL26,9606.0,Homo sapiens (human),Acrylamide results in increased expression of KLHL26 mRNA,,,PMID:32763439,https://www.ncbi.nlm.nih.gov/pubmed/32763439,32763439,,
925,707380,6579,Comparative Toxicogenomics Database (CTD),Acrylamide,D020106,Acrylamide,https://ctdbase.org/detail.go?type=chem&acc=D020106,26249,KLHL3,https://ctdbase.org/detail.go?type=gene&acc=26249,,,26249.0,KLHL3,10090.0,Mus musculus (house mouse),Acrylamide results in decreased expression of KLHL3 mRNA,,,PMID:30807115,https://www.ncbi.nlm.nih.gov/pubmed/30807115,30807115,,
926,707381,6579,Comparative Toxicogenomics Database (CTD),Acrylamide,D020106,Acrylamide,https://ctdbase.org/detail.go?type=chem&acc=D020106,401265,KLHL31,https://ctdbase.org/detail.go?type=gene&acc=401265,,,401265.0,KLHL31,10090.0,Mus musculus (house mouse),Acrylamide results in decreased expression of KLHL31 mRNA,,,PMID:30807115,https://www.ncbi.nlm.nih.gov/pubmed/30807115,30807115,,
927,707382,6579,Comparative Toxicogenomics Database (CTD),Acrylamide,D020106,Acrylamide,https://ctdbase.org/detail.go?type=chem&acc=D020106,401265,KLHL31,https://ctdbase.org/detail.go?type=gene&acc=401265,,,401265.0,KLHL31,10116.0,Rattus norvegicus (Norway rat),Acrylamide results in decreased expression of KLHL31 mRNA,,,PMID:28959563,https://www.ncbi.nlm.nih.gov/pubmed/28959563,28959563,,
928,707383,6579,Comparative Toxicogenomics Database (CTD),Acrylamide,D020106,Acrylamide,https://ctdbase.org/detail.go?type=chem&acc=D020106,114792,KLHL32,https://ctdbase.org/detail.go?type=gene&acc=114792,,,114792.0,KLHL32,9606.0,Homo sapiens (human),Acrylamide results in increased expression of KLHL32 mRNA,,,PMID:32763439,https://www.ncbi.nlm.nih.gov/pubmed/32763439,32763439,,
929,707384,6579,Comparative Toxicogenomics Database (CTD),Acrylamide,D020106,Acrylamide,https://ctdbase.org/detail.go?type=chem&acc=D020106,114792,KLHL32,https://ctdbase.org/detail.go?type=gene&acc=114792,,,114792.0,KLHL32,10116.0,Rattus norvegicus (Norway rat),Acrylamide results in increased expression of KLHL32 mRNA,,,PMID:28959563,https://www.ncbi.nlm.nih.gov/pubmed/28959563,28959563,,
930,517265,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,84792,FAM220A,https://ctdbase.org/detail.go?type=gene&acc=84792,,,84792.0,FAM220A,9606.0,Homo sapiens (human),Bisphenol A results in increased expression of FAM220A mRNA,,,PMID:29275510,https://www.ncbi.nlm.nih.gov/pubmed/29275510,29275510,,
931,517266,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,84792,FAM220A,https://ctdbase.org/detail.go?type=gene&acc=84792,,,84792.0,FAM220A,10116.0,Rattus norvegicus (Norway rat),Bisphenol A results in decreased expression of FAM220A mRNA,,,PMID:25181051,https://www.ncbi.nlm.nih.gov/pubmed/25181051,25181051,,
932,517453,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,84915,FAM222A,https://ctdbase.org/detail.go?type=gene&acc=84915,,,84915.0,FAM222A,7955.0,Danio rerio (zebrafish),Bisphenol A results in increased methylation of FAM222A intron,,,PMID:30906313,https://www.ncbi.nlm.nih.gov/pubmed/30906313,30906313,,
933,517454,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,84915,FAM222A,https://ctdbase.org/detail.go?type=gene&acc=84915,,,84915.0,FAM222A,10090.0,Mus musculus (house mouse),Bisphenol A results in decreased methylation of FAM222A promoter,,,PMID:27312807,https://www.ncbi.nlm.nih.gov/pubmed/27312807,27312807,,
934,517455,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,84915,FAM222A,https://ctdbase.org/detail.go?type=gene&acc=84915,,,84915.0,FAM222A,10116.0,Rattus norvegicus (Norway rat),Bisphenol A results in decreased expression of FAM222A mRNA,,,PMID:25181051,https://www.ncbi.nlm.nih.gov/pubmed/25181051,25181051,,
935,517456,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,55731,FAM222B,https://ctdbase.org/detail.go?type=gene&acc=55731,,,55731.0,FAM222B,42520.0,Peromyscus californicus (California mouse),Bisphenol A results in increased expression of FAM222B mRNA,,,PMID:28196854,https://www.ncbi.nlm.nih.gov/pubmed/28196854,28196854,,
936,517457,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,55731,FAM222B,https://ctdbase.org/detail.go?type=gene&acc=55731,,,55731.0,FAM222B,10116.0,Rattus norvegicus (Norway rat),Bisphenol A affects the expression of FAM222B mRNA,,,PMID:25181051,https://www.ncbi.nlm.nih.gov/pubmed/25181051,25181051,,
937,518561,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,131177,FAM3D,https://ctdbase.org/detail.go?type=gene&acc=131177,,,131177.0,FAM3D,10116.0,Rattus norvegicus (Norway rat),Bisphenol A results in decreased expression of FAM3D mRNA,,,PMID:25181051,https://www.ncbi.nlm.nih.gov/pubmed/25181051,25181051,,
938,518562,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,131583,FAM43A,https://ctdbase.org/detail.go?type=gene&acc=131583,,,131583.0,FAM43A,9606.0,Homo sapiens (human),Bisphenol A results in increased expression of FAM43A mRNA,,,PMID:29275510,https://www.ncbi.nlm.nih.gov/pubmed/29275510,29275510,,
939,518563,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,131583,FAM43A,https://ctdbase.org/detail.go?type=gene&acc=131583,,,131583.0,FAM43A,10090.0,Mus musculus (house mouse),Bisphenol A results in increased expression of FAM43A mRNA,,,PMID:32156529,https://www.ncbi.nlm.nih.gov/pubmed/32156529,32156529,,
940,518564,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,131583,FAM43A,https://ctdbase.org/detail.go?type=gene&acc=131583,,,131583.0,FAM43A,10116.0,Rattus norvegicus (Norway rat),Bisphenol A affects the expression of FAM43A mRNA,,,PMID:25181051,https://www.ncbi.nlm.nih.gov/pubmed/25181051,25181051,,
941,518565,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,131583,FAM43A,https://ctdbase.org/detail.go?type=gene&acc=131583,,,131583.0,FAM43A,10116.0,Rattus norvegicus (Norway rat),Bisphenol A results in decreased expression of FAM43A mRNA,,,PMID:34947998,https://www.ncbi.nlm.nih.gov/pubmed/34947998,34947998,,
942,518566,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,421845,FAM46A,https://ctdbase.org/detail.go?type=gene&acc=421845,,,421845.0,FAM46A,9606.0,Homo sapiens (human),Bisphenol A results in decreased expression of FAM46A mrna|bisphenol A results in increased expression of FAM46A mRNA,,,PMID:36232920,https://www.ncbi.nlm.nih.gov/pubmed/36232920,36232920,,
943,518567,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,421845,FAM46A,https://ctdbase.org/detail.go?type=gene&acc=421845,,,421845.0,FAM46A,10090.0,Mus musculus (house mouse),Bisphenol A results in increased expression of FAM46A mRNA,,,PMID:30951980,https://www.ncbi.nlm.nih.gov/pubmed/30951980,30951980,,
944,518568,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,421845,FAM46A,https://ctdbase.org/detail.go?type=gene&acc=421845,,,421845.0,FAM46A,10116.0,Rattus norvegicus (Norway rat),Bisphenol A results in increased expression of FAM46A mRNA,,,PMID:32145629,https://www.ncbi.nlm.nih.gov/pubmed/32145629,32145629,,
945,521657,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,2191,FAP,https://ctdbase.org/detail.go?type=gene&acc=2191,,,2191.0,FAP,9606.0,Homo sapiens (human),Bisphenol A results in increased methylation of FAP gene|[bisphenol A co-treated with fulvestrant] results in increased methylation of FAP gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
946,521658,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,2191,FAP,https://ctdbase.org/detail.go?type=gene&acc=2191,,,2191.0,FAP,9606.0,Homo sapiens (human),Bisphenol A results in increased expression of FAP protein,,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
947,521659,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,2191,FAP,https://ctdbase.org/detail.go?type=gene&acc=2191,,,2191.0,FAP,9606.0,Homo sapiens (human),[INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bisphenol A] results in decreased expression of FAP mRNA,,,PMID:28628672,https://www.ncbi.nlm.nih.gov/pubmed/28628672,28628672,,
948,521660,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,2191,FAP,https://ctdbase.org/detail.go?type=gene&acc=2191,,,2191.0,FAP,10090.0,Mus musculus (house mouse),Bisphenol A results in increased expression of FAP mRNA,,,PMID:30951980,https://www.ncbi.nlm.nih.gov/pubmed/30951980,30951980,,
949,521661,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,2191,FAP,https://ctdbase.org/detail.go?type=gene&acc=2191,,,2191.0,FAP,10116.0,Rattus norvegicus (Norway rat),Bisphenol A affects the expression of FAP mRNA,,,PMID:25181051,https://www.ncbi.nlm.nih.gov/pubmed/25181051,25181051,,
950,521662,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,84188,FAR1,https://ctdbase.org/detail.go?type=gene&acc=84188,,,84188.0,FAR1,7955.0,Danio rerio (zebrafish),Bisphenol A affects the expression of FAR1 mRNA,,,PMID:21786754,https://www.ncbi.nlm.nih.gov/pubmed/21786754,21786754,,
951,521845,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,55711,FAR2,https://ctdbase.org/detail.go?type=gene&acc=55711,,,55711.0,FAR2,9606.0,Homo sapiens (human),[INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bisphenol A] results in decreased expression of FAR2 mRNA,,,PMID:28628672,https://www.ncbi.nlm.nih.gov/pubmed/28628672,28628672,,
952,521846,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,55711,FAR2,https://ctdbase.org/detail.go?type=gene&acc=55711,,,55711.0,FAR2,10090.0,Mus musculus (house mouse),Bisphenol A results in decreased expression of FAR2 mRNA,,,PMID:32156529,https://www.ncbi.nlm.nih.gov/pubmed/32156529,32156529,,
953,521847,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,55711,FAR2,https://ctdbase.org/detail.go?type=gene&acc=55711,,,55711.0,FAR2,10090.0,Mus musculus (house mouse),Bisphenol A results in increased methylation of FAR2 promoter,,,PMID:27312807,https://www.ncbi.nlm.nih.gov/pubmed/27312807,27312807,,
954,521848,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,55711,FAR2,https://ctdbase.org/detail.go?type=gene&acc=55711,,,55711.0,FAR2,10116.0,Rattus norvegicus (Norway rat),Bisphenol A results in decreased expression of FAR2 mRNA,,,PMID:25181051,https://www.ncbi.nlm.nih.gov/pubmed/25181051,25181051,,
955,521849,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,440905,FAR2P1,https://ctdbase.org/detail.go?type=gene&acc=440905,,,440905.0,FAR2P1,9606.0,Homo sapiens (human),Bisphenol A results in decreased expression of FAR2P1 mRNA,,,PMID:36232920,https://www.ncbi.nlm.nih.gov/pubmed/36232920,36232920,,
956,522025,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,10160,FARP1,https://ctdbase.org/detail.go?type=gene&acc=10160,,,10160.0,FARP1,10090.0,Mus musculus (house mouse),Bisphenol A results in increased expression of FARP1 mRNA,,,PMID:30951980,https://www.ncbi.nlm.nih.gov/pubmed/30951980,30951980,,
957,522026,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,10160,FARP1,https://ctdbase.org/detail.go?type=gene&acc=10160,,,10160.0,FARP1,9940.0,Ovis aries (sheep),[[biotin co-treated with pantothenic acid co-treated with INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with rosiglitazone] results in increased susceptibility to bisphenol A] which results in decreased expression of FARP1 mRNA,,,PMID:35504463,https://www.ncbi.nlm.nih.gov/pubmed/35504463,35504463,,
958,522027,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,10160,FARP1,https://ctdbase.org/detail.go?type=gene&acc=10160,,,10160.0,FARP1,9940.0,Ovis aries (sheep),Bisphenol A results in decreased expression of FARP1 mRNA,,,PMID:35817127,https://www.ncbi.nlm.nih.gov/pubmed/35817127,35817127,,
959,522028,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,10160,FARP1,https://ctdbase.org/detail.go?type=gene&acc=10160,,,10160.0,FARP1,10116.0,Rattus norvegicus (Norway rat),Bisphenol A affects the expression of FARP1 mRNA,,,PMID:25181051,https://www.ncbi.nlm.nih.gov/pubmed/25181051,25181051,,
960,522200,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,9855,FARP2,https://ctdbase.org/detail.go?type=gene&acc=9855,,,9855.0,FARP2,10090.0,Mus musculus (house mouse),Bisphenol A affects the methylation of FARP2 promoter,,,PMID:27334623,https://www.ncbi.nlm.nih.gov/pubmed/27334623,27334623,,
961,522371,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,2193,FARSA,https://ctdbase.org/detail.go?type=gene&acc=2193,,,2193.0,FARSA,10116.0,Rattus norvegicus (Norway rat),Bisphenol A results in decreased expression of FARSA mRNA,,,PMID:30816183|PMID:32528016|PMID:34947998,https://www.ncbi.nlm.nih.gov/pubmed/30816183|https://www.ncbi.nlm.nih.gov/pubmed/32528016|https://www.ncbi.nlm.nih.gov/pubmed/34947998,30816183|32528016|34947998,,
962,523152,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,2194,FASN,https://ctdbase.org/detail.go?type=gene&acc=2194,,,2194.0,FASN,9606.0,Homo sapiens (human),Bisphenol A affects the expression of FASN mRNA,,,PMID:24793377|PMID:30903817|PMID:32175033,https://www.ncbi.nlm.nih.gov/pubmed/24793377|https://www.ncbi.nlm.nih.gov/pubmed/30903817|https://www.ncbi.nlm.nih.gov/pubmed/32175033,24793377|30903817|32175033,,
963,524216,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,2196,FAT2,https://ctdbase.org/detail.go?type=gene&acc=2196,,,2196.0,FAT2,9606.0,Homo sapiens (human),[bisphenol A co-treated with fulvestrant] results in decreased methylation of FAT2 gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
964,524217,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,2196,FAT2,https://ctdbase.org/detail.go?type=gene&acc=2196,,,2196.0,FAT2,10090.0,Mus musculus (house mouse),Bisphenol A results in decreased expression of FAT2 mRNA,,,PMID:32926169,https://www.ncbi.nlm.nih.gov/pubmed/32926169,32926169,,
965,524218,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,2196,FAT2,https://ctdbase.org/detail.go?type=gene&acc=2196,,,2196.0,FAT2,10116.0,Rattus norvegicus (Norway rat),Bisphenol A results in decreased expression of FAT2 mRNA,,,PMID:25181051|PMID:30816183|PMID:32528016,https://www.ncbi.nlm.nih.gov/pubmed/25181051|https://www.ncbi.nlm.nih.gov/pubmed/30816183|https://www.ncbi.nlm.nih.gov/pubmed/32528016,25181051|30816183|32528016,,
966,524219,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,2196,FAT2,https://ctdbase.org/detail.go?type=gene&acc=2196,,,2196.0,FAT2,10116.0,Rattus norvegicus (Norway rat),Bisphenol A results in increased methylation of FAT2 gene,,,PMID:28505145,https://www.ncbi.nlm.nih.gov/pubmed/28505145,28505145,,
967,524220,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,120114,FAT3,https://ctdbase.org/detail.go?type=gene&acc=120114,,,120114.0,FAT3,9606.0,Homo sapiens (human),Bisphenol A results in increased methylation of FAT3 gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
968,524221,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,120114,FAT3,https://ctdbase.org/detail.go?type=gene&acc=120114,,,120114.0,FAT3,10090.0,Mus musculus (house mouse),Bisphenol A results in decreased expression of FAT3 mRNA,,,PMID:32156529,https://www.ncbi.nlm.nih.gov/pubmed/32156529,32156529,,
969,527747,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,126433,FBXO27,https://ctdbase.org/detail.go?type=gene&acc=126433,,,126433.0,FBXO27,10116.0,Rattus norvegicus (Norway rat),Bisphenol A results in decreased expression of FBXO27 mRNA,,,PMID:30816183,https://www.ncbi.nlm.nih.gov/pubmed/30816183,30816183,,
970,527748,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,23219,FBXO28,https://ctdbase.org/detail.go?type=gene&acc=23219,,,23219.0,FBXO28,7955.0,Danio rerio (zebrafish),Bisphenol A affects the expression of FBXO28 mRNA,,,PMID:21786754,https://www.ncbi.nlm.nih.gov/pubmed/21786754,21786754,,
971,527749,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,23219,FBXO28,https://ctdbase.org/detail.go?type=gene&acc=23219,,,23219.0,FBXO28,9606.0,Homo sapiens (human),Bisphenol A results in increased methylation of FBXO28 gene|[bisphenol A co-treated with fulvestrant] results in increased methylation of FBXO28 gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
972,527750,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,23219,FBXO28,https://ctdbase.org/detail.go?type=gene&acc=23219,,,23219.0,FBXO28,10116.0,Rattus norvegicus (Norway rat),Bisphenol A results in decreased expression of FBXO28 mRNA,,,PMID:25181051,https://www.ncbi.nlm.nih.gov/pubmed/25181051,25181051,,
973,527751,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,23219,FBXO28,https://ctdbase.org/detail.go?type=gene&acc=23219,,,23219.0,FBXO28,10116.0,Rattus norvegicus (Norway rat),Bisphenol A results in increased expression of FBXO28 mRNA,,,PMID:30816183|PMID:32528016,https://www.ncbi.nlm.nih.gov/pubmed/30816183|https://www.ncbi.nlm.nih.gov/pubmed/32528016,30816183|32528016,,
974,527752,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,26273,FBXO3,https://ctdbase.org/detail.go?type=gene&acc=26273,,,26273.0,FBXO3,7955.0,Danio rerio (zebrafish),Bisphenol A affects the expression of FBXO3 mRNA,,,PMID:21786754,https://www.ncbi.nlm.nih.gov/pubmed/21786754,21786754,,
975,527753,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,26273,FBXO3,https://ctdbase.org/detail.go?type=gene&acc=26273,,,26273.0,FBXO3,9606.0,Homo sapiens (human),Bisphenol A results in increased methylation of FBXO3 gene|[bisphenol A co-treated with fulvestrant] results in increased methylation of FBXO3 gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
976,527754,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,26273,FBXO3,https://ctdbase.org/detail.go?type=gene&acc=26273,,,26273.0,FBXO3,9606.0,Homo sapiens (human),[INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bisphenol A] results in increased expression of FBXO3 mRNA,,,PMID:28628672,https://www.ncbi.nlm.nih.gov/pubmed/28628672,28628672,,
977,529588,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,54461,FBXW5,https://ctdbase.org/detail.go?type=gene&acc=54461,,,54461.0,FBXW5,9606.0,Homo sapiens (human),[INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bisphenol A] results in increased expression of FBXW5 mRNA,,,PMID:28628672,https://www.ncbi.nlm.nih.gov/pubmed/28628672,28628672,,
978,529589,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,54461,FBXW5,https://ctdbase.org/detail.go?type=gene&acc=54461,,,54461.0,FBXW5,10116.0,Rattus norvegicus (Norway rat),[bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of FBXW5 mRNA,,,PMID:36041667,https://www.ncbi.nlm.nih.gov/pubmed/36041667,36041667,,
979,529590,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,54461,FBXW5,https://ctdbase.org/detail.go?type=gene&acc=54461,,,54461.0,FBXW5,10116.0,Rattus norvegicus (Norway rat),Bisphenol A results in increased expression of FBXW5 mRNA,,,PMID:25181051,https://www.ncbi.nlm.nih.gov/pubmed/25181051,25181051,,
980,529591,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,55294,FBXW7,https://ctdbase.org/detail.go?type=gene&acc=55294,,,55294.0,FBXW7,9606.0,Homo sapiens (human),Bisphenol A results in decreased methylation of FBXW7 gene|[bisphenol A co-treated with fulvestrant] results in decreased methylation of FBXW7 gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
981,529592,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,55294,FBXW7,https://ctdbase.org/detail.go?type=gene&acc=55294,,,55294.0,FBXW7,10090.0,Mus musculus (house mouse),Bisphenol A results in decreased expression of FBXW7 mRNA,,,PMID:29161229|PMID:32156529,https://www.ncbi.nlm.nih.gov/pubmed/29161229|https://www.ncbi.nlm.nih.gov/pubmed/32156529,29161229|32156529,,
982,529593,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,55294,FBXW7,https://ctdbase.org/detail.go?type=gene&acc=55294,,,55294.0,FBXW7,10090.0,Mus musculus (house mouse),Bisphenol A results in increased expression of FBXW7 mRNA,,,PMID:26063408,https://www.ncbi.nlm.nih.gov/pubmed/26063408,26063408,,
983,529594,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,55294,FBXW7,https://ctdbase.org/detail.go?type=gene&acc=55294,,,55294.0,FBXW7,10116.0,Rattus norvegicus (Norway rat),[bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of FBXW7 mRNA,,,PMID:36041667,https://www.ncbi.nlm.nih.gov/pubmed/36041667,36041667,,
984,529733,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,84261,FBXW9,https://ctdbase.org/detail.go?type=gene&acc=84261,,,84261.0,FBXW9,10116.0,Rattus norvegicus (Norway rat),Bisphenol A results in decreased expression of FBXW9 mRNA,,,PMID:30816183|PMID:34947998,https://www.ncbi.nlm.nih.gov/pubmed/30816183|https://www.ncbi.nlm.nih.gov/pubmed/34947998,30816183|34947998,,
985,529734,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,84261,FBXW9,https://ctdbase.org/detail.go?type=gene&acc=84261,,,84261.0,FBXW9,10116.0,Rattus norvegicus (Norway rat),Bisphenol A results in increased expression of FBXW9 mRNA,,,PMID:25181051,https://www.ncbi.nlm.nih.gov/pubmed/25181051,25181051,,
986,529735,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,83953,FCAMR,https://ctdbase.org/detail.go?type=gene&acc=83953,,,83953.0,FCAMR,10090.0,Mus musculus (house mouse),Bisphenol A results in increased methylation of FCAMR promoter,,,PMID:27312807,https://www.ncbi.nlm.nih.gov/pubmed/27312807,27312807,,
987,529736,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,83953,FCAMR,https://ctdbase.org/detail.go?type=gene&acc=83953,,,83953.0,FCAMR,10116.0,Rattus norvegicus (Norway rat),Bisphenol A results in decreased expression of FCAMR mRNA,,,PMID:25181051,https://www.ncbi.nlm.nih.gov/pubmed/25181051,25181051,,
988,529737,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,2204,FCAR,https://ctdbase.org/detail.go?type=gene&acc=2204,,,2204.0,FCAR,10116.0,Rattus norvegicus (Norway rat),Bisphenol A results in decreased expression of FCAR mRNA,,,PMID:25181051,https://www.ncbi.nlm.nih.gov/pubmed/25181051,25181051,,
989,529738,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,2205,FCER1A,https://ctdbase.org/detail.go?type=gene&acc=2205,,,2205.0,FCER1A,10116.0,Rattus norvegicus (Norway rat),Bisphenol A results in decreased expression of FCER1A mRNA,,,PMID:25181051,https://www.ncbi.nlm.nih.gov/pubmed/25181051,25181051,,
990,529739,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,2207,FCER1G,https://ctdbase.org/detail.go?type=gene&acc=2207,,,2207.0,FCER1G,7955.0,Danio rerio (zebrafish),Bisphenol A results in decreased expression of FCER1G mRNA,,,PMID:33243503,https://www.ncbi.nlm.nih.gov/pubmed/33243503,33243503,,
991,529740,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,2207,FCER1G,https://ctdbase.org/detail.go?type=gene&acc=2207,,,2207.0,FCER1G,9606.0,Homo sapiens (human),[bisphenol A co-treated with fulvestrant] results in decreased methylation of FCER1G gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
992,699785,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,604,BCL6,https://ctdbase.org/detail.go?type=gene&acc=604,,,604.0,BCL6,10116.0,Rattus norvegicus (Norway rat),Bisphenol A results in decreased expression of BCL6 mRNA,,,PMID:30816183,https://www.ncbi.nlm.nih.gov/pubmed/30816183,30816183,,
993,699786,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,604,BCL6,https://ctdbase.org/detail.go?type=gene&acc=604,,,604.0,BCL6,10116.0,Rattus norvegicus (Norway rat),Bisphenol A results in increased expression of BCL6 mRNA,,,PMID:25181051|PMID:32145629,https://www.ncbi.nlm.nih.gov/pubmed/25181051|https://www.ncbi.nlm.nih.gov/pubmed/32145629,25181051|32145629,,
994,699787,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,393707,BCL6AA,https://ctdbase.org/detail.go?type=gene&acc=393707,,,393707.0,bcl6aa,7955.0,Danio rerio (zebrafish),Bisphenol A results in decreased methylation of BCL6AA intron,,,PMID:30906313,https://www.ncbi.nlm.nih.gov/pubmed/30906313,30906313,,
995,699788,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,393707,BCL6AA,https://ctdbase.org/detail.go?type=gene&acc=393707,,,393707.0,bcl6aa,143606.0,Gobiocypris rarus,Bisphenol A results in increased expression of BCL6AA mRNA,,,PMID:26364221,https://www.ncbi.nlm.nih.gov/pubmed/26364221,26364221,,
996,699789,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,393707,BCL6AA,https://ctdbase.org/detail.go?type=gene&acc=393707,,,393707.0,bcl6aa,8090.0,Oryzias latipes (Japanese medaka),Bisphenol A results in increased expression of BCL6AA mRNA,,,PMID:37581432,https://www.ncbi.nlm.nih.gov/pubmed/37581432,37581432,,
997,699790,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,100001936,BCL6AB,https://ctdbase.org/detail.go?type=gene&acc=100001936,,,100001936.0,bcl6ab,7955.0,Danio rerio (zebrafish),Bisphenol A affects the expression of BCL6AB mRNA,,,PMID:21786754,https://www.ncbi.nlm.nih.gov/pubmed/21786754,21786754,,
998,699791,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,255877,BCL6B,https://ctdbase.org/detail.go?type=gene&acc=255877,,,255877.0,BCL6B,10090.0,Mus musculus (house mouse),Bisphenol A results in increased expression of BCL6B mRNA,,,PMID:32156529,https://www.ncbi.nlm.nih.gov/pubmed/32156529,32156529,,
999,699792,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,255877,BCL6B,https://ctdbase.org/detail.go?type=gene&acc=255877,,,255877.0,BCL6B,10116.0,Rattus norvegicus (Norway rat),Bisphenol A affects the expression of BCL6B mRNA,,,PMID:25181051,https://www.ncbi.nlm.nih.gov/pubmed/25181051,25181051,,
1000,699941,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,5891,MOK,https://ctdbase.org/detail.go?type=gene&acc=5891,,,5891.0,MOK,9606.0,Homo sapiens (human),Bisphenol A results in decreased expression of MOK mRNA,,,PMID:29275510,https://www.ncbi.nlm.nih.gov/pubmed/29275510,29275510,,
1001,700665,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,9479,MAPK8IP1,https://ctdbase.org/detail.go?type=gene&acc=9479,,,9479.0,MAPK8IP1,10090.0,Mus musculus (house mouse),Bisphenol A results in increased expression of MAPK8IP1 mRNA,,,PMID:32156529,https://www.ncbi.nlm.nih.gov/pubmed/32156529,32156529,,
1002,701448,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,347411,MPC1L,https://ctdbase.org/detail.go?type=gene&acc=347411,,,347411.0,MPC1L,10116.0,Rattus norvegicus (Norway rat),Bisphenol A results in decreased expression of MPC1L mRNA,,,PMID:25181051,https://www.ncbi.nlm.nih.gov/pubmed/25181051,25181051,,
1003,701449,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,25874,MPC2,https://ctdbase.org/detail.go?type=gene&acc=25874,,,25874.0,MPC2,9606.0,Homo sapiens (human),Bisphenol A affects the expression of MPC2 mRNA,,,PMID:30903817,https://www.ncbi.nlm.nih.gov/pubmed/30903817,30903817,,
1004,701450,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,25874,MPC2,https://ctdbase.org/detail.go?type=gene&acc=25874,,,25874.0,MPC2,9606.0,Homo sapiens (human),Bisphenol A results in decreased expression of MPC2 mRNA,,,PMID:29275510,https://www.ncbi.nlm.nih.gov/pubmed/29275510,29275510,,
1005,701451,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,25874,MPC2,https://ctdbase.org/detail.go?type=gene&acc=25874,,,25874.0,MPC2,9606.0,Homo sapiens (human),Bisphenol A results in decreased expression of MPC2 protein,,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
1006,701609,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,25874,MPC2,https://ctdbase.org/detail.go?type=gene&acc=25874,,,25874.0,MPC2,10090.0,Mus musculus (house mouse),Bisphenol A results in increased expression of MPC2 mRNA,,,PMID:33221593,https://www.ncbi.nlm.nih.gov/pubmed/33221593,33221593,,
1007,701791,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,22924,MAPRE3,https://ctdbase.org/detail.go?type=gene&acc=22924,,,22924.0,MAPRE3,10116.0,Rattus norvegicus (Norway rat),[bisphenol A co-treated with genistein] results in decreased methylation of MAPRE3 gene|bisphenol A results in decreased methylation of MAPRE3 gene|bisphenol A results in increased methylation of MAPRE3 gene,,,PMID:28505145,https://www.ncbi.nlm.nih.gov/pubmed/28505145,28505145,,
1008,701792,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,22924,MAPRE3,https://ctdbase.org/detail.go?type=gene&acc=22924,,,22924.0,MAPRE3,10116.0,Rattus norvegicus (Norway rat),Bisphenol A results in decreased expression of MAPRE3 mRNA,,,PMID:25181051,https://www.ncbi.nlm.nih.gov/pubmed/25181051,25181051,,
1009,702258,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,393666,ARL3L1,https://ctdbase.org/detail.go?type=gene&acc=393666,,,393666.0,arl3l1,7955.0,Danio rerio (zebrafish),Bisphenol A results in decreased methylation of ARL3L1 3' utr|bisphenol A results in increased methylation of ARL3L1 intron|bisphenol A results in decreased methylation of ARL3L1 intron,,,PMID:30906313,https://www.ncbi.nlm.nih.gov/pubmed/30906313,30906313,,
1010,702259,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,10124,ARL4A,https://ctdbase.org/detail.go?type=gene&acc=10124,,,10124.0,ARL4A,9606.0,Homo sapiens (human),[bisphenol A co-treated with fulvestrant] results in increased methylation of ARL4A gene|bisphenol A results in decreased methylation of ARL4A gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
1011,702260,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,393834,ARL4AA,https://ctdbase.org/detail.go?type=gene&acc=393834,,,393834.0,arl4aa,7955.0,Danio rerio (zebrafish),Bisphenol A affects the expression of ARL4AA mRNA,,,PMID:21786754,https://www.ncbi.nlm.nih.gov/pubmed/21786754,21786754,,
1012,702261,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,393834,ARL4AA,https://ctdbase.org/detail.go?type=gene&acc=393834,,,393834.0,arl4aa,7955.0,Danio rerio (zebrafish),Bisphenol A results in increased expression of ARL4AA mRNA,,,PMID:33243503,https://www.ncbi.nlm.nih.gov/pubmed/33243503,33243503,,
1013,702262,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,100136836,NECTIN1A,https://ctdbase.org/detail.go?type=gene&acc=100136836,,,100136836.0,nectin1a,7955.0,Danio rerio (zebrafish),Bisphenol A results in increased methylation of NECTIN1A intron,,,PMID:30906313,https://www.ncbi.nlm.nih.gov/pubmed/30906313,30906313,,
1014,702263,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,5819,NECTIN2,https://ctdbase.org/detail.go?type=gene&acc=5819,,,5819.0,NECTIN2,9606.0,Homo sapiens (human),Bisphenol A results in decreased expression of NECTIN2 mRNA,,,PMID:25047013,https://www.ncbi.nlm.nih.gov/pubmed/25047013,25047013,,
1015,702264,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,5819,NECTIN2,https://ctdbase.org/detail.go?type=gene&acc=5819,,,5819.0,NECTIN2,9606.0,Homo sapiens (human),Bisphenol A results in decreased methylation of NECTIN2 gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
1016,702265,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,5819,NECTIN2,https://ctdbase.org/detail.go?type=gene&acc=5819,,,5819.0,NECTIN2,9606.0,Homo sapiens (human),Bisphenol A results in increased expression of NECTIN2 protein,,,PMID:32981897,https://www.ncbi.nlm.nih.gov/pubmed/32981897,32981897,,
1017,702736,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,92979,MARCHF9,https://ctdbase.org/detail.go?type=gene&acc=92979,,,92979.0,MARCHF9,10116.0,Rattus norvegicus (Norway rat),Bisphenol A results in increased expression of MARCHF9 mRNA,,,PMID:30816183,https://www.ncbi.nlm.nih.gov/pubmed/30816183,30816183,,
1018,702737,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,4082,MARCKS,https://ctdbase.org/detail.go?type=gene&acc=4082,,,4082.0,MARCKS,9606.0,Homo sapiens (human),Bisphenol A results in increased expression of MARCKS mRNA,,,PMID:29718440,https://www.ncbi.nlm.nih.gov/pubmed/29718440,29718440,,
1019,702738,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,4082,MARCKS,https://ctdbase.org/detail.go?type=gene&acc=4082,,,4082.0,MARCKS,9606.0,Homo sapiens (human),Bisphenol A results in increased expression of MARCKS protein,,,PMID:34186270|PMID:37567409,https://www.ncbi.nlm.nih.gov/pubmed/34186270|https://www.ncbi.nlm.nih.gov/pubmed/37567409,34186270|37567409,,
1020,702911,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,23204,ARL6IP1,https://ctdbase.org/detail.go?type=gene&acc=23204,,,23204.0,ARL6IP1,10090.0,Mus musculus (house mouse),Bisphenol A results in increased methylation of ARL6IP1 promoter,,,PMID:27312807,https://www.ncbi.nlm.nih.gov/pubmed/27312807,27312807,,
1021,702912,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,23204,ARL6IP1,https://ctdbase.org/detail.go?type=gene&acc=23204,,,23204.0,ARL6IP1,10116.0,Rattus norvegicus (Norway rat),Bisphenol A results in decreased expression of ARL6IP1 mRNA,,,PMID:30816183|PMID:34947998,https://www.ncbi.nlm.nih.gov/pubmed/30816183|https://www.ncbi.nlm.nih.gov/pubmed/34947998,30816183|34947998,,
1022,702913,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,23204,ARL6IP1,https://ctdbase.org/detail.go?type=gene&acc=23204,,,23204.0,ARL6IP1,10116.0,Rattus norvegicus (Norway rat),Bisphenol A results in increased expression of ARL6IP1 mRNA,,,PMID:25181051|PMID:33296240,https://www.ncbi.nlm.nih.gov/pubmed/25181051|https://www.ncbi.nlm.nih.gov/pubmed/33296240,25181051|33296240,,
1023,702914,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,51329,ARL6IP4,https://ctdbase.org/detail.go?type=gene&acc=51329,,,51329.0,ARL6IP4,7955.0,Danio rerio (zebrafish),Bisphenol A affects the expression of ARL6IP4 mRNA,,,PMID:21786754,https://www.ncbi.nlm.nih.gov/pubmed/21786754,21786754,,
1024,702915,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,51329,ARL6IP4,https://ctdbase.org/detail.go?type=gene&acc=51329,,,51329.0,ARL6IP4,10090.0,Mus musculus (house mouse),Bisphenol A results in decreased methylation of ARL6IP4 promoter,,,PMID:27312807,https://www.ncbi.nlm.nih.gov/pubmed/27312807,27312807,,
1025,702916,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,51329,ARL6IP4,https://ctdbase.org/detail.go?type=gene&acc=51329,,,51329.0,ARL6IP4,10116.0,Rattus norvegicus (Norway rat),[bisphenol A co-treated with estradiol] results in decreased expression of ARL6IP4 mRNA,,,PMID:26496021,https://www.ncbi.nlm.nih.gov/pubmed/26496021,26496021,,
1026,702917,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,51329,ARL6IP4,https://ctdbase.org/detail.go?type=gene&acc=51329,,,51329.0,ARL6IP4,10116.0,Rattus norvegicus (Norway rat),Bisphenol A results in increased expression of ARL6IP4 mRNA,,,PMID:25181051|PMID:34947998,https://www.ncbi.nlm.nih.gov/pubmed/25181051|https://www.ncbi.nlm.nih.gov/pubmed/34947998,25181051|34947998,,
1027,703071,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,6927,HNF1A,https://ctdbase.org/detail.go?type=gene&acc=6927,,,6927.0,HNF1A,10090.0,Mus musculus (house mouse),Bisphenol A affects the methylation of HNF1A promoter,,,PMID:27334623,https://www.ncbi.nlm.nih.gov/pubmed/27334623,27334623,,
1028,703442,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,5782,PTPN12,https://ctdbase.org/detail.go?type=gene&acc=5782,,,5782.0,PTPN12,10116.0,Rattus norvegicus (Norway rat),Bisphenol A results in increased methylation of PTPN12 gene,,,PMID:28505145,https://www.ncbi.nlm.nih.gov/pubmed/28505145,28505145,,
1029,704545,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,339541,ARMH1,https://ctdbase.org/detail.go?type=gene&acc=339541,,,339541.0,ARMH1,7955.0,Danio rerio (zebrafish),Bisphenol A results in increased methylation of ARMH1 intron,,,PMID:30906313,https://www.ncbi.nlm.nih.gov/pubmed/30906313,30906313,,
1030,704546,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,339541,ARMH1,https://ctdbase.org/detail.go?type=gene&acc=339541,,,339541.0,ARMH1,9606.0,Homo sapiens (human),[bisphenol A co-treated with fulvestrant] results in increased methylation of ARMH1 gene|bisphenol A results in increased methylation of ARMH1 gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
1031,704547,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,84930,MASTL,https://ctdbase.org/detail.go?type=gene&acc=84930,,,84930.0,MASTL,10116.0,Rattus norvegicus (Norway rat),Bisphenol A results in decreased expression of MASTL mRNA,,,PMID:25181051|PMID:34947998,https://www.ncbi.nlm.nih.gov/pubmed/25181051|https://www.ncbi.nlm.nih.gov/pubmed/34947998,25181051|34947998,,
1032,704548,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,84930,MASTL,https://ctdbase.org/detail.go?type=gene&acc=84930,,,84930.0,MASTL,10116.0,Rattus norvegicus (Norway rat),Bisphenol A results in increased expression of MASTL mRNA,,,PMID:32145629,https://www.ncbi.nlm.nih.gov/pubmed/32145629,32145629,,
1033,704549,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,4143,MAT1A,https://ctdbase.org/detail.go?type=gene&acc=4143,,,4143.0,MAT1A,7955.0,Danio rerio (zebrafish),Bisphenol A results in increased expression of MAT1A mRNA,,,PMID:30248606,https://www.ncbi.nlm.nih.gov/pubmed/30248606,30248606,,
1034,704550,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,4143,MAT1A,https://ctdbase.org/detail.go?type=gene&acc=4143,,,4143.0,MAT1A,9606.0,Homo sapiens (human),Bisphenol A results in decreased expression of MAT1A protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
1035,704551,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,4143,MAT1A,https://ctdbase.org/detail.go?type=gene&acc=4143,,,4143.0,MAT1A,9606.0,Homo sapiens (human),Bisphenol A results in increased methylation of MAT1A gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
1036,704552,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,4143,MAT1A,https://ctdbase.org/detail.go?type=gene&acc=4143,,,4143.0,MAT1A,10090.0,Mus musculus (house mouse),Bisphenol A results in increased expression of MAT1A mRNA,,,PMID:30245210,https://www.ncbi.nlm.nih.gov/pubmed/30245210,30245210,,
1037,705183,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,336082,NELL2B,https://ctdbase.org/detail.go?type=gene&acc=336082,,,336082.0,nell2b,7955.0,Danio rerio (zebrafish),Bisphenol A results in increased methylation of NELL2B intron,,,PMID:30906313,https://www.ncbi.nlm.nih.gov/pubmed/30906313,30906313,,
1038,705184,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,336082,NELL2B,https://ctdbase.org/detail.go?type=gene&acc=336082,,,336082.0,nell2b,143606.0,Gobiocypris rarus,Bisphenol A results in increased expression of NELL2B mRNA,,,PMID:26364221,https://www.ncbi.nlm.nih.gov/pubmed/26364221,26364221,,
1039,705185,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,9147,NEMF,https://ctdbase.org/detail.go?type=gene&acc=9147,,,9147.0,NEMF,9606.0,Homo sapiens (human),Bisphenol A results in increased methylation of NEMF gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
1040,705186,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,9147,NEMF,https://ctdbase.org/detail.go?type=gene&acc=9147,,,9147.0,NEMF,9606.0,Homo sapiens (human),[phenolsulfonphthalein deficiency co-treated with bisphenol A] results in increased expression of NEMF protein,,,PMID:31629898,https://www.ncbi.nlm.nih.gov/pubmed/31629898,31629898,,
1041,705187,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,9147,NEMF,https://ctdbase.org/detail.go?type=gene&acc=9147,,,9147.0,NEMF,10090.0,Mus musculus (house mouse),Bisphenol A results in decreased expression of NEMF mRNA,,,PMID:33221593|PMID:37894381,https://www.ncbi.nlm.nih.gov/pubmed/33221593|https://www.ncbi.nlm.nih.gov/pubmed/37894381,33221593|37894381,,
1042,705188,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,9147,NEMF,https://ctdbase.org/detail.go?type=gene&acc=9147,,,9147.0,NEMF,10090.0,Mus musculus (house mouse),Bisphenol A results in increased expression of NEMF mRNA,,,PMID:26063408,https://www.ncbi.nlm.nih.gov/pubmed/26063408,26063408,,
1043,705189,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,23306,NEMP1,https://ctdbase.org/detail.go?type=gene&acc=23306,,,23306.0,NEMP1,9606.0,Homo sapiens (human),[bisphenol A co-treated with fulvestrant] results in decreased methylation of NEMP1 gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
1044,705190,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,23306,NEMP1,https://ctdbase.org/detail.go?type=gene&acc=23306,,,23306.0,NEMP1,10116.0,Rattus norvegicus (Norway rat),Bisphenol A results in increased expression of NEMP1 mRNA,,,PMID:25181051,https://www.ncbi.nlm.nih.gov/pubmed/25181051,25181051,,
1045,705681,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,57506,MAVS,https://ctdbase.org/detail.go?type=gene&acc=57506,,,57506.0,MAVS,10116.0,Rattus norvegicus (Norway rat),Bisphenol A affects the expression of MAVS mRNA,,,PMID:25181051,https://www.ncbi.nlm.nih.gov/pubmed/25181051,25181051,,
1046,705682,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,57506,MAVS,https://ctdbase.org/detail.go?type=gene&acc=57506,,,57506.0,MAVS,10116.0,Rattus norvegicus (Norway rat),Bisphenol A results in decreased expression of MAVS mRNA,,,PMID:30816183|PMID:34947998,https://www.ncbi.nlm.nih.gov/pubmed/30816183|https://www.ncbi.nlm.nih.gov/pubmed/34947998,30816183|34947998,,
1047,705683,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,4149,MAX,https://ctdbase.org/detail.go?type=gene&acc=4149,,,4149.0,MAX,7955.0,Danio rerio (zebrafish),Bisphenol A affects the expression of MAX mRNA,,,PMID:21786754,https://www.ncbi.nlm.nih.gov/pubmed/21786754,21786754,,
1048,705684,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,4149,MAX,https://ctdbase.org/detail.go?type=gene&acc=4149,,,4149.0,MAX,8090.0,Oryzias latipes (Japanese medaka),Bisphenol A results in increased expression of MAX mRNA,,,PMID:37581432,https://www.ncbi.nlm.nih.gov/pubmed/37581432,37581432,,
1049,705685,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,4149,MAX,https://ctdbase.org/detail.go?type=gene&acc=4149,,,4149.0,MAX,10116.0,Rattus norvegicus (Norway rat),Bisphenol A affects the expression of MAX mRNA,,,PMID:25181051,https://www.ncbi.nlm.nih.gov/pubmed/25181051,25181051,,
1050,705686,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,4149,MAX,https://ctdbase.org/detail.go?type=gene&acc=4149,,,4149.0,MAX,10116.0,Rattus norvegicus (Norway rat),Bisphenol A results in increased expression of MAX mRNA,,,PMID:34947998,https://www.ncbi.nlm.nih.gov/pubmed/34947998,34947998,,
1051,705687,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,4149,MAX,https://ctdbase.org/detail.go?type=gene&acc=4149,,,4149.0,MAX,10116.0,Rattus norvegicus (Norway rat),Bisphenol A results in increased methylation of MAX gene,,,PMID:28505145,https://www.ncbi.nlm.nih.gov/pubmed/28505145,28505145,,
1052,705688,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,4150,MAZ,https://ctdbase.org/detail.go?type=gene&acc=4150,,,4150.0,MAZ,9606.0,Homo sapiens (human),Bisphenol A affects the expression of MAZ mRNA,,,PMID:21826169,https://www.ncbi.nlm.nih.gov/pubmed/21826169,21826169,,
1053,706069,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,10093,ARPC4,https://ctdbase.org/detail.go?type=gene&acc=10093,,,10093.0,ARPC4,10116.0,Rattus norvegicus (Norway rat),[bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of ARPC4 mRNA,,,PMID:36041667,https://www.ncbi.nlm.nih.gov/pubmed/36041667,36041667,,
1054,706070,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,445305,ARPC4L,https://ctdbase.org/detail.go?type=gene&acc=445305,,,445305.0,arpc4l,7955.0,Danio rerio (zebrafish),Bisphenol A affects the expression of ARPC4L mRNA,,,PMID:21786754,https://www.ncbi.nlm.nih.gov/pubmed/21786754,21786754,,
1055,706071,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,445305,ARPC4L,https://ctdbase.org/detail.go?type=gene&acc=445305,,,445305.0,arpc4l,7955.0,Danio rerio (zebrafish),Bisphenol A results in increased methylation of ARPC4L promoter|bisphenol A results in increased methylation of ARPC4L intron,,,PMID:30906313,https://www.ncbi.nlm.nih.gov/pubmed/30906313,30906313,,
1056,706072,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,100526693,ARPC4-TTLL3,https://ctdbase.org/detail.go?type=gene&acc=100526693,,,100526693.0,ARPC4-TTLL3,9606.0,Homo sapiens (human),Bisphenol A results in increased expression of ARPC4-TTLL3 protein,,,PMID:33376534,https://www.ncbi.nlm.nih.gov/pubmed/33376534,33376534,,
1057,706073,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,10092,ARPC5,https://ctdbase.org/detail.go?type=gene&acc=10092,,,10092.0,ARPC5,9606.0,Homo sapiens (human),Bisphenol A results in increased expression of ARPC5 protein,,,PMID:34186270|PMID:37567409,https://www.ncbi.nlm.nih.gov/pubmed/34186270|https://www.ncbi.nlm.nih.gov/pubmed/37567409,34186270|37567409,,
1058,706523,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,393947,ARPP19B,https://ctdbase.org/detail.go?type=gene&acc=393947,,,393947.0,arpp19b,7955.0,Danio rerio (zebrafish),Bisphenol A results in increased methylation of ARPP19B promoter,,,PMID:30906313,https://www.ncbi.nlm.nih.gov/pubmed/30906313,30906313,,
1059,706524,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,10777,ARPP21,https://ctdbase.org/detail.go?type=gene&acc=10777,,,10777.0,ARPP21,7955.0,Danio rerio (zebrafish),Bisphenol A results in increased methylation of ARPP21 intron,,,PMID:30906313,https://www.ncbi.nlm.nih.gov/pubmed/30906313,30906313,,
1060,706525,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,10777,ARPP21,https://ctdbase.org/detail.go?type=gene&acc=10777,,,10777.0,ARPP21,9606.0,Homo sapiens (human),Bisphenol A results in increased methylation of ARPP21 gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
1061,706686,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,391356,PTRHD1,https://ctdbase.org/detail.go?type=gene&acc=391356,,,391356.0,PTRHD1,8478.0,Chrysemys picta bellii (western painted turtle),Bisphenol A results in increased expression of PTRHD1 mRNA,,,PMID:28159858,https://www.ncbi.nlm.nih.gov/pubmed/28159858,28159858,,
1062,707180,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,10150,MBNL2,https://ctdbase.org/detail.go?type=gene&acc=10150,,,10150.0,MBNL2,10116.0,Rattus norvegicus (Norway rat),Bisphenol A results in increased methylation of MBNL2 gene,,,PMID:28505145,https://www.ncbi.nlm.nih.gov/pubmed/28505145,28505145,,
1063,708039,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,796115,NEXMIFB,https://ctdbase.org/detail.go?type=gene&acc=796115,,,796115.0,nexmifb,7955.0,Danio rerio (zebrafish),Bisphenol A results in decreased methylation of NEXMIFB intron|bisphenol A results in increased methylation of NEXMIFB intron,,,PMID:30906313,https://www.ncbi.nlm.nih.gov/pubmed/30906313,30906313,,
1064,708040,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,91624,NEXN,https://ctdbase.org/detail.go?type=gene&acc=91624,,,91624.0,NEXN,9606.0,Homo sapiens (human),Bisphenol A results in decreased expression of NEXN mRNA,,,PMID:25047013|PMID:27685785,https://www.ncbi.nlm.nih.gov/pubmed/25047013|https://www.ncbi.nlm.nih.gov/pubmed/27685785,25047013|27685785,,
1065,708041,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,91624,NEXN,https://ctdbase.org/detail.go?type=gene&acc=91624,,,91624.0,NEXN,9606.0,Homo sapiens (human),Bisphenol A results in increased expression of NEXN protein,,,PMID:34186270|PMID:37567409,https://www.ncbi.nlm.nih.gov/pubmed/34186270|https://www.ncbi.nlm.nih.gov/pubmed/37567409,34186270|37567409,,
1066,708042,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,91624,NEXN,https://ctdbase.org/detail.go?type=gene&acc=91624,,,91624.0,NEXN,10090.0,Mus musculus (house mouse),Bisphenol A results in decreased expression of NEXN mRNA,,,PMID:33221593,https://www.ncbi.nlm.nih.gov/pubmed/33221593,33221593,,
1067,708043,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,91624,NEXN,https://ctdbase.org/detail.go?type=gene&acc=91624,,,91624.0,NEXN,10090.0,Mus musculus (house mouse),Bisphenol A results in decreased methylation of NEXN promoter,,,PMID:27312807,https://www.ncbi.nlm.nih.gov/pubmed/27312807,27312807,,
1068,708044,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,91624,NEXN,https://ctdbase.org/detail.go?type=gene&acc=91624,,,91624.0,NEXN,10116.0,Rattus norvegicus (Norway rat),Bisphenol A affects the expression of NEXN mRNA,,,PMID:25181051,https://www.ncbi.nlm.nih.gov/pubmed/25181051,25181051,,
1069,708045,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,91624,NEXN,https://ctdbase.org/detail.go?type=gene&acc=91624,,,91624.0,NEXN,10116.0,Rattus norvegicus (Norway rat),Bisphenol A results in increased expression of NEXN mRNA,,,PMID:30816183|PMID:32528016|PMID:34947998,https://www.ncbi.nlm.nih.gov/pubmed/30816183|https://www.ncbi.nlm.nih.gov/pubmed/32528016|https://www.ncbi.nlm.nih.gov/pubmed/34947998,30816183|32528016|34947998,,
1070,708046,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,79642,ARSJ,https://ctdbase.org/detail.go?type=gene&acc=79642,,,79642.0,ARSJ,8090.0,Oryzias latipes (Japanese medaka),Bisphenol A results in increased expression of ARSJ mRNA,,,PMID:32622090,https://www.ncbi.nlm.nih.gov/pubmed/32622090,32622090,,
1071,700504,6626,Comparative Toxicogenomics Database (CTD),"4,4'-Sulfonyldiphenol",C543008,bis(4-hydroxyphenyl)sulfone,https://ctdbase.org/detail.go?type=chem&acc=C543008,3972,LHB,https://ctdbase.org/detail.go?type=gene&acc=3972,,,3972.0,LHB,10116.0,Rattus norvegicus (Norway rat),Bis(4-hydroxyphenyl)sulfone results in decreased expression of LHB protein,,,PMID:31424294,https://www.ncbi.nlm.nih.gov/pubmed/31424294,31424294,,
1072,700505,6626,Comparative Toxicogenomics Database (CTD),"4,4'-Sulfonyldiphenol",C543008,bis(4-hydroxyphenyl)sulfone,https://ctdbase.org/detail.go?type=chem&acc=C543008,3998,LMAN1,https://ctdbase.org/detail.go?type=gene&acc=3998,,,3998.0,LMAN1,9606.0,Homo sapiens (human),Bis(4-hydroxyphenyl)sulfone affects the expression of LMAN1 protein,,,PMID:31945527,https://www.ncbi.nlm.nih.gov/pubmed/31945527,31945527,,
1073,700506,6626,Comparative Toxicogenomics Database (CTD),"4,4'-Sulfonyldiphenol",C543008,bis(4-hydroxyphenyl)sulfone,https://ctdbase.org/detail.go?type=chem&acc=C543008,3972,LHB,https://ctdbase.org/detail.go?type=gene&acc=3972,,,3972.0,LHB,10116.0,Rattus norvegicus (Norway rat),Bis(4-hydroxyphenyl)sulfone results in increased expression of LHB protein|bis(4-hydroxyphenyl)sulfone results in increased expression of LHB mRNA,,,PMID:37357847,https://www.ncbi.nlm.nih.gov/pubmed/37357847,37357847,,
1074,700507,6626,Comparative Toxicogenomics Database (CTD),"4,4'-Sulfonyldiphenol",C543008,bis(4-hydroxyphenyl)sulfone,https://ctdbase.org/detail.go?type=chem&acc=C543008,3973,LHCGR,https://ctdbase.org/detail.go?type=gene&acc=3973,,,3973.0,LHCGR,10116.0,Rattus norvegicus (Norway rat),Bis(4-hydroxyphenyl)sulfone results in decreased expression of LHCGR mRNA,,,PMID:37357847,https://www.ncbi.nlm.nih.gov/pubmed/37357847,37357847,,
1075,700508,6626,Comparative Toxicogenomics Database (CTD),"4,4'-Sulfonyldiphenol",C543008,bis(4-hydroxyphenyl)sulfone,https://ctdbase.org/detail.go?type=chem&acc=C543008,10184,LHFPL2,https://ctdbase.org/detail.go?type=gene&acc=10184,,,10184.0,LHFPL2,9606.0,Homo sapiens (human),[INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of LHFPL2 mRNA,,,PMID:28628672,https://www.ncbi.nlm.nih.gov/pubmed/28628672,28628672,,
1076,700509,6626,Comparative Toxicogenomics Database (CTD),"4,4'-Sulfonyldiphenol",C543008,bis(4-hydroxyphenyl)sulfone,https://ctdbase.org/detail.go?type=chem&acc=C543008,10184,LHFPL2,https://ctdbase.org/detail.go?type=gene&acc=10184,,,10184.0,LHFPL2,10090.0,Mus musculus (house mouse),Bis(4-hydroxyphenyl)sulfone results in increased expression of LHFPL2 mrna|[bis(4-hydroxyphenyl)sulfone co-treated with tretinoin] results in decreased expression of LHFPL2 mRNA,,,PMID:30951980,https://www.ncbi.nlm.nih.gov/pubmed/30951980,30951980,,
1077,700510,6626,Comparative Toxicogenomics Database (CTD),"4,4'-Sulfonyldiphenol",C543008,bis(4-hydroxyphenyl)sulfone,https://ctdbase.org/detail.go?type=chem&acc=C543008,10186,LHFPL6,https://ctdbase.org/detail.go?type=gene&acc=10186,,,10186.0,LHFPL6,10090.0,Mus musculus (house mouse),Bis(4-hydroxyphenyl)sulfone results in increased expression of LHFPL6 mRNA,,,PMID:30951980,https://www.ncbi.nlm.nih.gov/pubmed/30951980,30951980,,
1078,700511,6626,Comparative Toxicogenomics Database (CTD),"4,4'-Sulfonyldiphenol",C543008,bis(4-hydroxyphenyl)sulfone,https://ctdbase.org/detail.go?type=chem&acc=C543008,64077,LHPP,https://ctdbase.org/detail.go?type=gene&acc=64077,,,64077.0,LHPP,9606.0,Homo sapiens (human),Bis(4-hydroxyphenyl)sulfone results in decreased methylation of LHPP gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
1079,700964,6626,Comparative Toxicogenomics Database (CTD),"4,4'-Sulfonyldiphenol",C543008,bis(4-hydroxyphenyl)sulfone,https://ctdbase.org/detail.go?type=chem&acc=C543008,8994,LIMD1,https://ctdbase.org/detail.go?type=gene&acc=8994,,,8994.0,LIMD1,9606.0,Homo sapiens (human),Bis(4-hydroxyphenyl)sulfone results in decreased methylation of LIMD1 gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
1080,700965,6626,Comparative Toxicogenomics Database (CTD),"4,4'-Sulfonyldiphenol",C543008,bis(4-hydroxyphenyl)sulfone,https://ctdbase.org/detail.go?type=chem&acc=C543008,8994,LIMD1,https://ctdbase.org/detail.go?type=gene&acc=8994,,,8994.0,LIMD1,10090.0,Mus musculus (house mouse),Bis(4-hydroxyphenyl)sulfone affects the methylation of LIMD1 gene,,,PMID:31683443,https://www.ncbi.nlm.nih.gov/pubmed/31683443,31683443,,
1081,701130,6626,Comparative Toxicogenomics Database (CTD),"4,4'-Sulfonyldiphenol",C543008,bis(4-hydroxyphenyl)sulfone,https://ctdbase.org/detail.go?type=chem&acc=C543008,80774,LIMD2,https://ctdbase.org/detail.go?type=gene&acc=80774,,,80774.0,LIMD2,10116.0,Rattus norvegicus (Norway rat),[bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of LIMD2 mRNA,,,PMID:36041667,https://www.ncbi.nlm.nih.gov/pubmed/36041667,36041667,,
1082,701131,6626,Comparative Toxicogenomics Database (CTD),"4,4'-Sulfonyldiphenol",C543008,bis(4-hydroxyphenyl)sulfone,https://ctdbase.org/detail.go?type=chem&acc=C543008,54923,LIME1,https://ctdbase.org/detail.go?type=gene&acc=54923,,,54923.0,LIME1,10090.0,Mus musculus (house mouse),Bis(4-hydroxyphenyl)sulfone results in decreased expression of LIME1 mRNA,,,PMID:30951980,https://www.ncbi.nlm.nih.gov/pubmed/30951980,30951980,,
1083,701602,6626,Comparative Toxicogenomics Database (CTD),"4,4'-Sulfonyldiphenol",C543008,bis(4-hydroxyphenyl)sulfone,https://ctdbase.org/detail.go?type=chem&acc=C543008,283688,LINC00927,https://ctdbase.org/detail.go?type=gene&acc=283688,,,283688.0,LINC00927,9606.0,Homo sapiens (human),Bis(4-hydroxyphenyl)sulfone results in increased methylation of LINC00927 gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
1084,701603,6626,Comparative Toxicogenomics Database (CTD),"4,4'-Sulfonyldiphenol",C543008,bis(4-hydroxyphenyl)sulfone,https://ctdbase.org/detail.go?type=chem&acc=C543008,402483,LINC01000,https://ctdbase.org/detail.go?type=gene&acc=402483,,,402483.0,LINC01000,9606.0,Homo sapiens (human),[INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of LINC01000 mRNA,,,PMID:28628672,https://www.ncbi.nlm.nih.gov/pubmed/28628672,28628672,,
1085,701604,6626,Comparative Toxicogenomics Database (CTD),"4,4'-Sulfonyldiphenol",C543008,bis(4-hydroxyphenyl)sulfone,https://ctdbase.org/detail.go?type=chem&acc=C543008,100507362,LINC01015,https://ctdbase.org/detail.go?type=gene&acc=100507362,,,100507362.0,LINC01015,9606.0,Homo sapiens (human),Bis(4-hydroxyphenyl)sulfone results in decreased methylation of LINC01015 gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
1086,701605,6626,Comparative Toxicogenomics Database (CTD),"4,4'-Sulfonyldiphenol",C543008,bis(4-hydroxyphenyl)sulfone,https://ctdbase.org/detail.go?type=chem&acc=C543008,100505875,LINC01088,https://ctdbase.org/detail.go?type=gene&acc=100505875,,,100505875.0,LINC01088,9606.0,Homo sapiens (human),[bis(4-hydroxyphenyl)sulfone co-treated with fulvestrant] results in decreased methylation of LINC01088 gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
1087,701606,6626,Comparative Toxicogenomics Database (CTD),"4,4'-Sulfonyldiphenol",C543008,bis(4-hydroxyphenyl)sulfone,https://ctdbase.org/detail.go?type=chem&acc=C543008,285419,LINC01091,https://ctdbase.org/detail.go?type=gene&acc=285419,,,285419.0,LINC01091,9606.0,Homo sapiens (human),Bis(4-hydroxyphenyl)sulfone results in decreased methylation of LINC01091 gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
1088,701607,6626,Comparative Toxicogenomics Database (CTD),"4,4'-Sulfonyldiphenol",C543008,bis(4-hydroxyphenyl)sulfone,https://ctdbase.org/detail.go?type=chem&acc=C543008,440925,LINC01124,https://ctdbase.org/detail.go?type=gene&acc=440925,,,440925.0,LINC01124,9606.0,Homo sapiens (human),Bis(4-hydroxyphenyl)sulfone results in decreased methylation of LINC01124 gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
1089,701608,6626,Comparative Toxicogenomics Database (CTD),"4,4'-Sulfonyldiphenol",C543008,bis(4-hydroxyphenyl)sulfone,https://ctdbase.org/detail.go?type=chem&acc=C543008,399827,LINC01164,https://ctdbase.org/detail.go?type=gene&acc=399827,,,399827.0,LINC01164,9606.0,Homo sapiens (human),Bis(4-hydroxyphenyl)sulfone results in decreased methylation of LINC01164 gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
1090,701793,6626,Comparative Toxicogenomics Database (CTD),"4,4'-Sulfonyldiphenol",C543008,bis(4-hydroxyphenyl)sulfone,https://ctdbase.org/detail.go?type=chem&acc=C543008,100996490,LINC01206,https://ctdbase.org/detail.go?type=gene&acc=100996490,,,100996490.0,LINC01206,9606.0,Homo sapiens (human),Bis(4-hydroxyphenyl)sulfone results in increased expression of LINC01206 mRNA,,,PMID:30616060,https://www.ncbi.nlm.nih.gov/pubmed/30616060,30616060,,
1091,701794,6626,Comparative Toxicogenomics Database (CTD),"4,4'-Sulfonyldiphenol",C543008,bis(4-hydroxyphenyl)sulfone,https://ctdbase.org/detail.go?type=chem&acc=C543008,401492,LINC01235,https://ctdbase.org/detail.go?type=gene&acc=401492,,,401492.0,LINC01235,9606.0,Homo sapiens (human),Bis(4-hydroxyphenyl)sulfone results in decreased methylation of LINC01235 gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
1092,701795,6626,Comparative Toxicogenomics Database (CTD),"4,4'-Sulfonyldiphenol",C543008,bis(4-hydroxyphenyl)sulfone,https://ctdbase.org/detail.go?type=chem&acc=C543008,727982,LINC01249,https://ctdbase.org/detail.go?type=gene&acc=727982,,,727982.0,LINC01249,9606.0,Homo sapiens (human),Bis(4-hydroxyphenyl)sulfone results in decreased expression of LINC01249 mRNA,,,PMID:33476716,https://www.ncbi.nlm.nih.gov/pubmed/33476716,33476716,,
1093,701796,6626,Comparative Toxicogenomics Database (CTD),"4,4'-Sulfonyldiphenol",C543008,bis(4-hydroxyphenyl)sulfone,https://ctdbase.org/detail.go?type=chem&acc=C543008,285084,LINC01305,https://ctdbase.org/detail.go?type=gene&acc=285084,,,285084.0,LINC01305,9606.0,Homo sapiens (human),Bis(4-hydroxyphenyl)sulfone results in increased methylation of LINC01305 gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
1094,701797,6626,Comparative Toxicogenomics Database (CTD),"4,4'-Sulfonyldiphenol",C543008,bis(4-hydroxyphenyl)sulfone,https://ctdbase.org/detail.go?type=chem&acc=C543008,254099,LINC01342,https://ctdbase.org/detail.go?type=gene&acc=254099,,,254099.0,LINC01342,9606.0,Homo sapiens (human),Bis(4-hydroxyphenyl)sulfone results in decreased methylation of LINC01342 gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
1095,701798,6626,Comparative Toxicogenomics Database (CTD),"4,4'-Sulfonyldiphenol",C543008,bis(4-hydroxyphenyl)sulfone,https://ctdbase.org/detail.go?type=chem&acc=C543008,728716,LINC01346,https://ctdbase.org/detail.go?type=gene&acc=728716,,,728716.0,LINC01346,9606.0,Homo sapiens (human),Bis(4-hydroxyphenyl)sulfone results in decreased methylation of LINC01346 gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
1096,703266,6626,Comparative Toxicogenomics Database (CTD),"4,4'-Sulfonyldiphenol",C543008,bis(4-hydroxyphenyl)sulfone,https://ctdbase.org/detail.go?type=chem&acc=C543008,4017,LOXL2,https://ctdbase.org/detail.go?type=gene&acc=4017,,,4017.0,LOXL2,10090.0,Mus musculus (house mouse),Bis(4-hydroxyphenyl)sulfone results in increased expression of LOXL2 mrna|[bis(4-hydroxyphenyl)sulfone co-treated with tretinoin] results in decreased expression of LOXL2 mRNA,,,PMID:30951980,https://www.ncbi.nlm.nih.gov/pubmed/30951980,30951980,,
1097,703267,6626,Comparative Toxicogenomics Database (CTD),"4,4'-Sulfonyldiphenol",C543008,bis(4-hydroxyphenyl)sulfone,https://ctdbase.org/detail.go?type=chem&acc=C543008,565508,LOXL2A,https://ctdbase.org/detail.go?type=gene&acc=565508,,,565508.0,loxl2a,7955.0,Danio rerio (zebrafish),Bis(4-hydroxyphenyl)sulfone results in decreased expression of LOXL2A mRNA,,,PMID:30265984,https://www.ncbi.nlm.nih.gov/pubmed/30265984,30265984,,
1098,703268,6626,Comparative Toxicogenomics Database (CTD),"4,4'-Sulfonyldiphenol",C543008,bis(4-hydroxyphenyl)sulfone,https://ctdbase.org/detail.go?type=chem&acc=C543008,84695,LOXL3,https://ctdbase.org/detail.go?type=gene&acc=84695,,,84695.0,LOXL3,10090.0,Mus musculus (house mouse),Bis(4-hydroxyphenyl)sulfone results in decreased methylation of LOXL3 exon,,,PMID:33297965,https://www.ncbi.nlm.nih.gov/pubmed/33297965,33297965,,
1099,703269,6626,Comparative Toxicogenomics Database (CTD),"4,4'-Sulfonyldiphenol",C543008,bis(4-hydroxyphenyl)sulfone,https://ctdbase.org/detail.go?type=chem&acc=C543008,84171,LOXL4,https://ctdbase.org/detail.go?type=gene&acc=84171,,,84171.0,LOXL4,9606.0,Homo sapiens (human),Bis(4-hydroxyphenyl)sulfone results in decreased expression of LOXL4 mRNA,,,PMID:25912373,https://www.ncbi.nlm.nih.gov/pubmed/25912373,25912373,,
1100,703270,6626,Comparative Toxicogenomics Database (CTD),"4,4'-Sulfonyldiphenol",C543008,bis(4-hydroxyphenyl)sulfone,https://ctdbase.org/detail.go?type=chem&acc=C543008,84171,LOXL4,https://ctdbase.org/detail.go?type=gene&acc=84171,,,84171.0,LOXL4,10090.0,Mus musculus (house mouse),Bis(4-hydroxyphenyl)sulfone results in increased expression of LOXL4 mRNA,,,PMID:30951980,https://www.ncbi.nlm.nih.gov/pubmed/30951980,30951980,,
1101,703595,6626,Comparative Toxicogenomics Database (CTD),"4,4'-Sulfonyldiphenol",C543008,bis(4-hydroxyphenyl)sulfone,https://ctdbase.org/detail.go?type=chem&acc=C543008,9227,LRAT,https://ctdbase.org/detail.go?type=gene&acc=9227,,,9227.0,LRAT,10090.0,Mus musculus (house mouse),Bis(4-hydroxyphenyl)sulfone results in increased expression of LRAT mRNA,,,PMID:30951980,https://www.ncbi.nlm.nih.gov/pubmed/30951980,30951980,,
1102,703766,6626,Comparative Toxicogenomics Database (CTD),"4,4'-Sulfonyldiphenol",C543008,bis(4-hydroxyphenyl)sulfone,https://ctdbase.org/detail.go?type=chem&acc=C543008,78999,LRFN4,https://ctdbase.org/detail.go?type=gene&acc=78999,,,78999.0,LRFN4,10116.0,Rattus norvegicus (Norway rat),[bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of LRFN4 mRNA,,,PMID:36041667,https://www.ncbi.nlm.nih.gov/pubmed/36041667,36041667,,
1103,703767,6626,Comparative Toxicogenomics Database (CTD),"4,4'-Sulfonyldiphenol",C543008,bis(4-hydroxyphenyl)sulfone,https://ctdbase.org/detail.go?type=chem&acc=C543008,136332,LRGUK,https://ctdbase.org/detail.go?type=gene&acc=136332,,,136332.0,LRGUK,10090.0,Mus musculus (house mouse),Bis(4-hydroxyphenyl)sulfone results in increased expression of LRGUK mRNA,,,PMID:30951980,https://www.ncbi.nlm.nih.gov/pubmed/30951980,30951980,,
1104,703768,6626,Comparative Toxicogenomics Database (CTD),"4,4'-Sulfonyldiphenol",C543008,bis(4-hydroxyphenyl)sulfone,https://ctdbase.org/detail.go?type=chem&acc=C543008,26018,LRIG1,https://ctdbase.org/detail.go?type=gene&acc=26018,,,26018.0,LRIG1,9606.0,Homo sapiens (human),Bis(4-hydroxyphenyl)sulfone affects the methylation of LRIG1 gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
1105,703769,6626,Comparative Toxicogenomics Database (CTD),"4,4'-Sulfonyldiphenol",C543008,bis(4-hydroxyphenyl)sulfone,https://ctdbase.org/detail.go?type=chem&acc=C543008,9860,LRIG2,https://ctdbase.org/detail.go?type=gene&acc=9860,,,9860.0,LRIG2,9606.0,Homo sapiens (human),Bis(4-hydroxyphenyl)sulfone results in increased methylation of LRIG2 gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
1106,703916,6626,Comparative Toxicogenomics Database (CTD),"4,4'-Sulfonyldiphenol",C543008,bis(4-hydroxyphenyl)sulfone,https://ctdbase.org/detail.go?type=chem&acc=C543008,345193,LRIT3,https://ctdbase.org/detail.go?type=gene&acc=345193,,,345193.0,LRIT3,10090.0,Mus musculus (house mouse),Bis(4-hydroxyphenyl)sulfone results in decreased methylation of LRIT3 exon,,,PMID:33297965,https://www.ncbi.nlm.nih.gov/pubmed/33297965,33297965,,
1107,703917,6626,Comparative Toxicogenomics Database (CTD),"4,4'-Sulfonyldiphenol",C543008,bis(4-hydroxyphenyl)sulfone,https://ctdbase.org/detail.go?type=chem&acc=C543008,4035,LRP1,https://ctdbase.org/detail.go?type=gene&acc=4035,,,4035.0,LRP1,9606.0,Homo sapiens (human),[INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of LRP1 mRNA,,,PMID:28628672,https://www.ncbi.nlm.nih.gov/pubmed/28628672,28628672,,
1108,703918,6626,Comparative Toxicogenomics Database (CTD),"4,4'-Sulfonyldiphenol",C543008,bis(4-hydroxyphenyl)sulfone,https://ctdbase.org/detail.go?type=chem&acc=C543008,4035,LRP1,https://ctdbase.org/detail.go?type=gene&acc=4035,,,4035.0,LRP1,10090.0,Mus musculus (house mouse),Bis(4-hydroxyphenyl)sulfone affects the methylation of LRP1 gene,,,PMID:31683443,https://www.ncbi.nlm.nih.gov/pubmed/31683443,31683443,,
1109,703919,6626,Comparative Toxicogenomics Database (CTD),"4,4'-Sulfonyldiphenol",C543008,bis(4-hydroxyphenyl)sulfone,https://ctdbase.org/detail.go?type=chem&acc=C543008,4035,LRP1,https://ctdbase.org/detail.go?type=gene&acc=4035,,,4035.0,LRP1,10090.0,Mus musculus (house mouse),Bis(4-hydroxyphenyl)sulfone results in decreased methylation of LRP1 exon,,,PMID:33297965,https://www.ncbi.nlm.nih.gov/pubmed/33297965,33297965,,
1110,703920,6626,Comparative Toxicogenomics Database (CTD),"4,4'-Sulfonyldiphenol",C543008,bis(4-hydroxyphenyl)sulfone,https://ctdbase.org/detail.go?type=chem&acc=C543008,4035,LRP1,https://ctdbase.org/detail.go?type=gene&acc=4035,,,4035.0,LRP1,10116.0,Rattus norvegicus (Norway rat),[bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of LRP1 mRNA,,,PMID:36041667,https://www.ncbi.nlm.nih.gov/pubmed/36041667,36041667,,
1111,703921,6626,Comparative Toxicogenomics Database (CTD),"4,4'-Sulfonyldiphenol",C543008,bis(4-hydroxyphenyl)sulfone,https://ctdbase.org/detail.go?type=chem&acc=C543008,4036,LRP2,https://ctdbase.org/detail.go?type=gene&acc=4036,,,4036.0,LRP2,10090.0,Mus musculus (house mouse),Bis(4-hydroxyphenyl)sulfone results in decreased expression of LRP2 mRNA,,,PMID:30951980,https://www.ncbi.nlm.nih.gov/pubmed/30951980,30951980,,
1112,704245,6626,Comparative Toxicogenomics Database (CTD),"4,4'-Sulfonyldiphenol",C543008,bis(4-hydroxyphenyl)sulfone,https://ctdbase.org/detail.go?type=chem&acc=C543008,131578,LRRC15,https://ctdbase.org/detail.go?type=gene&acc=131578,,,131578.0,LRRC15,10090.0,Mus musculus (house mouse),Bis(4-hydroxyphenyl)sulfone results in increased expression of LRRC15 mRNA,,,PMID:30951980,https://www.ncbi.nlm.nih.gov/pubmed/30951980,30951980,,
1113,704246,6626,Comparative Toxicogenomics Database (CTD),"4,4'-Sulfonyldiphenol",C543008,bis(4-hydroxyphenyl)sulfone,https://ctdbase.org/detail.go?type=chem&acc=C543008,10234,LRRC17,https://ctdbase.org/detail.go?type=gene&acc=10234,,,10234.0,LRRC17,9606.0,Homo sapiens (human),Bis(4-hydroxyphenyl)sulfone results in decreased expression of LRRC17 mRNA,,,PMID:25912373,https://www.ncbi.nlm.nih.gov/pubmed/25912373,25912373,,
1114,704247,6626,Comparative Toxicogenomics Database (CTD),"4,4'-Sulfonyldiphenol",C543008,bis(4-hydroxyphenyl)sulfone,https://ctdbase.org/detail.go?type=chem&acc=C543008,10234,LRRC17,https://ctdbase.org/detail.go?type=gene&acc=10234,,,10234.0,LRRC17,10090.0,Mus musculus (house mouse),Bis(4-hydroxyphenyl)sulfone results in increased expression of LRRC17 mrna|[bis(4-hydroxyphenyl)sulfone co-treated with tretinoin] results in decreased expression of LRRC17 mRNA,,,PMID:30951980,https://www.ncbi.nlm.nih.gov/pubmed/30951980,30951980,,
1115,704248,6626,Comparative Toxicogenomics Database (CTD),"4,4'-Sulfonyldiphenol",C543008,bis(4-hydroxyphenyl)sulfone,https://ctdbase.org/detail.go?type=chem&acc=C543008,474354,LRRC18,https://ctdbase.org/detail.go?type=gene&acc=474354,,,474354.0,LRRC18,10090.0,Mus musculus (house mouse),Bis(4-hydroxyphenyl)sulfone results in increased expression of LRRC18 mRNA,,,PMID:30951980,https://www.ncbi.nlm.nih.gov/pubmed/30951980,30951980,,
1116,704249,6626,Comparative Toxicogenomics Database (CTD),"4,4'-Sulfonyldiphenol",C543008,bis(4-hydroxyphenyl)sulfone,https://ctdbase.org/detail.go?type=chem&acc=C543008,79442,LRRC2,https://ctdbase.org/detail.go?type=gene&acc=79442,,,79442.0,LRRC2,10116.0,Rattus norvegicus (Norway rat),[bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of LRRC2 mRNA,,,PMID:36041667,https://www.ncbi.nlm.nih.gov/pubmed/36041667,36041667,,
1117,704250,6626,Comparative Toxicogenomics Database (CTD),"4,4'-Sulfonyldiphenol",C543008,bis(4-hydroxyphenyl)sulfone,https://ctdbase.org/detail.go?type=chem&acc=C543008,10233,LRRC23,https://ctdbase.org/detail.go?type=gene&acc=10233,,,10233.0,LRRC23,10090.0,Mus musculus (house mouse),Bis(4-hydroxyphenyl)sulfone results in increased expression of LRRC23 mRNA,,,PMID:30951980,https://www.ncbi.nlm.nih.gov/pubmed/30951980,30951980,,
1118,704251,6626,Comparative Toxicogenomics Database (CTD),"4,4'-Sulfonyldiphenol",C543008,bis(4-hydroxyphenyl)sulfone,https://ctdbase.org/detail.go?type=chem&acc=C543008,126364,LRRC25,https://ctdbase.org/detail.go?type=gene&acc=126364,,,126364.0,LRRC25,10116.0,Rattus norvegicus (Norway rat),[bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of LRRC25 mRNA,,,PMID:36041667,https://www.ncbi.nlm.nih.gov/pubmed/36041667,36041667,,
1119,704394,6626,Comparative Toxicogenomics Database (CTD),"4,4'-Sulfonyldiphenol",C543008,bis(4-hydroxyphenyl)sulfone,https://ctdbase.org/detail.go?type=chem&acc=C543008,55631,LRRC40,https://ctdbase.org/detail.go?type=gene&acc=55631,,,55631.0,LRRC40,9606.0,Homo sapiens (human),Bis(4-hydroxyphenyl)sulfone results in decreased methylation of LRRC40 gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
1120,704395,6626,Comparative Toxicogenomics Database (CTD),"4,4'-Sulfonyldiphenol",C543008,bis(4-hydroxyphenyl)sulfone,https://ctdbase.org/detail.go?type=chem&acc=C543008,254050,LRRC43,https://ctdbase.org/detail.go?type=gene&acc=254050,,,254050.0,LRRC43,10116.0,Rattus norvegicus (Norway rat),[bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of LRRC43 mRNA,,,PMID:36041667,https://www.ncbi.nlm.nih.gov/pubmed/36041667,36041667,,
1121,704396,6626,Comparative Toxicogenomics Database (CTD),"4,4'-Sulfonyldiphenol",C543008,bis(4-hydroxyphenyl)sulfone,https://ctdbase.org/detail.go?type=chem&acc=C543008,201255,LRRC45,https://ctdbase.org/detail.go?type=gene&acc=201255,,,201255.0,LRRC45,10090.0,Mus musculus (house mouse),Bis(4-hydroxyphenyl)sulfone results in increased methylation of LRRC45 exon,,,PMID:33297965,https://www.ncbi.nlm.nih.gov/pubmed/33297965,33297965,,
1122,701301,6758,Comparative Toxicogenomics Database (CTD),Rotenone,D012402,Rotenone,https://ctdbase.org/detail.go?type=chem&acc=D012402,51385,ZNF589,https://ctdbase.org/detail.go?type=gene&acc=51385,,,51385.0,ZNF589,9606.0,Homo sapiens (human),Rotenone results in decreased expression of ZNF589 mRNA,,,PMID:33512557,https://www.ncbi.nlm.nih.gov/pubmed/33512557,33512557,,
1123,701302,6758,Comparative Toxicogenomics Database (CTD),Rotenone,D012402,Rotenone,https://ctdbase.org/detail.go?type=chem&acc=D012402,51042,ZNF593,https://ctdbase.org/detail.go?type=gene&acc=51042,,,51042.0,ZNF593,10116.0,Rattus norvegicus (Norway rat),Rotenone results in decreased expression of ZNF593 mRNA,,,PMID:19013527,https://www.ncbi.nlm.nih.gov/pubmed/19013527,19013527,,
1124,701303,6758,Comparative Toxicogenomics Database (CTD),Rotenone,D012402,Rotenone,https://ctdbase.org/detail.go?type=chem&acc=D012402,91120,ZNF682,https://ctdbase.org/detail.go?type=gene&acc=91120,,,91120.0,ZNF682,9606.0,Homo sapiens (human),Rotenone results in increased expression of ZNF682 mRNA,,,PMID:33512557,https://www.ncbi.nlm.nih.gov/pubmed/33512557,33512557,,
1125,701304,6758,Comparative Toxicogenomics Database (CTD),Rotenone,D012402,Rotenone,https://ctdbase.org/detail.go?type=chem&acc=D012402,79755,ZNF750,https://ctdbase.org/detail.go?type=gene&acc=79755,,,79755.0,ZNF750,10116.0,Rattus norvegicus (Norway rat),Rotenone results in increased expression of ZNF750 mRNA,,,PMID:28374803,https://www.ncbi.nlm.nih.gov/pubmed/28374803,28374803,,
1126,701305,6758,Comparative Toxicogenomics Database (CTD),Rotenone,D012402,Rotenone,https://ctdbase.org/detail.go?type=chem&acc=D012402,126208,ZNF787,https://ctdbase.org/detail.go?type=gene&acc=126208,,,126208.0,ZNF787,10116.0,Rattus norvegicus (Norway rat),Rotenone results in increased expression of ZNF787 mRNA,,,PMID:19013527,https://www.ncbi.nlm.nih.gov/pubmed/19013527,19013527,,
1127,701306,6758,Comparative Toxicogenomics Database (CTD),Rotenone,D012402,Rotenone,https://ctdbase.org/detail.go?type=chem&acc=D012402,220869,ZNG1E,https://ctdbase.org/detail.go?type=gene&acc=220869,,,220869.0,ZNG1E,9606.0,Homo sapiens (human),Rotenone results in decreased expression of ZNG1E mRNA,,,PMID:33512557,https://www.ncbi.nlm.nih.gov/pubmed/33512557,33512557,,
1128,701307,6758,Comparative Toxicogenomics Database (CTD),Rotenone,D012402,Rotenone,https://ctdbase.org/detail.go?type=chem&acc=D012402,10534,ZNRD2,https://ctdbase.org/detail.go?type=gene&acc=10534,,,10534.0,ZNRD2,10116.0,Rattus norvegicus (Norway rat),Rotenone results in increased expression of ZNRD2 mRNA,,,PMID:28374803,https://www.ncbi.nlm.nih.gov/pubmed/28374803,28374803,,
1129,701308,6758,Comparative Toxicogenomics Database (CTD),Rotenone,D012402,Rotenone,https://ctdbase.org/detail.go?type=chem&acc=D012402,223082,ZNRF2,https://ctdbase.org/detail.go?type=gene&acc=223082,,,223082.0,ZNRF2,10090.0,Mus musculus (house mouse),Rotenone results in decreased expression of ZNRF2 mRNA,,,PMID:23186747,https://www.ncbi.nlm.nih.gov/pubmed/23186747,23186747,,
1130,705520,7237,Comparative Toxicogenomics Database (CTD),O-Xylene,D014992,Xylenes,https://ctdbase.org/detail.go?type=chem&acc=D014992,1636,ACE,https://ctdbase.org/detail.go?type=gene&acc=1636,,,1636.0,ACE,9606.0,Homo sapiens (human),[toluene co-treated with ethylbenzene co-treated with xylenes] results in decreased methylation of ACE gene|[toluene co-treated with ethylbenzene co-treated with xylenes] results in increased expression of ACE mRNA,,,PMID:26018793,https://www.ncbi.nlm.nih.gov/pubmed/26018793,26018793,,
1131,705521,7237,Comparative Toxicogenomics Database (CTD),O-Xylene,D014992,Xylenes,https://ctdbase.org/detail.go?type=chem&acc=D014992,105387,AKR1C14,https://ctdbase.org/detail.go?type=gene&acc=105387,,,105387.0,Akr1c14,10116.0,Rattus norvegicus (Norway rat),Xylenes results in decreased expression of AKR1C14 mRNA,,,PMID:33662507,https://www.ncbi.nlm.nih.gov/pubmed/33662507,33662507,,
1132,705522,7237,Comparative Toxicogenomics Database (CTD),O-Xylene,D014992,Xylenes,https://ctdbase.org/detail.go?type=chem&acc=D014992,207,AKT1,https://ctdbase.org/detail.go?type=gene&acc=207,,,207.0,AKT1,10116.0,Rattus norvegicus (Norway rat),Xylenes results in decreased phosphorylation of AKT1 protein,,,PMID:33662507,https://www.ncbi.nlm.nih.gov/pubmed/33662507,33662507,,
1133,705523,7237,Comparative Toxicogenomics Database (CTD),O-Xylene,D014992,Xylenes,https://ctdbase.org/detail.go?type=chem&acc=D014992,213,ALB,https://ctdbase.org/detail.go?type=gene&acc=213,,,213.0,ALB,9606.0,Homo sapiens (human),[xylenes co-treated with toluene] results in increased secretion of ALB protein,,,PMID:15895243,https://www.ncbi.nlm.nih.gov/pubmed/15895243,15895243,,
1134,705524,7237,Comparative Toxicogenomics Database (CTD),O-Xylene,D014992,Xylenes,https://ctdbase.org/detail.go?type=chem&acc=D014992,656,BMP8B,https://ctdbase.org/detail.go?type=gene&acc=656,,,656.0,BMP8B,9606.0,Homo sapiens (human),[toluene co-treated with ethylbenzene co-treated with xylenes] results in decreased expression of BMP8B mrna|[toluene co-treated with ethylbenzene co-treated with xylenes] results in increased methylation of BMP8B gene,,,PMID:26018793,https://www.ncbi.nlm.nih.gov/pubmed/26018793,26018793,,
1135,705525,7237,Comparative Toxicogenomics Database (CTD),O-Xylene,D014992,Xylenes,https://ctdbase.org/detail.go?type=chem&acc=D014992,6715,SRD5A1,https://ctdbase.org/detail.go?type=gene&acc=6715,,,6715.0,SRD5A1,10116.0,Rattus norvegicus (Norway rat),Xylenes results in decreased expression of SRD5A1 mRNA,,,PMID:33662507,https://www.ncbi.nlm.nih.gov/pubmed/33662507,33662507,,
1136,705526,7237,Comparative Toxicogenomics Database (CTD),O-Xylene,D014992,Xylenes,https://ctdbase.org/detail.go?type=chem&acc=D014992,59283,CACNG8,https://ctdbase.org/detail.go?type=gene&acc=59283,,,59283.0,CACNG8,9606.0,Homo sapiens (human),[toluene co-treated with xylenes co-treated with ethylbenzene] results in decreased expression of CACNG8 mrna|[toluene co-treated with xylenes co-treated with ethylbenzene] results in increased methylation of CACNG8 gene,,,PMID:33438815,https://www.ncbi.nlm.nih.gov/pubmed/33438815,33438815,,
1137,705527,7237,Comparative Toxicogenomics Database (CTD),O-Xylene,D014992,Xylenes,https://ctdbase.org/detail.go?type=chem&acc=D014992,79012,CAMKV,https://ctdbase.org/detail.go?type=gene&acc=79012,,,79012.0,CAMKV,9606.0,Homo sapiens (human),[toluene co-treated with xylenes co-treated with ethylbenzene] results in decreased expression of CAMKV mRNA,,,PMID:33438815,https://www.ncbi.nlm.nih.gov/pubmed/33438815,33438815,,
1138,705921,7237,Comparative Toxicogenomics Database (CTD),O-Xylene,D014992,Xylenes,https://ctdbase.org/detail.go?type=chem&acc=D014992,7461,CLIP2,https://ctdbase.org/detail.go?type=gene&acc=7461,,,7461.0,CLIP2,9606.0,Homo sapiens (human),[toluene co-treated with xylenes co-treated with ethylbenzene] results in decreased expression of CLIP2 mrna|[toluene co-treated with xylenes co-treated with ethylbenzene] results in increased methylation of CLIP2 gene,,,PMID:33438815,https://www.ncbi.nlm.nih.gov/pubmed/33438815,33438815,,
1139,705922,7237,Comparative Toxicogenomics Database (CTD),O-Xylene,D014992,Xylenes,https://ctdbase.org/detail.go?type=chem&acc=D014992,79937,CNTNAP3,https://ctdbase.org/detail.go?type=gene&acc=79937,,,79937.0,CNTNAP3,9606.0,Homo sapiens (human),[toluene co-treated with xylenes co-treated with ethylbenzene] results in decreased expression of CNTNAP3 mrna|[toluene co-treated with xylenes co-treated with ethylbenzene] results in increased methylation of CNTNAP3 gene,,,PMID:33438815,https://www.ncbi.nlm.nih.gov/pubmed/33438815,33438815,,
1140,705923,7237,Comparative Toxicogenomics Database (CTD),O-Xylene,D014992,Xylenes,https://ctdbase.org/detail.go?type=chem&acc=D014992,20309,CXCL15,https://ctdbase.org/detail.go?type=gene&acc=20309,,,20309.0,Cxcl15,10090.0,Mus musculus (house mouse),[formaldehyde co-treated with benzene co-treated with toluene co-treated with xylenes] results in increased expression of CXCL15 protein,,,PMID:24733833,https://www.ncbi.nlm.nih.gov/pubmed/24733833,24733833,,
1141,705924,7237,Comparative Toxicogenomics Database (CTD),O-Xylene,D014992,Xylenes,https://ctdbase.org/detail.go?type=chem&acc=D014992,2920,CXCL2,https://ctdbase.org/detail.go?type=gene&acc=2920,,,2920.0,CXCL2,10090.0,Mus musculus (house mouse),Xylenes results in increased expression of CXCL2 protein,,,PMID:23178550,https://www.ncbi.nlm.nih.gov/pubmed/23178550,23178550,,
1142,699288,7847,Comparative Toxicogenomics Database (CTD),Acrolein,D000171,Acrolein,https://ctdbase.org/detail.go?type=chem&acc=D000171,203062,TSNARE1,https://ctdbase.org/detail.go?type=gene&acc=203062,,,203062.0,TSNARE1,9606.0,Homo sapiens (human),[air pollutants results in increased abundance of [acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with ozone]] which results in decreased expression of TSNARE1 mrna|[acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with ozone] results in decreased expression of TSNARE1 mRNA,,,PMID:32699268,https://www.ncbi.nlm.nih.gov/pubmed/32699268,32699268,,
1143,699289,7847,Comparative Toxicogenomics Database (CTD),Acrolein,D000171,Acrolein,https://ctdbase.org/detail.go?type=chem&acc=D000171,7106,TSPAN4,https://ctdbase.org/detail.go?type=gene&acc=7106,,,7106.0,TSPAN4,9606.0,Homo sapiens (human),[acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with ozone] results in increased oxidation of TSPAN4 mrna|[air pollutants results in increased abundance of [acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with ozone]] which results in increased oxidation of TSPAN4 mRNA,,,PMID:32699268,https://www.ncbi.nlm.nih.gov/pubmed/32699268,32699268,,
1144,699290,7847,Comparative Toxicogenomics Database (CTD),Acrolein,D000171,Acrolein,https://ctdbase.org/detail.go?type=chem&acc=D000171,10098,TSPAN5,https://ctdbase.org/detail.go?type=gene&acc=10098,,,10098.0,TSPAN5,9606.0,Homo sapiens (human),[acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with ozone] results in increased oxidation of TSPAN5 mrna|[air pollutants results in increased abundance of [acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with ozone]] which results in increased oxidation of TSPAN5 mRNA,,,PMID:32699268,https://www.ncbi.nlm.nih.gov/pubmed/32699268,32699268,,
1145,702589,8289,Comparative Toxicogenomics Database (CTD),Triphenyl phosphate,C005445,triphenyl phosphate,https://ctdbase.org/detail.go?type=chem&acc=C005445,27250,PDCD4,https://ctdbase.org/detail.go?type=gene&acc=27250,,,27250.0,PDCD4,10116.0,Rattus norvegicus (Norway rat),Triphenyl phosphate results in increased expression of PDCD4 mRNA,,,PMID:30589522,https://www.ncbi.nlm.nih.gov/pubmed/30589522,30589522,,
1146,702590,8289,Comparative Toxicogenomics Database (CTD),Triphenyl phosphate,C005445,triphenyl phosphate,https://ctdbase.org/detail.go?type=chem&acc=C005445,5138,PDE2A,https://ctdbase.org/detail.go?type=gene&acc=5138,,,5138.0,PDE2A,10116.0,Rattus norvegicus (Norway rat),Triphenyl phosphate results in decreased expression of PDE2A mRNA,,,PMID:30589522,https://www.ncbi.nlm.nih.gov/pubmed/30589522,30589522,,
1147,702591,8289,Comparative Toxicogenomics Database (CTD),Triphenyl phosphate,C005445,triphenyl phosphate,https://ctdbase.org/detail.go?type=chem&acc=C005445,5140,PDE3B,https://ctdbase.org/detail.go?type=gene&acc=5140,,,5140.0,PDE3B,10116.0,Rattus norvegicus (Norway rat),Triphenyl phosphate results in increased expression of PDE3B mRNA,,,PMID:30589522,https://www.ncbi.nlm.nih.gov/pubmed/30589522,30589522,,
1148,702592,8289,Comparative Toxicogenomics Database (CTD),Triphenyl phosphate,C005445,triphenyl phosphate,https://ctdbase.org/detail.go?type=chem&acc=C005445,5147,PDE6D,https://ctdbase.org/detail.go?type=gene&acc=5147,,,5147.0,PDE6D,35525.0,Daphnia magna,Triphenyl phosphate results in increased expression of PDE6D mRNA,,,PMID:29287174,https://www.ncbi.nlm.nih.gov/pubmed/29287174,29287174,,
1149,703435,8289,Comparative Toxicogenomics Database (CTD),Triphenyl phosphate,C005445,triphenyl phosphate,https://ctdbase.org/detail.go?type=chem&acc=C005445,57475,PLEKHH1,https://ctdbase.org/detail.go?type=gene&acc=57475,,,57475.0,PLEKHH1,10116.0,Rattus norvegicus (Norway rat),Triphenyl phosphate results in increased expression of PLEKHH1 mRNA,,,PMID:30589522,https://www.ncbi.nlm.nih.gov/pubmed/30589522,30589522,,
1150,703436,8289,Comparative Toxicogenomics Database (CTD),Triphenyl phosphate,C005445,triphenyl phosphate,https://ctdbase.org/detail.go?type=chem&acc=C005445,5346,PLIN1,https://ctdbase.org/detail.go?type=gene&acc=5346,,,5346.0,PLIN1,9606.0,Homo sapiens (human),[1-methyl-3-isobutylxanthine co-treated with INS protein co-treated with triphenyl phosphate analog] results in increased expression of PLIN1 protein|[1-methyl-3-isobutylxanthine co-treated with INS protein co-treated with triphenyl phosphate] results in increased expression of PLIN1 mrna|[1-methyl-3-isobutylxanthine co-treated with INS protein co-treated with triphenyl phosphate] results in increased expression of PLIN1 protein|[1-methyl-3-isobutylxanthine co-treated with INS protein co-treated with triphenyl phosphate analog] results in increased expression of PLIN1 mRNA,,,PMID:28437481,https://www.ncbi.nlm.nih.gov/pubmed/28437481,28437481,,
1151,703437,8289,Comparative Toxicogenomics Database (CTD),Triphenyl phosphate,C005445,triphenyl phosphate,https://ctdbase.org/detail.go?type=chem&acc=C005445,5346,PLIN1,https://ctdbase.org/detail.go?type=gene&acc=5346,,,5346.0,PLIN1,9606.0,Homo sapiens (human),Triphenyl phosphate results in increased expression of PLIN1 mRNA,,,PMID:28934090,https://www.ncbi.nlm.nih.gov/pubmed/28934090,28934090,,
1152,703438,8289,Comparative Toxicogenomics Database (CTD),Triphenyl phosphate,C005445,triphenyl phosphate,https://ctdbase.org/detail.go?type=chem&acc=C005445,5346,PLIN1,https://ctdbase.org/detail.go?type=gene&acc=5346,,,5346.0,PLIN1,10090.0,Mus musculus (house mouse),[triphenyl phosphate co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of PLIN1 mRNA,,,PMID:34323617,https://www.ncbi.nlm.nih.gov/pubmed/34323617,34323617,,
1153,703439,8289,Comparative Toxicogenomics Database (CTD),Triphenyl phosphate,C005445,triphenyl phosphate,https://ctdbase.org/detail.go?type=chem&acc=C005445,5346,PLIN1,https://ctdbase.org/detail.go?type=gene&acc=5346,,,5346.0,PLIN1,10090.0,Mus musculus (house mouse),Triphenyl phosphate results in increased expression of PLIN1 protein,,,PMID:25062436,https://www.ncbi.nlm.nih.gov/pubmed/25062436,25062436,,
1154,703440,8289,Comparative Toxicogenomics Database (CTD),Triphenyl phosphate,C005445,triphenyl phosphate,https://ctdbase.org/detail.go?type=chem&acc=C005445,123,PLIN2,https://ctdbase.org/detail.go?type=gene&acc=123,,,123.0,PLIN2,10116.0,Rattus norvegicus (Norway rat),Triphenyl phosphate results in decreased expression of PLIN2 mRNA,,,PMID:30589522,https://www.ncbi.nlm.nih.gov/pubmed/30589522,30589522,,
1155,703441,8289,Comparative Toxicogenomics Database (CTD),Triphenyl phosphate,C005445,triphenyl phosphate,https://ctdbase.org/detail.go?type=chem&acc=C005445,10226,PLIN3,https://ctdbase.org/detail.go?type=gene&acc=10226,,,10226.0,PLIN3,10116.0,Rattus norvegicus (Norway rat),Triphenyl phosphate results in increased expression of PLIN3 mRNA,,,PMID:30589522,https://www.ncbi.nlm.nih.gov/pubmed/30589522,30589522,,
1156,703770,8289,Comparative Toxicogenomics Database (CTD),Triphenyl phosphate,C005445,triphenyl phosphate,https://ctdbase.org/detail.go?type=chem&acc=C005445,10957,PNRC1,https://ctdbase.org/detail.go?type=gene&acc=10957,,,10957.0,PNRC1,10116.0,Rattus norvegicus (Norway rat),Triphenyl phosphate results in decreased expression of PNRC1 mRNA,,,PMID:30589522,https://www.ncbi.nlm.nih.gov/pubmed/30589522,30589522,,
1157,703771,8289,Comparative Toxicogenomics Database (CTD),Triphenyl phosphate,C005445,triphenyl phosphate,https://ctdbase.org/detail.go?type=chem&acc=C005445,54107,POLE3,https://ctdbase.org/detail.go?type=gene&acc=54107,,,54107.0,POLE3,7955.0,Danio rerio (zebrafish),Triphenyl phosphate results in decreased expression of POLE3 mRNA,,,PMID:31368501,https://www.ncbi.nlm.nih.gov/pubmed/31368501,31368501,,
1158,703772,8289,Comparative Toxicogenomics Database (CTD),Triphenyl phosphate,C005445,triphenyl phosphate,https://ctdbase.org/detail.go?type=chem&acc=C005445,5443,POMC,https://ctdbase.org/detail.go?type=gene&acc=5443,,,5443.0,POMC,10090.0,Mus musculus (house mouse),"[tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with tritolyl phosphates] results in increased expression of POMC mRNA",,,PMID:29112739,https://www.ncbi.nlm.nih.gov/pubmed/29112739,29112739,,
1159,703773,8289,Comparative Toxicogenomics Database (CTD),Triphenyl phosphate,C005445,triphenyl phosphate,https://ctdbase.org/detail.go?type=chem&acc=C005445,353221,POMCA,https://ctdbase.org/detail.go?type=gene&acc=353221,,,353221.0,pomca,7955.0,Danio rerio (zebrafish),Triphenyl phosphate results in increased expression of POMCA mRNA,,,PMID:26865342,https://www.ncbi.nlm.nih.gov/pubmed/26865342,26865342,,
1160,704856,8289,Comparative Toxicogenomics Database (CTD),Triphenyl phosphate,C005445,triphenyl phosphate,https://ctdbase.org/detail.go?type=chem&acc=C005445,254427,PROSER2,https://ctdbase.org/detail.go?type=gene&acc=254427,,,254427.0,PROSER2,10116.0,Rattus norvegicus (Norway rat),Triphenyl phosphate results in increased expression of PROSER2 mRNA,,,PMID:30589522,https://www.ncbi.nlm.nih.gov/pubmed/30589522,30589522,,
1161,704857,8289,Comparative Toxicogenomics Database (CTD),Triphenyl phosphate,C005445,triphenyl phosphate,https://ctdbase.org/detail.go?type=chem&acc=C005445,406758,PRPF4BB,https://ctdbase.org/detail.go?type=gene&acc=406758,,,406758.0,prpf4bb,7955.0,Danio rerio (zebrafish),Triphenyl phosphate results in increased expression of PRPF4BB mRNA,,,PMID:31368501,https://www.ncbi.nlm.nih.gov/pubmed/31368501,31368501,,
1162,704858,8289,Comparative Toxicogenomics Database (CTD),Triphenyl phosphate,C005445,triphenyl phosphate,https://ctdbase.org/detail.go?type=chem&acc=C005445,140620,PRPS1A,https://ctdbase.org/detail.go?type=gene&acc=140620,,,140620.0,prps1a,7955.0,Danio rerio (zebrafish),Triphenyl phosphate results in increased expression of PRPS1A mRNA,,,PMID:31368501,https://www.ncbi.nlm.nih.gov/pubmed/31368501,31368501,,
1163,704859,8289,Comparative Toxicogenomics Database (CTD),Triphenyl phosphate,C005445,triphenyl phosphate,https://ctdbase.org/detail.go?type=chem&acc=C005445,557848,PRR12B,https://ctdbase.org/detail.go?type=gene&acc=557848,,,557848.0,prr12b,7955.0,Danio rerio (zebrafish),Triphenyl phosphate affects the expression of PRR12B mRNA,,,PMID:31368501,https://www.ncbi.nlm.nih.gov/pubmed/31368501,31368501,,
1164,704860,8289,Comparative Toxicogenomics Database (CTD),Triphenyl phosphate,C005445,triphenyl phosphate,https://ctdbase.org/detail.go?type=chem&acc=C005445,54458,PRR13,https://ctdbase.org/detail.go?type=gene&acc=54458,,,54458.0,PRR13,7955.0,Danio rerio (zebrafish),Triphenyl phosphate affects the expression of PRR13 mRNA,,,PMID:31368501,https://www.ncbi.nlm.nih.gov/pubmed/31368501,31368501,,
1165,704861,8289,Comparative Toxicogenomics Database (CTD),Triphenyl phosphate,C005445,triphenyl phosphate,https://ctdbase.org/detail.go?type=chem&acc=C005445,23215,PRRC2C,https://ctdbase.org/detail.go?type=gene&acc=23215,,,23215.0,PRRC2C,7955.0,Danio rerio (zebrafish),Triphenyl phosphate results in decreased expression of PRRC2C mRNA,,,PMID:31368501,https://www.ncbi.nlm.nih.gov/pubmed/31368501,31368501,,
1166,704862,8289,Comparative Toxicogenomics Database (CTD),Triphenyl phosphate,C005445,triphenyl phosphate,https://ctdbase.org/detail.go?type=chem&acc=C005445,337089,PRRX1B,https://ctdbase.org/detail.go?type=gene&acc=337089,,,337089.0,prrx1b,7955.0,Danio rerio (zebrafish),Triphenyl phosphate results in increased expression of PRRX1B mRNA,,,PMID:31368501,https://www.ncbi.nlm.nih.gov/pubmed/31368501,31368501,,
1167,706679,8289,Comparative Toxicogenomics Database (CTD),Triphenyl phosphate,C005445,triphenyl phosphate,https://ctdbase.org/detail.go?type=chem&acc=C005445,54778,RNF111,https://ctdbase.org/detail.go?type=gene&acc=54778,,,54778.0,RNF111,7955.0,Danio rerio (zebrafish),Triphenyl phosphate results in decreased expression of RNF111 mRNA,,,PMID:31368501,https://www.ncbi.nlm.nih.gov/pubmed/31368501,31368501,,
1168,706680,8289,Comparative Toxicogenomics Database (CTD),Triphenyl phosphate,C005445,triphenyl phosphate,https://ctdbase.org/detail.go?type=chem&acc=C005445,66381,RNF113A2,https://ctdbase.org/detail.go?type=gene&acc=66381,,,66381.0,Rnf113a2,10116.0,Rattus norvegicus (Norway rat),Triphenyl phosphate results in increased expression of RNF113A2 mRNA,,,PMID:30589522,https://www.ncbi.nlm.nih.gov/pubmed/30589522,30589522,,
1169,706681,8289,Comparative Toxicogenomics Database (CTD),Triphenyl phosphate,C005445,triphenyl phosphate,https://ctdbase.org/detail.go?type=chem&acc=C005445,51444,RNF138,https://ctdbase.org/detail.go?type=gene&acc=51444,,,51444.0,RNF138,10116.0,Rattus norvegicus (Norway rat),Triphenyl phosphate results in increased expression of RNF138 mRNA,,,PMID:30589522,https://www.ncbi.nlm.nih.gov/pubmed/30589522,30589522,,
1170,706682,8289,Comparative Toxicogenomics Database (CTD),Triphenyl phosphate,C005445,triphenyl phosphate,https://ctdbase.org/detail.go?type=chem&acc=C005445,9604,RNF14,https://ctdbase.org/detail.go?type=gene&acc=9604,,,9604.0,RNF14,10116.0,Rattus norvegicus (Norway rat),Triphenyl phosphate results in increased expression of RNF14 mRNA,,,PMID:30589522,https://www.ncbi.nlm.nih.gov/pubmed/30589522,30589522,,
1171,706683,8289,Comparative Toxicogenomics Database (CTD),Triphenyl phosphate,C005445,triphenyl phosphate,https://ctdbase.org/detail.go?type=chem&acc=C005445,9781,RNF144A,https://ctdbase.org/detail.go?type=gene&acc=9781,,,9781.0,RNF144A,10116.0,Rattus norvegicus (Norway rat),Triphenyl phosphate results in decreased expression of RNF144A mRNA,,,PMID:30589522,https://www.ncbi.nlm.nih.gov/pubmed/30589522,30589522,,
1172,706684,8289,Comparative Toxicogenomics Database (CTD),Triphenyl phosphate,C005445,triphenyl phosphate,https://ctdbase.org/detail.go?type=chem&acc=C005445,81790,RNF170,https://ctdbase.org/detail.go?type=gene&acc=81790,,,81790.0,RNF170,10116.0,Rattus norvegicus (Norway rat),Triphenyl phosphate results in increased expression of RNF170 mRNA,,,PMID:30589522,https://www.ncbi.nlm.nih.gov/pubmed/30589522,30589522,,
1173,706685,8289,Comparative Toxicogenomics Database (CTD),Triphenyl phosphate,C005445,triphenyl phosphate,https://ctdbase.org/detail.go?type=chem&acc=C005445,80352,RNF39,https://ctdbase.org/detail.go?type=gene&acc=80352,,,80352.0,RNF39,10116.0,Rattus norvegicus (Norway rat),Triphenyl phosphate results in increased expression of RNF39 mRNA,,,PMID:30589522,https://www.ncbi.nlm.nih.gov/pubmed/30589522,30589522,,
1174,706840,8289,Comparative Toxicogenomics Database (CTD),Triphenyl phosphate,C005445,triphenyl phosphate,https://ctdbase.org/detail.go?type=chem&acc=C005445,57140,RNPEPL1,https://ctdbase.org/detail.go?type=gene&acc=57140,,,57140.0,RNPEPL1,10116.0,Rattus norvegicus (Norway rat),Triphenyl phosphate results in increased expression of RNPEPL1 mRNA,,,PMID:30589522,https://www.ncbi.nlm.nih.gov/pubmed/30589522,30589522,,
1175,706841,8289,Comparative Toxicogenomics Database (CTD),Triphenyl phosphate,C005445,triphenyl phosphate,https://ctdbase.org/detail.go?type=chem&acc=C005445,6119,RPA3,https://ctdbase.org/detail.go?type=gene&acc=6119,,,6119.0,RPA3,10116.0,Rattus norvegicus (Norway rat),Triphenyl phosphate affects the expression of RPA3 mRNA,,,PMID:30589522,https://www.ncbi.nlm.nih.gov/pubmed/30589522,30589522,,
1176,706842,8289,Comparative Toxicogenomics Database (CTD),Triphenyl phosphate,C005445,triphenyl phosphate,https://ctdbase.org/detail.go?type=chem&acc=C005445,79657,RPAP3,https://ctdbase.org/detail.go?type=gene&acc=79657,,,79657.0,RPAP3,10116.0,Rattus norvegicus (Norway rat),Triphenyl phosphate affects the expression of RPAP3 mRNA,,,PMID:30589522,https://www.ncbi.nlm.nih.gov/pubmed/30589522,30589522,,
1177,706843,8289,Comparative Toxicogenomics Database (CTD),Triphenyl phosphate,C005445,triphenyl phosphate,https://ctdbase.org/detail.go?type=chem&acc=C005445,22934,RPIA,https://ctdbase.org/detail.go?type=gene&acc=22934,,,22934.0,RPIA,7955.0,Danio rerio (zebrafish),Triphenyl phosphate results in increased expression of RPIA mRNA,,,PMID:31368501,https://www.ncbi.nlm.nih.gov/pubmed/31368501,31368501,,
1178,706844,8289,Comparative Toxicogenomics Database (CTD),Triphenyl phosphate,C005445,triphenyl phosphate,https://ctdbase.org/detail.go?type=chem&acc=C005445,6134,RPL10,https://ctdbase.org/detail.go?type=gene&acc=6134,,,6134.0,RPL10,7955.0,Danio rerio (zebrafish),[triphenyl phosphate co-treated with fenretinide] results in increased expression of RPL10 mRNA,,,PMID:31368501,https://www.ncbi.nlm.nih.gov/pubmed/31368501,31368501,,
1179,706845,8289,Comparative Toxicogenomics Database (CTD),Triphenyl phosphate,C005445,triphenyl phosphate,https://ctdbase.org/detail.go?type=chem&acc=C005445,4736,RPL10A,https://ctdbase.org/detail.go?type=gene&acc=4736,,,4736.0,RPL10A,7955.0,Danio rerio (zebrafish),Triphenyl phosphate affects the expression of RPL10A mrna|[triphenyl phosphate co-treated with fenretinide] results in increased expression of RPL10A mRNA,,,PMID:31368501,https://www.ncbi.nlm.nih.gov/pubmed/31368501,31368501,,
1180,706846,8289,Comparative Toxicogenomics Database (CTD),Triphenyl phosphate,C005445,triphenyl phosphate,https://ctdbase.org/detail.go?type=chem&acc=C005445,6135,RPL11,https://ctdbase.org/detail.go?type=gene&acc=6135,,,6135.0,RPL11,7955.0,Danio rerio (zebrafish),Triphenyl phosphate results in increased expression of RPL11 mrna|[triphenyl phosphate co-treated with fenretinide] results in increased expression of RPL11 mRNA,,,PMID:31368501,https://www.ncbi.nlm.nih.gov/pubmed/31368501,31368501,,
1181,706847,8289,Comparative Toxicogenomics Database (CTD),Triphenyl phosphate,C005445,triphenyl phosphate,https://ctdbase.org/detail.go?type=chem&acc=C005445,6137,RPL13,https://ctdbase.org/detail.go?type=gene&acc=6137,,,6137.0,RPL13,7955.0,Danio rerio (zebrafish),Triphenyl phosphate results in increased expression of RPL13 mRNA,,,PMID:31368501,https://www.ncbi.nlm.nih.gov/pubmed/31368501,31368501,,
1182,704098,10133,Comparative Toxicogenomics Database (CTD),Chenodiol,D002635,Chenodeoxycholic Acid,https://ctdbase.org/detail.go?type=chem&acc=D002635,1116,CHI3L1,https://ctdbase.org/detail.go?type=gene&acc=1116,,,1116.0,CHI3L1,9606.0,Homo sapiens (human),[glycochenodeoxycholic acid co-treated with deoxycholic acid co-treated with chenodeoxycholic acid co-treated with glycodeoxycholic acid co-treated with glycocholic acid co-treated with nefazodone] results in decreased expression of CHI3L1 mrna|[glycochenodeoxycholic acid co-treated with deoxycholic acid co-treated with chenodeoxycholic acid co-treated with glycodeoxycholic acid co-treated with glycocholic acid co-treated with atazanavir sulfate] results in decreased expression of CHI3L1 mrna|[glycochenodeoxycholic acid co-treated with deoxycholic acid co-treated with chenodeoxycholic acid co-treated with glycodeoxycholic acid co-treated with glycocholic acid co-treated with acetaminophen] results in increased expression of CHI3L1 mrna|[glycochenodeoxycholic acid co-treated with deoxycholic acid co-treated with chenodeoxycholic acid co-treated with glycodeoxycholic acid co-treated with glycocholic acid co-treated with cyclosporine] results in decreased expression of CHI3L1 mrna|[glycochenodeoxycholic acid co-treated with deoxycholic acid co-treated with chenodeoxycholic acid co-treated with glycodeoxycholic acid co-treated with glycocholic acid co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt] results in decreased expression of CHI3L1 mRNA,,,PMID:33819548,https://www.ncbi.nlm.nih.gov/pubmed/33819548,33819548,,
1183,704099,10133,Comparative Toxicogenomics Database (CTD),Chenodiol,D002635,Chenodeoxycholic Acid,https://ctdbase.org/detail.go?type=chem&acc=D002635,1277,COL1A1,https://ctdbase.org/detail.go?type=gene&acc=1277,,,1277.0,COL1A1,10090.0,Mus musculus (house mouse),Chenodeoxycholic acid inhibits the reaction [[methionine deficiency co-treated with choline deficiency] results in increased expression of COL1A1 mrna],,,PMID:27773935,https://www.ncbi.nlm.nih.gov/pubmed/27773935,27773935,,
1184,704100,10133,Comparative Toxicogenomics Database (CTD),Chenodiol,D002635,Chenodeoxycholic Acid,https://ctdbase.org/detail.go?type=chem&acc=D002635,1277,COL1A1,https://ctdbase.org/detail.go?type=gene&acc=1277,,,1277.0,COL1A1,10116.0,Rattus norvegicus (Norway rat),Chenodeoxycholic acid results in decreased expression of COL1A1 mRNA,,,PMID:15980055,https://www.ncbi.nlm.nih.gov/pubmed/15980055,15980055,,
1185,704101,10133,Comparative Toxicogenomics Database (CTD),Chenodiol,D002635,Chenodeoxycholic Acid,https://ctdbase.org/detail.go?type=chem&acc=D002635,1278,COL1A2,https://ctdbase.org/detail.go?type=gene&acc=1278,,,1278.0,COL1A2,10090.0,Mus musculus (house mouse),Chenodeoxycholic acid inhibits the reaction [[methionine deficiency co-treated with choline deficiency] results in increased expression of COL1A2 mrna],,,PMID:27773935,https://www.ncbi.nlm.nih.gov/pubmed/27773935,27773935,,
1186,704102,10133,Comparative Toxicogenomics Database (CTD),Chenodiol,D002635,Chenodeoxycholic Acid,https://ctdbase.org/detail.go?type=chem&acc=D002635,11151,CORO1A,https://ctdbase.org/detail.go?type=gene&acc=11151,,,11151.0,CORO1A,9606.0,Homo sapiens (human),[chenodeoxycholic acid co-treated with tretinoin] results in decreased expression of CORO1A mrna|chenodeoxycholic acid results in decreased expression of CORO1A mRNA,,,PMID:16040207,https://www.ncbi.nlm.nih.gov/pubmed/16040207,16040207,,
1187,704103,10133,Comparative Toxicogenomics Database (CTD),Chenodiol,D002635,Chenodeoxycholic Acid,https://ctdbase.org/detail.go?type=chem&acc=D002635,1374,CPT1A,https://ctdbase.org/detail.go?type=gene&acc=1374,,,1374.0,CPT1A,10090.0,Mus musculus (house mouse),Chenodeoxycholic acid inhibits the reaction [[methionine deficiency co-treated with choline deficiency] results in decreased expression of CPT1A mrna],,,PMID:27773935,https://www.ncbi.nlm.nih.gov/pubmed/27773935,27773935,,
1188,704244,10133,Comparative Toxicogenomics Database (CTD),Chenodiol,D002635,Chenodeoxycholic Acid,https://ctdbase.org/detail.go?type=chem&acc=D002635,3627,CXCL10,https://ctdbase.org/detail.go?type=gene&acc=3627,,,3627.0,CXCL10,10090.0,Mus musculus (house mouse),Chenodeoxycholic acid results in increased expression of CXCL10 mRNA,,,PMID:21224055,https://www.ncbi.nlm.nih.gov/pubmed/21224055,21224055,,
1189,704855,10133,Comparative Toxicogenomics Database (CTD),Chenodiol,D002635,Chenodeoxycholic Acid,https://ctdbase.org/detail.go?type=chem&acc=D002635,6580,SLC22A1,https://ctdbase.org/detail.go?type=gene&acc=6580,,,6580.0,SLC22A1,9606.0,Homo sapiens (human),Chenodeoxycholic acid results in decreased expression of SLC22A1 mRNA,,,PMID:27174168,https://www.ncbi.nlm.nih.gov/pubmed/27174168,27174168,,
1190,707173,10229,Comparative Toxicogenomics Database (CTD),9-Phenanthrol,C091375,9-phenanthrol,https://ctdbase.org/detail.go?type=chem&acc=C091375,8204,NRIP1,https://ctdbase.org/detail.go?type=gene&acc=8204,,,8204.0,NRIP1,9606.0,Homo sapiens (human),9-phenanthrol results in increased expression of NRIP1 mRNA,,,PMID:22989670,https://www.ncbi.nlm.nih.gov/pubmed/22989670,22989670,,
1191,707174,10229,Comparative Toxicogenomics Database (CTD),9-Phenanthrol,C091375,9-phenanthrol,https://ctdbase.org/detail.go?type=chem&acc=C091375,5468,PPARG,https://ctdbase.org/detail.go?type=gene&acc=5468,,,5468.0,PPARG,9606.0,Homo sapiens (human),9-phenanthrol binds to and results in increased activity of PPARG protein|9-phenanthrol binds to and affects the activity of PPARG protein,,,PMID:33049310,https://www.ncbi.nlm.nih.gov/pubmed/33049310,33049310,,
1192,707175,10229,Comparative Toxicogenomics Database (CTD),9-Phenanthrol,C091375,9-phenanthrol,https://ctdbase.org/detail.go?type=chem&acc=C091375,6331,SCN5A,https://ctdbase.org/detail.go?type=gene&acc=6331,,,6331.0,SCN5A,9606.0,Homo sapiens (human),9-phenanthrol results in decreased activity of SCN5A protein mutant form,,,PMID:30153324,https://www.ncbi.nlm.nih.gov/pubmed/30153324,30153324,,
1193,707176,10229,Comparative Toxicogenomics Database (CTD),9-Phenanthrol,C091375,9-phenanthrol,https://ctdbase.org/detail.go?type=chem&acc=C091375,6401,SELE,https://ctdbase.org/detail.go?type=gene&acc=6401,,,6401.0,SELE,9606.0,Homo sapiens (human),9-phenanthrol inhibits the reaction [hydrogen peroxide results in increased secretion of SELE protein],,,PMID:28214884,https://www.ncbi.nlm.nih.gov/pubmed/28214884,28214884,,
1194,707177,10229,Comparative Toxicogenomics Database (CTD),9-Phenanthrol,C091375,9-phenanthrol,https://ctdbase.org/detail.go?type=chem&acc=C091375,7067,THRA,https://ctdbase.org/detail.go?type=gene&acc=7067,,,7067.0,THRA,8479.0,Chrysemys picta (Painted turtle),9-phenanthrol binds to and results in increased activity of THRA protein,,,PMID:33049310,https://www.ncbi.nlm.nih.gov/pubmed/33049310,33049310,,
1195,707178,10229,Comparative Toxicogenomics Database (CTD),9-Phenanthrol,C091375,9-phenanthrol,https://ctdbase.org/detail.go?type=chem&acc=C091375,30670,THRAA,https://ctdbase.org/detail.go?type=gene&acc=30670,,,30670.0,thraa,7955.0,Danio rerio (zebrafish),9-phenanthrol binds to and results in increased activity of THRAA protein,,,PMID:33049310,https://www.ncbi.nlm.nih.gov/pubmed/33049310,33049310,,
1196,707179,10229,Comparative Toxicogenomics Database (CTD),9-Phenanthrol,C091375,9-phenanthrol,https://ctdbase.org/detail.go?type=chem&acc=C091375,397942,THRA.L,https://ctdbase.org/detail.go?type=gene&acc=397942,,,397942.0,thra.L,8355.0,Xenopus laevis (African clawed frog),9-phenanthrol binds to and results in increased activity of THRA.L protein,,,PMID:33049310,https://www.ncbi.nlm.nih.gov/pubmed/33049310,33049310,,
1197,707539,10255,Comparative Toxicogenomics Database (CTD),Kainic acid,D007608,Kainic Acid,https://ctdbase.org/detail.go?type=chem&acc=D007608,18669,ABCB1B,https://ctdbase.org/detail.go?type=gene&acc=18669,,,18669.0,Abcb1b,10116.0,Rattus norvegicus (Norway rat),Kainic acid results in increased expression of ABCB1B protein|kainic acid results in increased expression of ABCB1B mRNA,,,PMID:14706787,https://www.ncbi.nlm.nih.gov/pubmed/14706787,14706787,,
1198,1685155,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,417820,TMEM5,https://ctdbase.org/detail.go?type=gene&acc=417820,,,417820.0,TMEM5,9606.0,Homo sapiens (human),Tretinoin results in decreased expression of TMEM5 mRNA,,,PMID:33167477,https://www.ncbi.nlm.nih.gov/pubmed/33167477,33167477,,
1199,1685156,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,23585,TMEM50A,https://ctdbase.org/detail.go?type=gene&acc=23585,,,23585.0,TMEM50A,9606.0,Homo sapiens (human),Tretinoin results in increased expression of TMEM50A mRNA,,,PMID:23724009,https://www.ncbi.nlm.nih.gov/pubmed/23724009,23724009,,
1200,1686690,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,943,TNFRSF8,https://ctdbase.org/detail.go?type=gene&acc=943,,,943.0,TNFRSF8,9606.0,Homo sapiens (human),Tretinoin results in decreased expression of TNFRSF8 protein,,,PMID:12441127,https://www.ncbi.nlm.nih.gov/pubmed/12441127,12441127,,
1201,1686691,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,3604,TNFRSF9,https://ctdbase.org/detail.go?type=gene&acc=3604,,,3604.0,TNFRSF9,9606.0,Homo sapiens (human),Tretinoin results in increased expression of TNFRSF9 mRNA,,,PMID:33167477,https://www.ncbi.nlm.nih.gov/pubmed/33167477,33167477,,
1202,1688784,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,79865,TREML2,https://ctdbase.org/detail.go?type=gene&acc=79865,,,79865.0,TREML2,9606.0,Homo sapiens (human),Tretinoin results in increased expression of TREML2 mRNA,,,PMID:33167477,https://www.ncbi.nlm.nih.gov/pubmed/33167477,33167477,,
1203,1688785,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,7200,TRH,https://ctdbase.org/detail.go?type=gene&acc=7200,,,7200.0,TRH,9606.0,Homo sapiens (human),Tretinoin results in decreased expression of TRH mRNA,,,PMID:33167477,https://www.ncbi.nlm.nih.gov/pubmed/33167477,33167477,,
1204,1688786,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,7200,TRH,https://ctdbase.org/detail.go?type=gene&acc=7200,,,7200.0,TRH,10090.0,Mus musculus (house mouse),Tretinoin results in decreased expression of TRH mRNA,,,PMID:16788091,https://www.ncbi.nlm.nih.gov/pubmed/16788091,16788091,,
1205,1688787,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,7200,TRH,https://ctdbase.org/detail.go?type=gene&acc=7200,,,7200.0,TRH,10116.0,Rattus norvegicus (Norway rat),Tretinoin results in increased expression of TRH mRNA,,,PMID:20488242,https://www.ncbi.nlm.nih.gov/pubmed/20488242,20488242,,
1206,1688788,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,51499,TRIAP1,https://ctdbase.org/detail.go?type=gene&acc=51499,,,51499.0,TRIAP1,9606.0,Homo sapiens (human),Tretinoin results in decreased expression of TRIAP1 mRNA,,,PMID:33167477,https://www.ncbi.nlm.nih.gov/pubmed/33167477,33167477,,
1207,1688789,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,10221,TRIB1,https://ctdbase.org/detail.go?type=gene&acc=10221,,,10221.0,TRIB1,9606.0,Homo sapiens (human),Tretinoin affects the expression of TRIB1 mRNA,,,PMID:15498508,https://www.ncbi.nlm.nih.gov/pubmed/15498508,15498508,,
1208,1688790,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,10221,TRIB1,https://ctdbase.org/detail.go?type=gene&acc=10221,,,10221.0,TRIB1,9606.0,Homo sapiens (human),Tretinoin results in increased expression of TRIB1 mRNA,,,PMID:23724009|PMID:33167477,https://www.ncbi.nlm.nih.gov/pubmed/23724009|https://www.ncbi.nlm.nih.gov/pubmed/33167477,23724009|33167477,,
1209,1688791,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,28951,TRIB2,https://ctdbase.org/detail.go?type=gene&acc=28951,,,28951.0,TRIB2,9606.0,Homo sapiens (human),Tretinoin results in increased expression of TRIB2 mRNA,,,PMID:16012519|PMID:23724009,https://www.ncbi.nlm.nih.gov/pubmed/16012519|https://www.ncbi.nlm.nih.gov/pubmed/23724009,16012519|23724009,,
1210,1689234,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,286827,TRIM59,https://ctdbase.org/detail.go?type=gene&acc=286827,,,286827.0,TRIM59,9606.0,Homo sapiens (human),Tretinoin results in decreased expression of TRIM59 mRNA,,,PMID:21934132,https://www.ncbi.nlm.nih.gov/pubmed/21934132,21934132,,
1211,1689235,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,117854,TRIM6,https://ctdbase.org/detail.go?type=gene&acc=117854,,,117854.0,TRIM6,9606.0,Homo sapiens (human),Tretinoin results in increased expression of TRIM6 mRNA,,,PMID:23830798,https://www.ncbi.nlm.nih.gov/pubmed/23830798,23830798,,
1212,1689236,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,201292,TRIM65,https://ctdbase.org/detail.go?type=gene&acc=201292,,,201292.0,TRIM65,9606.0,Homo sapiens (human),Tretinoin results in decreased expression of TRIM65 mRNA,,,PMID:33167477,https://www.ncbi.nlm.nih.gov/pubmed/33167477,33167477,,
1213,1689542,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,388610,TRNP1,https://ctdbase.org/detail.go?type=gene&acc=388610,,,388610.0,TRNP1,9606.0,Homo sapiens (human),Tretinoin results in increased expression of TRNP1 mRNA,,,PMID:21934132,https://www.ncbi.nlm.nih.gov/pubmed/21934132,21934132,,
1214,1689543,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,7216,TRO,https://ctdbase.org/detail.go?type=gene&acc=7216,,,7216.0,TRO,9606.0,Homo sapiens (human),Tretinoin results in increased expression of TRO mRNA,,,PMID:23830798,https://www.ncbi.nlm.nih.gov/pubmed/23830798,23830798,,
1215,1689544,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,10024,TROAP,https://ctdbase.org/detail.go?type=gene&acc=10024,,,10024.0,TROAP,9606.0,Homo sapiens (human),Tretinoin results in decreased expression of TROAP mRNA,,,PMID:15498508|PMID:23724009|PMID:33167477,https://www.ncbi.nlm.nih.gov/pubmed/15498508|https://www.ncbi.nlm.nih.gov/pubmed/23724009|https://www.ncbi.nlm.nih.gov/pubmed/33167477,15498508|23724009|33167477,,
1216,1690595,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,7270,TTF1,https://ctdbase.org/detail.go?type=gene&acc=7270,,,7270.0,TTF1,9606.0,Homo sapiens (human),Tretinoin results in decreased expression of TTF1 mRNA,,,PMID:21924320,https://www.ncbi.nlm.nih.gov/pubmed/21924320,21924320,,
1217,1690596,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,7270,TTF1,https://ctdbase.org/detail.go?type=gene&acc=7270,,,7270.0,TTF1,10090.0,Mus musculus (house mouse),Tretinoin results in increased expression of TTF1 mRNA,,,PMID:15328022,https://www.ncbi.nlm.nih.gov/pubmed/15328022,15328022,,
1218,1691161,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,10381,TUBB3,https://ctdbase.org/detail.go?type=gene&acc=10381,,,10381.0,TUBB3,10090.0,Mus musculus (house mouse),Tretinoin results in increased expression of TUBB3 mrna|tetrachlorodibenzodioxin inhibits the reaction [tretinoin results in increased expression of TUBB3 protein]|tetrachlorodibenzodioxin inhibits the reaction [tretinoin results in increased expression of TUBB3 mrna],,,PMID:34627992,https://www.ncbi.nlm.nih.gov/pubmed/34627992,34627992,,
1219,1691162,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,10381,TUBB3,https://ctdbase.org/detail.go?type=gene&acc=10381,,,10381.0,TUBB3,10090.0,Mus musculus (house mouse),Tretinoin results in increased expression of TUBB3 protein,,,PMID:16009726|PMID:16613989|PMID:17064353|PMID:19135036|PMID:19808863|PMID:30114691|PMID:34627992,https://www.ncbi.nlm.nih.gov/pubmed/16009726|https://www.ncbi.nlm.nih.gov/pubmed/16613989|https://www.ncbi.nlm.nih.gov/pubmed/17064353|https://www.ncbi.nlm.nih.gov/pubmed/19135036|https://www.ncbi.nlm.nih.gov/pubmed/19808863|https://www.ncbi.nlm.nih.gov/pubmed/30114691|https://www.ncbi.nlm.nih.gov/pubmed/34627992,16009726|16613989|17064353|19135036|19808863|30114691|34627992,,
1220,1691163,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,10381,TUBB3,https://ctdbase.org/detail.go?type=gene&acc=10381,,,10381.0,TUBB3,10116.0,Rattus norvegicus (Norway rat),Tretinoin results in decreased expression of TUBB3 mRNA,,,PMID:20488242|PMID:24977338,https://www.ncbi.nlm.nih.gov/pubmed/20488242|https://www.ncbi.nlm.nih.gov/pubmed/24977338,20488242|24977338,,
1221,1691164,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,10382,TUBB4A,https://ctdbase.org/detail.go?type=gene&acc=10382,,,10382.0,TUBB4A,9606.0,Homo sapiens (human),Tretinoin results in decreased expression of TUBB4A mRNA,,,PMID:23724009,https://www.ncbi.nlm.nih.gov/pubmed/23724009,23724009,,
1222,1691575,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,10628,TXNIP,https://ctdbase.org/detail.go?type=gene&acc=10628,,,10628.0,TXNIP,9606.0,Homo sapiens (human),Tretinoin results in increased expression of TXNIP mRNA,,,PMID:33167477,https://www.ncbi.nlm.nih.gov/pubmed/33167477,33167477,,
1223,1691576,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,7296,TXNRD1,https://ctdbase.org/detail.go?type=gene&acc=7296,,,7296.0,TXNRD1,10116.0,Rattus norvegicus (Norway rat),Tretinoin results in decreased expression of TXNRD1 protein|tretinoin results in decreased expression of TXNRD1 mRNA,,,PMID:30267739,https://www.ncbi.nlm.nih.gov/pubmed/30267739,30267739,,
1224,1691577,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,10587,TXNRD2,https://ctdbase.org/detail.go?type=gene&acc=10587,,,10587.0,TXNRD2,10116.0,Rattus norvegicus (Norway rat),Tretinoin results in decreased expression of TXNRD2 mRNA,,,PMID:30267739,https://www.ncbi.nlm.nih.gov/pubmed/30267739,30267739,,
1225,1691578,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,114112,TXNRD3,https://ctdbase.org/detail.go?type=gene&acc=114112,,,114112.0,TXNRD3,9606.0,Homo sapiens (human),Tretinoin results in decreased expression of TXNRD3 mRNA,,,PMID:33167477,https://www.ncbi.nlm.nih.gov/pubmed/33167477,33167477,,
1226,1691579,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,7297,TYK2,https://ctdbase.org/detail.go?type=gene&acc=7297,,,7297.0,TYK2,9606.0,Homo sapiens (human),Tretinoin results in increased expression of TYK2 mRNA,,,PMID:33167477,https://www.ncbi.nlm.nih.gov/pubmed/33167477,33167477,,
1227,1691580,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,7298,TYMS,https://ctdbase.org/detail.go?type=gene&acc=7298,,,7298.0,TYMS,9606.0,Homo sapiens (human),Tretinoin results in decreased expression of TYMS mRNA,,,PMID:16249480|PMID:21934132|PMID:33167477,https://www.ncbi.nlm.nih.gov/pubmed/16249480|https://www.ncbi.nlm.nih.gov/pubmed/21934132|https://www.ncbi.nlm.nih.gov/pubmed/33167477,16249480|21934132|33167477,,
1228,1691581,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,7299,TYR,https://ctdbase.org/detail.go?type=gene&acc=7299,,,7299.0,TYR,7955.0,Danio rerio (zebrafish),Tretinoin results in increased expression of TYR mRNA,,,PMID:32553615,https://www.ncbi.nlm.nih.gov/pubmed/32553615,32553615,,
1229,1691890,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,9898,UBAP2L,https://ctdbase.org/detail.go?type=gene&acc=9898,,,9898.0,UBAP2L,9606.0,Homo sapiens (human),Tretinoin results in decreased expression of UBAP2L protein,,,PMID:30093655,https://www.ncbi.nlm.nih.gov/pubmed/30093655,30093655,,
1230,1691891,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,84959,UBASH3B,https://ctdbase.org/detail.go?type=gene&acc=84959,,,84959.0,UBASH3B,9606.0,Homo sapiens (human),Tretinoin results in decreased expression of UBASH3B mRNA,,,PMID:33167477,https://www.ncbi.nlm.nih.gov/pubmed/33167477,33167477,,
1231,1691892,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,84959,UBASH3B,https://ctdbase.org/detail.go?type=gene&acc=84959,,,84959.0,UBASH3B,9606.0,Homo sapiens (human),Tretinoin results in increased expression of UBASH3B mRNA,,,PMID:21934132,https://www.ncbi.nlm.nih.gov/pubmed/21934132,21934132,,
1232,1691893,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,7316,UBC,https://ctdbase.org/detail.go?type=gene&acc=7316,,,7316.0,UBC,9606.0,Homo sapiens (human),Tretinoin results in increased expression of UBC mRNA,,,PMID:33167477,https://www.ncbi.nlm.nih.gov/pubmed/33167477,33167477,,
1233,1691894,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,10537,UBD,https://ctdbase.org/detail.go?type=gene&acc=10537,,,10537.0,UBD,9606.0,Homo sapiens (human),Tretinoin results in increased expression of UBD mRNA,,,PMID:16951191|PMID:23830798,https://www.ncbi.nlm.nih.gov/pubmed/16951191|https://www.ncbi.nlm.nih.gov/pubmed/23830798,16951191|23830798,,
1234,1691895,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,7319,UBE2A,https://ctdbase.org/detail.go?type=gene&acc=7319,,,7319.0,UBE2A,9606.0,Homo sapiens (human),[tretinoin co-treated with ascorbic acid] results in decreased expression of UBE2A mRNA,,,PMID:16443354,https://www.ncbi.nlm.nih.gov/pubmed/16443354,16443354,,
1235,1691896,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,11065,UBE2C,https://ctdbase.org/detail.go?type=gene&acc=11065,,,11065.0,UBE2C,9606.0,Homo sapiens (human),Tretinoin results in decreased expression of UBE2C mRNA,,,PMID:21934132,https://www.ncbi.nlm.nih.gov/pubmed/21934132,21934132,,
1236,1692551,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,51377,UCHL5,https://ctdbase.org/detail.go?type=gene&acc=51377,,,51377.0,UCHL5,9606.0,Homo sapiens (human),Tretinoin results in decreased expression of UCHL5 mRNA,,,PMID:21934132|PMID:33167477,https://www.ncbi.nlm.nih.gov/pubmed/21934132|https://www.ncbi.nlm.nih.gov/pubmed/33167477,21934132|33167477,,
1237,1692685,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,56886,UGGT1,https://ctdbase.org/detail.go?type=gene&acc=56886,,,56886.0,UGGT1,9606.0,Homo sapiens (human),Tretinoin results in decreased expression of UGGT1 mRNA,,,PMID:23724009,https://www.ncbi.nlm.nih.gov/pubmed/23724009,23724009,,
1238,1692686,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,55757,UGGT2,https://ctdbase.org/detail.go?type=gene&acc=55757,,,55757.0,UGGT2,9606.0,Homo sapiens (human),Tretinoin results in decreased expression of UGGT2 mRNA,,,PMID:33167477,https://www.ncbi.nlm.nih.gov/pubmed/33167477,33167477,,
1239,1692687,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,7360,UGP2,https://ctdbase.org/detail.go?type=gene&acc=7360,,,7360.0,UGP2,9606.0,Homo sapiens (human),Tretinoin results in increased expression of UGP2 mRNA,,,PMID:33167477,https://www.ncbi.nlm.nih.gov/pubmed/33167477,33167477,,
1240,1692688,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,54658,UGT1A1,https://ctdbase.org/detail.go?type=gene&acc=54658,,,54658.0,UGT1A1,7955.0,Danio rerio (zebrafish),Tretinoin results in increased expression of UGT1A1 mRNA,,,PMID:30248606,https://www.ncbi.nlm.nih.gov/pubmed/30248606,30248606,,
1241,1692689,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,24862,UGT2B,https://ctdbase.org/detail.go?type=gene&acc=24862,,,24862.0,Ugt2b,10116.0,Rattus norvegicus (Norway rat),Tretinoin results in increased expression of UGT2B mRNA,,,PMID:24977338,https://www.ncbi.nlm.nih.gov/pubmed/24977338,24977338,,
1242,1692969,445154,Drug Gene Interaction database (DGIdb),Resveratrol,,RESVERATROL,https://www.dgidb.org/drugs/rxcui:1000492,,NFKB2,https://www.dgidb.org/genes/hgnc:7795,,,4791.0,NFKB2,9606.0,Homo sapiens (human),,,,,,,,
1243,1692970,445154,Drug Gene Interaction database (DGIdb),Resveratrol,,RESVERATROL,https://www.dgidb.org/drugs/rxcui:1000492,,TP53,https://www.dgidb.org/genes/hgnc:11998,,,7157.0,TP53,9606.0,Homo sapiens (human),,,,,,,,
1244,1685296,445354,Comparative Toxicogenomics Database (CTD),Retinol,D014801,Vitamin A,https://ctdbase.org/detail.go?type=chem&acc=D014801,960,CD44,https://ctdbase.org/detail.go?type=gene&acc=960,,,960.0,CD44,10090.0,Mus musculus (house mouse),Vitamin A results in increased expression of CD44 protein,,,PMID:16724877,https://www.ncbi.nlm.nih.gov/pubmed/16724877,16724877,,
1245,1685297,445354,Comparative Toxicogenomics Database (CTD),Retinol,D014801,Vitamin A,https://ctdbase.org/detail.go?type=chem&acc=D014801,999,CDH1,https://ctdbase.org/detail.go?type=gene&acc=999,,,999.0,CDH1,9606.0,Homo sapiens (human),Vitamin A affects the expression of CDH1 mRNA,,,PMID:17034753,https://www.ncbi.nlm.nih.gov/pubmed/17034753,17034753,,
1246,1685298,445354,Comparative Toxicogenomics Database (CTD),Retinol,D014801,Vitamin A,https://ctdbase.org/detail.go?type=chem&acc=D014801,999,CDH1,https://ctdbase.org/detail.go?type=gene&acc=999,,,999.0,CDH1,8022.0,Oncorhynchus mykiss (rainbow trout),[vitamin A co-treated with cholecalciferol co-treated with vitamin E co-treated with ascorbic acid] inhibits the reaction [[cyhalothrin co-treated with chlorantranilipole] results in decreased expression of CDH1 protein],,,PMID:36813254,https://www.ncbi.nlm.nih.gov/pubmed/36813254,36813254,,
1247,1685299,445354,Comparative Toxicogenomics Database (CTD),Retinol,D014801,Vitamin A,https://ctdbase.org/detail.go?type=chem&acc=D014801,1277,COL1A1,https://ctdbase.org/detail.go?type=gene&acc=1277,,,1277.0,COL1A1,9606.0,Homo sapiens (human),Vitamin A results in increased expression of COL1A1 mRNA,,,PMID:17034753,https://www.ncbi.nlm.nih.gov/pubmed/17034753,17034753,,
1248,1685300,445354,Comparative Toxicogenomics Database (CTD),Retinol,D014801,Vitamin A,https://ctdbase.org/detail.go?type=chem&acc=D014801,1277,COL1A1,https://ctdbase.org/detail.go?type=gene&acc=1277,,,1277.0,COL1A1,10090.0,Mus musculus (house mouse),Vitamin A results in increased expression of COL1A1 mrna|[cryptoxanthins co-treated with vitamin A] results in increased expression of COL1A1 mRNA,,,PMID:15962303,https://www.ncbi.nlm.nih.gov/pubmed/15962303,15962303,,
1249,1685301,445354,Comparative Toxicogenomics Database (CTD),Retinol,D014801,Vitamin A,https://ctdbase.org/detail.go?type=chem&acc=D014801,1280,COL2A1,https://ctdbase.org/detail.go?type=gene&acc=1280,,,1280.0,COL2A1,10090.0,Mus musculus (house mouse),RARG gene mutant form inhibits the reaction [[RARA gene mutant form co-treated with vitamin A] results in decreased expression of COL2A1 mrna]|[rara gene mutant form co-treated with vitamin A] results in decreased expression of COL2A1 mRNA,,,PMID:16397886,https://www.ncbi.nlm.nih.gov/pubmed/16397886,16397886,,
1250,1685302,445354,Comparative Toxicogenomics Database (CTD),Retinol,D014801,Vitamin A,https://ctdbase.org/detail.go?type=chem&acc=D014801,1284,COL4A2,https://ctdbase.org/detail.go?type=gene&acc=1284,,,1284.0,COL4A2,9606.0,Homo sapiens (human),Vitamin A results in increased expression of COL4A2 mRNA,,,PMID:17034753,https://www.ncbi.nlm.nih.gov/pubmed/17034753,17034753,,
1251,1685303,445354,Comparative Toxicogenomics Database (CTD),Retinol,D014801,Vitamin A,https://ctdbase.org/detail.go?type=chem&acc=D014801,4514,COX3,https://ctdbase.org/detail.go?type=gene&acc=4514,,,4514.0,COX3,10116.0,Rattus norvegicus (Norway rat),Vitamin A deficiency results in decreased expression of COX3 mRNA,,,PMID:12163651,https://www.ncbi.nlm.nih.gov/pubmed/12163651,12163651,,
1252,1686219,445354,Comparative Toxicogenomics Database (CTD),Retinol,D014801,Vitamin A,https://ctdbase.org/detail.go?type=chem&acc=D014801,2321,FLT1,https://ctdbase.org/detail.go?type=gene&acc=2321,,,2321.0,FLT1,9554.0,Papio (baboons),Vitamin A results in decreased expression of FLT1 mRNA,,,PMID:17426644,https://www.ncbi.nlm.nih.gov/pubmed/17426644,17426644,,
1253,1686220,445354,Comparative Toxicogenomics Database (CTD),Retinol,D014801,Vitamin A,https://ctdbase.org/detail.go?type=chem&acc=D014801,2335,FN1,https://ctdbase.org/detail.go?type=gene&acc=2335,,,2335.0,FN1,9606.0,Homo sapiens (human),Vitamin A results in decreased secretion of FN1 protein,,,PMID:17225872,https://www.ncbi.nlm.nih.gov/pubmed/17225872,17225872,,
1254,1686221,445354,Comparative Toxicogenomics Database (CTD),Retinol,D014801,Vitamin A,https://ctdbase.org/detail.go?type=chem&acc=D014801,2339,FNTA,https://ctdbase.org/detail.go?type=gene&acc=2339,,,2339.0,FNTA,10116.0,Rattus norvegicus (Norway rat),[vitamin A co-treated with perillyl alcohol] results in decreased expression of FNTA protein,,,PMID:15959631,https://www.ncbi.nlm.nih.gov/pubmed/15959631,15959631,,
1255,1686222,445354,Comparative Toxicogenomics Database (CTD),Retinol,D014801,Vitamin A,https://ctdbase.org/detail.go?type=chem&acc=D014801,2342,FNTB,https://ctdbase.org/detail.go?type=gene&acc=2342,,,2342.0,FNTB,10116.0,Rattus norvegicus (Norway rat),Vitamin A results in increased expression of FNTB mrna|[perillyl alcohol co-treated with vitamin A] results in decreased expression of FNTB mrna|vitamin A results in increased expression of FNTB protein,,,PMID:15959631,https://www.ncbi.nlm.nih.gov/pubmed/15959631,15959631,,
1256,1686223,445354,Comparative Toxicogenomics Database (CTD),Retinol,D014801,Vitamin A,https://ctdbase.org/detail.go?type=chem&acc=D014801,3169,FOXA1,https://ctdbase.org/detail.go?type=gene&acc=3169,,,3169.0,FOXA1,9606.0,Homo sapiens (human),Vitamin A results in increased expression of FOXA1 mRNA,,,PMID:17034753,https://www.ncbi.nlm.nih.gov/pubmed/17034753,17034753,,
1257,1686224,445354,Comparative Toxicogenomics Database (CTD),Retinol,D014801,Vitamin A,https://ctdbase.org/detail.go?type=chem&acc=D014801,3170,FOXA2,https://ctdbase.org/detail.go?type=gene&acc=3170,,,3170.0,FOXA2,10116.0,Rattus norvegicus (Norway rat),Vitamin A inhibits the reaction [nitrofen results in decreased expression of FOXA2 protein],,,PMID:16863852,https://www.ncbi.nlm.nih.gov/pubmed/16863852,16863852,,
1258,1686225,445354,Comparative Toxicogenomics Database (CTD),Retinol,D014801,Vitamin A,https://ctdbase.org/detail.go?type=chem&acc=D014801,2495,FTH1,https://ctdbase.org/detail.go?type=gene&acc=2495,,,2495.0,FTH1,10116.0,Rattus norvegicus (Norway rat),Vitamin A deficiency results in decreased expression of FTH1 mrna|vitamin A deficiency results in decreased expression of FTH1 protein|iron deficiency promotes the reaction [vitamin A deficiency results in decreased expression of FTH1 protein],,,PMID:22154532,https://www.ncbi.nlm.nih.gov/pubmed/22154532,22154532,,
1259,1687087,445354,Comparative Toxicogenomics Database (CTD),Retinol,D014801,Vitamin A,https://ctdbase.org/detail.go?type=chem&acc=D014801,5604,MAP2K1,https://ctdbase.org/detail.go?type=gene&acc=5604,,,5604.0,MAP2K1,10116.0,Rattus norvegicus (Norway rat),"Vitamin A results in increased phosphorylation of MAP2K1 protein|ag 1879 inhibits the reaction [vitamin A results in increased phosphorylation of MAP2K1 protein]|6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid inhibits the reaction [vitamin A results in increased phosphorylation of MAP2K1 protein]|mannitol inhibits the reaction [vitamin A results in increased phosphorylation of MAP2K1 protein]",,,PMID:16510265,https://www.ncbi.nlm.nih.gov/pubmed/16510265,16510265,,
1260,1687088,445354,Comparative Toxicogenomics Database (CTD),Retinol,D014801,Vitamin A,https://ctdbase.org/detail.go?type=chem&acc=D014801,5605,MAP2K2,https://ctdbase.org/detail.go?type=gene&acc=5605,,,5605.0,MAP2K2,10116.0,Rattus norvegicus (Norway rat),"AG 1879 inhibits the reaction [vitamin A results in increased phosphorylation of MAP2K2 protein]|6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid inhibits the reaction [vitamin A results in increased phosphorylation of MAP2K2 protein]|mannitol inhibits the reaction [vitamin A results in increased phosphorylation of MAP2K2 protein]|vitamin A results in increased phosphorylation of MAP2K2 protein",,,PMID:16510265,https://www.ncbi.nlm.nih.gov/pubmed/16510265,16510265,,
1261,1687089,445354,Comparative Toxicogenomics Database (CTD),Retinol,D014801,Vitamin A,https://ctdbase.org/detail.go?type=chem&acc=D014801,5594,MAPK1,https://ctdbase.org/detail.go?type=gene&acc=5594,,,5594.0,MAPK1,10116.0,Rattus norvegicus (Norway rat),"AG 1879 inhibits the reaction [vitamin A results in increased phosphorylation of MAPK1 protein]|vitamin A results in increased phosphorylation of MAPK1 protein|6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid inhibits the reaction [vitamin A results in increased phosphorylation of MAPK1 protein]|2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [vitamin A results in increased phosphorylation of MAPK1 protein]",,,PMID:16510265,https://www.ncbi.nlm.nih.gov/pubmed/16510265,16510265,,
1262,1687502,445354,Comparative Toxicogenomics Database (CTD),Retinol,D014801,Vitamin A,https://ctdbase.org/detail.go?type=chem&acc=D014801,4586,MUC5AC,https://ctdbase.org/detail.go?type=gene&acc=4586,,,4586.0,MUC5AC,9606.0,Homo sapiens (human),Vitamin A results in increased expression of MUC5AC mRNA,,,PMID:17034753,https://www.ncbi.nlm.nih.gov/pubmed/17034753,17034753,,
1263,1687503,445354,Comparative Toxicogenomics Database (CTD),Retinol,D014801,Vitamin A,https://ctdbase.org/detail.go?type=chem&acc=D014801,4609,MYC,https://ctdbase.org/detail.go?type=gene&acc=4609,,,4609.0,MYC,9606.0,Homo sapiens (human),Vitamin A results in decreased expression of MYC mRNA,,,PMID:17219422,https://www.ncbi.nlm.nih.gov/pubmed/17219422,17219422,,
1264,1687504,445354,Comparative Toxicogenomics Database (CTD),Retinol,D014801,Vitamin A,https://ctdbase.org/detail.go?type=chem&acc=D014801,8648,NCOA1,https://ctdbase.org/detail.go?type=gene&acc=8648,,,8648.0,NCOA1,10090.0,Mus musculus (house mouse),Vitamin A affects the reaction [NCOA1 protein binds to PCK1 promoter],,,PMID:16317119,https://www.ncbi.nlm.nih.gov/pubmed/16317119,16317119,,
1265,1687505,445354,Comparative Toxicogenomics Database (CTD),Retinol,D014801,Vitamin A,https://ctdbase.org/detail.go?type=chem&acc=D014801,50674,NEUROG3,https://ctdbase.org/detail.go?type=gene&acc=50674,,,50674.0,NEUROG3,10090.0,Mus musculus (house mouse),Vitamin A results in decreased expression of NEUROG3 mRNA,,,PMID:30944279,https://www.ncbi.nlm.nih.gov/pubmed/30944279,30944279,,
1266,1687506,445354,Comparative Toxicogenomics Database (CTD),Retinol,D014801,Vitamin A,https://ctdbase.org/detail.go?type=chem&acc=D014801,9368,NHERF1,https://ctdbase.org/detail.go?type=gene&acc=9368,,,9368.0,NHERF1,9913.0,Bos taurus (cattle),[vitamin A co-treated with RLBP1 protein] binds to NHERF1 protein,,,PMID:16553463,https://www.ncbi.nlm.nih.gov/pubmed/16553463,16553463,,
1267,1687507,445354,Comparative Toxicogenomics Database (CTD),Retinol,D014801,Vitamin A,https://ctdbase.org/detail.go?type=chem&acc=D014801,7080,NKX2-1,https://ctdbase.org/detail.go?type=gene&acc=7080,,,7080.0,NKX2-1,9606.0,Homo sapiens (human),Vitamin A inhibits the reaction [nitrofen results in decreased expression of NKX2-1 mrna],,,PMID:16490937,https://www.ncbi.nlm.nih.gov/pubmed/16490937,16490937,,
1268,1687508,445354,Comparative Toxicogenomics Database (CTD),Retinol,D014801,Vitamin A,https://ctdbase.org/detail.go?type=chem&acc=D014801,7080,NKX2-1,https://ctdbase.org/detail.go?type=gene&acc=7080,,,7080.0,NKX2-1,10116.0,Rattus norvegicus (Norway rat),Vitamin A inhibits the reaction [nitrofen results in decreased expression of NKX2-1 protein],,,PMID:16863852,https://www.ncbi.nlm.nih.gov/pubmed/16863852,16863852,,
1269,1689777,445354,Comparative Toxicogenomics Database (CTD),Retinol,D014801,Vitamin A,https://ctdbase.org/detail.go?type=chem&acc=D014801,7345,UCHL1,https://ctdbase.org/detail.go?type=gene&acc=7345,,,7345.0,UCHL1,10116.0,Rattus norvegicus (Norway rat),[valproic acid co-treated with vitamin A deficiency] affects the expression of UCHL1 protein,,,PMID:32526256,https://www.ncbi.nlm.nih.gov/pubmed/32526256,32526256,,
1270,1689778,445354,Comparative Toxicogenomics Database (CTD),Retinol,D014801,Vitamin A,https://ctdbase.org/detail.go?type=chem&acc=D014801,7350,UCP1,https://ctdbase.org/detail.go?type=gene&acc=7350,,,7350.0,UCP1,10116.0,Rattus norvegicus (Norway rat),LEP gene mutant form promotes the reaction [vitamin A results in increased expression of UCP1 mrna],,,PMID:16493122,https://www.ncbi.nlm.nih.gov/pubmed/16493122,16493122,,
1271,1689779,445354,Comparative Toxicogenomics Database (CTD),Retinol,D014801,Vitamin A,https://ctdbase.org/detail.go?type=chem&acc=D014801,54658,UGT1A1,https://ctdbase.org/detail.go?type=gene&acc=54658,,,54658.0,UGT1A1,10116.0,Rattus norvegicus (Norway rat),Vitamin A inhibits the reaction [triiodothyronine results in decreased expression of UGT1A1 mrna],,,PMID:11299074,https://www.ncbi.nlm.nih.gov/pubmed/11299074,11299074,,
1272,1689780,445354,Comparative Toxicogenomics Database (CTD),Retinol,D014801,Vitamin A,https://ctdbase.org/detail.go?type=chem&acc=D014801,54578,UGT1A6,https://ctdbase.org/detail.go?type=gene&acc=54578,,,54578.0,UGT1A6,10116.0,Rattus norvegicus (Norway rat),Vitamin A deficiency results in decreased expression of UGT1A6 mRNA,,,PMID:12163651,https://www.ncbi.nlm.nih.gov/pubmed/12163651,12163651,,
1273,1689781,445354,Comparative Toxicogenomics Database (CTD),Retinol,D014801,Vitamin A,https://ctdbase.org/detail.go?type=chem&acc=D014801,54578,UGT1A6,https://ctdbase.org/detail.go?type=gene&acc=54578,,,54578.0,UGT1A6,10116.0,Rattus norvegicus (Norway rat),Vitamin A inhibits the reaction [triiodothyronine results in increased expression of UGT1A6 mrna],,,PMID:11299074,https://www.ncbi.nlm.nih.gov/pubmed/11299074,11299074,,
1274,1689782,445354,Comparative Toxicogenomics Database (CTD),Retinol,D014801,Vitamin A,https://ctdbase.org/detail.go?type=chem&acc=D014801,7422,VEGFA,https://ctdbase.org/detail.go?type=gene&acc=7422,,,7422.0,VEGFA,9554.0,Papio (baboons),Vitamin A results in decreased expression of VEGFA mRNA,,,PMID:17426644,https://www.ncbi.nlm.nih.gov/pubmed/17426644,17426644,,
1275,1692971,445354,Therapeutic Target Database (TTD),Retinol,D0S7WX,Vitamin A,https://idrblab.net/ttd/data/drug/details/D0S7WX,T46456,Retinoic acid receptor RXR-gamma (RXRG),https://idrblab.net/ttd/data/target/details/T46456,P48443,Retinoic acid receptor RXR-gamma,6258.0,RXRG,9606.0,Homo sapiens (human),Binder,,,,,,,
1276,1692972,445355,Comparative Toxicogenomics Database (CTD),Diundecyl Phosphatidyl Choline,C015153,"1,2-dilauroylphosphatidylcholine",https://ctdbase.org/detail.go?type=chem&acc=C015153,266682,CYP3A2,https://ctdbase.org/detail.go?type=gene&acc=266682,,,266682.0,Cyp3a2,10116.0,Rattus norvegicus (Norway rat),"[1,2-dilauroylphosphatidylcholine co-treated with 1,2-oleoylphosphatidylcholine co-treated with phosphatidylserines co-treated with sodium cholate] results in increased activity of CYP3A2 protein",,,PMID:1627548,https://www.ncbi.nlm.nih.gov/pubmed/1627548,1627548,,
1277,1692973,445355,Comparative Toxicogenomics Database (CTD),Diundecyl Phosphatidyl Choline,C015153,"1,2-dilauroylphosphatidylcholine",https://ctdbase.org/detail.go?type=chem&acc=C015153,1576,CYP3A4,https://ctdbase.org/detail.go?type=gene&acc=1576,,,1576.0,CYP3A4,9606.0,Homo sapiens (human),"[1,2-dilauroylphosphatidylcholine co-treated with 1,2-oleoylphosphatidylcholine co-treated with phosphatidylserines co-treated with sodium cholate] results in increased activity of CYP3A4 protein",,,PMID:1627548,https://www.ncbi.nlm.nih.gov/pubmed/1627548,1627548,,
1278,1692974,445355,Comparative Toxicogenomics Database (CTD),Diundecyl Phosphatidyl Choline,C015153,"1,2-dilauroylphosphatidylcholine",https://ctdbase.org/detail.go?type=chem&acc=C015153,2494,NR5A2,https://ctdbase.org/detail.go?type=gene&acc=2494,,,2494.0,NR5A2,10090.0,Mus musculus (house mouse),"1,2-dilauroylphosphatidylcholine results in increased expression of NR5A2",,,PMID:24459144,https://www.ncbi.nlm.nih.gov/pubmed/24459144,24459144,,
1279,1692975,445355,Comparative Toxicogenomics Database (CTD),Diundecyl Phosphatidyl Choline,C015153,"1,2-dilauroylphosphatidylcholine",https://ctdbase.org/detail.go?type=chem&acc=C015153,5444,PON1,https://ctdbase.org/detail.go?type=gene&acc=5444,,,5444.0,PON1,9606.0,Homo sapiens (human),"1,2-dilauroylphosphatidylcholine results in increased activity of PON1 protein",,,PMID:12963475,https://www.ncbi.nlm.nih.gov/pubmed/12963475,12963475,,
1280,1689783,445528,Comparative Toxicogenomics Database (CTD),"(4S,5S)-1,2-Dithiane-4,5-diol",C060456,"(4S,5S)-4,5-dihydroxy-1,2-dithiane",https://ctdbase.org/detail.go?type=chem&acc=C060456,13087,CYP2A5,https://ctdbase.org/detail.go?type=gene&acc=13087,,,13087.0,Cyp2a5,10090.0,Mus musculus (house mouse),"[CYP2A5 protein co-treated with POR protein] inhibits the reaction [(4S,5S)-4,5-dihydroxy-1,2-dithiane results in increased expression of UGT1A1 mrna]|[cyp2a5 protein co-treated with POR protein] inhibits the reaction [(4S,5S)-4,5-dihydroxy-1,2-dithiane results in increased cleavage of CASP3 protein]|[cyp2a5 protein co-treated with POR protein] inhibits the reaction [(4S,5S)-4,5-dihydroxy-1,2-dithiane results in increased splicing of XBP1 mrna]|(4s,5s)-4,5-dihydroxy-1,2-dithiane results in increased expression of CYP2A5 protein",,,PMID:35341795,https://www.ncbi.nlm.nih.gov/pubmed/35341795,35341795,,
1281,1689784,445528,Comparative Toxicogenomics Database (CTD),"(4S,5S)-1,2-Dithiane-4,5-diol",C060456,"(4S,5S)-4,5-dihydroxy-1,2-dithiane",https://ctdbase.org/detail.go?type=chem&acc=C060456,3309,HSPA5,https://ctdbase.org/detail.go?type=gene&acc=3309,,,3309.0,HSPA5,10090.0,Mus musculus (house mouse),"(4S,5S)-4,5-dihydroxy-1,2-dithiane results in increased expression of HSPA5 mRNA",,,PMID:14610226|PMID:35341795,https://www.ncbi.nlm.nih.gov/pubmed/14610226|https://www.ncbi.nlm.nih.gov/pubmed/35341795,14610226|35341795,,
1282,1690889,446220,Toxin and Toxin Target Database (T3DB),Cocaine,T3D2927,Cocaine,http://www.t3db.ca/toxins/T3D2927,BE0000581,D(3) dopamine receptor,http://www.t3db.ca/biodb/bio_entities/BE0000581,P35462,D(3) dopamine receptor,1814.0,DRD3,9606.0,Homo sapiens (human),"Cocaine produces anesthesia by inhibiting excitation of nerve endings or by blocking conduction in peripheral nerves. this is achieved by reversibly binding to and inactivating sodium channels. sodium influx through these channels is necessary for the depolarization of nerve cell membranes and subsequent propagation of impulses along the course of the nerve. cocaine is the only local anesthetic with vasoconstrictive properties. this is a result of its blockade of norepinephrine reuptake in the autonomic nervous system. cocaine binds differentially to the dopamine, serotonin, and norepinephrine transport proteins and directly prevents the re-uptake of dopamine, serotonin, and norepinephrine into pre-synaptic neurons. cocaine also produces a number of indirect actions, which alter other neuromodulatory systems (i.e., opioidergic, glutamatergic, and gabaergic systems).",,,PMID:17139284|PMID:17016423|PMID:17671965|PMID:12893467|PMID:15671872,https://www.ncbi.nlm.nih.gov/pubmed/17139284|https://www.ncbi.nlm.nih.gov/pubmed/17016423|https://www.ncbi.nlm.nih.gov/pubmed/17671965|https://www.ncbi.nlm.nih.gov/pubmed/12893467|https://www.ncbi.nlm.nih.gov/pubmed/15671872,17139284|17016423|17671965|12893467|15671872,,
1283,1690890,446220,Toxin and Toxin Target Database (T3DB),Cocaine,T3D2927,Cocaine,http://www.t3db.ca/toxins/T3D2927,BE0000632,Kappa-type opioid receptor,http://www.t3db.ca/biodb/bio_entities/BE0000632,P41145,Kappa-type opioid receptor,4986.0,OPRK1,9606.0,Homo sapiens (human),"Cocaine produces anesthesia by inhibiting excitation of nerve endings or by blocking conduction in peripheral nerves. this is achieved by reversibly binding to and inactivating sodium channels. sodium influx through these channels is necessary for the depolarization of nerve cell membranes and subsequent propagation of impulses along the course of the nerve. cocaine is the only local anesthetic with vasoconstrictive properties. this is a result of its blockade of norepinephrine reuptake in the autonomic nervous system. cocaine binds differentially to the dopamine, serotonin, and norepinephrine transport proteins and directly prevents the re-uptake of dopamine, serotonin, and norepinephrine into pre-synaptic neurons. cocaine also produces a number of indirect actions, which alter other neuromodulatory systems (i.e., opioidergic, glutamatergic, and gabaergic systems).",,,PMID:17139284|PMID:17016423|PMID:15901784|PMID:15608558|PMID:16924269,https://www.ncbi.nlm.nih.gov/pubmed/17139284|https://www.ncbi.nlm.nih.gov/pubmed/17016423|https://www.ncbi.nlm.nih.gov/pubmed/15901784|https://www.ncbi.nlm.nih.gov/pubmed/15608558|https://www.ncbi.nlm.nih.gov/pubmed/16924269,17139284|17016423|15901784|15608558|16924269,,
1284,1690891,446220,Toxin and Toxin Target Database (T3DB),Cocaine,T3D2927,Cocaine,http://www.t3db.ca/toxins/T3D2927,BE0000020,D(1A) dopamine receptor,http://www.t3db.ca/biodb/bio_entities/BE0000020,P21728,D(1A) dopamine receptor,1812.0,DRD1,9606.0,Homo sapiens (human),"Cocaine produces anesthesia by inhibiting excitation of nerve endings or by blocking conduction in peripheral nerves. this is achieved by reversibly binding to and inactivating sodium channels. sodium influx through these channels is necessary for the depolarization of nerve cell membranes and subsequent propagation of impulses along the course of the nerve. cocaine is the only local anesthetic with vasoconstrictive properties. this is a result of its blockade of norepinephrine reuptake in the autonomic nervous system. cocaine binds differentially to the dopamine, serotonin, and norepinephrine transport proteins and directly prevents the re-uptake of dopamine, serotonin, and norepinephrine into pre-synaptic neurons. cocaine also produces a number of indirect actions, which alter other neuromodulatory systems (i.e., opioidergic, glutamatergic, and gabaergic systems).",,,PMID:17139284|PMID:17016423|PMID:16492766|PMID:9686407,https://www.ncbi.nlm.nih.gov/pubmed/17139284|https://www.ncbi.nlm.nih.gov/pubmed/17016423|https://www.ncbi.nlm.nih.gov/pubmed/16492766|https://www.ncbi.nlm.nih.gov/pubmed/9686407,17139284|17016423|16492766|9686407,,
1285,1690892,446220,Toxin and Toxin Target Database (T3DB),Cocaine,T3D2927,Cocaine,http://www.t3db.ca/toxins/T3D2927,BE0000197,Sodium channel protein type 5 subunit alpha,http://www.t3db.ca/biodb/bio_entities/BE0000197,Q14524,Sodium channel protein type 5 subunit alpha,6331.0,SCN5A,9606.0,Homo sapiens (human),"Cocaine produces anesthesia by inhibiting excitation of nerve endings or by blocking conduction in peripheral nerves. this is achieved by reversibly binding to and inactivating sodium channels. sodium influx through these channels is necessary for the depolarization of nerve cell membranes and subsequent propagation of impulses along the course of the nerve. cocaine is the only local anesthetic with vasoconstrictive properties. this is a result of its blockade of norepinephrine reuptake in the autonomic nervous system. cocaine binds differentially to the dopamine, serotonin, and norepinephrine transport proteins and directly prevents the re-uptake of dopamine, serotonin, and norepinephrine into pre-synaptic neurons. cocaine also produces a number of indirect actions, which alter other neuromodulatory systems (i.e., opioidergic, glutamatergic, and gabaergic systems).",,,PMID:17139284|PMID:17016423|PMID:17038146|PMID:15880981,https://www.ncbi.nlm.nih.gov/pubmed/17139284|https://www.ncbi.nlm.nih.gov/pubmed/17016423|https://www.ncbi.nlm.nih.gov/pubmed/17038146|https://www.ncbi.nlm.nih.gov/pubmed/15880981,17139284|17016423|17038146|15880981,,
1286,1694093,447715,Comparative Toxicogenomics Database (CTD),Obeticholic Acid,C464660,obeticholic acid,https://ctdbase.org/detail.go?type=chem&acc=C464660,949,SCARB1,https://ctdbase.org/detail.go?type=gene&acc=949,,,949.0,SCARB1,9606.0,Homo sapiens (human),Obeticholic acid results in increased expression of SCARB1 mRNA,,,PMID:27939613,https://www.ncbi.nlm.nih.gov/pubmed/27939613,27939613,,
1287,1694094,447715,Comparative Toxicogenomics Database (CTD),Obeticholic Acid,C464660,obeticholic acid,https://ctdbase.org/detail.go?type=chem&acc=C464660,6382,SDC1,https://ctdbase.org/detail.go?type=gene&acc=6382,,,6382.0,SDC1,9606.0,Homo sapiens (human),Obeticholic acid results in increased expression of SDC1 mRNA,,,PMID:27939613,https://www.ncbi.nlm.nih.gov/pubmed/27939613,27939613,,
1288,1694095,447715,Comparative Toxicogenomics Database (CTD),Obeticholic Acid,C464660,obeticholic acid,https://ctdbase.org/detail.go?type=chem&acc=C464660,6389,SDHA,https://ctdbase.org/detail.go?type=gene&acc=6389,,,6389.0,SDHA,10090.0,Mus musculus (house mouse),Obeticholic acid inhibits the reaction [dietary fats results in decreased expression of SDHA protein],,,PMID:26655953,https://www.ncbi.nlm.nih.gov/pubmed/26655953,26655953,,
1289,1694096,447715,Comparative Toxicogenomics Database (CTD),Obeticholic Acid,C464660,obeticholic acid,https://ctdbase.org/detail.go?type=chem&acc=C464660,6403,SELP,https://ctdbase.org/detail.go?type=gene&acc=6403,,,6403.0,SELP,10090.0,Mus musculus (house mouse),NR1H4 gene mutant form inhibits the reaction [obeticholic acid inhibits the reaction [TNF results in increased expression of SELP mrna]]|obeticholic acid inhibits the reaction [TNF results in increased expression of SELP mrna],,,PMID:22135065,https://www.ncbi.nlm.nih.gov/pubmed/22135065,22135065,,
1290,1694097,447715,Comparative Toxicogenomics Database (CTD),Obeticholic Acid,C464660,obeticholic acid,https://ctdbase.org/detail.go?type=chem&acc=C464660,5265,SERPINA1,https://ctdbase.org/detail.go?type=gene&acc=5265,,,5265.0,SERPINA1,9606.0,Homo sapiens (human),Obeticholic acid results in decreased expression of SERPINA1 mRNA,,,PMID:27939613,https://www.ncbi.nlm.nih.gov/pubmed/27939613,27939613,,
1291,1694098,447715,Comparative Toxicogenomics Database (CTD),Obeticholic Acid,C464660,obeticholic acid,https://ctdbase.org/detail.go?type=chem&acc=C464660,5054,SERPINE1,https://ctdbase.org/detail.go?type=gene&acc=5054,,,5054.0,SERPINE1,9606.0,Homo sapiens (human),Obeticholic acid results in decreased expression of SERPINE1 mRNA,,,PMID:27939613,https://www.ncbi.nlm.nih.gov/pubmed/27939613,27939613,,
1292,1694394,447715,Comparative Toxicogenomics Database (CTD),Obeticholic Acid,C464660,obeticholic acid,https://ctdbase.org/detail.go?type=chem&acc=C464660,200931,SLC51A,https://ctdbase.org/detail.go?type=gene&acc=200931,,,200931.0,SLC51A,10090.0,Mus musculus (house mouse),Obeticholic acid results in increased expression of SLC51A mrna|obeticholic acid results in increased expression of SLC51A protein,,,PMID:26655953,https://www.ncbi.nlm.nih.gov/pubmed/26655953,26655953,,
1293,1694395,447715,Comparative Toxicogenomics Database (CTD),Obeticholic Acid,C464660,obeticholic acid,https://ctdbase.org/detail.go?type=chem&acc=C464660,123264,SLC51B,https://ctdbase.org/detail.go?type=gene&acc=123264,,,123264.0,SLC51B,9606.0,Homo sapiens (human),Obeticholic acid results in increased expression of SLC51B mRNA,,,PMID:27939613,https://www.ncbi.nlm.nih.gov/pubmed/27939613,27939613,,
1294,1694396,447715,Comparative Toxicogenomics Database (CTD),Obeticholic Acid,C464660,obeticholic acid,https://ctdbase.org/detail.go?type=chem&acc=C464660,123264,SLC51B,https://ctdbase.org/detail.go?type=gene&acc=123264,,,123264.0,SLC51B,10090.0,Mus musculus (house mouse),Obeticholic acid results in increased expression of SLC51B mRNA,,,PMID:26655953,https://www.ncbi.nlm.nih.gov/pubmed/26655953,26655953,,
1295,1694397,447715,Comparative Toxicogenomics Database (CTD),Obeticholic Acid,C464660,obeticholic acid,https://ctdbase.org/detail.go?type=chem&acc=C464660,123264,SLC51B,https://ctdbase.org/detail.go?type=gene&acc=123264,,,123264.0,SLC51B,10116.0,Rattus norvegicus (Norway rat),Obeticholic acid results in increased expression of SLC51B mrna|obeticholic acid inhibits the reaction [pyrazinamide results in decreased expression of SLC51B mrna],,,PMID:27255380,https://www.ncbi.nlm.nih.gov/pubmed/27255380,27255380,,
1296,1694398,447715,Comparative Toxicogenomics Database (CTD),Obeticholic Acid,C464660,obeticholic acid,https://ctdbase.org/detail.go?type=chem&acc=C464660,28248,SLCO1A1,https://ctdbase.org/detail.go?type=gene&acc=28248,,,28248.0,Slco1a1,10116.0,Rattus norvegicus (Norway rat),Obeticholic acid inhibits the reaction [pyrazinamide results in decreased expression of SLCO1A1 mrna]|obeticholic acid results in increased expression of SLCO1A1 mRNA,,,PMID:27255380,https://www.ncbi.nlm.nih.gov/pubmed/27255380,27255380,,
1297,1694399,447715,Comparative Toxicogenomics Database (CTD),Obeticholic Acid,C464660,obeticholic acid,https://ctdbase.org/detail.go?type=chem&acc=C464660,10599,SLCO1B1,https://ctdbase.org/detail.go?type=gene&acc=10599,,,10599.0,SLCO1B1,9606.0,Homo sapiens (human),Obeticholic acid results in decreased expression of SLCO1B1 mRNA,,,PMID:27939613,https://www.ncbi.nlm.nih.gov/pubmed/27939613,27939613,,
1298,1694400,447715,Comparative Toxicogenomics Database (CTD),Obeticholic Acid,C464660,obeticholic acid,https://ctdbase.org/detail.go?type=chem&acc=C464660,28253,SLCO1B2,https://ctdbase.org/detail.go?type=gene&acc=28253,,,28253.0,Slco1b2,10116.0,Rattus norvegicus (Norway rat),Obeticholic acid results in increased expression of SLCO1B2 mrna|obeticholic acid inhibits the reaction [pyrazinamide results in decreased expression of SLCO1B2 mrna],,,PMID:27255380,https://www.ncbi.nlm.nih.gov/pubmed/27255380,27255380,,
1299,1694566,447715,Comparative Toxicogenomics Database (CTD),Obeticholic Acid,C464660,obeticholic acid,https://ctdbase.org/detail.go?type=chem&acc=C464660,6721,SREBF2,https://ctdbase.org/detail.go?type=gene&acc=6721,,,6721.0,SREBF2,9606.0,Homo sapiens (human),Obeticholic acid results in decreased expression of SREBF2 mRNA,,,PMID:27939613,https://www.ncbi.nlm.nih.gov/pubmed/27939613,27939613,,
1300,1694567,447715,Comparative Toxicogenomics Database (CTD),Obeticholic Acid,C464660,obeticholic acid,https://ctdbase.org/detail.go?type=chem&acc=C464660,6721,SREBF2,https://ctdbase.org/detail.go?type=gene&acc=6721,,,6721.0,SREBF2,10090.0,Mus musculus (house mouse),Obeticholic acid inhibits the reaction [dietary fats results in increased expression of SREBF2 mrna],,,PMID:26655953,https://www.ncbi.nlm.nih.gov/pubmed/26655953,26655953,,
1301,1694568,447715,Comparative Toxicogenomics Database (CTD),Obeticholic Acid,C464660,obeticholic acid,https://ctdbase.org/detail.go?type=chem&acc=C464660,6822,SULT2A1,https://ctdbase.org/detail.go?type=gene&acc=6822,,,6822.0,SULT2A1,10090.0,Mus musculus (house mouse),Obeticholic acid promotes the reaction [1-naphthylisothiocyanate results in increased expression of SULT2A1 mrna],,,PMID:29660435,https://www.ncbi.nlm.nih.gov/pubmed/29660435,29660435,,
1302,1694569,447715,Comparative Toxicogenomics Database (CTD),Obeticholic Acid,C464660,obeticholic acid,https://ctdbase.org/detail.go?type=chem&acc=C464660,26099,SZRD1,https://ctdbase.org/detail.go?type=gene&acc=26099,,,26099.0,SZRD1,9606.0,Homo sapiens (human),Obeticholic acid results in increased expression of SZRD1 mRNA,,,PMID:27939613,https://www.ncbi.nlm.nih.gov/pubmed/27939613,27939613,,
1303,1694570,447715,Comparative Toxicogenomics Database (CTD),Obeticholic Acid,C464660,obeticholic acid,https://ctdbase.org/detail.go?type=chem&acc=C464660,10454,TAB1,https://ctdbase.org/detail.go?type=gene&acc=10454,,,10454.0,TAB1,9606.0,Homo sapiens (human),Obeticholic acid results in decreased expression of TAB1 mRNA,,,PMID:27939613,https://www.ncbi.nlm.nih.gov/pubmed/27939613,27939613,,
1304,1694571,447715,Comparative Toxicogenomics Database (CTD),Obeticholic Acid,C464660,obeticholic acid,https://ctdbase.org/detail.go?type=chem&acc=C464660,6892,TAPBP,https://ctdbase.org/detail.go?type=gene&acc=6892,,,6892.0,TAPBP,9606.0,Homo sapiens (human),Obeticholic acid results in decreased expression of TAPBP mRNA,,,PMID:27939613,https://www.ncbi.nlm.nih.gov/pubmed/27939613,27939613,,
1305,1694572,447715,Comparative Toxicogenomics Database (CTD),Obeticholic Acid,C464660,obeticholic acid,https://ctdbase.org/detail.go?type=chem&acc=C464660,6919,TCEA2,https://ctdbase.org/detail.go?type=gene&acc=6919,,,6919.0,TCEA2,9606.0,Homo sapiens (human),Obeticholic acid results in increased expression of TCEA2 mRNA,,,PMID:27939613,https://www.ncbi.nlm.nih.gov/pubmed/27939613,27939613,,
1306,1693214,447905,Comparative Toxicogenomics Database (CTD),"3-(3-(N-(2-Chloro-3-trifluoromethylbenzyl)(2,2-diphenylethyl)amino)propoxy)phenylacetic acid",C473027,GW 3965,https://ctdbase.org/detail.go?type=chem&acc=C473027,5360,PLTP,https://ctdbase.org/detail.go?type=gene&acc=5360,,,5360.0,PLTP,9606.0,Homo sapiens (human),GW 3965 results in increased expression of PLTP mRNA,,,PMID:17449538,https://www.ncbi.nlm.nih.gov/pubmed/17449538,17449538,,
1307,1693813,448013,Comparative Toxicogenomics Database (CTD),Epothilone B,C093788,epothilone B,https://ctdbase.org/detail.go?type=chem&acc=C093788,4803,NGF,https://ctdbase.org/detail.go?type=gene&acc=4803,,,4803.0,NGF,10116.0,Rattus norvegicus (Norway rat),Epothilone B promotes the reaction [[potassium co-treated with NGF protein] results in increased secretion of CALCA protein]|epothilone B affects the reaction [[capsaicin co-treated with NGF protein] results in increased secretion of CALCA protein],,,PMID:26883566,https://www.ncbi.nlm.nih.gov/pubmed/26883566,26883566,,
1308,1693814,448110,Therapeutic Target Database (TTD),,D0S4SQ,2-phenylamino-9-(4-hydroxy-butyl)-6-oxopurine,https://idrblab.net/ttd/data/drug/details/D0S4SQ,T30081,Thymidine kinase 1 (TK1),https://idrblab.net/ttd/data/target/details/T30081,P04183,"Thymidine kinase, cytosolic",7083.0,TK1,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
1309,1693815,448222,Drug Gene Interaction database (DGIdb),5'-N-Ethylcarboxamidoadenosine,,PF-00489791,https://www.dgidb.org/drugs/iuphar.ligand:8377,,PDE5A,https://www.dgidb.org/genes/hgnc:8784,,,8654.0,PDE5A,9606.0,Homo sapiens (human),,,,,,,,
1310,1693816,448222,Comparative Toxicogenomics Database (CTD),5'-N-Ethylcarboxamidoadenosine,D019830,Adenosine-5'-(N-ethylcarboxamide),https://ctdbase.org/detail.go?type=chem&acc=D019830,134,ADORA1,https://ctdbase.org/detail.go?type=gene&acc=134,,,134.0,ADORA1,9606.0,Homo sapiens (human),Adenosine-5'-(N-ethylcarboxamide) binds to and results in increased activity of ADORA1 protein,,,PMID:12523489,https://www.ncbi.nlm.nih.gov/pubmed/12523489,12523489,,
1311,1694160,449054,Drug Gene Interaction database (DGIdb),RepSox,,GW786460X,https://www.dgidb.org/drugs/chembl:CHEMBL185238,,YES1,https://www.dgidb.org/genes/hgnc:12841,,,7525.0,YES1,9606.0,Homo sapiens (human),,,,,,,,
1312,1694161,449097,IUPHAR/BPS Guide to PHARMACOLOGY,"(3R)-1'-(9-anthrylcarbonyl)-3-(morpholin-4-ylcarbonyl)-1,4'-bipiperidine",12243,CP-640186,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=12243,1264,Acetyl-CoA carboxylase 2,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1264,,,116719.0,Acacb,10116.0,Rattus norvegicus (Norway rat),Inhibition,pIC50,7.21,PMID:19853443,https://www.ncbi.nlm.nih.gov/pubmed/19853443,19853443,,
1313,1694162,449097,IUPHAR/BPS Guide to PHARMACOLOGY,"(3R)-1'-(9-anthrylcarbonyl)-3-(morpholin-4-ylcarbonyl)-1,4'-bipiperidine",12243,CP-640186,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=12243,1263,Acetyl-CoA carboxylase 1,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1263,P11497,Acetyl-CoA carboxylase 1 ,60581.0,Acaca,10116.0,Rattus norvegicus (Norway rat),Inhibition,pIC50,7.28,PMID:19853443,https://www.ncbi.nlm.nih.gov/pubmed/19853443,19853443,,
1314,1694163,449097,IUPHAR/BPS Guide to PHARMACOLOGY,"(3R)-1'-(9-anthrylcarbonyl)-3-(morpholin-4-ylcarbonyl)-1,4'-bipiperidine",12243,CP-640186,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=12243,1264,Acetyl-CoA carboxylase 2,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1264,O00763,Acetyl-CoA carboxylase 2,32.0,ACACB,9606.0,Homo sapiens (human),Inhibition,pIC50,7.42,PMID:16973360,https://www.ncbi.nlm.nih.gov/pubmed/16973360,16973360,,
1315,1685149,451668,Comparative Toxicogenomics Database (CTD),Decitabine,D000077209,Decitabine,https://ctdbase.org/detail.go?type=chem&acc=D000077209,4436,MSH2,https://ctdbase.org/detail.go?type=gene&acc=4436,,,4436.0,MSH2,9606.0,Homo sapiens (human),Decitabine inhibits the reaction [cadmium chloride results in decreased expression of MSH2 mrna]|decitabine inhibits the reaction [cadmium chloride results in decreased expression of MSH2 protein],,,PMID:22112500,https://www.ncbi.nlm.nih.gov/pubmed/22112500,22112500,,
1316,1685150,451668,Comparative Toxicogenomics Database (CTD),Decitabine,D000077209,Decitabine,https://ctdbase.org/detail.go?type=chem&acc=D000077209,4436,MSH2,https://ctdbase.org/detail.go?type=gene&acc=4436,,,4436.0,MSH2,9606.0,Homo sapiens (human),Decitabine results in decreased methylation of MSH2 promoter,,,PMID:19032668,https://www.ncbi.nlm.nih.gov/pubmed/19032668,19032668,,
1317,1685151,451668,Comparative Toxicogenomics Database (CTD),Decitabine,D000077209,Decitabine,https://ctdbase.org/detail.go?type=chem&acc=D000077209,4436,MSH2,https://ctdbase.org/detail.go?type=gene&acc=4436,,,4436.0,MSH2,9606.0,Homo sapiens (human),Decitabine results in increased expression of MSH2 mRNA,,,PMID:19032668|PMID:22082530,https://www.ncbi.nlm.nih.gov/pubmed/19032668|https://www.ncbi.nlm.nih.gov/pubmed/22082530,19032668|22082530,,
1318,1685152,451668,Comparative Toxicogenomics Database (CTD),Decitabine,D000077209,Decitabine,https://ctdbase.org/detail.go?type=chem&acc=D000077209,4438,MSH4,https://ctdbase.org/detail.go?type=gene&acc=4438,,,4438.0,MSH4,9606.0,Homo sapiens (human),Decitabine results in increased expression of MSH4 mRNA,,,PMID:22082530,https://www.ncbi.nlm.nih.gov/pubmed/22082530,22082530,,
1319,1685153,451668,Comparative Toxicogenomics Database (CTD),Decitabine,D000077209,Decitabine,https://ctdbase.org/detail.go?type=chem&acc=D000077209,2956,MSH6,https://ctdbase.org/detail.go?type=gene&acc=2956,,,2956.0,MSH6,9606.0,Homo sapiens (human),Decitabine results in increased expression of MSH6 mRNA,,,PMID:22082530,https://www.ncbi.nlm.nih.gov/pubmed/22082530,22082530,,
1320,1685154,451668,Comparative Toxicogenomics Database (CTD),Decitabine,D000077209,Decitabine,https://ctdbase.org/detail.go?type=chem&acc=D000077209,4440,MSI1,https://ctdbase.org/detail.go?type=gene&acc=4440,,,4440.0,MSI1,9606.0,Homo sapiens (human),TP53 protein affects the reaction [decitabine results in decreased expression of MSI1 mrna]|decitabine results in decreased expression of MSI1 mRNA,,,PMID:19363521,https://www.ncbi.nlm.nih.gov/pubmed/19363521,19363521,,
1321,1685460,451668,Comparative Toxicogenomics Database (CTD),Decitabine,D000077209,Decitabine,https://ctdbase.org/detail.go?type=chem&acc=D000077209,644314,MT1IP,https://ctdbase.org/detail.go?type=gene&acc=644314,,,644314.0,MT1IP,9606.0,Homo sapiens (human),Decitabine affects the expression of MT1IP mRNA,,,PMID:23300844,https://www.ncbi.nlm.nih.gov/pubmed/23300844,23300844,,
1322,1685461,451668,Comparative Toxicogenomics Database (CTD),Decitabine,D000077209,Decitabine,https://ctdbase.org/detail.go?type=chem&acc=D000077209,4499,MT1M,https://ctdbase.org/detail.go?type=gene&acc=4499,,,4499.0,MT1M,9606.0,Homo sapiens (human),Decitabine results in increased expression of MT1M mRNA,,,PMID:21856257|PMID:22971577,https://www.ncbi.nlm.nih.gov/pubmed/21856257|https://www.ncbi.nlm.nih.gov/pubmed/22971577,21856257|22971577,,
1323,1694648,454202,Therapeutic Target Database (TTD),KT5720,D0G2VC,KT-5720,https://idrblab.net/ttd/data/drug/details/D0G2VC,T55729,Stress-activated protein kinase 2b (p38 beta),https://idrblab.net/ttd/data/target/details/T55729,Q15759,Mitogen-activated protein kinase 11,5600.0,MAPK11,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
1324,1685738,483751,BindingDB,"4-(3-Benzylphenyl)-2,4-dioxo-butanoic acid",23400,(2Z)-4-(3-benzylphenyl)-2-hydroxy-4-oxobut-2-enoic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=23400,2393,Gag-Pol polyprotein [1148-1435],https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2393,P04585,Gag-Pol polyprotein,155348.0,gag-pol,11706.0,HIV-1 M:B_HXB2R,,IC50 (nM),26,PMID:18565342|DOI:10.1016/j.jmb.2008.04.054,https://www.ncbi.nlm.nih.gov/pubmed/18565342|https://doi.org/10.1016/j.jmb.2008.04.054,18565342,10.1016/j.jmb.2008.04.054,
1325,1687268,497559,BindingDB,(4S)-4-[[(2S)-2-acetamido-2-cyclohexyl-acetyl]amino]-5-[[(1S)-2-[[(1R)-2-hydroxy-2-oxo-1-(sulfanylmethyl)ethyl]amino]-1-(2-naphthylmethyl)-2-oxo-ethyl]amino]-5-oxo-pentanoic acid,92894,"NS3 Protease Inhibitor, 5",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=92894,5319,Genome polyprotein,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5319,,,,,,,,Ki (nM),500,PMID:19839643|DOI:10.1021/bi9016928,https://www.ncbi.nlm.nih.gov/pubmed/19839643|https://doi.org/10.1021/bi9016928,19839643,10.1021/bi9016928,
1326,1687269,497564,BindingDB,"(4S)-4-[[(2S)-5-hydroxy-2-[[(2S)-2-[(4-hydroxy-4-oxo-butanoyl)amino]-3,3-diphenyl-propanoyl]amino]-5-oxo-pentanoyl]amino]-5-[[(1R)-2-hydroxy-2-oxo-1-(sulfanylmethyl)ethyl]amino]-5-oxo-pentanoic acid",92892,"NS3 Protease Inhibitor, 3",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=92892,5319,Genome polyprotein,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5319,,,,,,,,Ki (nM),520,PMID:19839643|DOI:10.1021/bi9016928,https://www.ncbi.nlm.nih.gov/pubmed/19839643|https://doi.org/10.1021/bi9016928,19839643,10.1021/bi9016928,
1327,1687270,516871,Comparative Toxicogenomics Database (CTD),Sodium thiocyanate,C024553,sodium thiocyanate,https://ctdbase.org/detail.go?type=chem&acc=C024553,4025,LPO,https://ctdbase.org/detail.go?type=gene&acc=4025,,,4025.0,LPO,9913.0,Bos taurus (cattle),Sodium thiocyanate inhibits the reaction [[LPO protein co-treated with hydrogen peroxide] results in increased oxidation of fenoterol]|sodium thiocyanate inhibits the reaction [[LPO protein co-treated with hydrogen peroxide] results in increased oxidation of albuterol],,,PMID:19462961,https://www.ncbi.nlm.nih.gov/pubmed/19462961,19462961,,
1328,1687271,516871,Comparative Toxicogenomics Database (CTD),Sodium thiocyanate,C024553,sodium thiocyanate,https://ctdbase.org/detail.go?type=chem&acc=C024553,6528,SLC5A5,https://ctdbase.org/detail.go?type=gene&acc=6528,,,6528.0,SLC5A5,9606.0,Homo sapiens (human),Sodium thiocyanate inhibits the reaction [SLC5A5 protein results in increased uptake of iodine],,,PMID:27979590,https://www.ncbi.nlm.nih.gov/pubmed/27979590,27979590,,
1329,1690315,637563,Comparative Toxicogenomics Database (CTD),Anethole,C006578,anethole,https://ctdbase.org/detail.go?type=chem&acc=C006578,3162,HMOX1,https://ctdbase.org/detail.go?type=gene&acc=3162,,,3162.0,HMOX1,10116.0,Rattus norvegicus (Norway rat),Anethole promotes the reaction [isoproterenol results in increased expression of HMOX1 mrna]|anethole promotes the reaction [isoproterenol results in increased expression of HMOX1 protein],,,PMID:35430261,https://www.ncbi.nlm.nih.gov/pubmed/35430261,35430261,,
1330,1690316,637563,Comparative Toxicogenomics Database (CTD),Anethole,C006578,anethole,https://ctdbase.org/detail.go?type=chem&acc=C006578,3551,IKBKB,https://ctdbase.org/detail.go?type=gene&acc=3551,,,3551.0,IKBKB,9606.0,Homo sapiens (human),Anethole results in decreased activity of IKBKB protein,,,PMID:10871845,https://www.ncbi.nlm.nih.gov/pubmed/10871845,10871845,,
1331,1690494,637563,Comparative Toxicogenomics Database (CTD),Anethole,C006578,anethole,https://ctdbase.org/detail.go?type=chem&acc=C006578,5599,MAPK8,https://ctdbase.org/detail.go?type=gene&acc=5599,,,5599.0,MAPK8,9606.0,Homo sapiens (human),Anethole inhibits the reaction [TNF protein results in increased activity of MAPK8 protein],,,PMID:10871845,https://www.ncbi.nlm.nih.gov/pubmed/10871845,10871845,,
1332,1690495,637563,Comparative Toxicogenomics Database (CTD),Anethole,C006578,anethole,https://ctdbase.org/detail.go?type=chem&acc=C006578,4313,MMP2,https://ctdbase.org/detail.go?type=gene&acc=4313,,,4313.0,MMP2,9606.0,Homo sapiens (human),Anethole results in decreased expression of MMP2 mrna|anethole results in decreased activity of MMP2 protein,,,PMID:21212515,https://www.ncbi.nlm.nih.gov/pubmed/21212515,21212515,,
1333,1690496,637563,Comparative Toxicogenomics Database (CTD),Anethole,C006578,anethole,https://ctdbase.org/detail.go?type=chem&acc=C006578,4318,MMP9,https://ctdbase.org/detail.go?type=gene&acc=4318,,,4318.0,MMP9,9606.0,Homo sapiens (human),Anethole results in decreased activity of MMP9 protein|anethole results in decreased expression of MMP9 mRNA,,,PMID:21212515,https://www.ncbi.nlm.nih.gov/pubmed/21212515,21212515,,
1334,1690497,637563,Comparative Toxicogenomics Database (CTD),Anethole,C006578,anethole,https://ctdbase.org/detail.go?type=chem&acc=C006578,4615,MYD88,https://ctdbase.org/detail.go?type=gene&acc=4615,,,4615.0,MYD88,10116.0,Rattus norvegicus (Norway rat),Anethole inhibits the reaction [isoproterenol results in increased expression of MYD88 protein]|anethole inhibits the reaction [isoproterenol results in increased expression of MYD88 mrna],,,PMID:35430261,https://www.ncbi.nlm.nih.gov/pubmed/35430261,35430261,,
1335,1690498,637563,Comparative Toxicogenomics Database (CTD),Anethole,C006578,anethole,https://ctdbase.org/detail.go?type=chem&acc=C006578,4780,NFE2L2,https://ctdbase.org/detail.go?type=gene&acc=4780,,,4780.0,NFE2L2,10116.0,Rattus norvegicus (Norway rat),Anethole promotes the reaction [isoproterenol results in increased expression of NFE2L2 mrna]|anethole promotes the reaction [isoproterenol results in increased expression of NFE2L2 protein],,,PMID:35430261,https://www.ncbi.nlm.nih.gov/pubmed/35430261,35430261,,
1336,1690499,637563,Comparative Toxicogenomics Database (CTD),Anethole,C006578,anethole,https://ctdbase.org/detail.go?type=chem&acc=C006578,4790,NFKB1,https://ctdbase.org/detail.go?type=gene&acc=4790,,,4790.0,NFKB1,9606.0,Homo sapiens (human),Anethole inhibits the reaction [lipopolysaccharides results in increased activity of [NFKB1 protein binds to RELA protein]]|anethole inhibits the reaction [hydrogen peroxide results in increased activity of [NFKB1 protein binds to RELA protein]]|anethole inhibits the reaction [okadaic acid results in increased activity of [NFKB1 protein binds to RELA protein]]|anethole inhibits the reaction [ceramides results in increased activity of [NFKB1 protein binds to RELA protein]]|anethole inhibits the reaction [TNF protein results in increased activity of [NFKB1 protein binds to RELA protein]],,,PMID:10871845,https://www.ncbi.nlm.nih.gov/pubmed/10871845,10871845,,
1337,1690500,637563,Comparative Toxicogenomics Database (CTD),Anethole,C006578,anethole,https://ctdbase.org/detail.go?type=chem&acc=C006578,4792,NFKBIA,https://ctdbase.org/detail.go?type=gene&acc=4792,,,4792.0,NFKBIA,9606.0,Homo sapiens (human),Anethole inhibits the reaction [TNF protein results in increased phosphorylation of NFKBIA protein]|anethole inhibits the reaction [TNF protein results in increased degradation of NFKBIA protein],,,PMID:10871845,https://www.ncbi.nlm.nih.gov/pubmed/10871845,10871845,,
1338,1690501,637563,Comparative Toxicogenomics Database (CTD),Anethole,C006578,anethole,https://ctdbase.org/detail.go?type=chem&acc=C006578,4792,NFKBIA,https://ctdbase.org/detail.go?type=gene&acc=4792,,,4792.0,NFKBIA,9606.0,Homo sapiens (human),Anethole results in decreased degradation of NFKBIA protein,,,PMID:21212515,https://www.ncbi.nlm.nih.gov/pubmed/21212515,21212515,,
1339,1693365,637568,Comparative Toxicogenomics Database (CTD),Dimethyl Fumarate,D000069462,Dimethyl Fumarate,https://ctdbase.org/detail.go?type=chem&acc=D000069462,5970,RELA,https://ctdbase.org/detail.go?type=gene&acc=5970,,,5970.0,RELA,9606.0,Homo sapiens (human),Dimethyl fumarate inhibits the reaction [TNF protein promotes the reaction [RELA protein binds to ICAM1 promoter]]|dimethyl fumarate inhibits the reaction [TNF protein results in increased activity of RELA protein]|dimethyl fumarate binds to and affects the localization of and results in decreased activity of RELA protein|dimethyl fumarate inhibits the reaction [TNF protein promotes the reaction [RELA protein binds to CCL2 promoter]],,,PMID:26683377,https://www.ncbi.nlm.nih.gov/pubmed/26683377,26683377,,
1340,1694308,637568,Comparative Toxicogenomics Database (CTD),Dimethyl Fumarate,D000069462,Dimethyl Fumarate,https://ctdbase.org/detail.go?type=chem&acc=D000069462,2730,GCLM,https://ctdbase.org/detail.go?type=gene&acc=2730,,,2730.0,GCLM,10090.0,Mus musculus (house mouse),Dimethyl fumarate results in increased expression of GCLM protein|nfe2l2 protein affects the reaction [dimethyl fumarate results in increased expression of GCLM mrna]|dimethyl fumarate results in increased expression of GCLM mRNA,,,PMID:27277809,https://www.ncbi.nlm.nih.gov/pubmed/27277809,27277809,,
1341,1694309,637568,Comparative Toxicogenomics Database (CTD),Dimethyl Fumarate,D000069462,Dimethyl Fumarate,https://ctdbase.org/detail.go?type=chem&acc=D000069462,2879,GPX4,https://ctdbase.org/detail.go?type=gene&acc=2879,,,2879.0,GPX4,9606.0,Homo sapiens (human),"Dimethyl fumarate inhibits the reaction [1,3-dichloro-2-propanol results in decreased expression of GPX4 protein]",,,PMID:35870111,https://www.ncbi.nlm.nih.gov/pubmed/35870111,35870111,,
1342,1694310,637568,Comparative Toxicogenomics Database (CTD),Dimethyl Fumarate,D000069462,Dimethyl Fumarate,https://ctdbase.org/detail.go?type=chem&acc=D000069462,2879,GPX4,https://ctdbase.org/detail.go?type=gene&acc=2879,,,2879.0,GPX4,9606.0,Homo sapiens (human),Dimethyl fumarate results in increased metabolism of GPX4 protein,,,PMID:29917289,https://www.ncbi.nlm.nih.gov/pubmed/29917289,29917289,,
1343,1694311,637568,Comparative Toxicogenomics Database (CTD),Dimethyl Fumarate,D000069462,Dimethyl Fumarate,https://ctdbase.org/detail.go?type=chem&acc=D000069462,2936,GSR,https://ctdbase.org/detail.go?type=gene&acc=2936,,,2936.0,GSR,10090.0,Mus musculus (house mouse),Dimethyl fumarate results in increased expression of GSR protein|nfe2l2 protein affects the reaction [dimethyl fumarate results in increased expression of GSR mrna]|dimethyl fumarate results in increased expression of GSR mRNA,,,PMID:27277809,https://www.ncbi.nlm.nih.gov/pubmed/27277809,27277809,,
1344,1689965,638278,Comparative Toxicogenomics Database (CTD),Trihydroxychalcone,C040920,isoliquiritigenin,https://ctdbase.org/detail.go?type=chem&acc=C040920,7184,HSP90B1,https://ctdbase.org/detail.go?type=gene&acc=7184,,,7184.0,HSP90B1,10116.0,Rattus norvegicus (Norway rat),[isoliquiritigenin co-treated with cisplatin] results in increased expression of HSP90B1 protein,,,PMID:37561086,https://www.ncbi.nlm.nih.gov/pubmed/37561086,37561086,,
1345,1689966,638278,Comparative Toxicogenomics Database (CTD),Trihydroxychalcone,C040920,isoliquiritigenin,https://ctdbase.org/detail.go?type=chem&acc=C040920,3309,HSPA5,https://ctdbase.org/detail.go?type=gene&acc=3309,,,3309.0,HSPA5,10116.0,Rattus norvegicus (Norway rat),[cisplatin co-treated with isoliquiritigenin] results in increased expression of HSPA5 mrna|isoliquiritigenin results in increased expression of HSPA5 mRNA,,,PMID:37561086,https://www.ncbi.nlm.nih.gov/pubmed/37561086,37561086,,
1346,1689967,638278,Comparative Toxicogenomics Database (CTD),Trihydroxychalcone,C040920,isoliquiritigenin,https://ctdbase.org/detail.go?type=chem&acc=C040920,3458,IFNG,https://ctdbase.org/detail.go?type=gene&acc=3458,,,3458.0,IFNG,9606.0,Homo sapiens (human),Isoliquiritigenin promotes the reaction [[TNF protein co-treated with IFNG protein] results in increased expression of CYP1B1 mrna],,,PMID:26134484,https://www.ncbi.nlm.nih.gov/pubmed/26134484,26134484,,
1347,1689968,638278,Comparative Toxicogenomics Database (CTD),Trihydroxychalcone,C040920,isoliquiritigenin,https://ctdbase.org/detail.go?type=chem&acc=C040920,3458,IFNG,https://ctdbase.org/detail.go?type=gene&acc=3458,,,3458.0,IFNG,10090.0,Mus musculus (house mouse),Isoliquiritigenin inhibits the reaction [[azoxymethane co-treated with dextran sulfate] results in decreased expression of IFNG protein],,,PMID:25026504,https://www.ncbi.nlm.nih.gov/pubmed/25026504,25026504,,
1348,1691574,642376,Comparative Toxicogenomics Database (CTD),3-Butylidenephthalide,C026105,butylidenephthalide,https://ctdbase.org/detail.go?type=chem&acc=C026105,4830,NME1,https://ctdbase.org/detail.go?type=gene&acc=4830,,,4830.0,NME1,9606.0,Homo sapiens (human),Butylidenephthalide results in increased expression of NME1 protein,,,PMID:23770345,https://www.ncbi.nlm.nih.gov/pubmed/23770345,23770345,,
1349,1692159,644019,IUPHAR/BPS Guide to PHARMACOLOGY,Cannabidiol,4150,cannabidiol,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4150,508,TRPV2,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=508,Q9WUD2,Transient receptor potential cation channel subfamily V member 2,29465.0,Trpv2,10116.0,Rattus norvegicus (Norway rat),Activation,pEC50,5.43,PMID:18550765,https://www.ncbi.nlm.nih.gov/pubmed/18550765,18550765,,
1350,1692160,644019,IUPHAR/BPS Guide to PHARMACOLOGY,Cannabidiol,4150,cannabidiol,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4150,509,TRPV3,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=509,,,497948.0,Trpv3,10116.0,Rattus norvegicus (Norway rat),Activation,pEC50,5.43,PMID:21726418,https://www.ncbi.nlm.nih.gov/pubmed/21726418,21726418,,
1351,1692161,644019,IUPHAR/BPS Guide to PHARMACOLOGY,Cannabidiol,4150,cannabidiol,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4150,500,TRPM8,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=500,Q7Z2W7,Transient receptor potential cation channel subfamily M member 8,79054.0,TRPM8,9606.0,Homo sapiens (human),,,5.5,,,,,
1352,1692162,644073,Drug Gene Interaction database (DGIdb),Buprenorphine,,BUPRENORPHINE,https://www.dgidb.org/drugs/rxcui:1819,,ARRB2,https://www.dgidb.org/genes/hgnc:712,,,409.0,ARRB2,9606.0,Homo sapiens (human),,,,,,,,
1353,1692163,644073,Drug Gene Interaction database (DGIdb),Buprenorphine,,BUPRENORPHINE,https://www.dgidb.org/drugs/rxcui:1819,,SLC6A4,https://www.dgidb.org/genes/hgnc:11050,,,6532.0,SLC6A4,9606.0,Homo sapiens (human),,,,,,,,
1354,1692164,644073,Drug Gene Interaction database (DGIdb),Buprenorphine,,BUPRENORPHINE,https://www.dgidb.org/drugs/rxcui:1819,,OPRK1,https://www.dgidb.org/genes/hgnc:8154,,,4986.0,OPRK1,9606.0,Homo sapiens (human),Agonist,,,,,,,
1355,1693132,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,25980,AAR2,https://ctdbase.org/detail.go?type=gene&acc=25980,,,25980.0,AAR2,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil results in increased expression of AAR2 mRNA,,,PMID:30047161,https://www.ncbi.nlm.nih.gov/pubmed/30047161,30047161,,
1356,1693133,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,441376,AARD,https://ctdbase.org/detail.go?type=gene&acc=441376,,,441376.0,AARD,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil results in increased expression of AARD mRNA,,,PMID:24780913,https://www.ncbi.nlm.nih.gov/pubmed/24780913,24780913,,
1357,1693579,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,58489,ABHD17C,https://ctdbase.org/detail.go?type=gene&acc=58489,,,58489.0,ABHD17C,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil results in increased expression of ABHD17C mRNA,,,PMID:24780913,https://www.ncbi.nlm.nih.gov/pubmed/24780913,24780913,,
1358,1693580,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,11057,ABHD2,https://ctdbase.org/detail.go?type=gene&acc=11057,,,11057.0,ABHD2,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil results in decreased expression of ABHD2 mRNA,,,PMID:24780913,https://www.ncbi.nlm.nih.gov/pubmed/24780913,24780913,,
1359,1693581,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,51099,ABHD5,https://ctdbase.org/detail.go?type=gene&acc=51099,,,51099.0,ABHD5,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil results in decreased expression of ABHD5 mRNA,,,PMID:30047161,https://www.ncbi.nlm.nih.gov/pubmed/30047161,30047161,,
1360,1694393,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,58,ACTA1,https://ctdbase.org/detail.go?type=gene&acc=58,,,58.0,ACTA1,8355.0,Xenopus laevis (African clawed frog),Propylthiouracil results in decreased expression of ACTA1 mRNA,,,PMID:17403546,https://www.ncbi.nlm.nih.gov/pubmed/17403546,17403546,,
1361,1686548,700999,Comparative Toxicogenomics Database (CTD),Thiocarbanilide,C032788,diphenylthiourea,https://ctdbase.org/detail.go?type=chem&acc=C032788,2052,EPHX1,https://ctdbase.org/detail.go?type=gene&acc=2052,,,2052.0,EPHX1,10116.0,Rattus norvegicus (Norway rat),Diphenylthiourea results in increased expression of EPHX1 protein|diphenylthiourea results in increased expression of EPHX1 mRNA,,,PMID:10190572,https://www.ncbi.nlm.nih.gov/pubmed/10190572,10190572,,
1362,1686549,700999,Comparative Toxicogenomics Database (CTD),Thiocarbanilide,C032788,diphenylthiourea,https://ctdbase.org/detail.go?type=chem&acc=C032788,2939,GSTA2,https://ctdbase.org/detail.go?type=gene&acc=2939,,,2939.0,GSTA2,10116.0,Rattus norvegicus (Norway rat),Diphenylthiourea results in increased expression of GSTA2 mrna|diphenylthiourea results in increased expression of GSTA2 protein,,,PMID:10190572,https://www.ncbi.nlm.nih.gov/pubmed/10190572,10190572,,
1363,1686550,700999,Drug Gene Interaction database (DGIdb),Thiocarbanilide,,CHEMBL:CHEMBL275260,https://www.dgidb.org/drugs/chembl:CHEMBL275260,,JUN,https://www.dgidb.org/genes/hgnc:6204,,,3725.0,JUN,9606.0,Homo sapiens (human),,,,,,,,
1364,1686551,700999,Drug Gene Interaction database (DGIdb),Thiocarbanilide,,CHEMBL:CHEMBL275260,https://www.dgidb.org/drugs/chembl:CHEMBL275260,,HSD17B10,https://www.dgidb.org/genes/hgnc:4800,,,3028.0,HSD17B10,9606.0,Homo sapiens (human),,,,,,,,
1365,1686552,702319,BindingDB,"2,3,4-Trimethyl-9-thia-1,5,7-triaza-fluoren-8-ylamine",27432,"11,12,13-trimethyl-8-thia-3,5,10-triazatricyclo[7.4.0.0^{2,7}]trideca-1(13),2(7),3,5,9,11-hexaen-6-amine",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27432,265,Cell division cycle 7-related protein kinase [58-574]/Protein DBF4 homolog A,https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=265,O00311,Cell division cycle 7-related protein kinase,8317.0,CDC7,9606.0,Homo sapiens (human),,Ki (nM),4,PMID:19071019|DOI:10.1016/j.bmcl.2008.11.093,https://www.ncbi.nlm.nih.gov/pubmed/19071019|https://doi.org/10.1016/j.bmcl.2008.11.093,19071019,10.1016/j.bmcl.2008.11.093,
1366,1686553,717531,Comparative Toxicogenomics Database (CTD),"3,4-Dimethoxycinnamic acid",C065784,"3-(3,4-dimethoxyphenyl)propenoic acid",https://ctdbase.org/detail.go?type=chem&acc=C065784,31,ACACA,https://ctdbase.org/detail.go?type=gene&acc=31,,,31.0,ACACA,9606.0,Homo sapiens (human),"3-(3,4-dimethoxyphenyl)propenoic acid inhibits the reaction [ethanol results in decreased phosphorylation of ACACA protein]",,,PMID:29940154,https://www.ncbi.nlm.nih.gov/pubmed/29940154,29940154,,
1367,1688298,935415,Therapeutic Target Database (TTD),"2-(4-methylphenyl)-1,2-benzisothiazol-3(2H)-one",D0IQ7Y,PBIT,https://idrblab.net/ttd/data/drug/details/D0IQ7Y,T56871,Lysine-specific demethylase 5B (KDM5B),https://idrblab.net/ttd/data/target/details/T56871,Q9UGL1,Lysine-specific demethylase 5B,10765.0,KDM5B,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
1368,1688299,935415,Therapeutic Target Database (TTD),"2-(4-methylphenyl)-1,2-benzisothiazol-3(2H)-one",D0IQ7Y,PBIT,https://idrblab.net/ttd/data/drug/details/D0IQ7Y,T85540,Lysine-specific demethylase 5C (KDM5C),https://idrblab.net/ttd/data/target/details/T85540,P41229,Lysine-specific demethylase 5C,8242.0,KDM5C,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
1369,1688300,935415,Therapeutic Target Database (TTD),"2-(4-methylphenyl)-1,2-benzisothiazol-3(2H)-one",D0IQ7Y,PBIT,https://idrblab.net/ttd/data/drug/details/D0IQ7Y,T28052,Lysine-specific demethylase 5A (KDM5A),https://idrblab.net/ttd/data/target/details/T28052,P29375,Lysine-specific demethylase 5A,5927.0,KDM5A,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
1370,1688301,941651,Drug Gene Interaction database (DGIdb),Thiothixene,,THIOTHIXENE,https://www.dgidb.org/drugs/rxcui:10510,,HTR2A,https://www.dgidb.org/genes/hgnc:5293,,,3356.0,HTR2A,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
1371,1688302,950368,Therapeutic Target Database (TTD),"3-amino-2-benzoyl-6-oxo-6H,7H-thieno[2,3-b]pyridine-5-carboxylic acid",D0N6BC,LDN-91946,https://idrblab.net/ttd/data/drug/details/D0N6BC,T56051,Ubiquitin thioesterase L1 (UCHL1),https://idrblab.net/ttd/data/target/details/T56051,P09936,Ubiquitin carboxyl-terminal hydrolase isozyme L1,7345.0,UCHL1,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
1372,1688303,950649,Drug Gene Interaction database (DGIdb),N-benzyl-4-methyl-6-piperidin-1-ylpyrimidin-2-amine,,CHEMBL:CHEMBL601135,https://www.dgidb.org/drugs/chembl:CHEMBL601135,,MCOLN3,https://www.dgidb.org/genes/hgnc:13358,,,55283.0,MCOLN3,9606.0,Homo sapiens (human),,,,,,,,
1373,1688304,969472,Drug Gene Interaction database (DGIdb),Eszopiclone,,ESZOPICLONE,https://www.dgidb.org/drugs/rxcui:461016,,TSPO,https://www.dgidb.org/genes/hgnc:1158,,,706.0,TSPO,9606.0,Homo sapiens (human),,,,,,,,
1374,1688305,969472,Drug Gene Interaction database (DGIdb),Eszopiclone,,ESZOPICLONE,https://www.dgidb.org/drugs/rxcui:461016,,GABRA1,https://www.dgidb.org/genes/hgnc:4075,,,2554.0,GABRA1,9606.0,Homo sapiens (human),,,,,,,,
1375,1688589,969472,DrugBank,Eszopiclone,DB00402,Eszopiclone,https://www.drugbank.ca/drugs/DB00402,BE0004797,Gamma-aminobutyric acid receptor subunit gamma-1,https://www.drugbank.ca/bio_entities/BE0004797,Q8N1C3,Gamma-aminobutyric acid receptor subunit gamma-1,2565.0,GABRG1,9606.0,Homo sapiens (human),Positive allosteric modulator,,,PMID:19698408|PMID:8241608|PMID:25817320,https://www.ncbi.nlm.nih.gov/pubmed/19698408|https://www.ncbi.nlm.nih.gov/pubmed/8241608|https://www.ncbi.nlm.nih.gov/pubmed/25817320,19698408|8241608|25817320,,
1376,1688590,969472,DrugBank,Eszopiclone,DB00402,Eszopiclone,https://www.drugbank.ca/drugs/DB00402,BE0004797,Gamma-aminobutyric acid receptor subunit gamma-2,https://www.drugbank.ca/bio_entities/BE0004797,P18507,Gamma-aminobutyric acid receptor subunit gamma-2,2566.0,GABRG2,9606.0,Homo sapiens (human),Positive allosteric modulator,,,PMID:19698408|PMID:8241608|PMID:25817320,https://www.ncbi.nlm.nih.gov/pubmed/19698408|https://www.ncbi.nlm.nih.gov/pubmed/8241608|https://www.ncbi.nlm.nih.gov/pubmed/25817320,19698408|8241608|25817320,,
1377,1688591,969472,DrugBank,Eszopiclone,DB00402,Eszopiclone,https://www.drugbank.ca/drugs/DB00402,BE0004797,Gamma-aminobutyric acid receptor subunit gamma-3,https://www.drugbank.ca/bio_entities/BE0004797,Q99928,Gamma-aminobutyric acid receptor subunit gamma-3,2567.0,GABRG3,9606.0,Homo sapiens (human),Positive allosteric modulator,,,PMID:19698408|PMID:8241608|PMID:25817320,https://www.ncbi.nlm.nih.gov/pubmed/19698408|https://www.ncbi.nlm.nih.gov/pubmed/8241608|https://www.ncbi.nlm.nih.gov/pubmed/25817320,19698408|8241608|25817320,,
1378,1688592,969472,DrugBank,Eszopiclone,DB00402,Eszopiclone,https://www.drugbank.ca/drugs/DB00402,BE0004797,Gamma-aminobutyric acid receptor subunit pi,https://www.drugbank.ca/bio_entities/BE0004797,O00591,Gamma-aminobutyric acid receptor subunit pi,2568.0,GABRP,9606.0,Homo sapiens (human),Positive allosteric modulator,,,PMID:19698408|PMID:8241608|PMID:25817320,https://www.ncbi.nlm.nih.gov/pubmed/19698408|https://www.ncbi.nlm.nih.gov/pubmed/8241608|https://www.ncbi.nlm.nih.gov/pubmed/25817320,19698408|8241608|25817320,,
1379,1688593,969472,DrugBank,Eszopiclone,DB00402,Eszopiclone,https://www.drugbank.ca/drugs/DB00402,BE0004797,Gamma-aminobutyric acid receptor subunit theta,https://www.drugbank.ca/bio_entities/BE0004797,Q9UN88,Gamma-aminobutyric acid receptor subunit theta,55879.0,GABRQ,9606.0,Homo sapiens (human),Positive allosteric modulator,,,PMID:19698408|PMID:8241608|PMID:25817320,https://www.ncbi.nlm.nih.gov/pubmed/19698408|https://www.ncbi.nlm.nih.gov/pubmed/8241608|https://www.ncbi.nlm.nih.gov/pubmed/25817320,19698408|8241608|25817320,,
1380,1689545,1349907,Comparative Toxicogenomics Database (CTD),Methimazole,D008713,Methimazole,https://ctdbase.org/detail.go?type=chem&acc=D008713,14349,FV1,https://ctdbase.org/detail.go?type=gene&acc=14349,,,14349.0,Fv1,10116.0,Rattus norvegicus (Norway rat),Methimazole results in decreased expression of FV1 mRNA,,,PMID:30047161,https://www.ncbi.nlm.nih.gov/pubmed/30047161,30047161,,
1381,1689546,1349907,Comparative Toxicogenomics Database (CTD),Methimazole,D008713,Methimazole,https://ctdbase.org/detail.go?type=chem&acc=D008713,50943,FOXP3,https://ctdbase.org/detail.go?type=gene&acc=50943,,,50943.0,FOXP3,10116.0,Rattus norvegicus (Norway rat),[buthionine sulfoximine results in increased susceptibility to methimazole] which results in increased expression of FOXP3 mRNA,,,PMID:26177832,https://www.ncbi.nlm.nih.gov/pubmed/26177832,26177832,,
1382,1689547,1349907,Comparative Toxicogenomics Database (CTD),Methimazole,D008713,Methimazole,https://ctdbase.org/detail.go?type=chem&acc=D008713,2356,FPGS,https://ctdbase.org/detail.go?type=gene&acc=2356,,,2356.0,FPGS,10116.0,Rattus norvegicus (Norway rat),Methimazole results in increased expression of FPGS mRNA,,,PMID:30047161,https://www.ncbi.nlm.nih.gov/pubmed/30047161,30047161,,
1383,1689548,1349907,Comparative Toxicogenomics Database (CTD),Methimazole,D008713,Methimazole,https://ctdbase.org/detail.go?type=chem&acc=D008713,341640,FREM2,https://ctdbase.org/detail.go?type=gene&acc=341640,,,341640.0,FREM2,10116.0,Rattus norvegicus (Norway rat),Methimazole results in decreased expression of FREM2 mRNA,,,PMID:30047161,https://www.ncbi.nlm.nih.gov/pubmed/30047161,30047161,,
1384,1689549,1349907,Comparative Toxicogenomics Database (CTD),Methimazole,D008713,Methimazole,https://ctdbase.org/detail.go?type=chem&acc=D008713,143678,FREY1,https://ctdbase.org/detail.go?type=gene&acc=143678,,,143678.0,FREY1,10116.0,Rattus norvegicus (Norway rat),Methimazole results in increased expression of FREY1 mRNA,,,PMID:22504374,https://www.ncbi.nlm.nih.gov/pubmed/22504374,22504374,,
1385,1689695,1349907,Comparative Toxicogenomics Database (CTD),Methimazole,D008713,Methimazole,https://ctdbase.org/detail.go?type=chem&acc=D008713,65991,FUNDC2,https://ctdbase.org/detail.go?type=gene&acc=65991,,,65991.0,FUNDC2,10116.0,Rattus norvegicus (Norway rat),Methimazole results in increased expression of FUNDC2 mRNA,,,PMID:22504374,https://www.ncbi.nlm.nih.gov/pubmed/22504374,22504374,,
1386,1689696,1349907,Comparative Toxicogenomics Database (CTD),Methimazole,D008713,Methimazole,https://ctdbase.org/detail.go?type=chem&acc=D008713,486,FXYD2,https://ctdbase.org/detail.go?type=gene&acc=486,,,486.0,FXYD2,10116.0,Rattus norvegicus (Norway rat),Methimazole results in increased expression of FXYD2 mRNA,,,PMID:30047161,https://www.ncbi.nlm.nih.gov/pubmed/30047161,30047161,,
1387,1689697,1349907,Comparative Toxicogenomics Database (CTD),Methimazole,D008713,Methimazole,https://ctdbase.org/detail.go?type=chem&acc=D008713,5349,FXYD3,https://ctdbase.org/detail.go?type=gene&acc=5349,,,5349.0,FXYD3,10116.0,Rattus norvegicus (Norway rat),Methimazole results in decreased expression of FXYD3 mRNA,,,PMID:30047161,https://www.ncbi.nlm.nih.gov/pubmed/30047161,30047161,,
1388,1689698,1349907,Comparative Toxicogenomics Database (CTD),Methimazole,D008713,Methimazole,https://ctdbase.org/detail.go?type=chem&acc=D008713,53827,FXYD5,https://ctdbase.org/detail.go?type=gene&acc=53827,,,53827.0,FXYD5,10116.0,Rattus norvegicus (Norway rat),Methimazole results in increased expression of FXYD5 mRNA,,,PMID:30047161,https://www.ncbi.nlm.nih.gov/pubmed/30047161,30047161,,
1389,1692001,1349907,Comparative Toxicogenomics Database (CTD),Methimazole,D008713,Methimazole,https://ctdbase.org/detail.go?type=chem&acc=D008713,2975,GTF3C1,https://ctdbase.org/detail.go?type=gene&acc=2975,,,2975.0,GTF3C1,10116.0,Rattus norvegicus (Norway rat),Methimazole results in decreased expression of GTF3C1 mRNA,,,PMID:30047161,https://www.ncbi.nlm.nih.gov/pubmed/30047161,30047161,,
1390,1692002,1349907,Comparative Toxicogenomics Database (CTD),Methimazole,D008713,Methimazole,https://ctdbase.org/detail.go?type=chem&acc=D008713,8225,GTPBP6,https://ctdbase.org/detail.go?type=gene&acc=8225,,,8225.0,GTPBP6,10116.0,Rattus norvegicus (Norway rat),Methimazole results in decreased expression of GTPBP6 mRNA,,,PMID:30047161,https://www.ncbi.nlm.nih.gov/pubmed/30047161,30047161,,
1391,1692003,1349907,Comparative Toxicogenomics Database (CTD),Methimazole,D008713,Methimazole,https://ctdbase.org/detail.go?type=chem&acc=D008713,121355,GTSF1,https://ctdbase.org/detail.go?type=gene&acc=121355,,,121355.0,GTSF1,10116.0,Rattus norvegicus (Norway rat),Methimazole results in decreased expression of GTSF1 mRNA,,,PMID:30047161,https://www.ncbi.nlm.nih.gov/pubmed/30047161,30047161,,
1392,1692004,1349907,Comparative Toxicogenomics Database (CTD),Methimazole,D008713,Methimazole,https://ctdbase.org/detail.go?type=chem&acc=D008713,2978,GUCA1A,https://ctdbase.org/detail.go?type=gene&acc=2978,,,2978.0,GUCA1A,10116.0,Rattus norvegicus (Norway rat),Methimazole results in increased expression of GUCA1A mRNA,,,PMID:30047161,https://www.ncbi.nlm.nih.gov/pubmed/30047161,30047161,,
1393,1692005,1349907,Comparative Toxicogenomics Database (CTD),Methimazole,D008713,Methimazole,https://ctdbase.org/detail.go?type=chem&acc=D008713,422407,GUCY1A3,https://ctdbase.org/detail.go?type=gene&acc=422407,,,422407.0,GUCY1A3,10116.0,Rattus norvegicus (Norway rat),Methimazole results in increased expression of GUCY1A3 mRNA,,,PMID:30047161,https://www.ncbi.nlm.nih.gov/pubmed/30047161,30047161,,
1394,1692544,1349907,Comparative Toxicogenomics Database (CTD),Methimazole,D008713,Methimazole,https://ctdbase.org/detail.go?type=chem&acc=D008713,147746,HIPK4,https://ctdbase.org/detail.go?type=gene&acc=147746,,,147746.0,HIPK4,10116.0,Rattus norvegicus (Norway rat),Methimazole results in decreased expression of HIPK4 mRNA,,,PMID:30047161,https://www.ncbi.nlm.nih.gov/pubmed/30047161,30047161,,
1395,1692545,1349907,Comparative Toxicogenomics Database (CTD),Methimazole,D008713,Methimazole,https://ctdbase.org/detail.go?type=chem&acc=D008713,361247,HIST1H2BD,https://ctdbase.org/detail.go?type=gene&acc=361247,,,361247.0,Hist1h2bd,10116.0,Rattus norvegicus (Norway rat),Methimazole results in increased expression of HIST1H2BD mRNA,,,PMID:30047161,https://www.ncbi.nlm.nih.gov/pubmed/30047161,30047161,,
1396,1692546,1349907,Comparative Toxicogenomics Database (CTD),Methimazole,D008713,Methimazole,https://ctdbase.org/detail.go?type=chem&acc=D008713,679983,HIST1H4A,https://ctdbase.org/detail.go?type=gene&acc=679983,,,679983.0,Hist1h4a,10116.0,Rattus norvegicus (Norway rat),Methimazole results in increased expression of HIST1H4A mRNA,,,PMID:30047161,https://www.ncbi.nlm.nih.gov/pubmed/30047161,30047161,,
1397,1692547,1349907,Comparative Toxicogenomics Database (CTD),Methimazole,D008713,Methimazole,https://ctdbase.org/detail.go?type=chem&acc=D008713,291152,HIST1H4M,https://ctdbase.org/detail.go?type=gene&acc=291152,,,291152.0,Hist1h4m,10116.0,Rattus norvegicus (Norway rat),Methimazole results in increased expression of HIST1H4M mRNA,,,PMID:30047161,https://www.ncbi.nlm.nih.gov/pubmed/30047161,30047161,,
1398,1692548,1349907,Comparative Toxicogenomics Database (CTD),Methimazole,D008713,Methimazole,https://ctdbase.org/detail.go?type=chem&acc=D008713,103229950,HIST3H2A,https://ctdbase.org/detail.go?type=gene&acc=103229950,,,103229950.0,HIST3H2A,10116.0,Rattus norvegicus (Norway rat),Methimazole results in decreased expression of HIST3H2A mRNA,,,PMID:30047161,https://www.ncbi.nlm.nih.gov/pubmed/30047161,30047161,,
1399,1692549,1349907,Comparative Toxicogenomics Database (CTD),Methimazole,D008713,Methimazole,https://ctdbase.org/detail.go?type=chem&acc=D008713,103229949,HIST3H2BB,https://ctdbase.org/detail.go?type=gene&acc=103229949,,,103229949.0,HIST3H2BB,10116.0,Rattus norvegicus (Norway rat),Methimazole results in decreased expression of HIST3H2BB mRNA,,,PMID:30047161,https://www.ncbi.nlm.nih.gov/pubmed/30047161,30047161,,
1400,1692550,1349907,Comparative Toxicogenomics Database (CTD),Methimazole,D008713,Methimazole,https://ctdbase.org/detail.go?type=chem&acc=D008713,3098,HK1,https://ctdbase.org/detail.go?type=gene&acc=3098,,,3098.0,HK1,10116.0,Rattus norvegicus (Norway rat),Methimazole results in increased expression of HK1 mRNA,,,PMID:22504374|PMID:30047161,https://www.ncbi.nlm.nih.gov/pubmed/22504374|https://www.ncbi.nlm.nih.gov/pubmed/30047161,22504374|30047161,,
1401,1685086,1378917,Therapeutic Target Database (TTD),3-Methylphenyl 4-benzylpiperidyl ketone,D0M5EU,(4-benzylpiperidin-1-yl)(m-tolyl)methanone,https://idrblab.net/ttd/data/drug/details/D0M5EU,T79068,Bacterial Fatty acid synthetase I (Bact inhA),https://idrblab.net/ttd/data/target/details/T79068,P9WGR1,Enoyl-[acyl-carrier-protein] reductase [NADH],886523.0,inhA,83332.0,Mycobacterium tuberculosis H37Rv,Inhibitor,,,,,,,
1402,1685087,1470715,Drug Gene Interaction database (DGIdb),N-isopropyl-5-methoxy-2-(2-pyridinyl)-4-pyrimidinamine,,CHEMBL:CHEMBL578675,https://www.dgidb.org/drugs/chembl:CHEMBL578675,,GMNN,https://www.dgidb.org/genes/hgnc:17493,,,51053.0,GMNN,9606.0,Homo sapiens (human),,,,,,,,
1403,1688412,1548972,Comparative Toxicogenomics Database (CTD),Fluvastatin,D000077340,Fluvastatin,https://ctdbase.org/detail.go?type=chem&acc=D000077340,2538,G6PC1,https://ctdbase.org/detail.go?type=gene&acc=2538,,,2538.0,G6PC1,9606.0,Homo sapiens (human),[fluvastatin co-treated with NR1I2 protein] results in increased expression of G6PC1 mRNA,,,PMID:24204015,https://www.ncbi.nlm.nih.gov/pubmed/24204015,24204015,,
1404,1688413,1548972,Comparative Toxicogenomics Database (CTD),Fluvastatin,D000077340,Fluvastatin,https://ctdbase.org/detail.go?type=chem&acc=D000077340,2539,G6PD,https://ctdbase.org/detail.go?type=gene&acc=2539,,,2539.0,G6PD,10116.0,Rattus norvegicus (Norway rat),Fluvastatin promotes the reaction [taxifolin inhibits the reaction [bisphenol A results in decreased activity of G6PD protein]]|taxifolin promotes the reaction [fluvastatin inhibits the reaction [bisphenol A results in decreased activity of G6PD protein]]|fluvastatin inhibits the reaction [bisphenol A results in decreased activity of G6PD protein],,,PMID:35465754,https://www.ncbi.nlm.nih.gov/pubmed/35465754,35465754,,
1405,1688414,1548972,Comparative Toxicogenomics Database (CTD),Fluvastatin,D000077340,Fluvastatin,https://ctdbase.org/detail.go?type=chem&acc=D000077340,4616,GADD45B,https://ctdbase.org/detail.go?type=gene&acc=4616,,,4616.0,GADD45B,9606.0,Homo sapiens (human),[zoledronic acid co-treated with fluvastatin] results in increased expression of GADD45B mRNA,,,PMID:16996129,https://www.ncbi.nlm.nih.gov/pubmed/16996129,16996129,,
1406,1688415,1548972,Comparative Toxicogenomics Database (CTD),Fluvastatin,D000077340,Fluvastatin,https://ctdbase.org/detail.go?type=chem&acc=D000077340,2936,GSR,https://ctdbase.org/detail.go?type=gene&acc=2936,,,2936.0,GSR,10116.0,Rattus norvegicus (Norway rat),Fluvastatin inhibits the reaction [bisphenol A results in decreased expression of GSR protein]|fluvastatin promotes the reaction [taxifolin inhibits the reaction [bisphenol A results in decreased expression of GSR protein]]|taxifolin promotes the reaction [fluvastatin inhibits the reaction [bisphenol A results in decreased expression of GSR protein]],,,PMID:35465754,https://www.ncbi.nlm.nih.gov/pubmed/35465754,35465754,,
1407,1688416,1548972,Comparative Toxicogenomics Database (CTD),Fluvastatin,D000077340,Fluvastatin,https://ctdbase.org/detail.go?type=chem&acc=D000077340,3117,HLA-DQA1,https://ctdbase.org/detail.go?type=gene&acc=3117,,,3117.0,HLA-DQA1,9606.0,Homo sapiens (human),Fluvastatin affects the expression of HLA-DQA1 mRNA,,,PMID:25811541,https://www.ncbi.nlm.nih.gov/pubmed/25811541,25811541,,
1408,1688417,1548972,Comparative Toxicogenomics Database (CTD),Fluvastatin,D000077340,Fluvastatin,https://ctdbase.org/detail.go?type=chem&acc=D000077340,3156,HMGCR,https://ctdbase.org/detail.go?type=gene&acc=3156,,,3156.0,HMGCR,9606.0,Homo sapiens (human),[APOB gene SNP co-treated with APOE gene SNP co-treated with HMGCR gene SNP co-treated with LDLR gene SNP co-treated with PCSK9 gene SNP co-treated with ABCA1 gene SNP co-treated with CETP gene SNP co-treated with LIPC gene SNP co-treated with LPL gene SNP] affects the susceptibility to fluvastatin,,,PMID:19773416,https://www.ncbi.nlm.nih.gov/pubmed/19773416,19773416,,
1409,1688418,1548972,Comparative Toxicogenomics Database (CTD),Fluvastatin,D000077340,Fluvastatin,https://ctdbase.org/detail.go?type=chem&acc=D000077340,3156,HMGCR,https://ctdbase.org/detail.go?type=gene&acc=3156,,,3156.0,HMGCR,9606.0,Homo sapiens (human),Fluvastatin results in decreased activity of HMGCR protein,,,PMID:8593127,https://www.ncbi.nlm.nih.gov/pubmed/8593127,8593127,,
1410,1688419,1548972,Comparative Toxicogenomics Database (CTD),Fluvastatin,D000077340,Fluvastatin,https://ctdbase.org/detail.go?type=chem&acc=D000077340,3156,HMGCR,https://ctdbase.org/detail.go?type=gene&acc=3156,,,3156.0,HMGCR,9606.0,Homo sapiens (human),Fluvastatin results in decreased activity of HMGCR protein,,,PMID:11335104|PMID:15802384|PMID:19496270|PMID:8729588|PMID:9703316,https://www.ncbi.nlm.nih.gov/pubmed/11335104|https://www.ncbi.nlm.nih.gov/pubmed/15802384|https://www.ncbi.nlm.nih.gov/pubmed/19496270|https://www.ncbi.nlm.nih.gov/pubmed/8729588|https://www.ncbi.nlm.nih.gov/pubmed/9703316,11335104|15802384|19496270|8729588|9703316,,
1411,1685376,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,2950,GSTP1,https://ctdbase.org/detail.go?type=gene&acc=2950,,,2950.0,GSTP1,10116.0,Rattus norvegicus (Norway rat),Thioacetamide results in increased expression of GSTP1 mRNA,,,PMID:10634158|PMID:23411599,https://www.ncbi.nlm.nih.gov/pubmed/10634158|https://www.ncbi.nlm.nih.gov/pubmed/23411599,10634158|23411599,,
1412,1686019,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,84705,GTPBP3,https://ctdbase.org/detail.go?type=gene&acc=84705,,,84705.0,GTPBP3,10141.0,Cavia porcellus (domestic guinea pig),Thioacetamide results in decreased expression of GTPBP3 mRNA,,,PMID:34492290,https://www.ncbi.nlm.nih.gov/pubmed/34492290,34492290,,
1413,1686226,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,3953,LEPR,https://ctdbase.org/detail.go?type=gene&acc=3953,,,3953.0,LEPR,7955.0,Danio rerio (zebrafish),Thioacetamide affects the expression of LEPR mRNA,,,PMID:25064622,https://www.ncbi.nlm.nih.gov/pubmed/25064622,25064622,,
1414,1686404,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,3959,LGALS3BP,https://ctdbase.org/detail.go?type=gene&acc=3959,,,3959.0,LGALS3BP,10116.0,Rattus norvegicus (Norway rat),[diethylnitrosamine co-treated with thioacetamide] results in increased expression of LGALS3BP mRNA,,,PMID:28943392,https://www.ncbi.nlm.nih.gov/pubmed/28943392,28943392,,
1415,1686405,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,3959,LGALS3BP,https://ctdbase.org/detail.go?type=gene&acc=3959,,,3959.0,LGALS3BP,10116.0,Rattus norvegicus (Norway rat),Thioacetamide results in increased expression of LGALS3BP mRNA,,,PMID:34492290,https://www.ncbi.nlm.nih.gov/pubmed/34492290,34492290,,
1416,1686406,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,3960,LGALS4,https://ctdbase.org/detail.go?type=gene&acc=3960,,,3960.0,LGALS4,10141.0,Cavia porcellus (domestic guinea pig),Thioacetamide results in increased expression of LGALS4 mRNA,,,PMID:34492290,https://www.ncbi.nlm.nih.gov/pubmed/34492290,34492290,,
1417,1686407,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,25475,LGALS5,https://ctdbase.org/detail.go?type=gene&acc=25475,,,25475.0,Lgals5,10116.0,Rattus norvegicus (Norway rat),Thioacetamide results in decreased expression of LGALS5 mRNA,,,PMID:23411599,https://www.ncbi.nlm.nih.gov/pubmed/23411599,23411599,,
1418,1686554,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,22927,HABP4,https://ctdbase.org/detail.go?type=gene&acc=22927,,,22927.0,HABP4,10141.0,Cavia porcellus (domestic guinea pig),Thioacetamide results in decreased expression of HABP4 mRNA,,,PMID:34492290,https://www.ncbi.nlm.nih.gov/pubmed/34492290,34492290,,
1419,1686555,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,9200,HACD1,https://ctdbase.org/detail.go?type=gene&acc=9200,,,9200.0,HACD1,10116.0,Rattus norvegicus (Norway rat),Thioacetamide results in increased expression of HACD1 mRNA,,,PMID:23411599|PMID:34492290,https://www.ncbi.nlm.nih.gov/pubmed/23411599|https://www.ncbi.nlm.nih.gov/pubmed/34492290,23411599|34492290,,
1420,1686849,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,5649,RELN,https://ctdbase.org/detail.go?type=gene&acc=5649,,,5649.0,RELN,10141.0,Cavia porcellus (domestic guinea pig),Thioacetamide results in decreased expression of RELN mrna|thioacetamide results in increased expression of RELN mRNA,,,PMID:34492290,https://www.ncbi.nlm.nih.gov/pubmed/34492290,34492290,,
1421,1686850,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,84957,RELT,https://ctdbase.org/detail.go?type=gene&acc=84957,,,84957.0,RELT,10141.0,Cavia porcellus (domestic guinea pig),Thioacetamide results in increased expression of RELT mRNA,,,PMID:34492290,https://www.ncbi.nlm.nih.gov/pubmed/34492290,34492290,,
1422,1686851,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,28954,REM1,https://ctdbase.org/detail.go?type=gene&acc=28954,,,28954.0,REM1,10141.0,Cavia porcellus (domestic guinea pig),Thioacetamide results in decreased expression of REM1 mRNA,,,PMID:34492290,https://www.ncbi.nlm.nih.gov/pubmed/34492290,34492290,,
1423,1686852,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,161253,REM2,https://ctdbase.org/detail.go?type=gene&acc=161253,,,161253.0,REM2,10141.0,Cavia porcellus (domestic guinea pig),Thioacetamide results in increased expression of REM2 mRNA,,,PMID:34492290,https://www.ncbi.nlm.nih.gov/pubmed/34492290,34492290,,
1424,1686853,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,161253,REM2,https://ctdbase.org/detail.go?type=gene&acc=161253,,,161253.0,REM2,10116.0,Rattus norvegicus (Norway rat),Thioacetamide results in increased expression of REM2 mRNA,,,PMID:23411599|PMID:34492290,https://www.ncbi.nlm.nih.gov/pubmed/23411599|https://www.ncbi.nlm.nih.gov/pubmed/34492290,23411599|34492290,,
1425,1686854,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,5972,REN,https://ctdbase.org/detail.go?type=gene&acc=5972,,,5972.0,REN,10141.0,Cavia porcellus (domestic guinea pig),Thioacetamide results in decreased expression of REN mRNA,,,PMID:34492290,https://www.ncbi.nlm.nih.gov/pubmed/34492290,34492290,,
1426,1686855,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,5973,RENBP,https://ctdbase.org/detail.go?type=gene&acc=5973,,,5973.0,RENBP,10141.0,Cavia porcellus (domestic guinea pig),Thioacetamide results in decreased expression of RENBP mRNA,,,PMID:34492290,https://www.ncbi.nlm.nih.gov/pubmed/34492290,34492290,,
1427,1686856,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,29803,REPIN1,https://ctdbase.org/detail.go?type=gene&acc=29803,,,29803.0,REPIN1,10141.0,Cavia porcellus (domestic guinea pig),Thioacetamide results in decreased expression of REPIN1 mRNA,,,PMID:34492290,https://www.ncbi.nlm.nih.gov/pubmed/34492290,34492290,,
1428,1687361,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,5985,RFC5,https://ctdbase.org/detail.go?type=gene&acc=5985,,,5985.0,RFC5,10141.0,Cavia porcellus (domestic guinea pig),Thioacetamide results in increased expression of RFC5 mrna|thioacetamide results in decreased expression of RFC5 mRNA,,,PMID:34492290,https://www.ncbi.nlm.nih.gov/pubmed/34492290,34492290,,
1429,1687362,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,317671,RFESD,https://ctdbase.org/detail.go?type=gene&acc=317671,,,317671.0,RFESD,10116.0,Rattus norvegicus (Norway rat),Thioacetamide results in decreased expression of RFESD mRNA,,,PMID:34492290,https://www.ncbi.nlm.nih.gov/pubmed/34492290,34492290,,
1430,1687363,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,117584,RFFL,https://ctdbase.org/detail.go?type=gene&acc=117584,,,117584.0,RFFL,10141.0,Cavia porcellus (domestic guinea pig),Thioacetamide results in increased expression of RFFL mRNA,,,PMID:34492290,https://www.ncbi.nlm.nih.gov/pubmed/34492290,34492290,,
1431,1687364,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,55312,RFK,https://ctdbase.org/detail.go?type=gene&acc=55312,,,55312.0,RFK,10116.0,Rattus norvegicus (Norway rat),Thioacetamide results in increased expression of RFK mRNA,,,PMID:34492290,https://www.ncbi.nlm.nih.gov/pubmed/34492290,34492290,,
1432,1687806,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,8786,RGS11,https://ctdbase.org/detail.go?type=gene&acc=8786,,,8786.0,RGS11,10141.0,Cavia porcellus (domestic guinea pig),Thioacetamide results in increased expression of RGS11 mRNA,,,PMID:34492290,https://www.ncbi.nlm.nih.gov/pubmed/34492290,34492290,,
1433,1687807,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,8786,RGS11,https://ctdbase.org/detail.go?type=gene&acc=8786,,,8786.0,RGS11,10116.0,Rattus norvegicus (Norway rat),[diethylnitrosamine co-treated with thioacetamide] results in increased expression of RGS11 mRNA,,,PMID:28943392,https://www.ncbi.nlm.nih.gov/pubmed/28943392,28943392,,
1434,1687808,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,10636,RGS14,https://ctdbase.org/detail.go?type=gene&acc=10636,,,10636.0,RGS14,10116.0,Rattus norvegicus (Norway rat),Thioacetamide results in increased expression of RGS14 mRNA,,,PMID:34492290,https://www.ncbi.nlm.nih.gov/pubmed/34492290,34492290,,
1435,1688078,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,83752,LONP2,https://ctdbase.org/detail.go?type=gene&acc=83752,,,83752.0,LONP2,10141.0,Cavia porcellus (domestic guinea pig),Thioacetamide results in decreased expression of LONP2 mRNA,,,PMID:34492290,https://www.ncbi.nlm.nih.gov/pubmed/34492290,34492290,,
1436,1688079,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,91694,LONRF1,https://ctdbase.org/detail.go?type=gene&acc=91694,,,91694.0,LONRF1,10116.0,Rattus norvegicus (Norway rat),Thioacetamide results in increased expression of LONRF1 mRNA,,,PMID:23411599,https://www.ncbi.nlm.nih.gov/pubmed/23411599,23411599,,
1437,1688080,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,79836,LONRF3,https://ctdbase.org/detail.go?type=gene&acc=79836,,,79836.0,LONRF3,10141.0,Cavia porcellus (domestic guinea pig),Thioacetamide results in increased expression of LONRF3 mRNA,,,PMID:34492290,https://www.ncbi.nlm.nih.gov/pubmed/34492290,34492290,,
1438,1688081,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,4015,LOX,https://ctdbase.org/detail.go?type=gene&acc=4015,,,4015.0,LOX,10116.0,Rattus norvegicus (Norway rat),Thioacetamide affects the expression of LOX mRNA,,,PMID:19483382,https://www.ncbi.nlm.nih.gov/pubmed/19483382,19483382,,
1439,1688082,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,4015,LOX,https://ctdbase.org/detail.go?type=gene&acc=4015,,,4015.0,LOX,10116.0,Rattus norvegicus (Norway rat),Thioacetamide results in increased expression of LOX mRNA,,,PMID:23411599,https://www.ncbi.nlm.nih.gov/pubmed/23411599,23411599,,
1440,1688184,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,57414,RHBDD2,https://ctdbase.org/detail.go?type=gene&acc=57414,,,57414.0,RHBDD2,10116.0,Rattus norvegicus (Norway rat),Thioacetamide results in decreased expression of RHBDD2 mRNA,,,PMID:34492290,https://www.ncbi.nlm.nih.gov/pubmed/34492290,34492290,,
1441,1688185,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,64285,RHBDF1,https://ctdbase.org/detail.go?type=gene&acc=64285,,,64285.0,RHBDF1,10141.0,Cavia porcellus (domestic guinea pig),Thioacetamide results in increased expression of RHBDF1 mRNA,,,PMID:34492290,https://www.ncbi.nlm.nih.gov/pubmed/34492290,34492290,,
1442,1688186,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,79651,RHBDF2,https://ctdbase.org/detail.go?type=gene&acc=79651,,,79651.0,RHBDF2,10116.0,Rattus norvegicus (Norway rat),Thioacetamide results in increased expression of RHBDF2 mRNA,,,PMID:23411599|PMID:34492290,https://www.ncbi.nlm.nih.gov/pubmed/23411599|https://www.ncbi.nlm.nih.gov/pubmed/34492290,23411599|34492290,,
1443,1688187,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,9028,RHBDL1,https://ctdbase.org/detail.go?type=gene&acc=9028,,,9028.0,RHBDL1,10141.0,Cavia porcellus (domestic guinea pig),Thioacetamide results in increased expression of RHBDL1 mRNA,,,PMID:34492290,https://www.ncbi.nlm.nih.gov/pubmed/34492290,34492290,,
1444,1688188,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,57127,RHBG,https://ctdbase.org/detail.go?type=gene&acc=57127,,,57127.0,RHBG,10141.0,Cavia porcellus (domestic guinea pig),Thioacetamide results in decreased expression of RHBG mRNA,,,PMID:34492290,https://www.ncbi.nlm.nih.gov/pubmed/34492290,34492290,,
1445,1688189,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,57127,RHBG,https://ctdbase.org/detail.go?type=gene&acc=57127,,,57127.0,RHBG,10116.0,Rattus norvegicus (Norway rat),Thioacetamide results in increased expression of RHBG mRNA,,,PMID:23411599,https://www.ncbi.nlm.nih.gov/pubmed/23411599,23411599,,
1446,1688190,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,563826,RHCGL1,https://ctdbase.org/detail.go?type=gene&acc=563826,,,563826.0,rhcgl1,7955.0,Danio rerio (zebrafish),Thioacetamide affects the expression of RHCGL1 mRNA,,,PMID:25064622,https://www.ncbi.nlm.nih.gov/pubmed/25064622,25064622,,
1447,1688191,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,6009,RHEB,https://ctdbase.org/detail.go?type=gene&acc=6009,,,6009.0,RHEB,10141.0,Cavia porcellus (domestic guinea pig),Thioacetamide results in increased expression of RHEB mRNA,,,PMID:34492290,https://www.ncbi.nlm.nih.gov/pubmed/34492290,34492290,,
1448,1688499,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,151354,LRATD1,https://ctdbase.org/detail.go?type=gene&acc=151354,,,151354.0,LRATD1,10141.0,Cavia porcellus (domestic guinea pig),Thioacetamide results in increased expression of LRATD1 mRNA,,,PMID:34492290,https://www.ncbi.nlm.nih.gov/pubmed/34492290,34492290,,
1449,1688500,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,157638,LRATD2,https://ctdbase.org/detail.go?type=gene&acc=157638,,,157638.0,LRATD2,10141.0,Cavia porcellus (domestic guinea pig),Thioacetamide results in decreased expression of LRATD2 mRNA,,,PMID:34492290,https://www.ncbi.nlm.nih.gov/pubmed/34492290,34492290,,
1450,1688501,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,157638,LRATD2,https://ctdbase.org/detail.go?type=gene&acc=157638,,,157638.0,LRATD2,10116.0,Rattus norvegicus (Norway rat),Thioacetamide results in increased expression of LRATD2 mRNA,,,PMID:23411599|PMID:34492290,https://www.ncbi.nlm.nih.gov/pubmed/23411599|https://www.ncbi.nlm.nih.gov/pubmed/34492290,23411599|34492290,,
1451,1688502,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,23423,TMED3,https://ctdbase.org/detail.go?type=gene&acc=23423,,,23423.0,TMED3,10141.0,Cavia porcellus (domestic guinea pig),Thioacetamide results in decreased expression of TMED3 mRNA,,,PMID:34492290,https://www.ncbi.nlm.nih.gov/pubmed/34492290,34492290,,
1452,1688503,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,222068,TMED4,https://ctdbase.org/detail.go?type=gene&acc=222068,,,222068.0,TMED4,10141.0,Cavia porcellus (domestic guinea pig),Thioacetamide results in decreased expression of TMED4 mRNA,,,PMID:34492290,https://www.ncbi.nlm.nih.gov/pubmed/34492290,34492290,,
1453,1688504,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,50999,TMED5,https://ctdbase.org/detail.go?type=gene&acc=50999,,,50999.0,TMED5,10116.0,Rattus norvegicus (Norway rat),Thioacetamide results in increased expression of TMED5 mRNA,,,PMID:34492290,https://www.ncbi.nlm.nih.gov/pubmed/34492290,34492290,,
1454,1688505,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,146456,TMED6,https://ctdbase.org/detail.go?type=gene&acc=146456,,,146456.0,TMED6,10141.0,Cavia porcellus (domestic guinea pig),Thioacetamide results in decreased expression of TMED6 mRNA,,,PMID:34492290,https://www.ncbi.nlm.nih.gov/pubmed/34492290,34492290,,
1455,1688506,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,51014,TMED7,https://ctdbase.org/detail.go?type=gene&acc=51014,,,51014.0,TMED7,10116.0,Rattus norvegicus (Norway rat),Thioacetamide affects the expression of TMED7 mRNA,,,PMID:19483382,https://www.ncbi.nlm.nih.gov/pubmed/19483382,19483382,,
1456,1688586,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,8676,STX11,https://ctdbase.org/detail.go?type=gene&acc=8676,,,8676.0,STX11,10116.0,Rattus norvegicus (Norway rat),Thioacetamide results in increased expression of STX11 mRNA,,,PMID:34492290,https://www.ncbi.nlm.nih.gov/pubmed/34492290,34492290,,
1457,1688587,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,53407,STX18,https://ctdbase.org/detail.go?type=gene&acc=53407,,,53407.0,STX18,10116.0,Rattus norvegicus (Norway rat),Thioacetamide results in increased expression of STX18 mRNA,,,PMID:34492290,https://www.ncbi.nlm.nih.gov/pubmed/34492290,34492290,,
1458,1688588,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,112755,STX1B,https://ctdbase.org/detail.go?type=gene&acc=112755,,,112755.0,STX1B,10141.0,Cavia porcellus (domestic guinea pig),Thioacetamide results in decreased expression of STX1B mRNA,,,PMID:34492290,https://www.ncbi.nlm.nih.gov/pubmed/34492290,34492290,,
1459,1688672,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,116844,LRG1,https://ctdbase.org/detail.go?type=gene&acc=116844,,,116844.0,LRG1,10141.0,Cavia porcellus (domestic guinea pig),Thioacetamide results in decreased expression of LRG1 mrna|thioacetamide results in increased expression of LRG1 mRNA,,,PMID:34492290,https://www.ncbi.nlm.nih.gov/pubmed/34492290,34492290,,
1460,1688673,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,55791,LRIF1,https://ctdbase.org/detail.go?type=gene&acc=55791,,,55791.0,LRIF1,10116.0,Rattus norvegicus (Norway rat),Thioacetamide results in increased expression of LRIF1 mRNA,,,PMID:23411599,https://www.ncbi.nlm.nih.gov/pubmed/23411599,23411599,,
1461,1688674,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,26018,LRIG1,https://ctdbase.org/detail.go?type=gene&acc=26018,,,26018.0,LRIG1,10141.0,Cavia porcellus (domestic guinea pig),Thioacetamide results in decreased expression of LRIG1 mRNA,,,PMID:34492290,https://www.ncbi.nlm.nih.gov/pubmed/34492290,34492290,,
1462,1688675,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,9860,LRIG2,https://ctdbase.org/detail.go?type=gene&acc=9860,,,9860.0,LRIG2,10116.0,Rattus norvegicus (Norway rat),Thioacetamide results in increased expression of LRIG2 mRNA,,,PMID:34492290,https://www.ncbi.nlm.nih.gov/pubmed/34492290,34492290,,
1463,1688676,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,84314,TMEM107,https://ctdbase.org/detail.go?type=gene&acc=84314,,,84314.0,TMEM107,10141.0,Cavia porcellus (domestic guinea pig),Thioacetamide results in increased expression of TMEM107 mRNA,,,PMID:34492290,https://www.ncbi.nlm.nih.gov/pubmed/34492290,34492290,,
1464,1688677,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,66000,TMEM108,https://ctdbase.org/detail.go?type=gene&acc=66000,,,66000.0,TMEM108,10141.0,Cavia porcellus (domestic guinea pig),Thioacetamide results in decreased expression of TMEM108 mRNA,,,PMID:34492290,https://www.ncbi.nlm.nih.gov/pubmed/34492290,34492290,,
1465,1688678,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,66000,TMEM108,https://ctdbase.org/detail.go?type=gene&acc=66000,,,66000.0,TMEM108,7955.0,Danio rerio (zebrafish),Thioacetamide affects the expression of TMEM108 mRNA,,,PMID:25064622,https://www.ncbi.nlm.nih.gov/pubmed/25064622,25064622,,
1466,1688679,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,79073,TMEM109,https://ctdbase.org/detail.go?type=gene&acc=79073,,,79073.0,TMEM109,10116.0,Rattus norvegicus (Norway rat),Thioacetamide results in increased expression of TMEM109 mRNA,,,PMID:34492290,https://www.ncbi.nlm.nih.gov/pubmed/34492290,34492290,,
1467,1688866,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,121227,LRIG3,https://ctdbase.org/detail.go?type=gene&acc=121227,,,121227.0,LRIG3,10141.0,Cavia porcellus (domestic guinea pig),Thioacetamide results in increased expression of LRIG3 mRNA,,,PMID:34492290,https://www.ncbi.nlm.nih.gov/pubmed/34492290,34492290,,
1468,1688867,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,83938,LRMDA,https://ctdbase.org/detail.go?type=gene&acc=83938,,,83938.0,LRMDA,10141.0,Cavia porcellus (domestic guinea pig),Thioacetamide results in decreased expression of LRMDA mRNA,,,PMID:34492290,https://www.ncbi.nlm.nih.gov/pubmed/34492290,34492290,,
1469,1688868,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,4035,LRP1,https://ctdbase.org/detail.go?type=gene&acc=4035,,,4035.0,LRP1,10141.0,Cavia porcellus (domestic guinea pig),Thioacetamide results in decreased expression of LRP1 mRNA,,,PMID:34492290,https://www.ncbi.nlm.nih.gov/pubmed/34492290,34492290,,
1470,1688966,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,60561,RINT1,https://ctdbase.org/detail.go?type=gene&acc=60561,,,60561.0,RINT1,10141.0,Cavia porcellus (domestic guinea pig),Thioacetamide results in increased expression of RINT1 mRNA,,,PMID:34492290,https://www.ncbi.nlm.nih.gov/pubmed/34492290,34492290,,
1471,1688967,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,83732,RIOK1,https://ctdbase.org/detail.go?type=gene&acc=83732,,,83732.0,RIOK1,10141.0,Cavia porcellus (domestic guinea pig),Thioacetamide results in increased expression of RIOK1 mRNA,,,PMID:34492290,https://www.ncbi.nlm.nih.gov/pubmed/34492290,34492290,,
1472,1688968,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,55781,RIOK2,https://ctdbase.org/detail.go?type=gene&acc=55781,,,55781.0,RIOK2,10141.0,Cavia porcellus (domestic guinea pig),Thioacetamide results in increased expression of RIOK2 mRNA,,,PMID:34492290,https://www.ncbi.nlm.nih.gov/pubmed/34492290,34492290,,
1473,1688969,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,55781,RIOK2,https://ctdbase.org/detail.go?type=gene&acc=55781,,,55781.0,RIOK2,10116.0,Rattus norvegicus (Norway rat),Thioacetamide results in increased expression of RIOK2 mRNA,,,PMID:23411599|PMID:34492290,https://www.ncbi.nlm.nih.gov/pubmed/23411599|https://www.ncbi.nlm.nih.gov/pubmed/34492290,23411599|34492290,,
1474,1688970,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,8780,RIOK3,https://ctdbase.org/detail.go?type=gene&acc=8780,,,8780.0,RIOK3,7955.0,Danio rerio (zebrafish),Thioacetamide affects the expression of RIOK3 mRNA,,,PMID:25064622,https://www.ncbi.nlm.nih.gov/pubmed/25064622,25064622,,
1475,1688971,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,8780,RIOK3,https://ctdbase.org/detail.go?type=gene&acc=8780,,,8780.0,RIOK3,10116.0,Rattus norvegicus (Norway rat),Thioacetamide results in increased expression of RIOK3 mRNA,,,PMID:34492290,https://www.ncbi.nlm.nih.gov/pubmed/34492290,34492290,,
1476,1689334,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,285362,SUMF1,https://ctdbase.org/detail.go?type=gene&acc=285362,,,285362.0,SUMF1,7955.0,Danio rerio (zebrafish),Thioacetamide affects the expression of SUMF1 mRNA,,,PMID:25064622,https://www.ncbi.nlm.nih.gov/pubmed/25064622,25064622,,
1477,1689335,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,25870,SUMF2,https://ctdbase.org/detail.go?type=gene&acc=25870,,,25870.0,SUMF2,10116.0,Rattus norvegicus (Norway rat),Thioacetamide results in decreased expression of SUMF2 mRNA,,,PMID:34492290,https://www.ncbi.nlm.nih.gov/pubmed/34492290,34492290,,
1478,1689336,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,6613,SUMO2,https://ctdbase.org/detail.go?type=gene&acc=6613,,,6613.0,SUMO2,10116.0,Rattus norvegicus (Norway rat),Thioacetamide results in increased expression of SUMO2 mRNA,,,PMID:34492290,https://www.ncbi.nlm.nih.gov/pubmed/34492290,34492290,,
1479,1689337,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,387082,SUMO4,https://ctdbase.org/detail.go?type=gene&acc=387082,,,387082.0,SUMO4,10116.0,Rattus norvegicus (Norway rat),Thioacetamide results in increased expression of SUMO4 mRNA,,,PMID:34492290,https://www.ncbi.nlm.nih.gov/pubmed/34492290,34492290,,
1480,1689338,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,25777,SUN2,https://ctdbase.org/detail.go?type=gene&acc=25777,,,25777.0,SUN2,10116.0,Rattus norvegicus (Norway rat),Thioacetamide results in decreased expression of SUN2 mRNA,,,PMID:34492290,https://www.ncbi.nlm.nih.gov/pubmed/34492290,34492290,,
1481,1689339,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,6821,SUOX,https://ctdbase.org/detail.go?type=gene&acc=6821,,,6821.0,SUOX,10141.0,Cavia porcellus (domestic guinea pig),Thioacetamide results in decreased expression of SUOX mRNA,,,PMID:34492290,https://www.ncbi.nlm.nih.gov/pubmed/34492290,34492290,,
1482,1689340,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,8464,SUPT3H,https://ctdbase.org/detail.go?type=gene&acc=8464,,,8464.0,SUPT3H,10141.0,Cavia porcellus (domestic guinea pig),Thioacetamide results in decreased expression of SUPT3H mRNA,,,PMID:34492290,https://www.ncbi.nlm.nih.gov/pubmed/34492290,34492290,,
1483,1689341,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,6827,SUPT4H1,https://ctdbase.org/detail.go?type=gene&acc=6827,,,6827.0,SUPT4H1,10141.0,Cavia porcellus (domestic guinea pig),Thioacetamide results in increased expression of SUPT4H1 mRNA,,,PMID:34492290,https://www.ncbi.nlm.nih.gov/pubmed/34492290,34492290,,
1484,1689432,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,122651,RNASE11,https://ctdbase.org/detail.go?type=gene&acc=122651,,,122651.0,RNASE11,10116.0,Rattus norvegicus (Norway rat),Thioacetamide results in decreased expression of RNASE11 mRNA,,,PMID:23411599,https://www.ncbi.nlm.nih.gov/pubmed/23411599,23411599,,
1485,1689433,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,440163,RNASE13,https://ctdbase.org/detail.go?type=gene&acc=440163,,,440163.0,RNASE13,10116.0,Rattus norvegicus (Norway rat),Thioacetamide results in decreased expression of RNASE13 mRNA,,,PMID:23411599|PMID:34492290,https://www.ncbi.nlm.nih.gov/pubmed/23411599|https://www.ncbi.nlm.nih.gov/pubmed/34492290,23411599|34492290,,
1486,1689434,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,6036,RNASE2,https://ctdbase.org/detail.go?type=gene&acc=6036,,,6036.0,RNASE2,10116.0,Rattus norvegicus (Norway rat),Thioacetamide results in increased expression of RNASE2 mRNA,,,PMID:34492290,https://www.ncbi.nlm.nih.gov/pubmed/34492290,34492290,,
1487,1689435,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,6038,RNASE4,https://ctdbase.org/detail.go?type=gene&acc=6038,,,6038.0,RNASE4,10116.0,Rattus norvegicus (Norway rat),[diethylnitrosamine co-treated with thioacetamide] results in decreased expression of RNASE4 mRNA,,,PMID:28943392,https://www.ncbi.nlm.nih.gov/pubmed/28943392,28943392,,
1488,1689436,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,6038,RNASE4,https://ctdbase.org/detail.go?type=gene&acc=6038,,,6038.0,RNASE4,10116.0,Rattus norvegicus (Norway rat),Thioacetamide affects the expression of RNASE4 mRNA,,,PMID:19483382,https://www.ncbi.nlm.nih.gov/pubmed/19483382,19483382,,
1489,1689437,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,6038,RNASE4,https://ctdbase.org/detail.go?type=gene&acc=6038,,,6038.0,RNASE4,10116.0,Rattus norvegicus (Norway rat),Thioacetamide results in decreased expression of RNASE4 mRNA,,,PMID:23411599|PMID:34492290,https://www.ncbi.nlm.nih.gov/pubmed/23411599|https://www.ncbi.nlm.nih.gov/pubmed/34492290,23411599|34492290,,
1490,1690809,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,4920,ROR2,https://ctdbase.org/detail.go?type=gene&acc=4920,,,4920.0,ROR2,10116.0,Rattus norvegicus (Norway rat),Thioacetamide affects the methylation of ROR2 promoter,,,PMID:25151969,https://www.ncbi.nlm.nih.gov/pubmed/25151969,25151969,,
1491,1690810,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,6095,RORA,https://ctdbase.org/detail.go?type=gene&acc=6095,,,6095.0,RORA,10141.0,Cavia porcellus (domestic guinea pig),Thioacetamide results in increased expression of RORA mrna|thioacetamide results in decreased expression of RORA mRNA,,,PMID:34492290,https://www.ncbi.nlm.nih.gov/pubmed/34492290,34492290,,
1492,1690962,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,6895,TARBP2,https://ctdbase.org/detail.go?type=gene&acc=6895,,,6895.0,TARBP2,10141.0,Cavia porcellus (domestic guinea pig),Thioacetamide results in increased expression of TARBP2 mRNA,,,PMID:34492290,https://www.ncbi.nlm.nih.gov/pubmed/34492290,34492290,,
1493,1690963,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,23435,TARDBP,https://ctdbase.org/detail.go?type=gene&acc=23435,,,23435.0,TARDBP,10116.0,Rattus norvegicus (Norway rat),Thioacetamide results in increased expression of TARDBP mRNA,,,PMID:34492290,https://www.ncbi.nlm.nih.gov/pubmed/34492290,34492290,,
1494,1690964,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,6897,TARS1,https://ctdbase.org/detail.go?type=gene&acc=6897,,,6897.0,TARS1,10116.0,Rattus norvegicus (Norway rat),Thioacetamide results in increased expression of TARS1 mRNA,,,PMID:34492290,https://www.ncbi.nlm.nih.gov/pubmed/34492290,34492290,,
1495,1690965,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,80222,TARS2,https://ctdbase.org/detail.go?type=gene&acc=80222,,,80222.0,TARS2,10141.0,Cavia porcellus (domestic guinea pig),Thioacetamide results in decreased expression of TARS2 mRNA,,,PMID:34492290,https://www.ncbi.nlm.nih.gov/pubmed/34492290,34492290,,
1496,1690966,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,123283,TARS3,https://ctdbase.org/detail.go?type=gene&acc=123283,,,123283.0,TARS3,10141.0,Cavia porcellus (domestic guinea pig),Thioacetamide results in decreased expression of TARS3 mrna|thioacetamide results in increased expression of TARS3 mRNA,,,PMID:34492290,https://www.ncbi.nlm.nih.gov/pubmed/34492290,34492290,,
1497,1690967,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,80835,TAS1R1,https://ctdbase.org/detail.go?type=gene&acc=80835,,,80835.0,TAS1R1,10141.0,Cavia porcellus (domestic guinea pig),Thioacetamide results in decreased expression of TAS1R1 mrna|thioacetamide results in increased expression of TAS1R1 mRNA,,,PMID:34492290,https://www.ncbi.nlm.nih.gov/pubmed/34492290,34492290,,
1498,1691074,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,54968,TMEM70,https://ctdbase.org/detail.go?type=gene&acc=54968,,,54968.0,TMEM70,10116.0,Rattus norvegicus (Norway rat),[diethylnitrosamine co-treated with thioacetamide] results in decreased expression of TMEM70 protein,,,PMID:27914986|PMID:28903497,https://www.ncbi.nlm.nih.gov/pubmed/27914986|https://www.ncbi.nlm.nih.gov/pubmed/28903497,27914986|28903497,,
1499,1691075,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,54968,TMEM70,https://ctdbase.org/detail.go?type=gene&acc=54968,,,54968.0,TMEM70,10116.0,Rattus norvegicus (Norway rat),Thioacetamide results in decreased expression of TMEM70 mRNA,,,PMID:27914986|PMID:28903497|PMID:34492290,https://www.ncbi.nlm.nih.gov/pubmed/27914986|https://www.ncbi.nlm.nih.gov/pubmed/28903497|https://www.ncbi.nlm.nih.gov/pubmed/34492290,27914986|28903497|34492290,,
1500,1691076,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,54968,TMEM70,https://ctdbase.org/detail.go?type=gene&acc=54968,,,54968.0,TMEM70,10116.0,Rattus norvegicus (Norway rat),Thioacetamide results in increased methylation of TMEM70 promoter,,,PMID:27914986,https://www.ncbi.nlm.nih.gov/pubmed/27914986,27914986,,
1501,1691077,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,137835,TMEM71,https://ctdbase.org/detail.go?type=gene&acc=137835,,,137835.0,TMEM71,10116.0,Rattus norvegicus (Norway rat),Thioacetamide results in increased expression of TMEM71 mRNA,,,PMID:34492290,https://www.ncbi.nlm.nih.gov/pubmed/34492290,34492290,,
1502,1691078,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,157753,TMEM74,https://ctdbase.org/detail.go?type=gene&acc=157753,,,157753.0,TMEM74,10141.0,Cavia porcellus (domestic guinea pig),Thioacetamide results in increased expression of TMEM74 mRNA,,,PMID:34492290,https://www.ncbi.nlm.nih.gov/pubmed/34492290,34492290,,
1503,1691789,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,81542,TMX1,https://ctdbase.org/detail.go?type=gene&acc=81542,,,81542.0,TMX1,10116.0,Rattus norvegicus (Norway rat),Thioacetamide results in increased expression of TMX1 mRNA,,,PMID:23411599,https://www.ncbi.nlm.nih.gov/pubmed/23411599,23411599,,
1504,1691790,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,51075,TMX2,https://ctdbase.org/detail.go?type=gene&acc=51075,,,51075.0,TMX2,10116.0,Rattus norvegicus (Norway rat),Thioacetamide results in increased expression of TMX2 mRNA,,,PMID:34492290,https://www.ncbi.nlm.nih.gov/pubmed/34492290,34492290,,
1505,1691791,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,54495,TMX3,https://ctdbase.org/detail.go?type=gene&acc=54495,,,54495.0,TMX3,10141.0,Cavia porcellus (domestic guinea pig),Thioacetamide results in increased expression of TMX3 mRNA,,,PMID:34492290,https://www.ncbi.nlm.nih.gov/pubmed/34492290,34492290,,
1506,1691792,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,56255,TMX4,https://ctdbase.org/detail.go?type=gene&acc=56255,,,56255.0,TMX4,10116.0,Rattus norvegicus (Norway rat),Thioacetamide results in increased expression of TMX4 mRNA,,,PMID:34492290,https://www.ncbi.nlm.nih.gov/pubmed/34492290,34492290,,
1507,1691793,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,3371,TNC,https://ctdbase.org/detail.go?type=gene&acc=3371,,,3371.0,TNC,10141.0,Cavia porcellus (domestic guinea pig),Thioacetamide results in increased expression of TNC mRNA,,,PMID:34492290,https://www.ncbi.nlm.nih.gov/pubmed/34492290,34492290,,
1508,1691998,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,170082,TCEANC,https://ctdbase.org/detail.go?type=gene&acc=170082,,,170082.0,TCEANC,10141.0,Cavia porcellus (domestic guinea pig),Thioacetamide results in decreased expression of TCEANC mRNA,,,PMID:34492290,https://www.ncbi.nlm.nih.gov/pubmed/34492290,34492290,,
1509,1691999,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,10915,TCERG1,https://ctdbase.org/detail.go?type=gene&acc=10915,,,10915.0,TCERG1,10141.0,Cavia porcellus (domestic guinea pig),Thioacetamide results in increased expression of TCERG1 mRNA,,,PMID:34492290,https://www.ncbi.nlm.nih.gov/pubmed/34492290,34492290,,
1510,1692000,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,10915,TCERG1,https://ctdbase.org/detail.go?type=gene&acc=10915,,,10915.0,TCERG1,10116.0,Rattus norvegicus (Norway rat),Thioacetamide results in increased expression of TCERG1 mRNA,,,PMID:23411599|PMID:34492290,https://www.ncbi.nlm.nih.gov/pubmed/23411599|https://www.ncbi.nlm.nih.gov/pubmed/34492290,23411599|34492290,,
1511,1692350,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,10116.0,Rattus norvegicus (Norway rat),Thalidomide inhibits the reaction [thioacetamide results in increased expression of TNF mrna],,,PMID:15464241,https://www.ncbi.nlm.nih.gov/pubmed/15464241,15464241,,
1512,1692351,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,10116.0,Rattus norvegicus (Norway rat),Thioacetamide results in increased expression of TNF mRNA,,,PMID:15135310|PMID:15464241|PMID:17292413|PMID:34792689,https://www.ncbi.nlm.nih.gov/pubmed/15135310|https://www.ncbi.nlm.nih.gov/pubmed/15464241|https://www.ncbi.nlm.nih.gov/pubmed/17292413|https://www.ncbi.nlm.nih.gov/pubmed/34792689,15135310|15464241|17292413|34792689,,
1513,1692352,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,10116.0,Rattus norvegicus (Norway rat),Thioacetamide results in increased expression of TNF protein,,,PMID:12963478|PMID:19822164|PMID:22564261|PMID:28181416|PMID:29738702|PMID:30500344|PMID:30883860|PMID:32718261|PMID:33503444|PMID:34792689|PMID:35961375|PMID:37150287,https://www.ncbi.nlm.nih.gov/pubmed/12963478|https://www.ncbi.nlm.nih.gov/pubmed/19822164|https://www.ncbi.nlm.nih.gov/pubmed/22564261|https://www.ncbi.nlm.nih.gov/pubmed/28181416|https://www.ncbi.nlm.nih.gov/pubmed/29738702|https://www.ncbi.nlm.nih.gov/pubmed/30500344|https://www.ncbi.nlm.nih.gov/pubmed/30883860|https://www.ncbi.nlm.nih.gov/pubmed/32718261|https://www.ncbi.nlm.nih.gov/pubmed/33503444|https://www.ncbi.nlm.nih.gov/pubmed/34792689|https://www.ncbi.nlm.nih.gov/pubmed/35961375|https://www.ncbi.nlm.nih.gov/pubmed/37150287,12963478|19822164|22564261|28181416|29738702|30500344|30883860|32718261|33503444|34792689|35961375|37150287,,
1514,1692353,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,405785,TNFA,https://ctdbase.org/detail.go?type=gene&acc=405785,,,405785.0,tnfa,7955.0,Danio rerio (zebrafish),Thioacetamide results in decreased expression of TNFA mrna|quercetin inhibits the reaction [thioacetamide results in decreased expression of TNFA mrna],,,PMID:34227734,https://www.ncbi.nlm.nih.gov/pubmed/34227734,34227734,,
1515,1692354,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,7126,TNFAIP1,https://ctdbase.org/detail.go?type=gene&acc=7126,,,7126.0,TNFAIP1,10141.0,Cavia porcellus (domestic guinea pig),Thioacetamide results in increased expression of TNFAIP1 mRNA,,,PMID:34492290,https://www.ncbi.nlm.nih.gov/pubmed/34492290,34492290,,
1516,1692355,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,7127,TNFAIP2,https://ctdbase.org/detail.go?type=gene&acc=7127,,,7127.0,TNFAIP2,10141.0,Cavia porcellus (domestic guinea pig),Thioacetamide results in increased expression of TNFAIP2 mrna|thioacetamide affects the expression of TNFAIP2 mRNA,,,PMID:34492290,https://www.ncbi.nlm.nih.gov/pubmed/34492290,34492290,,
1517,1692356,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,27341,RRP7A,https://ctdbase.org/detail.go?type=gene&acc=27341,,,27341.0,RRP7A,10116.0,Rattus norvegicus (Norway rat),Thioacetamide results in increased expression of RRP7A mRNA,,,PMID:34492290,https://www.ncbi.nlm.nih.gov/pubmed/34492290,34492290,,
1518,1692357,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,23378,RRP8,https://ctdbase.org/detail.go?type=gene&acc=23378,,,23378.0,RRP8,10116.0,Rattus norvegicus (Norway rat),Thioacetamide results in increased expression of RRP8 mRNA,,,PMID:34492290,https://www.ncbi.nlm.nih.gov/pubmed/34492290,34492290,,
1519,1692437,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,6996,TDG,https://ctdbase.org/detail.go?type=gene&acc=6996,,,6996.0,TDG,10116.0,Rattus norvegicus (Norway rat),Thioacetamide results in increased expression of TDG mRNA,,,PMID:23411599,https://www.ncbi.nlm.nih.gov/pubmed/23411599,23411599,,
1520,1692438,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,6999,TDO2,https://ctdbase.org/detail.go?type=gene&acc=6999,,,6999.0,TDO2,10141.0,Cavia porcellus (domestic guinea pig),Thioacetamide results in decreased expression of TDO2 mRNA,,,PMID:34492290,https://www.ncbi.nlm.nih.gov/pubmed/34492290,34492290,,
1521,1692439,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,55775,TDP1,https://ctdbase.org/detail.go?type=gene&acc=55775,,,55775.0,TDP1,10141.0,Cavia porcellus (domestic guinea pig),Thioacetamide results in decreased expression of TDP1 mrna|thioacetamide results in increased expression of TDP1 mRNA,,,PMID:34492290,https://www.ncbi.nlm.nih.gov/pubmed/34492290,34492290,,
1522,1692440,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,51567,TDP2,https://ctdbase.org/detail.go?type=gene&acc=51567,,,51567.0,TDP2,10141.0,Cavia porcellus (domestic guinea pig),Thioacetamide results in increased expression of TDP2 mRNA,,,PMID:34492290,https://www.ncbi.nlm.nih.gov/pubmed/34492290,34492290,,
1523,1692441,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,81550,TDRD3,https://ctdbase.org/detail.go?type=gene&acc=81550,,,81550.0,TDRD3,10116.0,Rattus norvegicus (Norway rat),Thioacetamide results in increased expression of TDRD3 mRNA,,,PMID:34492290,https://www.ncbi.nlm.nih.gov/pubmed/34492290,34492290,,
1524,1692442,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,122402,TDRD9,https://ctdbase.org/detail.go?type=gene&acc=122402,,,122402.0,TDRD9,10141.0,Cavia porcellus (domestic guinea pig),Thioacetamide results in decreased expression of TDRD9 mRNA,,,PMID:34492290,https://www.ncbi.nlm.nih.gov/pubmed/34492290,34492290,,
1525,1692443,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,157695,TDRP,https://ctdbase.org/detail.go?type=gene&acc=157695,,,157695.0,TDRP,10141.0,Cavia porcellus (domestic guinea pig),Thioacetamide results in increased expression of TDRP mRNA,,,PMID:34492290,https://www.ncbi.nlm.nih.gov/pubmed/34492290,34492290,,
1526,1693126,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,29842,TFCP2L1,https://ctdbase.org/detail.go?type=gene&acc=29842,,,29842.0,TFCP2L1,10116.0,Rattus norvegicus (Norway rat),Thioacetamide results in increased expression of TFCP2L1 mRNA,,,PMID:23411599|PMID:34492290,https://www.ncbi.nlm.nih.gov/pubmed/23411599|https://www.ncbi.nlm.nih.gov/pubmed/34492290,23411599|34492290,,
1527,1693127,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,7027,TFDP1,https://ctdbase.org/detail.go?type=gene&acc=7027,,,7027.0,TFDP1,10141.0,Cavia porcellus (domestic guinea pig),Thioacetamide results in increased expression of TFDP1 mRNA,,,PMID:34492290,https://www.ncbi.nlm.nih.gov/pubmed/34492290,34492290,,
1528,1693128,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,7027,TFDP1,https://ctdbase.org/detail.go?type=gene&acc=7027,,,7027.0,TFDP1,9606.0,Homo sapiens (human),Thioacetamide results in decreased expression of TFDP1 mRNA,,,PMID:11793227,https://www.ncbi.nlm.nih.gov/pubmed/11793227,11793227,,
1529,1693129,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,7029,TFDP2,https://ctdbase.org/detail.go?type=gene&acc=7029,,,7029.0,TFDP2,10116.0,Rattus norvegicus (Norway rat),Thioacetamide results in decreased expression of TFDP2 mRNA,,,PMID:34492290,https://www.ncbi.nlm.nih.gov/pubmed/34492290,34492290,,
1530,1693130,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,7030,TFE3,https://ctdbase.org/detail.go?type=gene&acc=7030,,,7030.0,TFE3,10116.0,Rattus norvegicus (Norway rat),Thioacetamide results in increased expression of TFE3 mRNA,,,PMID:34492290,https://www.ncbi.nlm.nih.gov/pubmed/34492290,34492290,,
1531,1693131,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,22797,TFEC,https://ctdbase.org/detail.go?type=gene&acc=22797,,,22797.0,TFEC,10141.0,Cavia porcellus (domestic guinea pig),Thioacetamide results in increased expression of TFEC mRNA,,,PMID:34492290,https://www.ncbi.nlm.nih.gov/pubmed/34492290,34492290,,
1532,1693277,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,7137,TNNI3,https://ctdbase.org/detail.go?type=gene&acc=7137,,,7137.0,TNNI3,10116.0,Rattus norvegicus (Norway rat),Thioacetamide results in decreased expression of TNNI3 mRNA,,,PMID:34492290,https://www.ncbi.nlm.nih.gov/pubmed/34492290,34492290,,
1533,1693278,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,7138,TNNT1,https://ctdbase.org/detail.go?type=gene&acc=7138,,,7138.0,TNNT1,10116.0,Rattus norvegicus (Norway rat),Thioacetamide results in decreased expression of TNNT1 mRNA,,,PMID:23411599,https://www.ncbi.nlm.nih.gov/pubmed/23411599,23411599,,
1534,1693279,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,3842,TNPO1,https://ctdbase.org/detail.go?type=gene&acc=3842,,,3842.0,TNPO1,10116.0,Rattus norvegicus (Norway rat),Thioacetamide results in increased expression of TNPO1 mRNA,,,PMID:23411599|PMID:34492290,https://www.ncbi.nlm.nih.gov/pubmed/23411599|https://www.ncbi.nlm.nih.gov/pubmed/34492290,23411599|34492290,,
1535,1693280,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,84629,TNRC18,https://ctdbase.org/detail.go?type=gene&acc=84629,,,84629.0,TNRC18,10141.0,Cavia porcellus (domestic guinea pig),Thioacetamide results in decreased expression of TNRC18 mRNA,,,PMID:34492290,https://www.ncbi.nlm.nih.gov/pubmed/34492290,34492290,,
1536,1693281,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,27327,TNRC6A,https://ctdbase.org/detail.go?type=gene&acc=27327,,,27327.0,TNRC6A,10116.0,Rattus norvegicus (Norway rat),Thioacetamide results in increased expression of TNRC6A mRNA,,,PMID:34492290,https://www.ncbi.nlm.nih.gov/pubmed/34492290,34492290,,
1537,1693282,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,23112,TNRC6B,https://ctdbase.org/detail.go?type=gene&acc=23112,,,23112.0,TNRC6B,10116.0,Rattus norvegicus (Norway rat),Thioacetamide results in decreased expression of TNRC6B mRNA,,,PMID:34492290,https://www.ncbi.nlm.nih.gov/pubmed/34492290,34492290,,
1538,1693283,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,57690,TNRC6C,https://ctdbase.org/detail.go?type=gene&acc=57690,,,57690.0,TNRC6C,10141.0,Cavia porcellus (domestic guinea pig),Thioacetamide results in decreased expression of TNRC6C mRNA,,,PMID:34492290,https://www.ncbi.nlm.nih.gov/pubmed/34492290,34492290,,
1539,1693284,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,7145,TNS1,https://ctdbase.org/detail.go?type=gene&acc=7145,,,7145.0,TNS1,10141.0,Cavia porcellus (domestic guinea pig),Thioacetamide results in decreased expression of TNS1 mRNA,,,PMID:34492290,https://www.ncbi.nlm.nih.gov/pubmed/34492290,34492290,,
1540,1693582,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,7040,TGFB1,https://ctdbase.org/detail.go?type=gene&acc=7040,,,7040.0,TGFB1,10090.0,Mus musculus (house mouse),TGFB1 protein affects the susceptibility to thioacetamide,,,PMID:15075984,https://www.ncbi.nlm.nih.gov/pubmed/15075984,15075984,,
1541,1693583,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,7040,TGFB1,https://ctdbase.org/detail.go?type=gene&acc=7040,,,7040.0,TGFB1,10090.0,Mus musculus (house mouse),TGFBR1 protein promotes the reaction [thioacetamide results in increased expression of TGFB1 mrna],,,PMID:28560358,https://www.ncbi.nlm.nih.gov/pubmed/28560358,28560358,,
1542,1693584,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,7040,TGFB1,https://ctdbase.org/detail.go?type=gene&acc=7040,,,7040.0,TGFB1,10090.0,Mus musculus (house mouse),Thioacetamide results in increased expression of TGFB1 mRNA,,,PMID:12085344|PMID:16126171|PMID:16511523|PMID:18606216|PMID:22863721|PMID:23408952|PMID:28560358|PMID:30625377,https://www.ncbi.nlm.nih.gov/pubmed/12085344|https://www.ncbi.nlm.nih.gov/pubmed/16126171|https://www.ncbi.nlm.nih.gov/pubmed/16511523|https://www.ncbi.nlm.nih.gov/pubmed/18606216|https://www.ncbi.nlm.nih.gov/pubmed/22863721|https://www.ncbi.nlm.nih.gov/pubmed/23408952|https://www.ncbi.nlm.nih.gov/pubmed/28560358|https://www.ncbi.nlm.nih.gov/pubmed/30625377,12085344|16126171|16511523|18606216|22863721|23408952|28560358|30625377,,
1543,1693585,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,7040,TGFB1,https://ctdbase.org/detail.go?type=gene&acc=7040,,,7040.0,TGFB1,10090.0,Mus musculus (house mouse),Thioacetamide results in increased expression of TGFB1 protein,,,PMID:21969711|PMID:23408952|PMID:28623179|PMID:30625377|PMID:32721574,https://www.ncbi.nlm.nih.gov/pubmed/21969711|https://www.ncbi.nlm.nih.gov/pubmed/23408952|https://www.ncbi.nlm.nih.gov/pubmed/28623179|https://www.ncbi.nlm.nih.gov/pubmed/30625377|https://www.ncbi.nlm.nih.gov/pubmed/32721574,21969711|23408952|28623179|30625377|32721574,,
1544,1693586,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,7040,TGFB1,https://ctdbase.org/detail.go?type=gene&acc=7040,,,7040.0,TGFB1,10116.0,Rattus norvegicus (Norway rat),AM 1241 inhibits the reaction [thioacetamide results in increased expression of TGFB1 mrna]|silymarin inhibits the reaction [thioacetamide results in increased expression of TGFB1 mrna],,,PMID:33503444,https://www.ncbi.nlm.nih.gov/pubmed/33503444,33503444,,
1545,1693694,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,7153,TOP2A,https://ctdbase.org/detail.go?type=gene&acc=7153,,,7153.0,TOP2A,10116.0,Rattus norvegicus (Norway rat),Thioacetamide results in increased expression of TOP2A protein,,,PMID:22659510|PMID:26011634|PMID:26558467,https://www.ncbi.nlm.nih.gov/pubmed/22659510|https://www.ncbi.nlm.nih.gov/pubmed/26011634|https://www.ncbi.nlm.nih.gov/pubmed/26558467,22659510|26011634|26558467,,
1546,1693695,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,619560,RUP2,https://ctdbase.org/detail.go?type=gene&acc=619560,,,619560.0,Rup2,10116.0,Rattus norvegicus (Norway rat),[diethylnitrosamine co-treated with thioacetamide] results in decreased expression of RUP2 mRNA,,,PMID:28943392,https://www.ncbi.nlm.nih.gov/pubmed/28943392,28943392,,
1547,1693696,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,619560,RUP2,https://ctdbase.org/detail.go?type=gene&acc=619560,,,619560.0,Rup2,10116.0,Rattus norvegicus (Norway rat),Thioacetamide results in decreased expression of RUP2 mRNA,,,PMID:23411599|PMID:34492290,https://www.ncbi.nlm.nih.gov/pubmed/23411599|https://www.ncbi.nlm.nih.gov/pubmed/34492290,23411599|34492290,,
1548,1693697,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,23623,RUSC1,https://ctdbase.org/detail.go?type=gene&acc=23623,,,23623.0,RUSC1,10116.0,Rattus norvegicus (Norway rat),Thioacetamide results in decreased expression of RUSC1 mRNA,,,PMID:34492290,https://www.ncbi.nlm.nih.gov/pubmed/34492290,34492290,,
1549,1693698,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,9853,RUSC2,https://ctdbase.org/detail.go?type=gene&acc=9853,,,9853.0,RUSC2,10116.0,Rattus norvegicus (Norway rat),Thioacetamide results in decreased expression of RUSC2 mRNA,,,PMID:34492290,https://www.ncbi.nlm.nih.gov/pubmed/34492290,34492290,,
1550,1693699,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,64755,RUSF1,https://ctdbase.org/detail.go?type=gene&acc=64755,,,64755.0,RUSF1,10141.0,Cavia porcellus (domestic guinea pig),Thioacetamide results in decreased expression of RUSF1 mRNA,,,PMID:34492290,https://www.ncbi.nlm.nih.gov/pubmed/34492290,34492290,,
1551,1693700,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,8607,RUVBL1,https://ctdbase.org/detail.go?type=gene&acc=8607,,,8607.0,RUVBL1,10141.0,Cavia porcellus (domestic guinea pig),Thioacetamide results in increased expression of RUVBL1 mRNA,,,PMID:34492290,https://www.ncbi.nlm.nih.gov/pubmed/34492290,34492290,,
1552,1693701,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,8607,RUVBL1,https://ctdbase.org/detail.go?type=gene&acc=8607,,,8607.0,RUVBL1,10116.0,Rattus norvegicus (Norway rat),Thioacetamide results in increased expression of RUVBL1 mRNA,,,PMID:23411599,https://www.ncbi.nlm.nih.gov/pubmed/23411599,23411599,,
1553,1694026,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,27324,TOX3,https://ctdbase.org/detail.go?type=gene&acc=27324,,,27324.0,TOX3,10141.0,Cavia porcellus (domestic guinea pig),Thioacetamide results in increased expression of TOX3 mRNA,,,PMID:34492290,https://www.ncbi.nlm.nih.gov/pubmed/34492290,34492290,,
1554,1694027,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,27324,TOX3,https://ctdbase.org/detail.go?type=gene&acc=27324,,,27324.0,TOX3,10116.0,Rattus norvegicus (Norway rat),Thioacetamide results in increased expression of TOX3 mRNA,,,PMID:23411599,https://www.ncbi.nlm.nih.gov/pubmed/23411599,23411599,,
1555,1694028,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,7157,TP53,https://ctdbase.org/detail.go?type=gene&acc=7157,,,7157.0,TP53,10141.0,Cavia porcellus (domestic guinea pig),Thioacetamide results in increased expression of TP53 mRNA,,,PMID:34492290,https://www.ncbi.nlm.nih.gov/pubmed/34492290,34492290,,
1556,1694029,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,7157,TP53,https://ctdbase.org/detail.go?type=gene&acc=7157,,,7157.0,TP53,7955.0,Danio rerio (zebrafish),Thioacetamide results in increased expression of TP53 protein|quercetin inhibits the reaction [thioacetamide results in increased expression of TP53 protein],,,PMID:34227734,https://www.ncbi.nlm.nih.gov/pubmed/34227734,34227734,,
1557,1694030,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,7157,TP53,https://ctdbase.org/detail.go?type=gene&acc=7157,,,7157.0,TP53,7955.0,Danio rerio (zebrafish),Thioacetamide results in increased expression of TP53 mRNA,,,PMID:17997003,https://www.ncbi.nlm.nih.gov/pubmed/17997003,17997003,,
1558,1694031,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,7157,TP53,https://ctdbase.org/detail.go?type=gene&acc=7157,,,7157.0,TP53,10116.0,Rattus norvegicus (Norway rat),Thioacetamide results in increased expression of and results in increased phosphorylation of and results in increased activity of TP53 protein,,,PMID:16937528,https://www.ncbi.nlm.nih.gov/pubmed/16937528,16937528,,
1559,1690210,2724251,Toxin and Toxin Target Database (T3DB),Prussian blue,T3D1684,Ferric hexacyanoferrate,http://www.t3db.ca/toxins/T3D1684,BE0003990,Cytochrome c oxidase subunit 6C,http://www.t3db.ca/biodb/bio_entities/BE0003990,P09669,Cytochrome c oxidase subunit 6C,1345.0,COX6C,9606.0,Homo sapiens (human),"Cyanide is an inhibitor of cytochrome c oxidase in the fourth complex of the electron transport chain (found in the membrane of the mitochondria of eukaryotic cells). it complexes with the ferric iron atom in this enzyme. the binding of cyanide to this cytochrome prevents transport of electrons from cytochrome c oxidase to oxygen. as a result, the electron transport chain is disrupted and the cell can no longer aerobically produce ATP for energy. tissues that mainly depend on aerobic respiration, such as the central nervous system and the heart, are particularly affected. (L97)",,,,,,,
1560,1690211,2724251,Toxin and Toxin Target Database (T3DB),Prussian blue,T3D1684,Ferric hexacyanoferrate,http://www.t3db.ca/toxins/T3D1684,BE0003996,"Cytochrome c oxidase subunit 7A1, mitochondrial",http://www.t3db.ca/biodb/bio_entities/BE0003996,P24310,"Cytochrome c oxidase subunit 7A1, mitochondrial",1346.0,COX7A1,9606.0,Homo sapiens (human),"Cyanide is an inhibitor of cytochrome c oxidase in the fourth complex of the electron transport chain (found in the membrane of the mitochondria of eukaryotic cells). it complexes with the ferric iron atom in this enzyme. the binding of cyanide to this cytochrome prevents transport of electrons from cytochrome c oxidase to oxygen. as a result, the electron transport chain is disrupted and the cell can no longer aerobically produce ATP for energy. tissues that mainly depend on aerobic respiration, such as the central nervous system and the heart, are particularly affected. (L97)",,,,,,,
1561,1687601,2724507,Toxin and Toxin Target Database (T3DB),Triphenylthioantimonate,T3D1896,Triphenylthioantimonate,http://www.t3db.ca/toxins/T3D1896,BE0000814,Glutathione S-transferase P,http://www.t3db.ca/biodb/bio_entities/BE0000814,P09211,Glutathione S-transferase P,2950.0,GSTP1,9606.0,Homo sapiens (human),"Trivalent antimony inhibits glutathione-S-transferases from human erythrocytes, reducing their detoxification ability. (L137)",,,,,,,
1562,1687602,2724507,Toxin and Toxin Target Database (T3DB),Triphenylthioantimonate,T3D1896,Triphenylthioantimonate,http://www.t3db.ca/toxins/T3D1896,BE0000808,Glutathione S-transferase kappa 1,http://www.t3db.ca/biodb/bio_entities/BE0000808,Q9Y2Q3,Glutathione S-transferase kappa 1,373156.0,GSTK1,9606.0,Homo sapiens (human),"Trivalent antimony inhibits glutathione-S-transferases from human erythrocytes, reducing their detoxification ability. (L137)",,,,,,,
1563,1687603,2724507,Toxin and Toxin Target Database (T3DB),Triphenylthioantimonate,T3D1896,Triphenylthioantimonate,http://www.t3db.ca/toxins/T3D1896,BE0000815,Glutathione S-transferase omega-1,http://www.t3db.ca/biodb/bio_entities/BE0000815,P78417,Glutathione S-transferase omega-1,9446.0,GSTO1,9606.0,Homo sapiens (human),"Trivalent antimony inhibits glutathione-S-transferases from human erythrocytes, reducing their detoxification ability. (L137)",,,,,,,
1564,1687604,2724507,Toxin and Toxin Target Database (T3DB),Triphenylthioantimonate,T3D1896,Triphenylthioantimonate,http://www.t3db.ca/toxins/T3D1896,BE0002291,Glutathione S-transferase omega-2,http://www.t3db.ca/biodb/bio_entities/BE0002291,Q9H4Y5,Glutathione S-transferase omega-2,119391.0,GSTO2,9606.0,Homo sapiens (human),"Trivalent antimony inhibits glutathione-S-transferases from human erythrocytes, reducing their detoxification ability. (L137)",,,,,,,
1565,1687605,2724507,Toxin and Toxin Target Database (T3DB),Triphenylthioantimonate,T3D1896,Triphenylthioantimonate,http://www.t3db.ca/toxins/T3D1896,BE0000818,Glutathione S-transferase theta-1,http://www.t3db.ca/biodb/bio_entities/BE0000818,P30711,Glutathione S-transferase theta-1,2952.0,GSTT1,9606.0,Homo sapiens (human),"Trivalent antimony inhibits glutathione-S-transferases from human erythrocytes, reducing their detoxification ability. (L137)",,,,,,,
1566,1687606,2724507,Toxin and Toxin Target Database (T3DB),Triphenylthioantimonate,T3D1896,Triphenylthioantimonate,http://www.t3db.ca/toxins/T3D1896,BE0004541,Glutathione S-transferase theta-2,http://www.t3db.ca/biodb/bio_entities/BE0004541,P0CG29,Glutathione S-transferase theta-2,2953.0,GSTT2,9606.0,Homo sapiens (human),"Trivalent antimony inhibits glutathione-S-transferases from human erythrocytes, reducing their detoxification ability. (L137)",,,,,,,
1567,1687607,2724507,Toxin and Toxin Target Database (T3DB),Triphenylthioantimonate,T3D1896,Triphenylthioantimonate,http://www.t3db.ca/toxins/T3D1896,BE0000819,Maleylacetoacetate isomerase,http://www.t3db.ca/biodb/bio_entities/BE0000819,O43708,Maleylacetoacetate isomerase,2954.0,GSTZ1,9606.0,Homo sapiens (human),"Trivalent antimony inhibits glutathione-S-transferases from human erythrocytes, reducing their detoxification ability. (L137)",,,,,,,
1568,1687608,2724507,Toxin and Toxin Target Database (T3DB),Triphenylthioantimonate,T3D1896,Triphenylthioantimonate,http://www.t3db.ca/toxins/T3D1896,BE0002282,Microsomal glutathione S-transferase 1,http://www.t3db.ca/biodb/bio_entities/BE0002282,P10620,Microsomal glutathione S-transferase 1,4257.0,MGST1,9606.0,Homo sapiens (human),"Trivalent antimony inhibits glutathione-S-transferases from human erythrocytes, reducing their detoxification ability. (L137)",,,,,,,
1569,1691786,2733526,Drug Gene Interaction database (DGIdb),Tamoxifen,,TAMOXIFEN,https://www.dgidb.org/drugs/rxcui:10324,,FMO3,https://www.dgidb.org/genes/hgnc:3771,,,2328.0,FMO3,9606.0,Homo sapiens (human),,,,,,,,
1570,1691787,2733526,Drug Gene Interaction database (DGIdb),Tamoxifen,,TAMOXIFEN,https://www.dgidb.org/drugs/rxcui:10324,,RRAS2,https://www.dgidb.org/genes/hgnc:17271,,,22800.0,RRAS2,9606.0,Homo sapiens (human),,,,,,,,
1571,1691788,2733526,Drug Gene Interaction database (DGIdb),Tamoxifen,,TAMOXIFEN,https://www.dgidb.org/drugs/rxcui:10324,,ABCB1,https://www.dgidb.org/genes/hgnc:40,,,5243.0,ABCB1,9606.0,Homo sapiens (human),,,,,,,,
1572,1690885,2825690,Comparative Toxicogenomics Database (CTD),3-Nitrobenzanthrone,C117220,3-nitrobenzanthrone,https://ctdbase.org/detail.go?type=chem&acc=C117220,8644,AKR1C3,https://ctdbase.org/detail.go?type=gene&acc=8644,,,8644.0,AKR1C3,9606.0,Homo sapiens (human),AKR1C3 protein results in increased reduction of 3-nitrobenzanthrone|[akr1c3 protein results in increased reduction of 3-nitrobenzanthrone] which results in increased chemical synthesis of 3-aminobenzanthrone|[akr1c3 protein results in increased reduction of 3-nitrobenzanthrone] which results in increased chemical synthesis of N-hydroxy-3-aminobenzanthrone,,,PMID:30406992,https://www.ncbi.nlm.nih.gov/pubmed/30406992,30406992,,
1573,1690886,2825690,Comparative Toxicogenomics Database (CTD),3-Nitrobenzanthrone,C117220,3-nitrobenzanthrone,https://ctdbase.org/detail.go?type=chem&acc=C117220,207,AKT1,https://ctdbase.org/detail.go?type=gene&acc=207,,,207.0,AKT1,9606.0,Homo sapiens (human),3-nitrobenzanthrone results in increased expression of and results in increased phosphorylation of AKT1 protein|ereg protein affects the reaction [3-nitrobenzanthrone results in increased phosphorylation of AKT1 protein],,,PMID:34036453,https://www.ncbi.nlm.nih.gov/pubmed/34036453,34036453,,
1574,1690887,2825690,Comparative Toxicogenomics Database (CTD),3-Nitrobenzanthrone,C117220,3-nitrobenzanthrone,https://ctdbase.org/detail.go?type=chem&acc=C117220,283,ANG,https://ctdbase.org/detail.go?type=gene&acc=283,,,283.0,ANG,9606.0,Homo sapiens (human),3-nitrobenzanthrone results in decreased expression of ANG mRNA,,,PMID:34036453,https://www.ncbi.nlm.nih.gov/pubmed/34036453,34036453,,
1575,1690888,2825690,Comparative Toxicogenomics Database (CTD),3-Nitrobenzanthrone,C117220,3-nitrobenzanthrone,https://ctdbase.org/detail.go?type=chem&acc=C117220,348,APOE,https://ctdbase.org/detail.go?type=gene&acc=348,,,348.0,APOE,9606.0,Homo sapiens (human),3-nitrobenzanthrone results in increased expression of APOE mRNA,,,PMID:34036453,https://www.ncbi.nlm.nih.gov/pubmed/34036453,34036453,,
1576,1693925,2859122,Drug Gene Interaction database (DGIdb),"3-Ethyl-2-[3-(1,3,3-trimethyl-1,3-dihydro-2H-indol-2-ylidene)-1-propen-1-yl]-1,3-benzothiazol-3-ium",,CHEMBL:CHEMBL601364,https://www.dgidb.org/drugs/chembl:CHEMBL601364,,ATAD5,https://www.dgidb.org/genes/hgnc:25752,,,79915.0,ATAD5,9606.0,Homo sapiens (human),,,,,,,,
1577,1693926,2859122,Drug Gene Interaction database (DGIdb),"3-Ethyl-2-[3-(1,3,3-trimethyl-1,3-dihydro-2H-indol-2-ylidene)-1-propen-1-yl]-1,3-benzothiazol-3-ium",,CHEMBL:CHEMBL601364,https://www.dgidb.org/drugs/chembl:CHEMBL601364,,MPHOSPH8,https://www.dgidb.org/genes/hgnc:29810,,,54737.0,MPHOSPH8,9606.0,Homo sapiens (human),,,,,,,,
1578,1693927,2859221,Drug Gene Interaction database (DGIdb),"3-[(2,4-Dimethoxyphenyl)amino]-5-phenyl-2-cyclohexen-1-one",,CHEMBL:CHEMBL582675,https://www.dgidb.org/drugs/chembl:CHEMBL582675,,APOBEC3F,https://www.dgidb.org/genes/hgnc:17356,,,200316.0,APOBEC3F,9606.0,Homo sapiens (human),,,,,,,,
1579,1693928,2864836,IUPHAR/BPS Guide to PHARMACOLOGY,4-(4-Benzhydrylpiperazin-1-yl)-1-methyl-3-nitroquinolin-2-one,13007,BMS-684,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=13007,3256,diacylglycerol kinase alpha,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3256,P23743,Diacylglycerol kinase alpha,,,9606.0,Homo sapiens (human),Inhibition,pIC50,7.82,PMID:37465293,https://www.ncbi.nlm.nih.gov/pubmed/37465293,37465293,,
1580,1693929,2865236,Drug Gene Interaction database (DGIdb),"11-(2-Fluorophenyl)-11,11a-dihydroindeno[2,1-c][1,5]benzothiazepin-12-one",,CHEMBL:CHEMBL606167,https://www.dgidb.org/drugs/chembl:CHEMBL606167,,KDM4A,https://www.dgidb.org/genes/hgnc:22978,,,9682.0,KDM4A,9606.0,Homo sapiens (human),,,,,,,,
1581,1693930,2865851,Drug Gene Interaction database (DGIdb),"11-(3-Fluorophenyl)-11,11a-dihydroindeno[2,1-c][1,5]benzothiazepin-12-one",,CHEMBL:CHEMBL586000,https://www.dgidb.org/drugs/chembl:CHEMBL586000,,MAPT,https://www.dgidb.org/genes/hgnc:6893,,,4137.0,MAPT,9606.0,Homo sapiens (human),,,,,,,,
1582,1693931,2873568,Drug Gene Interaction database (DGIdb),"1-Phenyl-3-p-tolyl-6,7-dihydro-5H-imidazo[2,1-b][1,3]thiazin-1-ium",,CHEMBL:CHEMBL582073,https://www.dgidb.org/drugs/chembl:CHEMBL582073,,NFE2L2,https://www.dgidb.org/genes/hgnc:7782,,,4780.0,NFE2L2,9606.0,Homo sapiens (human),,,,,,,,
1583,1693932,2874943,IUPHAR/BPS Guide to PHARMACOLOGY,N-{2-Furan-2-yl-1-[(pyridin-3-ylmethyl)-carbamoyl]-vinyl}-benzamide,8517,IS1,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=8517,335,PKR1,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=335,Q8TCW9,Prokineticin receptor 1,10887.0,PROKR1,9606.0,Homo sapiens (human),Agonist,pEC50,5.6,PMID:25831128,https://www.ncbi.nlm.nih.gov/pubmed/25831128,25831128,,
1584,1693446,3001028,Therapeutic Target Database (TTD),Estrone sulfate,D04AXP,[3H]estrone-3-sulphate,https://idrblab.net/ttd/data/drug/details/D04AXP,T00569,Sodium-independent organic anion transporter (SLCO1A2),https://idrblab.net/ttd/data/target/details/T00569,P46721,Solute carrier organic anion transporter family member 1A2,6579.0,SLCO1A2,9606.0,Homo sapiens (human),Modulator,,,,,,,
1585,1693447,3001028,Therapeutic Target Database (TTD),Estrone sulfate,D04AXP,[3H]estrone-3-sulphate,https://idrblab.net/ttd/data/drug/details/D04AXP,T99255,Organic anion transporter D (SLCO3A1),https://idrblab.net/ttd/data/target/details/T99255,Q9UIG8,Solute carrier organic anion transporter family member 3A1,28232.0,SLCO3A1,9606.0,Homo sapiens (human),Modulator,,,,,,,
1586,1693448,3001028,Therapeutic Target Database (TTD),Estrone sulfate,D04AXP,[3H]estrone-3-sulphate,https://idrblab.net/ttd/data/drug/details/D04AXP,T97322,Organic anion transporter E (SLCO4A1),https://idrblab.net/ttd/data/target/details/T97322,Q96BD0,Solute carrier organic anion transporter family member 4A1,28231.0,SLCO4A1,9606.0,Homo sapiens (human),Modulator,,,,,,,
1587,1693449,3001028,Therapeutic Target Database (TTD),Estrone sulfate,D04AXP,[3H]estrone-3-sulphate,https://idrblab.net/ttd/data/drug/details/D04AXP,T34064,Organic anion transporter B (SLCO2B1),https://idrblab.net/ttd/data/target/details/T34064,O94956,Solute carrier organic anion transporter family member 2B1 ,11309.0,SLCO2B1,9606.0,Homo sapiens (human),Modulator,,,,,,,
1588,1693450,3001028,Therapeutic Target Database (TTD),Estrone sulfate,D04AXP,[3H]estrone-3-sulphate,https://idrblab.net/ttd/data/drug/details/D04AXP,T46814,Liver organic anion transporter 1 (SLCO1B1),https://idrblab.net/ttd/data/target/details/T46814,Q9Y6L6,Solute carrier organic anion transporter family member 1B1,10599.0,SLCO1B1,9606.0,Homo sapiens (human),Modulator,,,,,,,
1589,1693451,3002977,Drug Gene Interaction database (DGIdb),Maraviroc,,MARAVIROC,https://www.dgidb.org/drugs/rxcui:620216,,CCR5,https://www.dgidb.org/genes/hgnc:1606,,,1234.0,CCR5,9606.0,Homo sapiens (human),,,,,,,,
1590,1693452,3004085,Therapeutic Target Database (TTD),"1,4-dimethoxy-10H-acridine-9-thione",D0VD8B,NSC-625987,https://idrblab.net/ttd/data/drug/details/D0VD8B,T85799,Cyclin-dependent kinase 4 (CDK4),https://idrblab.net/ttd/data/target/details/T85799,P11802,Cyclin-dependent kinase 4,1019.0,CDK4,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
1591,1693453,3004085,Therapeutic Target Database (TTD),"1,4-dimethoxy-10H-acridine-9-thione",D0VD8B,NSC-625987,https://idrblab.net/ttd/data/drug/details/D0VD8B,T70176,Cyclin-dependent kinase 2 (CDK2),https://idrblab.net/ttd/data/target/details/T70176,P24941,Cyclin-dependent kinase 2,1017.0,CDK2,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
1592,1687501,3007984,Comparative Toxicogenomics Database (CTD),"(3S,6R,9S,12R,15S,18R)-3,9,15-tribenzyl-4,10,16-trimethyl-6,12,18-tri(propan-2-yl)-1,7,13-trioxa-4,10,16-triazacyclooctadecane-2,5,8,11,14,17-hexone",C004456,beauvericin,https://ctdbase.org/detail.go?type=chem&acc=C004456,205,AK4,https://ctdbase.org/detail.go?type=gene&acc=205,,,205.0,AK4,9606.0,Homo sapiens (human),[beauvericin co-treated with enniatins] results in decreased expression of AK4 mRNA,,,PMID:31100301,https://www.ncbi.nlm.nih.gov/pubmed/31100301,31100301,,
1593,1687809,3007984,Comparative Toxicogenomics Database (CTD),"(3S,6R,9S,12R,15S,18R)-3,9,15-tribenzyl-4,10,16-trimethyl-6,12,18-tri(propan-2-yl)-1,7,13-trioxa-4,10,16-triazacyclooctadecane-2,5,8,11,14,17-hexone",C004456,beauvericin,https://ctdbase.org/detail.go?type=chem&acc=C004456,515,ATP5PB,https://ctdbase.org/detail.go?type=gene&acc=515,,,515.0,ATP5PB,9606.0,Homo sapiens (human),[beauvericin co-treated with enniatins] results in decreased expression of ATP5PB protein,,,PMID:32407736,https://www.ncbi.nlm.nih.gov/pubmed/32407736,32407736,,
1594,1687810,3007984,Comparative Toxicogenomics Database (CTD),"(3S,6R,9S,12R,15S,18R)-3,9,15-tribenzyl-4,10,16-trimethyl-6,12,18-tri(propan-2-yl)-1,7,13-trioxa-4,10,16-triazacyclooctadecane-2,5,8,11,14,17-hexone",C004456,beauvericin,https://ctdbase.org/detail.go?type=chem&acc=C004456,522,ATP5PF,https://ctdbase.org/detail.go?type=gene&acc=522,,,522.0,ATP5PF,9606.0,Homo sapiens (human),[beauvericin co-treated with enniatins] results in decreased expression of ATP5PF protein,,,PMID:32407736,https://www.ncbi.nlm.nih.gov/pubmed/32407736,32407736,,
1595,1687811,3007984,Comparative Toxicogenomics Database (CTD),"(3S,6R,9S,12R,15S,18R)-3,9,15-tribenzyl-4,10,16-trimethyl-6,12,18-tri(propan-2-yl)-1,7,13-trioxa-4,10,16-triazacyclooctadecane-2,5,8,11,14,17-hexone",C004456,beauvericin,https://ctdbase.org/detail.go?type=chem&acc=C004456,4508,ATP6,https://ctdbase.org/detail.go?type=gene&acc=4508,,,4508.0,ATP6,9606.0,Homo sapiens (human),[plant extracts co-treated with ochratoxin A co-treated with zearalenone co-treated with beauvericin] results in decreased expression of ATP6 mrna|[plant extracts co-treated with beauvericin] results in decreased expression of ATP6 mrna|[beauvericin co-treated with enniatins] results in decreased expression of ATP6 mrna|[beauvericin co-treated with enniatins co-treated with ochratoxin A] results in increased expression of ATP6 mrna|[plant extracts co-treated with beauvericin co-treated with enniatins] results in decreased expression of ATP6 mRNA,,,PMID:34015425,https://www.ncbi.nlm.nih.gov/pubmed/34015425,34015425,,
1596,1687812,3007984,Comparative Toxicogenomics Database (CTD),"(3S,6R,9S,12R,15S,18R)-3,9,15-tribenzyl-4,10,16-trimethyl-6,12,18-tri(propan-2-yl)-1,7,13-trioxa-4,10,16-triazacyclooctadecane-2,5,8,11,14,17-hexone",C004456,beauvericin,https://ctdbase.org/detail.go?type=chem&acc=C004456,4508,ATP6,https://ctdbase.org/detail.go?type=gene&acc=4508,,,4508.0,ATP6,9606.0,Homo sapiens (human),[beauvericin co-treated with enniatins] results in increased expression of ATP6 mRNA,,,PMID:31100301,https://www.ncbi.nlm.nih.gov/pubmed/31100301,31100301,,
1597,1687813,3007984,Comparative Toxicogenomics Database (CTD),"(3S,6R,9S,12R,15S,18R)-3,9,15-tribenzyl-4,10,16-trimethyl-6,12,18-tri(propan-2-yl)-1,7,13-trioxa-4,10,16-triazacyclooctadecane-2,5,8,11,14,17-hexone",C004456,beauvericin,https://ctdbase.org/detail.go?type=chem&acc=C004456,4508,ATP6,https://ctdbase.org/detail.go?type=gene&acc=4508,,,4508.0,ATP6,9606.0,Homo sapiens (human),Beauvericin results in decreased expression of ATP6 mRNA,,,PMID:29203277|PMID:31100301|PMID:34015425,https://www.ncbi.nlm.nih.gov/pubmed/29203277|https://www.ncbi.nlm.nih.gov/pubmed/31100301|https://www.ncbi.nlm.nih.gov/pubmed/34015425,29203277|31100301|34015425,,
1598,1688972,3007984,Comparative Toxicogenomics Database (CTD),"(3S,6R,9S,12R,15S,18R)-3,9,15-tribenzyl-4,10,16-trimethyl-6,12,18-tri(propan-2-yl)-1,7,13-trioxa-4,10,16-triazacyclooctadecane-2,5,8,11,14,17-hexone",C004456,beauvericin,https://ctdbase.org/detail.go?type=chem&acc=C004456,79363,CPLANE2,https://ctdbase.org/detail.go?type=gene&acc=79363,,,79363.0,CPLANE2,9606.0,Homo sapiens (human),[beauvericin co-treated with enniatins] results in increased expression of CPLANE2 protein,,,PMID:32407736,https://www.ncbi.nlm.nih.gov/pubmed/32407736,32407736,,
1599,1688973,3007984,Comparative Toxicogenomics Database (CTD),"(3S,6R,9S,12R,15S,18R)-3,9,15-tribenzyl-4,10,16-trimethyl-6,12,18-tri(propan-2-yl)-1,7,13-trioxa-4,10,16-triazacyclooctadecane-2,5,8,11,14,17-hexone",C004456,beauvericin,https://ctdbase.org/detail.go?type=chem&acc=C004456,8904,CPNE1,https://ctdbase.org/detail.go?type=gene&acc=8904,,,8904.0,CPNE1,9606.0,Homo sapiens (human),Beauvericin results in decreased expression of CPNE1 mRNA,,,PMID:29203277,https://www.ncbi.nlm.nih.gov/pubmed/29203277,29203277,,
1600,1689438,3007984,Comparative Toxicogenomics Database (CTD),"(3S,6R,9S,12R,15S,18R)-3,9,15-tribenzyl-4,10,16-trimethyl-6,12,18-tri(propan-2-yl)-1,7,13-trioxa-4,10,16-triazacyclooctadecane-2,5,8,11,14,17-hexone",C004456,beauvericin,https://ctdbase.org/detail.go?type=chem&acc=C004456,2936,GSR,https://ctdbase.org/detail.go?type=gene&acc=2936,,,2936.0,GSR,10029.0,Cricetulus griseus (Chinese hamster),Acetylcysteine inhibits the reaction [beauvericin results in decreased activity of GSR protein]|beauvericin results in decreased activity of GSR protein,,,PMID:24613870,https://www.ncbi.nlm.nih.gov/pubmed/24613870,24613870,,
1601,1689439,3007984,Comparative Toxicogenomics Database (CTD),"(3S,6R,9S,12R,15S,18R)-3,9,15-tribenzyl-4,10,16-trimethyl-6,12,18-tri(propan-2-yl)-1,7,13-trioxa-4,10,16-triazacyclooctadecane-2,5,8,11,14,17-hexone",C004456,beauvericin,https://ctdbase.org/detail.go?type=chem&acc=C004456,3074,HEXB,https://ctdbase.org/detail.go?type=gene&acc=3074,,,3074.0,HEXB,9606.0,Homo sapiens (human),[beauvericin co-treated with enniatins] results in decreased expression of HEXB protein,,,PMID:32407736,https://www.ncbi.nlm.nih.gov/pubmed/32407736,32407736,,
1602,1689854,3007984,Comparative Toxicogenomics Database (CTD),"(3S,6R,9S,12R,15S,18R)-3,9,15-tribenzyl-4,10,16-trimethyl-6,12,18-tri(propan-2-yl)-1,7,13-trioxa-4,10,16-triazacyclooctadecane-2,5,8,11,14,17-hexone",C004456,beauvericin,https://ctdbase.org/detail.go?type=chem&acc=C004456,51350,KRT76,https://ctdbase.org/detail.go?type=gene&acc=51350,,,51350.0,KRT76,9606.0,Homo sapiens (human),[beauvericin co-treated with enniatins] results in decreased expression of KRT76 protein,,,PMID:32407736,https://www.ncbi.nlm.nih.gov/pubmed/32407736,32407736,,
1603,1689855,3007984,Comparative Toxicogenomics Database (CTD),"(3S,6R,9S,12R,15S,18R)-3,9,15-tribenzyl-4,10,16-trimethyl-6,12,18-tri(propan-2-yl)-1,7,13-trioxa-4,10,16-triazacyclooctadecane-2,5,8,11,14,17-hexone",C004456,beauvericin,https://ctdbase.org/detail.go?type=chem&acc=C004456,3920,LAMP2,https://ctdbase.org/detail.go?type=gene&acc=3920,,,3920.0,LAMP2,9606.0,Homo sapiens (human),[beauvericin co-treated with enniatins] results in decreased expression of LAMP2 protein,,,PMID:32407736,https://www.ncbi.nlm.nih.gov/pubmed/32407736,32407736,,
1604,1689856,3007984,Comparative Toxicogenomics Database (CTD),"(3S,6R,9S,12R,15S,18R)-3,9,15-tribenzyl-4,10,16-trimethyl-6,12,18-tri(propan-2-yl)-1,7,13-trioxa-4,10,16-triazacyclooctadecane-2,5,8,11,14,17-hexone",C004456,beauvericin,https://ctdbase.org/detail.go?type=chem&acc=C004456,27040,LAT,https://ctdbase.org/detail.go?type=gene&acc=27040,,,27040.0,LAT,9606.0,Homo sapiens (human),Beauvericin results in decreased expression of LAT mRNA,,,PMID:29203277,https://www.ncbi.nlm.nih.gov/pubmed/29203277,29203277,,
1605,1689857,3007984,Comparative Toxicogenomics Database (CTD),"(3S,6R,9S,12R,15S,18R)-3,9,15-tribenzyl-4,10,16-trimethyl-6,12,18-tri(propan-2-yl)-1,7,13-trioxa-4,10,16-triazacyclooctadecane-2,5,8,11,14,17-hexone",C004456,beauvericin,https://ctdbase.org/detail.go?type=chem&acc=C004456,56891,LGALS14,https://ctdbase.org/detail.go?type=gene&acc=56891,,,56891.0,LGALS14,9606.0,Homo sapiens (human),[beauvericin co-treated with enniatins] results in increased expression of LGALS14 protein,,,PMID:32407736,https://www.ncbi.nlm.nih.gov/pubmed/32407736,32407736,,
1606,1689858,3007984,Comparative Toxicogenomics Database (CTD),"(3S,6R,9S,12R,15S,18R)-3,9,15-tribenzyl-4,10,16-trimethyl-6,12,18-tri(propan-2-yl)-1,7,13-trioxa-4,10,16-triazacyclooctadecane-2,5,8,11,14,17-hexone",C004456,beauvericin,https://ctdbase.org/detail.go?type=chem&acc=C004456,5594,MAPK1,https://ctdbase.org/detail.go?type=gene&acc=5594,,,5594.0,MAPK1,10116.0,Rattus norvegicus (Norway rat),Beauvericin results in decreased phosphorylation of MAPK1 protein,,,PMID:25178661,https://www.ncbi.nlm.nih.gov/pubmed/25178661,25178661,,
1607,1689859,3007984,Comparative Toxicogenomics Database (CTD),"(3S,6R,9S,12R,15S,18R)-3,9,15-tribenzyl-4,10,16-trimethyl-6,12,18-tri(propan-2-yl)-1,7,13-trioxa-4,10,16-triazacyclooctadecane-2,5,8,11,14,17-hexone",C004456,beauvericin,https://ctdbase.org/detail.go?type=chem&acc=C004456,5595,MAPK3,https://ctdbase.org/detail.go?type=gene&acc=5595,,,5595.0,MAPK3,10116.0,Rattus norvegicus (Norway rat),Beauvericin results in decreased phosphorylation of MAPK3 protein,,,PMID:25178661,https://www.ncbi.nlm.nih.gov/pubmed/25178661,25178661,,
1608,1690204,3007984,Comparative Toxicogenomics Database (CTD),"(3S,6R,9S,12R,15S,18R)-3,9,15-tribenzyl-4,10,16-trimethyl-6,12,18-tri(propan-2-yl)-1,7,13-trioxa-4,10,16-triazacyclooctadecane-2,5,8,11,14,17-hexone",C004456,beauvericin,https://ctdbase.org/detail.go?type=chem&acc=C004456,4536,ND2,https://ctdbase.org/detail.go?type=gene&acc=4536,,,4536.0,ND2,9606.0,Homo sapiens (human),Beauvericin results in increased expression of ND2 mrna|[beauvericin co-treated with enniatins] results in increased expression of ND2 mrna|[plant extracts co-treated with beauvericin co-treated with enniatins] results in increased expression of ND2 mrna|[beauvericin co-treated with enniatins co-treated with ochratoxin A] results in increased expression of ND2 mrna|[plant extracts co-treated with ochratoxin A co-treated with zearalenone co-treated with beauvericin] results in increased expression of ND2 mrna|[plant extracts co-treated with beauvericin] results in increased expression of ND2 mRNA,,,PMID:34015425,https://www.ncbi.nlm.nih.gov/pubmed/34015425,34015425,,
1609,1690205,3007984,Comparative Toxicogenomics Database (CTD),"(3S,6R,9S,12R,15S,18R)-3,9,15-tribenzyl-4,10,16-trimethyl-6,12,18-tri(propan-2-yl)-1,7,13-trioxa-4,10,16-triazacyclooctadecane-2,5,8,11,14,17-hexone",C004456,beauvericin,https://ctdbase.org/detail.go?type=chem&acc=C004456,4536,ND2,https://ctdbase.org/detail.go?type=gene&acc=4536,,,4536.0,ND2,9606.0,Homo sapiens (human),[beauvericin co-treated with enniatins] results in decreased expression of ND2 mRNA,,,PMID:31100301,https://www.ncbi.nlm.nih.gov/pubmed/31100301,31100301,,
1610,1690206,3007984,Comparative Toxicogenomics Database (CTD),"(3S,6R,9S,12R,15S,18R)-3,9,15-tribenzyl-4,10,16-trimethyl-6,12,18-tri(propan-2-yl)-1,7,13-trioxa-4,10,16-triazacyclooctadecane-2,5,8,11,14,17-hexone",C004456,beauvericin,https://ctdbase.org/detail.go?type=chem&acc=C004456,4536,ND2,https://ctdbase.org/detail.go?type=gene&acc=4536,,,4536.0,ND2,9606.0,Homo sapiens (human),Beauvericin results in decreased expression of ND2 mRNA,,,PMID:29203277|PMID:31100301,https://www.ncbi.nlm.nih.gov/pubmed/29203277|https://www.ncbi.nlm.nih.gov/pubmed/31100301,29203277|31100301,,
1611,1690207,3007984,Comparative Toxicogenomics Database (CTD),"(3S,6R,9S,12R,15S,18R)-3,9,15-tribenzyl-4,10,16-trimethyl-6,12,18-tri(propan-2-yl)-1,7,13-trioxa-4,10,16-triazacyclooctadecane-2,5,8,11,14,17-hexone",C004456,beauvericin,https://ctdbase.org/detail.go?type=chem&acc=C004456,4537,ND3,https://ctdbase.org/detail.go?type=gene&acc=4537,,,4537.0,ND3,9606.0,Homo sapiens (human),[plant extracts co-treated with beauvericin co-treated with enniatins] results in increased expression of ND3 mrna|[beauvericin co-treated with enniatins] results in decreased expression of ND3 mrna|[beauvericin co-treated with enniatins co-treated with ochratoxin A] results in increased expression of ND3 mrna|beauvericin results in increased expression of ND3 mrna|[plant extracts co-treated with ochratoxin A co-treated with zearalenone co-treated with beauvericin] results in increased expression of ND3 mrna|[plant extracts co-treated with beauvericin] results in increased expression of ND3 mRNA,,,PMID:34015425,https://www.ncbi.nlm.nih.gov/pubmed/34015425,34015425,,
1612,1690208,3007984,Comparative Toxicogenomics Database (CTD),"(3S,6R,9S,12R,15S,18R)-3,9,15-tribenzyl-4,10,16-trimethyl-6,12,18-tri(propan-2-yl)-1,7,13-trioxa-4,10,16-triazacyclooctadecane-2,5,8,11,14,17-hexone",C004456,beauvericin,https://ctdbase.org/detail.go?type=chem&acc=C004456,4537,ND3,https://ctdbase.org/detail.go?type=gene&acc=4537,,,4537.0,ND3,9606.0,Homo sapiens (human),[beauvericin co-treated with enniatins] results in increased expression of ND3 mRNA,,,PMID:31100301,https://www.ncbi.nlm.nih.gov/pubmed/31100301,31100301,,
1613,1690209,3007984,Comparative Toxicogenomics Database (CTD),"(3S,6R,9S,12R,15S,18R)-3,9,15-tribenzyl-4,10,16-trimethyl-6,12,18-tri(propan-2-yl)-1,7,13-trioxa-4,10,16-triazacyclooctadecane-2,5,8,11,14,17-hexone",C004456,beauvericin,https://ctdbase.org/detail.go?type=chem&acc=C004456,4537,ND3,https://ctdbase.org/detail.go?type=gene&acc=4537,,,4537.0,ND3,9606.0,Homo sapiens (human),Beauvericin results in decreased expression of ND3 mRNA,,,PMID:29203277|PMID:31100301,https://www.ncbi.nlm.nih.gov/pubmed/29203277|https://www.ncbi.nlm.nih.gov/pubmed/31100301,29203277|31100301,,
1614,1690811,3007984,Comparative Toxicogenomics Database (CTD),"(3S,6R,9S,12R,15S,18R)-3,9,15-tribenzyl-4,10,16-trimethyl-6,12,18-tri(propan-2-yl)-1,7,13-trioxa-4,10,16-triazacyclooctadecane-2,5,8,11,14,17-hexone",C004456,beauvericin,https://ctdbase.org/detail.go?type=chem&acc=C004456,5074,PAWR,https://ctdbase.org/detail.go?type=gene&acc=5074,,,5074.0,PAWR,9606.0,Homo sapiens (human),Beauvericin results in decreased expression of PAWR mRNA,,,PMID:29203277,https://www.ncbi.nlm.nih.gov/pubmed/29203277,29203277,,
1615,1690812,3007984,Comparative Toxicogenomics Database (CTD),"(3S,6R,9S,12R,15S,18R)-3,9,15-tribenzyl-4,10,16-trimethyl-6,12,18-tri(propan-2-yl)-1,7,13-trioxa-4,10,16-triazacyclooctadecane-2,5,8,11,14,17-hexone",C004456,beauvericin,https://ctdbase.org/detail.go?type=chem&acc=C004456,22984,PDCD11,https://ctdbase.org/detail.go?type=gene&acc=22984,,,22984.0,PDCD11,9606.0,Homo sapiens (human),Beauvericin results in decreased expression of PDCD11 mRNA,,,PMID:29203277,https://www.ncbi.nlm.nih.gov/pubmed/29203277,29203277,,
1616,1690813,3007984,Comparative Toxicogenomics Database (CTD),"(3S,6R,9S,12R,15S,18R)-3,9,15-tribenzyl-4,10,16-trimethyl-6,12,18-tri(propan-2-yl)-1,7,13-trioxa-4,10,16-triazacyclooctadecane-2,5,8,11,14,17-hexone",C004456,beauvericin,https://ctdbase.org/detail.go?type=chem&acc=C004456,5134,PDCD2,https://ctdbase.org/detail.go?type=gene&acc=5134,,,5134.0,PDCD2,9606.0,Homo sapiens (human),Beauvericin results in decreased expression of PDCD2 mRNA,,,PMID:29203277,https://www.ncbi.nlm.nih.gov/pubmed/29203277,29203277,,
1617,1690814,3007984,Comparative Toxicogenomics Database (CTD),"(3S,6R,9S,12R,15S,18R)-3,9,15-tribenzyl-4,10,16-trimethyl-6,12,18-tri(propan-2-yl)-1,7,13-trioxa-4,10,16-triazacyclooctadecane-2,5,8,11,14,17-hexone",C004456,beauvericin,https://ctdbase.org/detail.go?type=chem&acc=C004456,84306,PDCD2L,https://ctdbase.org/detail.go?type=gene&acc=84306,,,84306.0,PDCD2L,9606.0,Homo sapiens (human),Beauvericin results in increased expression of PDCD2L mRNA,,,PMID:29203277,https://www.ncbi.nlm.nih.gov/pubmed/29203277,29203277,,
1618,1690815,3007984,Comparative Toxicogenomics Database (CTD),"(3S,6R,9S,12R,15S,18R)-3,9,15-tribenzyl-4,10,16-trimethyl-6,12,18-tri(propan-2-yl)-1,7,13-trioxa-4,10,16-triazacyclooctadecane-2,5,8,11,14,17-hexone",C004456,beauvericin,https://ctdbase.org/detail.go?type=chem&acc=C004456,27250,PDCD4,https://ctdbase.org/detail.go?type=gene&acc=27250,,,27250.0,PDCD4,9606.0,Homo sapiens (human),Beauvericin results in decreased expression of PDCD4 mRNA,,,PMID:29203277,https://www.ncbi.nlm.nih.gov/pubmed/29203277,29203277,,
1619,1690816,3007984,Comparative Toxicogenomics Database (CTD),"(3S,6R,9S,12R,15S,18R)-3,9,15-tribenzyl-4,10,16-trimethyl-6,12,18-tri(propan-2-yl)-1,7,13-trioxa-4,10,16-triazacyclooctadecane-2,5,8,11,14,17-hexone",C004456,beauvericin,https://ctdbase.org/detail.go?type=chem&acc=C004456,9141,PDCD5,https://ctdbase.org/detail.go?type=gene&acc=9141,,,9141.0,PDCD5,9606.0,Homo sapiens (human),Beauvericin results in increased expression of PDCD5 mRNA,,,PMID:29203277,https://www.ncbi.nlm.nih.gov/pubmed/29203277,29203277,,
1620,1692235,3007984,Comparative Toxicogenomics Database (CTD),"(3S,6R,9S,12R,15S,18R)-3,9,15-tribenzyl-4,10,16-trimethyl-6,12,18-tri(propan-2-yl)-1,7,13-trioxa-4,10,16-triazacyclooctadecane-2,5,8,11,14,17-hexone",C004456,beauvericin,https://ctdbase.org/detail.go?type=chem&acc=C004456,10383,TUBB4B,https://ctdbase.org/detail.go?type=gene&acc=10383,,,10383.0,TUBB4B,9606.0,Homo sapiens (human),[beauvericin co-treated with enniatins] results in increased expression of TUBB4B protein,,,PMID:32407736,https://www.ncbi.nlm.nih.gov/pubmed/32407736,32407736,,
1621,1692236,3007984,Comparative Toxicogenomics Database (CTD),"(3S,6R,9S,12R,15S,18R)-3,9,15-tribenzyl-4,10,16-trimethyl-6,12,18-tri(propan-2-yl)-1,7,13-trioxa-4,10,16-triazacyclooctadecane-2,5,8,11,14,17-hexone",C004456,beauvericin,https://ctdbase.org/detail.go?type=chem&acc=C004456,10628,TXNIP,https://ctdbase.org/detail.go?type=gene&acc=10628,,,10628.0,TXNIP,9606.0,Homo sapiens (human),[beauvericin co-treated with enniatins co-treated with ochratoxin A] results in increased expression of TXNIP mrna|[plant extracts co-treated with beauvericin co-treated with enniatins] results in increased expression of TXNIP mrna|beauvericin results in decreased expression of TXNIP mrna|[plant extracts co-treated with beauvericin] results in increased expression of TXNIP mRNA,,,PMID:34015425,https://www.ncbi.nlm.nih.gov/pubmed/34015425,34015425,,
1622,1692237,3007984,Comparative Toxicogenomics Database (CTD),"(3S,6R,9S,12R,15S,18R)-3,9,15-tribenzyl-4,10,16-trimethyl-6,12,18-tri(propan-2-yl)-1,7,13-trioxa-4,10,16-triazacyclooctadecane-2,5,8,11,14,17-hexone",C004456,beauvericin,https://ctdbase.org/detail.go?type=chem&acc=C004456,10628,TXNIP,https://ctdbase.org/detail.go?type=gene&acc=10628,,,10628.0,TXNIP,9606.0,Homo sapiens (human),Beauvericin results in increased expression of TXNIP mRNA,,,PMID:29203277,https://www.ncbi.nlm.nih.gov/pubmed/29203277,29203277,,
1623,1692238,3008304,IUPHAR/BPS Guide to PHARMACOLOGY,"1-(4-Bromobenzyl)indole-2,3-dione",7632,VU0119498,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7632,17,M5 receptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=17,P08912,Muscarinic acetylcholine receptor M5,1133.0,CHRM5,9606.0,Homo sapiens (human),Positive,pEC50,5.4,PMID:19438238,https://www.ncbi.nlm.nih.gov/pubmed/19438238,19438238,,
1624,1692239,3008897,Drug Gene Interaction database (DGIdb),Censavudine,,CENSAVUDINE,https://www.dgidb.org/drugs/ncit:C166942,,ERVW-4,https://www.dgidb.org/genes/hgnc:39043,,,100616496.0,ERVW-4,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
1625,1692240,3009355,Drug Gene Interaction database (DGIdb),Vicriviroc,,VICRIVIROC,https://www.dgidb.org/drugs/ncit:C73589,,CCR5,https://www.dgidb.org/genes/hgnc:1606,,,1234.0,CCR5,9606.0,Homo sapiens (human),,,,,,,,
1626,1692241,3013845,Therapeutic Target Database (TTD),Nocardimicin A,D09YBC,NOCARDIMICIN A,https://idrblab.net/ttd/data/drug/details/D09YBC,T67684,Muscarinic acetylcholine receptor M3 (CHRM3),https://idrblab.net/ttd/data/target/details/T67684,P20309,Muscarinic acetylcholine receptor M3,1131.0,CHRM3,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
1627,1692242,3013846,Therapeutic Target Database (TTD),nocardimicin B,D02EXX,GNF-PF-5618,https://idrblab.net/ttd/data/drug/details/D02EXX,T28893,Muscarinic acetylcholine receptor M1 (CHRM1),https://idrblab.net/ttd/data/target/details/T28893,P11229,Muscarinic acetylcholine receptor M1,1128.0,CHRM1,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
1628,1694164,3018598,BindingDB,Sulmepride,10889,2-methoxy-N-[(1-methylpyrrolidin-2-yl)methyl]-5-sulfamoylbenzamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10889,4167,Carbonic anhydrase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=4167,,,,,,,,Ki (nM),812,PMID:19450983|DOI:10.1016/j.bmc.2009.05.002,https://www.ncbi.nlm.nih.gov/pubmed/19450983|https://doi.org/10.1016/j.bmc.2009.05.002,19450983,10.1016/j.bmc.2009.05.002,
1629,1694165,3018598,BindingDB,Sulmepride,10889,2-methoxy-N-[(1-methylpyrrolidin-2-yl)methyl]-5-sulfamoylbenzamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10889,4166,Carbonic anhydrase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=4166,Q5AJ71,Carbonic anhydrase,3636621.0,NCE103,237561.0,Candida albicans SC5314,,Ki (nM),760,PMID:19450983|DOI:10.1016/j.bmc.2009.05.002,https://www.ncbi.nlm.nih.gov/pubmed/19450983|https://doi.org/10.1016/j.bmc.2009.05.002,19450983,10.1016/j.bmc.2009.05.002,
1630,1694166,3025961,Comparative Toxicogenomics Database (CTD),2-Methyl-6-(phenylethynyl)pyridine,C121465,6-methyl-2-(phenylethynyl)pyridine,https://ctdbase.org/detail.go?type=chem&acc=C121465,2081,ERN1,https://ctdbase.org/detail.go?type=gene&acc=2081,,,2081.0,ERN1,10116.0,Rattus norvegicus (Norway rat),6-methyl-2-(phenylethynyl)pyridine inhibits the reaction [cocaine results in increased expression of ERN1 protein],,,PMID:17303341,https://www.ncbi.nlm.nih.gov/pubmed/17303341,17303341,,
1631,1694167,3025961,Comparative Toxicogenomics Database (CTD),2-Methyl-6-(phenylethynyl)pyridine,C121465,6-methyl-2-(phenylethynyl)pyridine,https://ctdbase.org/detail.go?type=chem&acc=C121465,2332,FMR1,https://ctdbase.org/detail.go?type=gene&acc=2332,,,2332.0,FMR1,10090.0,Mus musculus (house mouse),FMR1 gene mutant form promotes the reaction [6-methyl-2-(phenylethynyl)pyridine binds to GRM5 protein],,,PMID:20393458,https://www.ncbi.nlm.nih.gov/pubmed/20393458,20393458,,
1632,1693207,3032552,Comparative Toxicogenomics Database (CTD),Nitrogen Dioxide,D009585,Nitrogen Dioxide,https://ctdbase.org/detail.go?type=chem&acc=D009585,781,CACNA2D1,https://ctdbase.org/detail.go?type=gene&acc=781,,,781.0,CACNA2D1,9606.0,Homo sapiens (human),[air pollutants results in increased abundance of nitrogen dioxide] which results in decreased methylation of CACNA2D1 gene,,,PMID:28843141,https://www.ncbi.nlm.nih.gov/pubmed/28843141,28843141,,
1633,1693208,3032552,Comparative Toxicogenomics Database (CTD),Nitrogen Dioxide,D009585,Nitrogen Dioxide,https://ctdbase.org/detail.go?type=chem&acc=D009585,796,CALCA,https://ctdbase.org/detail.go?type=gene&acc=796,,,796.0,CALCA,10140.0,Cavia (guinea pigs),Nitrogen dioxide results in decreased expression of CALCA protein,,,PMID:8880101,https://www.ncbi.nlm.nih.gov/pubmed/8880101,8880101,,
1634,1693209,3032552,Comparative Toxicogenomics Database (CTD),Nitrogen Dioxide,D009585,Nitrogen Dioxide,https://ctdbase.org/detail.go?type=chem&acc=D009585,823,CAPN1,https://ctdbase.org/detail.go?type=gene&acc=823,,,823.0,CAPN1,9823.0,Sus scrofa (pig),Nitrogen dioxide results in decreased expression of CAPN1 mRNA,,,PMID:9728040,https://www.ncbi.nlm.nih.gov/pubmed/9728040,9728040,,
1635,1693210,3032552,Comparative Toxicogenomics Database (CTD),Nitrogen Dioxide,D009585,Nitrogen Dioxide,https://ctdbase.org/detail.go?type=chem&acc=D009585,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,9606.0,Homo sapiens (human),[vehicle emissions results in increased abundance of nitrogen dioxide] which results in decreased expression of CAT mrna|[air pollutants results in increased abundance of nitrogen dioxide] which results in decreased expression of CAT mrna|[air pollutants results in increased abundance of nitrogen dioxide] which results in increased methylation of CAT gene|[vehicle emissions results in increased abundance of nitrogen dioxide] which results in increased methylation of CAT gene,,,PMID:27448387,https://www.ncbi.nlm.nih.gov/pubmed/27448387,27448387,,
1636,1693211,3032552,Comparative Toxicogenomics Database (CTD),Nitrogen Dioxide,D009585,Nitrogen Dioxide,https://ctdbase.org/detail.go?type=chem&acc=D009585,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,10090.0,Mus musculus (house mouse),CAT protein inhibits the reaction [nitrogen dioxide results in decreased expression of CCND1 mrna],,,PMID:12600834,https://www.ncbi.nlm.nih.gov/pubmed/12600834,12600834,,
1637,1693212,3032552,Comparative Toxicogenomics Database (CTD),Nitrogen Dioxide,D009585,Nitrogen Dioxide,https://ctdbase.org/detail.go?type=chem&acc=D009585,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,10116.0,Rattus norvegicus (Norway rat),Nitrogen dioxide results in increased expression of CAT mRNA,,,PMID:15336314,https://www.ncbi.nlm.nih.gov/pubmed/15336314,15336314,,
1638,1693213,3032552,Comparative Toxicogenomics Database (CTD),Nitrogen Dioxide,D009585,Nitrogen Dioxide,https://ctdbase.org/detail.go?type=chem&acc=D009585,6356,CCL11,https://ctdbase.org/detail.go?type=gene&acc=6356,,,6356.0,CCL11,10090.0,Mus musculus (house mouse),Nitrogen dioxide results in increased expression of CCL11 mRNA,,,PMID:10715624,https://www.ncbi.nlm.nih.gov/pubmed/10715624,10715624,,
1639,1693809,3032552,Comparative Toxicogenomics Database (CTD),Nitrogen Dioxide,D009585,Nitrogen Dioxide,https://ctdbase.org/detail.go?type=chem&acc=D009585,2353,FOS,https://ctdbase.org/detail.go?type=gene&acc=2353,,,2353.0,FOS,10116.0,Rattus norvegicus (Norway rat),Nitrogen dioxide results in increased expression of FOS protein,,,PMID:22621880,https://www.ncbi.nlm.nih.gov/pubmed/22621880,22621880,,
1640,1693810,3032552,Comparative Toxicogenomics Database (CTD),Nitrogen Dioxide,D009585,Nitrogen Dioxide,https://ctdbase.org/detail.go?type=chem&acc=D009585,2305,FOXM1,https://ctdbase.org/detail.go?type=gene&acc=2305,,,2305.0,FOXM1,9606.0,Homo sapiens (human),Nitrogen dioxide results in increased expression of FOXM1 mRNA,,,PMID:27206323,https://www.ncbi.nlm.nih.gov/pubmed/27206323,27206323,,
1641,1693811,3032552,Comparative Toxicogenomics Database (CTD),Nitrogen Dioxide,D009585,Nitrogen Dioxide,https://ctdbase.org/detail.go?type=chem&acc=D009585,50943,FOXP3,https://ctdbase.org/detail.go?type=gene&acc=50943,,,50943.0,FOXP3,9606.0,Homo sapiens (human),[air pollutants results in increased abundance of nitrogen dioxide] which results in increased methylation of FOXP3 promoter,,,PMID:29317916,https://www.ncbi.nlm.nih.gov/pubmed/29317916,29317916,,
1642,1693812,3032552,Comparative Toxicogenomics Database (CTD),Nitrogen Dioxide,D009585,Nitrogen Dioxide,https://ctdbase.org/detail.go?type=chem&acc=D009585,2730,GCLM,https://ctdbase.org/detail.go?type=gene&acc=2730,,,2730.0,GCLM,10116.0,Rattus norvegicus (Norway rat),Nitrogen dioxide results in decreased expression of GCLM mRNA,,,PMID:16049373,https://www.ncbi.nlm.nih.gov/pubmed/16049373,16049373,,
1643,1694312,3033637,DrugBank,Nizax,DB00585,Nizatidine,https://www.drugbank.ca/drugs/DB00585,BE0002180,Cholinesterase,https://www.drugbank.ca/bio_entities/BE0002180,P06276,Cholinesterase,590.0,BCHE,9606.0,Homo sapiens (human),Inhibitor,,,PMID:8095733,https://www.ncbi.nlm.nih.gov/pubmed/8095733,8095733,,
1644,1694313,3033637,DrugBank,Nizax,DB00585,Nizatidine,https://www.drugbank.ca/drugs/DB00585,BE0001032,Multidrug resistance protein 1,https://www.drugbank.ca/bio_entities/BE0001032,P08183,ATP-dependent translocase ABCB1,5243.0,ABCB1,9606.0,Homo sapiens (human),Substrate,,,PMID:19319690,https://www.ncbi.nlm.nih.gov/pubmed/19319690,19319690,,
1645,1694314,3033767,Comparative Toxicogenomics Database (CTD),Droloxifene,C038345,droloxifene,https://ctdbase.org/detail.go?type=chem&acc=C038345,1576,CYP3A4,https://ctdbase.org/detail.go?type=gene&acc=1576,,,1576.0,CYP3A4,9606.0,Homo sapiens (human),Droloxifene results in decreased activity of CYP3A4 protein,,,PMID:12419016,https://www.ncbi.nlm.nih.gov/pubmed/12419016,12419016,,
1646,1694315,3033767,Comparative Toxicogenomics Database (CTD),Droloxifene,C038345,droloxifene,https://ctdbase.org/detail.go?type=chem&acc=C038345,1577,CYP3A5,https://ctdbase.org/detail.go?type=gene&acc=1577,,,1577.0,CYP3A5,9606.0,Homo sapiens (human),Droloxifene results in decreased activity of CYP3A5 protein,,,PMID:12419016,https://www.ncbi.nlm.nih.gov/pubmed/12419016,12419016,,
1647,1685739,3034378,Comparative Toxicogenomics Database (CTD),Benfuresate,C480688,benfuresate,https://ctdbase.org/detail.go?type=chem&acc=C480688,8856,NR1I2,https://ctdbase.org/detail.go?type=gene&acc=8856,,,8856.0,NR1I2,9606.0,Homo sapiens (human),Benfuresate binds to and results in increased activity of NR1I2 protein,,,PMID:21115097,https://www.ncbi.nlm.nih.gov/pubmed/21115097,21115097,,
1648,1685740,3034814,Drug Gene Interaction database (DGIdb),LY-53857 free base,,"[D-TPI6, LEU13 &PSI;(CH2NH)-LEU14]BOMBESIN-(6-14)",https://www.dgidb.org/drugs/iuphar.ligand:6183,,GRPR,https://www.dgidb.org/genes/hgnc:4609,,,2925.0,GRPR,9606.0,Homo sapiens (human),,,,,,,,
1649,1685741,3035442,Drug Gene Interaction database (DGIdb),Amibegron,,AMIBEGRON,https://www.dgidb.org/drugs/ncit:C77932,,ADRB3,https://www.dgidb.org/genes/hgnc:288,,,155.0,ADRB3,9606.0,Homo sapiens (human),,,,,,,,
1650,1685742,3035449,Drug Gene Interaction database (DGIdb),Met-lys-bradykinin,,[3H]GBR12935,https://www.dgidb.org/drugs/iuphar.ligand:4638,,ALOX15,https://www.dgidb.org/genes/hgnc:433,,,246.0,ALOX15,9606.0,Homo sapiens (human),,,,,,,,
1651,1685743,3035449,Drug Gene Interaction database (DGIdb),Met-lys-bradykinin,,[3H]GBR12935,https://www.dgidb.org/drugs/iuphar.ligand:4638,,CYP2D6,https://www.dgidb.org/genes/hgnc:2625,,,1565.0,CYP2D6,9606.0,Homo sapiens (human),,,,,,,,
1652,1694473,3035449,Drug Gene Interaction database (DGIdb),Met-lys-bradykinin,,[3H]GBR12935,https://www.dgidb.org/drugs/iuphar.ligand:4638,,CBX1,https://www.dgidb.org/genes/hgnc:1551,,,10951.0,CBX1,9606.0,Homo sapiens (human),,,,,,,,
1653,1694474,3035714,Drug Gene Interaction database (DGIdb),Abt-751,,ABT-751,https://www.dgidb.org/drugs/drugbank:DB12254,,TUBA4A,https://www.dgidb.org/genes/hgnc:12407,,,7277.0,TUBA4A,9606.0,Homo sapiens (human),,,,,,,,
1654,1694475,3035714,Drug Gene Interaction database (DGIdb),Abt-751,,ABT-751,https://www.dgidb.org/drugs/drugbank:DB12254,,TUBA3D,https://www.dgidb.org/genes/hgnc:24071,,,113457.0,TUBA3D,9606.0,Homo sapiens (human),,,,,,,,
1655,1694476,3035714,Drug Gene Interaction database (DGIdb),Abt-751,,ABT-751,https://www.dgidb.org/drugs/drugbank:DB12254,,TUBA1A,https://www.dgidb.org/genes/hgnc:20766,,,7846.0,TUBA1A,9606.0,Homo sapiens (human),,,,,,,,
1656,1694477,3035714,Drug Gene Interaction database (DGIdb),Abt-751,,ABT-751,https://www.dgidb.org/drugs/drugbank:DB12254,,TUBB6,https://www.dgidb.org/genes/hgnc:20776,,,84617.0,TUBB6,9606.0,Homo sapiens (human),,,,,,,,
1657,1694478,3035714,Drug Gene Interaction database (DGIdb),Abt-751,,ABT-751,https://www.dgidb.org/drugs/drugbank:DB12254,,TUBB4A,https://www.dgidb.org/genes/hgnc:20774,,,10382.0,TUBB4A,9606.0,Homo sapiens (human),,,,,,,,
1658,1694479,3035842,BindingDB,Immepip,22542,4-(1H-imidazol-4-ylmethyl)piperidine,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=22542,2288,Histamine H3 receptor,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2288,Q9Y5N1,Histamine H3 receptor,11255.0,HRH3,9606.0,Homo sapiens (human),,Ki (nM),0.407,PMID:18433114|DOI:10.1021/jm7014149,https://www.ncbi.nlm.nih.gov/pubmed/18433114|https://doi.org/10.1021/jm7014149,18433114,10.1021/jm7014149,
1659,1694480,3035850,IUPHAR/BPS Guide to PHARMACOLOGY,Chloro-IB-MECA,457,Cl-IB-MECA,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=457,18,A1 receptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=18,Q60612,Adenosine receptor A1,11539.0,Adora1,10090.0,Mus musculus (house mouse),Agonist,pKi,7.46,,,,,
1660,1685744,3038472,Drug Gene Interaction database (DGIdb),Irampanel,,IRAMPANEL,https://www.dgidb.org/drugs/ncit:C65960,,GRIA1,https://www.dgidb.org/genes/hgnc:4571,,,2890.0,GRIA1,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
1661,1685745,3038472,Drug Gene Interaction database (DGIdb),Irampanel,,IRAMPANEL,https://www.dgidb.org/drugs/ncit:C65960,,SCN11A,https://www.dgidb.org/genes/hgnc:10583,,,11280.0,SCN11A,9606.0,Homo sapiens (human),Blocker,,,,,,,
1662,1694643,3038525,Comparative Toxicogenomics Database (CTD),Neflamapimod,C464966,VX-745,https://ctdbase.org/detail.go?type=chem&acc=C464966,3576,CXCL8,https://ctdbase.org/detail.go?type=gene&acc=3576,,,3576.0,CXCL8,9606.0,Homo sapiens (human),VX-745 inhibits the reaction [lipopolysaccharides results in increased expression of CXCL8 protein],,,PMID:28629242,https://www.ncbi.nlm.nih.gov/pubmed/28629242,28629242,,
1663,1694644,3038525,Comparative Toxicogenomics Database (CTD),Neflamapimod,C464966,VX-745,https://ctdbase.org/detail.go?type=chem&acc=C464966,3553,IL1B,https://ctdbase.org/detail.go?type=gene&acc=3553,,,3553.0,IL1B,9606.0,Homo sapiens (human),VX-745 inhibits the reaction [lipopolysaccharides results in increased expression of IL1B protein],,,PMID:28629242,https://www.ncbi.nlm.nih.gov/pubmed/28629242,28629242,,
1664,1694645,3038525,Comparative Toxicogenomics Database (CTD),Neflamapimod,C464966,VX-745,https://ctdbase.org/detail.go?type=chem&acc=C464966,3569,IL6,https://ctdbase.org/detail.go?type=gene&acc=3569,,,3569.0,IL6,9606.0,Homo sapiens (human),VX-745 inhibits the reaction [TNF protein results in increased secretion of IL6 protein]|vx-745 results in decreased secretion of IL6 protein,,,PMID:12393542,https://www.ncbi.nlm.nih.gov/pubmed/12393542,12393542,,
1665,1694646,3038525,Comparative Toxicogenomics Database (CTD),Neflamapimod,C464966,VX-745,https://ctdbase.org/detail.go?type=chem&acc=C464966,1432,MAPK14,https://ctdbase.org/detail.go?type=gene&acc=1432,,,1432.0,MAPK14,9606.0,Homo sapiens (human),VX-745 results in decreased activity of MAPK14 protein,,,PMID:28629242,https://www.ncbi.nlm.nih.gov/pubmed/28629242,28629242,,
1666,1694647,3038525,Comparative Toxicogenomics Database (CTD),Neflamapimod,C464966,VX-745,https://ctdbase.org/detail.go?type=chem&acc=C464966,6582,SLC22A2,https://ctdbase.org/detail.go?type=gene&acc=6582,,,6582.0,SLC22A2,9606.0,Homo sapiens (human),VX-745 inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium],,,PMID:21599003,https://www.ncbi.nlm.nih.gov/pubmed/21599003,21599003,,
1667,1687357,3085092,Comparative Toxicogenomics Database (CTD),Salinomycin,C010327,salinomycin,https://ctdbase.org/detail.go?type=chem&acc=C010327,1857,DVL3,https://ctdbase.org/detail.go?type=gene&acc=1857,,,1857.0,DVL3,9606.0,Homo sapiens (human),Salinomycin results in decreased expression of DVL3 mRNA,,,PMID:19682730,https://www.ncbi.nlm.nih.gov/pubmed/19682730,19682730,,
1668,1687358,3085092,Comparative Toxicogenomics Database (CTD),Salinomycin,C010327,salinomycin,https://ctdbase.org/detail.go?type=chem&acc=C010327,9451,EIF2AK3,https://ctdbase.org/detail.go?type=gene&acc=9451,,,9451.0,EIF2AK3,9606.0,Homo sapiens (human),[salinomycin co-treated with calcitriol] results in increased expression of EIF2AK3 mrna|salinomycin results in increased expression of EIF2AK3 mRNA,,,PMID:35914560,https://www.ncbi.nlm.nih.gov/pubmed/35914560,35914560,,
1669,1687359,3085092,Comparative Toxicogenomics Database (CTD),Salinomycin,C010327,salinomycin,https://ctdbase.org/detail.go?type=chem&acc=C010327,9470,EIF4E2,https://ctdbase.org/detail.go?type=gene&acc=9470,,,9470.0,EIF4E2,9606.0,Homo sapiens (human),Salinomycin results in decreased expression of EIF4E2 mRNA,,,PMID:19682730,https://www.ncbi.nlm.nih.gov/pubmed/19682730,19682730,,
1670,1687360,3085092,Comparative Toxicogenomics Database (CTD),Salinomycin,C010327,salinomycin,https://ctdbase.org/detail.go?type=chem&acc=C010327,26610,ELP4,https://ctdbase.org/detail.go?type=gene&acc=26610,,,26610.0,ELP4,9606.0,Homo sapiens (human),Salinomycin results in decreased expression of ELP4 mRNA,,,PMID:19682730,https://www.ncbi.nlm.nih.gov/pubmed/19682730,19682730,,
1671,1687958,3085092,Comparative Toxicogenomics Database (CTD),Salinomycin,C010327,salinomycin,https://ctdbase.org/detail.go?type=chem&acc=C010327,3014,H2AX,https://ctdbase.org/detail.go?type=gene&acc=3014,,,3014.0,H2AX,9606.0,Homo sapiens (human),[salinomycin co-treated with calcitriol] results in decreased expression of H2AX mrna|salinomycin results in decreased expression of H2AX mRNA,,,PMID:35914560,https://www.ncbi.nlm.nih.gov/pubmed/35914560,35914560,,
1672,1687959,3085092,Comparative Toxicogenomics Database (CTD),Salinomycin,C010327,salinomycin,https://ctdbase.org/detail.go?type=chem&acc=C010327,3074,HEXB,https://ctdbase.org/detail.go?type=gene&acc=3074,,,3074.0,HEXB,10116.0,Rattus norvegicus (Norway rat),Zinc chloride inhibits the reaction [salinomycin results in increased secretion of HEXB protein],,,PMID:15272608,https://www.ncbi.nlm.nih.gov/pubmed/15272608,15272608,,
1673,1687960,3085092,Comparative Toxicogenomics Database (CTD),Salinomycin,C010327,salinomycin,https://ctdbase.org/detail.go?type=chem&acc=C010327,3091,HIF1A,https://ctdbase.org/detail.go?type=gene&acc=3091,,,3091.0,HIF1A,9606.0,Homo sapiens (human),Salinomycin results in decreased expression of HIF1A mRNA,,,PMID:19682730,https://www.ncbi.nlm.nih.gov/pubmed/19682730,19682730,,
1674,1687961,3085092,Comparative Toxicogenomics Database (CTD),Salinomycin,C010327,salinomycin,https://ctdbase.org/detail.go?type=chem&acc=C010327,9653,HS2ST1,https://ctdbase.org/detail.go?type=gene&acc=9653,,,9653.0,HS2ST1,9606.0,Homo sapiens (human),Salinomycin results in decreased expression of HS2ST1 mRNA,,,PMID:19682730,https://www.ncbi.nlm.nih.gov/pubmed/19682730,19682730,,
1675,1687962,3085092,Comparative Toxicogenomics Database (CTD),Salinomycin,C010327,salinomycin,https://ctdbase.org/detail.go?type=chem&acc=C010327,3309,HSPA5,https://ctdbase.org/detail.go?type=gene&acc=3309,,,3309.0,HSPA5,9606.0,Homo sapiens (human),Calcitriol promotes the reaction [salinomycin results in increased expression of HSPA5 mrna]|[calcitriol co-treated with salinomycin] results in increased expression of HSPA5 mrna|salinomycin results in increased expression of HSPA5 mRNA,,,PMID:35914560,https://www.ncbi.nlm.nih.gov/pubmed/35914560,35914560,,
1676,1687963,3086599,Comparative Toxicogenomics Database (CTD),2-(4-(2-Carboxyethyl)phenethylamino)-5'-N-ethylcarboxamidoadenosine,C061282,2-(4-(2-carboxyethyl)phenethylamino)-5'-N-ethylcarboxamidoadenosine,https://ctdbase.org/detail.go?type=chem&acc=C061282,135,ADORA2A,https://ctdbase.org/detail.go?type=gene&acc=135,,,135.0,ADORA2A,9606.0,Homo sapiens (human),2-(4-(2-carboxyethyl)phenethylamino)-5'-N-ethylcarboxamidoadenosine inhibits the reaction [caffeine results in decreased expression of ADORA2A protein]|2-(4-(2-carboxyethyl)phenethylamino)-5'-N-ethylcarboxamidoadenosine inhibits the reaction [caffeine results in decreased expression of ADORA2A mrna],,,PMID:26367767,https://www.ncbi.nlm.nih.gov/pubmed/26367767,26367767,,
1677,1687964,3086599,Comparative Toxicogenomics Database (CTD),2-(4-(2-Carboxyethyl)phenethylamino)-5'-N-ethylcarboxamidoadenosine,C061282,2-(4-(2-carboxyethyl)phenethylamino)-5'-N-ethylcarboxamidoadenosine,https://ctdbase.org/detail.go?type=chem&acc=C061282,135,ADORA2A,https://ctdbase.org/detail.go?type=gene&acc=135,,,135.0,ADORA2A,10090.0,Mus musculus (house mouse),ADORA2A protein results in increased susceptibility to 2-(4-(2-carboxyethyl)phenethylamino)-5'-N-ethylcarboxamidoadenosine,,,PMID:11172060,https://www.ncbi.nlm.nih.gov/pubmed/11172060,11172060,,
1678,1687965,3086599,Comparative Toxicogenomics Database (CTD),2-(4-(2-Carboxyethyl)phenethylamino)-5'-N-ethylcarboxamidoadenosine,C061282,2-(4-(2-carboxyethyl)phenethylamino)-5'-N-ethylcarboxamidoadenosine,https://ctdbase.org/detail.go?type=chem&acc=C061282,135,ADORA2A,https://ctdbase.org/detail.go?type=gene&acc=135,,,135.0,ADORA2A,10116.0,Rattus norvegicus (Norway rat),2-(4-(2-carboxyethyl)phenethylamino)-5'-N-ethylcarboxamidoadenosine binds to and results in increased activity of ADORA2A protein,,,PMID:15452191|PMID:19749167|PMID:19966059,https://www.ncbi.nlm.nih.gov/pubmed/15452191|https://www.ncbi.nlm.nih.gov/pubmed/19749167|https://www.ncbi.nlm.nih.gov/pubmed/19966059,15452191|19749167|19966059,,
1679,1693062,3420363,BindingDB,N-(furan-2-ylmethyl)-2-hydrazinyl-7H-purin-6-amine,188523,PUG-3,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=188523,7921,"Solute carrier family 2, facilitated glucose transporter member 1",https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=7921,P11166,"Solute carrier family 2, facilitated glucose transporter member 1",6513.0,SLC2A1,9606.0,Homo sapiens (human),,IC50 (nM),2.71e+4,PMID:27128978|DOI:10.1021/acschembio.6b00304,https://www.ncbi.nlm.nih.gov/pubmed/27128978|https://doi.org/10.1021/acschembio.6b00304,27128978,10.1021/acschembio.6b00304,
1680,1692791,3423265,Comparative Toxicogenomics Database (CTD),Sodium dodecyl sulfate,D012967,Sodium Dodecyl Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D012967,196,AHR,https://ctdbase.org/detail.go?type=gene&acc=196,,,196.0,AHR,9606.0,Homo sapiens (human),Sodium dodecyl sulfate results in decreased expression of AHR mRNA,,,PMID:31734321,https://www.ncbi.nlm.nih.gov/pubmed/31734321,31734321,,
1681,1692968,3423265,Comparative Toxicogenomics Database (CTD),Sodium dodecyl sulfate,D012967,Sodium Dodecyl Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D012967,397,ARHGDIB,https://ctdbase.org/detail.go?type=gene&acc=397,,,397.0,ARHGDIB,9606.0,Homo sapiens (human),Sodium dodecyl sulfate results in decreased expression of ARHGDIB mRNA,,,PMID:20713136,https://www.ncbi.nlm.nih.gov/pubmed/20713136,20713136,,
1682,1692853,3463933,Comparative Toxicogenomics Database (CTD),"2,5-dichloro-N-(2-methyl-4-nitrophenyl)benzenesulfonamide",C575430,FH535,https://ctdbase.org/detail.go?type=chem&acc=C575430,595,CCND1,https://ctdbase.org/detail.go?type=gene&acc=595,,,595.0,CCND1,10116.0,Rattus norvegicus (Norway rat),FH535 results in decreased expression of CCND1 mrna|fh535 inhibits the reaction [WNT3A protein results in increased expression of CCND1 mrna],,,PMID:25381574,https://www.ncbi.nlm.nih.gov/pubmed/25381574,25381574,,
1683,1692854,3463933,Comparative Toxicogenomics Database (CTD),"2,5-dichloro-N-(2-methyl-4-nitrophenyl)benzenesulfonamide",C575430,FH535,https://ctdbase.org/detail.go?type=chem&acc=C575430,1543,CYP1A1,https://ctdbase.org/detail.go?type=gene&acc=1543,,,1543.0,CYP1A1,9606.0,Homo sapiens (human),FH535 inhibits the reaction [tetrachlorodibenzodioxin results in increased expression of CYP1A1 mrna]|fh535 inhibits the reaction [beta-naphthoflavone results in increased expression of CYP1A1 mrna]|fh535 inhibits the reaction [2-tert-butylhydroquinone results in increased expression of CYP1A1 mrna],,,PMID:25174530,https://www.ncbi.nlm.nih.gov/pubmed/25174530,25174530,,
1684,1692855,3463933,Comparative Toxicogenomics Database (CTD),"2,5-dichloro-N-(2-methyl-4-nitrophenyl)benzenesulfonamide",C575430,FH535,https://ctdbase.org/detail.go?type=chem&acc=C575430,51176,LEF1,https://ctdbase.org/detail.go?type=gene&acc=51176,,,51176.0,LEF1,10116.0,Rattus norvegicus (Norway rat),[FH535 co-treated with bisphenol A] results in decreased expression of LEF1 mrna|wnt3a protein promotes the reaction [FH535 results in decreased expression of LEF1 mrna]|fh535 inhibits the reaction [WNT3A protein results in increased expression of LEF1 mrna]|fh535 results in decreased expression of LEF1 mRNA,,,PMID:25381574,https://www.ncbi.nlm.nih.gov/pubmed/25381574,25381574,,
1685,1692856,3463933,Comparative Toxicogenomics Database (CTD),"2,5-dichloro-N-(2-methyl-4-nitrophenyl)benzenesulfonamide",C575430,FH535,https://ctdbase.org/detail.go?type=chem&acc=C575430,346389,MACC1,https://ctdbase.org/detail.go?type=gene&acc=346389,,,346389.0,MACC1,9606.0,Homo sapiens (human),FH535 inhibits the reaction [MACC1 protein results in increased expression of S100A4 protein],,,PMID:36008464,https://www.ncbi.nlm.nih.gov/pubmed/36008464,36008464,,
1686,1692857,3463933,Comparative Toxicogenomics Database (CTD),"2,5-dichloro-N-(2-methyl-4-nitrophenyl)benzenesulfonamide",C575430,FH535,https://ctdbase.org/detail.go?type=chem&acc=C575430,6275,S100A4,https://ctdbase.org/detail.go?type=gene&acc=6275,,,6275.0,S100A4,9606.0,Homo sapiens (human),FH535 inhibits the reaction [MACC1 protein results in increased expression of S100A4 protein],,,PMID:36008464,https://www.ncbi.nlm.nih.gov/pubmed/36008464,36008464,,
1687,1692858,3463933,Comparative Toxicogenomics Database (CTD),"2,5-dichloro-N-(2-methyl-4-nitrophenyl)benzenesulfonamide",C575430,FH535,https://ctdbase.org/detail.go?type=chem&acc=C575430,89780,WNT3A,https://ctdbase.org/detail.go?type=gene&acc=89780,,,89780.0,WNT3A,10116.0,Rattus norvegicus (Norway rat),WNT3A protein promotes the reaction [FH535 results in decreased expression of LEF1 mrna]|fh535 inhibits the reaction [WNT3A protein results in increased expression of LEF1 mrna]|fh535 inhibits the reaction [WNT3A protein results in increased expression of CCND1 mrna],,,PMID:25381574,https://www.ncbi.nlm.nih.gov/pubmed/25381574,25381574,,
1688,1692859,3491105,Drug Gene Interaction database (DGIdb),5-Chloro-7-[1-piperidinyl(2-pyridinyl)methyl]-8-quinolinol,,CHEMBL:CHEMBL1503729,https://www.dgidb.org/drugs/chembl:CHEMBL1503729,,KDM4A,https://www.dgidb.org/genes/hgnc:22978,,,9682.0,KDM4A,9606.0,Homo sapiens (human),,,,,,,,
1689,1692860,3491105,Drug Gene Interaction database (DGIdb),5-Chloro-7-[1-piperidinyl(2-pyridinyl)methyl]-8-quinolinol,,CHEMBL:CHEMBL1503729,https://www.dgidb.org/drugs/chembl:CHEMBL1503729,,EHMT2,https://www.dgidb.org/genes/hgnc:14129,,,10919.0,EHMT2,9606.0,Homo sapiens (human),,,,,,,,
1690,1693056,3516032,BindingDB,5-Chloro-7-[(4-ethyl-1-piperazinyl)-(3-pyridinyl)methyl]-8-quinolinol,49152,5-chloranyl-7-[(4-ethylpiperazin-1-yl)-pyridin-3-yl-methyl]quinolin-8-ol,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=49152,2645,Histone deacetylase 7,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2645,Q8WUI4,Histone deacetylase 7,51564.0,HDAC7,9606.0,Homo sapiens (human),,IC50 (nM),8.44e+3,PMID:27064299|DOI:10.1021/acschembio.6b00012,https://www.ncbi.nlm.nih.gov/pubmed/27064299|https://doi.org/10.1021/acschembio.6b00012,27064299,10.1021/acschembio.6b00012,
1691,1693057,3567002,IUPHAR/BPS Guide to PHARMACOLOGY,"5-methyl-3-[3-[4-[2-(2,2,2-trifluoroethoxy)phenyl]piperazin-1-yl]propyl]-1H-pyrimidine-2,4-dione",7381,RS-100329,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7381,24,α1D-adrenoceptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=24,P25100,Alpha-1D adrenergic receptor,146.0,ADRA1D,9606.0,Homo sapiens (human),Antagonist,pKi,7.6 - 7.9,PMID:10369480|PMID:32608144,https://www.ncbi.nlm.nih.gov/pubmed/10369480|https://www.ncbi.nlm.nih.gov/pubmed/32608144,10369480|32608144,,
1692,1693058,3635406,BindingDB,8-(Trifluoromethyl)-9H-purin-6-amine,154573,8-(trifluoromethyl)-9H-purin-6-amine (4),https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=154573,4753,Replicase polyprotein 1ab,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=4753,P0C6X7,Replicase polyprotein 1ab,1489680.0,ORF1ab,694009.0,Severe acute respiratory syndrome-related coronavirus,,IC50 (nM),13900,PMID:34798775|DOI:10.1021/acs.jmedchem.1c00409,https://www.ncbi.nlm.nih.gov/pubmed/34798775|https://doi.org/10.1021/acs.jmedchem.1c00409,34798775,10.1021/acs.jmedchem.1c00409,
1693,1693059,3644637,Drug Gene Interaction database (DGIdb),6-Chloro-5-methyl-1-((2-(2-methylpyrid-3-yloxy)pyrid-5-yl)carbamoyl)indoline,,GF109203X,https://www.dgidb.org/drugs/iuphar.ligand:5193,,MAPK1,https://www.dgidb.org/genes/hgnc:6871,,,5594.0,MAPK1,9606.0,Homo sapiens (human),,,,,,,,
1694,1693060,3645619,Drug Gene Interaction database (DGIdb),N-((4-(2-cyanophenyl)-1-piperazinyl)methyl)-3-methylbenzamide,,IL-10,https://www.dgidb.org/drugs/iuphar.ligand:4975,,PTGER1,https://www.dgidb.org/genes/hgnc:9593,,,5731.0,PTGER1,9606.0,Homo sapiens (human),,,,,,,,
1695,1693063,3645619,Drug Gene Interaction database (DGIdb),N-((4-(2-cyanophenyl)-1-piperazinyl)methyl)-3-methylbenzamide,,IL-10,https://www.dgidb.org/drugs/iuphar.ligand:4975,,ALK,https://www.dgidb.org/genes/hgnc:427,,,238.0,ALK,9606.0,Homo sapiens (human),,,,,,,,
1696,1693061,3651377,BindingDB,"3-[3-Tert-butylsulfanyl-1-[(4-chlorophenyl)methyl]-5-propan-2-ylindol-2-yl]-2,2-dimethylpropanoic acid",50006805,"3-(1-(4-chlorobenzyl)-3-(tert-butylthio)-5-isopropyl-1H-indol-2-yl)-2,2-dimethylpropanoic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50006805,770,Replicase polyprotein 1ab,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=770,P0DTD1,Replicase polyprotein 1ab,,,2697049.0,Severe acute respiratory syndrome coronavirus 2,,IC50 (nM),21520,PMID:34798775|DOI:10.1021/acs.jmedchem.1c00409,https://www.ncbi.nlm.nih.gov/pubmed/34798775|https://doi.org/10.1021/acs.jmedchem.1c00409,34798775,10.1021/acs.jmedchem.1c00409,
1697,1689852,4521392,Comparative Toxicogenomics Database (CTD),"4-(4-(benzo[d][1,3]dioxol-5-yl)-5-(pyridin-2-yl)-1H-imidazol-2-yl)benzamide",C459179,"4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide",https://ctdbase.org/detail.go?type=chem&acc=C459179,50649,ARHGEF4,https://ctdbase.org/detail.go?type=gene&acc=50649,,,50649.0,ARHGEF4,9606.0,Homo sapiens (human),"[NOG protein co-treated with valproic acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ARHGEF4 mrna|[nog protein co-treated with vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ARHGEF4 mrna|[nog protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ARHGEF4 mrna|[nog protein co-treated with phenylmercuric acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ARHGEF4 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
1698,1689853,4521392,Comparative Toxicogenomics Database (CTD),"4-(4-(benzo[d][1,3]dioxol-5-yl)-5-(pyridin-2-yl)-1H-imidazol-2-yl)benzamide",C459179,"4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide",https://ctdbase.org/detail.go?type=chem&acc=C459179,55701,ARHGEF40,https://ctdbase.org/detail.go?type=gene&acc=55701,,,55701.0,ARHGEF40,9606.0,Homo sapiens (human),"[NOG protein co-treated with p-chloromercuribenzoic acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ARHGEF40 mrna|[nog protein co-treated with valproic acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ARHGEF40 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
1699,1691369,4521392,Comparative Toxicogenomics Database (CTD),"4-(4-(benzo[d][1,3]dioxol-5-yl)-5-(pyridin-2-yl)-1H-imidazol-2-yl)benzamide",C459179,"4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide",https://ctdbase.org/detail.go?type=chem&acc=C459179,8082,SSPN,https://ctdbase.org/detail.go?type=gene&acc=8082,,,8082.0,SSPN,9606.0,Homo sapiens (human),"[NOG protein co-treated with phenylmercuric acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SSPN mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
1700,1691370,4521392,Comparative Toxicogenomics Database (CTD),"4-(4-(benzo[d][1,3]dioxol-5-yl)-5-(pyridin-2-yl)-1H-imidazol-2-yl)benzamide",C459179,"4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide",https://ctdbase.org/detail.go?type=chem&acc=C459179,6745,SSR1,https://ctdbase.org/detail.go?type=gene&acc=6745,,,6745.0,SSR1,9606.0,Homo sapiens (human),"[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of SSR1 protein",,,PMID:37664457,https://www.ncbi.nlm.nih.gov/pubmed/37664457,37664457,,
1701,1691371,4521392,Comparative Toxicogenomics Database (CTD),"4-(4-(benzo[d][1,3]dioxol-5-yl)-5-(pyridin-2-yl)-1H-imidazol-2-yl)benzamide",C459179,"4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide",https://ctdbase.org/detail.go?type=chem&acc=C459179,6745,SSR1,https://ctdbase.org/detail.go?type=gene&acc=6745,,,6745.0,SSR1,9606.0,Homo sapiens (human),"[NOG protein co-treated with valproic acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SSR1 mrna|[nog protein co-treated with phenylmercuric acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SSR1 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
1702,1691372,4521392,Comparative Toxicogenomics Database (CTD),"4-(4-(benzo[d][1,3]dioxol-5-yl)-5-(pyridin-2-yl)-1H-imidazol-2-yl)benzamide",C459179,"4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide",https://ctdbase.org/detail.go?type=chem&acc=C459179,165679,SPTSSB,https://ctdbase.org/detail.go?type=gene&acc=165679,,,165679.0,SPTSSB,9606.0,Homo sapiens (human),"[NOG protein co-treated with valproic acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SPTSSB mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
1703,1692088,4521392,Comparative Toxicogenomics Database (CTD),"4-(4-(benzo[d][1,3]dioxol-5-yl)-5-(pyridin-2-yl)-1H-imidazol-2-yl)benzamide",C459179,"4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide",https://ctdbase.org/detail.go?type=chem&acc=C459179,51490,SPOUT1,https://ctdbase.org/detail.go?type=gene&acc=51490,,,51490.0,SPOUT1,9606.0,Homo sapiens (human),"[NOG protein co-treated with valproic acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SPOUT1 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
1704,1692089,4521392,Comparative Toxicogenomics Database (CTD),"4-(4-(benzo[d][1,3]dioxol-5-yl)-5-(pyridin-2-yl)-1H-imidazol-2-yl)benzamide",C459179,"4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide",https://ctdbase.org/detail.go?type=chem&acc=C459179,6696,SPP1,https://ctdbase.org/detail.go?type=gene&acc=6696,,,6696.0,SPP1,9606.0,Homo sapiens (human),"[NOG protein co-treated with phenylmercuric acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SPP1 mrna|[nog protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SPP1 mrna|[nog protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SPP1 mrna|[nog protein co-treated with panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SPP1 mrna|[nog protein co-treated with p-chloromercuribenzoic acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SPP1 mrna|[nog protein co-treated with valproic acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SPP1 mrna|[nog protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SPP1 mrna|[nog protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SPP1 mrna|[nog protein co-treated with mercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SPP1 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
1705,1692090,4521392,Comparative Toxicogenomics Database (CTD),"4-(4-(benzo[d][1,3]dioxol-5-yl)-5-(pyridin-2-yl)-1H-imidazol-2-yl)benzamide",C459179,"4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide",https://ctdbase.org/detail.go?type=chem&acc=C459179,84888,SPPL2A,https://ctdbase.org/detail.go?type=gene&acc=84888,,,84888.0,SPPL2A,9606.0,Homo sapiens (human),"[NOG protein co-treated with phenylmercuric acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SPPL2A mrna|[nog protein co-treated with valproic acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SPPL2A mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
1706,1692091,4521392,Comparative Toxicogenomics Database (CTD),"4-(4-(benzo[d][1,3]dioxol-5-yl)-5-(pyridin-2-yl)-1H-imidazol-2-yl)benzamide",C459179,"4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide",https://ctdbase.org/detail.go?type=chem&acc=C459179,161742,SPRED1,https://ctdbase.org/detail.go?type=gene&acc=161742,,,161742.0,SPRED1,9606.0,Homo sapiens (human),"[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SPRED1 mrna|[nog protein co-treated with phenylmercuric acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SPRED1 mrna|[nog protein co-treated with valproic acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SPRED1 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
1707,1685377,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,4968,OGG1,https://ctdbase.org/detail.go?type=gene&acc=4968,,,4968.0,OGG1,9606.0,Homo sapiens (human),Quercetin results in increased expression of OGG1 mrna|quercetin promotes the reaction [hydrogen peroxide results in increased expression of OGG1 mrna],,,PMID:19651184,https://www.ncbi.nlm.nih.gov/pubmed/19651184,19651184,,
1708,1685378,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,11339,OIP5,https://ctdbase.org/detail.go?type=gene&acc=11339,,,11339.0,OIP5,9606.0,Homo sapiens (human),Quercetin results in decreased expression of OIP5 mRNA,,,PMID:21632981,https://www.ncbi.nlm.nih.gov/pubmed/21632981,21632981,,
1709,1685379,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,283298,OLFML1,https://ctdbase.org/detail.go?type=gene&acc=283298,,,283298.0,OLFML1,9606.0,Homo sapiens (human),Quercetin results in decreased expression of OLFML1 mRNA,,,PMID:21632981,https://www.ncbi.nlm.nih.gov/pubmed/21632981,21632981,,
1710,1685380,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,56944,OLFML3,https://ctdbase.org/detail.go?type=gene&acc=56944,,,56944.0,OLFML3,9606.0,Homo sapiens (human),Quercetin results in decreased expression of OLFML3 mRNA,,,PMID:21632981,https://www.ncbi.nlm.nih.gov/pubmed/21632981,21632981,,
1711,1685381,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,4973,OLR1,https://ctdbase.org/detail.go?type=gene&acc=4973,,,4973.0,OLR1,9606.0,Homo sapiens (human),[quercetin co-treated with ascorbic acid] results in increased expression of OLR1 mRNA,,,PMID:17639512,https://www.ncbi.nlm.nih.gov/pubmed/17639512,17639512,,
1712,1685382,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,4973,OLR1,https://ctdbase.org/detail.go?type=gene&acc=4973,,,4973.0,OLR1,9606.0,Homo sapiens (human),Quercetin inhibits the reaction [lipids results in increased expression of OLR1],,,PMID:16891912,https://www.ncbi.nlm.nih.gov/pubmed/16891912,16891912,,
1713,1685383,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,4973,OLR1,https://ctdbase.org/detail.go?type=gene&acc=4973,,,4973.0,OLR1,10116.0,Rattus norvegicus (Norway rat),Quercetin affects the expression of OLR1 mRNA,,,PMID:18178720,https://www.ncbi.nlm.nih.gov/pubmed/18178720,18178720,,
1714,1685540,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,259072,OR52X1,https://ctdbase.org/detail.go?type=gene&acc=259072,,,259072.0,Or52x1,10116.0,Rattus norvegicus (Norway rat),Quercetin results in decreased expression of OR52X1 mRNA,,,PMID:17103110,https://www.ncbi.nlm.nih.gov/pubmed/17103110,17103110,,
1715,1685541,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,258483,OR9S15,https://ctdbase.org/detail.go?type=gene&acc=258483,,,258483.0,Or9s15,10116.0,Rattus norvegicus (Norway rat),Quercetin results in decreased expression of OR9S15 mRNA,,,PMID:17103110,https://www.ncbi.nlm.nih.gov/pubmed/17103110,17103110,,
1716,1685542,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,4998,ORC1,https://ctdbase.org/detail.go?type=gene&acc=4998,,,4998.0,ORC1,9606.0,Homo sapiens (human),Quercetin results in increased expression of ORC1 mRNA,,,PMID:21632981,https://www.ncbi.nlm.nih.gov/pubmed/21632981,21632981,,
1717,1685543,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,4999,ORC2,https://ctdbase.org/detail.go?type=gene&acc=4999,,,4999.0,ORC2,9606.0,Homo sapiens (human),Quercetin results in decreased expression of ORC2 mRNA,,,PMID:21632981|PMID:23727915,https://www.ncbi.nlm.nih.gov/pubmed/21632981|https://www.ncbi.nlm.nih.gov/pubmed/23727915,21632981|23727915,,
1718,1685544,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,23594,ORC6,https://ctdbase.org/detail.go?type=gene&acc=23594,,,23594.0,ORC6,9606.0,Homo sapiens (human),Quercetin results in increased expression of ORC6 mRNA,,,PMID:21632981,https://www.ncbi.nlm.nih.gov/pubmed/21632981,21632981,,
1719,1685545,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,5004,ORM1,https://ctdbase.org/detail.go?type=gene&acc=5004,,,5004.0,ORM1,9606.0,Homo sapiens (human),Quercetin results in decreased expression of ORM1 mRNA,,,PMID:21632981,https://www.ncbi.nlm.nih.gov/pubmed/21632981,21632981,,
1720,1685546,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,5005,ORM2,https://ctdbase.org/detail.go?type=gene&acc=5005,,,5005.0,ORM2,9606.0,Homo sapiens (human),Quercetin results in decreased expression of ORM2 mRNA,,,PMID:21632981,https://www.ncbi.nlm.nih.gov/pubmed/21632981,21632981,,
1721,1685547,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,29095,ORMDL2,https://ctdbase.org/detail.go?type=gene&acc=29095,,,29095.0,ORMDL2,9606.0,Homo sapiens (human),Quercetin results in increased expression of ORMDL2 mRNA,,,PMID:21632981,https://www.ncbi.nlm.nih.gov/pubmed/21632981,21632981,,
1722,1685876,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,78990,OTUB2,https://ctdbase.org/detail.go?type=gene&acc=78990,,,78990.0,OTUB2,9606.0,Homo sapiens (human),Quercetin results in increased expression of OTUB2 mRNA,,,PMID:21632981,https://www.ncbi.nlm.nih.gov/pubmed/21632981,21632981,,
1723,1685877,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,55593,OTUD5,https://ctdbase.org/detail.go?type=gene&acc=55593,,,55593.0,OTUD5,9606.0,Homo sapiens (human),Quercetin results in decreased phosphorylation of OTUD5 protein,,,PMID:35688186,https://www.ncbi.nlm.nih.gov/pubmed/35688186,35688186,,
1724,1685878,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,51633,OTUD6B,https://ctdbase.org/detail.go?type=gene&acc=51633,,,51633.0,OTUD6B,9606.0,Homo sapiens (human),Quercetin results in decreased expression of OTUD6B mRNA,,,PMID:21632981,https://www.ncbi.nlm.nih.gov/pubmed/21632981,21632981,,
1725,1685879,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,92106,OXNAD1,https://ctdbase.org/detail.go?type=gene&acc=92106,,,92106.0,OXNAD1,9606.0,Homo sapiens (human),Quercetin results in decreased expression of OXNAD1 mRNA,,,PMID:21632981,https://www.ncbi.nlm.nih.gov/pubmed/21632981,21632981,,
1726,1685880,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,55074,OXR1,https://ctdbase.org/detail.go?type=gene&acc=55074,,,55074.0,OXR1,9606.0,Homo sapiens (human),Quercetin results in decreased expression of OXR1 mRNA,,,PMID:21632981,https://www.ncbi.nlm.nih.gov/pubmed/21632981,21632981,,
1727,1685881,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,5021,OXTR,https://ctdbase.org/detail.go?type=gene&acc=5021,,,5021.0,OXTR,9606.0,Homo sapiens (human),Quercetin results in increased expression of OXTR mRNA,,,PMID:21632981,https://www.ncbi.nlm.nih.gov/pubmed/21632981,21632981,,
1728,1685882,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,5029,P2RY2,https://ctdbase.org/detail.go?type=gene&acc=5029,,,5029.0,P2RY2,9606.0,Homo sapiens (human),Quercetin results in increased expression of P2RY2 mRNA,,,PMID:15309432,https://www.ncbi.nlm.nih.gov/pubmed/15309432,15309432,,
1729,1685883,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,100196098,P2RY5,https://ctdbase.org/detail.go?type=gene&acc=100196098,,,100196098.0,,9606.0,Homo sapiens (human),Quercetin results in decreased expression of P2RY5 mRNA,,,PMID:21632981,https://www.ncbi.nlm.nih.gov/pubmed/21632981,21632981,,
1730,1687264,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,5125,PCSK5,https://ctdbase.org/detail.go?type=gene&acc=5125,,,5125.0,PCSK5,9606.0,Homo sapiens (human),Quercetin results in increased expression of PCSK5 mRNA,,,PMID:21632981,https://www.ncbi.nlm.nih.gov/pubmed/21632981,21632981,,
1731,1687265,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,255738,PCSK9,https://ctdbase.org/detail.go?type=gene&acc=255738,,,255738.0,PCSK9,9606.0,Homo sapiens (human),Quercetin results in decreased expression of PCSK9 mRNA,,,PMID:21632981,https://www.ncbi.nlm.nih.gov/pubmed/21632981,21632981,,
1732,1687266,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,5130,PCYT1A,https://ctdbase.org/detail.go?type=gene&acc=5130,,,5130.0,PCYT1A,9606.0,Homo sapiens (human),Quercetin results in increased phosphorylation of PCYT1A protein,,,PMID:35688186,https://www.ncbi.nlm.nih.gov/pubmed/35688186,35688186,,
1733,1687267,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,27250,PDCD4,https://ctdbase.org/detail.go?type=gene&acc=27250,,,27250.0,PDCD4,9606.0,Homo sapiens (human),[quercetin co-treated with hyperoside] results in increased expression of PDCD4 mrna|mir21 mRNA inhibits the reaction [[quercetin co-treated with hyperoside] results in increased expression of PDCD4 mrna]|[quercetin co-treated with hyperoside] results in increased expression of PDCD4 protein|mir21 mRNA inhibits the reaction [[quercetin co-treated with hyperoside] results in increased expression of PDCD4 protein],,,PMID:25354548,https://www.ncbi.nlm.nih.gov/pubmed/25354548,25354548,,
1734,1689077,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,5295,PIK3R1,https://ctdbase.org/detail.go?type=gene&acc=5295,,,5295.0,PIK3R1,10090.0,Mus musculus (house mouse),Quercetin inhibits the reaction [diethylnitrosamine results in increased expression of PIK3R1 protein modified form],,,PMID:34726822,https://www.ncbi.nlm.nih.gov/pubmed/34726822,34726822,,
1735,1689078,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,5295,PIK3R1,https://ctdbase.org/detail.go?type=gene&acc=5295,,,5295.0,PIK3R1,10090.0,Mus musculus (house mouse),Quercetin results in decreased phosphorylation of PIK3R1 protein,,,PMID:25658812,https://www.ncbi.nlm.nih.gov/pubmed/25658812,25658812,,
1736,1689079,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,5295,PIK3R1,https://ctdbase.org/detail.go?type=gene&acc=5295,,,5295.0,PIK3R1,10116.0,Rattus norvegicus (Norway rat),Quercetin inhibits the reaction [oxygen deficiency results in increased expression of PIK3R1 mrna],,,PMID:26476374,https://www.ncbi.nlm.nih.gov/pubmed/26476374,26476374,,
1737,1689080,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,8503,PIK3R3,https://ctdbase.org/detail.go?type=gene&acc=8503,,,8503.0,PIK3R3,9606.0,Homo sapiens (human),Quercetin results in increased expression of PIK3R3 mRNA,,,PMID:30152185,https://www.ncbi.nlm.nih.gov/pubmed/30152185,30152185,,
1738,1689081,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,29990,PILRB,https://ctdbase.org/detail.go?type=gene&acc=29990,,,29990.0,PILRB,9606.0,Homo sapiens (human),Quercetin results in increased expression of PILRB mRNA,,,PMID:21632981,https://www.ncbi.nlm.nih.gov/pubmed/21632981,21632981,,
1739,1689082,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,54478,PIMREG,https://ctdbase.org/detail.go?type=gene&acc=54478,,,54478.0,PIMREG,10116.0,Rattus norvegicus (Norway rat),Quercetin affects the expression of PIMREG mRNA,,,PMID:18178720,https://www.ncbi.nlm.nih.gov/pubmed/18178720,18178720,,
1740,1689083,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,5300,PIN1,https://ctdbase.org/detail.go?type=gene&acc=5300,,,5300.0,PIN1,9606.0,Homo sapiens (human),Quercetin results in decreased expression of PIN1 protein,,,PMID:20804812,https://www.ncbi.nlm.nih.gov/pubmed/20804812,20804812,,
1741,1689084,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,8395,PIP5K1B,https://ctdbase.org/detail.go?type=gene&acc=8395,,,8395.0,PIP5K1B,9606.0,Homo sapiens (human),Quercetin results in decreased expression of PIP5K1B mRNA,,,PMID:21632981,https://www.ncbi.nlm.nih.gov/pubmed/21632981,21632981,,
1742,1689237,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,8544,PIR,https://ctdbase.org/detail.go?type=gene&acc=8544,,,8544.0,PIR,9606.0,Homo sapiens (human),Quercetin results in decreased expression of PIR mRNA,,,PMID:21632981,https://www.ncbi.nlm.nih.gov/pubmed/21632981,21632981,,
1743,1689238,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,395364,PIT54,https://ctdbase.org/detail.go?type=gene&acc=395364,,,395364.0,PIT54,9031.0,Gallus gallus (chicken),Quercetin results in increased expression of PIT54 mRNA,,,PMID:21356098,https://www.ncbi.nlm.nih.gov/pubmed/21356098,21356098,,
1744,1689239,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,57095,PITHD1,https://ctdbase.org/detail.go?type=gene&acc=57095,,,57095.0,PITHD1,9606.0,Homo sapiens (human),Quercetin results in increased expression of PITHD1 mRNA,,,PMID:21632981,https://www.ncbi.nlm.nih.gov/pubmed/21632981,21632981,,
1745,1689240,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,26207,PITPNC1,https://ctdbase.org/detail.go?type=gene&acc=26207,,,26207.0,PITPNC1,9606.0,Homo sapiens (human),Quercetin affects the expression of PITPNC1 mRNA,,,PMID:21632981,https://www.ncbi.nlm.nih.gov/pubmed/21632981,21632981,,
1746,1689241,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,9600,PITPNM1,https://ctdbase.org/detail.go?type=gene&acc=9600,,,9600.0,PITPNM1,9606.0,Homo sapiens (human),Quercetin results in increased expression of PITPNM1 mRNA,,,PMID:21632981,https://www.ncbi.nlm.nih.gov/pubmed/21632981,21632981,,
1747,1689699,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,5328,PLAU,https://ctdbase.org/detail.go?type=gene&acc=5328,,,5328.0,PLAU,9606.0,Homo sapiens (human),Quercetin results in increased expression of PLAU protein|dactinomycin inhibits the reaction [quercetin results in increased expression of PLAU mrna],,,PMID:11236827,https://www.ncbi.nlm.nih.gov/pubmed/11236827,11236827,,
1748,1689700,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,5328,PLAU,https://ctdbase.org/detail.go?type=gene&acc=5328,,,5328.0,PLAU,9606.0,Homo sapiens (human),Quercetin results in decreased expression of PLAU mRNA,,,PMID:21308698,https://www.ncbi.nlm.nih.gov/pubmed/21308698,21308698,,
1749,1689701,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,5328,PLAU,https://ctdbase.org/detail.go?type=gene&acc=5328,,,5328.0,PLAU,9606.0,Homo sapiens (human),Quercetin results in decreased expression of PLAU protein,,,PMID:23645742,https://www.ncbi.nlm.nih.gov/pubmed/23645742,23645742,,
1750,1689702,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,5328,PLAU,https://ctdbase.org/detail.go?type=gene&acc=5328,,,5328.0,PLAU,9606.0,Homo sapiens (human),Quercetin results in increased expression of PLAU mRNA,,,PMID:11236827|PMID:12724357,https://www.ncbi.nlm.nih.gov/pubmed/11236827|https://www.ncbi.nlm.nih.gov/pubmed/12724357,11236827|12724357,,
1751,1690309,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,9240,PNMA1,https://ctdbase.org/detail.go?type=gene&acc=9240,,,9240.0,PNMA1,9606.0,Homo sapiens (human),Quercetin results in increased expression of PNMA1 mRNA,,,PMID:21632981,https://www.ncbi.nlm.nih.gov/pubmed/21632981,21632981,,
1752,1690310,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,84968,PNMA6A,https://ctdbase.org/detail.go?type=gene&acc=84968,,,84968.0,PNMA6A,9606.0,Homo sapiens (human),Quercetin results in decreased expression of PNMA6A mRNA,,,PMID:21632981,https://www.ncbi.nlm.nih.gov/pubmed/21632981,21632981,,
1753,1690311,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,4860,PNP,https://ctdbase.org/detail.go?type=gene&acc=4860,,,4860.0,PNP,9606.0,Homo sapiens (human),Quercetin results in increased expression of PNP mRNA,,,PMID:21632981,https://www.ncbi.nlm.nih.gov/pubmed/21632981,21632981,,
1754,1690312,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,57104,PNPLA2,https://ctdbase.org/detail.go?type=gene&acc=57104,,,57104.0,PNPLA2,10090.0,Mus musculus (house mouse),Quercetin inhibits the reaction [dietary fats results in decreased expression of PNPLA2 mrna],,,PMID:24025686,https://www.ncbi.nlm.nih.gov/pubmed/24025686,24025686,,
1755,1690313,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,80339,PNPLA3,https://ctdbase.org/detail.go?type=gene&acc=80339,,,80339.0,PNPLA3,9606.0,Homo sapiens (human),Quercetin results in decreased expression of PNPLA3 mRNA,,,PMID:21632981,https://www.ncbi.nlm.nih.gov/pubmed/21632981,21632981,,
1756,1690314,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,80339,PNPLA3,https://ctdbase.org/detail.go?type=gene&acc=80339,,,80339.0,PNPLA3,10090.0,Mus musculus (house mouse),Quercetin results in decreased expression of PNPLA3 mRNA,,,PMID:17032037,https://www.ncbi.nlm.nih.gov/pubmed/17032037,17032037,,
1757,1691897,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,55844,PPP2R2D,https://ctdbase.org/detail.go?type=gene&acc=55844,,,55844.0,PPP2R2D,9606.0,Homo sapiens (human),Quercetin results in increased expression of PPP2R2D mRNA,,,PMID:30152185,https://www.ncbi.nlm.nih.gov/pubmed/30152185,30152185,,
1758,1692444,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,5576,PRKAR2A,https://ctdbase.org/detail.go?type=gene&acc=5576,,,5576.0,PRKAR2A,9913.0,Bos taurus (cattle),Quercetin results in increased expression of PRKAR2A protein modified form,,,PMID:22488414,https://www.ncbi.nlm.nih.gov/pubmed/22488414,22488414,,
1759,1692614,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,5580,PRKCD,https://ctdbase.org/detail.go?type=gene&acc=5580,,,5580.0,PRKCD,9606.0,Homo sapiens (human),Quercetin inhibits the reaction [tetradecanoylphorbol acetate results in increased phosphorylation of and affects the localization of PRKCD protein]|quercetin inhibits the reaction [histamine results in increased phosphorylation of and affects the localization of PRKCD protein],,,PMID:23333628,https://www.ncbi.nlm.nih.gov/pubmed/23333628,23333628,,
1760,1692615,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,5580,PRKCD,https://ctdbase.org/detail.go?type=gene&acc=5580,,,5580.0,PRKCD,9606.0,Homo sapiens (human),Quercetin inhibits the reaction [oxygen deficiency results in increased activity of and results in increased localization of PRKCD protein],,,PMID:11424089,https://www.ncbi.nlm.nih.gov/pubmed/11424089,11424089,,
1761,1692616,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,5580,PRKCD,https://ctdbase.org/detail.go?type=gene&acc=5580,,,5580.0,PRKCD,9606.0,Homo sapiens (human),Quercetin inhibits the reaction [tetradecanoylphorbol acetate affects the localization of PRKCD protein],,,PMID:18628248,https://www.ncbi.nlm.nih.gov/pubmed/18628248,18628248,,
1762,1692617,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,5580,PRKCD,https://ctdbase.org/detail.go?type=gene&acc=5580,,,5580.0,PRKCD,9606.0,Homo sapiens (human),Quercetin results in decreased activity of and results in decreased phosphorylation of PRKCD protein,,,PMID:19297429,https://www.ncbi.nlm.nih.gov/pubmed/19297429,19297429,,
1763,1692618,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,5580,PRKCD,https://ctdbase.org/detail.go?type=gene&acc=5580,,,5580.0,PRKCD,10090.0,Mus musculus (house mouse),Quercetin affects the localization of PRKCD protein,,,PMID:15538571|PMID:24275163,https://www.ncbi.nlm.nih.gov/pubmed/15538571|https://www.ncbi.nlm.nih.gov/pubmed/24275163,15538571|24275163,,
1764,1692619,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,5580,PRKCD,https://ctdbase.org/detail.go?type=gene&acc=5580,,,5580.0,PRKCD,10090.0,Mus musculus (house mouse),Quercetin results in increased expression of PRKCD mrna|quercetin results in increased cleavage of PRKCD protein,,,PMID:26076811,https://www.ncbi.nlm.nih.gov/pubmed/26076811,26076811,,
1765,1692620,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,5580,PRKCD,https://ctdbase.org/detail.go?type=gene&acc=5580,,,5580.0,PRKCD,10090.0,Mus musculus (house mouse),Tetradecanoylphorbol acetate promotes the reaction [quercetin affects the localization of PRKCD protein],,,PMID:15538571,https://www.ncbi.nlm.nih.gov/pubmed/15538571,15538571,,
1766,1692621,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,5581,PRKCE,https://ctdbase.org/detail.go?type=gene&acc=5581,,,5581.0,PRKCE,10090.0,Mus musculus (house mouse),Quercetin results in decreased expression of PRKCE mRNA,,,PMID:26076811,https://www.ncbi.nlm.nih.gov/pubmed/26076811,26076811,,
1767,1694091,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,5743,PTGS2,https://ctdbase.org/detail.go?type=gene&acc=5743,,,5743.0,PTGS2,9606.0,Homo sapiens (human),Quercetin metabolite results in decreased activity of PTGS2 protein,,,PMID:15225597,https://www.ncbi.nlm.nih.gov/pubmed/15225597,15225597,,
1768,1694092,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,5743,PTGS2,https://ctdbase.org/detail.go?type=gene&acc=5743,,,5743.0,PTGS2,9606.0,Homo sapiens (human),Quercetin metabolite results in decreased expression of PTGS2 mRNA,,,PMID:14988445|PMID:15225597,https://www.ncbi.nlm.nih.gov/pubmed/14988445|https://www.ncbi.nlm.nih.gov/pubmed/15225597,14988445|15225597,,
1769,1686012,5280453,Comparative Toxicogenomics Database (CTD),Calcitriol,D002117,Calcitriol,https://ctdbase.org/detail.go?type=chem&acc=D002117,30844,EHD4,https://ctdbase.org/detail.go?type=gene&acc=30844,,,30844.0,EHD4,9606.0,Homo sapiens (human),Calcitriol results in increased expression of EHD4 mRNA,,,PMID:16002434,https://www.ncbi.nlm.nih.gov/pubmed/16002434,16002434,,
1770,1686013,5280453,Comparative Toxicogenomics Database (CTD),Calcitriol,D002117,Calcitriol,https://ctdbase.org/detail.go?type=chem&acc=D002117,26298,EHF,https://ctdbase.org/detail.go?type=gene&acc=26298,,,26298.0,EHF,9606.0,Homo sapiens (human),Calcitriol results in increased expression of EHF mRNA,,,PMID:26485663,https://www.ncbi.nlm.nih.gov/pubmed/26485663,26485663,,
1771,1686014,5280453,Comparative Toxicogenomics Database (CTD),Calcitriol,D002117,Calcitriol,https://ctdbase.org/detail.go?type=chem&acc=D002117,9451,EIF2AK3,https://ctdbase.org/detail.go?type=gene&acc=9451,,,9451.0,EIF2AK3,9606.0,Homo sapiens (human),[salinomycin co-treated with calcitriol] results in increased expression of EIF2AK3 mRNA,,,PMID:35914560,https://www.ncbi.nlm.nih.gov/pubmed/35914560,35914560,,
1772,1686015,5280453,Comparative Toxicogenomics Database (CTD),Calcitriol,D002117,Calcitriol,https://ctdbase.org/detail.go?type=chem&acc=D002117,440275,EIF2AK4,https://ctdbase.org/detail.go?type=gene&acc=440275,,,440275.0,EIF2AK4,10090.0,Mus musculus (house mouse),Calcitriol affects the expression of EIF2AK4 mRNA,,,PMID:15138306,https://www.ncbi.nlm.nih.gov/pubmed/15138306,15138306,,
1773,1686016,5280453,Comparative Toxicogenomics Database (CTD),Calcitriol,D002117,Calcitriol,https://ctdbase.org/detail.go?type=chem&acc=D002117,1965,EIF2S1,https://ctdbase.org/detail.go?type=gene&acc=1965,,,1965.0,EIF2S1,9606.0,Homo sapiens (human),Calcitriol results in decreased expression of EIF2S1 mRNA,,,PMID:16847355,https://www.ncbi.nlm.nih.gov/pubmed/16847355,16847355,,
1774,1686017,5280453,Comparative Toxicogenomics Database (CTD),Calcitriol,D002117,Calcitriol,https://ctdbase.org/detail.go?type=chem&acc=D002117,8894,EIF2S2,https://ctdbase.org/detail.go?type=gene&acc=8894,,,8894.0,EIF2S2,9606.0,Homo sapiens (human),Calcitriol results in decreased expression of EIF2S2 mRNA,,,PMID:15951637|PMID:16847355,https://www.ncbi.nlm.nih.gov/pubmed/15951637|https://www.ncbi.nlm.nih.gov/pubmed/16847355,15951637|16847355,,
1775,1686018,5280453,Comparative Toxicogenomics Database (CTD),Calcitriol,D002117,Calcitriol,https://ctdbase.org/detail.go?type=chem&acc=D002117,1968,EIF2S3,https://ctdbase.org/detail.go?type=gene&acc=1968,,,1968.0,EIF2S3,9606.0,Homo sapiens (human),Calcitriol results in decreased expression of EIF2S3 mRNA,,,PMID:16847355,https://www.ncbi.nlm.nih.gov/pubmed/16847355,16847355,,
1776,1686408,5280453,Comparative Toxicogenomics Database (CTD),Calcitriol,D002117,Calcitriol,https://ctdbase.org/detail.go?type=chem&acc=D002117,956,ENTPD3,https://ctdbase.org/detail.go?type=gene&acc=956,,,956.0,ENTPD3,9606.0,Homo sapiens (human),Calcitriol results in increased expression of ENTPD3 mRNA,,,PMID:16002434,https://www.ncbi.nlm.nih.gov/pubmed/16002434,16002434,,
1777,1686409,5280453,Comparative Toxicogenomics Database (CTD),Calcitriol,D002117,Calcitriol,https://ctdbase.org/detail.go?type=chem&acc=D002117,377841,ENTPD8,https://ctdbase.org/detail.go?type=gene&acc=377841,,,377841.0,ENTPD8,9606.0,Homo sapiens (human),[testosterone co-treated with calcitriol] results in increased expression of ENTPD8 mrna|calcitriol results in increased expression of ENTPD8 mRNA,,,PMID:21592394,https://www.ncbi.nlm.nih.gov/pubmed/21592394,21592394,,
1778,1686410,5280453,Comparative Toxicogenomics Database (CTD),Calcitriol,D002117,Calcitriol,https://ctdbase.org/detail.go?type=chem&acc=D002117,9413,ENTREP1,https://ctdbase.org/detail.go?type=gene&acc=9413,,,9413.0,ENTREP1,9606.0,Homo sapiens (human),Calcitriol results in increased expression of ENTREP1 mrna|[testosterone co-treated with calcitriol] results in increased expression of ENTREP1 mRNA,,,PMID:21592394,https://www.ncbi.nlm.nih.gov/pubmed/21592394,21592394,,
1779,1686411,5280453,Comparative Toxicogenomics Database (CTD),Calcitriol,D002117,Calcitriol,https://ctdbase.org/detail.go?type=chem&acc=D002117,8320,EOMES,https://ctdbase.org/detail.go?type=gene&acc=8320,,,8320.0,EOMES,9606.0,Homo sapiens (human),Calcitriol results in increased expression of EOMES mRNA,,,PMID:16002434,https://www.ncbi.nlm.nih.gov/pubmed/16002434,16002434,,
1780,1686692,5280453,Comparative Toxicogenomics Database (CTD),Calcitriol,D002117,Calcitriol,https://ctdbase.org/detail.go?type=chem&acc=D002117,9700,ESPL1,https://ctdbase.org/detail.go?type=gene&acc=9700,,,9700.0,ESPL1,9606.0,Homo sapiens (human),[testosterone co-treated with calcitriol] results in decreased expression of ESPL1 mrna|calcitriol results in decreased expression of ESPL1 mRNA,,,PMID:21592394,https://www.ncbi.nlm.nih.gov/pubmed/21592394,21592394,,
1781,1686693,5280453,Comparative Toxicogenomics Database (CTD),Calcitriol,D002117,Calcitriol,https://ctdbase.org/detail.go?type=chem&acc=D002117,2099,ESR1,https://ctdbase.org/detail.go?type=gene&acc=2099,,,2099.0,ESR1,9606.0,Homo sapiens (human),Calcitriol results in increased expression of ESR1 mRNA,,,PMID:16002434|PMID:26485663,https://www.ncbi.nlm.nih.gov/pubmed/16002434|https://www.ncbi.nlm.nih.gov/pubmed/26485663,16002434|26485663,,
1782,1686694,5280453,Comparative Toxicogenomics Database (CTD),Calcitriol,D002117,Calcitriol,https://ctdbase.org/detail.go?type=chem&acc=D002117,54845,ESRP1,https://ctdbase.org/detail.go?type=gene&acc=54845,,,54845.0,ESRP1,9606.0,Homo sapiens (human),Calcitriol results in increased expression of ESRP1 mRNA,,,PMID:26485663,https://www.ncbi.nlm.nih.gov/pubmed/26485663,26485663,,
1783,1686695,5280453,Comparative Toxicogenomics Database (CTD),Calcitriol,D002117,Calcitriol,https://ctdbase.org/detail.go?type=chem&acc=D002117,55224,ETNK2,https://ctdbase.org/detail.go?type=gene&acc=55224,,,55224.0,ETNK2,9606.0,Homo sapiens (human),Calcitriol results in increased expression of ETNK2 mRNA,,,PMID:16002434,https://www.ncbi.nlm.nih.gov/pubmed/16002434,16002434,,
1784,1686696,5280453,Comparative Toxicogenomics Database (CTD),Calcitriol,D002117,Calcitriol,https://ctdbase.org/detail.go?type=chem&acc=D002117,2114,ETS2,https://ctdbase.org/detail.go?type=gene&acc=2114,,,2114.0,ETS2,9606.0,Homo sapiens (human),Calcitriol results in decreased expression of ETS2 mRNA,,,PMID:16002434,https://www.ncbi.nlm.nih.gov/pubmed/16002434,16002434,,
1785,1686697,5280453,Comparative Toxicogenomics Database (CTD),Calcitriol,D002117,Calcitriol,https://ctdbase.org/detail.go?type=chem&acc=D002117,2118,ETV4,https://ctdbase.org/detail.go?type=gene&acc=2118,,,2118.0,ETV4,9606.0,Homo sapiens (human),Calcitriol results in increased expression of ETV4 mRNA,,,PMID:12040012,https://www.ncbi.nlm.nih.gov/pubmed/12040012,12040012,,
1786,1686953,5280453,Comparative Toxicogenomics Database (CTD),Calcitriol,D002117,Calcitriol,https://ctdbase.org/detail.go?type=chem&acc=D002117,2167,FABP4,https://ctdbase.org/detail.go?type=gene&acc=2167,,,2167.0,FABP4,10090.0,Mus musculus (house mouse),Calcitriol inhibits the reaction [1-methyl-3-isobutylxanthine results in increased expression of FABP4 mrna],,,PMID:9564879,https://www.ncbi.nlm.nih.gov/pubmed/9564879,9564879,,
1787,1686954,5280453,Comparative Toxicogenomics Database (CTD),Calcitriol,D002117,Calcitriol,https://ctdbase.org/detail.go?type=chem&acc=D002117,2167,FABP4,https://ctdbase.org/detail.go?type=gene&acc=2167,,,2167.0,FABP4,10090.0,Mus musculus (house mouse),"Pregna-4,17-diene-3,16-dione promotes the reaction [calcitriol results in decreased expression of FABP4 protein]|calcitriol results in decreased expression of FABP4 protein|calcitriol promotes the reaction [pregna-4,17-diene-3,16-dione results in decreased expression of FABP4 protein]",,,PMID:17959142,https://www.ncbi.nlm.nih.gov/pubmed/17959142,17959142,,
1788,1686955,5280453,Comparative Toxicogenomics Database (CTD),Calcitriol,D002117,Calcitriol,https://ctdbase.org/detail.go?type=chem&acc=D002117,2167,FABP4,https://ctdbase.org/detail.go?type=gene&acc=2167,,,2167.0,FABP4,10090.0,Mus musculus (house mouse),Calcitriol results in decreased expression of FABP4 mRNA,,,PMID:16368784|PMID:16813520,https://www.ncbi.nlm.nih.gov/pubmed/16368784|https://www.ncbi.nlm.nih.gov/pubmed/16813520,16368784|16813520,,
1789,1686956,5280453,Comparative Toxicogenomics Database (CTD),Calcitriol,D002117,Calcitriol,https://ctdbase.org/detail.go?type=chem&acc=D002117,3992,FADS1,https://ctdbase.org/detail.go?type=gene&acc=3992,,,3992.0,FADS1,9606.0,Homo sapiens (human),Calcitriol results in increased expression of FADS1 mrna|[testosterone co-treated with calcitriol] results in increased expression of FADS1 mRNA,,,PMID:21592394,https://www.ncbi.nlm.nih.gov/pubmed/21592394,21592394,,
1790,1686957,5280453,Comparative Toxicogenomics Database (CTD),Calcitriol,D002117,Calcitriol,https://ctdbase.org/detail.go?type=chem&acc=D002117,83641,FAM107B,https://ctdbase.org/detail.go?type=gene&acc=83641,,,83641.0,FAM107B,9606.0,Homo sapiens (human),Calcitriol results in increased expression of FAM107B mRNA,,,PMID:16002434,https://www.ncbi.nlm.nih.gov/pubmed/16002434,16002434,,
1791,1686958,5280453,Comparative Toxicogenomics Database (CTD),Calcitriol,D002117,Calcitriol,https://ctdbase.org/detail.go?type=chem&acc=D002117,83541,FAM110A,https://ctdbase.org/detail.go?type=gene&acc=83541,,,83541.0,FAM110A,9606.0,Homo sapiens (human),Calcitriol results in increased expression of FAM110A mRNA,,,PMID:26485663,https://www.ncbi.nlm.nih.gov/pubmed/26485663,26485663,,
1792,1686959,5280453,Comparative Toxicogenomics Database (CTD),Calcitriol,D002117,Calcitriol,https://ctdbase.org/detail.go?type=chem&acc=D002117,642273,FAM110C,https://ctdbase.org/detail.go?type=gene&acc=642273,,,642273.0,FAM110C,9606.0,Homo sapiens (human),Calcitriol results in increased expression of FAM110C mRNA,,,PMID:21592394|PMID:26485663,https://www.ncbi.nlm.nih.gov/pubmed/21592394|https://www.ncbi.nlm.nih.gov/pubmed/26485663,21592394|26485663,,
1793,1686960,5280453,Comparative Toxicogenomics Database (CTD),Calcitriol,D002117,Calcitriol,https://ctdbase.org/detail.go?type=chem&acc=D002117,642273,FAM110C,https://ctdbase.org/detail.go?type=gene&acc=642273,,,642273.0,FAM110C,9606.0,Homo sapiens (human),[testosterone co-treated with calcitriol] results in increased expression of FAM110C mRNA,,,PMID:21592394,https://www.ncbi.nlm.nih.gov/pubmed/21592394,21592394,,
1794,1687090,5280453,Comparative Toxicogenomics Database (CTD),Calcitriol,D002117,Calcitriol,https://ctdbase.org/detail.go?type=chem&acc=D002117,374393,FAM111B,https://ctdbase.org/detail.go?type=gene&acc=374393,,,374393.0,FAM111B,9606.0,Homo sapiens (human),[testosterone co-treated with calcitriol] results in decreased expression of FAM111B mrna|calcitriol results in decreased expression of FAM111B mRNA,,,PMID:21592394,https://www.ncbi.nlm.nih.gov/pubmed/21592394,21592394,,
1795,1687091,5280453,Comparative Toxicogenomics Database (CTD),Calcitriol,D002117,Calcitriol,https://ctdbase.org/detail.go?type=chem&acc=D002117,9715,FAM131B,https://ctdbase.org/detail.go?type=gene&acc=9715,,,9715.0,FAM131B,9606.0,Homo sapiens (human),[testosterone co-treated with calcitriol] results in increased expression of FAM131B mrna|calcitriol results in increased expression of FAM131B mRNA,,,PMID:21592394,https://www.ncbi.nlm.nih.gov/pubmed/21592394,21592394,,
1796,1687092,5280453,Comparative Toxicogenomics Database (CTD),Calcitriol,D002117,Calcitriol,https://ctdbase.org/detail.go?type=chem&acc=D002117,29057,FAM156A,https://ctdbase.org/detail.go?type=gene&acc=29057,,,29057.0,FAM156A,9606.0,Homo sapiens (human),[testosterone co-treated with calcitriol] results in decreased expression of FAM156A mrna|calcitriol results in decreased expression of FAM156A mRNA,,,PMID:21592394,https://www.ncbi.nlm.nih.gov/pubmed/21592394,21592394,,
1797,1687093,5280453,Comparative Toxicogenomics Database (CTD),Calcitriol,D002117,Calcitriol,https://ctdbase.org/detail.go?type=chem&acc=D002117,63920,FAM200C,https://ctdbase.org/detail.go?type=gene&acc=63920,,,63920.0,FAM200C,9606.0,Homo sapiens (human),Calcitriol results in increased expression of FAM200C mRNA,,,PMID:16002434,https://www.ncbi.nlm.nih.gov/pubmed/16002434,16002434,,
1798,1687094,5280453,Comparative Toxicogenomics Database (CTD),Calcitriol,D002117,Calcitriol,https://ctdbase.org/detail.go?type=chem&acc=D002117,56975,FAM20C,https://ctdbase.org/detail.go?type=gene&acc=56975,,,56975.0,FAM20C,9606.0,Homo sapiens (human),Calcitriol results in increased expression of FAM20C mRNA,,,PMID:16002434,https://www.ncbi.nlm.nih.gov/pubmed/16002434,16002434,,
1799,1690095,5280453,Comparative Toxicogenomics Database (CTD),Calcitriol,D002117,Calcitriol,https://ctdbase.org/detail.go?type=chem&acc=D002117,26585,GREM1,https://ctdbase.org/detail.go?type=gene&acc=26585,,,26585.0,GREM1,9606.0,Homo sapiens (human),Calcitriol results in decreased expression of GREM1 mRNA,,,PMID:16002434|PMID:26485663,https://www.ncbi.nlm.nih.gov/pubmed/16002434|https://www.ncbi.nlm.nih.gov/pubmed/26485663,16002434|26485663,,
1800,1690968,5280453,Comparative Toxicogenomics Database (CTD),Calcitriol,D002117,Calcitriol,https://ctdbase.org/detail.go?type=chem&acc=D002117,3146,HMGB1,https://ctdbase.org/detail.go?type=gene&acc=3146,,,3146.0,HMGB1,9606.0,Homo sapiens (human),[testosterone co-treated with calcitriol] results in decreased expression of HMGB1 mrna|calcitriol results in decreased expression of HMGB1 mRNA,,,PMID:21592394,https://www.ncbi.nlm.nih.gov/pubmed/21592394,21592394,,
1801,1690969,5280453,Comparative Toxicogenomics Database (CTD),Calcitriol,D002117,Calcitriol,https://ctdbase.org/detail.go?type=chem&acc=D002117,3146,HMGB1,https://ctdbase.org/detail.go?type=gene&acc=3146,,,3146.0,HMGB1,10116.0,Rattus norvegicus (Norway rat),Calcitriol results in decreased expression of HMGB1 mrna|calcitriol results in decreased expression of HMGB1 protein,,,PMID:32147540,https://www.ncbi.nlm.nih.gov/pubmed/32147540,32147540,,
1802,1691245,5280453,Comparative Toxicogenomics Database (CTD),Calcitriol,D002117,Calcitriol,https://ctdbase.org/detail.go?type=chem&acc=D002117,9455,HOMER2,https://ctdbase.org/detail.go?type=gene&acc=9455,,,9455.0,HOMER2,9606.0,Homo sapiens (human),Calcitriol results in increased expression of HOMER2 mRNA,,,PMID:26485663,https://www.ncbi.nlm.nih.gov/pubmed/26485663,26485663,,
1803,1691246,5280453,Comparative Toxicogenomics Database (CTD),Calcitriol,D002117,Calcitriol,https://ctdbase.org/detail.go?type=chem&acc=D002117,51361,HOOK1,https://ctdbase.org/detail.go?type=gene&acc=51361,,,51361.0,HOOK1,9606.0,Homo sapiens (human),Calcitriol results in increased expression of HOOK1 mRNA,,,PMID:26485663,https://www.ncbi.nlm.nih.gov/pubmed/26485663,26485663,,
1804,1691247,5280453,Comparative Toxicogenomics Database (CTD),Calcitriol,D002117,Calcitriol,https://ctdbase.org/detail.go?type=chem&acc=D002117,3206,HOXA10,https://ctdbase.org/detail.go?type=gene&acc=3206,,,3206.0,HOXA10,9606.0,Homo sapiens (human),[calcitriol binds to VDR protein] which results in increased expression of HOXA10 mrna|[calcitriol binds to VDR protein] which binds to HOXA10 promoter|calcitriol affects the expression of HOXA10 mRNA,,,PMID:16632680,https://www.ncbi.nlm.nih.gov/pubmed/16632680,16632680,,
1805,1691248,5280453,Comparative Toxicogenomics Database (CTD),Calcitriol,D002117,Calcitriol,https://ctdbase.org/detail.go?type=chem&acc=D002117,3202,HOXA5,https://ctdbase.org/detail.go?type=gene&acc=3202,,,3202.0,HOXA5,9606.0,Homo sapiens (human),Calcitriol results in decreased expression of HOXA5 mrna|[testosterone co-treated with calcitriol] results in decreased expression of HOXA5 mRNA,,,PMID:21592394,https://www.ncbi.nlm.nih.gov/pubmed/21592394,21592394,,
1806,1691249,5280453,Comparative Toxicogenomics Database (CTD),Calcitriol,D002117,Calcitriol,https://ctdbase.org/detail.go?type=chem&acc=D002117,3240,HP,https://ctdbase.org/detail.go?type=gene&acc=3240,,,3240.0,HP,9606.0,Homo sapiens (human),Calcitriol results in increased expression of HP protein,,,PMID:27107558,https://www.ncbi.nlm.nih.gov/pubmed/27107558,27107558,,
1807,1691250,5280453,Comparative Toxicogenomics Database (CTD),Calcitriol,D002117,Calcitriol,https://ctdbase.org/detail.go?type=chem&acc=D002117,3248,HPGD,https://ctdbase.org/detail.go?type=gene&acc=3248,,,3248.0,HPGD,9606.0,Homo sapiens (human),[testosterone co-treated with calcitriol] results in increased expression of HPGD mrna|calcitriol results in increased expression of HPGD mRNA,,,PMID:21592394,https://www.ncbi.nlm.nih.gov/pubmed/21592394,21592394,,
1808,1691251,5280453,Comparative Toxicogenomics Database (CTD),Calcitriol,D002117,Calcitriol,https://ctdbase.org/detail.go?type=chem&acc=D002117,3249,HPN,https://ctdbase.org/detail.go?type=gene&acc=3249,,,3249.0,HPN,9606.0,Homo sapiens (human),Calcitriol results in increased expression of HPN mRNA,,,PMID:26485663,https://www.ncbi.nlm.nih.gov/pubmed/26485663,26485663,,
1809,1691252,5280453,Comparative Toxicogenomics Database (CTD),Calcitriol,D002117,Calcitriol,https://ctdbase.org/detail.go?type=chem&acc=D002117,3251,HPRT1,https://ctdbase.org/detail.go?type=gene&acc=3251,,,3251.0,HPRT1,9606.0,Homo sapiens (human),[testosterone co-treated with calcitriol] results in decreased expression of HPRT1 mrna|calcitriol results in decreased expression of HPRT1 mRNA,,,PMID:21592394,https://www.ncbi.nlm.nih.gov/pubmed/21592394,21592394,,
1810,1685229,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,9481,SLC25A27,https://ctdbase.org/detail.go?type=gene&acc=9481,,,9481.0,SLC25A27,9606.0,Homo sapiens (human),Cyclosporine results in increased expression of SLC25A27 mRNA,,,PMID:27989131,https://www.ncbi.nlm.nih.gov/pubmed/27989131,27989131,,
1811,1685230,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,81894,SLC25A28,https://ctdbase.org/detail.go?type=gene&acc=81894,,,81894.0,SLC25A28,10090.0,Mus musculus (house mouse),Cyclosporine results in increased expression of SLC25A28 mRNA,,,PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/19770486,19770486,,
1812,1685231,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,5250,SLC25A3,https://ctdbase.org/detail.go?type=gene&acc=5250,,,5250.0,SLC25A3,9606.0,Homo sapiens (human),Cyclosporine results in decreased expression of SLC25A3 mRNA,,,PMID:25562108,https://www.ncbi.nlm.nih.gov/pubmed/25562108,25562108,,
1813,1685232,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,5250,SLC25A3,https://ctdbase.org/detail.go?type=gene&acc=5250,,,5250.0,SLC25A3,9606.0,Homo sapiens (human),Cyclosporine results in increased methylation of SLC25A3 promoter,,,PMID:27989131,https://www.ncbi.nlm.nih.gov/pubmed/27989131,27989131,,
1814,1685233,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,5250,SLC25A3,https://ctdbase.org/detail.go?type=gene&acc=5250,,,5250.0,SLC25A3,10116.0,Rattus norvegicus (Norway rat),Cyclosporine inhibits the reaction [SLC25A3 protein binds to PPIF protein],,,PMID:18667415,https://www.ncbi.nlm.nih.gov/pubmed/18667415,18667415,,
1815,1685234,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,253512,SLC25A30,https://ctdbase.org/detail.go?type=gene&acc=253512,,,253512.0,SLC25A30,9606.0,Homo sapiens (human),Cyclosporine results in decreased expression of SLC25A30 mRNA,,,PMID:25562108,https://www.ncbi.nlm.nih.gov/pubmed/25562108,25562108,,
1816,1685235,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,81034,SLC25A32,https://ctdbase.org/detail.go?type=gene&acc=81034,,,81034.0,SLC25A32,9606.0,Homo sapiens (human),Cyclosporine results in increased expression of SLC25A32 mRNA,,,PMID:20106945|PMID:25562108,https://www.ncbi.nlm.nih.gov/pubmed/20106945|https://www.ncbi.nlm.nih.gov/pubmed/25562108,20106945|25562108,,
1817,1685236,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,84275,SLC25A33,https://ctdbase.org/detail.go?type=gene&acc=84275,,,84275.0,SLC25A33,9606.0,Homo sapiens (human),Cyclosporine results in decreased expression of SLC25A33 mRNA,,,PMID:20106945,https://www.ncbi.nlm.nih.gov/pubmed/20106945,20106945,,
1818,1687714,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,8671,SLC4A4,https://ctdbase.org/detail.go?type=gene&acc=8671,,,8671.0,SLC4A4,10090.0,Mus musculus (house mouse),Cyclosporine results in decreased expression of SLC4A4 mRNA,,,PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/19770486,19770486,,
1819,1687715,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,23446,SLC44A1,https://ctdbase.org/detail.go?type=gene&acc=23446,,,23446.0,SLC44A1,9606.0,Homo sapiens (human),Cyclosporine results in decreased expression of SLC44A1 mRNA,,,PMID:24907557|PMID:25562108,https://www.ncbi.nlm.nih.gov/pubmed/24907557|https://www.ncbi.nlm.nih.gov/pubmed/25562108,24907557|25562108,,
1820,1687716,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,23446,SLC44A1,https://ctdbase.org/detail.go?type=gene&acc=23446,,,23446.0,SLC44A1,9606.0,Homo sapiens (human),Cyclosporine results in increased expression of SLC44A1 mRNA,,,PMID:27989131,https://www.ncbi.nlm.nih.gov/pubmed/27989131,27989131,,
1821,1687717,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,57153,SLC44A2,https://ctdbase.org/detail.go?type=gene&acc=57153,,,57153.0,SLC44A2,9606.0,Homo sapiens (human),Cyclosporine results in decreased expression of SLC44A2 mRNA,,,PMID:24907557,https://www.ncbi.nlm.nih.gov/pubmed/24907557,24907557,,
1822,1687718,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,57153,SLC44A2,https://ctdbase.org/detail.go?type=gene&acc=57153,,,57153.0,SLC44A2,9606.0,Homo sapiens (human),Cyclosporine results in increased expression of SLC44A2 mRNA,,,PMID:25562108,https://www.ncbi.nlm.nih.gov/pubmed/25562108,25562108,,
1823,1687719,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,126969,SLC44A3,https://ctdbase.org/detail.go?type=gene&acc=126969,,,126969.0,SLC44A3,9606.0,Homo sapiens (human),Cyclosporine results in decreased expression of SLC44A3 mRNA,,,PMID:20106945|PMID:24907557|PMID:25562108|PMID:27989131,https://www.ncbi.nlm.nih.gov/pubmed/20106945|https://www.ncbi.nlm.nih.gov/pubmed/24907557|https://www.ncbi.nlm.nih.gov/pubmed/25562108|https://www.ncbi.nlm.nih.gov/pubmed/27989131,20106945|24907557|25562108|27989131,,
1824,1687720,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,80736,SLC44A4,https://ctdbase.org/detail.go?type=gene&acc=80736,,,80736.0,SLC44A4,9606.0,Homo sapiens (human),Cyclosporine results in decreased expression of SLC44A4 mRNA,,,PMID:25562108,https://www.ncbi.nlm.nih.gov/pubmed/25562108,25562108,,
1825,1687721,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,204962,SLC44A5,https://ctdbase.org/detail.go?type=gene&acc=204962,,,204962.0,SLC44A5,9606.0,Homo sapiens (human),Cyclosporine results in decreased expression of SLC44A5 mRNA,,,PMID:20106945|PMID:25562108,https://www.ncbi.nlm.nih.gov/pubmed/20106945|https://www.ncbi.nlm.nih.gov/pubmed/25562108,20106945|25562108,,
1826,1688075,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,123264,SLC51B,https://ctdbase.org/detail.go?type=gene&acc=123264,,,123264.0,SLC51B,9606.0,Homo sapiens (human),Cyclosporine results in decreased expression of SLC51B mRNA,,,PMID:25562108|PMID:32253466|PMID:34681664,https://www.ncbi.nlm.nih.gov/pubmed/25562108|https://www.ncbi.nlm.nih.gov/pubmed/32253466|https://www.ncbi.nlm.nih.gov/pubmed/34681664,25562108|32253466|34681664,,
1827,1688076,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,123264,SLC51B,https://ctdbase.org/detail.go?type=gene&acc=123264,,,123264.0,SLC51B,9606.0,Homo sapiens (human),Cyclosporine results in increased expression of SLC51B mRNA,,,PMID:20106945|PMID:21632981|PMID:27989131,https://www.ncbi.nlm.nih.gov/pubmed/20106945|https://www.ncbi.nlm.nih.gov/pubmed/21632981|https://www.ncbi.nlm.nih.gov/pubmed/27989131,20106945|21632981|27989131,,
1828,1688077,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,79581,SLC52A2,https://ctdbase.org/detail.go?type=gene&acc=79581,,,79581.0,SLC52A2,9606.0,Homo sapiens (human),Cyclosporine results in increased expression of SLC52A2 mRNA,,,PMID:20106945,https://www.ncbi.nlm.nih.gov/pubmed/20106945,20106945,,
1829,1691071,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,23642,SNHG1,https://ctdbase.org/detail.go?type=gene&acc=23642,,,23642.0,SNHG1,9606.0,Homo sapiens (human),Cyclosporine results in increased expression of SNHG1 mRNA,,,PMID:20106945,https://www.ncbi.nlm.nih.gov/pubmed/20106945,20106945,,
1830,1691072,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,285958,SNHG15,https://ctdbase.org/detail.go?type=gene&acc=285958,,,285958.0,SNHG15,9606.0,Homo sapiens (human),Cyclosporine results in increased expression of SNHG15 mRNA,,,PMID:20106945,https://www.ncbi.nlm.nih.gov/pubmed/20106945,20106945,,
1831,1691073,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,388796,SNHG17,https://ctdbase.org/detail.go?type=gene&acc=388796,,,388796.0,SNHG17,9606.0,Homo sapiens (human),Cyclosporine results in increased expression of SNHG17 mRNA,,,PMID:27989131,https://www.ncbi.nlm.nih.gov/pubmed/27989131,27989131,,
1832,1691373,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,677838,SNORA61,https://ctdbase.org/detail.go?type=gene&acc=677838,,,677838.0,SNORA61,9606.0,Homo sapiens (human),Cyclosporine results in increased expression of SNORA61 mRNA,,,PMID:20106945,https://www.ncbi.nlm.nih.gov/pubmed/20106945,20106945,,
1833,1691374,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,26784,SNORA64,https://ctdbase.org/detail.go?type=gene&acc=26784,,,26784.0,SNORA64,9606.0,Homo sapiens (human),Cyclosporine results in decreased expression of SNORA64 mRNA,,,PMID:21632981,https://www.ncbi.nlm.nih.gov/pubmed/21632981,21632981,,
1834,1691375,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,26784,SNORA64,https://ctdbase.org/detail.go?type=gene&acc=26784,,,26784.0,SNORA64,9606.0,Homo sapiens (human),Cyclosporine results in increased expression of SNORA64 mRNA,,,PMID:20106945,https://www.ncbi.nlm.nih.gov/pubmed/20106945,20106945,,
1835,1691376,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,389084,SNORC,https://ctdbase.org/detail.go?type=gene&acc=389084,,,389084.0,SNORC,9606.0,Homo sapiens (human),Cyclosporine results in increased expression of SNORC mRNA,,,PMID:27989131,https://www.ncbi.nlm.nih.gov/pubmed/27989131,27989131,,
1836,1692092,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,8651,SOCS1,https://ctdbase.org/detail.go?type=gene&acc=8651,,,8651.0,SOCS1,9606.0,Homo sapiens (human),Cyclosporine results in decreased expression of SOCS1 mRNA,,,PMID:25562108,https://www.ncbi.nlm.nih.gov/pubmed/25562108,25562108,,
1837,1692093,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,8651,SOCS1,https://ctdbase.org/detail.go?type=gene&acc=8651,,,8651.0,SOCS1,9606.0,Homo sapiens (human),Cyclosporine results in decreased methylation of SOCS1 promoter,,,PMID:27989131,https://www.ncbi.nlm.nih.gov/pubmed/27989131,27989131,,
1838,1692094,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,445073,SOCS1A,https://ctdbase.org/detail.go?type=gene&acc=445073,,,445073.0,socs1a,7955.0,Danio rerio (zebrafish),Cyclosporine affects the expression of SOCS1A mRNA,,,PMID:25064622,https://www.ncbi.nlm.nih.gov/pubmed/25064622,25064622,,
1839,1692095,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,8835,SOCS2,https://ctdbase.org/detail.go?type=gene&acc=8835,,,8835.0,SOCS2,7955.0,Danio rerio (zebrafish),Cyclosporine affects the expression of SOCS2 mRNA,,,PMID:25064622,https://www.ncbi.nlm.nih.gov/pubmed/25064622,25064622,,
1840,1692682,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,6659,SOX4,https://ctdbase.org/detail.go?type=gene&acc=6659,,,6659.0,SOX4,9606.0,Homo sapiens (human),Cyclosporine results in increased expression of SOX4 mRNA,,,PMID:25562108,https://www.ncbi.nlm.nih.gov/pubmed/25562108,25562108,,
1841,1692683,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,6660,SOX5,https://ctdbase.org/detail.go?type=gene&acc=6660,,,6660.0,SOX5,9606.0,Homo sapiens (human),Cyclosporine results in decreased expression of SOX5 mRNA,,,PMID:25562108,https://www.ncbi.nlm.nih.gov/pubmed/25562108,25562108,,
1842,1692684,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,55553,SOX6,https://ctdbase.org/detail.go?type=gene&acc=55553,,,55553.0,SOX6,9606.0,Homo sapiens (human),Cyclosporine results in decreased expression of SOX6 mRNA,,,PMID:25562108|PMID:27989131,https://www.ncbi.nlm.nih.gov/pubmed/25562108|https://www.ncbi.nlm.nih.gov/pubmed/27989131,25562108|27989131,,
1843,1694024,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,161742,SPRED1,https://ctdbase.org/detail.go?type=gene&acc=161742,,,161742.0,SPRED1,9606.0,Homo sapiens (human),Cyclosporine results in increased expression of SPRED1 mRNA,,,PMID:20106945,https://www.ncbi.nlm.nih.gov/pubmed/20106945,20106945,,
1844,1694025,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,161742,SPRED1,https://ctdbase.org/detail.go?type=gene&acc=161742,,,161742.0,SPRED1,10090.0,Mus musculus (house mouse),Cyclosporine results in increased expression of SPRED1 mRNA,,,PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/19770486,19770486,,
1845,1685454,5328127,BindingDB,"1-[2-Amino-6-(3,5-dimethoxyphenyl)pyrido[2,3-d]pyrimidin-7-yl]-3-tert-butylurea",3443,"1-[2-amino-6-(3,5-dimethoxyphenyl)pyrido[2,3-d]pyrimidin-7-yl]-3-tert-butylurea",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=3443,13,Proto-oncogene tyrosine-protein kinase Src,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=13,P12931,Proto-oncogene tyrosine-protein kinase Src,6714.0,SRC,9606.0,Homo sapiens (human),,IC50 (nM),>50000,DOI:10.1074/jbc.M606873200,https://doi.org/10.1074/jbc.M606873200,,10.1074/jbc.M606873200,
1846,1685455,5328940,Drug Gene Interaction database (DGIdb),Bosutinib,,BOSUTINIB,https://www.dgidb.org/drugs/rxcui:1307619,,ABL1,https://www.dgidb.org/genes/hgnc:76,,,25.0,ABL1,9606.0,Homo sapiens (human),,,,,,,,
1847,1685456,5328940,Drug Gene Interaction database (DGIdb),Bosutinib,,BOSUTINIB,https://www.dgidb.org/drugs/rxcui:1307619,,ABL1,https://www.dgidb.org/genes/hgnc:76,,,25.0,ABL1,9606.0,Homo sapiens (human),,,,,,,,
1848,1685457,5328940,Drug Gene Interaction database (DGIdb),Bosutinib,,BOSUTINIB,https://www.dgidb.org/drugs/rxcui:1307619,,ABL1,https://www.dgidb.org/genes/hgnc:76,,,25.0,ABL1,9606.0,Homo sapiens (human),,,,,,,,
1849,1685458,5328940,Drug Gene Interaction database (DGIdb),Bosutinib,,BOSUTINIB,https://www.dgidb.org/drugs/rxcui:1307619,,LYN,https://www.dgidb.org/genes/hgnc:6735,,,4067.0,LYN,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
1850,1685459,5328969,DrugBank,(2e)-N-{4-[(3-Bromophenyl)amino]quinazolin-6-Yl}-4-(Dimethylamino)but-2-Enamide,DB08564,(2E)-N-{4-[(3-bromophenyl)amino]quinazolin-6-yl}-4-(dimethylamino)but-2-enamide,https://www.drugbank.ca/drugs/DB08564,BE0000838,Proto-oncogene tyrosine-protein kinase Src,https://www.drugbank.ca/bio_entities/BE0000838,P12931,Proto-oncogene tyrosine-protein kinase Src,6714.0,SRC,9606.0,Homo sapiens (human),,,,PMID:10592235,https://www.ncbi.nlm.nih.gov/pubmed/10592235,10592235,,
1851,1688861,5329126,BindingDB,"1-[2-Amino-6-(3,5-diethylphenyl)pyrido[2,3-d]pyrimidin-7-yl]-3-tert-butylurea",4842,"1-[2-amino-6-(3,5-diethylphenyl)pyrido[2,3-d]pyrimidin-7-yl]-3-tert-butylurea",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=4842,13,Proto-oncogene tyrosine-protein kinase Src,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=13,P12931,Proto-oncogene tyrosine-protein kinase Src,6714.0,SRC,9606.0,Homo sapiens (human),,IC50 (nM),>50000,DOI:10.1074/jbc.M606873200,https://doi.org/10.1074/jbc.M606873200,,10.1074/jbc.M606873200,
1852,1688862,5329126,BindingDB,"1-[2-Amino-6-(3,5-diethylphenyl)pyrido[2,3-d]pyrimidin-7-yl]-3-tert-butylurea",4842,"1-[2-amino-6-(3,5-diethylphenyl)pyrido[2,3-d]pyrimidin-7-yl]-3-tert-butylurea",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=4842,694,Fibroblast growth factor receptor 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=694,P11362,Fibroblast growth factor receptor 1,2260.0,FGFR1,9606.0,Homo sapiens (human),,IC50 (nM),7760,DOI:10.1074/jbc.M606873200,https://doi.org/10.1074/jbc.M606873200,,10.1074/jbc.M606873200,
1853,1688863,5329127,BindingDB,"1-[2-Amino-6-(2-methoxyphenyl)pyrido[2,3-d]pyrimidin-7-yl]-3-tert-butylurea",4843,"1-[2-amino-6-(2-methoxyphenyl)pyrido[2,3-d]pyrimidin-7-yl]-3-tert-butylurea",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=4843,694,Fibroblast growth factor receptor 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=694,P11362,Fibroblast growth factor receptor 1,2260.0,FGFR1,9606.0,Homo sapiens (human),,IC50 (nM),11220,DOI:10.1074/jbc.M606873200,https://doi.org/10.1074/jbc.M606873200,,10.1074/jbc.M606873200,
1854,1688864,5329127,BindingDB,"1-[2-Amino-6-(2-methoxyphenyl)pyrido[2,3-d]pyrimidin-7-yl]-3-tert-butylurea",4843,"1-[2-amino-6-(2-methoxyphenyl)pyrido[2,3-d]pyrimidin-7-yl]-3-tert-butylurea",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=4843,13,Proto-oncogene tyrosine-protein kinase Src,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=13,P12931,Proto-oncogene tyrosine-protein kinase Src,6714.0,SRC,9606.0,Homo sapiens (human),,IC50 (nM),10430,DOI:10.1074/jbc.M606873200,https://doi.org/10.1074/jbc.M606873200,,10.1074/jbc.M606873200,
1855,1688865,5329127,BindingDB,"1-[2-Amino-6-(2-methoxyphenyl)pyrido[2,3-d]pyrimidin-7-yl]-3-tert-butylurea",4843,"1-[2-amino-6-(2-methoxyphenyl)pyrido[2,3-d]pyrimidin-7-yl]-3-tert-butylurea",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=4843,575,Platelet-derived growth factor receptor beta,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=575,P09619,Platelet-derived growth factor receptor beta,5159.0,PDGFRB,9606.0,Homo sapiens (human),,IC50 (nM),4480,DOI:10.1074/jbc.M606873200,https://doi.org/10.1074/jbc.M606873200,,10.1074/jbc.M606873200,
1856,1689961,5329140,BindingDB,3-Substituted indolin-2-one 11c,4889,"3-(4-methyl-5-{[(3Z)-2-oxo-5-sulfamoyl-2,3-dihydro-1H-indol-3-ylidene]methyl}-1H-pyrrol-3-yl)propanoic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=4889,520,Epidermal growth factor receptor,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=520,P00533,Epidermal growth factor receptor,1956.0,EGFR,9606.0,Homo sapiens (human),,IC50 (nM),>100000,PMID:10602697|DOI:10.1021/jm9904295,https://www.ncbi.nlm.nih.gov/pubmed/10602697|https://doi.org/10.1021/jm9904295,10602697,10.1021/jm9904295,
1857,1689962,5329141,BindingDB,3-Substituted indolin-2-one 11d,4890,"3-(5-{[(3Z)-6-methoxy-2-oxo-2,3-dihydro-1H-indol-3-ylidene]methyl}-4-methyl-1H-pyrrol-3-yl)propanoic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=4890,520,Epidermal growth factor receptor,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=520,P00533,Epidermal growth factor receptor,1956.0,EGFR,9606.0,Homo sapiens (human),,IC50 (nM),>100000,PMID:10602697|DOI:10.1021/jm9904295,https://www.ncbi.nlm.nih.gov/pubmed/10602697|https://doi.org/10.1021/jm9904295,10602697,10.1021/jm9904295,
1858,1689963,5329141,BindingDB,3-Substituted indolin-2-one 11d,4890,"3-(5-{[(3Z)-6-methoxy-2-oxo-2,3-dihydro-1H-indol-3-ylidene]methyl}-4-methyl-1H-pyrrol-3-yl)propanoic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=4890,692,Vascular endothelial growth factor receptor 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=692,P35968,Vascular endothelial growth factor receptor 2,3791.0,KDR,9606.0,Homo sapiens (human),,IC50 (nM),1350,PMID:10602697|DOI:10.1021/jm9904295,https://www.ncbi.nlm.nih.gov/pubmed/10602697|https://doi.org/10.1021/jm9904295,10602697,10.1021/jm9904295,
1859,1689964,5329141,BindingDB,3-Substituted indolin-2-one 11d,4890,"3-(5-{[(3Z)-6-methoxy-2-oxo-2,3-dihydro-1H-indol-3-ylidene]methyl}-4-methyl-1H-pyrrol-3-yl)propanoic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=4890,694,Fibroblast growth factor receptor 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=694,P11362,Fibroblast growth factor receptor 1,2260.0,FGFR1,9606.0,Homo sapiens (human),,IC50 (nM),3890,PMID:10602697|DOI:10.1021/jm9904295,https://www.ncbi.nlm.nih.gov/pubmed/10602697|https://doi.org/10.1021/jm9904295,10602697,10.1021/jm9904295,
1860,1690088,5329141,BindingDB,3-Substituted indolin-2-one 11d,4890,"3-(5-{[(3Z)-6-methoxy-2-oxo-2,3-dihydro-1H-indol-3-ylidene]methyl}-4-methyl-1H-pyrrol-3-yl)propanoic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=4890,575,Platelet-derived growth factor receptor beta,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=575,P09619,Platelet-derived growth factor receptor beta,5159.0,PDGFRB,9606.0,Homo sapiens (human),,IC50 (nM),140,PMID:10602697|DOI:10.1021/jm9904295,https://www.ncbi.nlm.nih.gov/pubmed/10602697|https://doi.org/10.1021/jm9904295,10602697,10.1021/jm9904295,
1861,1690089,5329142,BindingDB,3-Substituted indolin-2-one 11e,4891,"3-(4-methyl-5-{[(3Z)-2-oxo-6-phenyl-2,3-dihydro-1H-indol-3-ylidene]methyl}-1H-pyrrol-3-yl)propanoic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=4891,575,Platelet-derived growth factor receptor beta,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=575,P09619,Platelet-derived growth factor receptor beta,5159.0,PDGFRB,9606.0,Homo sapiens (human),,IC50 (nM),160,PMID:10602697|DOI:10.1021/jm9904295,https://www.ncbi.nlm.nih.gov/pubmed/10602697|https://doi.org/10.1021/jm9904295,10602697,10.1021/jm9904295,
1862,1690090,5329142,BindingDB,3-Substituted indolin-2-one 11e,4891,"3-(4-methyl-5-{[(3Z)-2-oxo-6-phenyl-2,3-dihydro-1H-indol-3-ylidene]methyl}-1H-pyrrol-3-yl)propanoic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=4891,694,Fibroblast growth factor receptor 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=694,P11362,Fibroblast growth factor receptor 1,2260.0,FGFR1,9606.0,Homo sapiens (human),,IC50 (nM),1050,PMID:10602697|DOI:10.1021/jm9904295,https://www.ncbi.nlm.nih.gov/pubmed/10602697|https://doi.org/10.1021/jm9904295,10602697,10.1021/jm9904295,
1863,1690091,5329142,BindingDB,3-Substituted indolin-2-one 11e,4891,"3-(4-methyl-5-{[(3Z)-2-oxo-6-phenyl-2,3-dihydro-1H-indol-3-ylidene]methyl}-1H-pyrrol-3-yl)propanoic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=4891,692,Vascular endothelial growth factor receptor 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=692,P35968,Vascular endothelial growth factor receptor 2,3791.0,KDR,9606.0,Homo sapiens (human),,IC50 (nM),300,PMID:10602697|DOI:10.1021/jm9904295,https://www.ncbi.nlm.nih.gov/pubmed/10602697|https://doi.org/10.1021/jm9904295,10602697,10.1021/jm9904295,
1864,1690092,5329142,BindingDB,3-Substituted indolin-2-one 11e,4891,"3-(4-methyl-5-{[(3Z)-2-oxo-6-phenyl-2,3-dihydro-1H-indol-3-ylidene]methyl}-1H-pyrrol-3-yl)propanoic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=4891,520,Epidermal growth factor receptor,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=520,P00533,Epidermal growth factor receptor,1956.0,EGFR,9606.0,Homo sapiens (human),,IC50 (nM),>100000,PMID:10602697|DOI:10.1021/jm9904295,https://www.ncbi.nlm.nih.gov/pubmed/10602697|https://doi.org/10.1021/jm9904295,10602697,10.1021/jm9904295,
1865,1690093,5329143,BindingDB,3-Substituted indolin-2-one 11f,4892,"3-(5-{[(3Z)-6-(3-methoxyphenyl)-2-oxo-2,3-dihydro-1H-indol-3-ylidene]methyl}-4-methyl-1H-pyrrol-3-yl)propanoic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=4892,520,Epidermal growth factor receptor,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=520,P00533,Epidermal growth factor receptor,1956.0,EGFR,9606.0,Homo sapiens (human),,IC50 (nM),>100000,PMID:10602697|DOI:10.1021/jm9904295,https://www.ncbi.nlm.nih.gov/pubmed/10602697|https://doi.org/10.1021/jm9904295,10602697,10.1021/jm9904295,
1866,1690094,5329143,BindingDB,3-Substituted indolin-2-one 11f,4892,"3-(5-{[(3Z)-6-(3-methoxyphenyl)-2-oxo-2,3-dihydro-1H-indol-3-ylidene]methyl}-4-methyl-1H-pyrrol-3-yl)propanoic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=4892,692,Vascular endothelial growth factor receptor 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=692,P35968,Vascular endothelial growth factor receptor 2,3791.0,KDR,9606.0,Homo sapiens (human),,IC50 (nM),90,PMID:10602697|DOI:10.1021/jm9904295,https://www.ncbi.nlm.nih.gov/pubmed/10602697|https://doi.org/10.1021/jm9904295,10602697,10.1021/jm9904295,
1867,1690597,5329148,BindingDB,3-Substituted indolin-2-one 16d,4898,"3-(2,4-dimethyl-5-{[(3Z)-2-oxo-5-sulfamoyl-2,3-dihydro-1H-indol-3-ylidene]methyl}-1H-pyrrol-3-yl)propanoic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=4898,575,Platelet-derived growth factor receptor beta,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=575,P09619,Platelet-derived growth factor receptor beta,5159.0,PDGFRB,9606.0,Homo sapiens (human),,IC50 (nM),1530,PMID:10602697|DOI:10.1021/jm9904295,https://www.ncbi.nlm.nih.gov/pubmed/10602697|https://doi.org/10.1021/jm9904295,10602697,10.1021/jm9904295,
1868,1690598,5329149,BindingDB,3-Substituted indolin-2-one 16e,4899,"3-(5-{[(3Z)-6-methoxy-2-oxo-2,3-dihydro-1H-indol-3-ylidene]methyl}-2,4-dimethyl-1H-pyrrol-3-yl)propanoic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=4899,575,Platelet-derived growth factor receptor beta,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=575,P09619,Platelet-derived growth factor receptor beta,5159.0,PDGFRB,9606.0,Homo sapiens (human),,IC50 (nM),550,PMID:10602697|DOI:10.1021/jm9904295,https://www.ncbi.nlm.nih.gov/pubmed/10602697|https://doi.org/10.1021/jm9904295,10602697,10.1021/jm9904295,
1869,1690599,5329149,BindingDB,3-Substituted indolin-2-one 16e,4899,"3-(5-{[(3Z)-6-methoxy-2-oxo-2,3-dihydro-1H-indol-3-ylidene]methyl}-2,4-dimethyl-1H-pyrrol-3-yl)propanoic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=4899,520,Epidermal growth factor receptor,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=520,P00533,Epidermal growth factor receptor,1956.0,EGFR,9606.0,Homo sapiens (human),,IC50 (nM),>100000,PMID:10602697|DOI:10.1021/jm9904295,https://www.ncbi.nlm.nih.gov/pubmed/10602697|https://doi.org/10.1021/jm9904295,10602697,10.1021/jm9904295,
1870,1690600,5329149,BindingDB,3-Substituted indolin-2-one 16e,4899,"3-(5-{[(3Z)-6-methoxy-2-oxo-2,3-dihydro-1H-indol-3-ylidene]methyl}-2,4-dimethyl-1H-pyrrol-3-yl)propanoic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=4899,692,Vascular endothelial growth factor receptor 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=692,P35968,Vascular endothelial growth factor receptor 2,3791.0,KDR,9606.0,Homo sapiens (human),,IC50 (nM),8290,PMID:10602697|DOI:10.1021/jm9904295,https://www.ncbi.nlm.nih.gov/pubmed/10602697|https://doi.org/10.1021/jm9904295,10602697,10.1021/jm9904295,
1871,1690601,5329149,BindingDB,3-Substituted indolin-2-one 16e,4899,"3-(5-{[(3Z)-6-methoxy-2-oxo-2,3-dihydro-1H-indol-3-ylidene]methyl}-2,4-dimethyl-1H-pyrrol-3-yl)propanoic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=4899,694,Fibroblast growth factor receptor 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=694,P11362,Fibroblast growth factor receptor 1,2260.0,FGFR1,9606.0,Homo sapiens (human),,IC50 (nM),5400,PMID:10602697|DOI:10.1021/jm9904295,https://www.ncbi.nlm.nih.gov/pubmed/10602697|https://doi.org/10.1021/jm9904295,10602697,10.1021/jm9904295,
1872,1690602,5329150,BindingDB,"(Z)-3-(2,4-dimethyl-5-((2-oxo-6-phenylindolin-3-ylidene)methyl)-1H-pyrrol-3-yl)propanoic acid",4900,"3-(2,4-dimethyl-5-{[(3Z)-2-oxo-6-phenyl-2,3-dihydro-1H-indol-3-ylidene]methyl}-1H-pyrrol-3-yl)propanoic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=4900,694,Fibroblast growth factor receptor 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=694,P11362,Fibroblast growth factor receptor 1,2260.0,FGFR1,9606.0,Homo sapiens (human),,IC50 (nM),2290,PMID:10602697|DOI:10.1021/jm9904295,https://www.ncbi.nlm.nih.gov/pubmed/10602697|https://doi.org/10.1021/jm9904295,10602697,10.1021/jm9904295,
1873,1691157,5329156,BindingDB,Indolin-2-one deriv. 4c,4906,"(3Z)-2-oxo-3-(4,5,6,7-tetrahydro-1H-indol-2-ylmethylidene)-2,3-dihydro-1H-indole-5-sulfonamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=4906,13,Proto-oncogene tyrosine-protein kinase Src,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=13,P12931,Proto-oncogene tyrosine-protein kinase Src,6714.0,SRC,9606.0,Homo sapiens (human),,IC50 (nM),80,PMID:10893303|DOI:10.1021/jm9906116,https://www.ncbi.nlm.nih.gov/pubmed/10893303|https://doi.org/10.1021/jm9906116,10893303,10.1021/jm9906116,
1874,1691158,5329156,BindingDB,Indolin-2-one deriv. 4c,4906,"(3Z)-2-oxo-3-(4,5,6,7-tetrahydro-1H-indol-2-ylmethylidene)-2,3-dihydro-1H-indole-5-sulfonamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=4906,575,Platelet-derived growth factor receptor beta,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=575,P09619,Platelet-derived growth factor receptor beta,5159.0,PDGFRB,9606.0,Homo sapiens (human),,IC50 (nM),11500,PMID:10893303|DOI:10.1021/jm9906116,https://www.ncbi.nlm.nih.gov/pubmed/10893303|https://doi.org/10.1021/jm9906116,10893303,10.1021/jm9906116,
1875,1691159,5329156,BindingDB,Indolin-2-one deriv. 4c,4906,"(3Z)-2-oxo-3-(4,5,6,7-tetrahydro-1H-indol-2-ylmethylidene)-2,3-dihydro-1H-indole-5-sulfonamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=4906,520,Epidermal growth factor receptor,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=520,P00533,Epidermal growth factor receptor,1956.0,EGFR,9606.0,Homo sapiens (human),,IC50 (nM),>100000,PMID:10893303|DOI:10.1021/jm9906116,https://www.ncbi.nlm.nih.gov/pubmed/10893303|https://doi.org/10.1021/jm9906116,10893303,10.1021/jm9906116,
1876,1691160,5329156,BindingDB,Indolin-2-one deriv. 4c,4906,"(3Z)-2-oxo-3-(4,5,6,7-tetrahydro-1H-indol-2-ylmethylidene)-2,3-dihydro-1H-indole-5-sulfonamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=4906,692,Vascular endothelial growth factor receptor 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=692,P35968,Vascular endothelial growth factor receptor 2,3791.0,KDR,9606.0,Homo sapiens (human),,IC50 (nM),30,PMID:10893303|DOI:10.1021/jm9906116,https://www.ncbi.nlm.nih.gov/pubmed/10893303|https://doi.org/10.1021/jm9906116,10893303,10.1021/jm9906116,
1877,1692157,5329166,BindingDB,Indolin-2-one deriv. 9d,4917,"(3Z)-3-{[3-(2-carboxyethyl)-4,5,6,7-tetrahydro-1H-indol-2-yl]methylidene}-2-oxo-2,3-dihydro-1H-indole-5-carboxylic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=4917,13,Proto-oncogene tyrosine-protein kinase Src,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=13,P12931,Proto-oncogene tyrosine-protein kinase Src,6714.0,SRC,9606.0,Homo sapiens (human),,IC50 (nM),60,PMID:10893303|DOI:10.1021/jm9906116,https://www.ncbi.nlm.nih.gov/pubmed/10893303|https://doi.org/10.1021/jm9906116,10893303,10.1021/jm9906116,
1878,1692158,5329166,BindingDB,Indolin-2-one deriv. 9d,4917,"(3Z)-3-{[3-(2-carboxyethyl)-4,5,6,7-tetrahydro-1H-indol-2-yl]methylidene}-2-oxo-2,3-dihydro-1H-indole-5-carboxylic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=4917,520,Epidermal growth factor receptor,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=520,P00533,Epidermal growth factor receptor,1956.0,EGFR,9606.0,Homo sapiens (human),,IC50 (nM),56500,PMID:10893303|DOI:10.1021/jm9906116,https://www.ncbi.nlm.nih.gov/pubmed/10893303|https://doi.org/10.1021/jm9906116,10893303,10.1021/jm9906116,
1879,1692784,5329172,BindingDB,Carboxamide deriv. 4x,4955,"(2R,3R,4S)-4-amino-2-{[2-(dimethylamino)ethyl](2-phenylethyl)carbamoyl}-3-acetamido-3,4-dihydro-2H-pyran-6-carboxylic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=4955,751,Neuraminidase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=751,Q6XUE4,Neuraminidase,,,382781.0,Influenza A virus (A/Singapore/1/1957(H2N2)),,IC50 (nM),>300000,PMID:9526555|DOI:10.1021/jm970374b,https://www.ncbi.nlm.nih.gov/pubmed/9526555|https://doi.org/10.1021/jm970374b,9526555,10.1021/jm970374b,
1880,1692785,5329173,BindingDB,Carboxamide deriv. 4ap,4973,"(2R,3R,4S)-4-amino-3-acetamido-2-(pyrrolidin-1-ylcarbonyl)-3,4-dihydro-2H-pyran-6-carboxylic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=4973,751,Neuraminidase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=751,Q6XUE4,Neuraminidase,,,382781.0,Influenza A virus (A/Singapore/1/1957(H2N2)),,IC50 (nM),2900,PMID:9526555|DOI:10.1021/jm970374b,https://www.ncbi.nlm.nih.gov/pubmed/9526555|https://doi.org/10.1021/jm970374b,9526555,10.1021/jm970374b,
1881,1692786,5329174,BindingDB,Carboxamide deriv. 4aq,4974,"(2R,3R,4S)-4-amino-3-acetamido-2-[(2-methylpyrrolidin-1-yl)carbonyl]-3,4-dihydro-2H-pyran-6-carboxylic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=4974,751,Neuraminidase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=751,Q6XUE4,Neuraminidase,,,382781.0,Influenza A virus (A/Singapore/1/1957(H2N2)),,IC50 (nM),310,PMID:9526555|DOI:10.1021/jm970374b,https://www.ncbi.nlm.nih.gov/pubmed/9526555|https://doi.org/10.1021/jm970374b,9526555,10.1021/jm970374b,
1882,1692787,5329174,BindingDB,Carboxamide deriv. 4aq,4974,"(2R,3R,4S)-4-amino-3-acetamido-2-[(2-methylpyrrolidin-1-yl)carbonyl]-3,4-dihydro-2H-pyran-6-carboxylic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=4974,752,Neuraminidase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=752,P16207,Neuraminidase,,,11547.0,Influenza B virus (STRAIN B/VICTORIA/3/85),,IC50 (nM),210000,PMID:9526555|DOI:10.1021/jm970374b,https://www.ncbi.nlm.nih.gov/pubmed/9526555|https://doi.org/10.1021/jm970374b,9526555,10.1021/jm970374b,
1883,1692788,5329175,BindingDB,"(2R,3R,4S)-4-amino-2-{[(2R,5R)-2,5-dimethylpyrrolidin-1-yl]carbonyl}-3-acetamido-3,4-dihydro-2H-pyran-6-carboxylic acid",4976,"(2R,3R,4S)-4-amino-2-{[(2R,5R)-2,5-dimethylpyrrolidin-1-yl]carbonyl}-3-acetamido-3,4-dihydro-2H-pyran-6-carboxylic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=4976,752,Neuraminidase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=752,P16207,Neuraminidase,,,11547.0,Influenza B virus (STRAIN B/VICTORIA/3/85),,IC50 (nM),4700,PMID:9526555|DOI:10.1021/jm970374b,https://www.ncbi.nlm.nih.gov/pubmed/9526555|https://doi.org/10.1021/jm970374b,9526555,10.1021/jm970374b,
1884,1692789,5329175,BindingDB,"(2R,3R,4S)-4-amino-2-{[(2R,5R)-2,5-dimethylpyrrolidin-1-yl]carbonyl}-3-acetamido-3,4-dihydro-2H-pyran-6-carboxylic acid",4976,"(2R,3R,4S)-4-amino-2-{[(2R,5R)-2,5-dimethylpyrrolidin-1-yl]carbonyl}-3-acetamido-3,4-dihydro-2H-pyran-6-carboxylic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=4976,751,Neuraminidase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=751,Q6XUE4,Neuraminidase,,,382781.0,Influenza A virus (A/Singapore/1/1957(H2N2)),,IC50 (nM),110,PMID:9526555|DOI:10.1021/jm970374b,https://www.ncbi.nlm.nih.gov/pubmed/9526555|https://doi.org/10.1021/jm970374b,9526555,10.1021/jm970374b,
1885,1692790,5329176,BindingDB,"(2R,3R,4S)-4-amino-2-{[(2S,5S)-2,5-dimethylpyrrolidin-1-yl]carbonyl}-3-acetamido-3,4-dihydro-2H-pyran-6-carboxylic acid",4977,"(2R,3R,4S)-4-amino-2-{[(2S,5S)-2,5-dimethylpyrrolidin-1-yl]carbonyl}-3-acetamido-3,4-dihydro-2H-pyran-6-carboxylic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=4977,751,Neuraminidase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=751,Q6XUE4,Neuraminidase,,,382781.0,Influenza A virus (A/Singapore/1/1957(H2N2)),,IC50 (nM),110,PMID:9526555|DOI:10.1021/jm970374b,https://www.ncbi.nlm.nih.gov/pubmed/9526555|https://doi.org/10.1021/jm970374b,9526555,10.1021/jm970374b,
1886,1693366,5331325,Comparative Toxicogenomics Database (CTD),4-hydroxy-N-[(E)-(4-propan-2-ylphenyl)methylideneamino]benzamide,C545235,GSK 4716,https://ctdbase.org/detail.go?type=chem&acc=C545235,2104,ESRRG,https://ctdbase.org/detail.go?type=gene&acc=2104,,,2104.0,ESRRG,9606.0,Homo sapiens (human),GSK 4716 binds to ESRRG protein,,,PMID:21958216,https://www.ncbi.nlm.nih.gov/pubmed/21958216,21958216,,
1887,1693367,5331386,BindingDB,3-chloro-N-[(Z)-(2-methylcyclohexylidene)amino]-1-benzothiophene-2-carboxamide,163680,3&#8208;Chloro&#8208;N&#39;&#8208;[(1Z)&#8208;2&#8208;methylcyclohexylidene]&#8208;1&#8208; benzothiophene&#8208;2&#8208;carbohydrazide (0154),https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=163680,7342,N-glycosylase/DNA lyase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=7342,O15527,N-glycosylase/DNA lyase,4968.0,OGG1,9606.0,Homo sapiens (human),,IC50 (nM),3.7e+2,PMID:26218629|DOI:10.1021/acschembio.5b00452,https://www.ncbi.nlm.nih.gov/pubmed/26218629|https://doi.org/10.1021/acschembio.5b00452,26218629,10.1021/acschembio.5b00452,
1888,1693368,5331386,BindingDB,3-chloro-N-[(Z)-(2-methylcyclohexylidene)amino]-1-benzothiophene-2-carboxamide,163680,3&#8208;Chloro&#8208;N&#39;&#8208;[(1Z)&#8208;2&#8208;methylcyclohexylidene]&#8208;1&#8208; benzothiophene&#8208;2&#8208;carbohydrazide (0154),https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=163680,7342,N-glycosylase/DNA lyase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=7342,O15527,N-glycosylase/DNA lyase,4968.0,OGG1,9606.0,Homo sapiens (human),,IC50 (nM),2.7e+2,PMID:26218629|DOI:10.1021/acschembio.5b00452,https://www.ncbi.nlm.nih.gov/pubmed/26218629|https://doi.org/10.1021/acschembio.5b00452,26218629,10.1021/acschembio.5b00452,
1889,1693369,5331416,Drug Gene Interaction database (DGIdb),benzaldehyde O-4-methoxyphenylcarbamoyl oxime,,CHEMBL:CHEMBL599469,https://www.dgidb.org/drugs/chembl:CHEMBL599469,,NPC1,https://www.dgidb.org/genes/hgnc:7897,,,4864.0,NPC1,9606.0,Homo sapiens (human),,,,,,,,
1890,1693370,5331459,BindingDB,3-bromo-N-[(Z)-hex-5-en-2-ylideneamino]benzamide,163689,3&#8208;Bromo&#8208;N&#39;&#8208;[(2Z)&#8208;hex&#8208;5&#8208;en&#8208;2&#8208;ylidene]benzohydrazide (0155),https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=163689,7342,N-glycosylase/DNA lyase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=7342,O15527,N-glycosylase/DNA lyase,4968.0,OGG1,9606.0,Homo sapiens (human),,IC50 (nM),3.78e+3,PMID:26218629|DOI:10.1021/acschembio.5b00452,https://www.ncbi.nlm.nih.gov/pubmed/26218629|https://doi.org/10.1021/acschembio.5b00452,26218629,10.1021/acschembio.5b00452,
1891,1693371,5331479,BindingDB,3-bromo-N-[(Z)-hexan-2-ylideneamino]benzamide,163690,3&#8208;Bromo&#8208;N&#39;&#8208;[(2Z)&#8208;hexan&#8208;2&#8208;ylidene]benzohydrazide (0156),https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=163690,7342,N-glycosylase/DNA lyase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=7342,O15527,N-glycosylase/DNA lyase,4968.0,OGG1,9606.0,Homo sapiens (human),,IC50 (nM),2.13e+3,PMID:26218629|DOI:10.1021/acschembio.5b00452,https://www.ncbi.nlm.nih.gov/pubmed/26218629|https://doi.org/10.1021/acschembio.5b00452,26218629,10.1021/acschembio.5b00452,
1892,1693372,5333989,BindingDB,,173592,"(E)-2-((E)-(3,5-Dichloro-2-hydroxybenzylidene)hydrazono)thiazolidin-4-one (5)",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=173592,2721,Urease subunit alpha,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2721,P41020,Urease subunit alpha,,,1474.0,Sporosarcina pasteurii,,IC50 (nM),2.671e+4,PMID:26520885|DOI:10.1016/j.bioorg.2015.10.005,https://www.ncbi.nlm.nih.gov/pubmed/26520885|https://doi.org/10.1016/j.bioorg.2015.10.005,26520885,10.1016/j.bioorg.2015.10.005,
1893,1694573,5357402,Comparative Toxicogenomics Database (CTD),Triphenyltin hydride,C030665,triphenyltin,https://ctdbase.org/detail.go?type=chem&acc=C030665,1588,CYP19A1,https://ctdbase.org/detail.go?type=gene&acc=1588,,,1588.0,CYP19A1,9606.0,Homo sapiens (human),Triphenyltin results in decreased expression of CYP19A1 mRNA,,,PMID:29549738,https://www.ncbi.nlm.nih.gov/pubmed/29549738,29549738,,
